Citrus Sinensis ID: 007967
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 583 | 2.2.26 [Sep-21-2011] | |||||||
| Q551H4 | 1028 | Serine/threonine-protein | yes | no | 0.418 | 0.237 | 0.554 | 1e-80 | |
| Q5R495 | 527 | Serine/threonine-protein | yes | no | 0.411 | 0.455 | 0.513 | 5e-71 | |
| Q9Z1W9 | 556 | STE20/SPS1-related prolin | yes | no | 0.411 | 0.431 | 0.521 | 6e-71 | |
| Q9UEW8 | 545 | STE20/SPS1-related prolin | yes | no | 0.411 | 0.440 | 0.521 | 8e-71 | |
| O88506 | 553 | STE20/SPS1-related prolin | no | no | 0.411 | 0.433 | 0.521 | 8e-71 | |
| O95747 | 527 | Serine/threonine-protein | no | no | 0.411 | 0.455 | 0.513 | 1e-70 | |
| Q863I2 | 529 | Serine/threonine-protein | no | no | 0.411 | 0.453 | 0.509 | 1e-70 | |
| Q6P9R2 | 527 | Serine/threonine-protein | no | no | 0.411 | 0.455 | 0.509 | 4e-70 | |
| O61122 | 478 | Serine/threonine-protein | no | no | 0.351 | 0.428 | 0.509 | 5e-55 | |
| Q9Y6E0 | 443 | Serine/threonine-protein | no | no | 0.344 | 0.453 | 0.504 | 1e-52 |
| >sp|Q551H4|FRAY2_DICDI Serine/threonine-protein kinase fray2 OS=Dictyostelium discoideum GN=fray2 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 301 bits (771), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 137/247 (55%), Positives = 179/247 (72%), Gaps = 3/247 (1%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSL HPNV+ + SFV + +LWV+M F++ GSC +M+ ++ GFEE I +ILKE LK
Sbjct: 122 MSLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFSFPQGFEEHVIATILKEALK 181
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A+ Y H+ G IHRD+K+GNIL+D+NG ++L+DFGVSA + DTG+ SRNTFVGTPCWMA
Sbjct: 182 AICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGVSATLIDTGET--SRNTFVGTPCWMA 239
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+++ Y+ DIWSFGITALELA G APF++YPPMKVLL+T+QN PP L+ D + K
Sbjct: 240 PEIME-QVNYDYAVDIWSFGITALELARGKAPFAEYPPMKVLLLTLQNPPPSLEGDGESK 298
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
+S SFK++V CL KD +KRP KLL+H FFK AK P+ V+ + A LPPL R + L
Sbjct: 299 WSHSFKDLVEKCLQKDPSKRPLPSKLLEHRFFKQAKKPDYLVQHILAKLPPLGQRYQMLS 358
Query: 241 LKDAAQL 247
A L
Sbjct: 359 EDSFAML 365
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5R495|OXSR1_PONAB Serine/threonine-protein kinase OSR1 OS=Pongo abelii GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (687), Expect = 5e-71, Method: Compositional matrix adjust.
Identities = 130/253 (51%), Positives = 171/253 (67%), Gaps = 13/253 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG------FEESAIGSI 54
MS HPN++ Y SFVV LW+VM ++ GS L ++K G +ES I +I
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
L+E L+ L+YLH+ G IHRDVKAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KADIWSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 173 L-----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L D + KK+ KSF++M+++CL KD KRPTA +LL+H FF+ AK E +K+
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQ 306
Query: 228 DLPPLWNRVKALQ 240
P + R K ++
Sbjct: 307 RAPTISERAKKVR 319
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z1W9|STK39_MOUSE STE20/SPS1-related proline-alanine-rich protein kinase OS=Mus musculus GN=Stk39 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (687), Expect = 6e-71, Method: Compositional matrix adjust.
Identities = 132/253 (52%), Positives = 172/253 (67%), Gaps = 13/253 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG------FEESAIGSI 54
MS HPNV+ Y SFVV LW+VM ++ GS L ++K G EE+ I +I
Sbjct: 125 MSQCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATI 184
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
LKE L+ LDYLHR G IHRD+KAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 185 LKEVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTF 244
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KAD+WSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 245 VGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPT 304
Query: 173 L-----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L D + KK+ KSF++++++CL KD +KRPTA +LLK FF+ AK E ++KL
Sbjct: 305 LETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLT 364
Query: 228 DLPPLWNRVKALQ 240
P + R K ++
Sbjct: 365 RTPDIAQRAKKVR 377
|
May act as a mediator of stress-activated signals. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UEW8|STK39_HUMAN STE20/SPS1-related proline-alanine-rich protein kinase OS=Homo sapiens GN=STK39 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 132/253 (52%), Positives = 172/253 (67%), Gaps = 13/253 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG------FEESAIGSI 54
MS HPNV+ Y SFVV LW+VM ++ GS L ++K G EE+ I +I
Sbjct: 113 MSQCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATI 172
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
LKE L+ LDYLHR G IHRD+KAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 173 LKEVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTF 232
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KAD+WSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 233 VGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPT 292
Query: 173 L-----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L D + KK+ KSF++++++CL KD +KRPTA +LLK FF+ AK E ++KL
Sbjct: 293 LETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLT 352
Query: 228 DLPPLWNRVKALQ 240
P + R K ++
Sbjct: 353 RTPDIAQRAKKVR 365
|
May act as a mediator of stress-activated signals. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88506|STK39_RAT STE20/SPS1-related proline-alanine-rich protein kinase OS=Rattus norvegicus GN=Stk39 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 8e-71, Method: Compositional matrix adjust.
Identities = 132/253 (52%), Positives = 172/253 (67%), Gaps = 13/253 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG------FEESAIGSI 54
MS HPNV+ Y SFVV LW+VM ++ GS L ++K G EE+ I +I
Sbjct: 122 MSQCSHPNVVTYYTSFVVKDELWLVMKLLSGGSMLDIIKYIVNRGEHKNGVLEEAIIATI 181
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
LKE L+ LDYLHR G IHRD+KAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 182 LKEVLEGLDYLHRNGQIHRDLKAGNILLGEDGSVQIADFGVSAFLATGGDVTRNKVRKTF 241
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KAD+WSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 242 VGTPCWMAPEVMEQVRGYDFKADMWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPT 301
Query: 173 L-----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L D + KK+ KSF++++++CL KD +KRPTA +LLK FF+ AK E ++KL
Sbjct: 302 LETGVEDKEMMKKYGKSFRKLLSLCLQKDPSKRPTAAELLKCKFFQKAKNREYLIEKLLT 361
Query: 228 DLPPLWNRVKALQ 240
P + R K ++
Sbjct: 362 RTPDIAQRAKKVR 374
|
May act as a mediator of stress-activated signals. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O95747|OXSR1_HUMAN Serine/threonine-protein kinase OSR1 OS=Homo sapiens GN=OXSR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 130/253 (51%), Positives = 170/253 (67%), Gaps = 13/253 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG------FEESAIGSI 54
MS HPN++ Y SFVV LW+VM ++ GS L ++K G +ES I +I
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
L+E L+ L+YLH+ G IHRDVKAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KADIWSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 173 L-----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L D + KK+ KSF++M+++CL KD KRPTA +LL+H FF+ AK E +K
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKTLQ 306
Query: 228 DLPPLWNRVKALQ 240
P + R K ++
Sbjct: 307 RAPTISERAKKVR 319
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q863I2|OXSR1_PIG Serine/threonine-protein kinase OSR1 OS=Sus scrofa GN=OXSR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 129/253 (50%), Positives = 171/253 (67%), Gaps = 13/253 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG------FEESAIGSI 54
MS HPN++ Y SFVV LW+VM ++ GS L ++K G +E+ I +I
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEATIATI 126
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
L+E L+ L+YLH+ G IHRDVKAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KADIWSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 173 L-----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L D + KK+ KSF++M+++CL KD KRPTA +LL+H FF+ AK E +K+
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEYLQEKILQ 306
Query: 228 DLPPLWNRVKALQ 240
P + R K ++
Sbjct: 307 RAPTISERAKKVR 319
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P9R2|OXSR1_MOUSE Serine/threonine-protein kinase OSR1 OS=Mus musculus GN=Oxsr1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (679), Expect = 4e-70, Method: Compositional matrix adjust.
Identities = 129/253 (50%), Positives = 170/253 (67%), Gaps = 13/253 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG------FEESAIGSI 54
MS HPN++ Y SFVV LW+VM ++ GS L ++K G +E I +I
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATI 126
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
L+E L+ L+YLH+ G IHRDVKAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KADIWSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 173 L-----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L D + KK+ KSF++M+++CL KD KRPTA +LL+H FF+ AK E +K+
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQ 306
Query: 228 DLPPLWNRVKALQ 240
P + R K ++
Sbjct: 307 RAPTISERSKKVR 319
|
Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O61122|SVKA_DICDI Serine/threonine-protein kinase svkA OS=Dictyostelium discoideum GN=svkA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 110/216 (50%), Positives = 143/216 (66%), Gaps = 11/216 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S + P V + + SF+ S LW++M ++A GS L LMK F+E I IL+E LK
Sbjct: 62 LSQCESPFVTKYFGSFLKGSKLWIIMEYLAGGSVLDLMKPG---PFDEGYIAIILRELLK 118
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+YLH +G IHRD+KA N+LL +G VKLADFGVS + D+ RNTFVGTP WMA
Sbjct: 119 GLEYLHSEGKIHRDIKAANVLLSASGDVKLADFGVSGQL---TDQMTKRNTFVGTPFWMA 175
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV++ +GY+SKADIWS GITALE+A G P + PM+ L + ++ PP L+ +
Sbjct: 176 PEVIK-QTGYDSKADIWSMGITALEMAKGEPPRADLHPMRALFLIPKDPPPTLEGN---- 230
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216
FSK FKE A+CL KD +RPTA+ LLKH F K AK
Sbjct: 231 FSKGFKEFCALCLNKDPNQRPTAKDLLKHKFIKAAK 266
|
Involved in regulation of actin cytoskeleton organization during cell motility; F-actin fragmenting and capping protein allowing dynamic rearrangements of the actin cytoskeleton. Also part of a regulatory pathway from the centrosome to the midzone, thus regulating the completion of cell division. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y6E0|STK24_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (529), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 107/212 (50%), Positives = 141/212 (66%), Gaps = 11/212 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S D P V + Y S++ D+ LW++M ++ GS L L++ D E+ I +IL+E LK
Sbjct: 86 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD---ETQIATILREILK 142
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
LDYLH + IHRD+KA N+LL +G VKLADFGV+ + DT Q RNTFVGTP WMA
Sbjct: 143 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKRNTFVGTPFWMA 199
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV++ S Y+SKADIWS GITA+ELA G P S+ PMKVL + +N PP L+ +
Sbjct: 200 PEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN---- 254
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
+SK KE V CL K+ + RPTA++LLKH F
Sbjct: 255 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 286
|
Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12. May act as a key regulator of axon regeneration in the optic nerve and radial nerve. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 583 | ||||||
| 359474143 | 732 | PREDICTED: uncharacterized protein LOC10 | 0.993 | 0.790 | 0.798 | 0.0 | |
| 297742429 | 729 | unnamed protein product [Vitis vinifera] | 0.993 | 0.794 | 0.798 | 0.0 | |
| 224058006 | 703 | predicted protein [Populus trichocarpa] | 0.962 | 0.798 | 0.789 | 0.0 | |
| 147822174 | 1077 | hypothetical protein VITISV_039089 [Viti | 0.993 | 0.537 | 0.796 | 0.0 | |
| 255555729 | 706 | serine/threonine protein kinase, putativ | 0.955 | 0.788 | 0.785 | 0.0 | |
| 224072289 | 674 | predicted protein [Populus trichocarpa] | 0.926 | 0.801 | 0.756 | 0.0 | |
| 356576612 | 704 | PREDICTED: uncharacterized protein LOC10 | 0.957 | 0.792 | 0.738 | 0.0 | |
| 307136083 | 714 | serine/threonine protein kinase [Cucumis | 0.965 | 0.788 | 0.742 | 0.0 | |
| 356535280 | 699 | PREDICTED: uncharacterized protein LOC10 | 0.950 | 0.792 | 0.738 | 0.0 | |
| 449456791 | 714 | PREDICTED: uncharacterized protein LOC10 | 0.965 | 0.788 | 0.741 | 0.0 |
| >gi|359474143|ref|XP_002280701.2| PREDICTED: uncharacterized protein LOC100249628 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2415), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/586 (79%), Positives = 513/586 (87%), Gaps = 7/586 (1%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPNVI+AYCSFVV+ NLWVVMPFMAEGSCLHLMKIAY DGFEESAIGSILKETLK
Sbjct: 71 MSLIDHPNVIKAYCSFVVERNLWVVMPFMAEGSCLHLMKIAYTDGFEESAIGSILKETLK 130
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLHR GHIHRDVKAGNILLD+NGVVKLADFGVSACMFD GDRQRSRNTFVGTPCWMA
Sbjct: 131 ALEYLHRHGHIHRDVKAGNILLDSNGVVKLADFGVSACMFDKGDRQRSRNTFVGTPCWMA 190
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPGSGY+ KADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK
Sbjct: 191 PEVLQPGSGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 250
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK AKPPELSVKKLFA+LPPLW RVKALQ
Sbjct: 251 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKQAKPPELSVKKLFAELPPLWQRVKALQ 310
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
LKDAAQLALKKMPSAEQEAISQSEY+RGVSAWNFDIEDLK QASLV+DDD++ E +EE+E
Sbjct: 311 LKDAAQLALKKMPSAEQEAISQSEYKRGVSAWNFDIEDLKVQASLVQDDDEIQEMREEDE 370
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQLYESLNKKGKALEGDSLD-R 359
S+KS V K + + SLGKS S + + R ++L E L+KKGK+L DSL+
Sbjct: 371 SMKSFVIDKDSSDSRSSLGKSISTND-NFFRGRITGDELAQAECLSKKGKSLRSDSLESS 429
Query: 360 NQENIALRKNGSSTEEMASTSEKDTM--QTKAKAVKSRHTQSGPLMPGMLLSHSSSERAR 417
NQE I K+ SS E M STSEKD + +TK + VK R TQSGPLMPG++LSHS S+R R
Sbjct: 430 NQEKIGQEKDISSAEMMPSTSEKDMVNAKTKTQMVKGRQTQSGPLMPGVVLSHSLSDRGR 489
Query: 418 NSERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKSK 477
+ ER E E QP TEK+NREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDS+++KSK
Sbjct: 490 SFERSENEIQPITEKANREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSLEEKSK 549
Query: 478 ANLVQIKGRFSVTSENLDLVKDIPLSTVPRR-SQGSPLRKSASVGDWIFESKQVPTSPSS 536
ANLVQIKGRFSVTSEN+DLVKDIPL V RR SQGSPLRKSASVGDW+F+SK + T+P
Sbjct: 550 ANLVQIKGRFSVTSENVDLVKDIPLCAVARRSSQGSPLRKSASVGDWMFDSKPMLTTP-- 607
Query: 537 KDLNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLDG 582
KD +N +VPAS+LMPHLQNLFQQTS QQDLI NLLNSLQ +E++D
Sbjct: 608 KDFSNSNVPASLLMPHLQNLFQQTSLQQDLITNLLNSLQSSEIVDA 653
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742429|emb|CBI34578.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2414), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/586 (79%), Positives = 513/586 (87%), Gaps = 7/586 (1%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPNVI+AYCSFVV+ NLWVVMPFMAEGSCLHLMKIAY DGFEESAIGSILKETLK
Sbjct: 68 MSLIDHPNVIKAYCSFVVERNLWVVMPFMAEGSCLHLMKIAYTDGFEESAIGSILKETLK 127
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLHR GHIHRDVKAGNILLD+NGVVKLADFGVSACMFD GDRQRSRNTFVGTPCWMA
Sbjct: 128 ALEYLHRHGHIHRDVKAGNILLDSNGVVKLADFGVSACMFDKGDRQRSRNTFVGTPCWMA 187
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPGSGY+ KADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK
Sbjct: 188 PEVLQPGSGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 247
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK AKPPELSVKKLFA+LPPLW RVKALQ
Sbjct: 248 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKQAKPPELSVKKLFAELPPLWQRVKALQ 307
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
LKDAAQLALKKMPSAEQEAISQSEY+RGVSAWNFDIEDLK QASLV+DDD++ E +EE+E
Sbjct: 308 LKDAAQLALKKMPSAEQEAISQSEYKRGVSAWNFDIEDLKVQASLVQDDDEIQEMREEDE 367
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQLYESLNKKGKALEGDSLD-R 359
S+KS V K + + SLGKS S + + R ++L E L+KKGK+L DSL+
Sbjct: 368 SMKSFVIDKDSSDSRSSLGKSISTND-NFFRGRITGDELAQAECLSKKGKSLRSDSLESS 426
Query: 360 NQENIALRKNGSSTEEMASTSEKDTM--QTKAKAVKSRHTQSGPLMPGMLLSHSSSERAR 417
NQE I K+ SS E M STSEKD + +TK + VK R TQSGPLMPG++LSHS S+R R
Sbjct: 427 NQEKIGQEKDISSAEMMPSTSEKDMVNAKTKTQMVKGRQTQSGPLMPGVVLSHSLSDRGR 486
Query: 418 NSERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKSK 477
+ ER E E QP TEK+NREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDS+++KSK
Sbjct: 487 SFERSENEIQPITEKANREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSLEEKSK 546
Query: 478 ANLVQIKGRFSVTSENLDLVKDIPLSTVPRR-SQGSPLRKSASVGDWIFESKQVPTSPSS 536
ANLVQIKGRFSVTSEN+DLVKDIPL V RR SQGSPLRKSASVGDW+F+SK + T+P
Sbjct: 547 ANLVQIKGRFSVTSENVDLVKDIPLCAVARRSSQGSPLRKSASVGDWMFDSKPMLTTP-- 604
Query: 537 KDLNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLDG 582
KD +N +VPAS+LMPHLQNLFQQTS QQDLI NLLNSLQ +E++D
Sbjct: 605 KDFSNSNVPASLLMPHLQNLFQQTSLQQDLITNLLNSLQSSEIVDA 650
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058006|ref|XP_002299433.1| predicted protein [Populus trichocarpa] gi|222846691|gb|EEE84238.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/583 (78%), Positives = 501/583 (85%), Gaps = 22/583 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPNVIRAYCSFVVD NLWVVMPFMAEGSCLHLMKIAYQ+GFEESAIGSILKETLK
Sbjct: 59 MSLIDHPNVIRAYCSFVVDQNLWVVMPFMAEGSCLHLMKIAYQEGFEESAIGSILKETLK 118
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLHRQGHIHRDVKAGNILLDTNG+VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA
Sbjct: 119 ALEYLHRQGHIHRDVKAGNILLDTNGIVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 178
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK
Sbjct: 179 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 238
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRPTAEKL+KHSFFK+AKPPELSVKKLFADLPPLWNRVKA+Q
Sbjct: 239 FSKSFKEMVAMCLVKDQTKRPTAEKLIKHSFFKNAKPPELSVKKLFADLPPLWNRVKAIQ 298
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
LKDAAQLALKKMPSAEQEA+SQSEYQRGVSAWNFD+EDLKAQASLVRDDDD+ ET+EE+E
Sbjct: 299 LKDAAQLALKKMPSAEQEALSQSEYQRGVSAWNFDLEDLKAQASLVRDDDDIPETREEDE 358
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQLYESLNKKGKALEGDSLDRN 360
S+K G K Q S G EL QA ++ +KGK E D L+ +
Sbjct: 359 SIKFG-GGKVINDRQLSGG------ELPQA------------DNFIRKGKLPESDLLETS 399
Query: 361 Q-ENIALRKNGSSTEEMASTSEKDTMQTKAKAVKSRHTQSGPLMPGMLLSHSSSERARNS 419
E + ++NGSS+E ASTSE Q KAK VKSR T SGPLMPG + SHS SER R S
Sbjct: 400 SLEKVGWKRNGSSSEAKASTSESVMAQAKAKTVKSRQTHSGPLMPGTVFSHSLSERGRTS 459
Query: 420 ERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKSKAN 479
ER E P E++ REVR+APSFSGPLMLPNRASANSLSAPIKSS G+RDS+D+KSK N
Sbjct: 460 ERFN-EIHPTAERATREVRKAPSFSGPLMLPNRASANSLSAPIKSSGGFRDSLDEKSKTN 518
Query: 480 LVQIKGRFSVTSENLDLVKDIPLSTVPRRSQGSPLRKSASVGDWIFESKQVPTSPSSKDL 539
LVQIKGRFSVTSENLDLVKDIPLSTVPRRS SPLRKSASVG+W+FE KQ+P + K++
Sbjct: 519 LVQIKGRFSVTSENLDLVKDIPLSTVPRRSSQSPLRKSASVGEWMFEPKQMPVNQPPKEV 578
Query: 540 NNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLDG 582
+N SV A +L+PHLQNLFQQTS QQD+IM+LLNSLQPAE ++
Sbjct: 579 SNNSVHA-LLLPHLQNLFQQTSIQQDIIMSLLNSLQPAEAIEA 620
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147822174|emb|CAN77043.1| hypothetical protein VITISV_039089 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 925 bits (2390), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/586 (79%), Positives = 512/586 (87%), Gaps = 7/586 (1%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPNVI+AYCSFVV+ NLWVVMPFMAEGSCLHLMKIAY DGFEESAIGSILKETLK
Sbjct: 187 MSLIDHPNVIKAYCSFVVERNLWVVMPFMAEGSCLHLMKIAYTDGFEESAIGSILKETLK 246
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLHR GHIHRDVKAGNILLD+NGVVKLADFGVSACMFD GDRQRSRNTFVGTPCWMA
Sbjct: 247 ALEYLHRHGHIHRDVKAGNILLDSNGVVKLADFGVSACMFDKGDRQRSRNTFVGTPCWMA 306
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPGSGY+ KADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK
Sbjct: 307 PEVLQPGSGYDFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 366
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK AKPPELSVKKLFA+LPPLW RVKALQ
Sbjct: 367 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKQAKPPELSVKKLFAELPPLWQRVKALQ 426
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
LKDAAQLALKKMPSAEQEAISQSEY+RGVSAWNFDIEDLK QASLV+DDD++ E +EE+E
Sbjct: 427 LKDAAQLALKKMPSAEQEAISQSEYKRGVSAWNFDIEDLKVQASLVQDDDEIQEMREEDE 486
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQLYESLNKKGKALEGDSLD-R 359
S+KS V K + + SLGKS S + + R ++L E L+KKGK+L DSL+
Sbjct: 487 SMKSFVIDKDSSDSRSSLGKSISTND-NFFRGRITGDELAQAECLSKKGKSLRSDSLESS 545
Query: 360 NQENIALRKNGSSTEEMASTSEKDTM--QTKAKAVKSRHTQSGPLMPGMLLSHSSSERAR 417
NQE I K+ SS E M STSEKD + +TK + VK R TQSGPLMPG++LSHS S+R R
Sbjct: 546 NQEKIGQEKDISSAEMMPSTSEKDMVNAKTKTQMVKGRQTQSGPLMPGVVLSHSLSDRGR 605
Query: 418 NSERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKSK 477
+ ER E E QP TEK+NREVRRAPSFSGPLMLP RASANSLSAPIKSSAGYRDS+++KSK
Sbjct: 606 SFERSENEIQPITEKANREVRRAPSFSGPLMLPXRASANSLSAPIKSSAGYRDSLEEKSK 665
Query: 478 ANLVQIKGRFSVTSENLDLVKDIPLSTVPRR-SQGSPLRKSASVGDWIFESKQVPTSPSS 536
ANLVQIKGRFSVTSEN+DLVKDIPL V RR SQGSPLRKSASVGDW+F+SK + T+P
Sbjct: 666 ANLVQIKGRFSVTSENVDLVKDIPLCAVARRSSQGSPLRKSASVGDWMFDSKPMLTTP-- 723
Query: 537 KDLNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLDG 582
KD +N +VPAS+LMPHLQNLFQQTS QQDLI NLLNSLQ +E++D
Sbjct: 724 KDFSNSNVPASLLMPHLQNLFQQTSLQQDLITNLLNSLQSSEIVDA 769
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555729|ref|XP_002518900.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223541887|gb|EEF43433.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 917 bits (2371), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/583 (78%), Positives = 497/583 (85%), Gaps = 26/583 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPNVIRA+CSFVVD NLWVVMPFM EGSCLHLMKIAY DGFEE+AI SILKETLK
Sbjct: 68 MSLIDHPNVIRAFCSFVVDRNLWVVMPFMDEGSCLHLMKIAYPDGFEEAAISSILKETLK 127
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
ALDYLH+QGHIHRDVKAGNILL+ NG+VKLADFGVSACMFDTGDRQR+RNTFVGTPCWMA
Sbjct: 128 ALDYLHQQGHIHRDVKAGNILLNRNGIVKLADFGVSACMFDTGDRQRARNTFVGTPCWMA 187
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK
Sbjct: 188 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 247
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ
Sbjct: 248 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 307
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
LKDAAQLALKKMPSAEQEA+SQSEYQRGVSAWNFDIEDLKAQASLVRDDDDM ET+EE E
Sbjct: 308 LKDAAQLALKKMPSAEQEALSQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMPETREEEE 367
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQLYESLNKKGKALEGDSLDRN 360
S++ SN ++ + E ++L SLN+KGK LE D L+
Sbjct: 368 SMRQC--------------GSNKVSIIHTVE-----DELPQAVSLNRKGKFLESDLLEAG 408
Query: 361 Q-ENIALRKNGSSTEEMASTSEKDTMQTKAKAVKSRHTQSGPLMPGMLLSHSSSERARNS 419
+ I +++GSS +E A TSEKD Q K KA KSR TQSGPL+PG +L HS S++ R
Sbjct: 409 YLDKIDSKRSGSSNDEKALTSEKDANQAKTKAAKSRQTQSGPLVPGAVLGHSLSDKGRFL 468
Query: 420 ERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKSKAN 479
ER P E++ REVR+APSFSGPLMLPNRASANSLSAPIKSS G+RDS+D+KSK N
Sbjct: 469 ERF-----PMAERTIREVRKAPSFSGPLMLPNRASANSLSAPIKSSGGFRDSLDEKSKTN 523
Query: 480 LVQIKGRFSVTSENLDLVKDIPLSTVPRR-SQGSPLRKSASVGDWIFESKQVPTSPSSKD 538
LVQIKGRFSVTSENLDLVKDIPLSTVPRR SQGSPLRKSASVGDW+FE KQ TS S K+
Sbjct: 524 LVQIKGRFSVTSENLDLVKDIPLSTVPRRSSQGSPLRKSASVGDWMFEPKQTSTSQSPKE 583
Query: 539 LNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLD 581
+ N S+PA +LMPHLQNLFQQTS QQDLI+NLL SLQPAE +D
Sbjct: 584 VINSSLPAPLLMPHLQNLFQQTSAQQDLIINLLMSLQPAEAVD 626
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224072289|ref|XP_002303687.1| predicted protein [Populus trichocarpa] gi|222841119|gb|EEE78666.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2280), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/587 (75%), Positives = 489/587 (83%), Gaps = 47/587 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPN+IRAYCSFVVD NLWVVMPFMAEGSCLHLMKIAY DGFEE AIGSILKETLK
Sbjct: 60 MSLIDHPNLIRAYCSFVVDHNLWVVMPFMAEGSCLHLMKIAYSDGFEEPAIGSILKETLK 119
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLH+QGHIHRDVKAGNILLDTNG VKLADFGVSACMFD GDRQRSRNTFVGTPCWMA
Sbjct: 120 ALEYLHQQGHIHRDVKAGNILLDTNGDVKLADFGVSACMFDAGDRQRSRNTFVGTPCWMA 179
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK
Sbjct: 180 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 239
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH KPPELSVKKLFADLPPLWNRVKA+Q
Sbjct: 240 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHVKPPELSVKKLFADLPPLWNRVKAIQ 299
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVR-DDDDMLETKEEN 299
LKDAAQLALKKMPSAEQEA+SQSEY RGVSAWNFD++DLKAQASLV+ DDDD+LET+EE+
Sbjct: 300 LKDAAQLALKKMPSAEQEALSQSEYHRGVSAWNFDLDDLKAQASLVQDDDDDILETREED 359
Query: 300 ESVKSSVGFKAGTGFQFSLGKSNSIAELSQAE-SRGPT-NQLQLYESLNKKGKALEGDSL 357
ES +E+ QAE SR + +L ++LN+KG+ E D L
Sbjct: 360 ES-----------------------SEMQQAEYSRQLSGGKLPRVDNLNRKGRLPESDLL 396
Query: 358 DR-NQENIALRKNGSSTEEMASTSEKDTMQTKAKAVKSRHTQSGPLMPGMLLSHSSSERA 416
+ +QE + ++NGSSTE ASTSE D MQ KAK VKSR T SGPLMPG +LSHS SER
Sbjct: 397 ETSSQEKVGWKRNGSSTEAKASTSENDVMQAKAKTVKSRQTLSGPLMPGTVLSHSLSERG 456
Query: 417 RNSERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKS 476
R SER P E++ RE+R+APSFSGPL+LPNRASANS SAPIKSS G+RDS+D+K
Sbjct: 457 RTSERS-----PTAERATREIRKAPSFSGPLILPNRASANSFSAPIKSSGGFRDSLDEKP 511
Query: 477 KANLVQIKGRFSVTSENLDLVKDIPLSTVPRRSQGSPLRKSASVGDWIFESKQVPTSPS- 535
K NLVQIKGRFSVTSENLDLVK SPL+KSASVG+W+FE KQ+P +
Sbjct: 512 KTNLVQIKGRFSVTSENLDLVK-------------SPLKKSASVGEWMFEPKQMPVNNQP 558
Query: 536 SKDLNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLDG 582
K++NN SVPA +L+PHLQNLFQQTS QQD+IMNLLNSLQPAE ++
Sbjct: 559 PKEVNNNSVPA-LLLPHLQNLFQQTSIQQDIIMNLLNSLQPAEAVEA 604
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576612|ref|XP_003556424.1| PREDICTED: uncharacterized protein LOC100783699 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2217), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/584 (73%), Positives = 478/584 (81%), Gaps = 26/584 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLI+HPNV+RAYCSFVV+ +LWVVM FMA+GSCLHLMK AY +GFEE+AIGSILKETLK
Sbjct: 65 MSLIEHPNVVRAYCSFVVERSLWVVMAFMAQGSCLHLMKAAYPEGFEEAAIGSILKETLK 124
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLHR GHIHRDVKAGNILLD NG VKLADFGVSACMFDTGDRQRSRNTFVGTPCW+A
Sbjct: 125 ALEYLHRHGHIHRDVKAGNILLDDNGQVKLADFGVSACMFDTGDRQRSRNTFVGTPCWIA 184
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPG+GYN KADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD+K
Sbjct: 185 PEVLQPGTGYNFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDRK 244
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRP+ EKLLKHSFFK AKPPELSVKKLFADLPPLWNRVK+LQ
Sbjct: 245 FSKSFKEMVAMCLVKDQTKRPSVEKLLKHSFFKQAKPPELSVKKLFADLPPLWNRVKSLQ 304
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
KDAAQLALKKMPSAEQEAISQSEY RGVSAWNFDI+DLKAQA+L++D DD+ E +EE+E
Sbjct: 305 HKDAAQLALKKMPSAEQEAISQSEYHRGVSAWNFDIDDLKAQAALMQDGDDIAEMREEDE 364
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQLYESLNKKGKALEGDSLDRN 360
+ K +K QF + + NS N LQ YE ++ G N
Sbjct: 365 N-KFFSSYKGTADSQFIVDEKNS-------------NNLQQYEFTSQVGS---------N 401
Query: 361 QENIALRKNGSSTEEMASTSEKD--TMQTKAKAVKSRHTQSGPLMPGMLLSHSSSERARN 418
++NGS E ST E D T + K ++VK TQSGPLMPG++L HSSSER R
Sbjct: 402 DIPQCEKRNGSVAEATPSTLENDVGTSKVKTQSVKLGKTQSGPLMPGLVLGHSSSERGRT 461
Query: 419 SERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKSKA 478
ER E E+Q EKSNR++RRAPSFSGPLMLPNRASANSLSAPIKSS G+RDS+DDKSKA
Sbjct: 462 FERFENENQLAGEKSNRDIRRAPSFSGPLMLPNRASANSLSAPIKSSGGFRDSLDDKSKA 521
Query: 479 NLVQIKGRFSVTSENLDLVKDIP-LSTVPRRSQGSPLRKSASVGDWIFESKQVPTSPSSK 537
NLVQIKGRFSVTSENLDLVKDIP S R SQGSP+RKSASVGDW+ + KQ+P SS
Sbjct: 522 NLVQIKGRFSVTSENLDLVKDIPVSSVSRRSSQGSPMRKSASVGDWMVDYKQMPIGQSSN 581
Query: 538 DLNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLD 581
D N ++PAS+L+PHL NLFQQTS QQDLIMNLLNSLQ AE +D
Sbjct: 582 DSANINIPASLLVPHLHNLFQQTSIQQDLIMNLLNSLQTAEAID 625
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|307136083|gb|ADN33931.1| serine/threonine protein kinase [Cucumis melo subsp. melo] | Back alignment and taxonomy information |
|---|
Score = 856 bits (2211), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/587 (74%), Positives = 483/587 (82%), Gaps = 24/587 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPN++RAYCSFVV+ NLWVVMPFMAEGSCLHLMK AY DGFEE AIGSILKETLK
Sbjct: 68 MSLIDHPNLVRAYCSFVVERNLWVVMPFMAEGSCLHLMKTAYSDGFEEVAIGSILKETLK 127
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLHRQGHIHRDVKAGNILLD+NG VKLADFGVSACMFDTGDRQRSRNTFVGTPCW
Sbjct: 128 ALEYLHRQGHIHRDVKAGNILLDSNGSVKLADFGVSACMFDTGDRQRSRNTFVGTPCW-- 185
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
ADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK+
Sbjct: 186 -------------ADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKR 232
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK+AKPPE+S+KKLFA+LPPL +RVK LQ
Sbjct: 233 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKNAKPPEVSLKKLFANLPPLSHRVKDLQ 292
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
LKDAAQLALKKMPSAEQEA+SQSEYQRGVSAWNFD+EDLKAQASLV +DDM E KEE E
Sbjct: 293 LKDAAQLALKKMPSAEQEALSQSEYQRGVSAWNFDVEDLKAQASLV--NDDMAEMKEEEE 350
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAE-SRGPTNQ-LQLYESLNKKGKALEGDSLD 358
++ +S K + L NS E SQ E G + Q L E LNK+G +E D+L
Sbjct: 351 NI-NSCSVKDAFYPRSILKNFNSCNESSQDEHGVGASGQGLSQVECLNKRGNFVESDALK 409
Query: 359 RNQENIALRKNGSSTEEMASTSEKDTMQ--TKAKAVKSRHTQSGPLMPGMLLSHSSSERA 416
+ ++NG+STE ASTS +D +Q TK + K R TQSGPL+PG++LSHS SER
Sbjct: 410 AGLQEKTGKRNGTSTEAEASTSGQDIVQGKTKTQVPKGRQTQSGPLLPGIVLSHSLSERV 469
Query: 417 RNSERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKS 476
R SER + E QP EK+ RE R+APSFSGPLMLPNRASANSLSAPIK S G+RDS+DDKS
Sbjct: 470 RGSERFDSEIQPSAEKNRREARQAPSFSGPLMLPNRASANSLSAPIKPSGGFRDSIDDKS 529
Query: 477 KANLVQIKGRFSVTSENLDLVKDIPLSTVPRR-SQGSPLRKSASVGDWIFESKQVPTSPS 535
KANLVQIKGRFSVTSENLDLVKDIPLSTV RR SQ SPLRKSASVGDWIF+SKQ + P
Sbjct: 530 KANLVQIKGRFSVTSENLDLVKDIPLSTVSRRSSQNSPLRKSASVGDWIFDSKQSVSQP- 588
Query: 536 SKDLNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLDG 582
K+ +N +VP S+L+PHLQNLF QTS QQDLI+NLLNSLQ A+V+D
Sbjct: 589 PKEASNTNVPTSILLPHLQNLFHQTSIQQDLIVNLLNSLQTADVVDA 635
|
Source: Cucumis melo subsp. melo Species: Cucumis melo Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535280|ref|XP_003536176.1| PREDICTED: uncharacterized protein LOC100811264 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2201), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/584 (73%), Positives = 480/584 (82%), Gaps = 30/584 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLI+HPNV+RA+CSFVV+ +LWVVM FMA+GSCLHLMK AY +GFEE+AIGSILKETLK
Sbjct: 65 MSLIEHPNVVRAFCSFVVERSLWVVMGFMAQGSCLHLMKAAYPEGFEEAAIGSILKETLK 124
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLHR GHIHRDVKAGNILLD NG+VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA
Sbjct: 125 ALEYLHRHGHIHRDVKAGNILLDDNGLVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 184
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPG+GYN KADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD+K
Sbjct: 185 PEVLQPGTGYNFKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDRK 244
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQTKRP+ EKLLKHSFFK AKPPELSVKKLFADLPPLWNRVK+LQ
Sbjct: 245 FSKSFKEMVAMCLVKDQTKRPSVEKLLKHSFFKQAKPPELSVKKLFADLPPLWNRVKSLQ 304
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
KDAA+LALKKMPSAEQEAISQSEY RGVSAWNFDI+DLKAQA+L++DDDD+ E +EE+E
Sbjct: 305 HKDAAELALKKMPSAEQEAISQSEYHRGVSAWNFDIDDLKAQAALMQDDDDIAEMREEDE 364
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQLYESLNKKGKALEGDSLDRN 360
+ K +K T QF + K NS N LQ E ++ G N
Sbjct: 365 N-KFFSSYKGTTDSQFIVDKKNS-------------NNLQQDEFTSQVGS---------N 401
Query: 361 QENIALRKNGSSTEEMASTSEKD--TMQTKAKAVKSRHTQSGPLMPGMLLSHSSSERARN 418
+ ++NGS E ST E D T + K ++VK TQSGPLMPG++L HSSSER R
Sbjct: 402 DIPKSEKRNGSVAEATPSTLENDVGTSKVKTQSVKLGKTQSGPLMPGLVLGHSSSERGRT 461
Query: 419 SERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKSKA 478
ER E E+Q EKSNR++RRAPSFSGPLMLPNRASANSLSAPIKSS G+RDS+DDKSKA
Sbjct: 462 FERFENENQLLGEKSNRDIRRAPSFSGPLMLPNRASANSLSAPIKSSGGFRDSLDDKSKA 521
Query: 479 NLVQIKGRFSVTSENLDLVKDIP-LSTVPRRSQGSPLRKSASVGDWIFESKQVPTSPSSK 537
NLVQIKGRFSVTSENLDLVKDIP S R SQGSP+RKSASVGDW+ + KQ+ SS
Sbjct: 522 NLVQIKGRFSVTSENLDLVKDIPVSSVSRRSSQGSPMRKSASVGDWMVDFKQM----SSN 577
Query: 538 DLNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLD 581
D N ++PAS+L+PHL NLFQQTS QQDLIMNLLNSLQ AE +D
Sbjct: 578 DSANINIPASLLVPHLHNLFQQTSIQQDLIMNLLNSLQTAEAID 621
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456791|ref|XP_004146132.1| PREDICTED: uncharacterized protein LOC101213683 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2200), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/587 (74%), Positives = 481/587 (81%), Gaps = 24/587 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPN++RAYCSFVV+ NLWVVMPFMAEGSCLHLMK AY DGFEE AIGSILKETLK
Sbjct: 68 MSLIDHPNLVRAYCSFVVERNLWVVMPFMAEGSCLHLMKTAYTDGFEEVAIGSILKETLK 127
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLHRQGHIHRDVKAGNILLD+NG VKLADFGVSACMFDTGDRQRSRNTFVGTPCW
Sbjct: 128 ALEYLHRQGHIHRDVKAGNILLDSNGSVKLADFGVSACMFDTGDRQRSRNTFVGTPCW-- 185
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
ADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK+
Sbjct: 186 -------------ADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKR 232
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
FSKSFKEMVAMCLVKDQ KRPTAEKL+KHSFFK+AKPPE+S+KKLFA+LPPL +RVK LQ
Sbjct: 233 FSKSFKEMVAMCLVKDQAKRPTAEKLIKHSFFKNAKPPEVSLKKLFANLPPLSHRVKDLQ 292
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
LKDAAQLALKKMPSAEQEA+SQSEYQRGVSAWNFD+EDLKAQASLV +DDM E KEE E
Sbjct: 293 LKDAAQLALKKMPSAEQEALSQSEYQRGVSAWNFDVEDLKAQASLV--NDDMAEMKEEEE 350
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAE-SRGPTNQ-LQLYESLNKKGKALEGDSLD 358
++ +S K + L NS E SQ E G + Q L E LNK+G +E D+L
Sbjct: 351 NI-NSCSVKDAFYPRSILRNFNSCNESSQDEHGVGASGQGLSQVECLNKRGNFVESDALK 409
Query: 359 RNQENIALRKNGSSTEEMASTSEKDTMQ--TKAKAVKSRHTQSGPLMPGMLLSHSSSERA 416
+ ++NG+STE ASTS +D +Q TK + K R TQSGPL+PG++LSHS SER
Sbjct: 410 AGLQEKTGKRNGTSTEAEASTSGQDIVQGKTKTQMPKGRQTQSGPLLPGIVLSHSLSERV 469
Query: 417 RNSERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSSAGYRDSMDDKS 476
R SER + E QP EK+ RE R+APSFSGPLMLPNRASANSLSAPIK S G+RDSMDDKS
Sbjct: 470 RGSERFDSEIQPSAEKNRREARQAPSFSGPLMLPNRASANSLSAPIKPSGGFRDSMDDKS 529
Query: 477 KANLVQIKGRFSVTSENLDLVKDIPLSTVPRR-SQGSPLRKSASVGDWIFESKQVPTSPS 535
KANLVQIKGRFSVTSENLDLVKDIPLSTV RR SQ SPLRKSASVGDWIF+SKQ + P
Sbjct: 530 KANLVQIKGRFSVTSENLDLVKDIPLSTVSRRSSQNSPLRKSASVGDWIFDSKQSVSQP- 588
Query: 536 SKDLNNCSVPASVLMPHLQNLFQQTSFQQDLIMNLLNSLQPAEVLDG 582
KD +N ++ SVL+PHLQNLF QTS QQDLI+NLLNSLQ A+V+D
Sbjct: 589 PKDASNTNMSTSVLLPHLQNLFHQTSIQQDLIVNLLNSLQTADVVDA 635
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 583 | ||||||
| TAIR|locus:2135016 | 709 | AT4G24100 [Arabidopsis thalian | 0.514 | 0.423 | 0.813 | 6.9e-195 | |
| TAIR|locus:2132716 | 711 | AT4G10730 [Arabidopsis thalian | 0.516 | 0.423 | 0.810 | 2.4e-190 | |
| TAIR|locus:2185440 | 674 | AT5G14720 [Arabidopsis thalian | 0.802 | 0.694 | 0.487 | 1.4e-116 | |
| TAIR|locus:2019878 | 687 | AT1G79640 [Arabidopsis thalian | 0.842 | 0.714 | 0.477 | 5.6e-116 | |
| TAIR|locus:2016164 | 594 | AT1G70430 [Arabidopsis thalian | 0.490 | 0.481 | 0.59 | 2.3e-95 | |
| DICTYBASE|DDB_G0276577 | 1028 | fray2 "FRAY subfamily protein | 0.397 | 0.225 | 0.570 | 5.1e-75 | |
| TAIR|locus:2129780 | 487 | AT4G14480 [Arabidopsis thalian | 0.656 | 0.786 | 0.422 | 1.7e-68 | |
| RGD|1310466 | 470 | Oxsr1 "oxidative-stress respon | 0.403 | 0.5 | 0.528 | 1.8e-68 | |
| UNIPROTKB|Q5R495 | 527 | OXSR1 "Serine/threonine-protei | 0.403 | 0.445 | 0.524 | 6e-68 | |
| MGI|MGI:1917378 | 527 | Oxsr1 "oxidative-stress respon | 0.403 | 0.445 | 0.520 | 3.3e-67 |
| TAIR|locus:2135016 AT4G24100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1311 (466.6 bits), Expect = 6.9e-195, Sum P(2) = 6.9e-195
Identities = 244/300 (81%), Positives = 264/300 (88%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPNVI+++CSF VD +LWVVMPFMA+GSCLHLMK AY DGFEESAI +LKETLK
Sbjct: 83 MSLIDHPNVIKSFCSFSVDHSLWVVMPFMAQGSCLHLMKTAYSDGFEESAICCVLKETLK 142
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
ALDYLHRQGHIHRDVKAGNILLD NG +KL DFGVSAC+FD GDRQR+RNTFVGTPCWMA
Sbjct: 143 ALDYLHRQGHIHRDVKAGNILLDDNGEIKLGDFGVSACLFDNGDRQRARNTFVGTPCWMA 202
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPG+GYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK
Sbjct: 203 PEVLQPGNGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 262
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVXXXX 240
FSKSFKEMVAMCLVKDQTKRPTAEKLLKHS FKH KPPE +VK LF+DLPPLW RV
Sbjct: 263 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSCFKHTKPPEQTVKILFSDLPPLWTRVKSLQ 322
Query: 241 XXXXXXXXXXXMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
M +A++EAISQSEYQRGVSAWNFD+ DLK QASL+ DDDD+ E+KE+ E
Sbjct: 323 DKDAQQLALKRMATADEEAISQSEYQRGVSAWNFDVRDLKTQASLLIDDDDLEESKEDEE 382
|
|
| TAIR|locus:2132716 AT4G10730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1313 (467.3 bits), Expect = 2.4e-190, Sum P(2) = 2.4e-190
Identities = 244/301 (81%), Positives = 266/301 (88%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+LIDHPNVI+++CSF VD +LWVVMPFMA+GSCLHLMK AY DGFEE+AI S+LKETLK
Sbjct: 97 MTLIDHPNVIKSFCSFAVDHHLWVVMPFMAQGSCLHLMKAAYPDGFEEAAICSMLKETLK 156
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
ALDYLHRQGHIHRDVKAGNILLD G +KL DFGVSAC+FD GDRQR+RNTFVGTPCWMA
Sbjct: 157 ALDYLHRQGHIHRDVKAGNILLDDTGEIKLGDFGVSACLFDNGDRQRARNTFVGTPCWMA 216
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK
Sbjct: 217 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 276
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVXXXX 240
FSKSFKE+VA+CLVKDQTKRPTAEKLLKHSFFK+ KPPE+ VKKLF DLPPLW RV
Sbjct: 277 FSKSFKELVALCLVKDQTKRPTAEKLLKHSFFKNVKPPEICVKKLFVDLPPLWTRVKALQ 336
Query: 241 XXXXXXXXXXXMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
M SA+Q+AISQSEYQRGVSAWNF+IEDLK QASL+ DDD + E++EE E
Sbjct: 337 AKDAAQLALKGMASADQDAISQSEYQRGVSAWNFNIEDLKEQASLLDDDDILTESREEEE 396
Query: 301 S 301
S
Sbjct: 397 S 397
|
|
| TAIR|locus:2185440 AT5G14720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1112 (396.5 bits), Expect = 1.4e-116, Sum P(2) = 1.4e-116
Identities = 248/509 (48%), Positives = 311/509 (61%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLI+HPNV++A+CSF LWVVMP+MA GSCLH++K +Y DGFEE I ++L+ETLK
Sbjct: 66 MSLINHPNVLQAHCSFTTGHQLWVVMPYMAGGSCLHIIKSSYPDGFEEPVIATLLRETLK 125
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL YLH GHIHRDVKAGNILLD+NG VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA
Sbjct: 126 ALVYLHAHGHIHRDVKAGNILLDSNGAVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 185
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+Q GY+ KAD+WSFGITALELAHGHAPFSKYPPMKVLLMT+QNAPPGLDY+RDK+
Sbjct: 186 PEVMQQLHGYDFKADVWSFGITALELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKR 245
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVXXXX 240
FSK+FKEMV CLVKD KRPT+EKLLKH FFKHA+P + VK + LPPL +R
Sbjct: 246 FSKAFKEMVGTCLVKDPKKRPTSEKLLKHPFFKHARPADYLVKTILNGLPPLGDRYRQIK 305
Query: 241 XXXXXXXXXXXMPSAEQEA-ISQSEYQRGVSAWNFDIEDLKAQASLVRDDD--------- 290
+E EA +SQ EY RG+SAWNF++EDLK QA+L+ DDD
Sbjct: 306 SKEADLLMQN---KSEYEAHLSQQEYIRGISAWNFNLEDLKTQAALISDDDTSHAEEPDF 362
Query: 291 DMLETKEENESVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQL----YESLN 346
+ + + ++ES S + + N I +L + + P LQ ++
Sbjct: 363 NQKQCERQDESALSPERASSSATAPSQDDELNDIHDLESSFASFPIKPLQALKGCFDISE 422
Query: 347 KKGKALEGDSLDRNQENIALRKNGSSTEEMASTS-EKDTMQTKAKAVKSRHTQSGPLMPG 405
+ A D D N + +S +A T+ E+DT + ++ + G
Sbjct: 423 DEDNATTPDWKDANVNSGQQLLTKASIGSLAETTKEEDTAAQNTSLPRHVISEQKKYLSG 482
Query: 406 MLLSHSSSERARNSERCEIESQPPTEKSNREVRRAPSFSGPLMLPNRASANSLSAPIKSS 465
++ S+ R I S E R + S+SG L R
Sbjct: 483 SIIPESTFSPKR------ITSDADREFQQRRYQTERSYSGSLY---RTK----------- 522
Query: 466 AGYRDSMDDKSKANLVQIKGRFSVTSENL 494
RDS+D+ S+ V+ KGRF VTS +L
Sbjct: 523 ---RDSVDETSEVPHVEHKGRFKVTSADL 548
|
|
| TAIR|locus:2019878 AT1G79640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1143 (407.4 bits), Expect = 5.6e-116, P = 5.6e-116
Identities = 246/515 (47%), Positives = 330/515 (64%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M L+DHPNV++++CSFV D NLWV+MP+M+ GSCLH++K AY DGFEE+ I +IL+E LK
Sbjct: 66 MMLVDHPNVLKSHCSFVSDHNLWVIMPYMSGGSCLHILKAAYPDGFEEAIIATILREALK 125
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
LDYLH+ GHIHRDVKAGNILL G VKL DFGVSAC+FD+GDRQR+RNTFVGTPCWMA
Sbjct: 126 GLDYLHQHGHIHRDVKAGNILLGARGAVKLGDFGVSACLFDSGDRQRTRNTFVGTPCWMA 185
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV++ GY+ KADIWSFGIT LELAHGHAPFSKYPPMKVLLMT+QNAPPGLDY+RDKK
Sbjct: 186 PEVMEQLHGYDFKADIWSFGITGLELAHGHAPFSKYPPMKVLLMTLQNAPPGLDYERDKK 245
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVXXXX 240
FS+SFK+M+A CLVKD +KRP+A+KLLKHSFFK A+ + +KL LP L NRV
Sbjct: 246 FSRSFKQMIASCLVKDPSKRPSAKKLLKHSFFKQARSSDYIARKLLDGLPDLVNRVQAIK 305
Query: 241 XXXXXXXXXXXMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
M E+E +SQ+EY+RG+S WNF+++D+KAQASL++D D ++
Sbjct: 306 RKEEDMLAQEKMADGEKEELSQNEYKRGISGWNFNLDDMKAQASLIQDMDCGF-----SD 360
Query: 301 SVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQ--LYESLN-KKGKALEGDSL 357
S+ S T Q +L ++ +E+ + + LQ ++ SL+ + K+ + SL
Sbjct: 361 SLSGSA-----TSLQ-ALDSQDTQSEIQEDTGQITNKYLQPLIHRSLSIARDKSDDDSSL 414
Query: 358 DRNQENIALRKNGSSTEEMASTSEKDTMQTKAKAVKSRHTQSGPL-MPGMLLSHSSSERA 416
+ + S E S + T A K S P P +++ SS
Sbjct: 415 ASPSYDSYVYS--SPRHEDLSLNNTHVGSTHANNGKPTDATSIPTNQPTEIIAGSSVLAD 472
Query: 417 RNSERCEIESQPPTEKSNREVRRAPSFSG--PLMLPNRASANSLSAPIKSSAGYRDSMDD 474
N + ES +K+ +++ + +G P + + P K+++ D DD
Sbjct: 473 GNGAPNKGES----DKTQEQLQNGSNCNGTHPTVGGDDVPTEMAVKPPKAASSL-DESDD 527
Query: 475 KSKANLVQIKGRFSVTSENLDLVKDIPLSTVPRRS 509
KSK +VQ +GRF VTSENLD+ K + S + ++S
Sbjct: 528 KSKPPVVQQRGRFKVTSENLDIEKVVAPSPILQKS 562
|
|
| TAIR|locus:2016164 AT1G70430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 917 (327.9 bits), Expect = 2.3e-95, Sum P(2) = 2.3e-95
Identities = 177/300 (59%), Positives = 217/300 (72%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSLIDHPN+++A+CSF+ S+LW+VMP+M+ GSC HLMK Y +G E+ I ++L+E LK
Sbjct: 66 MSLIDHPNLLKAHCSFIDSSSLWIVMPYMSGGSCFHLMKSVYPEGLEQPIIATLLREVLK 125
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL YLHRQGHIHRDVKAGNIL+ + GVVKL DFGVSACMFD+G+R ++RNTFVGTPCWMA
Sbjct: 126 ALVYLHRQGHIHRDVKAGNILIHSKGVVKLGDFGVSACMFDSGERMQTRNTFVGTPCWMA 185
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+Q GY+ K LAHGHAPFSKYPPMKVLLMT+QNAPP LDYDRDKK
Sbjct: 186 PEVMQQLDGYDFKY-----------LAHGHAPFSKYPPMKVLLMTLQNAPPRLDYDRDKK 234
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVXXXX 240
FSKSF+E++A CLVKD KRPTA KLLKH FFKHA+ + +K+ L PL R
Sbjct: 235 FSKSFRELIAACLVKDPKKRPTAAKLLKHPFFKHARSTDYLSRKILHGLSPLGERFKKLK 294
Query: 241 XXXXXXXXXXXMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENE 300
+ ++E +SQ EY RG+SAWNFD+E L+ QASLV ++ + E E
Sbjct: 295 EAEAELFKGI---NGDKEQLSQHEYMRGISAWNFDLEALRRQASLVIIPNEEIYNSEIQE 351
|
|
| DICTYBASE|DDB_G0276577 fray2 "FRAY subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 5.1e-75, Sum P(2) = 5.1e-75
Identities = 134/235 (57%), Positives = 176/235 (74%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSL HPNV+ + SFV + +LWV+M F++ GSC +M+ ++ GFEE I +ILKE LK
Sbjct: 122 MSLCHHPNVVAYHTSFVYNESLWVIMDFLSAGSCSDIMRFSFPQGFEEHVIATILKEALK 181
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A+ Y H+ G IHRD+K+GNIL+D+NG ++L+DFGVSA + DTG+ SRNTFVGTPCWMA
Sbjct: 182 AICYFHKTGRIHRDIKSGNILIDSNGNIQLSDFGVSATLIDTGET--SRNTFVGTPCWMA 239
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+++ + Y+ DIWSFGITALELA G APF++YPPMKVLL+T+QN PP L+ D + K
Sbjct: 240 PEIMEQVN-YDYAVDIWSFGITALELARGKAPFAEYPPMKVLLLTLQNPPPSLEGDGESK 298
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNR 235
+S SFK++V CL KD +KRP KLL+H FFK AK P+ V+ + A LPPL R
Sbjct: 299 WSHSFKDLVEKCLQKDPSKRPLPSKLLEHRFFKQAKKPDYLVQHILAKLPPLGQR 353
|
|
| TAIR|locus:2129780 AT4G14480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 695 (249.7 bits), Expect = 1.7e-68, P = 1.7e-68
Identities = 173/409 (42%), Positives = 225/409 (55%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MSL+ HPN++ AYCSF VD LWVVMPFM+ GS ++ ++ G E+ I LKETL
Sbjct: 66 MSLLSHPNILNAYCSFTVDRCLWVVMPFMSCGSLHSIVSSSFPSGLPENCISVFLKETLN 125
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFD-----TGDRQRS-RNTFV- 113
A+ YLH QGH+HRD+KAGNIL+D++G VKLADFGVSA +++ +G S R T +
Sbjct: 126 AISYLHDQGHLHRDIKAGNILVDSDGSVKLADFGVSASIYEPVTSSSGTTSSSLRLTDIA 185
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL 173
GTP WMAPEV+ +GY KADIWSFGITALELAHG P S PP+K LLM I
Sbjct: 186 GTPYWMAPEVVHSHTGYGFKADIWSFGITALELAHGRPPLSHLPPLKSLLMKITKRFHFS 245
Query: 174 DYD---------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKK 224
DY+ +KKFSK+F+EMV +CL +D TKRP+AEKLLKH FFK+ K + VK
Sbjct: 246 DYEINTSGSSKKGNKKFSKAFREMVGLCLEQDPTKRPSAEKLLKHPFFKNCKGLDFVVKN 305
Query: 225 LFADLPPLWNRVXXXXXXXXXXXXXXXMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQAS 284
+ L L N E+E + R +S WNF +DL+
Sbjct: 306 V---LHSLSNAEQMFMESQILIKSVGDDDEEEEEEDEEIVKNRRISGWNFREDDLQLSPV 362
Query: 285 LVRDDDDMLET--KEENESV-KSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQLQL 341
+ D E+ +EE++S K TG++ LG SN A+ + E G L L
Sbjct: 363 FPATESDSSESSPREEDQSKDKKEDDNVTITGYELGLGLSNEEAKNQEGEVVGFDKDLVL 422
Query: 342 YESLNKKGKALEGDSLDRNQENIALRKNGSSTEEMASTSEKDTMQTKAK 390
E L K+LE R + +I + EE + E M K K
Sbjct: 423 -EKLKVLKKSLEHQ---RARVSIIIEALSGDKEEKSREEELLEMVEKLK 467
|
|
| RGD|1310466 Oxsr1 "oxidative-stress responsive 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 648 (233.2 bits), Expect = 1.8e-68, Sum P(2) = 1.8e-68
Identities = 131/248 (52%), Positives = 174/248 (70%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK--IA---YQDG-FEESAIGSI 54
MS HPN++ Y SFVV LW+VM ++ GS L ++K +A ++ G +ES I +I
Sbjct: 10 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKGGVLDESTIATI 69
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
L+E L+ L+YLH+ G IHRDVKAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 70 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 129
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KADIWSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 130 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 189
Query: 173 LD---YDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
LD D++ KK+ KSF++M+++CL KD KRPTA +LL+H FF+ AK E +K+
Sbjct: 190 LDTGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQ 249
Query: 228 DLPPLWNR 235
P + R
Sbjct: 250 RAPTISER 257
|
|
| UNIPROTKB|Q5R495 OXSR1 "Serine/threonine-protein kinase OSR1" [Pongo abelii (taxid:9601)] | Back alignment and assigned GO terms |
|---|
Score = 645 (232.1 bits), Expect = 6.0e-68, Sum P(2) = 6.0e-68
Identities = 130/248 (52%), Positives = 174/248 (70%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK--IA---YQDG-FEESAIGSI 54
MS HPN++ Y SFVV LW+VM ++ GS L ++K +A ++ G +ES I +I
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
L+E L+ L+YLH+ G IHRDVKAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KADIWSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 173 LD---YDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L+ D++ KK+ KSF++M+++CL KD KRPTA +LL+H FF+ AK E +K+
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQ 306
Query: 228 DLPPLWNR 235
P + R
Sbjct: 307 RAPTISER 314
|
|
| MGI|MGI:1917378 Oxsr1 "oxidative-stress responsive 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 3.3e-67, Sum P(2) = 3.3e-67
Identities = 129/248 (52%), Positives = 173/248 (69%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK--IA---YQDG-FEESAIGSI 54
MS HPN++ Y SFVV LW+VM ++ GS L ++K +A ++ G +E I +I
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEPTIATI 126
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
L+E L+ L+YLH+ G IHRDVKAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KADIWSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 173 LD---YDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFA 227
L+ D++ KK+ KSF++M+++CL KD KRPTA +LL+H FF+ AK E +K+
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEKILQ 306
Query: 228 DLPPLWNR 235
P + R
Sbjct: 307 RAPTISER 314
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.I.8386.1 | hypothetical protein (692 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 583 | |||
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-140 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-94 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-90 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-84 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-75 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-71 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-68 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-68 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-66 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-63 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-63 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-62 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-61 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-60 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-57 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-54 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-53 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-53 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-51 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-49 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-49 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-49 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-48 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-47 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-47 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-47 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-47 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-46 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-45 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-45 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-45 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-45 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-45 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-44 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-43 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-43 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-42 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-42 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-41 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-41 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-39 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-38 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-37 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-37 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-36 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-36 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-36 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-35 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-33 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-32 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-31 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-31 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-31 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-28 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-27 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-26 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-26 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-24 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-24 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-22 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-22 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-21 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-21 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-21 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-21 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-21 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-20 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-20 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-19 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-19 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-18 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-04 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 406 bits (1046), Expect = e-140
Identities = 132/215 (61%), Positives = 169/215 (78%), Gaps = 3/215 (1%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETL 59
MS +HPNV++ Y SFVV LW+VMP+++ GS L +MK +Y + G +E+ I ++LKE L
Sbjct: 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCW 118
K L+YLH G IHRD+KAGNILL +G VK+ADFGVSA + D GDR + R TFVGTPCW
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
MAPEV++ GY+ KADIWSFGITA+ELA G AP+SKYPPMKVL++T+QN PP L+ D
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232
Query: 179 -KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
KK+SKSF++M+++CL KD +KRPTAE+LLKH FF
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 290 bits (745), Expect = 1e-94
Identities = 110/218 (50%), Positives = 141/218 (64%), Gaps = 10/218 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S P + + Y SF+ S LW++M + GSCL L+K +E+ I IL+E L
Sbjct: 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLL 109
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+YLH +G IHRD+KA NILL G VKLADFGVS + T + RNTFVGTP WMA
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK---RNTFVGTPFWMA 166
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV++ SGY+ KADIWS GITA+ELA G P S PM+VL + +N PP L+ K
Sbjct: 167 PEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE---GNK 222
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
FSK FK+ V++CL KD +RP+A++LLKH F K AK
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 9e-90
Identities = 107/211 (50%), Positives = 136/211 (64%), Gaps = 8/211 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HPN+++ Y S++ LW+VM F + GS L+K Q ES I + KE LK
Sbjct: 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ-TLTESQIAYVCKELLK 109
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+YLH G IHRD+KA NILL ++G VKL DFG+SA + DT ++RNT VGTP WMA
Sbjct: 110 GLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT----KARNTMVGTPYWMA 165
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+ G Y+ KADIWS GITA+ELA G P+S+ PPMK L N PPGL +K
Sbjct: 166 PEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL--RNPEK 222
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+S FK+ + CL K+ KRPTAE+LLKH F
Sbjct: 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 262 bits (673), Expect = 3e-84
Identities = 100/209 (47%), Positives = 131/209 (62%), Gaps = 9/209 (4%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
D P +++ Y S+ +++LW+VM + GS +MKI E I +IL +TLK L+Y
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEY 114
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH IHRD+KAGNILL+ G KLADFGVS + DT RNT +GTP WMAPEV+
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---MAKRNTVIGTPFWMAPEVI 171
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD-KKFSK 183
Q GYN+KADIWS GITA+E+A G P+S PM+ + M PP L D +K+S
Sbjct: 172 QE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL---SDPEKWSP 227
Query: 184 SFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
F + V CLVKD +RP+A +LL+H F
Sbjct: 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 3e-75
Identities = 82/212 (38%), Positives = 111/212 (52%), Gaps = 8/212 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + HPN++R Y F + L++VM + G L+K + E L++ L
Sbjct: 51 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILS 108
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLH +G +HRD+K NILLD +G VKLADFG++ + D TFVGTP +MA
Sbjct: 109 ALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQL----DPGEKLTTFVGTPEYMA 164
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVL G GY DIWS G+ EL G PF + L I P +
Sbjct: 165 PEVLL-GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWD 222
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
S K+++ LVKD KR TAE+ L+H FF
Sbjct: 223 ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 6e-71
Identities = 95/216 (43%), Positives = 128/216 (59%), Gaps = 11/216 (5%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFE--ESAIGSILKETLKALD 63
HPN++ Y S++V LWVVM +M GS L I Q+ E I + +E L+ L+
Sbjct: 74 HPNIVDYYDSYLVGDELWVVMEYMDGGS---LTDIITQNFVRMNEPQIAYVCREVLQGLE 130
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLH Q IHRD+K+ NILL +G VKLADFG +A + + RN+ VGTP WMAPEV
Sbjct: 131 YLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL---TKEKSKRNSVVGTPYWMAPEV 187
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
++ Y K DIWS GI +E+A G P+ + PP++ L + P L +K+S
Sbjct: 188 IK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKN--PEKWSP 244
Query: 184 SFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
FK+ + CLVKD KRP+AE+LL+H F K A P E
Sbjct: 245 EFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 1e-68
Identities = 92/210 (43%), Positives = 123/210 (58%), Gaps = 8/210 (3%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
HPN++ + S++ LW+VM + GS + ++ + E I + +ETLK L Y
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAY 116
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH G IHRD+K NILL +G VKLADFGVSA + T + R +F+GTP WMAPEV
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK---RKSFIGTPYWMAPEVA 173
Query: 125 Q--PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTIQNAPPGLDYDRDKKF 181
GY+ K DIW+ GITA+ELA P PM+ L L++ N PP D++ K+
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE-KW 232
Query: 182 SKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
S F + + CL KD KRPTA KLL+H F
Sbjct: 233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 220 bits (564), Expect = 7e-68
Identities = 95/219 (43%), Positives = 127/219 (57%), Gaps = 17/219 (7%)
Query: 5 DHPNVIRAYCSF------VVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILK 56
+HPN+ Y +F D LW+VM GS L+K + G +E I IL+
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
ETL+ L YLH IHRD+K NILL N VKL DFGVSA + T R RNTF+GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR---RNTFIGTP 177
Query: 117 CWMAPEVL----QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
WMAPEV+ QP + Y++++D+WS GITA+ELA G P PM+ L +N PP
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
L + +SK F + ++ CL+K+ +RP E+LL+H F
Sbjct: 238 L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 9e-66
Identities = 93/224 (41%), Positives = 135/224 (60%), Gaps = 10/224 (4%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
PN+ + Y S++ LW++M + GS LMK E I I++E L AL Y
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKY 116
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
+H+ G IHRD+KA NIL+ G VKL DFGV+A + + +RS TFVGTP WMAPEV+
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA-LLNQNSSKRS--TFVGTPYWMAPEVI 173
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS 184
G Y++KADIWS GIT E+A G+ P+S + +++ ++ PP L+ D +SK
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE---DNGYSKL 230
Query: 185 FKEMVAMCLVKDQTKRPTAEKLLKHSFFK-HAKPPELSVKKLFA 227
+E VA CL ++ +R +AE+LLK + K H+K P +K+L +
Sbjct: 231 LREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELIS 274
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 3e-63
Identities = 82/214 (38%), Positives = 116/214 (54%), Gaps = 7/214 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + HPN++R +F +L++VM + G ++ E I + L+
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY--LSRGGPLSEDEAKKIALQILR 109
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+YLH G IHRD+K NILLD NGVVK+ADFG++ + S TFVGTP +MA
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFVGTPWYMA 166
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFS--KYPPMKVLLMTIQNAPPGLDYDRD 178
PEVL G+GY K D+WS G+ EL G PFS L+ I P D +
Sbjct: 167 PEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKW 226
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
S+ K+++ CL KD +KRPTAE++L+H +F
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 4e-63
Identities = 96/219 (43%), Positives = 134/219 (61%), Gaps = 16/219 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S HPN++ Y ++ ++ LW+++ F G+ +M + + G E I + ++ L+
Sbjct: 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM-LELERGLTEPQIRYVCRQMLE 114
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL++LH IHRD+KAGNILL +G VKLADFGVSA T Q+ R+TF+GTP WMA
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQK-RDTFIGTPYWMA 171
Query: 121 PEVL-------QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL 173
PEV+ P Y+ KADIWS GIT +ELA P + PM+VLL +++ PP L
Sbjct: 172 PEVVACETFKDNP---YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL 228
Query: 174 DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
D+ K+S SF + + CLVKD RPTA +LLKH F
Sbjct: 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 8e-62
Identities = 111/217 (51%), Positives = 142/217 (65%), Gaps = 12/217 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S D P V + Y S++ + LW++M ++ GS L L++ F+E I ++LKE LK
Sbjct: 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILK 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
LDYLH + IHRD+KA N+LL G VKLADFGV+ + DT Q RNTFVGTP WMA
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMA 169
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+Q S Y+SKADIWS GITA+ELA G P S PM+VL + +N PP L +
Sbjct: 170 PEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE---- 224
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF-KHAK 216
FSK FKE + CL KD + RPTA++LLKH F K+AK
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 2e-61
Identities = 107/211 (50%), Positives = 138/211 (65%), Gaps = 11/211 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S D P + R Y S++ + LW++M ++ GS L L+K EE+ I +IL+E LK
Sbjct: 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILK 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
LDYLH + IHRD+KA N+LL G VKLADFGV+ + DT Q RNTFVGTP WMA
Sbjct: 113 GLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRNTFVGTPFWMA 169
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV++ S Y+ KADIWS GITA+ELA G P S PM+VL + +N+PP L + +
Sbjct: 170 PEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL----EGQ 224
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+SK FKE V CL KD RPTA++LLKH F
Sbjct: 225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 7e-60
Identities = 100/253 (39%), Positives = 131/253 (51%), Gaps = 40/253 (15%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HPN++ SF+VDS L+VV P MA GSC L+K + +G E AI ILK+ L
Sbjct: 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC--- 117
ALDY+H +G IHR VKA +ILL +G V L+ S M G RQR P
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR---VVHDFPKSSV 169
Query: 118 ----WMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
W++PEVLQ GYN K+DI+S GITA ELA+GH PF P ++LL ++ P
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPC 229
Query: 173 L-------DYDRD----------------------KKFSKSFKEMVAMCLVKDQTKRPTA 203
L Y+ + FS+ F + V +CL +D RP+A
Sbjct: 230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA 289
Query: 204 EKLLKHSFFKHAK 216
+LL HSFFK K
Sbjct: 290 SQLLNHSFFKQCK 302
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 3e-59
Identities = 109/217 (50%), Positives = 143/217 (65%), Gaps = 12/217 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S D P V + Y S++ D+ LW++M ++ GS L L++ D E+ I +IL+E LK
Sbjct: 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD---ETQIATILREILK 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
LDYLH + IHRD+KA N+LL +G VKLADFGV+ + DT Q RNTFVGTP WMA
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKRNTFVGTPFWMA 169
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV++ S Y+SKADIWS GITA+ELA G P S+ PMKVL + +N PP L +
Sbjct: 170 PEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTL----EGN 224
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF-FKHAK 216
+SK KE V CL K+ + RPTA++LLKH F + AK
Sbjct: 225 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 9e-57
Identities = 78/216 (36%), Positives = 118/216 (54%), Gaps = 12/216 (5%)
Query: 1 MSLIDHPNVIRAYCSFV--VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+S + HPN++R Y S + L + + +++ GS L+K + E I ++
Sbjct: 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFG-KLPEPVIRKYTRQI 110
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
L+ L YLH G +HRD+K NIL+D++GVVKLADFG + + + GTP W
Sbjct: 111 LEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYW 169
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA--PPGLDYD 176
MAPEV++ G Y ADIWS G T +E+A G P+S+ L I ++ PP +
Sbjct: 170 MAPEVIR-GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEI--- 225
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
+ S+ K+ + CL +D KRPTA++LL+H F
Sbjct: 226 -PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 79/212 (37%), Positives = 118/212 (55%), Gaps = 10/212 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + HPN+++ S +L++++ + GS ++K + F ES + + + L+
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK-KF-GPFPESLVAVYVYQVLQ 110
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L YLH QG IHRD+KA NIL +GVVKLADFGV+ D + + VGTP WMA
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVAT---KLNDVSKDDASVVGTPYWMA 167
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV++ SG ++ +DIWS G T +EL G+ P+ PM L +Q+ P L +
Sbjct: 168 PEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL----PEG 222
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
S K+ + C KD RPTA++LLKH +
Sbjct: 223 ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-53
Identities = 84/215 (39%), Positives = 124/215 (57%), Gaps = 13/215 (6%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
+ P V++ Y +F + + +V+ +M GS L+K E + I ++ LK LDY
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK--KVGKIPEPVLAYIARQILKGLDY 114
Query: 65 LHRQGH-IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
LH + H IHRD+K N+L+++ G VK+ADFG+S + +T D+ NTFVGT +M+PE
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ---CNTFVGTVTYMSPER 171
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK--VLLMTIQN-APPGLDYDRDKK 180
+Q S Y+ ADIWS G+T LE A G PF L+ I + PP L ++
Sbjct: 172 IQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLP---AEE 227
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215
FS F++ ++ CL KD KRP+A +LL+H F K A
Sbjct: 228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 3e-53
Identities = 84/215 (39%), Positives = 116/215 (53%), Gaps = 9/215 (4%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN++ Y S++V LWVVM F+ G+ L I E I ++ LKAL +L
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGA---LTDIVTHTRMNEEQIATVCLAVLKALSFL 131
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H QG IHRD+K+ +ILL ++G VKL+DFG A + R++S VGTP WMAPEV+
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPEVIS 188
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSF 185
Y ++ DIWS GI +E+ G P+ PP++ + N PP L K S
Sbjct: 189 R-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL--KNLHKVSPRL 245
Query: 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
+ + LV+D +R TA +LL H F A PP
Sbjct: 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 93/216 (43%), Positives = 124/216 (57%), Gaps = 16/216 (7%)
Query: 6 HPNVIRAYCSFVV------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
H N+ Y +F+ D LW+VM F GS L+K + +E I I +E L
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ L +LH IHRD+K N+LL N VKL DFGVSA + T R RNTF+GTP WM
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWM 188
Query: 120 APEVL----QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY 175
APEV+ P + Y+ ++DIWS GITA+E+A G P PM+ L + +N PP L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL-- 246
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+ KK+SK F + + CLVK+ RP+ E+LLKH F
Sbjct: 247 -KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-50
Identities = 86/233 (36%), Positives = 123/233 (52%), Gaps = 19/233 (8%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
D P +++ Y F+ DS++++ M M+ +CL + Q E +G + +KAL Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 65 L-HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
L + G IHRDVK NILLD +G VKL DFG+S + D+ + RS G +MAPE
Sbjct: 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS----AGCAAYMAPER 185
Query: 124 LQP---GSGYNSKADIWSFGITALELAHGHAPFSKYPPMK----VLLMTIQNAPPGLDYD 176
+ P Y+ +AD+WS GI+ +ELA G P Y K VL +Q PP L
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFP---YKNCKTEFEVLTKILQEEPPSLPP- 241
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADL 229
++ FS F V +CL KD KRP +LL+H F + + E+ V F D+
Sbjct: 242 -NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWFQDV 293
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 72/210 (34%), Positives = 104/210 (49%), Gaps = 41/210 (19%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ ++HPN+++ Y F +++L++VM + GS L+K + E I IL + L+
Sbjct: 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILE 103
Query: 61 ALDYLHRQGHIHRDVKAGNILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
L+YLH G IHRD+K NILLD NG VKLADFG+S + T VGTP +M
Sbjct: 104 GLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL---LKTIVGTPAYM 160
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
APEVL Y+ K+DIWS G+ EL
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------- 187
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
K+++ L KD KRP+A+++L+H
Sbjct: 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 2e-49
Identities = 92/216 (42%), Positives = 127/216 (58%), Gaps = 16/216 (7%)
Query: 6 HPNVIRAYCSFV------VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
H N+ Y +F+ +D LW+VM F GS L+K + +E I I +E L
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ L +LH+ IHRD+K N+LL N VKL DFGVSA + T R RNTF+GTP WM
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWM 178
Query: 120 APEVL----QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY 175
APEV+ P + Y+ K+D+WS GITA+E+A G P PM+ L + +N P L
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL-- 236
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+ KK+SK F+ + CLVK+ ++RPT E+L+KH F
Sbjct: 237 -KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 8e-49
Identities = 81/217 (37%), Positives = 119/217 (54%), Gaps = 20/217 (9%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKI--AYQDGFEESAIGSILKETLKAL 62
+ P ++ Y +F + ++ + M +M GS L KI Q E +G I LK L
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGS---LDKILKEVQGRIPERILGKIAVAVLKGL 113
Query: 63 DYLHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
YLH + I HRDVK NIL+++ G +KL DFGVS + ++ TFVGT +MAP
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-----LAKTFVGTSSYMAP 168
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPFSK--YPPMKVL-LMT--IQNAPPGLDYD 176
E +Q Y+ K+DIWS G++ +ELA G P+ PP + L+ + PP L
Sbjct: 169 ERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG 227
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
KFS F++ V +CL+KD +RP+ ++LL+H F K
Sbjct: 228 ---KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 9e-48
Identities = 96/223 (43%), Positives = 124/223 (55%), Gaps = 16/223 (7%)
Query: 2 SLIDHPNVIRAYCSF-----VVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSI 54
SL +HPNV++ Y F +V LW+V+ GS L+K G +E+ I I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L L L +LH IHRDVK NILL T G VKL DFGVSA + T R R RNT VG
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLR-RNTSVG 190
Query: 115 TPCWMAPEVL----QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAP 170
TP WMAPEV+ Q Y+++ D+WS GITA+EL G P P+K L +N P
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
P L + +K+ +SF ++ CL+KD RP+ LL+H F K
Sbjct: 251 PTLLH--PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 78/213 (36%), Positives = 117/213 (54%), Gaps = 13/213 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S + HPN+++ + + NL++ + + GS L+K Y F E I ++ L
Sbjct: 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK-KY-GSFPEPVIRLYTRQILL 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+YLH + +HRD+K NIL+DTNGVVKLADFG++ + + +F G+P WMA
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKSFKGSPYWMA 169
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM--TIQNAPPGLDYDRD 178
PEV+ GY ADIWS G T LE+A G P+S+ + + + PP D+
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDH--- 226
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
S K+ + CL +D + RPTA +LL+H F
Sbjct: 227 --LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 96/221 (43%), Positives = 121/221 (54%), Gaps = 16/221 (7%)
Query: 2 SLIDHPNVIRAYCSF-----VVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSI 54
+L DHPNV++ Y + LW+V+ GS L+K + G EE I I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L E L L +LH IHRDVK NILL T G VKL DFGVSA + T R RNT VG
Sbjct: 130 LHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR---RNTSVG 186
Query: 115 TPCWMAPEVL----QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAP 170
TP WMAPEV+ Q S Y+++ D+WS GITA+EL G P + PM+ L +N P
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
P L + + +S F + + CL KD KRPT LL+H F
Sbjct: 247 PTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 1e-47
Identities = 100/212 (47%), Positives = 127/212 (59%), Gaps = 15/212 (7%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALDY 64
H N++ + S++ LW+ M F GS L I + G ES I + +ETL+ L Y
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGS---LQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV- 123
LH +G +HRD+K NILL NG VKLADFGVSA + T +++S F+GTP WMAPEV
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS---FIGTPYWMAPEVA 178
Query: 124 -LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTIQN-APPGLDYDRDK- 179
++ GYN DIW+ GITA+ELA P PM+ L LMT N PP L +DK
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL---KDKM 235
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
K+S SF V M L K+ KRPTAEKLL+H F
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 4e-47
Identities = 85/212 (40%), Positives = 121/212 (57%), Gaps = 9/212 (4%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN++ S++V LWVVM ++A GS L + + +E I ++ +E L+AL++L
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGS---LTDVVTETCMDEGQIAAVCRECLQALEFL 131
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H IHRD+K+ NILL +G VKL DFG A + Q R+T VGTP WMAPEV+
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSF 185
Y K DIWS GI A+E+ G P+ P++ L + N P + +K S F
Sbjct: 189 R-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--ELQNPEKLSAIF 245
Query: 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
++ + CL D KR +A++LL+H F K AKP
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 86/217 (39%), Positives = 114/217 (52%), Gaps = 14/217 (6%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ HPN I ++ + W+VM + GS ++++ ++ +E I +I L+ L
Sbjct: 72 LRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLA 129
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLH IHRD+KAGNILL G VKLADFG SA + N+FVGTP WMAPEV
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPA------NSFVGTPYWMAPEV 182
Query: 124 -LQPGSG-YNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKF 181
L G Y+ K D+WS GIT +ELA P M L QN P L + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSN---DW 239
Query: 182 SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
S F+ V CL K RP++E+LLKH F +PP
Sbjct: 240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 6e-46
Identities = 69/210 (32%), Positives = 108/210 (51%), Gaps = 10/210 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
+ ++HPN+I+ Y SF L +VM + G +K ++G F E I +
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
AL YLH + +HRD+K NI L +NG+VKL DFG+S + T D T VGTP +
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---LAKTVVGTPYY 169
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
++PE+ Q YN K+DIWS G EL PF +++ L ++ P +
Sbjct: 170 LSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS--- 225
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
++S + +V+ L KD +RP+ ++L+
Sbjct: 226 -QYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 88/211 (41%), Positives = 130/211 (61%), Gaps = 10/211 (4%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
DHPN+++ +F ++NLW+++ F A G+ +M + + E I + K+TL+AL+Y
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPLTEPQIRVVCKQTLEALNY 118
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH IHRD+KAGNIL +G +KLADFGVSA +T QR R++F+GTP WMAPEV+
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQR-RDSFIGTPYWMAPEVV 175
Query: 125 QPGSG----YNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
+ Y+ KAD+WS GIT +E+A P + PM+VLL ++ PP L + +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--AQPSR 233
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+S FK+ + CL K+ R T +LL+H F
Sbjct: 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 4e-45
Identities = 78/235 (33%), Positives = 121/235 (51%), Gaps = 17/235 (7%)
Query: 6 HPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKETLKA 61
P +++ Y +F+ S++ + M + GS + K + G E +G I + LK
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
L YLH + IHRD+K NILL G VKL DFGVS + ++ TF GT +MAP
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-----GTFTGTSFYMAP 172
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPF-----SKYPPMKVLLMTIQNAPPGL--D 174
E +Q G Y+ +D+WS G+T LE+A PF P+++L + P L +
Sbjct: 173 ERIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADL 229
K+S+ FK+ + CL KD T+RPT +L+H + K ++++ K A +
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFVAQV 286
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 5e-45
Identities = 92/260 (35%), Positives = 130/260 (50%), Gaps = 46/260 (17%)
Query: 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKAL 62
L +HPN++ +F+ D+ LWVV FMA GS L+ + DG E AI IL+ LKAL
Sbjct: 55 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKAL 114
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF----VGTPCW 118
DY+H G++HR VKA +IL+ +G V L+ + M + G R R + F V W
Sbjct: 115 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 119 MAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL-------------- 163
++PEVLQ GY++K+DI+S GITA ELA+GH PF P ++LL
Sbjct: 175 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT 234
Query: 164 ------MTIQNAPPGLDYD---------------------RDKKFSKSFKEMVAMCLVKD 196
+T++ + G + ++ FS F V CL ++
Sbjct: 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN 294
Query: 197 QTKRPTAEKLLKHSFFKHAK 216
RP+A LL HSFFK K
Sbjct: 295 PDARPSASTLLNHSFFKQIK 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 5e-45
Identities = 91/273 (33%), Positives = 137/273 (50%), Gaps = 49/273 (17%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN++ ++ F S LWV+ PFMA GS L+K + +G E+ IG+IL L+ L+YL
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF----VGTPCWMAP 121
H+ G+IHR++KA +IL+ +G+V L+ + G + + F W++P
Sbjct: 118 HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177
Query: 122 EVL-QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI-------------- 166
E+L Q GYN K+DI+S GITA ELA G PF ++LL +
Sbjct: 178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237
Query: 167 ------QNAPPGLD-----------------YDR-----DKKFSKSFKEMVAMCLVKDQT 198
+N+ G+D +R K FS +F+ +V +CL +D
Sbjct: 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297
Query: 199 KRPTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
KRP+A LL H+FFK K E + + + LPP
Sbjct: 298 KRPSASSLLSHAFFKQVK--EQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-45
Identities = 93/212 (43%), Positives = 125/212 (58%), Gaps = 15/212 (7%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALDY 64
H N++ + S++ LW+ M + GS L I + G E I + +ETL+ L Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGS---LQDIYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV- 123
LH +G +HRD+K NILL NG VKLADFGV+A + T +++S F+GTP WMAPEV
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS---FIGTPYWMAPEVA 178
Query: 124 -LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL-LMTIQN-APPGLDYDRDK- 179
++ GYN DIW+ GITA+ELA P PM+ L LM+ N PP L +DK
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL---KDKT 235
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
K+S +F V + L K+ KRPTAE+LL H F
Sbjct: 236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 1e-44
Identities = 85/213 (39%), Positives = 123/213 (57%), Gaps = 10/213 (4%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
+HP +++ +F D LW+++ F G+ +M + G E I I ++ L+AL Y
Sbjct: 67 NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVICRQMLEALQY 125
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH IHRD+KAGN+LL +G +KLADFGVSA T R R++F+GTP WMAPEV+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEVV 182
Query: 125 ----QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
+ Y+ KADIWS GIT +E+A P + PM+VLL ++ PP L + K
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--SQPSK 240
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+S F++ + L K RP+A +LL+H F
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 2e-43
Identities = 74/216 (34%), Positives = 108/216 (50%), Gaps = 16/216 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETL 59
+S I+HP +++ + +F + L++V+ + G HL K F E E +
Sbjct: 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR---FSEERARFYAAEIV 103
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL+YLH G I+RD+K NILLD +G +KL DFG++ + G R NTF GTP ++
Sbjct: 104 LALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR---TNTFCGTPEYL 160
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
APEVL G GY D WS G+ E+ G PF K + I P +
Sbjct: 161 APEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPLRF----PE 214
Query: 180 KFSKSFKEMVAMCLVKDQTKRPT---AEKLLKHSFF 212
S +++++ L KD TKR AE++ H FF
Sbjct: 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 5e-43
Identities = 77/214 (35%), Positives = 118/214 (55%), Gaps = 12/214 (5%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY---QDGFEESAIGSILKETLKALD 63
P +++ Y + + + W+ M M + S K Y + E +G I T+KAL+
Sbjct: 63 PYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 64 YLHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
YL + I HRDVK NILLD NG +KL DFG+S + D+ + R G +MAPE
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----AGCRPYMAPE 177
Query: 123 VLQPGS--GYNSKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTIQNAPPGLDYDRDK 179
+ P + GY+ ++D+WS GIT E+A G P+ K+ L ++ PP L ++
Sbjct: 178 RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+FS SF + +CL+KD++KRP ++LL+H F K
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 84/212 (39%), Positives = 120/212 (56%), Gaps = 9/212 (4%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
+PN++ S++V LWVVM ++A GS L + + +E I ++ +E L+ALD+L
Sbjct: 75 NPNIVNYLDSYLVGDELWVVMEYLAGGS---LTDVVTETCMDEGQIAAVCRECLQALDFL 131
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H IHRD+K+ NILL +G VKL DFG A Q R+T VGTP WMAPEV+
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSF 185
Y K DIWS GI A+E+ G P+ P++ L + N P L ++ S F
Sbjct: 189 R-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL--QNPERLSAVF 245
Query: 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
++ + CL D +R +A++LL+H F K AKP
Sbjct: 246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 3e-42
Identities = 89/215 (41%), Positives = 115/215 (53%), Gaps = 13/215 (6%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
H NV+ Y S++V LWVVM F+ G+ L I E I ++ LKAL L
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGA---LTDIVTHTRMNEEQIAAVCLAVLKALSVL 132
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H QG IHRD+K+ +ILL +G VKL+DFG A + R R + VGTP WMAPE++
Sbjct: 133 HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPELIS 189
Query: 126 --PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
P Y + DIWS GI +E+ G P+ PP+K + M N PP L K S
Sbjct: 190 RLP---YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL--KNLHKVSP 244
Query: 184 SFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
S K + LV+D +R TA +LLKH F A PP
Sbjct: 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (381), Expect = 2e-41
Identities = 85/212 (40%), Positives = 120/212 (56%), Gaps = 9/212 (4%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
+PN++ S++V LWVVM ++A GS L + + +E I ++ +E L+AL++L
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGS---LTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H IHRD+K+ NILL +G VKL DFG A Q R+T VGTP WMAPEV+
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSF 185
Y K DIWS GI A+E+ G P+ P++ L + N P L +K S F
Sbjct: 190 R-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEKLSAIF 246
Query: 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
++ + CL D KR +A++LL+H F K AKP
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 5e-41
Identities = 85/217 (39%), Positives = 123/217 (56%), Gaps = 9/217 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + +PN++ SF+V L+VVM ++A GS L + + +E+ I ++ +E L+
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS---LTDVVTETCMDEAQIAAVCRECLQ 126
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL++LH IHRD+K+ N+LL +G VKL DFG A Q R+T VGTP WMA
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMA 183
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+ Y K DIWS GI A+E+ G P+ P++ L + N P L +K
Sbjct: 184 PEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL--QNPEK 240
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
S F++ + CL D KR +A++LL+H F K AKP
Sbjct: 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 1e-40
Identities = 81/213 (38%), Positives = 117/213 (54%), Gaps = 9/213 (4%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
H NV+ Y S++V LWVVM F+ G+ L I E I ++ L+AL YL
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGA---LTDIVTHTRMNEEQIATVCLSVLRALSYL 134
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H QG IHRD+K+ +ILL ++G +KL+DFG A R + VGTP WMAPEV+
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA---QVSKEVPKRKSLVGTPYWMAPEVIS 191
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSF 185
Y ++ DIWS GI +E+ G P+ PP++ + N PP + K S
Sbjct: 192 RLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV--KDSHKVSSVL 248
Query: 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
+ + + LV++ ++R TA++LL+H F K A PP
Sbjct: 249 RGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 72/216 (33%), Positives = 109/216 (50%), Gaps = 10/216 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ L+ HPN+++ Y V +++ M + + G+ L++ + +E I + L+
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLE 110
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSR-NTFVGTPCWM 119
L YLH G +HRD+K NI LD NGV+KL DFG + + + + GTP +M
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170
Query: 120 APEV--LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI--QNAPPGLDY 175
APEV G G+ ADIWS G LE+A G P+S+ ++ + + PP D
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDS 230
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+ K F + CL D KRPTA +LL+H F
Sbjct: 231 LQLSPEGKDFLD---RCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 73/223 (32%), Positives = 111/223 (49%), Gaps = 18/223 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK-IAYQDGFEESAIGSILKETL 59
+S P V++ Y SF NL++VM ++ G L++ + +E + E +
Sbjct: 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS---LDEDVARIYIAEIV 103
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSA-----CMFDTGDRQRSRNTFVG 114
AL+YLH G IHRD+K NIL+D+NG +KL DFG+S + D ++ VG
Sbjct: 104 LALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG-L 173
TP ++APEV+ G G++ D WS G E G PF P + QN G +
Sbjct: 164 TPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----IFQNILNGKI 218
Query: 174 DYDRDKKFSKSFKEMVAMCLVKDQTKRPTA---EKLLKHSFFK 213
++ D + S ++++ LV D KR A E++ H FFK
Sbjct: 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 80/219 (36%), Positives = 114/219 (52%), Gaps = 14/219 (6%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ HPN I ++ + W+VM + GS L+++ ++ +E I +I L+ L
Sbjct: 78 LKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLA 135
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLH IHRD+KAGNILL G VKLADFG + + N+FVGTP WMAPEV
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFG-------SASKSSPANSFVGTPYWMAPEV 188
Query: 124 L--QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKF 181
+ Y+ K D+WS GIT +ELA P M L QN P L + ++
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---QSNEW 245
Query: 182 SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
+ SF+ V CL K +RP + +LL+H F + +P +
Sbjct: 246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARV 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 39/238 (16%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
L HP +I+ Y +F + NL+ V+ + G L ++ +E E L
Sbjct: 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR--KYGSLDEKCTRFYAAEILL 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD---------------- 104
AL+YLH +G IHRD+K NILLD + +K+ DFG +A + D
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFG-TAKVLDPNSSPESNKGDATNIDSQI 172
Query: 105 --RQRSRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPF---SKYPP 158
+R +FVGT +++PE+L +G +S D+W+ G ++ G PF ++Y
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSS--DLWALGCIIYQMLTGKPPFRGSNEY-- 228
Query: 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA----EKLLKHSFF 212
+ I L+Y F K+++ LV D R ++L H FF
Sbjct: 229 --LTFQKILK----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 6e-37
Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + H +++ Y D L + M +M GS +K AY E+ ++ L+
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK-AY-GALTETVTRKYTRQILE 115
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSA-----CMFDTGDRQRSRNTFVGT 115
++YLH +HRD+K NIL D+ G VKL DFG S C TG + + GT
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK-----SVTGT 170
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL-MTIQNAPPGLD 174
P WM+PEV+ G GY KAD+WS G T +E+ P++++ M + + Q P L
Sbjct: 171 PYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
S + + V++ KRP+AE+LL+H F
Sbjct: 230 SH----VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 83/214 (38%), Positives = 111/214 (51%), Gaps = 14/214 (6%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN I+ ++ + W+VM + GS L+++ ++ +E I ++ L+ L YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL- 124
H IHRDVKAGNILL G+VKL DFG ++ M N FVGTP WMAPEV+
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANXFVGTPYWMAPEVIL 184
Query: 125 -QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
Y+ K D+WS GIT +ELA P M L QN P L + +S+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QSGHWSE 241
Query: 184 SFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
F+ V CL K RPT+E LLKH F +P
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 78/214 (36%), Positives = 116/214 (54%), Gaps = 9/214 (4%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
H NV+ Y S++V LWV+M F+ G+ L I Q E I ++ + L+AL YL
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGA---LTDIVSQTRLNEEQIATVCESVLQALCYL 133
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H QG IHRD+K+ +ILL +G VKL+DFG A + +++S VGTP WMAPEV+
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWMAPEVIS 190
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSF 185
+ Y ++ DIWS GI +E+ G P+ P++ + + PP L K S
Sbjct: 191 R-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--KNAHKISPVL 247
Query: 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
++ + L ++ +R TA++LL H F PE
Sbjct: 248 RDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 71/216 (32%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 6 HPNVIRAYCSFVVDSN--LWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKETLKA 61
HPN++R Y + SN L++VM + G L++ ++ EE I IL + L A
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 62 LDYLHRQGH-----IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
L H + +HRD+K NI LD N VKL DFG++ + G T+VGTP
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---GHDSSFAKTYVGTP 174
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
+M+PE L S Y+ K+DIWS G EL PF+ L I+ +
Sbjct: 175 YYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGK----FR 228
Query: 177 R-DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
R ++S E++ L D KRP+ E+LL+
Sbjct: 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 86/216 (39%), Positives = 113/216 (52%), Gaps = 14/216 (6%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
I HPN I ++ + W+VM + GS L+++ ++ +E I +I L+ L
Sbjct: 82 IKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLA 139
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLH IHRD+KAGNILL G VKLADFG SA + N+FVGTP WMAPEV
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASIASPA------NSFVGTPYWMAPEV 192
Query: 124 L--QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKF 181
+ Y+ K D+WS GIT +ELA P M L QN P L + ++
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL---QSNEW 249
Query: 182 SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
S F+ V CL K RPT+E+LLKH F +P
Sbjct: 250 SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-36
Identities = 77/223 (34%), Positives = 116/223 (52%), Gaps = 15/223 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
M +D P + Y + + ++W+ M M + S K Y G E +G I
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSI 112
Query: 59 LKALDYLHRQGH-IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+KAL+YLH + IHRDVK N+L++ NG VKL DFG+S + D+ ++ G
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCKP 168
Query: 118 WMAPEVLQP---GSGYNSKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTIQNAPPGL 173
+MAPE + P GY+ K+D+WS GIT +ELA G P+ + P + L ++ P L
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL 228
Query: 174 DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216
+ KFS F++ V CL K+ +RP +LL+H FF+
Sbjct: 229 PAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 4e-36
Identities = 85/249 (34%), Positives = 118/249 (47%), Gaps = 15/249 (6%)
Query: 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK-IAYQDGFEESAIGSILKETLK 60
SL PN+++ Y F + +L++VM ++ GS L+K I + ES IL + L
Sbjct: 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRSR---NTFVGTP 116
AL+YLH +G IHRD+K NILLD +G VVKL DFG++ + D G +T VGTP
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 117 CWMAPEVLQPGSG--YNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQN------ 168
+MAPEVL S +S +DIWS GIT EL G PF T++
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 169 --APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLF 226
L + SK+ +++ L KD R ++ L H H K E + L
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 227 ADLPPLWNR 235
R
Sbjct: 293 KPDDSAPLR 301
|
Length = 384 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 76/224 (33%), Positives = 117/224 (52%), Gaps = 25/224 (11%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALD 63
P ++ Y +F+ ++N+ + M FM GS L +I + G +G I ++ L
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGS---LDRIYKKGGPIPVEILGKIAVAVVEGLT 117
Query: 64 YLHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
YL+ I HRD+K NIL+++ G +KL DFGVS + ++ +TFVGT +M+PE
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-----IADTFVGTSTYMSPE 172
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP--------PMKVLLM---TIQNAPP 171
+Q G Y K+D+WS GI+ +ELA G PF+ PM +L + +Q PP
Sbjct: 173 RIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231
Query: 172 GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215
L F + ++ V CL+KD T+RPT ++L F A
Sbjct: 232 RLPSSD---FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 3e-35
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 8/211 (3%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ H N+++ + + D+ + + M F+ GS ++ E K+ L +
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVA 116
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSA--CMFD-TGDRQRSRNTFVGTPCWMA 120
YLH +HRD+K N++L NG++KL DFG + G + GTP WMA
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+ SGY K+DIWS G T E+A G P + + + A GL
Sbjct: 177 PEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHRGLMPRLPDS 233
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
FS + + V CL +DQ +RP+A +LL+H F
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 75/211 (35%), Positives = 112/211 (53%), Gaps = 14/211 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
+SL+ HPN+I Y F+ D+ L + M + A G L+ KI Q G FEE + L +
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEY-ANGGTLY-DKIVRQKGQLFEEEMVLWYLFQI 110
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+ A+ Y+H+ G +HRD+K NI L G++KL DFG+S + G T VGTP +
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEYSMAETVVGTPYY 167
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ-NAPPGLDYDR 177
M+PE+ Q G YN K+DIW+ G EL F P+ +++ +Q N P +
Sbjct: 168 MSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS--- 223
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+S +V L +D KRPTA+++L
Sbjct: 224 --VYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 81/251 (32%), Positives = 118/251 (47%), Gaps = 50/251 (19%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH 66
P ++ Y +F D + + M M GS ++K A + E+ +G I L+ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYL- 115
Query: 67 RQGH--IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
R+ H +HRDVK NIL+++ G +KL DFGVS + D+ N+FVGT +M+PE L
Sbjct: 116 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERL 170
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPF------------------------------- 153
Q G+ Y ++DIWS G++ +E+A G P
Sbjct: 171 Q-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229
Query: 154 --SKYPPMKV--LLMTIQNA-PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
PM + LL I N PP L FS F++ V CL K+ +R ++L K
Sbjct: 230 PPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTK 286
Query: 209 HSFFKHAKPPE 219
H F K A+ E
Sbjct: 287 HPFIKRAELEE 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 9/212 (4%)
Query: 4 IDHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKAL 62
+DH N++ Y F L + + ++ GS ++ + FEE + ++ L+ L
Sbjct: 65 LDHLNIV-QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGL 121
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
YLH +G +HRD+KA N+L+D +G+ K++DFG+S D D + G+ WMAPE
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND-QNMSMQGSVFWMAPE 180
Query: 123 VLQP-GSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTIQNAPPGLDYDRDK 179
V+ GY++K DIWS G LE+ G P+S + + L ++APP + D
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP-IPPDVSM 239
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
S + + C + RPTA +LL+H F
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 70/253 (27%), Positives = 106/253 (41%), Gaps = 62/253 (24%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
L +HPN+++ F + L+ V +M EG+ LMK F ES I SI+ + L+
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTF---VGTP 116
L ++H+ G HRD+K N+L+ VVK+ADFG++ R+ RSR + V T
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA--------REIRSRPPYTDYVSTR 162
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS---------------------- 154
+ APE+L + Y+S DIW+ G EL F
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222
Query: 155 -------------KYPPMKVLLMT--IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK 199
++P + I NA P +++ L D K
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEA------------IDLIKDMLRWDPKK 270
Query: 200 RPTAEKLLKHSFF 212
RPTA + L+H +F
Sbjct: 271 RPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 70/239 (29%), Positives = 112/239 (46%), Gaps = 30/239 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++ D P +++ Y SF + +L++VM +M G ++L+ I F E + E +
Sbjct: 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-IRKDV-FPEETARFYIAELVL 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD---------------- 104
ALD +H+ G IHRD+K NIL+D +G +KLADFG+ M D
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 105 ----------RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154
R+ N+ VGTP ++APEVL+ G+ Y + D WS G+ E+ +G PF
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFY 231
Query: 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ I N L + D S +++ L + + + E++ H FFK
Sbjct: 232 SDTLQET-YNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 12/212 (5%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ H N+++ S + +L + + ++ GS L+ FEE+ + + +++ LK L+
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLN 120
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS----ACMFDTGDRQRSRNTFVGTPCWM 119
YLH +G IHRD+K NIL+D G +K++DFG+S A T +R + G+ WM
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQGSVFWM 179
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
APEV++ S Y KADIWS G +E+ G PF ++ + +NA P + +
Sbjct: 180 APEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN--- 235
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
S + + D KRPTA +LLKH F
Sbjct: 236 -ISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 72/214 (33%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
D P +I Y +F V++ + + FM GS KI E +G I +K L Y
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIP------EHVLGRIAVAVVKGLTY 110
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
L +HRDVK N+L++T G VKL DFGVS + ++ T+VGT +MAPE +
Sbjct: 111 LWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERI 165
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYP-------PMKVLLMTIQNAPPGLDYDR 177
G Y +D+WS GI+ +ELA G P+ + P+++L + PP L
Sbjct: 166 S-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP--- 221
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+FS+ F + C+ K +RP E L+ H F
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 19/168 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESA----IGSIL 55
+ +HP +++ Y +F ++++M + G L I G F+E I ++
Sbjct: 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE---LWTILRDRGLFDEYTARFYIACVV 103
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
A +YLH +G I+RD+K N+LLD+NG VKL DFG + + Q++ TF GT
Sbjct: 104 L----AFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTW-TFCGT 155
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS--KYPPMKV 161
P ++APE++ GY+ D WS GI EL G PF PM++
Sbjct: 156 PEYVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI 202
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
+ I HP ++ Y SF DSNL++VM ++ G ++ + G F E + +
Sbjct: 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPVARFYAAQVV 111
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRN-TFVGTPCW 118
AL+YLH ++RD+K N+LLD++G +K+ DFG F R + R T GTP +
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFG-----FAK--RVKGRTYTLCGTPEY 164
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
+APE++ GY D W+ GI E+ G+ PF P+++ ++
Sbjct: 165 LAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-----KVRFP 218
Query: 179 KKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFK 213
FS K+++ L D TKR + H +F
Sbjct: 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 10/217 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S+ + P + + +F NL++VM + G L L+ Y+D F+E L E +
Sbjct: 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDMAQFYLAELVL 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A+ +H+ G++HRD+K N+L+D G +KLADFG +A + T ++ + VGTP ++A
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL--TANKMVNSKLPVGTPDYIA 171
Query: 121 PEVLQ-----PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY 175
PEVL Y + D WS G+ A E+ +G +PF + K I N L +
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIMNFQRFLKF 230
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
D K S F +++ L+ Q +R E L H FF
Sbjct: 231 PEDPKVSSDFLDLI-QSLLCGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 1 MSLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + HPN++R C+ L++V +M G L ++ + + + + +
Sbjct: 55 MKKLSHPNIVRLLGVCT--QGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQI 111
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP-C 117
K ++YL + +HRD+ A N L+ N VVK++DFG+S +++ ++ + P
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL--PIK 169
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQN----APPG 172
WMAPE L+ + SK+D+WSFG+ E+ G P+ +VL + P
Sbjct: 170 WMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPEN 228
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207
E++ C D RPT +L+
Sbjct: 229 C--------PDELYELMLQCWAYDPEDRPTFSELV 255
|
Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKETLKA 61
+DHPNVI+ SF+ ++ L +V+ G ++K + E I + A
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT-----FVGTP 116
L+++H + +HRD+K N+ + GVVKL D G+ R S T VGTP
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG--------RFFSSKTTAAHSLVGTP 170
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTIQNAPPGLD 174
+M+PE + +GYN K+DIWS G E+A +PF K + + P L
Sbjct: 171 YYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207
D +S+ +++V+ C+ D KRP +L
Sbjct: 230 ADH---YSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 8/210 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++ +D +IR Y SF+ L +VM + G L+K+ E + + L
Sbjct: 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L +LH + +HRD+K+ N+ LD VK+ D GV+ + D NT VGTP +++
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLS 169
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+ + YN K+D+W+ G+ E G PF ++L I+ P + +
Sbjct: 170 PELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV----SQM 224
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210
+S+ +++ CL KD +RP +LL++
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 69/219 (31%), Positives = 113/219 (51%), Gaps = 13/219 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ ++HP++IR + DS+ + + +MA GS HL+ F+E+ I + ++ L+
Sbjct: 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLR 114
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRS-RNTFVGTPCW 118
L YLH IHRDVK N+L+D+ G +++ADFG +A + G + +GT +
Sbjct: 115 GLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS--KYPPMKVLLMTIQNA--PPGLD 174
MAPEVL+ G Y D+WS G +E+A P++ K+ L+ I +A P
Sbjct: 175 MAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP--- 230
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ S +++ CL RP + +LLKH F+
Sbjct: 231 -SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
++ ++HPN+I +F+ + L +VM + G + + E I I +
Sbjct: 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
L+ L LH Q +HRD+K+ NILL N +VK+ D G+S + ++ T +GTP +
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQIGTPHY 167
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR- 177
MAPEV + G Y+ K+DIWS G E+A PF M+ L +Q Y
Sbjct: 168 MAPEVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRG----KYPPI 221
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210
+S+ + + L RP +K+L
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + HPNV+R C + L++V+ +M G L ++ + F ++ +
Sbjct: 50 MKKLGHPNVVRLLGVC--TEEEPLYLVLEYMEGGDLLDYLR-KSRPVFPSPEKSTLSLKD 106
Query: 59 L--------KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRN 110
L K ++YL + +HRD+ A N L+ + VVK++DFG+S ++D ++
Sbjct: 107 LLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 111 TFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTIQ 167
+ WMAPE L+ G + SK+D+WSFG+ E+ G P YP + +L ++
Sbjct: 167 GKLPIR-WMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP---YPGLSNEEVLEYLR 221
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
G + + E++ C D RPT +L++
Sbjct: 222 K---GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 53/154 (34%), Positives = 80/154 (51%), Gaps = 9/154 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSC-LHLMKIAYQDGFEESAIGSILKETL 59
+ ++HP ++ + SF + N+++V+ + G HL + + F E + + E +
Sbjct: 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIV 110
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL+YLH +G IHRD+K NILLD G V + DF + A + GTP +M
Sbjct: 111 LALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNI-ATKVTPD---TLTTSTSGTPGYM 166
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153
APEVL GY+ D WS G+TA E G P+
Sbjct: 167 APEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 15/212 (7%)
Query: 1 MSLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M +DHPNV++ C+ + L++VM +M G L ++ + S + S +
Sbjct: 55 MRKLDHPNVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQI 111
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ ++YL + IHRD+ A N L+ N VVK++DFG+S D R R + P
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYRKRGGKL--PIR 168
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
WMAPE L+ G + SK+D+WSFG+ E+ G P YP M + ++ G
Sbjct: 169 WMAPESLKEGK-FTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEV-LEYLKNGYRLP 223
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+ +++ C +D RPT +L++
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 74/235 (31%), Positives = 122/235 (51%), Gaps = 21/235 (8%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDG-FEESAIGSILKETLKALDY 64
P ++ + +F D+ L +++ ++ G HL YQ F ES + + E + ALD+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHL----YQREHFTESEVRVYIAEIVLALDH 120
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH+ G I+RD+K NILLD+ G V L DFG+S F + +R+ +F GT +MAPEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK-EFLAEEEERA-YSFCGTIEYMAPEVI 178
Query: 125 QPGS-GYNSKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTIQNAPPGLDYDRDK 179
+ GS G++ D WS G+ EL G +PF+ + ++ +++ PP K
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP-----FPK 233
Query: 180 KFSKSFKEMVAMCLVKDQTKR---PTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
S ++ + L KD KR A+++ H FF+ +L+ K++ A P
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 70/235 (29%), Positives = 100/235 (42%), Gaps = 36/235 (15%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN+I+ F +L++V FM + L+K Q G ES I S L + L+ L +
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIK-DRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H G +HRD+K N+L++T GV+KLADFG A F + R +V T + APE+L
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFG-LARSFGS--PVRPYTHYVVTRWYRAPELLL 171
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYP-----------------PMKVLLMTIQN 168
GY++ DIWS G EL F P P + +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLF---PGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228
Query: 169 APPGLDYDRDKKFSKSFKEMV-----------AMCLVKDQTKRPTAEKLLKHSFF 212
+ KK ++ + L D KR TAE+ L H +F
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 9e-28
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M +DHPN+++ C+ + L +VM +M G L ++ S + S +
Sbjct: 55 MRKLDHPNIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI 112
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ ++YL + IHRD+ A N L+ N VVK++DFG+S D + + + P
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS-RDLYDDDYYKVKGGKL--PIR 169
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKV-----------LLMT 165
WMAPE L+ G + SK+D+WSFG+ E+ G P YP M L
Sbjct: 170 WMAPESLKEGK-FTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYRLPK 225
Query: 166 IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
N PP L +K M+ C +D RPT +L++
Sbjct: 226 PPNCPPEL-----------YKLML-QCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 27/230 (11%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM-KIAYQDGFEESAIGSILKETLKALDYL 65
P ++ Y +F ++ +++ M +M GS L +G E + I +K L +L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 66 HRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS-RNTFVGTPCWMAPEV 123
+ +I HRDVK N+L++ NG VKL DFGVS G+ S T +G +MAPE
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPER 172
Query: 124 LQPGSG-----YNSKADIWSFGITALELAHGHAPFSKYPP------MKVLLMTIQNAPPG 172
++ G Y ++D+WS G++ LE+A G P YPP L + PP
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSAIVDGDPPT 229
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSV 222
L +S ++ VA CL K +RPT +LL+H + K ++ +
Sbjct: 230 LPSG----YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDM 275
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 66/242 (27%), Positives = 104/242 (42%), Gaps = 42/242 (17%)
Query: 4 IDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLH-LMKIAYQDG--FEESAIGSILK 56
+ HPN++R +V S ++++V +M H L + F ES I +K
Sbjct: 55 LRHPNIVRLKE--IVTSKGKGSIYMVFEYMD-----HDLTGLLDSPEVKFTESQIKCYMK 107
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
+ L+ L YLH G +HRD+K NIL++ +GV+KLADFG++ T V T
Sbjct: 108 QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYTNRVITL 165
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---------------------SK 155
+ PE+L + Y + D+WS G EL G F
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225
Query: 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVK-----DQTKRPTAEKLLKHS 210
+P + L P R ++F K + A+ L+ D KR +A++ L+H
Sbjct: 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285
Query: 211 FF 212
+F
Sbjct: 286 YF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 14/212 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ L+ HPN+I Y +F+ D L +VM + G+ ++ +E I + L
Sbjct: 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL ++H + +HRD+K NILLD + VVK+ DFG+S + + T VGTPC++
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVGTPCYI 168
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTIQNAPPGLDYDR 177
+PE+ + G YN K+DIW+ G ELA F + P + + +M+ AP DR
Sbjct: 169 SPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS---DR 224
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+S ++++ L D +KRP +++
Sbjct: 225 ---YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 69/249 (27%), Positives = 113/249 (45%), Gaps = 47/249 (18%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILKETLKALD 63
D+P V++ Y SF ++ L+++M ++ G + LMK +D F E + ET+ A+D
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAID 115
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACM------------------------ 99
+H+ G+IHRD+K N+LLD G +KL+DFG+ C
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL--CTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 100 -----FDTGDR----QRSRNTF----VGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146
+ + +R+R VGTP ++APEV +GYN + D WS G+ E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEM 232
Query: 147 AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVA--MCLVKDQTKRPTAE 204
G+ PF P + I N L + + S K+++ C + +
Sbjct: 233 LVGYPPFCSDNPQETYR-KIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVN 291
Query: 205 KLLKHSFFK 213
++ H FFK
Sbjct: 292 EIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + P V + Y SF L++VM ++ G C L+K G E + E +
Sbjct: 51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVL 108
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
++ LH++G IHRD+K N+L+D G +KL DFG+S + FVGTP ++A
Sbjct: 109 GVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-------FVGTPDYLA 161
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV---LLMTIQNAPPGLDYDR 177
PE + G G + +D WS G E G+ PF P V +L N P +
Sbjct: 162 PETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP-----EE 215
Query: 178 DKKF-SKSFKEMVAMCLVKDQTKRPTA---EKLLKHSFFK 213
K+F S +++ L D KR A +++ H FFK
Sbjct: 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 70/199 (35%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 19 DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78
+ L + M +M GS +K AY ES ++ L+ + YLH +HRD+K
Sbjct: 78 EKTLTIFMEYMPGGSVKDQLK-AY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGA 135
Query: 79 NILLDTNGVVKLADFGVSA-----CMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSK 133
NIL D+ G VKL DFG S CM TG R + GTP WM+PEV+ G GY K
Sbjct: 136 NILRDSAGNVKLGDFGASKRLQTICMSGTGIR-----SVTGTPYWMSPEVIS-GEGYGRK 189
Query: 134 ADIWSFGITALELAHGHAPFSKYPPMKVLL-MTIQNAPPGLDYDRDKKFSKSFKEMVAMC 192
AD+WS G T +E+ P+++Y M + + Q P L S+ ++ + C
Sbjct: 190 ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL----PSHISEHARDFLG-C 244
Query: 193 LVKDQTKRPTAEKLLKHSF 211
+ + RP+AE+LL+H F
Sbjct: 245 IFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 59/240 (24%), Positives = 97/240 (40%), Gaps = 43/240 (17%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAE--GSCLHLMKIAYQDGFEESAIGSILKETLKA 61
+ HPN+++ + L++V + L + I SI+ + L+
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPG----PLSPNLIKSIMYQLLRG 110
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS-ACMFDTGDRQRSRNTF---VGTPC 117
L Y H +HRD+K NIL++ +GV+KLADFG++ A T+ V T
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-------RTYTHEVVTLW 163
Query: 118 WMAPEVLQPGSGYNSKADIWSFG-ITALELAHGHAPF---------------------SK 155
+ APE+L Y++ DIWS G I A E+ G F
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFA-EMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 156 YP---PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
+P + T PP + ++++ L + KR +A++ LKH +F
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 79/313 (25%), Positives = 127/313 (40%), Gaps = 74/313 (23%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALDY 64
HP + + + F L+ VM ++ G LM + G F+E E + L +
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIVLGLQF 111
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH +G I+RD+K N+LLD+ G +K+ADFG+ C + TF GTP ++APE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKIADFGM--CKEGILGGVTTS-TFCGTPDYIAPEIL 168
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD------RD 178
Y D W+ G+ E+ G +PF G D D +
Sbjct: 169 S-YQPYGPAVDWWALGVLLYEMLAGQSPF-----------------EGDDEDELFQSILE 210
Query: 179 KK--FSKSF-KEMVAMC---LVKDQTKR----PTAEK-LLKHSFFKHAKPPELSVKKLFA 227
+ + + KE ++ L K+ KR PT E+ + H FF+ +L K++
Sbjct: 211 DEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEI-- 268
Query: 228 DLPPLWNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVR 287
PP ++K + VS NFD E K + L
Sbjct: 269 -KPPFKPKIKG---------------------------RFDVS--NFDDEFTKEKPVLTP 298
Query: 288 DDDDMLETKEENE 300
D+ ++ ++ E
Sbjct: 299 PDEAIIRNIDQEE 311
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 68/245 (27%), Positives = 102/245 (41%), Gaps = 42/245 (17%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG---FEESAIGSILKETLK 60
+ HPN+I F SN+ +V FM E ++K D + I S + TL+
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIK----DKSIVLTPADIKSYMLMTLR 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+YLH +HRD+K N+L+ ++GV+KLADFG+ A F G R V T + A
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGL-ARSF--GSPNRKMTHQVVTRWYRA 170
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPF----------------------SKYPP 158
PE+L Y D+WS G EL PF +P
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 159 MKVLL--MTIQNAPPGLDYDRDKKFSKSFKEMV---AMCLVKDQTKRPTAEKLLKHSFFK 213
+ L + + PP + F + + + L + KR TA + L+H +F
Sbjct: 230 VTSLPDYVEFKPFPP---TPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
Query: 214 HAKPP 218
+ P
Sbjct: 287 NDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 71/259 (27%), Positives = 109/259 (42%), Gaps = 44/259 (16%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++ +DHP + Y SF ++ L +VM + G L++ E E L
Sbjct: 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSR----------- 109
AL+YLH G ++RD+K NILL +G + L+DF +S D S+
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS-KQSDVEPPPVSKALRKGSRRSSV 173
Query: 110 ----------------NTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153
N+FVGT ++APEV+ G G+ S D W+ GI E+ +G PF
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPF 232
Query: 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR----PTAEKLLKH 209
K I + S S ++++ LVKD +KR A ++ +H
Sbjct: 233 -KGSNRDETFSNILKKEV--TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289
Query: 210 SFFK--------HAKPPEL 220
FF+ H PP +
Sbjct: 290 PFFRGVNWALIRHTTPPII 308
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 71/223 (31%), Positives = 116/223 (52%), Gaps = 20/223 (8%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
++HPNV++ + F + + V++ FM GS L IA +E + + ++ L +
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGS-LEGTHIA-----DEQFLADVARQILSGIA 182
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLHR+ +HRD+K N+L+++ VK+ADFGVS + T D N+ VGT +M+PE
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIAYMSPER 239
Query: 124 ----LQPGSGYNSKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTI-QNAPPGLDYD 176
L G+ DIWS G++ LE G PF + L+ I + PP +
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP----E 295
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
S+ F+ ++ CL ++ KR +A +LL+H F A+P +
Sbjct: 296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338
|
Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 31/234 (13%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
H N++ +F L++V + E + L L++ A G A+ S + + L+A+ Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEY-VERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H IHRD+K NIL+ +GV+KL DFG + + +V T + APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARAL--RARPASPLTDYVATRWYRAPELLV 174
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPP--GLDYDRD-- 178
+ Y D+W+ G EL G F S + ++ + PP + +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234
Query: 179 --------------------KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
K S + + CL D +R T ++LL+H +F
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 72/222 (32%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQD-GFEESAIGSILKETLK 60
S + H N+++ S + + M + GS L++ + E I K+ L+
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRN----TFVGT 115
L YLH +HRD+K N+L++T +GVVK++DFG T R N TF GT
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG-------TSKRLAGINPCTETFTGT 172
Query: 116 PCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPF----SKYPPM-KVLLMTIQNA 169
+MAPEV+ G GY + ADIWS G T +E+A G PF M KV + I
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPE 232
Query: 170 PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
P + S K + C D KR +A LL+ F
Sbjct: 233 IP-------ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 82/296 (27%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HP + +C+F +L+ VM ++ G + I F+E+ E + L +L
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMF--HIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFD-TGDRQRSRNTFVGTPCWMAPEVL 124
H++G I+RD+K N+LLD +G +K+ADFG+ C + G+ + S TF GTP ++APE+L
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGM--CKENMNGEGKAS--TFCGTPDYIAPEIL 168
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS 184
+ G YN D WSFG+ E+ G +PF + L +I N P + SK
Sbjct: 169 K-GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-LFDSILNDRPHF----PRWISKE 222
Query: 185 FKEMVAMCLVKDQTKR-PTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQLKD 243
K+ ++ +D TKR + +H FF+ L +++ PP +VK
Sbjct: 223 AKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREI---PPPFKPKVK------ 273
Query: 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEEN 299
S S+ NFD E + L D +L + ++
Sbjct: 274 -----------------SPSDAS------NFDREFTNEKVRLSPVDKKLLASMDQE 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 69/235 (29%), Positives = 122/235 (51%), Gaps = 15/235 (6%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
+HP + YC+F NL+ VM ++ G + ++ ++ F+ E + L +
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQF 111
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH +G ++RD+K NILLDT+G +K+ADFG+ C + ++ TF GTP ++APE+L
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGHIKIADFGM--CKENMLGDAKT-CTFCGTPDYIAPEIL 168
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS 184
G YN+ D WSFG+ E+ G +PF + + L +I+ P Y R ++
Sbjct: 169 L-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-LFQSIRMDNPC--YPR--WLTRE 222
Query: 185 FKEMVAMCLVKDQTKRPTAE-KLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKA 238
K+++ V++ +R + + +H FF+ L +++ PP +VK+
Sbjct: 223 AKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREI---EPPFKPKVKS 274
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 13/214 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG---FEESAIGSILKE 57
+S +DHP +++ + SF+ ++ + EG L + E+ + +
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEY-CEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
L + Y+H++ +HRD+KA NI L N ++K+ DFGVS + + D TF GTP
Sbjct: 115 LLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLA---TTFTGTPY 170
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
+M+PE L+ GY+SK+DIWS G E+ F + V+L ++ P L
Sbjct: 171 YMSPEALK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---- 225
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+ +S+ ++ L KD + RP+A ++L++ F
Sbjct: 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 78/262 (29%), Positives = 123/262 (46%), Gaps = 56/262 (21%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
+ P ++ Y +F D + + M M GS ++K A + E +G + L+ L Y
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAY 118
Query: 65 LHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
L + I HRDVK NIL+++ G +KL DFGVS + D+ N+FVGT +M+PE
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPER 173
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL------------------MT 165
LQ G+ Y+ ++DIWS G++ +ELA G P PP L ++
Sbjct: 174 LQ-GTHYSVQSDIWSMGLSLVELAIGRYPIP--PPDAKELEAIFGRPVVDGEEGEPHSIS 230
Query: 166 IQNAPPG-------------------LDYDRDKK--------FSKSFKEMVAMCLVKDQT 198
+ PPG LDY ++ F+ F+E V CL+K+
Sbjct: 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPA 290
Query: 199 KRPTAEKLLKHSFFKHAKPPEL 220
+R + L+ H+F K ++ E+
Sbjct: 291 ERADLKMLMNHTFIKRSEVEEV 312
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 76/220 (34%), Positives = 112/220 (50%), Gaps = 13/220 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ + P V++ +C+F D L++VM +M G ++LM E E +
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVL 153
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
ALD +H G IHRDVK N+LLD +G +KLADFG M +TG +T VGTP +++
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG--MVRCDTAVGTPDYIS 211
Query: 121 PEVL--QPGSGYNSK-ADIWSFGITALELAHGHAPFSKYPPMKV-LLMTIQNAPPGLDYD 176
PEVL Q G GY + D WS G+ E+ G PF Y V I + L++
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF--YADSLVGTYSKIMDHKNSLNFP 269
Query: 177 RDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKH 214
D + SK K ++ L + + R E++ +H FFK+
Sbjct: 270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 79/261 (30%), Positives = 123/261 (47%), Gaps = 56/261 (21%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
+ P ++ Y +F D + + M M GS ++K A + E +G + +K L Y
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTY 118
Query: 65 LHRQGH--IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
L R+ H +HRDVK NIL+++ G +KL DFGVS + D+ N+FVGT +M+PE
Sbjct: 119 L-REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPE 172
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGH-------------------------------- 150
LQ G+ Y+ ++DIWS G++ +E+A G
Sbjct: 173 RLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231
Query: 151 ----APFSKY-----PPMKV--LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK 199
P S Y PPM + LL I N PP F F++ V CL+K+ +
Sbjct: 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAE 289
Query: 200 RPTAEKLLKHSFFKHAKPPEL 220
R ++L+ H+F K ++ E+
Sbjct: 290 RADLKQLMVHAFIKRSEAEEV 310
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 19 DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78
+ L + + +M GS +K AY E+ ++ L+ + YLH +HRD+K
Sbjct: 78 EKKLSIFVEYMPGGSIKDQLK-AY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135
Query: 79 NILLDTNGVVKLADFGVSA-----CMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSK 133
NIL D+ G VKL DFG S CM TG + + GTP WM+PEV+ G GY K
Sbjct: 136 NILRDSAGNVKLGDFGASKRIQTICMSGTGIK-----SVTGTPYWMSPEVIS-GEGYGRK 189
Query: 134 ADIWSFGITALELAHGHAPFSKYPPMKVLL-MTIQNAPPGLDYDRDKKFSKSFKEMVAMC 192
AD+WS T +E+ P+++Y M + + Q P L S + ++ +
Sbjct: 190 ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML----PDGVSDACRDFLKQI 245
Query: 193 LVKDQTKRPTAEKLLKHSF 211
V+++ +RPTAE LL+H F
Sbjct: 246 FVEEK-RRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 29/204 (14%)
Query: 19 DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78
+ L + M M GS +K +Y E+ ++ L+ + YLH +HRD+K
Sbjct: 78 ERTLSIFMEHMPGGSIKDQLK-SY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135
Query: 79 NILLDTNGVVKLADFGVSA-----CMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSK 133
NIL D+ G VKL DFG S C+ TG + + GTP WM+PEV+ G GY K
Sbjct: 136 NILRDSVGNVKLGDFGASKRLQTICLSGTGMK-----SVTGTPYWMSPEVIS-GEGYGRK 189
Query: 134 ADIWSFGITALELAHGHAPFSKYPPMKVLL-MTIQNAPPGL-----DYDRDKKFSKSFKE 187
ADIWS G T +E+ P++++ M + + Q P L D+ RD F K
Sbjct: 190 ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD--FLKR--- 244
Query: 188 MVAMCLVKDQTKRPTAEKLLKHSF 211
+ + RP+A++LL+H+F
Sbjct: 245 -----IFVEAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 73/219 (33%), Positives = 112/219 (51%), Gaps = 13/219 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ + +++ + +F D L++VM +M G ++LM + D E+ A E +
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA-EVVL 153
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
ALD +H G IHRDVK N+LLD +G +KLADFG CM + +T VGTP +++
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMVRCDTAVGTPDYIS 211
Query: 121 PEVL--QPGSG-YNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMT-IQNAPPGLDYD 176
PEVL Q G G Y + D WS G+ E+ G PF Y V + I + L +
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMDHKNSLTFP 269
Query: 177 RDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFK 213
D + SK K+++ L + + R +++ H FFK
Sbjct: 270 DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 72/236 (30%), Positives = 128/236 (54%), Gaps = 21/236 (8%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKALDYL 65
P ++ + +F D+ L +++ ++ G HL + ++ F+E + E + AL++L
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHL 121
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H+ G I+RD+K NILLD+NG V L DFG+S F + +R+ + F GT +MAP++++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYS-FCGTIEYMAPDIVR 179
Query: 126 PG-SGYNSKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTIQNAPPGLDYDRDKK 180
G G++ D WS G+ EL G +PF+ K ++ +++ PP ++
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-----YPQE 234
Query: 181 FSKSFKEMVAMCLVKDQTKR----PT-AEKLLKHSFFKHAKPPELSVKKLFADLPP 231
S K+++ L+KD KR P+ A+++ KH FF+ +L+ KK+ A P
Sbjct: 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 5e-23
Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKETLKA 61
++HPNVI+ SF+ D+ L +V+ G ++K + E + + A
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
++++H + +HRD+K N+ + GVVKL D G+ F + + + ++ VGTP +M+P
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSS--KTTAAHSLVGTPYYMSP 175
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD--RDK 179
E + +GYN K+DIWS G E+A +PF K+ L ++ DY +
Sbjct: 176 ERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG---DKMNLFSLCQKIEQCDYPPLPTE 231
Query: 180 KFSKSFKEMVAMCLVKDQTKRP 201
+S+ +E+V+MC+ D +RP
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 7e-23
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKETLKA 61
++HPNVI+ Y SF+ D+ L +V+ G ++K + E + + A
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
L+++H + +HRD+K N+ + GVVKL D G+ F + + + ++ VGTP +M+P
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSS--KTTAAHSLVGTPYYMSP 175
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTIQNAPPGLDYDRDK 179
E + +GYN K+DIWS G E+A +PF K + Q P L D
Sbjct: 176 ERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH-- 232
Query: 180 KFSKSFKEMVAMCLVKDQTKRP 201
+S+ +++V MC+ D KRP
Sbjct: 233 -YSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 52/149 (34%), Positives = 75/149 (50%), Gaps = 7/149 (4%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HP ++ + F + ++ VM + A G LM + D F E + L YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGD---LMMHIHTDVFSEPRAVFYAACVVLGLQYL 117
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H ++RD+K N+LLDT G VK+ADFG+ C G R+ +TF GTP ++APEVL
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL--CKEGMGFGDRT-STFCGTPEFLAPEVLT 174
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFS 154
+ Y D W G+ E+ G +PF
Sbjct: 175 -ETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + HP +++ Y L++V FM G L+ ++ Q + + S+ ++ +
Sbjct: 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR-QRQGKLSKDMLLSMCQDVCE 111
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
++YL R IHRD+ A N L+ + GVVK++DFG++ + D S F P W
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF---PVKWS 168
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
PEV S Y+SK+D+WSFG+ E+ G PF K +V+ M + G R
Sbjct: 169 PPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR----GFRLYRP 223
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
K S + E++ C + RPT +LL+
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 53/143 (37%), Positives = 82/143 (57%), Gaps = 7/143 (4%)
Query: 15 SFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74
+F ++NL++VM + G L L+ ++D E L E + A+D +H+ G++HRD
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLS-KFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRD 127
Query: 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP---GSG-Y 130
+K N+LLD NG ++LADFG +C+ D N VGTP +++PE+LQ G G Y
Sbjct: 128 IKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 131 NSKADIWSFGITALELAHGHAPF 153
+ D WS G+ E+ +G PF
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-22
Identities = 75/220 (34%), Positives = 108/220 (49%), Gaps = 13/220 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ + P V++ + +F D L++VM +M G ++LM E E +
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVL 153
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
ALD +H G IHRDVK N+LLD +G +KLADFG CM + +T VGTP +++
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 121 PEVL--QPGSGYNSK-ADIWSFGITALELAHGHAPFSKYPPMKV-LLMTIQNAPPGLDYD 176
PEVL Q G GY + D WS G+ E+ G PF Y V I N L +
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--YADSLVGTYSKIMNHKNSLTFP 269
Query: 177 RDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKH 214
D SK K ++ L + + R E++ +H FFK+
Sbjct: 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 71/252 (28%), Positives = 110/252 (43%), Gaps = 48/252 (19%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALD 63
D+ V++ Y SF NL+ VM ++ G +M + + G FEE + E A++
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGD---MMSLLIRLGIFEEDLARFYIAELTCAIE 115
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFG----------------------------- 94
+H+ G IHRD+K NIL+D +G +KL DFG
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 95 ----VSACMFDTGDRQRSR-------NTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITA 143
+ C +R+R R ++ VGTP ++APEVL +GY D WS G+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL 234
Query: 144 LELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVA--MCLVKDQTKRP 201
E+ G PF P + L I N L K S+ +++ C +D+ +
Sbjct: 235 YEMLVGQPPFLADTPAETQLKVI-NWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKN 293
Query: 202 TAEKLLKHSFFK 213
A+++ H FFK
Sbjct: 294 GADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ HP +IR + + L+++M ++ G ++ + + F S E + AL+
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALE 115
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLH + ++RD+K NILLD G +KL DFG F R R+ T GTP ++APEV
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFG-----FAKKLRDRTW-TLCGTPEYLAPEV 169
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
+Q G+N D W+ GI E+ G+ PF P + + L++ R
Sbjct: 170 IQ-SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---LEFPR--HLDL 223
Query: 184 SFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKH 214
K+++ LV D+T+R A+ + H +FK
Sbjct: 224 YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 72/217 (33%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK-IAYQDG--FEESAIGSILKETLK 60
+ HPN++ + SF + L++VM + G LMK I Q G F E I S +
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGD---LMKRINRQRGVLFSEDQILSWFVQISL 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVV-KLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
L ++H + +HRD+K+ NI L NG+V KL DFG++ + D+ + T VGTP ++
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY---TCVGTPYYL 169
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQN--AP--PGLDY 175
+PE+ Q YN+K DIWS G EL PF +++L Q AP P
Sbjct: 170 SPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSR 228
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
D S+ FK V + RP+ +LK F
Sbjct: 229 DLRSLISQLFK-------VSPR-DRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 67/244 (27%), Positives = 117/244 (47%), Gaps = 28/244 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSC-LHLMKIAYQDGFEESAIGSILKETL 59
+ + ++ +F +L +VM M G H+ + + GF E+ + +
Sbjct: 47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQII 105
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
L++LH++ ++RD+K N+LLD +G V+++D G+ A G + + R GTP +M
Sbjct: 106 CGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL-AVELKGGKKIKGR---AGTPGYM 161
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK----VLLMTIQNAPPGLDY 175
APEVLQ G Y+ D ++ G T E+ G +PF + + T++ A D
Sbjct: 162 APEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD- 219
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKLFADL- 229
KFS K++ L KD KR +A+++ +H FK +L+ ++L A +
Sbjct: 220 ----KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK-----DLNWRRLEAGML 270
Query: 230 -PPL 232
PP
Sbjct: 271 EPPF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 72/237 (30%), Positives = 118/237 (49%), Gaps = 19/237 (8%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKALD 63
++P + YC+F +L+ VM F+ G + H+ D + + + E + L
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAA---EIVCGLQ 110
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDT-GDRQRSRNTFVGTPCWMAPE 122
+LH +G I+RD+K N++LD +G +K+ADFG+ C + GD + S TF GTP ++APE
Sbjct: 111 FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGM--CKENVFGDNRAS--TFCGTPDYIAPE 166
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFS 182
+LQ G Y D WSFG+ E+ G +PF ++ + P Y R +
Sbjct: 167 ILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP---HYPR--WIT 220
Query: 183 KSFKEMVAMCLVKDQTKRPTAEKLLK-HSFFKHAKPPELSVKKLFADLPPLWNRVKA 238
K K+++ +D T+R ++ H FFK L ++L PP +VK+
Sbjct: 221 KESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKREL---DPPFKPKVKS 274
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 74/247 (29%), Positives = 116/247 (46%), Gaps = 30/247 (12%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKALD 63
+HP + + YC F L+ VM F+ G + H+ K F+E+ E AL
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALM 110
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCWMAPE 122
+LH +G I+RD+K N+LLD G KLADFG M G ++ +TF GTP ++APE
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA---PPGLDYDRDK 179
+LQ Y D W+ G+ E+ GHAPF + + + P L D
Sbjct: 167 ILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAV- 224
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTA------EKLLKHSFFKHAKPPELSVKKLFADLPPLW 233
+++ + K+ T R + E +L+H FFK +L+ +++ PP
Sbjct: 225 -------DILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQI---EPPFR 274
Query: 234 NRVKALQ 240
R+K+ +
Sbjct: 275 PRIKSRE 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 68/236 (28%), Positives = 118/236 (50%), Gaps = 22/236 (9%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQ-DGFEESAIGSILKETLKALDY 64
P ++ + +F ++ L +++ +++ G HL YQ D F E + E + AL++
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL----YQRDNFSEDEVRFYSGEIILALEH 120
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH+ G ++RD+K NILLD+ G V L DFG+S F + +++R+ +F GT +MAPE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKERTY-SFCGTIEYMAPEII 178
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTIQNAPPGLDYDRDKK 180
+ G+ D WS GI EL G +PF+ + +V ++ PP
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-----FPSF 233
Query: 181 FSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
++++ L KD KR A ++ +H FFK L+++K+ P
Sbjct: 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRP 289
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 55/154 (35%), Positives = 80/154 (51%), Gaps = 9/154 (5%)
Query: 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDG-FEESAIGSILKETL 59
L + P ++ SF DS+L++V +M+ G HL K +G F E + E +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELV 106
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL++LH+ ++RD+K NILLD G + L DFG+S + NTF GT ++
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTNTFCGTTEYL 163
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153
APEVL GY D WS G+ E+ G +PF
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 29/234 (12%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
HP V++ F S +VM +M L + + E+ + S ++ LK +
Sbjct: 56 CQHPYVVKLLDVFPHGSGFVLVMEYMPSD--LSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
Y+H G +HRD+K N+L+ +GV+K+ADFG++ + R S V T + APE+
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ--VATRWYRAPEL 171
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM-------KVLLMTIQNAPPGL--- 173
L Y+ D+W+ G EL +G F + + L + PGL
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231
Query: 174 -DYDR-----------DKKF---SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
DY++ ++ F S +++ LV D +KR +A + L+H +F
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCL--HLMKIAYQDG-FEESAIGSILKETLKAL 62
HPN++R Y +F+ + L++VM + EG+ L H + + F E I +I + + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLI-EGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 63 DYLHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF----VGTPC 117
YLH++ I HRD+ NI+L + V + DFG++ +Q+ + VGT
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA--------KQKQPESKLTSVVGTIL 178
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD- 176
+ PE+++ Y KAD+W+FG ++ PF M L I A Y+
Sbjct: 179 YSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEA----VYEP 232
Query: 177 -RDKKFSKSFKEMVAMCLVKDQTKRP 201
+ +S+ +++ CL D RP
Sbjct: 233 LPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 53/153 (34%), Positives = 85/153 (55%), Gaps = 7/153 (4%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
D+ + + +F ++NL++VM + G L L+ ++D E L E + A+D
Sbjct: 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLS-KFEDRLPEDMARFYLAEMVIAIDS 117
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
+H+ ++HRD+K NIL+D NG ++LADFG + + G Q S VGTP +++PE+L
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS--VAVGTPDYISPEIL 175
Query: 125 QP---GSG-YNSKADIWSFGITALELAHGHAPF 153
Q G G Y + D WS G+ E+ +G PF
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 50/143 (34%), Positives = 78/143 (54%), Gaps = 7/143 (4%)
Query: 15 SFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74
+F ++ L++VM + G L L+ ++D E + E + A+ +H+ ++HRD
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLS-KFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRD 127
Query: 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP---GSG-Y 130
+K N+LLD NG ++LADFG M G Q S VGTP +++PE+LQ G G Y
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS--VAVGTPDYISPEILQAMEDGMGKY 185
Query: 131 NSKADIWSFGITALELAHGHAPF 153
+ D WS G+ E+ +G PF
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 12/213 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
+S + HPN+++ SF + NL++VM + EG L+ KI Q G F E I +
Sbjct: 53 LSNMKHPNIVQYQESFEENGNLYIVMDY-CEGGDLY-KKINAQRGVLFPEDQILDWFVQI 110
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
AL ++H + +HRD+K+ NI L +G +KL DFG++ + T + R T +GTP +
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR---TCIGTPYY 167
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
++PE+ + YN+K+DIW+ G E+ F ++L I+ + P +
Sbjct: 168 LSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV----S 222
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+S + +V+ ++ RP+ +L+ +F
Sbjct: 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-21
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
++ + HPN++ SF D +L++VM + G + KI Q G F E I +
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQ--KIKLQRGKLFPEDTILQWFVQM 109
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+ ++H + +HRD+K+ NI L NG VKL DFG + + G T+VGTP +
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA---CTYVGTPYY 166
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS----KYPPMKVLLMTIQNAPPGLD 174
+ PE+ + YN+K+DIWS G EL PF K +KV + + P
Sbjct: 167 VPPEIWE-NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYS 225
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210
Y+ + FK ++ RP+A +L
Sbjct: 226 YELRSLIKQMFK--------RNPRSRPSATTILSRG 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 54/185 (29%), Positives = 79/185 (42%), Gaps = 22/185 (11%)
Query: 41 AYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMF 100
E I ++ + L AL LHRQ K+GNILL +G++KL G A
Sbjct: 9 VRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT 60
Query: 101 DTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160
R P +MAPEV+Q G Y KADI+S GIT E P+++ +
Sbjct: 61 PEQSRP--------DPYFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELS 111
Query: 161 VLLMTIQNAPPGLDYDRDKKF-----SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215
+L + N P D ++SF++ + +C + +R A L H A
Sbjct: 112 AILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFA 171
Query: 216 KPPEL 220
+ EL
Sbjct: 172 ETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 52/150 (34%), Positives = 85/150 (56%), Gaps = 6/150 (4%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
++HP +++ + +F + L++++ F+ G +++ + F E + L E ALD
Sbjct: 55 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF--TRLSKEVMFTEEDVKFYLAELALALD 112
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
+LH G I+RD+K NILLD G +KL DFG+S ++ D ++ +F GT +MAPEV
Sbjct: 113 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEV 169
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPF 153
+ G+ AD WSFG+ E+ G PF
Sbjct: 170 VNR-RGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-20
Identities = 74/268 (27%), Positives = 129/268 (48%), Gaps = 21/268 (7%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQD--GFEESAIGSILKETLKAL 62
DH +++ + F D L ++M + + G +K ++ F+E +G + + + AL
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
D +H + +HRD+K+ NI L G++KL DFG S D+ + ++F GTP ++APE
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA-SSFCGTPYYLAPE 241
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK-KF 181
+ + Y+ KAD+WS G+ EL H PF K P + ++ + YD
Sbjct: 242 LWERKR-YSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVLYG----KYDPFPCPV 295
Query: 182 SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQL 241
S K ++ L K+ RPT ++LL F K+ V LF D+ + +
Sbjct: 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY-------VANLFQDIV---RHSETISP 345
Query: 242 KDAAQLALKKMPSAEQEAISQSEYQRGV 269
D ++ L+++ + + A S + GV
Sbjct: 346 HDREEI-LRQLQESGERAPPPSSIRYGV 372
|
Length = 478 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 15/211 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H +++ Y +++V +M+ G L+ ++ + F+ S + + K+ +
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCE 111
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT--PC- 117
+ YL + IHRD+ A N L+D G VK++DFG+S + D D S VG+ P
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSS---VGSKFPVR 166
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
W PEVL S ++SK+D+W+FG+ E+ + G P+ ++ + + Q GL
Sbjct: 167 WSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ----GLRLY 221
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207
R S+ ++ C + +RPT ++LL
Sbjct: 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 12/232 (5%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ HP ++ +F L++++ +++ G M + + F E L E AL+
Sbjct: 57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLSEISLALE 114
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
+LH+QG I+RD+K NILLD G VKL DFG+ C + + +TF GT +MAPE+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGL--CKESIHEGTVT-HTFCGTIEYMAPEI 171
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFS---KYPPMKVLLMTIQNAPPGLDYDRDKK 180
L SG+ D WS G ++ G PF+ + + +L N PP L +
Sbjct: 172 LMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDL 230
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPL 232
K K + L A ++ H FF+H +L +K+ PL
Sbjct: 231 LKKLLKRNPSSRL---GAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPL 279
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 66/237 (27%), Positives = 101/237 (42%), Gaps = 29/237 (12%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKAL 62
+ HP ++ CSF ++ ++ ++ F+ G HL K F E + A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAF 131
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRN-TFVGTPCWMAP 121
+YLH + I+RD+K N+LLD G VK+ DFG + + R T GTP ++AP
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA-------KKVPDRTFTLCGTPEYLAP 184
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV---LLMTIQNAPPGLDYDRD 178
EV+Q G+ D W+ G+ E G+ PF P ++ +L P D R
Sbjct: 185 EVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD-GRA 242
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEK-----LLKHSFFKHAKPPELSVKKLFADLP 230
+ K L D TKR K + H +F A +L + A +P
Sbjct: 243 RDLVKGL-------LQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIP 292
|
Length = 329 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 31/199 (15%)
Query: 41 AYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMF 100
Y +G +ES + L + L+ +++ H IHRD+K NIL+ +GVVKL DFG + +
Sbjct: 92 KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151
Query: 101 DTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA--P------ 152
G+ +V T + APE+L + Y DIW+ G E+ G P
Sbjct: 152 APGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208
Query: 153 -------------------FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCL 193
F K P + + L+ R K S ++ CL
Sbjct: 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLE-KRFPKLSGLVLDLAKQCL 267
Query: 194 VKDQTKRPTAEKLLKHSFF 212
D RP++ +LL H FF
Sbjct: 268 RIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 21/239 (8%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKALDY 64
HP + SF L VM + G HL + + F E E + AL Y
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGY 110
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH ++RD+K N++LD +G +K+ DFG+ C D + TF GTP ++APEVL
Sbjct: 111 LHSCDVVYRDLKLENLMLDKDGHIKITDFGL--CKEGISD-GATMKTFCGTPEYLAPEVL 167
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS 184
+ + Y D W G+ E+ G PF K+ + + + + S
Sbjct: 168 E-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----EIRFPRTLSPE 221
Query: 185 FKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKA 238
K ++A L KD +R A+++++H FF ++ KKL PP +V +
Sbjct: 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKL---EPPFKPQVTS 277
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-20
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 9 VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ 68
V++ + SF NL+++M F+ G + L+ +D E + ET+ A+D +H+
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 69 GHIHRDVKAGNILLDTNGVVKLADFGVSACM----------------------------- 99
G IHRD+K N+LLD+ G VKL+DFG+ +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 100 -FDTGDRQRSRNTF--VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156
+T R R + F VGTP ++APEV +GYN D WS G+ E+ G+ PF
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAM--CLVKDQTKRPTAEKLLKHSFFK 213
P + + N L + + S+ K+++ C + + P E++ + FF+
Sbjct: 240 TPQET-YKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 72/229 (31%), Positives = 109/229 (47%), Gaps = 37/229 (16%)
Query: 1 MSLIDHPNVIRA-YCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKET 58
++L P + + F L+ VM ++ G LM Q G F+E E
Sbjct: 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD---LMYHIQQVGKFKEPHAVFYAAEI 110
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSAC---MFDTGDRQRSRNTFVGT 115
L +LH +G I+RD+K N++LD G +K+ADFG+ C +F G R TF GT
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM--CKENIFG-GKTTR---TFCGT 164
Query: 116 PCWMAPEVL--QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL 173
P ++APE++ QP Y D W+FG+ E+ G PF + L +I
Sbjct: 165 PDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQSIM------ 214
Query: 174 DYDRDKKFSKSF-KEMVAMC---LVKDQTKR----PTAEKLLK-HSFFK 213
+ + + KS KE V++C L K KR PT E+ ++ H+FF+
Sbjct: 215 --EHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 8e-20
Identities = 55/149 (36%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM-KIAYQDGFEESAIGSILKETLKALDY 64
HP + +C F L+ VM ++ G LM +I F+E E AL +
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGD---LMFQIQRSRKFDEPRSRFYAAEVTLALMF 111
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LHR G I+RD+K NILLD G KLADFG+ G + TF GTP ++APE+L
Sbjct: 112 LHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYIAPEIL 168
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPF 153
Q Y D W+ G+ E+ G PF
Sbjct: 169 QELE-YGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 52/173 (30%), Positives = 89/173 (51%), Gaps = 12/173 (6%)
Query: 46 FEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
F E+ + E + L+++H + ++RD+K NILLD +G V+++D G+ AC F
Sbjct: 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL-ACDFS---- 148
Query: 106 QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMT 165
++ + VGT +MAPEVLQ G Y+S AD +S G +L GH+PF ++
Sbjct: 149 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E 206
Query: 166 IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFK 213
I + + FS + ++ L +D +R A+++ +H FF+
Sbjct: 207 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 9/212 (4%)
Query: 1 MSLIDHPNVIRAYCSFV-VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
+S + HPN++ S+ D L++VM F G H +K E+ + +
Sbjct: 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIA 112
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL YLH + +HRD+K N+ L ++K+ D G++ + + D +T +GTP +M
Sbjct: 113 MALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYM 169
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
+PE+ YN K+D+W+ G E+A F+ ++ I+ P + K
Sbjct: 170 SPELFS-NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM----PK 224
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+S E++A L K KRP+ + +L+ +
Sbjct: 225 DYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + HPN+++ Y +++V +MA G L+ ++ + + + + +
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCE 111
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT--PC- 117
A++YL G IHRD+ A N L+ + VVK++DFG++ + D D+ S GT P
Sbjct: 112 AMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD--DQYTSS---QGTKFPVK 166
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
W PEV ++SK+D+WSFG+ E+ + G P+ ++ +V+ ++ G
Sbjct: 167 WAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV----ESVSAGYRLY 221
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
R K ++ C + RP +KLL
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 75/240 (31%), Positives = 116/240 (48%), Gaps = 29/240 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
++ ++ P ++ SF L++V+ F+ G H ++ ++G F+ S E L
Sbjct: 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ---REGRFDLSRARFYTAELL 103
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL+ LH+ I+RD+K NILLD G + L DFG+ C + D ++ NTF GTP ++
Sbjct: 104 CALENLHKFNVIYRDLKPENILLDYQGHIALCDFGL--CKLNMKDDDKT-NTFCGTPEYL 160
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKYPPM-KVLLMTIQNAPPGLDYD 176
APE+L G GY D W+ G+ E+ G PF M + +L P G D D
Sbjct: 161 APELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRD 219
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKR---PTAEKLLKHSFFKHAKPPELSVKKLFAD--LPP 231
K+++ L +D T+R A+++ H FF +LS KKL PP
Sbjct: 220 A--------KDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS-----QLSWKKLLMKGIQPP 266
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 66/239 (27%), Positives = 107/239 (44%), Gaps = 38/239 (15%)
Query: 9 VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ 68
V++ + SF NL+++M F+ G + L+ +D E A + ET+ A+D +H+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 69 GHIHRDVKAGNILLDTNGVVKLADFGV---------------------SACMFDTGDRQR 107
G IHRD+K N+LLD G VKL+DFG+ S F + +R
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 108 SRNTF-----------VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156
T+ VGTP ++APEV +GYN D WS G+ E+ G+ PF
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFK 213
P + + N L + + S+ K+++ + + E++ H FF+
Sbjct: 240 TPQET-YRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 33/235 (14%)
Query: 5 DHPNVIRAY--CSFVVDSN---LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
+HPN++R C L +V + + +L K + G I ++++ L
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLPPETIKDLMRQLL 117
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ +D+LH +HRD+K NIL+ ++G VK+ADFG++ + + + V T +
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR----IYSFEMALTSVVVTLWYR 173
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTIQNAPPGLDYDR 177
APEVL S Y + D+WS G EL F L + + P ++ R
Sbjct: 174 APEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232
Query: 178 D---------KKFSKSFKEMV-AMC----------LVKDQTKRPTAEKLLKHSFF 212
+ +SFK V +C L + KR +A + L+H +F
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI--------LKE 57
+++ +F D L++ M ++ G L+ + +G + + E
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL----------NNLGVLSEDHARFYMAE 109
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+A+D LH G+IHRD+K N L+D +G +KL DFG+S + N+ VG+P
Sbjct: 110 MFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA------NSVVGSPD 163
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY-- 175
+MAPEVL+ G GY+ D WS G E G PFS P + ++ L
Sbjct: 164 YMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWKETLQRPV 221
Query: 176 --DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK--------HAKPP 218
D S +++ + + + E + H FFK KPP
Sbjct: 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPP 274
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 20/217 (9%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
D P ++ +F L ++ M G LH ++ F E + E + L++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGD-LH-YHLSQHGVFSEKEMRFYATEIILGLEH 112
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
+H + ++RD+K NILLD +G V+++D G+ AC F ++ + VGT +MAPEVL
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGL-ACDFS----KKKPHASVGTHGYMAPEVL 167
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM---KVLLMTIQNAPPGLDYDRDKKF 181
Q G+ Y+S AD +S G +L GH+PF ++ ++ MT+ ++ + F
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----VNVELPDSF 222
Query: 182 SKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFK 213
S K ++ L +D +KR A+++ +H FFK
Sbjct: 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI------ 54
++ ++P V+ +CSF +L +VM ++ G C L+K IG++
Sbjct: 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK----------NIGALPVDMAR 104
Query: 55 --LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS--ACM----------F 100
ET+ AL+YLH G +HRD+K N+L+ + G +KL DFG+S M
Sbjct: 105 MYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164
Query: 101 DTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160
+ R+ GTP ++APEV+ GY D W+ GI E G PF P +
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
Query: 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR---PTAEKLLKHSFFKH 214
+ I + + D+ +++++ L ++ +R A ++ +H FF
Sbjct: 224 LFGQVISDDIEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 16/231 (6%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HP + SF L VM ++ G ++ + F E E + ALDYL
Sbjct: 54 HPFLTSLKYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGAEIVSALDYL 111
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H ++RD+K N++LD +G +K+ DFG+ C D + TF GTP ++APEVL+
Sbjct: 112 HSGKIVYRDLKLENLMLDKDGHIKITDFGL--CKEGITD-AATMKTFCGTPEYLAPEVLE 168
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSF 185
+ Y D W G+ E+ G PF K+ + + D + S
Sbjct: 169 -DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----DIKFPRTLSADA 222
Query: 186 KEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
K +++ L+KD KR A+++++HSFF ++ KKL P
Sbjct: 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 39/240 (16%)
Query: 2 SLIDHPNVIRAYCSFVVDS---NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
L HPN++R + D L +V M + + L+K + E + S + +
Sbjct: 53 RLSPHPNILRL-IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRP-LPEKRVKSYMYQL 109
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
LK+LD++HR G HRD+K NIL+ + ++KLADFG S + ++ T +
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SCR---GIYSKPPYTEYISTRWY 164
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---------SKY------PPMKVLL 163
APE L Y K DIW+ G E+ F +K P +VL
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224
Query: 164 MTIQNAPPGLDYDRDKK----FSKSFKEMVAMC-------LVKDQTKRPTAEKLLKHSFF 212
++ ++Y+ K K A L D +R TA++ L+H +F
Sbjct: 225 KFRKSR--HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 31/233 (13%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN++ F L +V + + + L+ ++ G E I I+ +TL+A+++
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYC-DHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H+ IHRDVK NIL+ G +KL DFG A + + +V T + APE+L
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGF-ARILTGPGDDYT--DYVATRWYRAPELLV 173
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQN----------------- 168
+ Y D+W+ G EL G + + L + +
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233
Query: 169 -------APPGLDYDRDKKFSKSFKEMVAM--CLVKDQTKRPTAEKLLKHSFF 212
P + K + S + + CL D T+R + E+LL+H +F
Sbjct: 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 39/247 (15%)
Query: 6 HPNVIRAYCSFVVDS--NLWVVMPFMAE--GSCLHLMKIAYQDGFEESAIGSILKETLKA 61
HPN++ V ++++VM + + S L M F ES + ++ + L+
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP----FSESQVKCLMLQLLRG 120
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
L YLH IHRD+K N+LL G +K+ADFG++ G + V T + AP
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR---TYGLPAKPMTPKVVTLWYRAP 177
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ--NAP-----PGLD 174
E+L + Y + D+W+ G EL ++ L + IQ P PG
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237
Query: 175 --------------YDRDK-KF---SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK--- 213
Y+ K KF S++ ++ L+ D KR TAE+ L+ S+FK
Sbjct: 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297
Query: 214 HAKPPEL 220
PE+
Sbjct: 298 LPCEPEM 304
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 6e-18
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H +++ Y + V + +++V +M++GS L +K + + +
Sbjct: 55 MKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ Y+ R ++HRD++A NIL+ N V K+ADFG++ + D R F P W
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIKWT 170
Query: 120 APEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE G + K+D+WSFGI EL G P YP M V + G
Sbjct: 171 APEAALYGR-FTIKSDVWSFGILLTELTTKGRVP---YPGM-VNREVLDQVERGYRMPCP 225
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
+ +S +++ C K+ +RPT E L
Sbjct: 226 PECPESLHDLMCQCWRKEPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 6/149 (4%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
+HP ++ + F +S L+ V+ ++ G + M+ Q E E AL+Y
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNY 111
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH +G I+RD+K N+LLD+ G +KL D+G+ GD + +TF GTP ++APE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEIL 168
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPF 153
+ G Y D W+ G+ E+ G +PF
Sbjct: 169 R-GEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 9e-18
Identities = 72/256 (28%), Positives = 106/256 (41%), Gaps = 54/256 (21%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
D+ V++ Y SF NL+ VM ++ G + L+ + F E + E A++
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMEVFPEVLARFYIAELTLAIES 116
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFG------------------------------ 94
+H+ G IHRD+K NIL+D +G +KL DFG
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 95 ---VSACMFDTGDR-----QRSR--------NTFVGTPCWMAPEVLQPGSGYNSKADIWS 138
VS C GDR QR+ ++ VGTP ++APEVL GY D WS
Sbjct: 177 WDDVSNCR--CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWS 233
Query: 139 FGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAM--CLVKD 196
G+ E+ G PF P + L I N L K S +++ C ++
Sbjct: 234 VGVILFEMLVGQPPFLAPTPTETQLKVI-NWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292
Query: 197 QTKRPTAEKLLKHSFF 212
+ R A+ + H FF
Sbjct: 293 RLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 61/253 (24%), Positives = 96/253 (37%), Gaps = 47/253 (18%)
Query: 3 LIDHPNVIRAYCSFVVDSN--------LWVVMPFMAEGSC--LHLMKIAYQDGFEESAIG 52
+ HPNV+ V + +++V P+M L + ES I
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK----LTESQIK 118
Query: 53 SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS--------ACMFDTGD 104
+ + L+ ++YLH +HRD+KA NIL+D G++K+ADFG++ G
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 105 RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGIT-------------ALELAHGHA 151
R V T + PE+L Y + DIW G ++ H
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
Query: 152 PFSKYPPMKVLLMTIQNAPPG-------LDYDR--DKKFSKSFKEMVAMC---LVKDQTK 199
F + PG +Y R +++F K E + + L D K
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 200 RPTAEKLLKHSFF 212
R TA L+H +F
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 18/196 (9%)
Query: 43 QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDT 102
GF+E E L+ LHR+ ++RD+K NILLD G ++++D G+ A
Sbjct: 96 NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL-AVEIPE 154
Query: 103 GDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162
G+ R R VGT +MAPEV++ Y D W G E+ G +PF + KV
Sbjct: 155 GETIRGR---VGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVK 209
Query: 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKP 217
++ + +KFS++ + + L KD R AE++ H FF+
Sbjct: 210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR---- 265
Query: 218 PELSVKKLFADL--PP 231
+ K+L A + PP
Sbjct: 266 -TANFKRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 59/168 (35%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 46 FEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDT--G 103
F E G + + L A+ ++H + IHRD+K+ NILL +NG+VKL DFG S T
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199
Query: 104 DRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163
D R TF GTP ++APE+ + Y+ KAD++S G+ EL PF +V+
Sbjct: 200 DVGR---TFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
Query: 164 MTIQNA----PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207
T+ PP + S +E+V L D +RP++ KLL
Sbjct: 256 KTLAGRYDPLPPSI--------SPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H ++ Y + V + +++V FM +GS L +K + + + +
Sbjct: 55 MKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ Y+ R +IHRD++A NIL+ N V K+ADFG++ + D R F P W
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF---PIKWT 170
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE G + K+D+WSFGI EL G P YP M V ++ G
Sbjct: 171 APEAALYGR-FTIKSDVWSFGILLTELVTKGRVP---YPGM-VNREVLEQVERGYRMPCP 225
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAE 204
+ +S E++ +C KD +RPT E
Sbjct: 226 QGCPESLHELMKLCWKKDPDERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 50/149 (33%), Positives = 80/149 (53%), Gaps = 6/149 (4%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
+HP ++ + F +S L+ V+ F++ G + M+ Q E E AL++
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNF 111
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH +G I+RD+K N+LLD G +KL D+G+ GD + +TF GTP ++APE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEIL 168
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPF 153
+ G Y D W+ G+ E+ G +PF
Sbjct: 169 R-GEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
+P ++ + F S L++V+ ++ G + M+ Q E E AL++L
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ--RQRKLPEEHARFYAAEICIALNFL 112
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H +G I+RD+K N+LLD +G +KL D+G+ GD + +TF GTP ++APE+L+
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILR 169
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPF 153
G Y D W+ G+ E+ G +PF
Sbjct: 170 -GEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H +++ Y + +++V +M++GS L +K S G L+ +
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK---------SGEGKKLRLP-Q 104
Query: 61 ALD----------YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRN 110
+D YL + +IHRD+ A NIL+ N V K+ADFG++ + D R
Sbjct: 105 LVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164
Query: 111 TFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQN 168
F P W APE G + K+D+WSFGI E+ +G P YP M ++
Sbjct: 165 KF---PIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVP---YPGM-TNREVLEQ 216
Query: 169 APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
G R + +++ C KD +RPT E L SF
Sbjct: 217 VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL--QSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL--------HLMKIAYQDGFEESAIG 52
M+ + HPN+++ + + L++V +MA+GS + ++ +A Q GF
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFA----- 108
Query: 53 SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF 112
+ + ++YL + +HRD+ A N+L+ + V K++DFG++ ++ S+
Sbjct: 109 ---LDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA--------KEASQGQD 157
Query: 113 VGT-PC-WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYP--PMKVLLMTIQ 167
G P W APE L+ +++K+D+WSFGI E+ + G P YP P+K ++ ++
Sbjct: 158 SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVPHVE 213
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207
G + + +++ C D KRPT ++L
Sbjct: 214 K---GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 71/256 (27%), Positives = 112/256 (43%), Gaps = 52/256 (20%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALD 63
D+ V+R Y SF NL+ VM ++ G +M + + G F E + E A++
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYIPGGD---MMSLLIRMGIFPEDLARFYIAELTCAVE 115
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGV--------SACMFDTGD----------- 104
+H+ G IHRD+K NIL+D +G +KL DFG+ + + +GD
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 105 ----------------------RQRSR---NTFVGTPCWMAPEVLQPGSGYNSKADIWSF 139
RQ R ++ VGTP ++APEVL +GY D WS
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSV 234
Query: 140 GITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEM-VAMCL-VKDQ 197
G+ E+ G PF P++ M + N L K S ++ + +C +D+
Sbjct: 235 GVILYEMLVGQPPFLAQTPLET-QMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDR 293
Query: 198 TKRPTAEKLLKHSFFK 213
+ A+++ H FFK
Sbjct: 294 LGKNGADEIKAHPFFK 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-17
Identities = 68/255 (26%), Positives = 103/255 (40%), Gaps = 50/255 (19%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
D P V+ Y SF L+++M F+ G L M I Y D F E + E + A++
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGD-LMTMLIKY-DTFSEDVTRFYMAECVLAIEA 116
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD---------------RQRSR 109
+H+ G IHRD+K NIL+D G +KL+DFG+S D R +R
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 110 NTF-----------------------------VGTPCWMAPEVLQPGSGYNSKADIWSFG 140
N+ VGTP ++APE+ GY + D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDWWSLG 235
Query: 141 ITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMV--AMCLVKDQT 198
E G PF + I N L + D S ++++ + +++
Sbjct: 236 AIMFECLIGWPPFCSENSHET-YRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRL 294
Query: 199 KRPTAEKLLKHSFFK 213
R A ++ H FF+
Sbjct: 295 GRGGAHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 28/219 (12%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH 66
P + + + F L+ VM ++ G ++ +I F+E E L +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMY--QIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL-- 124
+G I+RD+K N++LD+ G +K+ADFG+ C + D ++ TF GTP ++APE++
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGM--CKENMWDGVTTK-TFCGTPDYIAPEIIAY 175
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS 184
QP Y D W+FG+ E+ G APF + L +I + + + KS
Sbjct: 176 QP---YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIM--------EHNVAYPKS 223
Query: 185 F-KEMVAMC---LVKDQTKR----PTAEKLLK-HSFFKH 214
KE VA+C + K KR P E+ +K H+FF++
Sbjct: 224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 23/228 (10%)
Query: 14 CSFVVDSNLWVVMPFMAEGSC-LHLMKIAYQD-GFEESAIGSILKETLKALDYLHRQGHI 71
+F ++L +VM M G H+ + ++ GF E + + L++LH++ I
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYN 131
+RD+K N+LLD +G V+++D G++ + D Q + GTP +MAPE+LQ G Y+
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAV---ELKDGQSKTKGYAGTPGFMAPELLQ-GEEYD 175
Query: 132 SKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEM 188
D ++ G+T E+ PF + K L I N + Y KFS + K
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VTY--PDKFSPASKSF 231
Query: 189 VAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
L KD KR + L H F+ +L+ ++L A + P
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFR-----DLNWRQLEAGMLP 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + HP +I+ Y ++ +++V M GS L ++ + + + +
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ YL Q +IHRD+ A N+L+ N + K+ADFG++ + + R F P W
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF---PIKWT 171
Query: 120 APEVLQPGSGYNS---KADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQN----APP 171
APE YN K+D+WSFGI E+ +G P+ +VL Q PP
Sbjct: 172 APEAAL----YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP 227
Query: 172 GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
G K +++ C +D RPT E L
Sbjct: 228 GC--------PKELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 64/246 (26%), Positives = 95/246 (38%), Gaps = 36/246 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-----LWVVMPFMAEGSCLHLMKIAYQDGF-EESAIGSI 54
+ + H N+I S +++V M + LH K+ + I
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLH--KVIKSPQPLTDDHIQYF 108
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L+ L YLH IHRD+K NIL+++N +K+ DFG++ + D + +V
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY-------------PPM 159
T + APE+L S Y DIWS G EL F Y P
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 160 KVLLM----TIQNAPPGLDYDRDKKFSKSFKE-------MVAMCLVKDQTKRPTAEKLLK 208
+ L +N L K SK F ++ LV D KR TA++ L
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 209 HSFFKH 214
H +
Sbjct: 289 HPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 75/239 (31%), Positives = 106/239 (44%), Gaps = 24/239 (10%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKALDY 64
HP ++ + SF L+ V+ ++ G HL + F E E AL Y
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS---FPEPRARFYAAEIASALGY 111
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LH I+RD+K NILLD+ G V L DFG+ C + ++ +TF GTP ++APEVL
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGL--CKEGI-EHSKTTSTFCGTPEYLAPEVL 168
Query: 125 --QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFS 182
QP Y+ D W G E+ +G PF + + I N P L + S
Sbjct: 169 RKQP---YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-MYDNILNKPLRLKPNI----S 220
Query: 183 KSFKEMVAMCLVKDQTKRPTAEKLLK----HSFFKHAKPPELSVKKLFADLPPLWNRVK 237
S + ++ L KD+TKR A+ H FF +L KK+ PP V
Sbjct: 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI---TPPFNPNVS 276
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 3/154 (1%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +DH N+IR Y V+ L +V GS L ++ F S + +
Sbjct: 50 MHSLDHENLIRLY-GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIAN 108
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YL + IHRD+ A NILL ++ VK+ DFG+ + D W A
Sbjct: 109 GMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 121 PEVLQPGSGYNSKADIWSFGITALEL-AHGHAPF 153
PE L+ + ++ +D+W FG+T E+ +G P+
Sbjct: 169 PESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H +++ Y + V + +++V +M++GS L +K + + + +
Sbjct: 55 MKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ Y+ R +IHRD+++ NIL+ V K+ADFG++ + D R F P W
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF---PIKWT 170
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVL--------LMTIQNAP 170
APE G + K+D+WSFGI EL G P+ +VL + Q+ P
Sbjct: 171 APEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCP 229
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
S E++ C KD +RPT E L
Sbjct: 230 I------------SLHELMLQCWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 62/195 (31%), Positives = 91/195 (46%), Gaps = 18/195 (9%)
Query: 45 GFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD 104
GFEE E L L+ LHR+ ++RD+K NILLD G ++++D G+ A G+
Sbjct: 98 GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL-AVKIPEGE 156
Query: 105 RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164
R R VGT +MAPEVL Y D W G E+ G +PF + KV
Sbjct: 157 SIRGR---VGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPF-RGRKEKVKRE 211
Query: 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPE 219
+ + KFS+ K + M L KD +R A ++ +H FF++
Sbjct: 212 EVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN----- 266
Query: 220 LSVKKLFADL--PPL 232
++ K+L A + PP
Sbjct: 267 MNFKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 28/228 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ +DHP+V+R + S + ++ M G L ++ ++D + + + K
Sbjct: 63 MASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAK 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ YL + +HRD+ A N+L+ T VK+ DFG+ A + D +++ P WM
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL-AKLLDVDEKE-YHAEGGKVPIKWM 178
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNA----PPGLD 174
A E + Y K+D+WS+G+T EL G P+ P +++ + + PP
Sbjct: 179 ALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICT 237
Query: 175 YDRDKKFSKSFKEMVAMCLVK----DQTKRPTAEKLLKHSFFKHAKPP 218
D V M LVK D RPT ++L+ F K A+ P
Sbjct: 238 ID------------VYMVLVKCWMIDAESRPTFKELIN-EFSKMARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 21/235 (8%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKAL 62
+ HP ++ + SF L+ V+ ++ G HL + + F E E AL
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASAL 109
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
YLH ++RD+K NILLD+ G + L DFG+ + + + +TF GTP ++APE
Sbjct: 110 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPE 166
Query: 123 VL--QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
VL QP Y+ D W G E+ +G PF + + I N P L
Sbjct: 167 VLHKQP---YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNKPLQL----KPN 218
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAE----KLLKHSFFKHAKPPELSVKKLFADLPP 231
+ S + ++ L KD+TKR A+ ++ H FF +L KK+ P
Sbjct: 219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNP 273
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 65/250 (26%), Positives = 101/250 (40%), Gaps = 46/250 (18%)
Query: 4 IDHPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKE 57
+DH NVI F S+L ++V M G+ L+ I + I ++ +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLN--NIVKCQKLSDDHIQFLVYQ 126
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSR--NTFVGT 115
L+ L Y+H G IHRD+K NI ++ + +K+ DFG++ R +V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--------RHTDDEMTGYVAT 178
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTIQNAPP-- 171
+ APE++ YN DIWS G EL G F S + +M + P
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 172 ---GLDYDRDKKFSKS--------FKEMVAMC-----------LVKDQTKRPTAEKLLKH 209
+ + + + +S FKE+ + LV D KR TA + L H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298
Query: 210 SFFKHAKPPE 219
+ PE
Sbjct: 299 PYLAEYHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSC-LHLMKIAYQDGFEESAIGSILKETLKAL 62
+ HP ++ + SF L+ V+ ++ G HL + + F E E A+
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAI 109
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
YLH I+RD+K NILLD+ G V L DFG+ + + + + +TF GTP ++APE
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPE 166
Query: 123 VL--QPGSGYNSKADIWSFGITALELAHGHAPF 153
VL +P Y+ D W G E+ +G PF
Sbjct: 167 VLRKEP---YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 31/241 (12%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKAL 62
+ HP ++ + SF L+ V+ F+ G HL + + F E E AL
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR---ERSFPEPRARFYAAEIASAL 109
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
YLH ++RD+K NILLD+ G V L DFG+ D + TF GTP ++APE
Sbjct: 110 GYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCGTPEYLAPE 166
Query: 123 VL--QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV---LLMTIQNAPPGLDYDR 177
V+ QP Y++ D W G E+ +G PF ++ +L PG
Sbjct: 167 VIRKQP---YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA---- 219
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAE----KLLKHSFFKHAKPPELSVKKLFADLPPLW 233
S + ++ L KD+ +R A+ ++ +H FF+ +L KK +PP +
Sbjct: 220 ----SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKK----IPPPF 271
Query: 234 N 234
N
Sbjct: 272 N 272
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 23/184 (12%)
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
E + AL+YLH + ++RD+K N++LD +G +K+ DFG+ C D + TF GTP
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL--CKEGISDGATMK-TFCGTP 159
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTIQNAPPGL 173
++APEVL+ + Y D W G+ E+ G PF +++LM P
Sbjct: 160 EYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP--- 215
Query: 174 DYDRDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKLFAD 228
+ S K ++A L KD +R A+++++H FF ++ KKL
Sbjct: 216 -----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL--- 267
Query: 229 LPPL 232
LPP
Sbjct: 268 LPPF 271
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 67/248 (27%), Positives = 100/248 (40%), Gaps = 46/248 (18%)
Query: 6 HPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
H NVI F D +L ++VMPFM L K+ + E I ++ + L
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT----DLGKLMKHEKLSEDRIQFLVYQML 128
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT--FVGTPC 117
K L Y+H G IHRD+K GN+ ++ + +K+ DFG++ RQ +V T
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------RQTDSEMTGYVVTRW 180
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTIQNAPPG--- 172
+ APEV+ Y DIWS G E+ G F + + L +M + P
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240
Query: 173 --LDYDRDKKFSKSFKE-------------------MVAMCLVKDQTKRPTAEKLLKHSF 211
L + K + K ++ LV D R TA + L H +
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300
Query: 212 FKHAKPPE 219
F+ PE
Sbjct: 301 FEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 27/231 (11%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN++ + +S L+++ F++ +L + + + S L + L+ + +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H + +HRD+K N+L+D GV+KLADFG++ G R V T + APEVL
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF---GIPVRVYTHEVVTLWYRAPEVLL 174
Query: 126 PGSGYNSKADIWSFGITALELA------HGHAPFSKYPPMKVLLMTIQNAP-PGLDYDRD 178
Y++ DIWS G E+A HG + + + +L T PG+ D
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234
Query: 179 KK----------FSKSFKEM-------VAMCLVKDQTKRPTAEKLLKHSFF 212
K + K + + L+ D KR +A+K L H +F
Sbjct: 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 6/159 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNL-WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M HPNV+ + VV+P+M G + ++ + + IG L +
Sbjct: 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVA 108
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-W 118
K ++YL + +HRD+ A N +LD + VK+ADFG++ ++D +T P W
Sbjct: 109 KGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157
MA E LQ + +K+D+WSFG+ EL AP YP
Sbjct: 169 MALESLQTQK-FTTKSDVWSFGVLLWELMTRGAP--PYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + HP ++R Y + V ++++ +M GS + +K + + + + +
Sbjct: 55 MKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ ++ R+ +IHRD++A NIL+ K+ADFG++ + D R F P W
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF---PIKWT 170
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE + G+ + K+D+WSFGI E+ +G P YP M IQN G R
Sbjct: 171 APEAINYGT-FTIKSDVWSFGILLTEIVTYGRIP---YPGMTN-PEVIQNLERGYRMPRP 225
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
+ E++ +C + +RPT E L
Sbjct: 226 DNCPEELYELMRLCWKEKPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 61/253 (24%), Positives = 98/253 (38%), Gaps = 49/253 (19%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQD-GFEESAIGSILKETL 59
M+ I H N++ +V + +VM MA L K+ + ES + IL + L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMAS----DLKKVVDRKIRLTESQVKCILLQIL 129
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSAC---------MFDTGDRQRSRN 110
L+ LH+ +HRD+ NI +++ G+ K+ADFG++ + QR
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 111 --TFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--------------- 153
+ V T + APE+L Y+ D+WS G EL G F
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249
Query: 154 ------SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMC-------LVKDQTKR 200
+P K L + + P + K F L + +R
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPR-----KPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 201 PTAEKLLKHSFFK 213
+A++ LKH +FK
Sbjct: 305 ISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKALDYL 65
P + + + F L+ VM ++ G + H+ ++ F+E E L +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFL 117
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL- 124
HR+G I+RD+K N++LD+ G +K+ADFG+ C D +R TF GTP ++APE++
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGM--CKEHMVDGVTTR-TFCGTPDYIAPEIIA 174
Query: 125 -QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
QP Y D W++G+ E+ G PF + L +I + + + K
Sbjct: 175 YQP---YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-LFQSIM--------EHNVSYPK 222
Query: 184 SF-KEMVAMC---LVKDQTKR----PTAEKLLK-HSFFK 213
S KE V++C + K +KR P E+ ++ H+FF+
Sbjct: 223 SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + HP +++ Y S + +V FM G CL A + F + + + + +
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHG-CLSDYLRAQRGKFSQETLLGMCLDVCE 111
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ YL IHRD+ A N L+ N VVK++DFG++ + D Q + +T P W
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD---QYTSSTGTKFPVKWS 168
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
+PEV Y+SK+D+WSFG+ E+ + G P+ +V ++ G +
Sbjct: 169 SPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV----VETINAGFRLYKP 223
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+ S+S E++ C + RP+ LL
Sbjct: 224 RLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 18/195 (9%)
Query: 45 GFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD 104
GF+E E L+ L R+ ++RD+K NILLD G ++++D G+ A G+
Sbjct: 98 GFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL-AVQIPEGE 156
Query: 105 RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164
R R VGT +MAPEV+ Y D W G E+ G +PF K +V
Sbjct: 157 TVRGR---VGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKE-RVKRE 211
Query: 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPE 219
+ + +KFS+ K + M L K+ +R A + +H FK
Sbjct: 212 EVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK-----N 266
Query: 220 LSVKKLFADL--PPL 232
++ K+L A++ PP
Sbjct: 267 INFKRLEANMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 50/170 (29%), Positives = 90/170 (52%), Gaps = 13/170 (7%)
Query: 1 MSLIDHPNVI--RAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ +DH N++ + C +L ++M ++ GS ++ Q ++ + +L +
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS----LRDYLQRHRDQINLKRLLLFS 115
Query: 59 L---KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
K +DYL Q +IHRD+ A NIL+++ +VK++DFG++ + + D +
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLM 164
W APE L+ S ++S +D+WSFG+T EL +G S+ PP + L M
Sbjct: 176 IFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDP--SQSPPAEFLRM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H ++R Y + ++++ +MA+GS L +K + + +
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ Y+ R+ +IHRD++A N+L+ + + K+ADFG++ + D R F P W
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF---PIKWT 171
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTIQNAPPGLDYD 176
APE + GS + K+D+WSFGI E+ +G P YP M ++ +Q G
Sbjct: 172 APEAINFGS-FTIKSDVWSFGILLYEIVTYGKIP---YPGMSNSDVMSALQR---GYRMP 224
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
R + +++ C + +RPT + L
Sbjct: 225 RMENCPDELYDIMKTCWKEKAEERPTFDYL 254
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 21 NLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79
+++VVM M S LH I + D E I L + L+ L Y+H IHRD+K N
Sbjct: 82 DVYVVMDLM--ESDLH--HIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSN 137
Query: 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNT-FVGTPCWMAPEVLQPGSGYNSKADIWS 138
+L++ + +++ DFG++ + + + T +V T + APE+L Y + D+WS
Sbjct: 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197
Query: 139 FG-ITALELAHGHA-PFSKY-------------PPMKVLLMT--------IQNAPPGLDY 175
G I A L P Y P +VL IQN P
Sbjct: 198 VGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPV 257
Query: 176 DRDKKFSKSFKE---MVAMCLVKDQTKRPTAEKLLKHSFFK 213
K F K+ E +++ L D +R T E+ L+H F
Sbjct: 258 PWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 66/267 (24%), Positives = 104/267 (38%), Gaps = 68/267 (25%)
Query: 3 LIDHPNVIRAYCSFVVDSN--LWVVMPFMAEGSCLH------LMK------IAYQDGFEE 48
L DHPN+++ +++ +++V +M + LH +++ I YQ
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYME--TDLHAVIRANILEDVHKRYIMYQ----- 115
Query: 49 SAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS 108
LKAL Y+H IHRD+K NILL+++ VKLADFG+ A +
Sbjct: 116 ---------LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL-ARSLSELEENPE 165
Query: 109 RNT---FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL--L 163
+V T + APE+L + Y D+WS G E+ G F + L +
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225
Query: 164 MTIQNAPPGLD----------------YDRDKKFSKSFKEMVAM-----------CLVKD 196
+ + P D R + K E++ LV +
Sbjct: 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPR---KPLDELLPKASDDALDLLKKLLVFN 282
Query: 197 QTKRPTAEKLLKHSFFK--HAKPPELS 221
KR TAE+ L+H + H E
Sbjct: 283 PNKRLTAEEALEHPYVAQFHNPSDEPV 309
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 19/233 (8%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKALDY 64
HP + SF L VM + G HL + + F E E + ALDY
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDY 110
Query: 65 LHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
LH + ++ +RD+K N++LD +G +K+ DFG+ G + TF GTP ++APEV
Sbjct: 111 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK---TFCGTPEYLAPEV 167
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
L+ + Y D W G+ E+ G PF K+ + + + + S
Sbjct: 168 LE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----EIRFPRTLSP 221
Query: 184 SFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
K +++ L KD +R A+++++H FF ++ KKL P
Sbjct: 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKP 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 45/154 (29%), Positives = 79/154 (51%), Gaps = 4/154 (2%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M I HPN+++ + +++ FM G+ L ++ + + + +
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A++YL ++ IHRD+ A N L+ N +VK+ADFG+S M TGD + W A
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTA 173
Query: 121 PEVLQPGSGYNSKADIWSFGITALELA-HGHAPF 153
PE L ++ K+D+W+FG+ E+A +G +P+
Sbjct: 174 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 40/201 (19%)
Query: 46 FEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
F S I ++K L L Y+HR +HRD+KA NIL+ +G++KLADFG++ + +
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175
Query: 106 QRSRNT-FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM----- 159
+ +R T V T + PE+L Y D+W G E+ +++ P M
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM------WTRSPIMQGNTE 229
Query: 160 -KVLLMTIQ-------NAPPGLD-YDRDKKFS--KSFKEMVAM----------------- 191
L + Q PG+D + KK + K V
Sbjct: 230 QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDK 289
Query: 192 CLVKDQTKRPTAEKLLKHSFF 212
LV D KR A+ L H FF
Sbjct: 290 LLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 7/163 (4%)
Query: 4 IDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKA 61
+ H N+++ CS L ++M ++ GS L + + + ++ +
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS---LRDYLPKHKLNLAQLLLFAQQICEG 119
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
+ YLH Q +IHRD+ A N+LLD + +VK+ DFG++ + + + R R W A
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164
E L+ + +D+WSFG+T EL H + PP K M
Sbjct: 180 ECLKENKFSYA-SDVWSFGVTLYELL-THCDSKQSPPKKFEEM 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 28/233 (12%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
++HPN+++ ++ L++V F+ + M + G I S L + L+ L
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
+ H +HRD+K N+L++T G +KLADFG++ G R+ V T + APE+
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEI 171
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSK-------YPPMKVLLMTIQNAPPGLDYD 176
L Y++ DIWS G E+ A F + + L + PG+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231
Query: 177 RDKKFS------KSFKEMVAMC-----------LVKDQTKRPTAEKLLKHSFF 212
D K S + F ++V L D KR +A+ L H FF
Sbjct: 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 28/231 (12%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN++R ++ L++V F+ + M + G + I S L + L+ + Y
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
H +HRD+K N+L+D G +KLADFG+ A F G R+ V T + APE+L
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGL-ARAF--GVPVRTYTHEVVTLWYRAPEILL 172
Query: 126 PGSGYNSKADIWSFGITALELAHGHAPFSK-------YPPMKVLLMTIQNAPPGL----D 174
Y++ DIWS G E+ + F + + L ++ PG+ D
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232
Query: 175 YD------RDKKFSKSFK-------EMVAMCLVKDQTKRPTAEKLLKHSFF 212
Y + SK ++++ LV D KR +A+ L+H +F
Sbjct: 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 11/208 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H +++ + + V ++++ FMA+GS L +K + + +
Sbjct: 55 MKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ ++ ++ +IHRD++A NIL+ + V K+ADFG++ + D R F P W
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIKWT 170
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE + GS + K+D+WSFGI +E+ +G P YP M I+ G R
Sbjct: 171 APEAINFGS-FTIKSDVWSFGILLMEIVTYGRIP---YPGMSN-PEVIRALERGYRMPRP 225
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
+ + ++ C +RPT E +
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
M DHPN+IR + ++ +M GS ++ DG F + +L+
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIA 116
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG-TPC- 117
+ YL ++HRD+ A NIL+++N V K++DFG+S D + + T G P
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR---RLEDSEATYTTKGGKIPIR 173
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVL--LMTIQNAPPGLD 174
W APE + + S +D+WSFGI E +++G P+ V+ + PP +D
Sbjct: 174 WTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMD 232
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ +++ C KD+ +RPT +++
Sbjct: 233 ------CPSALYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++ I+HP + Y SF +S L++V+ F+ G ++ F + +
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVL 142
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+YL ++RD+K N+LLD +G +K+ DFG A + DT T GTP ++A
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF-AKVVDT-----RTYTLCGTPEYIA 196
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+L G+ AD W+ GI E+ G PF P L+ Q G+ Y K
Sbjct: 197 PEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQKILEGIIY-FPKF 250
Query: 181 FSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFF 212
+ K ++ L D TKR A+ + +H +F
Sbjct: 251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 41/112 (36%), Positives = 62/112 (55%), Gaps = 8/112 (7%)
Query: 46 FEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
F E I S +K+ L+ L+Y H++ +HRD+K NILL+ G +KLADFG+ A ++++ +
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEES 171
Query: 106 QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157
+ N V T + PE+L Y D+WS G EL F+K P
Sbjct: 172 RPYTNK-VITLWYRPPELLLGEERYGPAIDVWSCGCILGEL------FTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 43 QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDT 102
+ GFEE E L+ LH++ ++RD+K NILLD +G ++++D G+ A
Sbjct: 96 EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL-AVHVPE 154
Query: 103 GDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162
G + R VGT +MAPEV++ Y D W+ G E+ G +PF + K+
Sbjct: 155 GQTIKGR---VGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKK-KIK 209
Query: 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKP 217
++ + + +KFS + + M L KD +R A ++ +H FK
Sbjct: 210 REEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ--- 266
Query: 218 PELSVKKLFADL--PPL 232
++ K+L A + PP
Sbjct: 267 --INFKRLEAGMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 67/245 (27%), Positives = 105/245 (42%), Gaps = 43/245 (17%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNL---WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKE 57
+ L HPN++ VV SNL ++VM ++ E LM+ Q F +S + ++ +
Sbjct: 59 LKL-QHPNIVTVK-EVVVGSNLDKIYMVMEYV-EHDLKSLMETMKQP-FLQSEVKCLMLQ 114
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
L + +LH +HRD+K N+LL+ G++K+ DFG+ A + G + V T
Sbjct: 115 LLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL-AREY--GSPLKPYTQLVVTLW 171
Query: 118 WMAPEVLQPGSGYNSKADIWSFG------ITALELAHGHAP------------------- 152
+ APE+L Y++ D+WS G +T L G +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231
Query: 153 --FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS---FKEMVAMCLVKDQTKRPTAEKLL 207
FS+ P K T P + S S F + + L D KR +AE L
Sbjct: 232 PGFSELPGAK--KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRL-LTYDPAKRISAEDAL 288
Query: 208 KHSFF 212
KH +F
Sbjct: 289 KHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
M DHPN+I + +V +M GS ++ DG F + +L+
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR--KHDGQFTVIQLVGMLRGIA 116
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT-PC- 117
+ YL G++HRD+ A NIL+++N V K++DFG+S + D D + + T G P
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIR 174
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQN--APPGLD 174
W APE + + S +D+WS+GI E +++G P+ + V+ + P +D
Sbjct: 175 WTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMD 233
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207
+ +++ C KD+ +RP E+++
Sbjct: 234 ------CPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
H ++I + V ++++ M +GS L ++ +++ + + + + YL
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125
Q IHRD+ A NIL+ + V K+ADFG++ + + + W APE
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---WTAPEAAS 177
Query: 126 PGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPM 159
G+ +++K+D+WSFGI E+ +G P YP M
Sbjct: 178 HGT-FSTKSDVWSFGILLYEMFTYGQVP---YPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M DHP++++ + ++ +W+VM G +++ + + +++ +
Sbjct: 61 MRQFDHPHIVK-LIGVITENPVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSYQLST 118
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
AL YL + +HRD+ A N+L+ + VKL DFG+S + D + S+ P WM
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL---PIKWM 175
Query: 120 APEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVL--------LMTIQNAP 170
APE + + S +D+W FG+ E L G PF V+ L N P
Sbjct: 176 APESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP 234
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
P L Y ++ C D +KRP +L
Sbjct: 235 PTL-YS-----------LMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVD-SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M+ + H N+++ V + L++V +MA+GS + ++ + + +
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-W 118
+A++YL +HRD+ A N+L+ + V K++DFG++ T D + P W
Sbjct: 113 EAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-------LPVKW 165
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
APE L+ +++K+D+WSFGI E+ + G P+ + P+K ++ ++ G D
Sbjct: 166 TAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEK---GYKMDA 220
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
+++ C D RP+ +L
Sbjct: 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 64/250 (25%), Positives = 100/250 (40%), Gaps = 47/250 (18%)
Query: 4 IDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKE 57
+ H NVI F + ++VMP+M L KI E + ++ +
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHP-LSEDKVQYLVYQ 125
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGV--SACMFDTGDRQRSRNTFVGT 115
L L Y+H G IHRD+K GN+ ++ + +K+ DFG+ A TG +V T
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--------YVVT 177
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ-NAPPGLD 174
+ APEV+ YN DIWS G E+ G F + L ++ PG +
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237
Query: 175 YDRD------------------KKFSKSFK-------EMVAMCLVKDQTKRPTAEKLLKH 209
+ + K FS F +++ L D KR TA + L+H
Sbjct: 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297
Query: 210 SFFKHAKPPE 219
+F + +
Sbjct: 298 PYFDSFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 56/207 (27%), Positives = 83/207 (40%), Gaps = 36/207 (17%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
I + L+AL YLH +G IHRDVK NI LD L DFG +AC D +
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG-AACKLDAHPDTPQCYGWS 248
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP-FSKYPP-----MKVLLMTIQ 167
GT +PE+L Y +K DIWS G+ E++ + F K ++ ++ +Q
Sbjct: 249 GTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307
Query: 168 NAPPGLDYDRDKKFSKSFKE--------------------------MVAMCLVKDQTKRP 201
P + K FK+ ++A L DQ RP
Sbjct: 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367
Query: 202 TAEKLLKHSFFKHAKPPELSVKKLFAD 228
+A+ +L F L++ +D
Sbjct: 368 SAQDILSLPLFTKEPINLLNI--TPSD 392
|
Length = 392 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 42/238 (17%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG----FEESAIGSILKETLKA 61
H N++R Y D L +V + C +K Y D + + S + + LK
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEY-----CDQDLK-KYFDSCNGDIDPEIVKSFMFQLLKG 111
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
L + H +HRD+K N+L++ NG +KLADFG++ G R + V T + P
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPP 168
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP----------MKVLLMTIQNAPP 171
+VL Y++ D+WS G ELA+ P +P ++L + + P
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEESWP 226
Query: 172 GLDYDRDKKFSKSF-----------------KEMVAMCLVKDQTKRPTAEKLLKHSFF 212
G+ D K + ++++ LV + +R +AE+ L+H +F
Sbjct: 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MS +HPN+++ +++ +++M M G L ++ A + F + LKE L
Sbjct: 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLL--TLKELLD 110
Query: 61 -ALD------YLHRQGHIHRDVKAGNILLDTNG-----VVKLADFGVSACMFDTGDRQRS 108
LD YL + IHRD+ A N L+ G VVK+ DFG++ ++ + D R
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS-DYYRK 169
Query: 109 RNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQ 167
+ WMAPE L G + +++D+WSFG+ E L G P+ +VL Q
Sbjct: 170 EGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL----Q 224
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT 202
+ G + + +++ C +D ++RPT
Sbjct: 225 HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETLKA-- 61
DHPN+++ V +++VM + GS L L K + +L+ +L A
Sbjct: 50 DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-----NRLTVKKLLQMSLDAAA 104
Query: 62 -LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS----ACMFDTGDRQRSRNTFVGTP 116
++YL + IHRD+ A N L+ N V+K++DFG+S ++ D + P
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ------IP 158
Query: 117 C-WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPM 159
W APE L G Y S++D+WS+GI E + G P YP M
Sbjct: 159 IKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTP---YPGM 199
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
M DHPN+I + ++ FM G+ ++ DG F + +L+
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIA 116
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT---- 115
+ YL ++HRD+ A NIL+++N V K++DFG+S + D S T+ +
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED----DTSDPTYTSSLGGK 172
Query: 116 -PC-WMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQN--AP 170
P W APE + + S +D+WS+GI E +++G P+ V+ Q+ P
Sbjct: 173 IPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP 231
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP 201
P +D + +++ C KD+ RP
Sbjct: 232 PPMD------CPTALHQLMLDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 53/210 (25%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL- 59
M+ + H N++R ++ + L++VM M++G+ ++ ++ G ++ +L+ +L
Sbjct: 53 MTKLHHKNLVR-LLGVILHNGLYIVMELMSKGNLVNFLR---TRGRALVSVIQLLQFSLD 108
Query: 60 --KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+ ++YL + +HRD+ A NIL+ +GV K++DFG++ N+ +
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVK- 162
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
W APE L+ ++SK+D+WS+G+ E+ ++G AP YP M + + + G +
Sbjct: 163 WTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAP---YPKMSLKEVK-ECVEKGYRME 217
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
+ ++ C + KRP+ KL
Sbjct: 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-13
Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 37/247 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN--LWVVMPFMAEGSCLHLMKIAYQ--DGFEESAIGSILK 56
M + H N++R F+ +N L+++M F G ++ Y+ EE AI I +
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 57 ETLKALDYLHR-------QGHIHRDVKAGNILLDT---------------NG--VVKLAD 92
+ L AL Y H + +HRD+K NI L T NG + K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 93 FGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL-QPGSGYNSKADIWSFGITALELAHGHA 151
FG+S + + ++ VGTP + +PE+L Y+ K+D+W+ G EL G
Sbjct: 186 FGLSKNI----GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
PF K L+ ++ P + K+ + K ++ + +RP+A + L +
Sbjct: 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNL----SAKERPSALQCLGYQI 297
Query: 212 FKHAKPP 218
K+ PP
Sbjct: 298 IKNVGPP 304
|
Length = 1021 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 42/107 (39%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 52 GSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
I K+ L+ L YLH Q IHRDVK NI ++ V + D G +
Sbjct: 160 LIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----G 215
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYP 157
GT APEVL YNSKADIWS GI E LA+ F P
Sbjct: 216 LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
|
Length = 357 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 53/165 (32%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 1 MSLIDHPNVIR--AYCSFVVDSNLW----VVMPFMAEGSCLHLMKIAYQDG-----FEES 49
M DHPNV+R C V+S + V++PFM G LH + + G
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGD-LHSFLLYSRLGDCPQYLPTQ 112
Query: 50 AIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSR 109
+ + + ++YL + IHRD+ A N +L+ N V +ADFG+S +++ GD R
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN-GDYYRQG 171
Query: 110 NTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPF 153
W+A E L Y +K+D+WSFG+T E+A G P+
Sbjct: 172 RIAKMPVKWIAIESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMP-FMAEGSCLHLMKIAYQDGFEESAIGSILKETLKAL 62
I+HP++I+ +F + +++P + + C +A + I +I + L+A+
Sbjct: 140 INHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY----LAAKRNIAICDILAIERSVLRAI 195
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
YLH IHRD+KA NI ++ G V L DFG +AC F + GT APE
Sbjct: 196 QYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AAC-FPVDINANKYYGWAGTIATNAPE 253
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGH 150
+L Y DIWS GI E+A H
Sbjct: 254 LLARDP-YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 53/232 (22%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA-------------------YQD 44
++HP+VI+ Y + D L +++ + GS ++ +
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 45 GFEESAIGSILK---ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMF- 100
+G ++ + + + YL +HRD+ A N+L+ +K++DFG+S ++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 101 DTGDRQRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPP 158
+ +RS+ P WMA E L Y +++D+WSFG+ E+ G P+ P
Sbjct: 180 EDSYVKRSKGRI---PVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 159 MKV--LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
++ LL T G +R + S+ ++ C ++ KRPT + K
Sbjct: 236 ERLFNLLKT------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKI-AYQDGFEESAIGSILKETL 59
M + H N++R + ++ L +V +M + M + + + + S + L
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS----RNTF--- 112
K + + H +HRD+K N+L++ G +KLADFG++ R+ NTF
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA----------RAFGIPVNTFSNE 160
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153
V T + AP+VL Y++ DIWS G E+ G F
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLH--LMKIAYQDGFEESAIG 52
M DHPNV++ S+L V++PFM G LH L+ E+ +
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGD-LHSFLLYSRLGGLPEKLPLQ 113
Query: 53 SILK---ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSR 109
++LK + ++YL + IHRD+ A N +L + V +ADFG+S ++ +GD R
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY-SGDYYRQG 172
Query: 110 NTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPF 153
W+A E L Y SK+D+W+FG+T E+A G P+
Sbjct: 173 RIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 67/266 (25%), Positives = 101/266 (37%), Gaps = 65/266 (24%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPF-MAEGSCLHLMKIAYQDG---FEESAIGSILKETL 59
+ H NV+ F+ ++ V + F AE ++K Q S + S+L + L
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 60 KALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFD-------TGDRQRS 108
+ YLH +HRD+K NIL+ GVVK+ D G+ A +F+ D
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL-ARLFNAPLKPLADLDP--- 174
Query: 109 RNTFVGTPCWMAPEVLQPGSGYNSKADIWSFG------ITALELAHG-HAPFSKYPP--- 158
V T + APE+L Y DIW+ G +T + G A K P
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 159 ------MKVLLMTIQNAPPGL----DYDRDKKF----------------------SKSFK 186
+VL + P + +YD K S+ F
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 187 EMVAMCLVKDQTKRPTAEKLLKHSFF 212
+ + D TKR TAE+ L+H +F
Sbjct: 292 LLRKLLEY-DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 64/276 (23%), Positives = 112/276 (40%), Gaps = 61/276 (22%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
+ ++H N+I F +L ++VM M C ++ + + + + +
Sbjct: 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLC----QVIHME-LDHERMSYL 128
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L + +LH G IHRD+K NI++ ++ +K+ DFG++ T +V
Sbjct: 129 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNFMMTPYVV 184
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS------------------KY 156
T + APEV+ G GY DIWS G EL G F
Sbjct: 185 TRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
Query: 157 PPMKVLLMTIQN------APPGL-------------DYDRDKKFSKSFKEMVAMCLVKDQ 197
M L T++N PG+ + +RDK + +++++ LV D
Sbjct: 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP 303
Query: 198 TKRPTAEKLLKHSFFK--------HAKPPELSVKKL 225
KR + ++ L+H + A PP++ +L
Sbjct: 304 DKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQL 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 59/227 (25%), Positives = 112/227 (49%), Gaps = 26/227 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +DH ++R ++L +V GS L ++ ++D + + + + K
Sbjct: 63 MGSLDHAYIVR-LLGICPGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAK 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ YL +HR++ A NILL ++ +V++ADFGV+ ++ D ++ + TP WM
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP--DDKKYFYSEHKTPIKWM 178
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
A E + G Y ++D+WS+G+T E+ ++G P++ P +V P L ++
Sbjct: 179 ALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---------PDL-LEKG 227
Query: 179 KKFSKS-------FKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
++ ++ + MV C + D+ RPT K L + F + A+ P
Sbjct: 228 ERLAQPQICTIDVYMVMVK-CWMIDENVRPTF-KELANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 44/199 (22%)
Query: 47 EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ 106
E+ I L + L+ L Y+H G +HRD+K NIL++ N +K+ DFG++ Q
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI-------Q 158
Query: 107 RSRNT-FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY--------- 156
+ T +V T + APE++ Y+ + DIWS G E+ G F
Sbjct: 159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218
Query: 157 ------PPMKVL--------LMTIQNAPPGLDYDRDKK-FSKSFK-------EMVAMCLV 194
PP V+ L +Q+ P R+ FS+ FK +++ LV
Sbjct: 219 TDLLGTPPDDVINTICSENTLRFVQSLP-----KREPVPFSEKFKNADPSAIDLLEKMLV 273
Query: 195 KDQTKRPTAEKLLKHSFFK 213
D KR +A + L H +
Sbjct: 274 FDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 1 MSLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M +D+P ++R C L +VM MA G L+ +D S + ++ +
Sbjct: 49 MHQLDNPYIVRMIGVCE---AEALMLVME-MASGGPLNKFLSGKKDEITVSNVVELMHQV 104
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ YL + +HRD+ A N+LL K++DFG+S + ++R + P
Sbjct: 105 SMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR-SAGKWPLK 163
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSK 155
W APE + ++S++D+WS+GIT E ++G P+ K
Sbjct: 164 WYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 32/234 (13%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGS-CLHLMKIAYQDGFEESAIGSILKETL 59
+S + PN+ R VD L ++M +M G L K + S+ TL
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 60 K--------ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
+ YL +HRD+ N L+ N +K+ADFG+S ++ + D R +
Sbjct: 133 LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY-SSDYYRVQGR 191
Query: 112 FVGTPCWMAPE-VLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL--MTIQN 168
WMA E VL + +K+D+W+FG+T E+ + P + L I+N
Sbjct: 192 APLPIRWMAWESVL--LGKFTTKSDVWAFGVTLWEI----LTLCREQPYEHLTDQQVIEN 245
Query: 169 APPGLDYDRDKKF---------SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
A G + D + K E++ C +D+ RPT ++ H F +
Sbjct: 246 A--GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 2/112 (1%)
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L+ L YLH G +HRD+K GN+L+++N V+K+ DFG++ + D + V
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA--RVEEPDESKHMTQEVV 166
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI 166
T + APE+L Y S DIWS G EL F P++ L +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEES-AIGSILKETL----- 59
H N+I + D L+V++ + ++G+ ++ G E S I + E +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 60 --------KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
+ ++YL Q IHRD+ A N+L+ N V+K+ADFG++ + + +++ N
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAP 170
+ WMAPE L Y ++D+WSFG+ E+ G +P+ P ++ + +
Sbjct: 200 RLPVK-WMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE--- 254
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
G D+ + M+ C + RPT ++L++
Sbjct: 255 -GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 51/229 (22%), Positives = 101/229 (44%), Gaps = 19/229 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSC-LHLMKIAYQDGFEESAIGSILKETL 59
+ ++ P ++ +F ++L +VM M G H+ + + G E + +
Sbjct: 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQIT 105
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ +LH ++RD+K N+LLD G +L+D G++ + D ++ GT +M
Sbjct: 106 CGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTITQRAGTNGYM 161
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM----KVLLMTIQNAPPGLDY 175
APE+L+ Y+ D ++ G + E+ G PF + ++ T+++ + +
Sbjct: 162 APEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE---VKF 217
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKR----PTAEKLLKHSFFKHAKPPEL 220
+ F++ K++ + L K R + KH FFK P L
Sbjct: 218 EHQ-NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-12
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 8/106 (7%)
Query: 52 GSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGV---VKLADFGVSACMFDTGDRQRS 108
G ++ + L AL H QG +HRD+K NI++ GV K+ DFG+ + D +
Sbjct: 82 GRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVA 141
Query: 109 RNT----FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGH 150
T +GTP + APE L+ G +D++++G+ LE G
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLR-GEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 50/183 (27%), Positives = 75/183 (40%), Gaps = 26/183 (14%)
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L+ L Y+H +HRD+K N+LL+TN +K+ DFG++ D +V
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTIQNAPPG 172
T + APE++ GY DIWS G E+ F Y L++ + P
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231
Query: 173 LDYD-----RDKKFSKS--FKEMVAM-----------------CLVKDQTKRPTAEKLLK 208
D + R + + KS FK V L + KR T E+ L
Sbjct: 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291
Query: 209 HSF 211
H +
Sbjct: 292 HPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 28/165 (16%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
M L++H N+I F +L ++VM M C Q + + +
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-----VIQMDLDHERMSYL 123
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT--- 111
L + L + +LH G IHRD+K NI++ ++ +K+ DFG++ R+ T
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----------RTAGTSFM 173
Query: 112 ---FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153
+V T + APEV+ G GY DIWS G E+ G F
Sbjct: 174 MTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 27/231 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM-------KIAYQDGFEESAIGS 53
MS + +PN+IR V D L ++ +M G + + + +I +
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 54 ILKETLK---ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRN 110
+L ++ + YL +HRD+ N L+ + +K+ADFG+S ++ +GD R +
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY-SGDYYRIQG 189
Query: 111 TFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL--MTIQN 168
V WMA E + G + + +D+W+FG+T E+ K P +L I+N
Sbjct: 190 RAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEM----FTLCKEQPYSLLSDEQVIEN 244
Query: 169 APPGL-DYDRDKKFSK------SFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
+ R S+ +++ C +D RPT K+ H F
Sbjct: 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI--HHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 24/162 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEG--------------SCLHLMKIAYQDGF 46
M + +V+R VVM MA+G + L Q
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 47 EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ 106
+ +A E + YL + +HRD+ A N ++ + VK+ DFG++ +++T +
Sbjct: 123 QMAA------EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 107 RSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA 147
+ + P WMAPE L+ G + +K+D+WSFG+ E+A
Sbjct: 177 KGGKGLL--PVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 53/220 (24%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEES--------------AI 51
H N+I + D L+V++ + ++G+ ++ G E +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 52 GSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
S + + ++YL + IHRD+ A N+L+ + V+K+ADFG++ + +++ N
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYP--PMKVLLMTIQN 168
+ WMAPE L Y ++D+WSFG+ E+ G +P YP P++ L ++
Sbjct: 203 RLPVK-WMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSP---YPGVPVEELFKLLKE 257
Query: 169 APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
G D+ + M+ C ++RPT ++L++
Sbjct: 258 ---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 27/192 (14%)
Query: 45 GFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTN-GVVKLADFGVSACMFDTG 103
I S + + LK + + H+ G +HRD+K N+L+D G++K+AD G+ F
Sbjct: 106 PLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA-FSIP 164
Query: 104 DRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163
+ + + T + APEVL + Y++ DIWS G E++ F ++ LL
Sbjct: 165 VKSYTHE--IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222
Query: 164 MTIQ--NAP-----PGLDYDRD---------KKFSKSFK-------EMVAMCLVKDQTKR 200
+ P PG+ RD + S++ +++ L D KR
Sbjct: 223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKR 282
Query: 201 PTAEKLLKHSFF 212
+A+ L H +F
Sbjct: 283 ISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 42/110 (38%), Positives = 59/110 (53%), Gaps = 13/110 (11%)
Query: 51 IGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRN 110
+ ++ ++ L A+DY+H +G IHRD+K N+L++ + L DFG +AC F G S +
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AAC-FARG----SWS 315
Query: 111 T-----FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFS 154
T GT APEVL G Y DIWS G+ E A H + FS
Sbjct: 316 TPFHYGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 38/167 (22%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ +++L + IHRD+ A NILL N VVK+ DFG++ ++ D R + + WM
Sbjct: 184 RGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK-WM 242
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE + Y +++D+WSFG+ E+ + G +P+ PG+ D +
Sbjct: 243 APESIF-DKVYTTQSDVWSFGVLLWEIFSLGASPY-----------------PGVQIDEE 284
Query: 179 KKFSKSFKEMVAM----------------CLVKDQTKRPTAEKLLKH 209
F + KE M C + RPT +L++
Sbjct: 285 --FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 5 DHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
+HPNV+R + V ++ L +V + + +L K+ + G I ++ + L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLL 120
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ LD+LH +HRD+K NIL+ ++G +KLADFG++ Q + + V T +
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWYR 176
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL 146
APEVL S Y + D+WS G E+
Sbjct: 177 APEVLLQ-SSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 31/194 (15%)
Query: 47 EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ 106
++ S + + L L Y+H +HRD+K GN+L++ + +K+ DFG+ A F +
Sbjct: 103 TDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL-ARGFSENPGE 161
Query: 107 RSR--NTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK---YPPMKV 161
+ +V T + APE++ Y D+WS G EL G P K Y
Sbjct: 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPVFKGKDYVDQLN 220
Query: 162 LLMTIQNAPP-----------GLDYDRD------KKFSKSFK-------EMVAMCLVKDQ 197
++ + P +Y R K F F +++ L D
Sbjct: 221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDP 280
Query: 198 TKRPTAEKLLKHSF 211
TKR + E+ L+H +
Sbjct: 281 TKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 6 HPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK---ETLK 60
H N+++ C+ + + ++M F+ GS +K + + LK + K
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+DYL + ++HRD+ A N+L+++ VK+ DFG++ + + ++ W A
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI 166
PE L Y + +D+WSFG+T EL S+ PM + L I
Sbjct: 181 PECLIQSKFYIA-SDVWSFGVTLYELLTYCD--SESSPMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 38/167 (22%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
K +++L + IHRD+ A NILL N VVK+ DFG++ ++ D R + + WM
Sbjct: 190 KGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK-WM 248
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE + Y ++D+WSFG+ E+ + G +P YP +K+ D
Sbjct: 249 APETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKI----------------D 288
Query: 179 KKFSKSFKEMVAM----------------CLVKDQTKRPTAEKLLKH 209
++F + KE M C + ++RPT +L++H
Sbjct: 289 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ +DHP ++R V +++ +A L ++ S + + +
Sbjct: 50 MAQLDHPCIVRLIG--VCKGEPLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAM 106
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACM--------FDTGDRQRSRNTF 112
+ YL + +HRD+ A N+LL K++DFG+S + T R +
Sbjct: 107 GMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK--- 163
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSK 155
W APE + G ++SK+D+WS+G+T E ++G P+ +
Sbjct: 164 -----WYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKA--- 61
DHPN+++ +++VM + G L ++ +E ++K L A
Sbjct: 50 DHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAG 105
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WMA 120
+ YL + IHRD+ A N L+ N V+K++DFG+S D S + P W A
Sbjct: 106 MAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTA 162
Query: 121 PEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPM 159
PE L G Y+S++D+WS+GI E + G P YP M
Sbjct: 163 PEALNYGR-YSSESDVWSYGILLWETFSLGVCP---YPGM 198
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L+ L Y+H +HRD+K N+LL+ N +K+ DFG++ + GD +V
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM---TEYVV 170
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146
T + APE+L S Y + D+WS G EL
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 39/238 (16%)
Query: 5 DHPNVIRAY---CSFVVDSNLWVVMPFMAEGSCL--HLMKIAYQDGFEESAIGSILKETL 59
DHPN++R + D V + F L +L K+ G I ++++ L
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVP-PPGLPAETIKDLMRQFL 118
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS---ACMFDTGDRQRSRNTFVGTP 116
+ LD+LH +HRD+K NIL+ + G VKLADFG++ +C Q + V T
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC-------QMALTPVVVTL 171
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTIQNAPPGLD 174
+ APEVL S Y + D+WS G E+ F L + + PP D
Sbjct: 172 WYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230
Query: 175 YDRD----------------KKFSKSFKEMVAMCLVK----DQTKRPTAEKLLKHSFF 212
+ RD + +E A L++ + KR +A + L+H FF
Sbjct: 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 36/203 (17%)
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L+ L Y HR+ +HRD+K N+L++ G +KLADFG++ ++ + V
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA---KSVPTKTYSNEVV 166
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK-------YPPMKVLLMTIQ 167
T + P+VL S Y+++ D+W G E+A G F + ++L +
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226
Query: 168 NAPPGL---DYDRDKKFSKSFK----------------EMVAMCLVKDQTKRPTAEKLLK 208
PG+ D ++ F K +K E++ L + KR +AE+ +K
Sbjct: 227 ETWPGISSNDEFKNYNFPK-YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285
Query: 209 HSFFK------HAKPPELSVKKL 225
H++F+ H+ P +S+ L
Sbjct: 286 HAYFRSLGTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 46/173 (26%), Positives = 83/173 (47%), Gaps = 18/173 (10%)
Query: 1 MSLID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M LI H N+I + L+V++ + A+G+ ++ G + + + + E
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 60 --------------KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
+ ++YL + IHRD+ A N+L+ + V+K+ADFG++ + D
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 106 QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYP 157
+++ N + WMAPE L Y ++D+WSFGI E+ G +P+ P
Sbjct: 191 KKTSNGRLPVK-WMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 55/188 (29%), Positives = 81/188 (43%), Gaps = 31/188 (16%)
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L+AL Y+H HRD+K NIL + + +K+ DFG++ F+ +V
Sbjct: 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 115 TPCWMAPEVLQPGS---GYNSKADIWSFGITALELAHGHAPFSKYPPMKVL-LMT-IQNA 169
T + APE+ GS Y DIWS G E+ G F + L L+T +
Sbjct: 169 TRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226
Query: 170 PPGLDYDR-------------DKK----FSKSFK--EMVAMCLVK-----DQTKRPTAEK 205
P R KK FS+ F + +A+ L++ D RPTAE+
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
Query: 206 LLKHSFFK 213
L +FK
Sbjct: 287 ALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 25/179 (13%)
Query: 1 MSLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKE-- 57
M +I H N+I + L+VV+ + A G+ ++ G S E
Sbjct: 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 58 -TLKAL-----------DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
T K L ++L + IHRD+ A N+L+ + V+K+ADFG++ D
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR---DIHHI 185
Query: 106 QRSRNTFVG-TPC-WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKV 161
R T G P WMAPE L Y ++D+WSFG+ E+ G +P YP + V
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSP---YPGIPV 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 32/192 (16%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
++ + L+ L Y+H IHRD+K N+ ++ + +K+ DFG++ T D +V
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTG---YV 178
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAP 170
T + APE++ YN DIWS G EL G F +K++L +
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238
Query: 171 PGL----DYDRDKKFSKSFKEMVAM-------------------CLVKDQTKRPTAEKLL 207
L + + + +S +M M LV D KR TA + L
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 208 KHSFFKHAKPPE 219
H++F P+
Sbjct: 299 AHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 36/194 (18%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT-- 111
++ + L+ L Y+H G IHRD+K N+ ++ + +++ DFG++ RQ
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA--------RQADDEMTG 174
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA--PFSKY------------P 157
+V T + APE++ YN DIWS G EL G A P + Y
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234
Query: 158 PMKVLLMTI---------QNAPPGLDYDRDKKFSKSFK---EMVAMCLVKDQTKRPTAEK 205
P +L I Q+ P D K F + +++ LV D KR +A +
Sbjct: 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294
Query: 206 LLKHSFFKHAKPPE 219
L H +F PE
Sbjct: 295 ALAHPYFSQYHDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKI-AYQDGFEESAIGSILKETL 59
++L P ++ Y S +N+++VM ++ G L+ I Y D EE A+ I E
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD--EEMAVKYI-SEVA 114
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS 96
ALDYLHR G IHRD+K N+L+ G +KL DFG+S
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 5 DHPNVIRAY-CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
D+PN I+ Y + ++ + M ++ +G L+K + E+ + I+++ ++AL+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLI-MDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALN 123
Query: 64 YLHRQGHIHRDVKAGNILLDTNGV-VKLADFGVSACMFDTGDRQRSRNTFVGTPC----- 117
LH+ IH D+K N+L D + L D+G+ +GTP
Sbjct: 124 DLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--------------IGTPSCYDGT 169
Query: 118 --WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP----PMKVLLMTIQNAPP 171
+ +PE ++ G Y+ D W+ G+ EL G PF + ++ LL Q P
Sbjct: 170 LDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP 228
Query: 172 GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK-LLKHSFFKH 214
K SK+ + V L + R T ++KH F K
Sbjct: 229 -----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 39/154 (25%), Positives = 76/154 (49%), Gaps = 5/154 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +D+P ++R + ++ W+++ +AE L+ + E I ++ +
Sbjct: 50 MQQLDNPYIVRMIG--ICEAESWMLVMELAELGPLNKF-LQKNKHVTEKNITELVHQVSM 106
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YL +HRD+ A N+LL T K++DFG+S + + +++ W A
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166
Query: 121 PEVLQPGSGYNSKADIWSFGITALE-LAHGHAPF 153
PE + ++SK+D+WSFG+ E ++G P+
Sbjct: 167 PECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 15/169 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFM----------AEGSCLHLMKIAYQDGFE--E 48
++ H N+++ Y +V +M + G +K E
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 49 SAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS 108
S + I + + YL Q +HRD+ N L+ + VVK+ DFG+S ++ T D R
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT-DYYRV 180
Query: 109 RNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKY 156
+ WM PE + + +++D+WSFG+ E+ +G P+
Sbjct: 181 GGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 6/148 (4%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
K + +L + IHRD+ A N+LL +VK+ DFG++ + + + N + WM
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-WM 210
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE + Y ++D+WS+GI E+ + G P YP M V + G +
Sbjct: 211 APESIFNCV-YTFESDVWSYGILLWEIFSLGSNP---YPGMPVDSKFYKLIKEGYRMAQP 266
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
+ +++ C D KRPT +++
Sbjct: 267 EHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 23/165 (13%)
Query: 53 SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGV-------VKLADFGVSACMFDTGDR 105
++ ++ AL YL + +H +V A NILL G+ +KL+D GVS
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL----- 175
Query: 106 QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPF-SKYPPMKVLL 163
SR V W+APE + G+ ++ AD WSFG T LE+ G P + P K
Sbjct: 176 --SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
Query: 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
++ P + K +++ CL + T+RP+ +L+
Sbjct: 234 YEKKHRLP-------EPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 64 YLHRQGHIHRDVKAGNILLDTNG---VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
YL IHRD+ A N LL G V K+ADFG++ ++ ++ + WM
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK-WMP 189
Query: 121 PEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLM 164
PE G + SK D+WSFG+ E+ + G+ P+ +V+
Sbjct: 190 PEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 38/144 (26%), Positives = 71/144 (49%), Gaps = 3/144 (2%)
Query: 21 NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80
NL +VM ++ G L +++ + + + K ++YL + ++HRD+ NI
Sbjct: 81 NLRLVMEYLPYG-SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNI 139
Query: 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFG 140
L+++ VK+ DFG++ + + + R W APE L S ++ +D+WSFG
Sbjct: 140 LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFG 198
Query: 141 ITALELAHGHAPFSKYPPMKVLLM 164
+ EL ++ S PP + + M
Sbjct: 199 VVLYEL-FTYSDKSCSPPAEFMRM 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 40/146 (27%), Positives = 75/146 (51%), Gaps = 5/146 (3%)
Query: 8 NVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR 67
N++ +F L++V ++ E + L L++ +G + S + + +KA+ + H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYV-EKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG 127
+HRD+K N+L+ N V+KL DFG + + + + + +V T + +PE+L G
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE--YVATRWYRSPELLL-G 175
Query: 128 SGYNSKADIWSFGITALELAHGHAPF 153
+ Y D+WS G EL+ G F
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 33/159 (20%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ DH N++R + + +V +M+ G+ ++ ++ + +L
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLAS 118
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV-----GT 115
+ YL G++H+ + A +L++++ V K++ F +S +
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSEAIYTTMSGKSP 171
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPF 153
W APE +Q ++S +D+WSFGI E +++G P+
Sbjct: 172 VLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
M H N+IR ++ +M G+ ++ DG F + +L+
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR--DHDGEFSSYQLVGMLRGIA 117
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT-PC- 117
+ YL ++HRD+ A NIL+++N K++DFG+S + D D + + T G P
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIR 175
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPF 153
W APE + + S +D+WSFGI E ++ G P+
Sbjct: 176 WTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 25/171 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNL-----------WVVMPFMAEGSCLHLMKIAYQDGFE-- 47
M DHPNVI+ ++ +L V++PFM G LH + + G E
Sbjct: 55 MKEFDHPNVIK-----LIGVSLRSRAKGRLPIPMVILPFMKHGD-LHTFLLMSRIGEEPF 108
Query: 48 ---ESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD 104
+ + + ++YL + IHRD+ A N +L+ N V +ADFG+S ++ +GD
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY-SGD 167
Query: 105 RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFS 154
R W+A E L Y + +D+W+FG+T E+ G P++
Sbjct: 168 YYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYA 217
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ +++L + IHRD+ A NILL N VVK+ DFG++ ++ D R + + WM
Sbjct: 185 RGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK-WM 243
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE + Y +++D+WSFG+ E+ + G +P YP +++ Q G
Sbjct: 244 APESIF-DKVYTTQSDVWSFGVLLWEIFSLGASP---YPGVQINEEFCQRLKDGTRMRAP 299
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+ + ++ C D +RPT L++
Sbjct: 300 ENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 25/175 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGS--------CLHLMKIAYQDGFEESAIG 52
M+ DHPN+++ V + ++ +MA G G
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 53 ------------SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMF 100
I K+ + YL + +HRD+ N L+ N VVK+ADFG+S ++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 101 DTGDRQRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPF 153
+ S N + P WM PE + Y +++D+W++G+ E+ ++G P+
Sbjct: 182 SADYYKASENDAI--PIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 77/310 (24%), Positives = 132/310 (42%), Gaps = 47/310 (15%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
M ++H N+I F +L ++VM M C Q + + +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYL 124
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L + +LH G IHRD+K NI++ ++ +K+ DFG++ T +V
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV 180
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLD 174
T + APEV+ G GY DIWS G E+ K+L PG D
Sbjct: 181 TRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVR----------HKILF-------PGRD 222
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFAD-LPPL- 232
Y +++K +++ C + +PT +++ K L+ KLF D L P
Sbjct: 223 Y--IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN----RPKYAGLTFPKLFPDSLFPAD 276
Query: 233 --WNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDD- 289
N++KA Q +D L P A++ ++ ++ ++ W +D +++A + D
Sbjct: 277 SEHNKLKASQARDLLSKMLVIDP-AKRISVDEALQHPYINVW-YDPAEVEAPPPQIYDKQ 334
Query: 290 -DDMLETKEE 298
D+ T EE
Sbjct: 335 LDEREHTIEE 344
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 66/278 (23%), Positives = 111/278 (39%), Gaps = 65/278 (23%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
M ++H N+I F +L ++VM M C Q + + +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ-----VIQMELDHERMSYL 131
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L + +LH G IHRD+K NI++ ++ +K+ DFG++ T +V
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV 187
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGH--------------------APFS 154
T + APEV+ G GY DIWS G E+ G P
Sbjct: 188 TRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 155 KYPPMKVLLMT----IQNAPPGLDYDRDKKF---------------SKSFKEMVAMCLVK 195
++ MK L T ++N P Y +K F + +++++ LV
Sbjct: 247 EF--MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 196 DQTKRPTAEKLLKHSFFK--------HAKPPELSVKKL 225
D +KR + ++ L+H + A PP++ K+L
Sbjct: 305 DASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQL 342
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 50/218 (22%), Positives = 102/218 (46%), Gaps = 21/218 (9%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEES--------------AI 51
H N+I + D L+V++ + ++G+ ++ G + S +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 52 GSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
S + + ++YL Q IHRD+ A N+L+ + V+K+ADFG++ + + +++ N
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAP 170
+ WMAPE L Y ++D+WSFG+ E+ G +P+ P ++ + +
Sbjct: 197 RLPVK-WMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE--- 251
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
G D+ + ++ C ++RPT ++L++
Sbjct: 252 -GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 7/163 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ +D+P+V R + S + ++ M G L ++ ++D + + + K
Sbjct: 63 MASVDNPHVCR-LLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAK 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
++YL + +HRD+ A N+L+ T VK+ DFG++ + D + P WM
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVPIKWM 178
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKV 161
A E + Y ++D+WS+G+T EL G P+ P ++
Sbjct: 179 ALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 12/150 (8%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-W 118
+ +DYL ++ IHRD+ A NIL+ N V K+ADFG+S G + T P W
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKTMGRLPVRW 189
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
MA E L S Y + +D+WS+G+ E+ G P+ ++ + P G ++
Sbjct: 190 MAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLPQGYRLEK 244
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207
+++ C + +RP+ ++L
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 37/94 (39%), Positives = 58/94 (61%), Gaps = 3/94 (3%)
Query: 53 SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF 112
+I+K+ L A++Y+H + IHRD+K NI L+ +G + L DFG +A F+ +R+ +
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEK-EREAFDYGW 328
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146
VGT +PE+L G GY DIWS G+ L++
Sbjct: 329 VGTVATNSPEILA-GDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 22/160 (13%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKETLKAL 62
HPN++R +++VM + G L ++ +G + + +++ +
Sbjct: 51 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGM 107
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT------P 116
+YL + IHRD+ A N L+ V+K++DFG+S R+ + T P
Sbjct: 108 EYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS--------REEEDGVYASTGGMKQIP 159
Query: 117 C-WMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFS 154
W APE L G Y+S++D+WSFGI E + G P++
Sbjct: 160 VKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYA 198
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 47/180 (26%), Positives = 74/180 (41%), Gaps = 38/180 (21%)
Query: 4 IDHPNV--IRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET--- 58
+ H N+ I C + V+ P+M G+ +K+ Q A T
Sbjct: 65 LSHQNILPILHVCIEDGEPPF-VLYPYMNWGN----LKLFLQQCRLGEANNPQALSTQQL 119
Query: 59 -------LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSA--------CMFDTG 103
+ YLH++G IH+D+ A N ++D VK+ D +S C+ D
Sbjct: 120 VHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 104 DRQRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKV 161
+R P WMA E L Y+S +D+WSFG+ EL G P+ + P ++
Sbjct: 180 NR----------PVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 25/170 (14%)
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
E L +LH+ IH D+ N L + VK+ D+G++ Q + ++
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE-------QYPEDYYITKD 160
Query: 117 C------WMAPEVLQP------GSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLL 163
C W+APE+++ K++IWS G+T EL P+ +VL
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220
Query: 164 MTIQNAPPGLDYDR-DKKFSKSFKEMVAMCLVKDQTKRPTAE---KLLKH 209
++ L + D K+S + E++ C + D RPTAE +LL +
Sbjct: 221 QVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 12/143 (8%)
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ YL + IHRD+ A N+L+ N K+ADFG+S G+ + T P WM
Sbjct: 131 GMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLS-----RGEEVYVKKTMGRLPVRWM 185
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
A E L S Y +K+D+WSFG+ E+ G P+ ++ + P G ++
Sbjct: 186 AIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY----EKLPQGYRMEKP 240
Query: 179 KKFSKSFKEMVAMCLVKDQTKRP 201
+ E++ C +RP
Sbjct: 241 RNCDDEVYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS--RNTF---V 113
L+ L Y H++ +HRD+K N+L+ G +KLADFG++ R +S T+ V
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA--------RAKSVPSKTYSNEV 164
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153
T + P+VL + Y++ D+W G E+A G F
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 25/183 (13%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILKET 58
MS + HPN++ + ++ ++A G LH L++ + + +K +
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD-LHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 59 LKALDYLHRQGHI-------------HRDVKAGNILLDTNGVVKLADFGVSACMFDTGD- 104
L D+LH I HRD+ A N L+ VK++DFG+S ++ + D
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-SADY 179
Query: 105 -RQRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKV 161
R +S++ P WM PE + G + +++DIWSFG+ E+ ++G P+ + +V
Sbjct: 180 YRVQSKSLL---PVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 162 LLM 164
+ M
Sbjct: 236 IEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 13/102 (12%)
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS-----RNT 111
+ L+ L Y+H Q +HRD+K N+L+ G +KLADFG++ R +S ++
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLA--------RAKSIPSQTYSS 162
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153
V T + P+VL + Y+S DIW G +E+ G F
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILKETL 59
MS + PN+IR + L ++ +M G L + Q+ E++ + +I TL
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 60 K--------ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
+ YL +HRD+ N L+ N +K+ADFG+S ++ +GD R +
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY-SGDYYRIQGR 191
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146
V WM+ E + G + + +D+W+FG+T E+
Sbjct: 192 AVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 44 DGFEESAIGSILKETL---KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMF 100
DG E +L T + +++L + +HRD+ A N+LL +VK+ DFG++ +
Sbjct: 229 DGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 101 DTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPM 159
+ +TF+ WMAPE + + Y + +D+WS+GI E+ + G P YP M
Sbjct: 289 HDSNYVSKGSTFLPVK-WMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTP---YPGM 343
Query: 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT 202
V G + ++ +++ C + KRP+
Sbjct: 344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 55/204 (26%), Positives = 84/204 (41%), Gaps = 29/204 (14%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+AL Y+H + HRD+K N+L+D N +KL DFG SA G R S ++ + +
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVS---YICSRFY 236
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ----------- 167
APE++ + Y + D+WS G E+ G+ FS + L+ IQ
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296
Query: 168 ---------NAPPGLDYDRDKKFSKSFKE----MVAMCLVKDQTKRPTAEKLLKHSFFKH 214
P D K F K + ++ L + KR + L FF
Sbjct: 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356
Query: 215 AKPPELSVKKLFADLPPLWNRVKA 238
+ P + + K LP L+N A
Sbjct: 357 LRDPCIKLPKYIDKLPDLFNFCDA 380
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 32/214 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSC---LHLMKIAYQDGFEESAIGSILKE 57
MS + H ++++ Y V D N+ +V ++ G LH K + + K+
Sbjct: 55 MSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQ 109
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGV-------VKLADFGVSACMFDTGDRQRSRN 110
AL YL + +H +V NIL+ G+ +KL+D G+ + +R R
Sbjct: 110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV-ER- 167
Query: 111 TFVGTPCWMAPEVLQPGSGY-NSKADIWSFGITALEL-AHGHAPFSKYPPM-KVLLMTIQ 167
P W+APE ++ G AD WSFG T LE+ ++G P S K Q
Sbjct: 168 ----IP-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ 222
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP 201
+ P D ++ C D TKRP
Sbjct: 223 HRLPMPD-------CAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 24 VVMPFMAEGSCLHLMKIAYQDGFEESAIGS---ILKETLK-------ALDYLHRQGHIHR 73
VVM MA G ++ + E+ G L+E ++ + YL+ + +HR
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEA--ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHR 143
Query: 74 DVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSK 133
D+ A N ++ + VK+ DFG++ +++T D R + WMAPE L+ G + +
Sbjct: 144 DLAARNCMVAHDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPVRWMAPESLKDGV-FTTS 201
Query: 134 ADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMC 192
+D+WSFG+ E+ P+ +VL + G D+ + +++ MC
Sbjct: 202 SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----GGYLDQPDNCPERVTDLMRMC 257
Query: 193 LVKDQTKRPT 202
+ RPT
Sbjct: 258 WQFNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 8/157 (5%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ H N++ + L +V ++ C ++ K + G + L + L+ L
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLS 117
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
Y+H++ +HRD+K N+L+ G +KLADFG++ + + V T + P+V
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARA---KSVPSHTYSNEVVTLWYRPPDV 174
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160
L + Y++ D+W G +E+ G A F P MK
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAF---PGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 7/163 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ +DHP+++R + + +V M G L + ++D + + + K
Sbjct: 63 MASMDHPHLVR-LLGVCLSPTIQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAK 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
+ YL + +HRD+ A N+L+ + VK+ DFG++ + GD + P WM
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL--EGDEKEYNADGGKMPIKWM 178
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKV 161
A E + + ++D+WS+G+T EL G P+ P ++
Sbjct: 179 ALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 44/191 (23%)
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L+ L+Y HR+ +HRD+K N+L++ G +KLADFG++ ++ + V
Sbjct: 110 LFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA---KSIPTKTYSNEVV 166
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG------------------------- 149
T + P++L + Y+++ D+W G E++ G
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226
Query: 150 --------HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP 201
+ F Y K + N P LD D + SK L + KR
Sbjct: 227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSK--------LLQFEGRKRI 278
Query: 202 TAEKLLKHSFF 212
+AE+ +KH +F
Sbjct: 279 SAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 67/252 (26%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESA-----IGSILKETLK 60
H N++R + L++V ++ L L K + D + A I + L + L+
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLD----LDLKK--HMDSSPDFAKNPRLIKTYLYQILR 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ Y H +HRD+K N+L+D +KLADFG++ G R+ V T +
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTFTHEVVTLWYR 170
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAP--------------------------- 152
APE+L Y++ DIWS G E+ + P
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRILGTPNEETWP 229
Query: 153 -----------FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP 201
F K+PP + + P G+D +++ L D +KR
Sbjct: 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVD-------------LLSKMLRLDPSKRI 276
Query: 202 TAEKLLKHSFFK 213
TA L+H +FK
Sbjct: 277 TARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK----IAYQDGF-EESAIGSILK---- 56
HPN+I + L++ + + G+ L ++ + F ++ S L
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 57 -----ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
+ + +DYL ++ IHRD+ A NIL+ N V K+ADFG+S G + T
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYVKKT 169
Query: 112 FVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNA 169
P WMA E L S Y + +D+WS+G+ E+ G P+ ++ +
Sbjct: 170 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKL 224
Query: 170 PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP 201
P G ++ +++ C + +RP
Sbjct: 225 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 45/181 (24%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH---LMKIAYQDGFEESAIGSILKE 57
M+ + HPN++ + + ++ ++ +G LH +M+ + D S +K
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD-LHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 58 TLKALDYLH-------------RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD 104
+L D+LH +H+D+ A NIL+ VK++D G+S ++ + D
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY-SAD 178
Query: 105 RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLL 163
R + + WM PE + G ++S +DIWSFG+ E+ + G P+ + +V+
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 164 M 164
M
Sbjct: 238 M 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 40/240 (16%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSC-LHLMKIAYQDGFEESAIG------- 52
+S + PN+IR V + L ++ +M G L D E
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 53 ---------SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTG 103
+ + + YL +HRD+ N L+ N +K+ADFG+S ++ G
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY-AG 191
Query: 104 DRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH--GHAPFSKYPPMKV 161
D R + V WMA E + G + + +D+W+FG+T E+ P+ + +V
Sbjct: 192 DYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV 250
Query: 162 LLMTIQNAPPGLDYDRDKKFS----------KSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
I+NA ++ RD+ + E++ C +D +RP+ + H+F
Sbjct: 251 ----IENAG---EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI--HAF 301
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 7/147 (4%)
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
E + YL+ +HRD+ A N ++ + VK+ DFG++ +++T D R +
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRKGGKGLLPV 185
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDY 175
WM+PE L+ G + + +D+WSFG+ E+A P+ +VL ++ GL
Sbjct: 186 RWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG---GL-L 240
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPT 202
D+ E++ MC + RP+
Sbjct: 241 DKPDNCPDMLFELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WMAPE 122
+LH+ IH D+ N LL + VK+ D+G+S + +V P W+APE
Sbjct: 115 HLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPE 172
Query: 123 VLQPGSG------YNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDY 175
++ G ++++WS G+T EL G P+ +VL T++ L
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232
Query: 176 DRDK-KFSKSFKEMVAMCLVKDQTKRPTAEKL 206
R K S + E++ C ++ + +RP+AE++
Sbjct: 233 PRLKLPLSDRWYEVMQFCWLQPE-QRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 6/148 (4%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+ +D+L + IHRDV A N+LL V K+ DFG++ + + + N + WM
Sbjct: 223 QGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK-WM 281
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE + Y ++D+WS+GI E+ + G +P YP + V + G R
Sbjct: 282 APESIF-DCVYTVQSDVWSYGILLWEIFSLGKSP---YPGILVNSKFYKMVKRGYQMSRP 337
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
++ MC + T+RPT ++
Sbjct: 338 DFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 49/171 (28%), Positives = 71/171 (41%), Gaps = 48/171 (28%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-- 117
K + +L + IHRD+ A NILL + K+ DFG++ D + N V
Sbjct: 225 KGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR------DIRNDSNYVVKGNARL 278
Query: 118 ---WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGL 173
WMAPE + Y ++D+WS+GI E+ + G +P YP M V
Sbjct: 279 PVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSP---YPGMPV------------ 322
Query: 174 DYDRDKKFSKSFKEMVAM----------------CLVKDQTKRPTAEKLLK 208
D KF K KE M C D KRPT +++++
Sbjct: 323 ----DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 40/187 (21%)
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF---- 112
+ L+ L Y H++ +HRD+K N+L++ G +KLADFG++ R +S T
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA--------RAKSVPTKTYSN 162
Query: 113 -VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA--PFSKYPPMKVLLMTIQNA 169
V T + P+VL + Y++ D+W G E+A G P S L+ +
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGT 222
Query: 170 P-----PGLDYDRDKKFSKSFKEMVAMCLVK-------------------DQTKRPTAEK 205
P PG+ + + + S F + A L+ + R +AE
Sbjct: 223 PTEETWPGITSNEEFR-SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281
Query: 206 LLKHSFF 212
L+HS+F
Sbjct: 282 ALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 37/162 (22%), Positives = 76/162 (46%), Gaps = 9/162 (5%)
Query: 49 SAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS 108
++ + +D+L +HRD+ A N L+ + VK++ +S ++++ + +
Sbjct: 117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-EYYKL 175
Query: 109 RNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTI 166
RN + P W+APE +Q +++K+D+WSFG+ E+ G PF +V L +
Sbjct: 176 RNALI--PLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-LNRL 231
Query: 167 QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
Q L+ + +++ C + RP+ +L+
Sbjct: 232 QAGK--LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 14/156 (8%)
Query: 4 IDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDG-------FEESAIGSI 54
+ HPNVI F+ D +W++ + AE H++K S + S+
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRN 110
L + L + YLH +HRD+K NIL+ G VK+AD G + +
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 111 TFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146
V T + APE+L Y DIW+ G EL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 38/156 (24%), Positives = 75/156 (48%), Gaps = 7/156 (4%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
I + + YL Q +HRD+ N L+ N +VK+ DFG+S ++ T + +T +
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPG 172
WM PE + + +++D+WSFG+ E+ +G P+ + +V+ Q G
Sbjct: 188 PIR-WMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ----G 241
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+R + K +++ C ++ +R +++ K
Sbjct: 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 17/155 (10%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCL--HLMKIAYQDGFEESAIGSILKETLKALDY 64
PN++ + V + ++++V+ AEG L H+ K E + E + ALD
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQH-AEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDA 100
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
LHR+G + RD+ NILLD G ++L F + + D+ D + N + APEV
Sbjct: 101 LHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV- 153
Query: 125 QPG--SGYNSKADIWSFGITALELAHGHAPFSKYP 157
G S D WS G EL G +P
Sbjct: 154 --GGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 14/156 (8%)
Query: 4 IDHPNVIRAYCSFV--VDSNLWVVMPFMAEGSCLHLMKIAYQDG-------FEESAIGSI 54
+ HPNVI F+ D +W++ + AE H++K + S+
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRN 110
L + L + YLH +HRD+K NIL+ G VK+AD G + +
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 111 TFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146
V T + APE+L Y DIW+ G EL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 14/162 (8%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-----------FEESAIG 52
+ H ++++ Y V L +V +M G ++ D +S +
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 53 SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF 112
I ++ + YL Q +HRD+ N L+ N +VK+ DFG+S ++ T + +T
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPF 153
+ WM PE + + +++D+WS G+ E+ +G P+
Sbjct: 184 LPIR-WMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+++L + +HRD+ A N+L+ +VK+ DFG++ + + +TF+ WM
Sbjct: 250 NGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK-WM 308
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYP 157
APE + + Y + +D+WSFGI E+ G P+ + P
Sbjct: 309 APESIF-NNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 33/164 (20%)
Query: 6 HPNVIRAY--CSFVVDSNL-WVVMPFMAEGSCL-HLMKIAYQ------DGFEESAIG--- 52
HP ++ Y CS D + + MP++ EG L L+K +Q + E++++G
Sbjct: 61 HPGIVPVYSICS---DGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 53 SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGV-----------SACMFD 101
SI + ++Y+H +G +HRD+K NILL G V + D+G D
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 102 TGDRQRSRNT----FVGTPCWMAPEVLQPGSGYNSKADIWSFGI 141
+ S T VGTP +MAPE L G + DI++ G+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGV 219
|
Length = 932 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 37/186 (19%), Positives = 79/186 (42%), Gaps = 36/186 (19%)
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTF----V 113
L+ L Y+H +HRD+K N+ ++T V+K+ DFG++ + D S + +
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV----DPHYSHKGYLSEGL 179
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL 173
T + +P +L + Y D+W+ G E+ G F+ ++ + + +++ P
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239
Query: 174 DYDRDKKFS--------------KSFKEMV------------AMCLVKDQTKRPTAEKLL 207
+ DR++ + + ++++ + L + R TAE+ L
Sbjct: 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQI-LTFNPMDRLTAEEAL 298
Query: 208 KHSFFK 213
H +
Sbjct: 299 MHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
K + YL +HRD+ A N+L+ + VK+ DFG+ A + D + + + WM
Sbjct: 120 KGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL-ARLLDIDETEYHADGGKVPIKWM 178
Query: 120 APEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKV--LLMTIQNAPPGLDYD 176
A E + + ++D+WS+G+T EL G P+ P ++ LL + P
Sbjct: 179 ALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP------ 231
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
+ + ++ C + D RP +L+ F + A+ P
Sbjct: 232 QPPICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 45/143 (31%), Positives = 63/143 (44%), Gaps = 27/143 (18%)
Query: 24 VVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHI-HRDVKAGNILL 82
+VMP G CL L I F + I+ +T ALDY H + H+ H D+K NIL+
Sbjct: 209 IVMP--KYGPCL-LDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILM 265
Query: 83 DTNGV----------------VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP 126
+T+ V++ D G C D + SR V T + +PEV+
Sbjct: 266 ETSDTVVDPVTNRALPPDPCRVRICDLG-GCC-----DERHSRTAIVSTRHYRSPEVVL- 318
Query: 127 GSGYNSKADIWSFGITALELAHG 149
G G+ D+WS G EL G
Sbjct: 319 GLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 16/167 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQD-----GFEESAIG--- 52
++++ H +++R Y L +V +M G ++ D G E+ A G
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120
Query: 53 -----SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQR 107
+I + + YL +HRD+ N L+ VVK+ DFG+S ++ T D R
Sbjct: 121 LGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DYYR 179
Query: 108 SRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPF 153
+ WM PE + + +++DIWSFG+ E+ +G P+
Sbjct: 180 VGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 21/48 (43%), Positives = 30/48 (62%), Gaps = 1/48 (2%)
Query: 51 IGSILKETLKALDYLHRQGHIHRDVKAGNILLD-TNGVVKLADFGVSA 97
I +I+++ L ALD LH G +HRDVK NI+ +G K+ D G +A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 22/57 (38%), Positives = 35/57 (61%)
Query: 43 QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACM 99
QD + + I ++++ L L LHR G +HRD+K N+L+ +G VK+ DFG + M
Sbjct: 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 32/119 (26%), Positives = 50/119 (42%), Gaps = 16/119 (13%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNG--------VVKLADFGVSACMFDTGDR 105
+ K+ AL +L +G H +V A N+LL +KL+D G+S +
Sbjct: 105 VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL----- 159
Query: 106 QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLL 163
+ + W+ PE ++ + AD WSFG T E+ + G P S K L
Sbjct: 160 --PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 15/108 (13%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGV-------VKLADFGVSACMFDTGDRQ 106
+ K+ AL YL + +H +V NILL G+ +KL+D G+ +
Sbjct: 110 VAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL------ 163
Query: 107 RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPF 153
SR V W+APE ++ + AD WSFG T E+ + G P
Sbjct: 164 -SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 36/158 (22%), Positives = 73/158 (46%), Gaps = 10/158 (6%)
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
E + ++H+ +H D+ N L ++ VK+ D+G+ + D + +
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPL 165
Query: 117 CWMAPEV---LQPG---SGYNSKADIWSFGITALELAHGHA-PFSKYPPMKVLLMTIQNA 169
W+APE+ G + +++W+ G+T EL A P+S +VL I++
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225
Query: 170 PPGLDYDR-DKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
L + + +S+ + E++ C + + KR TAE++
Sbjct: 226 QVKLFKPQLELPYSERWYEVLQFCWLSPE-KRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 29/110 (26%), Positives = 49/110 (44%), Gaps = 3/110 (2%)
Query: 103 GDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162
G +GTP ++APE+L G + D W+ G+ E G PF+ P +V
Sbjct: 531 GAAPVEGERILGTPDYLAPELLL-GKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVF 589
Query: 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212
+ P + ++K S + + + + L D TKR ++L +H F
Sbjct: 590 QNILNRDIPWPE--GEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 27/112 (24%), Positives = 57/112 (50%), Gaps = 3/112 (2%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
I+ + +++L +H+D+ N+L+ VK++D G+ ++ + N+ +
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLM 164
WM+PE + G ++ +DIWS+G+ E+ ++G P+ Y V+ M
Sbjct: 189 PIR-WMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 17/47 (36%), Positives = 30/47 (63%)
Query: 51 IGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSA 97
I +I+K+ L L+Y+H G H D+K NI++D N + D+G+++
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 23/95 (24%), Positives = 36/95 (37%), Gaps = 10/95 (10%)
Query: 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH 66
P V S D +++M ++ EG + E+ I L E L L L
Sbjct: 56 PKV---LASGESDGWSYLLMEWI-EGE-----TLDEVSEEEKEDIAEQLAELLAKLHQLP 106
Query: 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFD 101
H D+ GNIL+D ++ + D+ A
Sbjct: 107 LLVLCHGDLHPGNILVDDGKILGIIDWE-YAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 583 | |||
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.67 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.62 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.59 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.53 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.53 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.51 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.38 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.38 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.32 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.31 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.27 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.17 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.04 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.75 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.67 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.61 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.57 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.42 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.3 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.1 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.04 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.21 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.77 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.59 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.81 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.52 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.3 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.93 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.6 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 92.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.19 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 91.73 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 91.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 91.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 91.09 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 91.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 91.0 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.86 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 90.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.35 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 87.94 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 87.11 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 86.26 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 85.97 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 85.75 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 85.7 | |
| PLN02236 | 344 | choline kinase | 85.53 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 84.98 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 84.77 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 84.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 82.64 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 81.93 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 81.89 |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-57 Score=474.46 Aligned_cols=276 Identities=70% Similarity=1.138 Sum_probs=253.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++++|||||++|++|..++.+|+||+||++|+++++|+..++.+|+|..|+.|++++++||.|||.+|.||||||+.||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnI 157 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNI 157 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccE
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCcccc-ccccCCCCCCCccc-ccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSR-NTFVGTPCWMAPEV-LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~-~~~~GT~~Y~APEi-l~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+.+|.|||+|||++.+++..+.+.+.. ++++||++|||||+ +....+|++|+||||||++..||.+|+.||..+++
T Consensus 158 Li~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 158 LIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred EEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 99999999999999999999999888777 88999999999999 56678999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCC-----CCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCchhhhhhhcCCCchH
Q 007967 159 MKVLLMTIQNAPP-----GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLW 233 (583)
Q Consensus 159 ~~~l~~~i~~~~~-----~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~ 233 (583)
++.+.+.+++.++ .++++..+.+++.|+++|..||++||.+|||++++|+|+||+.++...+.....+...++++
T Consensus 238 mkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~~l~~l~~l~ 317 (516)
T KOG0582|consen 238 MKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKKLLQSLPPLG 317 (516)
T ss_pred HHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchhhhccCCcHH
Confidence 9999999999998 67777888999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhHHHHHHHHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhccc
Q 007967 234 NRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASL 285 (583)
Q Consensus 234 ~r~~~~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l 285 (583)
.+++..+.++..+.... .+. .+++++++ .|+|+.+++..++.+
T Consensus 318 ~r~~~~q~~~~~~~~~~------~~~-~~~e~~~~--~W~f~~~~~~~~~~~ 360 (516)
T KOG0582|consen 318 TRFKKSQSKEESQISGL------SGN-PLSEYQKG--EWNFDYEDLDEEASL 360 (516)
T ss_pred HHHHHHHhhhccccccc------cCC-chhhhcCC--Cccccccchhccccc
Confidence 99988776654322111 111 15677777 999999999988777
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=396.08 Aligned_cols=211 Identities=31% Similarity=0.478 Sum_probs=185.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||||+++++|+..+..|+||||++||+|++.+..+ +.+.|...+.+++||+.||.|||++||+||||||+||
T Consensus 230 LkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNI 307 (475)
T KOG0615|consen 230 LKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENI 307 (475)
T ss_pred HHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceE
Confidence 67899999999999999999999999999999999988764 7789999999999999999999999999999999999
Q ss_pred EEcCC---CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC--CCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 81 LLDTN---GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG--SGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 81 Lld~~---g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~--~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|+..+ ..+||+|||+|+... ......++||||.|.|||++... ..|..++||||+||+||.+|+|.+||.+
T Consensus 308 Ll~~~~e~~llKItDFGlAK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 308 LLSNDAEDCLLKITDFGLAKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred EeccCCcceEEEecccchhhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 99766 689999999997542 22334679999999999999842 2345589999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
......+.+.+..+...+-...|..+++++++||.+||..||++|||+.|+|+||||+.++.
T Consensus 384 ~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 384 EYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 66555566777777666666778999999999999999999999999999999999997763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=380.39 Aligned_cols=223 Identities=34% Similarity=0.554 Sum_probs=194.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|..++||+||+++..|++...+|||+||+.||+|+..|.+ .+.|+|..++.|+.+|+.||.|||++|||||||||+||
T Consensus 79 L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI 156 (357)
T KOG0598|consen 79 LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI 156 (357)
T ss_pred HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence 3568999999999999999999999999999999998876 48899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|+|.+|+|+|+|||+|+.....+.. ..++|||+.|||||++. ..+|+..+|||||||++|+|++|.+||.+.+..+
T Consensus 157 LLd~~GHi~LtDFgL~k~~~~~~~~---t~tfcGT~eYmAPEil~-~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 157 LLDEQGHIKLTDFGLCKEDLKDGDA---TRTFCGTPEYMAPEILL-GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred eecCCCcEEEeccccchhcccCCCc---cccccCCccccChHHHh-cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 9999999999999999866554433 34689999999999998 6799999999999999999999999999866555
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC----CHHHHHhccccccCCCCchhhhhhhcCCCchH
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP----TAEKLLKHSFFKHAKPPELSVKKLFADLPPLW 233 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~ 233 (583)
....+...... ..+..++.+++++|.++|.+||++|. .+.+|.+||||+.++|..+..+++.+++.|..
T Consensus 233 ~~~~I~~~k~~----~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~ 305 (357)
T KOG0598|consen 233 MYDKILKGKLP----LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNV 305 (357)
T ss_pred HHHHHhcCcCC----CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCC
Confidence 54444443211 22345899999999999999999996 68999999999999999998888887776543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=393.41 Aligned_cols=204 Identities=33% Similarity=0.597 Sum_probs=182.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.|.|||||++|++|++..++|||.|+|..|+|..++++ .+.++|.+++.+++||+.||.|||+++|||||||.+|||
T Consensus 73 r~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlf 150 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLF 150 (592)
T ss_pred HhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhee
Confidence 578999999999999999999999999999999999885 488999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+.+|||+|||+|+.+...+++. .+.||||.|+|||++. ..++++.+||||+||+||.||.|++||....- +.
T Consensus 151 L~~~~~VKIgDFGLAt~le~~~Erk---~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-ke 225 (592)
T KOG0575|consen 151 LNENMNVKIGDFGLATQLEYDGERK---KTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-KE 225 (592)
T ss_pred ecCcCcEEecccceeeeecCccccc---ceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchH-HH
Confidence 9999999999999998875544443 4689999999999998 78999999999999999999999999988544 33
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
....+... .|..+..+|.++++||.+||..||.+|||+++||.|+||+..-
T Consensus 226 ty~~Ik~~----~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 226 TYNKIKLN----EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred HHHHHHhc----CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 33444432 4555678999999999999999999999999999999996543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=375.05 Aligned_cols=209 Identities=36% Similarity=0.696 Sum_probs=184.1
Q ss_pred CCCCCCcccceEEEEEECCE-EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~-l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeN 79 (583)
+..+|||||.+|++|..++. ++|+||||+||+|.++++.. +.++|..+..|+++|++||.|||. ++||||||||.|
T Consensus 132 ~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsN 209 (364)
T KOG0581|consen 132 RSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSN 209 (364)
T ss_pred hhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHH
Confidence 45689999999999999995 99999999999999998764 779999999999999999999995 999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC---
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY--- 156 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~--- 156 (583)
||++..|.|||||||++..+... ..++++||..|||||.+. +..|+.++||||||++++||++|+.||...
T Consensus 210 lLvNskGeVKicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~-g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~ 283 (364)
T KOG0581|consen 210 LLVNSKGEVKICDFGVSGILVNS-----IANTFVGTSAYMSPERIS-GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP 283 (364)
T ss_pred eeeccCCCEEeccccccHHhhhh-----hcccccccccccChhhhc-CCcCCcccceecccHHHHHHhhCCCCCCCcCCC
Confidence 99999999999999999877543 457899999999999998 678999999999999999999999999763
Q ss_pred --ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCchh
Q 007967 157 --PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELS 221 (583)
Q Consensus 157 --~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~~ 221 (583)
...+.+..++.+.++.++.. .+|++|++||..||.+||.+|||+.++++|||++....+...
T Consensus 284 ~~~~~~Ll~~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd 347 (364)
T KOG0581|consen 284 YLDIFELLCAIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD 347 (364)
T ss_pred CCCHHHHHHHHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence 33445555555566655422 599999999999999999999999999999999987765544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=399.22 Aligned_cols=254 Identities=31% Similarity=0.479 Sum_probs=219.5
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||+|+++|++|++..++|+||||+.||++.++++ .+.|+|..++.|+++|+.||.|||++||||||||.+|||+|.
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~ 503 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT 503 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc
Confidence 69999999999999999999999999999554432 477999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
+|++||+|||+++.....+. ...++||||.|||||++. ...|+.++|||+|||+|||||.|..||.+.++.+. +.
T Consensus 504 eGh~kiADFGlcKe~m~~g~---~TsTfCGTpey~aPEil~-e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-Fd 578 (694)
T KOG0694|consen 504 EGHVKIADFGLCKEGMGQGD---RTSTFCGTPEFLAPEVLT-EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FD 578 (694)
T ss_pred cCcEEecccccccccCCCCC---ccccccCChhhcChhhhc-cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HH
Confidence 99999999999976543332 346899999999999998 77899999999999999999999999999666554 45
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCchHHHHhHH
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKAL 239 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~~r~~~~ 239 (583)
.|.+..+ ..+..+|.++.++++++|.++|++|+. +++|.+||||+.++|..+..+.+.++|.|..+-
T Consensus 579 sI~~d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~---- 650 (694)
T KOG0694|consen 579 SIVNDEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKG---- 650 (694)
T ss_pred HHhcCCC----CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCC----
Confidence 5554433 334679999999999999999999986 589999999999999999998888887665321
Q ss_pred HHHHHHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCcccccccccee
Q 007967 240 QLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESV 302 (583)
Q Consensus 240 ~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv 302 (583)
. -+..|||.+++.+.+.|+..+......+++.+|.
T Consensus 651 ----------------------~------~D~snFd~eFt~e~p~Lt~~~~~~l~~~~q~~F~ 685 (694)
T KOG0694|consen 651 ----------------------P------EDVSNFDEEFTSEKPALTPSDPRPLTEEEQEAFR 685 (694)
T ss_pred ----------------------h------hhhcccchhhhcCCCccCCCCccccchhhHHHhc
Confidence 0 1345999999999999999888888888888884
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=361.48 Aligned_cols=217 Identities=30% Similarity=0.537 Sum_probs=194.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.+.||+|+++++.|.+.+++|+||||.+||.|+.++++. +.|+|..++.+++||+.||+|||+++|++|||||+||
T Consensus 98 L~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENi 175 (355)
T KOG0616|consen 98 LKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENL 175 (355)
T ss_pred HhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHe
Confidence 46788999999999999999999999999999999999875 7899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|+|.+|++||+|||+|+.... + ..+.||||.|+|||++. ..+|+.++|||+|||++|||+.|.+||....+++
T Consensus 176 LlD~~G~iKitDFGFAK~v~~-----r-T~TlCGTPeYLAPEii~-sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 176 LLDQNGHIKITDFGFAKRVSG-----R-TWTLCGTPEYLAPEIIQ-SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred eeccCCcEEEEeccceEEecC-----c-EEEecCCccccChHHhh-cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 999999999999999986522 1 35789999999999998 7899999999999999999999999999988866
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
....++.. . ...+..++.++++||+++|+.|-.+|. ...+|..||||+.++|..+..+++.+++.|
T Consensus 249 iY~KI~~~-~----v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 249 IYEKILEG-K----VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred HHHHHHhC-c----ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 55444443 2 333478999999999999999999994 578999999999999999988888877755
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=382.39 Aligned_cols=212 Identities=31% Similarity=0.597 Sum_probs=188.1
Q ss_pred CCCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|.+| +||.|++||..|+|+..+|+|+||+++|+|+++|++. +.|+|..++.++.||+.||+|||++|||||||||+|
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 3455 8999999999999999999999999999999999886 889999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCC--------ccc--cccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDR--------QRS--RNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~--------~~~--~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
||||.+|++||+|||.|+.+...... ... ...++||..|.+||+|. ....++.+|||+||||+|.|+.|
T Consensus 205 ILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 205 ILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred eeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcC
Confidence 99999999999999988765322111 011 14589999999999998 66789999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCch
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~ 220 (583)
.+||.+.++.-.+..++. ++|..+..+++.+++||+++|..||.+|+|+.+|.+||||..++|..+
T Consensus 284 ~PPFra~NeyliFqkI~~-----l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 284 QPPFRAANEYLIFQKIQA-----LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred CCCCccccHHHHHHHHHH-----hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 999999887766655544 466777889999999999999999999999999999999999999873
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=385.24 Aligned_cols=206 Identities=28% Similarity=0.523 Sum_probs=184.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++|.||||+++|++|+++.++|+|.||++||.|++++.. +++++|.+++++++||+.|+.|||..+|+||||||+|+
T Consensus 66 MkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENl 143 (786)
T KOG0588|consen 66 MKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENL 143 (786)
T ss_pred HHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhh
Confidence 7899999999999999999999999999999999999877 48899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++..++|||+|||+|..-. ......+.||+|+|.|||++.+..+.+.++||||||||||.||+|+.||++.+ ..
T Consensus 144 LLd~~~nIKIADFGMAsLe~----~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-ir 218 (786)
T KOG0588|consen 144 LLDVKNNIKIADFGMASLEV----PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-IR 218 (786)
T ss_pred hhhcccCEeeeccceeeccc----CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-HH
Confidence 99999999999999987432 22345678999999999999977777899999999999999999999999744 45
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.++..++.+. |..+..++.++.+||.+||..||.+|+|.++|++|||+.....
T Consensus 219 ~LLlKV~~G~----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 219 VLLLKVQRGV----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHcCc----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 5555555543 3445789999999999999999999999999999999997654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=378.59 Aligned_cols=209 Identities=41% Similarity=0.757 Sum_probs=190.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+..+|+|||++++.|..++.+|+|||||+||+|.+++.. ..++|..|+.|+++++.||+|||.+||+|||||.+||
T Consensus 324 m~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnI 400 (550)
T KOG0578|consen 324 MRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNI 400 (550)
T ss_pred HHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeecccccee
Confidence 6778999999999999999999999999999999998875 4599999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||+|+.+.... ..+.+.+|||+|||||++. ...|++++||||||++++||+-|.+||-..++..
T Consensus 401 LL~~~g~vKltDFGFcaqi~~~~---~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr 476 (550)
T KOG0578|consen 401 LLTMDGSVKLTDFGFCAQISEEQ---SKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 476 (550)
T ss_pred EeccCCcEEEeeeeeeecccccc---CccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHH
Confidence 99999999999999998775443 2456789999999999998 6789999999999999999999999999888888
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.+..+..++.+.+. .+..+|..+++|+.+||+.|+.+|+++.|||+||||+.+...
T Consensus 477 AlyLIa~ng~P~lk--~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ 532 (550)
T KOG0578|consen 477 ALYLIATNGTPKLK--NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPE 532 (550)
T ss_pred HHHHHhhcCCCCcC--CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence 88888888776654 457899999999999999999999999999999999766543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.13 Aligned_cols=224 Identities=32% Similarity=0.535 Sum_probs=189.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
...++|+||+||..|++..++||||||++||++..+|... +.++|..++.++.+++.||+-||+.|+|||||||+|+|
T Consensus 196 ~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL 273 (550)
T KOG0605|consen 196 AEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL 273 (550)
T ss_pred hhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence 3458999999999999999999999999999999998764 78999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccC---------------------CCCc------c-----------------ccccccCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDT---------------------GDRQ------R-----------------SRNTFVGTPC 117 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~---------------------~~~~------~-----------------~~~~~~GT~~ 117 (583)
||..|+|||+|||+|.-+... .+.. . .....+|||.
T Consensus 274 iD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPD 353 (550)
T KOG0605|consen 274 IDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPD 353 (550)
T ss_pred ecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcc
Confidence 999999999999998533210 0000 0 0133589999
Q ss_pred CCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCC
Q 007967 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQ 197 (583)
Q Consensus 118 Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP 197 (583)
|||||++. +.+|+..+||||||||+||||.|.+||.+.++.+... .+.+....+.++....++++++|||.+||+ ||
T Consensus 354 YiAPEVll-~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~r-kI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 354 YIAPEVLL-GKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYR-KIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred ccchHHHh-cCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence 99999999 6789999999999999999999999999988766654 444445556777778899999999999999 99
Q ss_pred CCCCC---HHHHHhccccccCCCCchhhhhhhcCCCch
Q 007967 198 TKRPT---AEKLLKHSFFKHAKPPELSVKKLFADLPPL 232 (583)
Q Consensus 198 ~kRpT---a~eIL~HpfFk~~~~~~~~~~~~~~~~~p~ 232 (583)
.+|.. ++||.+||||+.++|..+.. ..++|.|.
T Consensus 431 ~~RLG~~G~~EIK~HPfF~~v~W~~l~~--~~apfvP~ 466 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKHPFFKGVDWDHLRE--MPAPFVPQ 466 (550)
T ss_pred HHhcCcccHHHHhcCCccccCCcchhhc--CCCCCCCC
Confidence 99985 89999999999999986533 23455443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=366.79 Aligned_cols=205 Identities=30% Similarity=0.535 Sum_probs=177.0
Q ss_pred CCCCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.+. ||||+++++++.....+|+|||||.||+|++++.. .+.+.|.+++.+++||+.|++|||++||+||||||+|
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~EN 150 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPEN 150 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHH
Confidence 35666 99999999999999999999999999999999887 5889999999999999999999999999999999999
Q ss_pred EEEcCC-CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCC-CccccccchhhHHhhhhhCCCCCCCCC
Q 007967 80 ILLDTN-GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGY-NSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 80 ILld~~-g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~y-s~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
||++.+ +++||+|||++.... .......+.|||+.|+|||++.+...| +.++|||||||+||.|++|..||....
T Consensus 151 illd~~~~~~Kl~DFG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 151 ILLDGNEGNLKLSDFGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred EEecCCCCCEEEeccccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 999999 999999999987552 122344678999999999999954415 589999999999999999999999855
Q ss_pred hHHHHHHHHhcCCCCCCccccccc-hHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKF-SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~-S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
..... ..+..... ..+..+ |.+++.|+.+||..||.+|+|+.+|+.||||+..
T Consensus 228 ~~~l~-~ki~~~~~----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 228 VPNLY-RKIRKGEF----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHH-HHHhcCCc----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 44443 34444432 333455 9999999999999999999999999999999973
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.60 Aligned_cols=214 Identities=33% Similarity=0.514 Sum_probs=186.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++++||+++.||..|+.++..|||||||.||+|..+.++...+.|+|..++.|+.+|+.||+|||-.|||+|||||+||
T Consensus 131 L~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENI 210 (459)
T KOG0610|consen 131 LSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENI 210 (459)
T ss_pred HHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCccee
Confidence 46799999999999999999999999999999999998888778899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCcccccc------C--------------------------CCC---------------------cc
Q 007967 81 LLDTNGVVKLADFGVSACMFD------T--------------------------GDR---------------------QR 107 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~------~--------------------------~~~---------------------~~ 107 (583)
||..+|+|.|+||-++..... . ... ..
T Consensus 211 LvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~ 290 (459)
T KOG0610|consen 211 LVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGA 290 (459)
T ss_pred EEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCc
Confidence 999999999999987643210 0 000 01
Q ss_pred ccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHH
Q 007967 108 SRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKE 187 (583)
Q Consensus 108 ~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkd 187 (583)
..+.++||-.|+|||++. +.+.+.++|||+|||++||||.|.-||.+....+.+..++.. +. .++..+.++..++|
T Consensus 291 RSnSFVGThEYlAPEvI~-G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-~l--~Fp~~~~vs~~akD 366 (459)
T KOG0610|consen 291 RSNSFVGTHEYLAPEVIR-GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-PL--KFPEEPEVSSAAKD 366 (459)
T ss_pred cccccccccccccceeee-cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-CC--cCCCCCcchhHHHH
Confidence 124579999999999999 788999999999999999999999999998876666555544 32 33444578999999
Q ss_pred HHHhhhcCCCCCCCC----HHHHHhccccccCCCC
Q 007967 188 MVAMCLVKDQTKRPT----AEKLLKHSFFKHAKPP 218 (583)
Q Consensus 188 LI~~cL~~DP~kRpT----a~eIL~HpfFk~~~~~ 218 (583)
||+++|.+||.+|+. |.||.+||||+.++|.
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 999999999999998 9999999999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=362.94 Aligned_cols=211 Identities=29% Similarity=0.473 Sum_probs=183.5
Q ss_pred CCCCC-CCcccceEEEEEECC-EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLID-HPNVIRAYCSFVVDS-NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~-HPNIVkl~~~f~d~~-~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|++|+ |||||++++++.+.+ .+||||||| ..+|.++|+.+ ++.|+|..|+.|++||++||+|+|.+|++|||+||+
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPE 139 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPE 139 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChh
Confidence 46787 999999999999988 999999999 57899999876 788999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||+.....|||+|||+|+.+.... ..+.++.|.||+|||++.....|+.++|+|++|||++|+.+-++.|.|.++
T Consensus 140 NiLi~~~~~iKiaDFGLARev~Skp----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 140 NILISGNDVIKIADFGLAREVRSKP----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred heEecccceeEecccccccccccCC----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 9999988999999999999774433 234689999999999999889999999999999999999999999999999
Q ss_pred HHHHHHHHhcC--CC--------------CCCccc---------cccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 159 MKVLLMTIQNA--PP--------------GLDYDR---------DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 159 ~~~l~~~i~~~--~~--------------~~~~~~---------~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
.+++..++.-. +. .+.++. -...+.++.+||.+||.|||.+||||.++|+||||+
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq 295 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ 295 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence 88887665421 11 111111 134688999999999999999999999999999999
Q ss_pred cCCC
Q 007967 214 HAKP 217 (583)
Q Consensus 214 ~~~~ 217 (583)
....
T Consensus 296 ~~~~ 299 (538)
T KOG0661|consen 296 VGRA 299 (538)
T ss_pred cccc
Confidence 7654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=334.10 Aligned_cols=206 Identities=28% Similarity=0.450 Sum_probs=182.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
++|.||||++|++.+...+..|||+|+|.||+|..-|-.. .-++|..+..+++||+.+|.|||.+||||||+||+|+|
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nll 142 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLL 142 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence 3689999999999999999999999999999996544432 45899999999999999999999999999999999999
Q ss_pred Ec---CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 82 LD---TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 82 ld---~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+- ....+||+|||+|..+. .......++|||.|||||+++ ..+|+..+|||++|||||.||.|.+||++.+.
T Consensus 143 LASK~~~A~vKL~~FGvAi~l~----~g~~~~G~~GtP~fmaPEvvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~ 217 (355)
T KOG0033|consen 143 LASKAKGAAVKLADFGLAIEVN----DGEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 217 (355)
T ss_pred eeeccCCCceeecccceEEEeC----CccccccccCCCcccCHHHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCccH
Confidence 94 34579999999997663 222345689999999999998 67899999999999999999999999999554
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
..+.+.|......++.+.|..+++++++||++||..||.+|+|+.|+|+|||+++-
T Consensus 218 -~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 218 -HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred -HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 56677777777778888899999999999999999999999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=336.17 Aligned_cols=205 Identities=28% Similarity=0.513 Sum_probs=183.2
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
..||||++++++|+.+..+++|+|.|..|.|++++... -.++|.+.++|++|++.|++|||.++||||||||+|||++
T Consensus 80 ~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 80 MGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD 157 (411)
T ss_pred cCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec
Confidence 48999999999999999999999999999999998764 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-----CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-----GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
++.+|||+|||+|..+ ..|. .....||||+|+|||.++. ..+|+..+|+|++|||+|-||.|.+|||....
T Consensus 158 dn~~i~isDFGFa~~l-~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQL-EPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred cccceEEeccceeecc-CCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 9999999999998765 3333 3345799999999999874 56899999999999999999999999987554
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+-.+ ..|..+...+..+.|..++...++||.+||+.||.+|.|++|+|+||||..+
T Consensus 234 mlML-R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 234 MLML-RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred HHHH-HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 4444 4455566677888899999999999999999999999999999999999654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.26 Aligned_cols=213 Identities=35% Similarity=0.598 Sum_probs=175.5
Q ss_pred CCCCCCCcccceEEEEEECC--EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS--NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~--~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++|||||++++...... .++++|||++||+|.+++..... .++|..++.+.+||++||+|||++|||||||||+
T Consensus 68 L~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~ 146 (313)
T KOG0198|consen 68 LSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPA 146 (313)
T ss_pred HHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccc
Confidence 46788999999999855544 69999999999999999987633 7999999999999999999999999999999999
Q ss_pred cEEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC-C
Q 007967 79 NILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK-Y 156 (583)
Q Consensus 79 NILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~-~ 156 (583)
|||++. ++.+||+|||++...............+.||+.|||||++..+...++++|||||||++.||++|+.||.. .
T Consensus 147 NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~ 226 (313)
T KOG0198|consen 147 NILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF 226 (313)
T ss_pred eEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc
Confidence 999999 79999999999876543122223334578999999999998533334599999999999999999999987 3
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.....++.+.... ..+ ..+..++.++++||.+||.++|.+||||.++|+|||.+....
T Consensus 227 ~~~~~~~~ig~~~--~~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 227 EEAEALLLIGRED--SLP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred chHHHHHHHhccC--CCC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 4444444444333 111 445679999999999999999999999999999999987553
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=340.17 Aligned_cols=209 Identities=30% Similarity=0.510 Sum_probs=177.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+|||||.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Ni 124 (312)
T cd05585 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENI 124 (312)
T ss_pred HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHe
Confidence 3568999999999999999999999999999999998875 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+
T Consensus 125 li~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~ 200 (312)
T cd05585 125 LLDYQGHIALCDFGLCKLNMKDD---DKTNTFCGTPEYLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200 (312)
T ss_pred EECCCCcEEEEECcccccCccCC---CccccccCCcccCCHHHHc-CCCCCCccceechhHHHHHHHhCCCCcCCCCHHH
Confidence 99999999999999986432221 1223468999999999998 5679999999999999999999999998866544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC---CHHHHHhccccccCCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP---TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp---Ta~eIL~HpfFk~~~~~~~ 220 (583)
.... +..... ..+..+++.+++||.+||.+||.+|| ++.++++||||....+...
T Consensus 201 ~~~~-~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~ 258 (312)
T cd05585 201 MYRK-ILQEPL----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKL 258 (312)
T ss_pred HHHH-HHcCCC----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHH
Confidence 4433 333222 23356889999999999999999997 5899999999998755443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=339.97 Aligned_cols=210 Identities=28% Similarity=0.454 Sum_probs=178.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|||||||.||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NI 126 (323)
T cd05571 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENL 126 (323)
T ss_pred HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHE
Confidence 3568999999999999999999999999999999988765 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||+++.....+ ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+.....
T Consensus 127 ll~~~~~~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 202 (323)
T cd05571 127 MLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (323)
T ss_pred EECCCCCEEEeeCCCCcccccCC---CcccceecCccccChhhhc-CCCCCccccCcccchhhhhhhcCCCCCCCCCHHH
Confidence 99999999999999986432221 1223468999999999997 5679999999999999999999999998765544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELS 221 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~ 221 (583)
.. ..+..... ..+..++.++++||.+||.+||.+|| ++.++++||||...++....
T Consensus 203 ~~-~~~~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 203 LF-ELILMEEI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVV 263 (323)
T ss_pred HH-HHHHcCCC----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 33 33333222 23356899999999999999999999 89999999999988765443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.36 Aligned_cols=207 Identities=28% Similarity=0.514 Sum_probs=178.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||||++++++++++++|||||||+||+|.++|+.. +.++|..++.++.||+.||++||+++||||||||.||
T Consensus 63 Lkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNi 140 (429)
T KOG0595|consen 63 LKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNI 140 (429)
T ss_pred HHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceE
Confidence 46789999999999999999999999999999999999874 7899999999999999999999999999999999999
Q ss_pred EEcCC------CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 81 LLDTN------GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 81 Lld~~------g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
||+.. -.+||+|||+|+.+.. .....+.||++.|||||++. ...|+.|+|+||+|+|+|+|++|++||.
T Consensus 141 LLs~~~~~~~~~~LKIADFGfAR~L~~----~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 141 LLSTTARNDTSPVLKIADFGFARFLQP----GSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred EeccCCCCCCCceEEecccchhhhCCc----hhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 99764 4689999999987632 23345689999999999997 6789999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..+..+.+. .++......+ .....++....+++...|..+|..|.+..+-+.|++.....
T Consensus 216 a~t~~eL~~-~~~k~~~~~~-~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 216 AETPKELLL-YIKKGNEIVP-VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCHHHHHH-HHhccccccC-chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 877755554 4443332222 23355777788999999999999999999999999987554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.86 Aligned_cols=209 Identities=28% Similarity=0.501 Sum_probs=178.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++|+|||+|.+.++|.....++||+|||+.. +++.+.+. +.++++..+..|++|++.|+.|||++++|||||||+||
T Consensus 55 LKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT-vL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI 132 (396)
T KOG0593|consen 55 LKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT-VLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI 132 (396)
T ss_pred HHhcccchHHHHHHHHHhcceeEEEeeecchH-HHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence 57899999999999999999999999999654 55555543 68899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||+.+|.+||||||+|+.+..+++. .+.++.|.||+|||.+.+...|+..+||||+||++.||++|.+.|.+.++.+
T Consensus 133 Lit~~gvvKLCDFGFAR~L~~pgd~---YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD 209 (396)
T KOG0593|consen 133 LITQNGVVKLCDFGFARTLSAPGDN---YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID 209 (396)
T ss_pred EEecCCcEEeccchhhHhhcCCcch---hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence 9999999999999999987654432 2458999999999999988999999999999999999999999999999988
Q ss_pred HHHHHHhcCC----------------CCCCccc----------cccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 161 VLLMTIQNAP----------------PGLDYDR----------DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 161 ~l~~~i~~~~----------------~~~~~~~----------~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
++..+..... .++..+. .+.++..+.+|+++||..||.+|++.+++|.|+||..
T Consensus 210 QLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 210 QLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 8765544110 0111111 1345677899999999999999999999999999943
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.44 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=224.6
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+-|++++++.+|++-+.+|+||||+.||+|...|+.. +.|.|..+..++.+|+-||-|||++|||+||||.+|||++.
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~ 485 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 485 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc
Confidence 4689999999999999999999999999999888765 78999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
+|+|||+|||+++.-...+ .+..++||||.|+|||++. ..+|+.++||||+||+||||+.|++||.+.++.+ ++.
T Consensus 486 eGHiKi~DFGmcKEni~~~---~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF~ 560 (683)
T KOG0696|consen 486 EGHIKIADFGMCKENIFDG---VTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQ 560 (683)
T ss_pred CCceEeeecccccccccCC---cceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH
Confidence 9999999999987543333 3345799999999999998 7899999999999999999999999999977644 445
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH-----HHHHhccccccCCCCchhhhhhhcCCCchHHHHhHH
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA-----EKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKAL 239 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa-----~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~~r~~~~ 239 (583)
.|..... ..++.+|.++.++++.+|.+.|.+|+.. .+|..||||+.++|..+...++.+++.|....
T Consensus 561 aI~ehnv----syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~---- 632 (683)
T KOG0696|consen 561 AIMEHNV----SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKC---- 632 (683)
T ss_pred HHHHccC----cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcccc----
Confidence 5554332 3357899999999999999999999864 68999999999999999998888887664321
Q ss_pred HHHHHHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeeee
Q 007967 240 QLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKSS 305 (583)
Q Consensus 240 ~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~as 305 (583)
+-+.-|||..++.+...|++-|-.....+|+.||+..+
T Consensus 633 ----------------------------~r~~eNFD~~Ft~~~~~lTPpD~~v~~nldq~eF~gFs 670 (683)
T KOG0696|consen 633 ----------------------------GRDAENFDKFFTREPTDLTPPDKLVMMNLDQSEFEGFS 670 (683)
T ss_pred ----------------------------CCchhhhhHHHhcCCCCCCCchHHHHhcCchhhcCcee
Confidence 22456899999999999999999999999999997544
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.96 Aligned_cols=206 Identities=33% Similarity=0.536 Sum_probs=175.6
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.+||||++++++|.+.+.+|+|||||.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~ 130 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD 130 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence 47999999999999999999999999999999887653 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
.++.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+....+...
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (320)
T cd05590 131 HEGHCKLADFGMCKEGIFNG---KTTSTFCGTPDYIAPEILQ-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206 (320)
T ss_pred CCCcEEEeeCCCCeecCcCC---CcccccccCccccCHHHHc-CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 99999999999986432221 1223468999999999997 5678999999999999999999999998876655443
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH------HHHHhccccccCCCCch
Q 007967 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA------EKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 164 ~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa------~eIL~HpfFk~~~~~~~ 220 (583)
.+..... ..+..++.++++||.+||++||.+|+++ +++++||||+.+.+..+
T Consensus 207 -~i~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~ 264 (320)
T cd05590 207 -AILNDEV----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264 (320)
T ss_pred -HHhcCCC----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 3333222 2234578999999999999999999998 99999999998876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.62 Aligned_cols=222 Identities=25% Similarity=0.378 Sum_probs=183.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+||
T Consensus 54 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05631 54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENI 133 (285)
T ss_pred HHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence 35689999999999999999999999999999998887654445699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... ......+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.....
T Consensus 134 ll~~~~~~kl~Dfg~~~~~~~~----~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 208 (285)
T cd05631 134 LLDDRGHIRISDLGLAVQIPEG----ETVRGRVGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV 208 (285)
T ss_pred EECCCCCEEEeeCCCcEEcCCC----CeecCCCCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch
Confidence 9999999999999998654211 1123457999999999998 5679999999999999999999999998754422
Q ss_pred ---HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 161 ---VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 161 ---~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
.+...+... .......++..+.+||.+||+.||.+||+ ++++++||||..+++..+......+++.|
T Consensus 209 ~~~~~~~~~~~~----~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 209 KREEVDRRVKED----QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred hHHHHHHHhhcc----cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCC
Confidence 222222221 22334568999999999999999999997 89999999999998877766655555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=353.76 Aligned_cols=206 Identities=52% Similarity=0.893 Sum_probs=187.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++++||||.++|+.|..+..+|++||||.||++.++++.. ..+.|.++..++++++.||.|||.++.+|||||+.||
T Consensus 65 Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaani 142 (467)
T KOG0201|consen 65 LSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANI 142 (467)
T ss_pred HHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccce
Confidence 45789999999999999999999999999999999998752 3359999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|+..+|.+||+|||++..+.... ..+.+++||++|||||+++ ..+|+.++||||||+++|||++|.+||.+..++.
T Consensus 143 l~s~~g~vkl~DfgVa~ql~~~~---~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 143 LLSESGDVKLADFGVAGQLTNTV---KRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred eEeccCcEEEEecceeeeeechh---hccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 99999999999999987664322 2337899999999999999 7799999999999999999999999999999988
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.++.+.++.++.++ ..+++.+++||..||++||..||+|.++|+|+|++...
T Consensus 219 vlflIpk~~PP~L~----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 219 VLFLIPKSAPPRLD----GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred EEEeccCCCCCccc----cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 88888887777665 37999999999999999999999999999999999854
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=335.02 Aligned_cols=206 Identities=28% Similarity=0.498 Sum_probs=176.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 72 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NI 149 (329)
T PTZ00263 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149 (329)
T ss_pred HHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence 4568999999999999999999999999999999998875 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||++..... .....+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.....
T Consensus 150 ll~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 222 (329)
T PTZ00263 150 LLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222 (329)
T ss_pred EECCCCCEEEeeccCceEcCC------CcceecCChhhcCHHHHc-CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH
Confidence 999999999999999875421 112468999999999998 5678999999999999999999999998866544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~ 220 (583)
.. ..+..... ..+..++..+++||.+||+.||.+|++ +++++.||||+...+..+
T Consensus 223 ~~-~~i~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~ 282 (329)
T PTZ00263 223 IY-EKILAGRL----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL 282 (329)
T ss_pred HH-HHHhcCCc----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 43 33333322 223457889999999999999999997 799999999998766544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=337.58 Aligned_cols=212 Identities=27% Similarity=0.452 Sum_probs=179.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 162 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 35689999999999999999999999999999999998753 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||++..... .....+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.....
T Consensus 163 Ll~~~~~ikL~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 235 (340)
T PTZ00426 163 LLDKDGFIKMTDFGFAKVVDT------RTYTLCGTPEYIAPEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL 235 (340)
T ss_pred EECCCCCEEEecCCCCeecCC------CcceecCChhhcCHHHHh-CCCCCccccccchhhHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999865421 123468999999999997 5678999999999999999999999998866544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLF 226 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~ 226 (583)
... .+..... ..+..+++.++++|++||+.||.+|+ +++++++||||.+.+|.........
T Consensus 236 ~~~-~i~~~~~----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~ 301 (340)
T PTZ00426 236 IYQ-KILEGII----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVE 301 (340)
T ss_pred HHH-HHhcCCC----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCC
Confidence 333 3333222 22356789999999999999999995 8999999999999887654444433
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=342.89 Aligned_cols=207 Identities=30% Similarity=0.521 Sum_probs=184.4
Q ss_pred CCCCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.+. |||||.++++|++...+|+|||+|.||+|++.+... .++|..+..+++||+.++.|||+.||+||||||+|
T Consensus 89 l~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN 165 (382)
T KOG0032|consen 89 LQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPEN 165 (382)
T ss_pred HHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHH
Confidence 45676 999999999999999999999999999999998765 49999999999999999999999999999999999
Q ss_pred EEEcC----CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 80 ILLDT----NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 80 ILld~----~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+.. ++.+|++|||+|..... .....+.+||++|+|||++. ...|+..+||||+||++|.|++|.+||++
T Consensus 166 ~L~~~~~~~~~~ik~~DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~-~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 166 LLLASKDEGSGRIKLIDFGLAKFIKP----GERLHTIVGTPEYVAPEVLG-GRPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred eeeccccCCCCcEEEeeCCCceEccC----CceEeeecCCccccCchhhc-CCCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 99953 35899999999976532 23345789999999999998 57899999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
........ .+......+..+.|..++..+++||.+||..||.+|+|+.++|+|||++...
T Consensus 241 ~~~~~~~~-~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 241 ETEFEIFL-AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred CChhHHHH-HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 87766665 4455555777888899999999999999999999999999999999998763
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=330.01 Aligned_cols=196 Identities=32% Similarity=0.566 Sum_probs=166.1
Q ss_pred CCCCCCCcccceEE-EEEECCE-EEEEEecCCCCCHHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CC--Ccc
Q 007967 1 MSLIDHPNVIRAYC-SFVVDSN-LWVVMPFMAEGSCLHLMKIAYQ--DGFEESAIGSILKETLKALDYLHR--QG--HIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~-~f~d~~~-l~LVmEy~~GGsL~dll~~~~~--~~~sE~~i~~I~~QIl~gL~yLHs--~g--IvH 72 (583)
|++|+|||||++|+ .|.++.. ++||||||++|+|..+|+.... +.++|..++.++.|++.||.+||. .. |+|
T Consensus 72 LkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH 151 (375)
T KOG0591|consen 72 LKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH 151 (375)
T ss_pred HHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee
Confidence 57899999999998 6666665 9999999999999999987643 449999999999999999999999 45 999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
|||||.||+|+.+|.+||+|||+++.+.. ......+++|||+||+||++. ..+|++++||||+||++|||+.-++|
T Consensus 152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~s---~~tfA~S~VGTPyYMSPE~i~-~~~Y~~kSDiWslGCllyEMcaL~~P 227 (375)
T KOG0591|consen 152 RDIKPANIFLTANGVVKLGDFGLGRFLSS---KTTFAHSLVGTPYYMSPERIH-ESGYNFKSDIWSLGCLLYEMCALQSP 227 (375)
T ss_pred ccCcchheEEcCCCceeeccchhHhHhcc---hhHHHHhhcCCCcccCHHHHh-cCCCCcchhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999986532 222345689999999999998 78999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA 203 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa 203 (583)
|.+.. ...+...|.+.. ++.-....+|.++.+||..|+..||..||+.
T Consensus 228 F~g~n-~~~L~~KI~qgd--~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 228 FYGDN-LLSLCKKIEQGD--YPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ccccc-HHHHHHHHHcCC--CCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 99964 444445555431 1111236799999999999999999999986
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=331.41 Aligned_cols=206 Identities=30% Similarity=0.470 Sum_probs=175.6
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.+||||++++++|.+++.+|+|||||+||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~ 130 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 48999999999999999999999999999999887653 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
.+|.+||+|||++....... ......+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+........
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 206 (321)
T cd05591 131 AEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQ-ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206 (321)
T ss_pred CCCCEEEeecccceecccCC---ccccccccCccccCHHHHc-CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999986532222 1223467999999999987 5678999999999999999999999999876655443
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-------CHHHHHhccccccCCCCch
Q 007967 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-------TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 164 ~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-------Ta~eIL~HpfFk~~~~~~~ 220 (583)
.. ..... ..+..++.++++||.+||.+||.+|+ ++.++++||||...++..+
T Consensus 207 ~i-~~~~~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~ 265 (321)
T cd05591 207 SI-LHDDV----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265 (321)
T ss_pred HH-HcCCC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 33 33222 22345789999999999999999999 9999999999988776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=332.81 Aligned_cols=249 Identities=28% Similarity=0.400 Sum_probs=210.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+..+||++..|.-.|+..+++|+||||.+||.|+-.+.+. +.|+|..++.+-.+|+.||.|||+++||+||||.+|+|
T Consensus 223 ~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLl 300 (516)
T KOG0690|consen 223 QNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLL 300 (516)
T ss_pred HhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhe
Confidence 4568999999999999999999999999999998877763 77999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
+|.+|+|||+|||+++.-...+. ...++||||.|+|||++. ...|+.++|||-+||++|||+||+.||...+. +.
T Consensus 301 LDkDGHIKitDFGLCKE~I~~g~---t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~k 375 (516)
T KOG0690|consen 301 LDKDGHIKITDFGLCKEEIKYGD---TTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EK 375 (516)
T ss_pred eccCCceEeeecccchhcccccc---eeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccch-hH
Confidence 99999999999999876544443 345799999999999998 77899999999999999999999999988554 45
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCchHHHH
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRV 236 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~~r~ 236 (583)
+++.|.-... ..+..++++++.|+..+|.+||.+|+. +.||.+|+||..++|.....+++.++++|....
T Consensus 376 LFeLIl~ed~----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtS- 450 (516)
T KOG0690|consen 376 LFELILMEDL----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTS- 450 (516)
T ss_pred HHHHHHhhhc----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccc-
Confidence 5555554332 334779999999999999999999975 899999999999999999889998888764321
Q ss_pred hHHHHHHHHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCcc
Q 007967 237 KALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDML 293 (583)
Q Consensus 237 ~~~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~ 293 (583)
......||.+++-....+++-|-...
T Consensus 451 -------------------------------etDTryFD~EFT~q~v~lTPP~r~~~ 476 (516)
T KOG0690|consen 451 -------------------------------ETDTRYFDEEFTSQPVTLTPPDRYGS 476 (516)
T ss_pred -------------------------------ccchhhhhhhhhcceeEecCCCCCCc
Confidence 11233578888777777776554443
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=333.44 Aligned_cols=205 Identities=29% Similarity=0.500 Sum_probs=172.0
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|.+.+.+|||||||+||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~ 131 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC
Confidence 799999999999999999999999999999988765 367999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC-------
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP------- 157 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~------- 157 (583)
++.+||+|||+++.....+. .....+||+.|+|||++. +..++.++|||||||++|+|++|+.||....
T Consensus 132 ~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~ 207 (329)
T cd05588 132 EGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207 (329)
T ss_pred CCCEEECcCccccccccCCC---ccccccCCccccCHHHHc-CCCCCCccceechHHHHHHHHHCCCCcccccccccccc
Confidence 99999999999864322221 223468999999999998 5678999999999999999999999996321
Q ss_pred -hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC------HHHHHhccccccCCCCc
Q 007967 158 -PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT------AEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 158 -~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT------a~eIL~HpfFk~~~~~~ 219 (583)
..+.+...+..... ..+..++..++++|.+||++||.+|+| ++++++||||...++..
T Consensus 208 ~~~~~~~~~~~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~ 272 (329)
T cd05588 208 NTEDYLFQVILEKQI----RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272 (329)
T ss_pred cchHHHHHHHHcCCC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHH
Confidence 12223333433322 223568899999999999999999987 79999999998876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=329.55 Aligned_cols=206 Identities=29% Similarity=0.489 Sum_probs=176.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++..+|+||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NI 132 (291)
T cd05612 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132 (291)
T ss_pred HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 45789999999999999999999999999999999998753 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||++..... .....+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.....
T Consensus 133 li~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~ 205 (291)
T cd05612 133 LLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEVIQ-SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205 (291)
T ss_pred EECCCCCEEEEecCcchhccC------CcccccCChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999875422 112457999999999987 5678999999999999999999999998876554
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~ 220 (583)
........ .. ..+..++..+++||++||+.||.+|++ ++++++||||+..++...
T Consensus 206 ~~~~i~~~-~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 265 (291)
T cd05612 206 IYEKILAG-KL----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDV 265 (291)
T ss_pred HHHHHHhC-Cc----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHH
Confidence 44333332 22 223457889999999999999999995 999999999998776443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=322.17 Aligned_cols=208 Identities=26% Similarity=0.377 Sum_probs=182.9
Q ss_pred CCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 4 IDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 4 L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
-.|||||.++++|+. ...+.+|||+|+||+|++.|.......|+|.++..|++||..|+.|||+.+|.||||||+|
T Consensus 112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpEN 191 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPEN 191 (400)
T ss_pred cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhh
Confidence 479999999999874 3569999999999999999988766779999999999999999999999999999999999
Q ss_pred EEEcC---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 80 ILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 80 ILld~---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
+|+.. +..+||+|||+|+.... .....+.|-||+|.|||++. ...|+..+|+||+||++|.||||.+||...
T Consensus 192 LLyt~t~~na~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 192 LLYTTTSPNAPLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred eeeecCCCCcceEecccccccccCC----CccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 99964 45799999999975432 34456789999999999997 567999999999999999999999999765
Q ss_pred Ch---HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 157 PP---MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 157 ~~---~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.. ...+...|..+...++.+.|..+|+.++++|+++|..+|.+|+|+++++.|||+.+..
T Consensus 267 hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 267 HGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 43 2234566777778888889999999999999999999999999999999999998653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.34 Aligned_cols=209 Identities=29% Similarity=0.475 Sum_probs=176.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI 126 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENL 126 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHe
Confidence 4578999999999999999999999999999999888765 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... .......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+
T Consensus 127 ll~~~~~~kL~DfG~~~~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~ 202 (328)
T cd05593 127 MLDKDGHIKITDFGLCKEGITD---AATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (328)
T ss_pred EECCCCcEEEecCcCCccCCCc---ccccccccCCcCccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999998643221 11223468999999999997 5678999999999999999999999998765544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~ 220 (583)
.. ..+..... ..+..++.++++||.+||.+||.+|+ ++.++++||||...++...
T Consensus 203 ~~-~~~~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~ 262 (328)
T cd05593 203 LF-ELILMEDI----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262 (328)
T ss_pred HH-HHhccCCc----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 33 33332222 23456899999999999999999997 8999999999998765443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.97 Aligned_cols=256 Identities=27% Similarity=0.500 Sum_probs=199.3
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.++||||++++++|.+.+.+|+|||||+||+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~ 129 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE
Confidence 358999999999999999999999999999999988653 568999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
+.++.+||+|||++....... ......+||+.|+|||++. +..++.++||||+||++|+|++|..||.+....+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~- 204 (316)
T cd05619 130 DTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL- 204 (316)
T ss_pred CCCCCEEEccCCcceECCCCC---CceeeecCCccccCHHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 999999999999986432111 1223467999999999997 56789999999999999999999999988665443
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHH-HHHhccccccCCCCchhhhhhhcCCCchHHHHhHHHH
Q 007967 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE-KLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQL 241 (583)
Q Consensus 163 ~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~-eIL~HpfFk~~~~~~~~~~~~~~~~~p~~~r~~~~~~ 241 (583)
...+....+. .+..++.++++||.+||..||.+||++. ++++||||+..++.........+++.+.
T Consensus 205 ~~~i~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~--------- 271 (316)
T cd05619 205 FQSIRMDNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPK--------- 271 (316)
T ss_pred HHHHHhCCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHHHhCCCCCCcCCC---------
Confidence 3334433222 2245789999999999999999999996 9999999999876544333222221110
Q ss_pred HHHHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccce
Q 007967 242 KDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENES 301 (583)
Q Consensus 242 ~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Ef 301 (583)
........+|+.+.++....+...+.......|.+.|
T Consensus 272 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (316)
T cd05619 272 -----------------------VKSANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMF 308 (316)
T ss_pred -----------------------CCCccchhhcChhhhcCCcccCCCccccccccccccc
Confidence 0111234566777776666666666666666666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.29 Aligned_cols=209 Identities=27% Similarity=0.468 Sum_probs=176.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|||||||.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI 126 (323)
T cd05595 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 126 (323)
T ss_pred HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 3568999999999999999999999999999999888765 35799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 127 ll~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 202 (323)
T cd05595 127 MLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202 (323)
T ss_pred EEcCCCCEEecccHHhccccCCC---CccccccCCcCcCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999876432221 1123467999999999997 5678999999999999999999999998765544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~ 220 (583)
.... +..... ..+..+++.+++||.+||.+||.+|+ ++.++++|+||....+...
T Consensus 203 ~~~~-~~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 262 (323)
T cd05595 203 LFEL-ILMEEI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 262 (323)
T ss_pred HHHH-HhcCCC----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 3333 322221 22356899999999999999999998 8999999999998775543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.02 Aligned_cols=210 Identities=30% Similarity=0.473 Sum_probs=177.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 51 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIl 128 (323)
T cd05575 51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL 128 (323)
T ss_pred hhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE
Confidence 568999999999999999999999999999999998865 367999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+.
T Consensus 129 l~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 204 (323)
T cd05575 129 LDSQGHVVLTDFGLCKEGIEHS---KTTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204 (323)
T ss_pred ECCCCcEEEeccCCCcccccCC---CccccccCChhhcChhhhc-CCCCCccccccccchhhhhhhcCCCCCCCCCHHHH
Confidence 9999999999999986432211 1223467999999999997 56799999999999999999999999988655443
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH----HHHHhccccccCCCCchhh
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA----EKLLKHSFFKHAKPPELSV 222 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa----~eIL~HpfFk~~~~~~~~~ 222 (583)
. ..+...... ....++..+.++|.+||++||.+||++ .++++||||....+..+..
T Consensus 205 ~-~~i~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~ 264 (323)
T cd05575 205 Y-DNILNKPLR----LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVN 264 (323)
T ss_pred H-HHHHcCCCC----CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhh
Confidence 3 333333222 234678999999999999999999987 6999999999877655433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.25 Aligned_cols=212 Identities=28% Similarity=0.458 Sum_probs=177.2
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.|+|||||+|.+...+. ..+|||+|||+. +|.-++.. ..-.|++.+|+.|++||+.||+|||.+||+|||||..
T Consensus 170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~S 247 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGS 247 (560)
T ss_pred HHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeecccccc
Confidence 5789999999999999887 689999999964 46555543 2356999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||||.+|.+||+|||+|+.+..... ...+..+-|+||+|||++.+...|+.++|+||+||||.||+.|++.|.+.++
T Consensus 248 NiLidn~G~LKiaDFGLAr~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 248 NILIDNNGVLKIADFGLARFYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred ceEEcCCCCEEeccccceeeccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 99999999999999999985533222 2234568899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcC--CCCCCcc----------------------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 159 MKVLLMTIQNA--PPGLDYD----------------------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 159 ~~~l~~~i~~~--~~~~~~~----------------------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.+++..++.-. +..-.|+ ....++..+.+|+..||+.||.+|.||.++|+|+||..
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 98886665521 1110011 12346788999999999999999999999999999954
Q ss_pred CC
Q 007967 215 AK 216 (583)
Q Consensus 215 ~~ 216 (583)
..
T Consensus 406 ~p 407 (560)
T KOG0600|consen 406 EP 407 (560)
T ss_pred CC
Confidence 43
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.53 Aligned_cols=212 Identities=22% Similarity=0.365 Sum_probs=168.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++..+|+|||||. ++|.+++... .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni 134 (303)
T cd07869 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL 134 (303)
T ss_pred HhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 457899999999999999999999999995 6787776543 46689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... ........|++.|+|||++.+...++.++||||+||++|+|++|..||.+.....
T Consensus 135 ll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 211 (303)
T cd07869 135 LISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211 (303)
T ss_pred EECCCCCEEECCCCcceeccCC---CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 9999999999999998643211 1122345789999999998755678999999999999999999999998765433
Q ss_pred HHHHHHhc---CCCC-----------C-----Cccc---------cccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQN---APPG-----------L-----DYDR---------DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~---~~~~-----------~-----~~~~---------~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.....+.. .+.. + .... ...++..+++||.+||++||.+|||+.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 212 DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 22222110 0000 0 0000 01245678999999999999999999999999999
Q ss_pred ccCCC
Q 007967 213 KHAKP 217 (583)
Q Consensus 213 k~~~~ 217 (583)
++++.
T Consensus 292 ~~~~~ 296 (303)
T cd07869 292 SDLPP 296 (303)
T ss_pred ccCCh
Confidence 98753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.56 Aligned_cols=209 Identities=28% Similarity=0.492 Sum_probs=177.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+||||+.||+|.+++.. .+.+.+..+..++.||+.||.|||++||+||||||+||
T Consensus 54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 131 (323)
T cd05584 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131 (323)
T ss_pred HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 4678999999999999999999999999999999998865 36689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||+++...... ......+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.....
T Consensus 132 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~ 207 (323)
T cd05584 132 LLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK 207 (323)
T ss_pred EECCCCCEEEeeCcCCeecccCC---CcccccCCCccccChhhcc-CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999986432222 1223467999999999997 5678999999999999999999999998866655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~ 220 (583)
........ . ...+..+++.+++||.+||.++|.+|| ++++++.||||+...+...
T Consensus 208 ~~~~~~~~-~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~ 267 (323)
T cd05584 208 TIDKILKG-K----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL 267 (323)
T ss_pred HHHHHHcC-C----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 44333332 2 223356789999999999999999999 8999999999998765444
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.90 Aligned_cols=208 Identities=28% Similarity=0.461 Sum_probs=175.4
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNI 80 (583)
+.++||||++++++|.+++.+|||||||.||+|..++.. ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 50 ~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NI 127 (325)
T cd05594 50 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127 (325)
T ss_pred HhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeE
Confidence 567999999999999999999999999999999888765 3579999999999999999999997 7999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||++........ .....+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.....
T Consensus 128 ll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~ 203 (325)
T cd05594 128 MLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203 (325)
T ss_pred EECCCCCEEEecCCCCeecCCCCc---ccccccCCcccCCHHHHc-cCCCCCccccccccceeeeeccCCCCCCCCCHHH
Confidence 999999999999999864322211 123467999999999997 5678999999999999999999999998765543
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~ 220 (583)
.. ..+..... ..+..+++++.+||.+||++||.+|+ ++.++++||||....+...
T Consensus 204 ~~-~~i~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~ 263 (325)
T cd05594 204 LF-ELILMEEI----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV 263 (325)
T ss_pred HH-HHHhcCCC----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 33 33333222 22356889999999999999999997 8999999999998775544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.47 Aligned_cols=215 Identities=29% Similarity=0.505 Sum_probs=175.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.++..+|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI 132 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 3567999999999999999999999999999999998875 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCC--------------------------------CccccccccCCCCCCCcccccCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGD--------------------------------RQRSRNTFVGTPCWMAPEVLQPGS 128 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~--------------------------------~~~~~~~~~GT~~Y~APEil~~~~ 128 (583)
|++.+|.+||+|||+++....... ........+||+.|+|||++. +.
T Consensus 133 Li~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~ 211 (363)
T cd05628 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QT 211 (363)
T ss_pred EECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CC
Confidence 999999999999999864321100 000112468999999999997 56
Q ss_pred CCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCC---CCCCHHH
Q 007967 129 GYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQT---KRPTAEK 205 (583)
Q Consensus 129 ~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~---kRpTa~e 205 (583)
.|+.++|||||||++|+|++|..||.+....+....+. .....+.++....++++++++|.+|+. +|. .||++++
T Consensus 212 ~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~e 289 (363)
T cd05628 212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVM-NWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEE 289 (363)
T ss_pred CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 79999999999999999999999998876655443333 322233334445688999999999776 444 4589999
Q ss_pred HHhccccccCCCCch
Q 007967 206 LLKHSFFKHAKPPEL 220 (583)
Q Consensus 206 IL~HpfFk~~~~~~~ 220 (583)
|++||||+..++..+
T Consensus 290 i~~hp~f~~~~~~~~ 304 (363)
T cd05628 290 IKTNPFFEGVDWEHI 304 (363)
T ss_pred HhCCCCCCCCCHHHH
Confidence 999999999886654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.87 Aligned_cols=207 Identities=31% Similarity=0.565 Sum_probs=175.3
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.++||||++++++|..+..+|+|||||+||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill 129 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE
Confidence 45899999999999999999999999999999988765 3679999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
+.++.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+..
T Consensus 130 ~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~ 205 (316)
T cd05592 130 DKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205 (316)
T ss_pred CCCCCEEEccCcCCeECCCCC---CccccccCCccccCHHHHc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999986542221 2233568999999999997 567899999999999999999999999987664444
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH-HHHHhccccccCCCCch
Q 007967 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA-EKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 163 ~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa-~eIL~HpfFk~~~~~~~ 220 (583)
..+....+. .+..++.++.+||.+||..||.+||++ .++++||||+...+..+
T Consensus 206 -~~i~~~~~~----~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05592 206 -DSILNDRPH----FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERL 259 (316)
T ss_pred -HHHHcCCCC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHHH
Confidence 333333222 235678999999999999999999986 58999999998765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.74 Aligned_cols=207 Identities=28% Similarity=0.474 Sum_probs=175.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||+||+|..++. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 57 ~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nil 133 (324)
T cd05589 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLL 133 (324)
T ss_pred cccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeE
Confidence 46789999999999999999999999999999988764 357999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++....... ......+|++.|+|||++. +..++.++|||||||++|+|++|..||.+....+.
T Consensus 134 l~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~ 209 (324)
T cd05589 134 LDTEGFVKIADFGLCKEGMGFG---DRTSTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV 209 (324)
T ss_pred ECCCCcEEeCcccCCccCCCCC---CcccccccCccccCHhHhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999876432211 1223578999999999997 56789999999999999999999999988665554
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCch
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~ 220 (583)
....... ... .+..++..+.++|.+||..||.+|| ++.++++||||++..+...
T Consensus 210 ~~~i~~~-~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~ 268 (324)
T cd05589 210 FDSIVND-EVR----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268 (324)
T ss_pred HHHHHhC-CCC----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence 4333332 222 2356789999999999999999999 6999999999998876544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=334.12 Aligned_cols=212 Identities=31% Similarity=0.488 Sum_probs=178.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 173 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 4578999999999999999999999999999999998764 4689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC---CCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG---SGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~---~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|++.+|.+||+|||++......+ .......+||+.|+|||++... ..++.++|||||||++|+|++|..||.+..
T Consensus 174 Ll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 174 LLDKSGHLKLADFGTCMKMDANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred EEcCCCCEEEEeccceeeccCCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 99999999999999986543221 1122356899999999998632 247899999999999999999999999866
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCC--CCCHHHHHhccccccCCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~k--RpTa~eIL~HpfFk~~~~~ 218 (583)
...... .+......+.++....++.++++||.+||+.+|.+ |+|++++++||||++..+.
T Consensus 252 ~~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 252 LVGTYS-KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHH-HHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 544443 33333333444555578999999999999999988 9999999999999986654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.66 Aligned_cols=208 Identities=28% Similarity=0.463 Sum_probs=175.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+++|||||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 132 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 3567899999999999999999999999999999999865 36789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++..... .....+||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+
T Consensus 133 l~~~~~~~kL~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 205 (333)
T cd05600 133 LIDASGHIKLTDFGLSKGIVT------YANSVVGSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205 (333)
T ss_pred EECCCCCEEEEeCcCCccccc------ccCCcccCccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCCHHH
Confidence 999999999999999865422 223568999999999998 5589999999999999999999999998866544
Q ss_pred HHHHHHhcCCCCCCccc----cccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 161 VLLMTIQNAPPGLDYDR----DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~----~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.... +......+..+. ...++.++.+||.+||..+|.+||++.++++||||....+.
T Consensus 206 ~~~~-i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 206 TWEN-LKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred HHHH-HHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 4332 222111111111 13578999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=327.01 Aligned_cols=211 Identities=27% Similarity=0.442 Sum_probs=174.4
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.+ +||||++++++|..++.+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred hccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 44 699999999999999999999999999999998765 367999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC---h
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP---P 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~---~ 158 (583)
++.+|.+||+|||+++....... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.... .
T Consensus 138 i~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 215 (332)
T cd05614 138 LDSEGHVVLTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215 (332)
T ss_pred ECCCCCEEEeeCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC
Confidence 99999999999999875432211 112346899999999999855568899999999999999999999996432 2
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchh
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELS 221 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~ 221 (583)
...+...+.... ...+..++..+++||.+||..||.+|| +++++++||||+...+....
T Consensus 216 ~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 279 (332)
T cd05614 216 QSEVSRRILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279 (332)
T ss_pred HHHHHHHHhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 222333333322 223356889999999999999999999 88999999999987655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.22 Aligned_cols=204 Identities=28% Similarity=0.488 Sum_probs=173.7
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|.+.+.+|+|||||.||+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~ 131 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS 131 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC
Confidence 799999999999999999999999999999988765 357999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
++.+||+|||++....... ......+|++.|+|||++. +..++.++|||||||++|+|++|..||.+....... .
T Consensus 132 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-~ 206 (318)
T cd05570 132 EGHIKIADFGMCKEGILGG---VTTSTFCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-Q 206 (318)
T ss_pred CCcEEecccCCCeecCcCC---CcccceecCccccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-H
Confidence 9999999999986432211 1123467999999999997 567899999999999999999999999876654433 3
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH-----HHHHhccccccCCCCc
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA-----EKLLKHSFFKHAKPPE 219 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa-----~eIL~HpfFk~~~~~~ 219 (583)
.+..... ..+..++..+++||.+||.+||.+|||+ .+++.||||+...+..
T Consensus 207 ~i~~~~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~ 262 (318)
T cd05570 207 SILEDEV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDK 262 (318)
T ss_pred HHHcCCC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 3333322 2235678999999999999999999999 9999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=327.32 Aligned_cols=212 Identities=28% Similarity=0.484 Sum_probs=175.5
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.+||||++++++|.+.+.+|+|||||+||+|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 53 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~ 130 (327)
T cd05617 53 SSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130 (327)
T ss_pred cCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe
Confidence 3799999999999999999999999999999988765 36799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC------C
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY------P 157 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~------~ 157 (583)
.++.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||... .
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~ 206 (327)
T cd05617 131 ADGHIKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206 (327)
T ss_pred CCCCEEEeccccceeccCCC---CceecccCCcccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc
Confidence 99999999999986432222 1223568999999999997 567899999999999999999999999642 2
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC------HHHHHhccccccCCCCchhhhhh
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT------AEKLLKHSFFKHAKPPELSVKKL 225 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT------a~eIL~HpfFk~~~~~~~~~~~~ 225 (583)
..+.+...+..... ..+..++..++++|.+||++||.+|++ ++++++||||+.+++..+.....
T Consensus 207 ~~~~~~~~~~~~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~ 276 (327)
T cd05617 207 TEDYLFQVILEKPI----RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQV 276 (327)
T ss_pred cHHHHHHHHHhCCC----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCC
Confidence 22333344433322 233567899999999999999999998 57999999999987665443333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.33 Aligned_cols=212 Identities=40% Similarity=0.722 Sum_probs=190.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|...+||+||+|++.|..++.+||+.|||.||-+..+|-.. ...++|..|..+++|++.||.|||+++|||||||.+||
T Consensus 83 La~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNi 161 (1187)
T KOG0579|consen 83 LAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNI 161 (1187)
T ss_pred hhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccce
Confidence 45678999999999999999999999999999887776544 67899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|++-+|.|+|+|||+++..... ...+.+++|||||||||++.+ ..+|+.++||||||++|.||..+.+|....
T Consensus 162 L~TldGdirLADFGVSAKn~~t---~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 162 LLTLDGDIRLADFGVSAKNKST---RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred EEEecCcEeeecccccccchhH---HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 9999999999999998765322 233457999999999999753 568999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
+++.+++.+.+..++.+- .+.+++..|++|+.+||.+||..||++.+||+||||.+++..
T Consensus 239 npMRVllKiaKSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 239 NPMRVLLKIAKSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred chHHHHHHHhhcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 999999988888887764 346899999999999999999999999999999999988765
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=319.26 Aligned_cols=214 Identities=27% Similarity=0.426 Sum_probs=175.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|..++.+|+|||||+||+|..++... ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 126 (280)
T cd05608 47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPE 126 (280)
T ss_pred HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 45789999999999999999999999999999998876432 2346899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.++|+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.....
T Consensus 127 Nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 127 NVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred HEEECCCCCEEEeeCccceecCCCC---ccccccCCCcCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999986542211 1123467899999999998 56789999999999999999999999976543
Q ss_pred HH---HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhh
Q 007967 159 MK---VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSV 222 (583)
Q Consensus 159 ~~---~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~ 222 (583)
.. .....+... ....+..++..+++++.+||+.||.+|| |++++++||||+...+..+..
T Consensus 203 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 270 (280)
T cd05608 203 KVENKELKQRILND----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270 (280)
T ss_pred chhHHHHHHhhccc----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence 21 122222111 1223356899999999999999999999 889999999999887665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=325.49 Aligned_cols=207 Identities=30% Similarity=0.526 Sum_probs=174.6
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.++||||++++++|.+++++|+|||||.||+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~ 129 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 45899999999999999999999999999999988765 3679999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
+.++.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+..... +
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-~ 204 (316)
T cd05620 130 DRDGHIKIADFGMCKENVFGD---NRASTFCGTPDYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-L 204 (316)
T ss_pred CCCCCEEeCccCCCeecccCC---CceeccCCCcCccCHHHHc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-H
Confidence 999999999999876432111 1223568999999999998 5679999999999999999999999998866543 3
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH-HHHHhccccccCCCCch
Q 007967 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA-EKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 163 ~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa-~eIL~HpfFk~~~~~~~ 220 (583)
...+....+.+ +..++.++++||.+||..||.+|+++ +++++||||+..++...
T Consensus 205 ~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~~ 259 (316)
T cd05620 205 FESIRVDTPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTAL 259 (316)
T ss_pred HHHHHhCCCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHHH
Confidence 34444333222 24578999999999999999999997 58999999998765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=332.95 Aligned_cols=214 Identities=30% Similarity=0.512 Sum_probs=176.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NI 132 (382)
T cd05625 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132 (382)
T ss_pred HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 35689999999999999999999999999999999988653 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCC--------------------------------------------CccccccccCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGD--------------------------------------------RQRSRNTFVGTP 116 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~--------------------------------------------~~~~~~~~~GT~ 116 (583)
|++.+|.+||+|||++..+..... ........+||+
T Consensus 133 Ll~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 212 (382)
T cd05625 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTP 212 (382)
T ss_pred EECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCc
Confidence 999999999999999753210000 000112357999
Q ss_pred CCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCC
Q 007967 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKD 196 (583)
Q Consensus 117 ~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~D 196 (583)
.|+|||++. +..|+.++|||||||++|+|++|+.||.+....+.....+. .......+....++++++++|.+|+ .+
T Consensus 213 ~Y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~~li~~l~-~~ 289 (382)
T cd05625 213 NYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN-WQTSLHIPPQAKLSPEASDLIIKLC-RG 289 (382)
T ss_pred ccCCHHHhc-CCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHc-cCCCcCCCCcccCCHHHHHHHHHHc-cC
Confidence 999999997 56799999999999999999999999998776555544433 2223334444678999999999976 59
Q ss_pred CCCCCC---HHHHHhccccccCCCCc
Q 007967 197 QTKRPT---AEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 197 P~kRpT---a~eIL~HpfFk~~~~~~ 219 (583)
|.+|++ +.++++||||+..++..
T Consensus 290 p~~R~~~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 290 PEDRLGKNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred HhHcCCCCCHHHHhcCCCcCCcChHH
Confidence 999997 99999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=330.92 Aligned_cols=213 Identities=30% Similarity=0.541 Sum_probs=177.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++++|||||||.||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI 132 (364)
T cd05599 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132 (364)
T ss_pred HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 3567999999999999999999999999999999998865 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCC-----------------------------------ccccccccCCCCCCCccccc
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDR-----------------------------------QRSRNTFVGTPCWMAPEVLQ 125 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~-----------------------------------~~~~~~~~GT~~Y~APEil~ 125 (583)
|++.+|.+||+|||++..+...... .......+||+.|+|||++.
T Consensus 133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (364)
T cd05599 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL 212 (364)
T ss_pred EECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc
Confidence 9999999999999998643211100 00112347999999999987
Q ss_pred CCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC---
Q 007967 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT--- 202 (583)
Q Consensus 126 ~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT--- 202 (583)
...|+.++|||||||++|+|++|..||.+....+.....+. ....+..+....+++.+++||.+||. +|.+|++
T Consensus 213 -~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~ 289 (364)
T cd05599 213 -QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN-WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNG 289 (364)
T ss_pred -CCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence 56799999999999999999999999988776555443333 22333334445689999999999997 9999998
Q ss_pred HHHHHhccccccCCCC
Q 007967 203 AEKLLKHSFFKHAKPP 218 (583)
Q Consensus 203 a~eIL~HpfFk~~~~~ 218 (583)
+.++++||||+..++.
T Consensus 290 ~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 290 VNEIKSHPFFKGVDWE 305 (364)
T ss_pred HHHHhcCCCcCCCCHH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=338.21 Aligned_cols=235 Identities=28% Similarity=0.368 Sum_probs=200.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.+++.|+||.+--.|++.+.+||||..|+||+|...|-.....+|+|..++.++++|+.||++||+.+||+|||||+|||
T Consensus 240 ~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNIL 319 (591)
T KOG0986|consen 240 EKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENIL 319 (591)
T ss_pred HHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhee
Confidence 46788999999999999999999999999999977666554568999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh---
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP--- 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~--- 158 (583)
+|+.|+|+|+|+|+|..+. .+.+. ...+||.+|||||++. +..|+..+|||+|||++|||+.|+.||....+
T Consensus 320 LDd~GhvRISDLGLAvei~-~g~~~---~~rvGT~GYMAPEvl~-ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk 394 (591)
T KOG0986|consen 320 LDDHGHVRISDLGLAVEIP-EGKPI---RGRVGTVGYMAPEVLQ-NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK 394 (591)
T ss_pred eccCCCeEeeccceEEecC-CCCcc---ccccCcccccCHHHHc-CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence 9999999999999997653 23332 2459999999999999 55699999999999999999999999977543
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCchH
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPPLW 233 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~ 233 (583)
.+.+...+.. .+.....++|+++++|.+.+|.+||.+|+. +.++.+||||+.++|..+....+.+++.|..
T Consensus 395 ~eEvdrr~~~----~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 395 REEVDRRTLE----DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred HHHHHHHHhc----chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence 2222222222 233444789999999999999999999975 6899999999999999999999999999988
Q ss_pred HHHhHHHHHHHH
Q 007967 234 NRVKALQLKDAA 245 (583)
Q Consensus 234 ~r~~~~~~~~~a 245 (583)
..+.+....++.
T Consensus 471 ~aVyakDv~DIe 482 (591)
T KOG0986|consen 471 GAVYAKDVLDIE 482 (591)
T ss_pred cccchhhhhhhh
Confidence 887776655433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.20 Aligned_cols=215 Identities=26% Similarity=0.388 Sum_probs=178.0
Q ss_pred CCCCCCCcccceEEEEEE-----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d-----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++|+||+.+++++.. -..+|+|+|+| +-+|..+|+.. ..+++..+..+++||++||+|+|+.||+||||
T Consensus 75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDL 151 (359)
T KOG0660|consen 75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDL 151 (359)
T ss_pred HHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccccccccc
Confidence 356789999999999976 35699999999 67788877652 44999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||.|+|++.+..+||||||+|+..... ......+.++-|.||+|||++.....|+.++||||+|||++||++|++.|.|
T Consensus 152 KPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 152 KPSNLLLNADCDLKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred chhheeeccCCCEEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 999999999999999999999876433 2333446789999999999998888999999999999999999999999998
Q ss_pred CChHHHHHHHHhcC-----------------------CC--CCC-ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQNA-----------------------PP--GLD-YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~~-----------------------~~--~~~-~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.+...++..++.-. +. ..+ ....++.++.+.+|+++||..||.+|+|++|+|+|
T Consensus 231 ~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 231 KDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 77666553333211 10 011 01124668889999999999999999999999999
Q ss_pred cccccCCCCc
Q 007967 210 SFFKHAKPPE 219 (583)
Q Consensus 210 pfFk~~~~~~ 219 (583)
|||.....++
T Consensus 311 PYl~~~hdp~ 320 (359)
T KOG0660|consen 311 PYLAPYHDPE 320 (359)
T ss_pred hhhhhhcCCc
Confidence 9999876543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=332.85 Aligned_cols=214 Identities=28% Similarity=0.485 Sum_probs=174.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+++|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NI 132 (377)
T cd05629 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132 (377)
T ss_pred HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 35689999999999999999999999999999999988653 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCC-----------c---------------------------------cccccccCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDR-----------Q---------------------------------RSRNTFVGTP 116 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~-----------~---------------------------------~~~~~~~GT~ 116 (583)
|++.++.+||+|||+++.+...... . ......+||+
T Consensus 133 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 212 (377)
T cd05629 133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP 212 (377)
T ss_pred EECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCc
Confidence 9999999999999998633211000 0 0001257999
Q ss_pred CCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCC
Q 007967 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKD 196 (583)
Q Consensus 117 ~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~D 196 (583)
.|+|||++. +..|+.++|||||||++|+|++|..||.+....+....+ ......+.++....++.++++||.+||. +
T Consensus 213 ~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i-~~~~~~~~~p~~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 213 DYIAPEIFL-QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKI-INWRETLYFPDDIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred cccCHHHHc-cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH-HccCCccCCCCCCCCCHHHHHHHHHHhc-C
Confidence 999999997 567999999999999999999999999886665444333 3222233334445688999999999998 7
Q ss_pred CCCC---CCHHHHHhccccccCCCCc
Q 007967 197 QTKR---PTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 197 P~kR---pTa~eIL~HpfFk~~~~~~ 219 (583)
|.+| +|+.++++||||+..++..
T Consensus 290 ~~~r~~r~~~~~~l~hp~~~~~~~~~ 315 (377)
T cd05629 290 AENRLGRGGAHEIKSHPFFRGVDWDT 315 (377)
T ss_pred HhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 7775 5999999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=325.34 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=223.3
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
-+||++|-++.+|+++..+++|.||.+||+|.-.|++ ++.++|+.++.+..+|+.||.|||++|||+||||.+|+|+|
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld 385 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD 385 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence 4799999999999999999999999999999877665 47899999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC-------C
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK-------Y 156 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~-------~ 156 (583)
..|+|||+|+|+++.-..+++. ..++||||.|+|||+++ +..|++.+|||+|||+++||+.|+.||.- .
T Consensus 386 aeghikltdygmcke~l~~gd~---tstfcgtpnyiapeilr-geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ 461 (593)
T KOG0695|consen 386 AEGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM 461 (593)
T ss_pred cCCceeecccchhhcCCCCCcc---cccccCCCcccchhhhc-ccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc
Confidence 9999999999998866555544 35799999999999999 78999999999999999999999999952 2
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC------HHHHHhccccccCCCCchhhhhhhcCCC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT------AEKLLKHSFFKHAKPPELSVKKLFADLP 230 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT------a~eIL~HpfFk~~~~~~~~~~~~~~~~~ 230 (583)
+..+.++.++......+ +..+|-.+..+++..|++||++|+. +.++..|+||+.++|..+..++..+++.
T Consensus 462 ntedylfqvilekqiri----prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~ 537 (593)
T KOG0695|consen 462 NTEDYLFQVILEKQIRI----PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQ 537 (593)
T ss_pred chhHHHHHHHhhhcccc----cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCC
Confidence 34556677776654433 3667888999999999999999964 6899999999999999888888877775
Q ss_pred chHHHHhHHHHHHHHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCcccccccccee
Q 007967 231 PLWNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESV 302 (583)
Q Consensus 231 p~~~r~~~~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv 302 (583)
|... ..+.-.+||-.++.+.+.++++|+|.+..+|+.||.
T Consensus 538 p~i~--------------------------------~d~~l~~fd~qft~e~~qltpdd~d~i~ridqsefe 577 (593)
T KOG0695|consen 538 PQIT--------------------------------DDYGLDNFDTQFTSEPVQLTPDDEDAIKRIDQSEFE 577 (593)
T ss_pred Cccc--------------------------------cccCccccccccccCCcccCCCCHHHHHhcchhhcC
Confidence 5321 123456899999999999999999999999999994
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=326.67 Aligned_cols=213 Identities=31% Similarity=0.493 Sum_probs=178.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|||||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI 133 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence 35679999999999999999999999999999999998764 35799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-----CCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-----GSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-----~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|++.+|.+||+|||++..+...... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||..
T Consensus 134 ll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 134 LIDRTGHIKLADFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred EECCCCCEEeccCCCCeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 9999999999999998755322211 2233578999999999863 34678999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
........... .......++....++..+++||.+||. +|.+|||+.++++||||...++.
T Consensus 212 ~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 212 GTSAKTYNNIM-NFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred CCHHHHHHHHH-cCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 66655443333 322233444445689999999999998 99999999999999999987654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.02 Aligned_cols=212 Identities=33% Similarity=0.544 Sum_probs=175.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.++..+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NI 173 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM 173 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 3568999999999999999999999999999999998864 4689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC---CCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG---SGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~---~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|++.++.+||+|||+|....... .....+.+||+.|+|||++... ..++.++||||+||++|+|++|..||.+..
T Consensus 174 Ll~~~~~~kL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 174 LLDKHGHLKLADFGTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred EECCCCCEEEEecccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 99999999999999987543221 1122356899999999998732 237899999999999999999999998866
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCC--CCCHHHHHhccccccCCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~k--RpTa~eIL~HpfFk~~~~~ 218 (583)
.......++ .....+.++....++..++++|.+||..++.+ |+|+.++++||||+...+.
T Consensus 252 ~~~~~~~i~-~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 252 LVGTYSKIM-DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred HHHHHHHHH-hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 554443333 33233444445568999999999999866544 8999999999999986554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=325.95 Aligned_cols=208 Identities=29% Similarity=0.497 Sum_probs=176.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 129 (318)
T cd05582 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 129 (318)
T ss_pred HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHe
Confidence 4578999999999999999999999999999999998765 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... ......+|++.|+|||++. ...++.++|||||||++|+|++|+.||.......
T Consensus 130 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 205 (318)
T cd05582 130 LLDEEGHIKLTDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205 (318)
T ss_pred EECCCCcEEEeeccCCcccCCCC---CceecccCChhhcCHHHHc-CCCCCCccceeccceEeeeeccCCCCCCCCCHHH
Confidence 99999999999999986542221 1223468999999999997 5678999999999999999999999998866655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~ 219 (583)
....... ... ..+..+++.+++||.+||++||.+||+ +.+++.||||....+..
T Consensus 206 ~~~~i~~-~~~----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T cd05582 206 TMTMILK-AKL----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK 264 (318)
T ss_pred HHHHHHc-CCC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHH
Confidence 4443333 222 223567899999999999999999999 78899999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.88 Aligned_cols=208 Identities=29% Similarity=0.498 Sum_probs=172.6
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.++||||++++++|.+++.+|+|||||++|+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili 129 (329)
T cd05618 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129 (329)
T ss_pred cCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 35899999999999999999999999999999887765 3679999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC------
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY------ 156 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~------ 156 (583)
+.++.+||+|||+++....... .....+||+.|+|||++. +..++.++|||||||++|+|++|..||...
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~ 205 (329)
T cd05618 130 DSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205 (329)
T ss_pred CCCCCEEEeeCCccccccCCCC---ccccccCCccccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc
Confidence 9999999999999864322221 223468999999999998 567899999999999999999999999531
Q ss_pred --ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC------HHHHHhccccccCCCCch
Q 007967 157 --PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT------AEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 157 --~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT------a~eIL~HpfFk~~~~~~~ 220 (583)
.....+...+..... ..+..++..+++||.+||++||.+||| +.++++||||+..++...
T Consensus 206 ~~~~~~~~~~~i~~~~~----~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~ 273 (329)
T cd05618 206 DQNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM 273 (329)
T ss_pred ccccHHHHHHHHhcCCC----CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHH
Confidence 111223333333222 234568899999999999999999998 589999999998766443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=320.10 Aligned_cols=207 Identities=21% Similarity=0.370 Sum_probs=168.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++.+|+||||+.+ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni 134 (288)
T cd07871 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL 134 (288)
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 3578999999999999999999999999974 888887643 34589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... .......|++.|+|||++.+...++.++||||+||++|+|++|++||.+....+
T Consensus 135 l~~~~~~~kl~DfG~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~ 211 (288)
T cd07871 135 LINEKGELKLADFGLARAKSVPT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211 (288)
T ss_pred EECCCCCEEECcCcceeeccCCC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999986432211 122345789999999998756678999999999999999999999998876555
Q ss_pred HHHHHHhcCC--CC--------------CCc---------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAP--PG--------------LDY---------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~--~~--------------~~~---------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+........ .. ..+ .....++.++++||.+||++||.+|||++|+|+||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 4433322110 00 000 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=325.84 Aligned_cols=209 Identities=29% Similarity=0.458 Sum_probs=176.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 51 ~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nil 128 (325)
T cd05602 51 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 128 (325)
T ss_pred HhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence 568999999999999999999999999999999998865 367899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+....+.
T Consensus 129 i~~~~~~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 204 (325)
T cd05602 129 LDSQGHIVLTDFGLCKENIEHN---GTTSTFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204 (325)
T ss_pred ECCCCCEEEccCCCCcccccCC---CCcccccCCccccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999986432221 1223568999999999998 56789999999999999999999999988665544
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHH----HHHhccccccCCCCchh
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE----KLLKHSFFKHAKPPELS 221 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~----eIL~HpfFk~~~~~~~~ 221 (583)
.... ..... .....++..++++|.+||++||.+|+++. ++++|+||...+|..+.
T Consensus 205 ~~~i-~~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 205 YDNI-LNKPL----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred HHHH-HhCCc----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHH
Confidence 4333 32222 22356889999999999999999999865 89999999987765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=325.92 Aligned_cols=207 Identities=29% Similarity=0.490 Sum_probs=174.2
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|.+...+|+|||||.||+|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~ 131 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA 131 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 799999999999999999999999999999988765 467999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
++.+||+|||++....... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.. .
T Consensus 132 ~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-~ 207 (330)
T cd05586 132 TGHIALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-R 207 (330)
T ss_pred CCCEEEecCCcCcCCCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-H
Confidence 9999999999986532221 12245689999999999975566899999999999999999999999886554433 3
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC----CHHHHHhccccccCCCCch
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP----TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp----Ta~eIL~HpfFk~~~~~~~ 220 (583)
.+......+. ...+++.+++||.+||++||.+|| ++.++++||||+...+...
T Consensus 208 ~i~~~~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~ 264 (330)
T cd05586 208 NIAFGKVRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLL 264 (330)
T ss_pred HHHcCCCCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHH
Confidence 3333222221 234789999999999999999998 7999999999998765443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=313.18 Aligned_cols=214 Identities=28% Similarity=0.374 Sum_probs=181.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||.+.++|...+.+.||+|||+ .+|...|+.. ...++...++.|+.++++||+|||++.|+||||||.|+
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL 132 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL 132 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence 467899999999999999999999999994 6788887754 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||+.+|.+||+|||+|+.+....... ...+-|.||+|||++.+.+.|+..+|+||+|||+.||+.|.+-|.|.++.+
T Consensus 133 Lis~~g~lKiADFGLAr~f~~p~~~~---~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid 209 (318)
T KOG0659|consen 133 LISSDGQLKIADFGLARFFGSPNRIQ---THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID 209 (318)
T ss_pred EEcCCCcEEeecccchhccCCCCccc---ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence 99999999999999998764433222 223789999999999999999999999999999999999999999999988
Q ss_pred HHHHHHhcC--CCCCCcc---------------------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNA--PPGLDYD---------------------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~--~~~~~~~---------------------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
++..++... +..-.|+ .....+.++.+|+.+||.+||.+|+|+.|+|+|+||+....
T Consensus 210 QL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 210 QLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred HHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 886666522 1111111 11234677899999999999999999999999999998765
Q ss_pred Cc
Q 007967 218 PE 219 (583)
Q Consensus 218 ~~ 219 (583)
+.
T Consensus 290 pt 291 (318)
T KOG0659|consen 290 PT 291 (318)
T ss_pred CC
Confidence 43
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.36 Aligned_cols=215 Identities=29% Similarity=0.494 Sum_probs=174.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+++|+|||||+||+|.+++... +.+++..++.+++||+.||+|||++||+||||||+||
T Consensus 55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Ni 132 (381)
T cd05626 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNI 132 (381)
T ss_pred HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHE
Confidence 45689999999999999999999999999999999988753 6699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCC--------------------------------------------CccccccccCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGD--------------------------------------------RQRSRNTFVGTP 116 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~--------------------------------------------~~~~~~~~~GT~ 116 (583)
|++.+|++||+|||++..+..... ........+||+
T Consensus 133 li~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 212 (381)
T cd05626 133 LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTP 212 (381)
T ss_pred EECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCc
Confidence 999999999999998753210000 000012468999
Q ss_pred CCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhc--
Q 007967 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLV-- 194 (583)
Q Consensus 117 ~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~-- 194 (583)
.|+|||++. +..|+.++|||||||++|||++|..||...........++. .......+....+++++++||.+||.
T Consensus 213 ~Y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~dli~~ll~~~ 290 (381)
T cd05626 213 NYIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN-WENTLHIPPQVKLSPEAVDLITKLCCSA 290 (381)
T ss_pred cccCHHHHc-CCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHc-cccccCCCCCCCCCHHHHHHHHHHccCc
Confidence 999999997 56799999999999999999999999988666554443332 22223344445689999999999665
Q ss_pred CCCCCCCCHHHHHhccccccCCCCc
Q 007967 195 KDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 195 ~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
.++..|+++.++++||||....+..
T Consensus 291 ~~~~~R~~~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 291 EERLGRNGADDIKAHPFFSEVDFSS 315 (381)
T ss_pred ccccCCCCHHHHhcCcccCCCChhH
Confidence 4555599999999999999877543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=317.89 Aligned_cols=207 Identities=24% Similarity=0.438 Sum_probs=167.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..++.+|+|||||.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 131 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL 131 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4578999999999999999999999999998766554332 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... ........|++.|+|||++. +..++.++|||||||++|+|++|++||.+....+
T Consensus 132 ll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 132 LISHNDVLKLCDFGFARNLSEGS--NANYTEYVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred EEcCCCcEEEeeccCcccccccc--cccccccccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999987542211 11223467899999999997 5678999999999999999999999998866544
Q ss_pred HHHHHHhcCC-------------C---CCCcc-----------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAP-------------P---GLDYD-----------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~-------------~---~~~~~-----------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+........ + ....+ ....++..+++||.+||++||.+|||++++|+||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 209 QLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 4322211100 0 00000 012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=333.96 Aligned_cols=208 Identities=26% Similarity=0.500 Sum_probs=186.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++..|||||+||++..+...+|||+|+=+||+|+++|... ..++.|..++.|++||+.|+.|||+..+|||||||+||
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENV 149 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENV 149 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCccee
Confidence 78899999999999999999999999999999999998665 57899999999999999999999999999999999998
Q ss_pred EE-cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 81 LL-DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 81 Ll-d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
.+ .+-|-|||+|||++-.+. +....++.||++.|-|||++.+...-.+++||||||||||.|+||++||...++.
T Consensus 150 VFFEKlGlVKLTDFGFSNkf~----PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 150 VFFEKLGLVKLTDFGFSNKFQ----PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred EEeeecCceEeeeccccccCC----CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 76 577999999999987552 2244578999999999999996655668999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
+.+.+++. ..|..+..++.++++||..||..||++|.+.++|..|+|++..+.+
T Consensus 226 ETLTmImD-----CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 226 ETLTMIMD-----CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhhhhhc-----ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 87766654 3566678899999999999999999999999999999999988754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=317.25 Aligned_cols=216 Identities=23% Similarity=0.374 Sum_probs=175.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|+++.++|+||||++||+|.+++.......+++..+..++.||+.||+|||++||+||||||+||
T Consensus 47 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Ni 126 (277)
T cd05607 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126 (277)
T ss_pred HHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhE
Confidence 35689999999999999999999999999999999888665455689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.++|+|||++....... ......|++.|+|||++. +..++.++||||+||++|+|++|..||.......
T Consensus 127 li~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~ 201 (277)
T cd05607 127 LLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201 (277)
T ss_pred EEcCCCCEEEeeceeeeecCCCc----eeeccCCCCCccCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh
Confidence 99999999999999986542211 112357899999999997 4569999999999999999999999997643311
Q ss_pred ---HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH----HHHHhccccccCCCCchhhhh
Q 007967 161 ---VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA----EKLLKHSFFKHAKPPELSVKK 224 (583)
Q Consensus 161 ---~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa----~eIL~HpfFk~~~~~~~~~~~ 224 (583)
.......... ... ....++.++++||.+||++||.+||++ +++++||||+.++++.+....
T Consensus 202 ~~~~~~~~~~~~~--~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~ 269 (277)
T cd05607 202 AKEELKRRTLEDE--VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGL 269 (277)
T ss_pred hHHHHHHHhhccc--ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCc
Confidence 1111111111 111 124578999999999999999999999 778899999988776554433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=325.18 Aligned_cols=208 Identities=28% Similarity=0.433 Sum_probs=175.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|..++.+|+|||||.||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 51 ~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIl 128 (325)
T cd05604 51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL 128 (325)
T ss_pred HhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 568999999999999999999999999999999888764 467999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||...+..+.
T Consensus 129 l~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~ 204 (325)
T cd05604 129 LDSQGHVVLTDFGLCKEGIAQS---DTTTTFCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204 (325)
T ss_pred ECCCCCEEEeecCCcccCCCCC---CCcccccCChhhCCHHHHc-CCCCCCcCccccccceehhhhcCCCCCCCCCHHHH
Confidence 9999999999999986432211 1223468999999999997 56789999999999999999999999988665544
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH----HHHHhccccccCCCCch
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA----EKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa----~eIL~HpfFk~~~~~~~ 220 (583)
....+ .... ......+..+.++|.+||.++|.+||++ .++++||||....+...
T Consensus 205 ~~~~~-~~~~----~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~ 262 (325)
T cd05604 205 YDNIL-HKPL----VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262 (325)
T ss_pred HHHHH-cCCc----cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 43333 3222 2234578899999999999999999976 69999999998765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=331.30 Aligned_cols=214 Identities=31% Similarity=0.498 Sum_probs=175.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni 132 (376)
T cd05598 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132 (376)
T ss_pred HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence 35689999999999999999999999999999999998653 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCC----------------------------------------CccccccccCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGD----------------------------------------RQRSRNTFVGTPCWMA 120 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~----------------------------------------~~~~~~~~~GT~~Y~A 120 (583)
|++.++.+||+|||+|..+..... ........+||+.|+|
T Consensus 133 ll~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 212 (376)
T cd05598 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA 212 (376)
T ss_pred EECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccC
Confidence 999999999999998742210000 0000123579999999
Q ss_pred cccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCC
Q 007967 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR 200 (583)
Q Consensus 121 PEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kR 200 (583)
||++. +..++.++|||||||++|+|++|+.||.+....+..... .........+....++..++++|.+|+ .+|.+|
T Consensus 213 PE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 213 PEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV-INWETTLHIPSQAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred HHHHc-CCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHH-hccCccccCCCCCCCCHHHHHHHHHHh-cCHhhc
Confidence 99997 667899999999999999999999999887665544333 222233333444568999999999976 599999
Q ss_pred C---CHHHHHhccccccCCCCc
Q 007967 201 P---TAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 201 p---Ta~eIL~HpfFk~~~~~~ 219 (583)
+ |+.++++||||+.+++..
T Consensus 290 ~~~~t~~ell~h~~~~~~~~~~ 311 (376)
T cd05598 290 LGKNGADEIKAHPFFKGIDFAS 311 (376)
T ss_pred CCCCCHHHHhCCCCcCCCCHHH
Confidence 9 999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=329.37 Aligned_cols=215 Identities=31% Similarity=0.520 Sum_probs=177.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
..++||||++++++|.+++++|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 56 ~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIl 133 (360)
T cd05627 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133 (360)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE
Confidence 467999999999999999999999999999999998865 367999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCC--------------------------------CccccccccCCCCCCCcccccCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGD--------------------------------RQRSRNTFVGTPCWMAPEVLQPGSG 129 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~--------------------------------~~~~~~~~~GT~~Y~APEil~~~~~ 129 (583)
++.+|.+||+|||++........ ........+||+.|+|||++. +..
T Consensus 134 i~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~ 212 (360)
T cd05627 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTG 212 (360)
T ss_pred ECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-CCC
Confidence 99999999999999864321100 000112458999999999997 678
Q ss_pred CCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC---CHHHH
Q 007967 130 YNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP---TAEKL 206 (583)
Q Consensus 130 ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp---Ta~eI 206 (583)
|+.++|||||||++|+|++|..||.+........... .....+.++....+++++++||.+|+ .||.+|+ ++.++
T Consensus 213 ~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~-~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 290 (360)
T cd05627 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVM-NWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEI 290 (360)
T ss_pred CCCcceeccccceeeecccCCCCCCCCCHHHHHHHHH-cCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence 9999999999999999999999998877655443333 32223333334458899999999977 5999998 48999
Q ss_pred HhccccccCCCCchh
Q 007967 207 LKHSFFKHAKPPELS 221 (583)
Q Consensus 207 L~HpfFk~~~~~~~~ 221 (583)
++||||+.++|..+.
T Consensus 291 ~~hp~f~~~~~~~~~ 305 (360)
T cd05627 291 KSHPFFEGVDWGHIR 305 (360)
T ss_pred hcCCCCCCCCHHHHh
Confidence 999999998876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.00 Aligned_cols=205 Identities=27% Similarity=0.415 Sum_probs=168.0
Q ss_pred CCCCCCcccceEEEEEE-----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d-----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++||||++++++|.. ...+++||||+. ++|.+++.......+++..+..++.||+.||.|||++||+|||||
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 34689999999999863 456999999996 689988876555669999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+|||++.++.+||+|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|.+||.+.
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 138 PQNILVTSSGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred HHHEEEcCCCCEEEccccceEeccCC----cccccccccccccChHHHh-CCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 99999999999999999998654221 1223467899999999997 567899999999999999999999999987
Q ss_pred ChHHHHHHHHhcCCCC--CCc--------------------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 157 PPMKVLLMTIQNAPPG--LDY--------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~--~~~--------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
...+.+..++...... ..+ .....++..+++||.+||+.||++|||+.++|+||||
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 213 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 7766554444321100 000 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=325.80 Aligned_cols=214 Identities=34% Similarity=0.547 Sum_probs=178.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++++|+|||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI 132 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI 132 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 35678999999999999999999999999999999998764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCC--------------------------CccccccccCCCCCCCcccccCCCCCCccc
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGD--------------------------RQRSRNTFVGTPCWMAPEVLQPGSGYNSKA 134 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~--------------------------~~~~~~~~~GT~~Y~APEil~~~~~ys~ks 134 (583)
|++.++.+||+|||++........ .........||+.|+|||++. +..++.++
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~ 211 (350)
T cd05573 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLEC 211 (350)
T ss_pred EECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCce
Confidence 999999999999999875533220 011223467999999999998 56899999
Q ss_pred cccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-HHHHHhccccc
Q 007967 135 DIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-AEKLLKHSFFK 213 (583)
Q Consensus 135 DIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-a~eIL~HpfFk 213 (583)
|||||||++|+|++|..||............. .....+..+....+++.+++||.+||. ||.+|++ ++++++||||+
T Consensus 212 DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~-~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~ 289 (350)
T cd05573 212 DWWSLGVILYEMLYGFPPFYSDTLQETYNKII-NWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289 (350)
T ss_pred eeEecchhhhhhccCCCCCCCCCHHHHHHHHh-ccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence 99999999999999999998876544443333 322223333344579999999999997 9999999 99999999999
Q ss_pred cCCCCc
Q 007967 214 HAKPPE 219 (583)
Q Consensus 214 ~~~~~~ 219 (583)
..++..
T Consensus 290 ~~~~~~ 295 (350)
T cd05573 290 GIDWEN 295 (350)
T ss_pred CCCHHH
Confidence 876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.24 Aligned_cols=228 Identities=27% Similarity=0.479 Sum_probs=185.2
Q ss_pred CCCCCCCcccceEEEEEECC-----EEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 1 MSLIDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~-----~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
|+.++|||||+|.-+|.... ++.||||||+ .+|...++.. .+..++...++-+.+||++||.|||+.||+||
T Consensus 71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHR 149 (364)
T KOG0658|consen 71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHR 149 (364)
T ss_pred HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccC
Confidence 67899999999999887432 5778999995 6788877753 24568999999999999999999999999999
Q ss_pred CCCCCcEEEcCC-CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 74 DVKAGNILLDTN-GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 74 DLKPeNILld~~-g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
||||.|||+|.+ |.+||||||.|+.+.. +... ..+..|.+|+|||.+.+...|+.+.||||+||+++||+.|++.
T Consensus 150 DIKPqNlLvD~~tg~LKicDFGSAK~L~~-~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~pl 225 (364)
T KOG0658|consen 150 DIKPQNLLVDPDTGVLKICDFGSAKVLVK-GEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPL 225 (364)
T ss_pred CCChheEEEcCCCCeEEeccCCcceeecc-CCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcc
Confidence 999999999976 8999999999876633 3332 4688899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcC-----------CC--------CCCcc-----ccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 153 FSKYPPMKVLLMTIQNA-----------PP--------GLDYD-----RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~-----------~~--------~~~~~-----~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|.|.+..+++..+++-. .+ .+... .....++++.+|+.++|.++|.+|.++.+++.
T Consensus 226 FpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 226 FPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 99998888876666511 01 11101 12456889999999999999999999999999
Q ss_pred ccccccCCCCchhhhhhhcCCCchHH
Q 007967 209 HSFFKHAKPPELSVKKLFADLPPLWN 234 (583)
Q Consensus 209 HpfFk~~~~~~~~~~~~~~~~~p~~~ 234 (583)
||||.....+........ +++++.+
T Consensus 306 h~fFdelr~~~~~l~~g~-~lp~lf~ 330 (364)
T KOG0658|consen 306 HPFFDELRDPNTKLPNGR-PLPPLFN 330 (364)
T ss_pred chhhHHhhCcCccCcCCC-cCCCccC
Confidence 999998876644333322 5555554
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.40 Aligned_cols=215 Identities=24% Similarity=0.359 Sum_probs=170.1
Q ss_pred CCCCCCCcccceEEEEEEC--------CEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--------SNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--------~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
|+.++|||||+++++|... ..+++|||||.+ +|.+++... ....+++..++.++.||+.||.|||++||
T Consensus 113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~I 191 (440)
T PTZ00036 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFI 191 (440)
T ss_pred HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 4678999999999987542 257899999974 677766542 23569999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCC-cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 71 IHRDVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 71 vHRDLKPeNILld~~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
+||||||+|||++.++ .+||+|||+|+.+.... .....+||+.|+|||++.+...|+.++|||||||++|+|++|
T Consensus 192 iHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG 267 (440)
T PTZ00036 192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267 (440)
T ss_pred ecCCcCHHHEEEcCCCCceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999998665 79999999987553211 123467899999999987556799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCC--------------CCCc----------cccccchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPP--------------GLDY----------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~--------------~~~~----------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
.+||.+....+.+..++..... .+.+ ..+...+.++++||.+||++||.+|||+.+
T Consensus 268 ~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e 347 (440)
T PTZ00036 268 YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE 347 (440)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 9999987766555444331100 0000 012246789999999999999999999999
Q ss_pred HHhccccccCCCCch
Q 007967 206 LLKHSFFKHAKPPEL 220 (583)
Q Consensus 206 IL~HpfFk~~~~~~~ 220 (583)
+|+||||.....+..
T Consensus 348 ~l~hp~f~~~~~~~~ 362 (440)
T PTZ00036 348 ALADPFFDDLRDPCI 362 (440)
T ss_pred HhCChhHHhhhcccc
Confidence 999999998765443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=323.34 Aligned_cols=214 Identities=25% Similarity=0.396 Sum_probs=168.5
Q ss_pred CCCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++||||+++++++... ..+|+||||| +++|.+++.. ...+++..+..++.||+.||.|||++||+||||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 129 (338)
T cd07859 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDL 129 (338)
T ss_pred HHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 4578999999999998643 3589999999 5789888765 356999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-CCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-GSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
||+|||++.++.+||+|||+++...............+||+.|+|||++.. ...++.++|||||||++|+|++|++||.
T Consensus 130 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 130 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred CHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999998754332222222234689999999999863 2578999999999999999999999998
Q ss_pred CCChHHHHHHHH--------------------------hcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTI--------------------------QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i--------------------------~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+......+.... ....+.........+++.+.++|.+||..||.+|||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 210 GKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 765433221110 000000001112346788999999999999999999999999
Q ss_pred ccccccCCC
Q 007967 209 HSFFKHAKP 217 (583)
Q Consensus 209 HpfFk~~~~ 217 (583)
||||+....
T Consensus 290 hp~f~~~~~ 298 (338)
T cd07859 290 DPYFKGLAK 298 (338)
T ss_pred CchhhhcCc
Confidence 999987664
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.94 Aligned_cols=216 Identities=25% Similarity=0.386 Sum_probs=179.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||.||+|.+++.......+++..+..++.||+.||.|||++|++||||||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (285)
T cd05605 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENI 133 (285)
T ss_pred HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHE
Confidence 35679999999999999999999999999999999887654445699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++...... ......+|++.|+|||++. ...++.++||||+||++|+|++|..||.+.....
T Consensus 134 l~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 134 LLDDYGHIRISDLGLAVEIPEG----ETIRGRVGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred EECCCCCEEEeeCCCceecCCC----CccccccCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 9999999999999998654211 1112457899999999997 5678999999999999999999999998765432
Q ss_pred HH---HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhh
Q 007967 161 VL---LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKL 225 (583)
Q Consensus 161 ~l---~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~ 225 (583)
.. ...+... ....+..++..+++||.+||..||.+|| +++++++||||...++........
T Consensus 209 ~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 277 (285)
T cd05605 209 KREEVERRVKED----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGML 277 (285)
T ss_pred HHHHHHHHhhhc----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCC
Confidence 22 2222221 2223456889999999999999999999 899999999999888776554433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.80 Aligned_cols=207 Identities=28% Similarity=0.447 Sum_probs=173.2
Q ss_pred CCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 3 LID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.+. |++|++++++|.+.+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil 133 (324)
T cd05587 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133 (324)
T ss_pred hcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence 344 456889999999999999999999999999988653 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|.+||+|||++....... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+......
T Consensus 134 l~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~ 209 (324)
T cd05587 134 LDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209 (324)
T ss_pred EcCCCCEEEeecCcceecCCCC---CceeeecCCccccChhhhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999976432111 1223468999999999998 56789999999999999999999999988665444
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH-----HHHHhccccccCCCCch
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA-----EKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa-----~eIL~HpfFk~~~~~~~ 220 (583)
... +..... ..+..++++++++|.+||.+||.+|+++ .++++||||+..++...
T Consensus 210 ~~~-i~~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~ 268 (324)
T cd05587 210 FQS-IMEHNV----SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268 (324)
T ss_pred HHH-HHcCCC----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 433 333222 2235688999999999999999999986 89999999998876544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.38 Aligned_cols=202 Identities=31% Similarity=0.527 Sum_probs=172.8
Q ss_pred CCCCCCCcccceEEEEEECC-EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS-NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG-HIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~-~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g-IvHRDLKPe 78 (583)
|+.++|||||++++++.... .++||||||++|+|.+++.......++...+..|+.+|++||.|||+++ ||||||||+
T Consensus 93 l~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~ 172 (362)
T KOG0192|consen 93 LSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSD 172 (362)
T ss_pred HHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChh
Confidence 45699999999999999887 7999999999999999998755678999999999999999999999999 999999999
Q ss_pred cEEEcCCC-cEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-CCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 79 NILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-GSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 79 NILld~~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|||++.++ ++||||||+++...... .......||+.|||||++.+ ...|+.|+|||||||++|||++|..||.+.
T Consensus 173 NiLv~~~~~~~KI~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~ 249 (362)
T KOG0192|consen 173 NILVDLKGKTLKIADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL 249 (362)
T ss_pred hEEEcCCCCEEEECCCccceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence 99999998 99999999997553221 22233689999999999985 357999999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
...........+.. ....+..+++.+..|+.+||..||.+||++.+|+.
T Consensus 250 ~~~~~~~~v~~~~~---Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 250 APVQVASAVVVGGL---RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhcCC---CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 88555555543321 12223448899999999999999999999998875
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.41 Aligned_cols=211 Identities=27% Similarity=0.429 Sum_probs=177.8
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.+||+|++++++|.+.+.+|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 135 (323)
T cd05616 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135 (323)
T ss_pred cCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC
Confidence 36999999999999999999999999999999887653 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
.++.+||+|||++....... ......+||+.|+|||++. ...++.++|||||||++|+|++|..||.+........
T Consensus 136 ~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 211 (323)
T cd05616 136 SEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 211 (323)
T ss_pred CCCcEEEccCCCceecCCCC---CccccCCCChhhcCHHHhc-CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999986432211 1223468999999999998 5679999999999999999999999998876654443
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhh
Q 007967 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKL 225 (583)
Q Consensus 164 ~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~ 225 (583)
.+..... ..+..++.+++++|.+||+++|.+|++ ..++++||||+.++|........
T Consensus 212 -~i~~~~~----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~ 273 (323)
T cd05616 212 -SIMEHNV----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEV 273 (323)
T ss_pred -HHHhCCC----CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCC
Confidence 3333322 223568899999999999999999998 48999999999988766554443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.34 Aligned_cols=208 Identities=28% Similarity=0.442 Sum_probs=174.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||+||+|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 51 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIl 128 (321)
T cd05603 51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENIL 128 (321)
T ss_pred HhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence 568999999999999999999999999999999887764 367999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|.+||+|||++...... .......+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+...
T Consensus 129 l~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~- 203 (321)
T cd05603 129 LDSQGHVVLTDFGLCKEGVEP---EETTSTFCGTPEYLAPEVLR-KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ- 203 (321)
T ss_pred ECCCCCEEEccCCCCccCCCC---CCccccccCCcccCCHHHhc-CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-
Confidence 999999999999998643221 11223468999999999997 5678999999999999999999999998865433
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH----HHHHhccccccCCCCch
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA----EKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa----~eIL~HpfFk~~~~~~~ 220 (583)
+...+..... ..+...+..+.++|.+||++||.+|+++ .++++|+||....+..+
T Consensus 204 ~~~~i~~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T cd05603 204 MYDNILHKPL----QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDL 262 (321)
T ss_pred HHHHHhcCCC----CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHH
Confidence 3334433322 2234578899999999999999999875 59999999998775543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.34 Aligned_cols=203 Identities=32% Similarity=0.565 Sum_probs=177.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||||.+++.|++..++|+|+|||.| +|+.++.. .+.++|+.++.|+++++.||.|||+++|+|||+||.||
T Consensus 55 ~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqni 131 (808)
T KOG0597|consen 55 LRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNI 131 (808)
T ss_pred HHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCccee
Confidence 4678999999999999999999999999976 99998875 58899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|++|+||||+|+.+.. .........|||.|||||++. +..|+..+|+||+|||+|||+.|++||.... ..
T Consensus 132 Ll~~~~~~KlcdFg~Ar~m~~---~t~vltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-i~ 206 (808)
T KOG0597|consen 132 LLEKGGTLKLCDFGLARAMST---NTSVLTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARS-IT 206 (808)
T ss_pred eecCCCceeechhhhhhhccc---CceeeeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHH-HH
Confidence 999999999999999986532 223344578999999999998 7899999999999999999999999997743 34
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.+...|...+.. .+...+..|+.|+..+|.+||.+|+|..+++.|||.+..
T Consensus 207 ~Lv~~I~~d~v~----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 207 QLVKSILKDPVK----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHhcCCCC----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 444445443332 235789999999999999999999999999999999854
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=327.23 Aligned_cols=212 Identities=33% Similarity=0.522 Sum_probs=175.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.++..+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 173 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 3567999999999999999999999999999999998864 4689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC---CCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG---SGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~---~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|++.+|.+||+|||++......+. ......+||+.|+|||++... ..++.++|||||||++|+|++|..||.+.+
T Consensus 174 ll~~~~~ikL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 174 LLDKSGHLKLADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred EECCCCCEEEEeCCceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 999999999999999875532211 122356899999999998732 237899999999999999999999998866
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCC--CCCHHHHHhccccccCCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~k--RpTa~eIL~HpfFk~~~~~ 218 (583)
..... ..+......+.++....++..++++|.+||..++.+ |++++++++|+||++..+.
T Consensus 252 ~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 252 LVGTY-SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred HHHHH-HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 54444 333333333445555678999999999999854433 7899999999999886543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.35 Aligned_cols=201 Identities=26% Similarity=0.481 Sum_probs=177.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+||||+.+|++|+..+.+.|||||..+|+|.+++... +.++|.++++|++||+.|+.|||.++++|||||.+||
T Consensus 107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENI 184 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENI 184 (668)
T ss_pred HhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhhe
Confidence 77899999999999999999999999999999999999875 7899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|+|.++++||+|||++-.+... ....++||+|-|.+||++.+...-++.+|.|||||+||.|+.|..||++.+. .
T Consensus 185 LLD~N~NiKIADFGLSNly~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-k 259 (668)
T KOG0611|consen 185 LLDQNNNIKIADFGLSNLYADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-K 259 (668)
T ss_pred eecCCCCeeeeccchhhhhccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-H
Confidence 9999999999999998755322 3346899999999999999666668999999999999999999999999554 5
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
.+...|.++... .+.-+..+.-||++||-.+|++|.|+++|-.|=|..
T Consensus 260 ~lvrQIs~GaYr-----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 260 RLVRQISRGAYR-----EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHhhccccc-----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 555666654322 134567899999999999999999999999998765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=331.33 Aligned_cols=209 Identities=29% Similarity=0.513 Sum_probs=170.6
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~-~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
|++++|||||+|+++..+ .+.+|||+|||..|.+... ..... +++.+++.|++.++.||+|||.+|||||||||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKP 238 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKP 238 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence 688999999999999986 4679999999999986542 22344 89999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCC--CCccccccccCCCCCCCcccccCC---CCCCccccccchhhHHhhhhhCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTG--DRQRSRNTFVGTPCWMAPEVLQPG---SGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~--~~~~~~~~~~GT~~Y~APEil~~~---~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
.|+||+.+|++||+|||++....... .........+|||.|+|||.+..+ ...+.+.||||+||+||-|+.|..|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 99999999999999999875331110 000111235899999999999852 2356789999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
|-+....+.. ..|.+.+ +.++..+.+.+.+++||.+||++||.+|+++.+|..|||...-
T Consensus 319 F~~~~~~~l~-~KIvn~p--L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 319 FFDDFELELF-DKIVNDP--LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccchHHHHH-HHHhcCc--ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9886665544 4444433 3444556788999999999999999999999999999999865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.64 Aligned_cols=212 Identities=27% Similarity=0.437 Sum_probs=178.5
Q ss_pred CCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
..++|||||.+.++.+.. +.+|+|||||+ -+|..+|... ...|...+++.++.|+++||+|||.+.|+|||||++|
T Consensus 130 l~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SN 207 (419)
T KOG0663|consen 130 LKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSN 207 (419)
T ss_pred HhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhh
Confidence 457899999999998854 56999999995 5688887654 4679999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
+|++..|.+||+|||+|+.+... ....+..+-|.||+|||++.+...|+.++|+||+|||+.||+.+++.|.+..+.
T Consensus 208 LLm~~~G~lKiaDFGLAR~ygsp---~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 208 LLLSHKGILKIADFGLAREYGSP---LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred eeeccCCcEEecccchhhhhcCC---cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence 99999999999999999876332 333445688999999999999999999999999999999999999999999998
Q ss_pred HHHHHHHhcC--C-----CCCC---------ccc-----------cccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNA--P-----PGLD---------YDR-----------DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~--~-----~~~~---------~~~-----------~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
+++..+++.. + +++. ++. ...+++...+|+..+|.+||.+|.||++.|+|.||
T Consensus 285 dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 285 DQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred HHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 8887666521 1 1110 000 01145888999999999999999999999999999
Q ss_pred ccCCCC
Q 007967 213 KHAKPP 218 (583)
Q Consensus 213 k~~~~~ 218 (583)
.+.+.+
T Consensus 365 ~e~P~p 370 (419)
T KOG0663|consen 365 RETPLP 370 (419)
T ss_pred ccCCCC
Confidence 986543
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.64 Aligned_cols=214 Identities=26% Similarity=0.446 Sum_probs=174.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nil 134 (332)
T cd05623 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134 (332)
T ss_pred hhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 4679999999999999999999999999999999998753 356999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
++.++.+||+|||++..+...+. ......+||+.|+|||++.. ...++.++|||||||++|+|++|+.||....
T Consensus 135 i~~~~~~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 135 MDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ECCCCCEEEeecchheecccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 99999999999999865433221 11234579999999999862 3468899999999999999999999998876
Q ss_pred hHHHHHHHHhcCCCCCCccc-cccchHHHHHHHHhhhcCCCCC--CCCHHHHHhccccccCCCCc
Q 007967 158 PMKVLLMTIQNAPPGLDYDR-DKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~-~~~~S~~lkdLI~~cL~~DP~k--RpTa~eIL~HpfFk~~~~~~ 219 (583)
..+....... ......++. ...+++++++||.+||+.++.. |++++++++||||..+++..
T Consensus 213 ~~~~~~~i~~-~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 213 LVETYGKIMN-HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred HHHHHHHHhC-CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 5555443333 222222221 2457999999999999765544 68999999999999887543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.58 Aligned_cols=211 Identities=43% Similarity=0.804 Sum_probs=192.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|.+.+.|+||+||+.|.....+|||||||..|++.++++.+ ++.++|.++..+++..++||+|||...-||||||..||
T Consensus 82 MQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNI 160 (502)
T KOG0574|consen 82 MQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNI 160 (502)
T ss_pred HHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccE
Confidence 56789999999999999999999999999999999998765 67899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|+.||+|||+|..+.+ ....+++.+|||.|||||++. .-+|+.++||||||++..||..|++||....++.
T Consensus 161 LLNT~G~AKLADFGVAGQLTD---TMAKRNTVIGTPFWMAPEVI~-EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 161 LLNTDGIAKLADFGVAGQLTD---TMAKRNTVIGTPFWMAPEVIE-EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred EEcccchhhhhhccccchhhh---hHHhhCccccCcccccHHHHH-HhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 999999999999999976643 344567899999999999998 6789999999999999999999999999999998
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.++++-.+.++.+. .+..+|.+|.+||+.||.+.|++|-|+.++++|||+++++.-
T Consensus 237 AIFMIPT~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 237 AIFMIPTKPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred eeEeccCCCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 88888777776654 456789999999999999999999999999999999988643
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.85 Aligned_cols=210 Identities=26% Similarity=0.450 Sum_probs=175.9
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||+|++++++|.+.+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 5788999999999999999999999999999987653 67999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
++.+||+|||++....... ......+||+.|+|||++. +..++.++||||+||++|+|++|..||.+.........
T Consensus 137 ~~~ikL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (323)
T cd05615 137 EGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212 (323)
T ss_pred CCCEEEeccccccccCCCC---ccccCccCCccccCHHHHc-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999986432221 1223467999999999997 56789999999999999999999999988766544433
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhh
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKL 225 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~ 225 (583)
... ... ..+..++.++++++.+||.++|.+|++ .+++++||||+..++........
T Consensus 213 i~~-~~~----~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~ 273 (323)
T cd05615 213 IME-HNV----SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREI 273 (323)
T ss_pred HHh-CCC----CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCC
Confidence 333 222 233568899999999999999999997 58999999999887665544433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.85 Aligned_cols=216 Identities=42% Similarity=0.732 Sum_probs=171.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..++.+|+|||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Ni 132 (327)
T cd08227 53 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 132 (327)
T ss_pred HHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhE
Confidence 35689999999999999999999999999999999998765556799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCcc----ccccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQR----SRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~----~~~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|++.++.++++|||.+......+.... ......++..|+|||++... ..|+.++|||||||++|+|++|..||..
T Consensus 133 l~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 133 LISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred EEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999986544332221111 01123567889999998743 4689999999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCCC-----------------------------------------CccccccchHHHHHHHHhhhc
Q 007967 156 YPPMKVLLMTIQNAPPGL-----------------------------------------DYDRDKKFSKSFKEMVAMCLV 194 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~-----------------------------------------~~~~~~~~S~~lkdLI~~cL~ 194 (583)
..........+....+.. ..+....+++.+++||.+||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 292 (327)
T cd08227 213 MPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQ 292 (327)
T ss_pred cchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHh
Confidence 554333322222111100 001123457789999999999
Q ss_pred CCCCCCCCHHHHHhccccccCC
Q 007967 195 KDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 195 ~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+||.+|||+.++++||||++..
T Consensus 293 ~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 293 RNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hCchhcCCHHHHhcChhhhhcc
Confidence 9999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=314.38 Aligned_cols=211 Identities=26% Similarity=0.402 Sum_probs=160.3
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAY-------QDGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~-------~~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
|+.++||||++++++|.. +..+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 130 (317)
T cd07868 52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 457899999999999964 467999999995 67888776431 12489999999999999999999999999
Q ss_pred ccCCCCCcEEE----cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 72 HRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 72 HRDLKPeNILl----d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
||||||+|||+ +..+.+||+|||+++...............+||+.|+|||++.+...|+.++||||+||++|+|+
T Consensus 131 HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 210 (317)
T cd07868 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred cCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH
Confidence 99999999999 45678999999998754332222222345688999999999985567899999999999999999
Q ss_pred hCCCCCCCCCh---------HHHHHHHHhc--CCCCCC---------------------c----------cccccchHHH
Q 007967 148 HGHAPFSKYPP---------MKVLLMTIQN--APPGLD---------------------Y----------DRDKKFSKSF 185 (583)
Q Consensus 148 tG~~PF~~~~~---------~~~l~~~i~~--~~~~~~---------------------~----------~~~~~~S~~l 185 (583)
+|.+||..... ...+...+.. .+.... + ......+..+
T Consensus 211 ~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (317)
T cd07868 211 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 290 (317)
T ss_pred hCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHH
Confidence 99999965321 1111111110 000000 0 0001234578
Q ss_pred HHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 186 KEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 186 kdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+||.+||++||.+|||++|+|+||||
T Consensus 291 ~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 291 FHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.46 Aligned_cols=209 Identities=33% Similarity=0.571 Sum_probs=170.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+++.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~N 134 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSN 134 (331)
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhh
Confidence 45789999999999999999999999999999999988753 5699999999999999999999986 69999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.+||+|||++...... ......|++.|+|||++. +..++.++|||||||++|+|++|+.||......
T Consensus 135 il~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 135 ILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred EEEcCCCcEEEccCccccccccc-----ccccCCCCcCcCCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999998654221 123467999999999998 567999999999999999999999999764432
Q ss_pred HHHHHHHhcCCC--------------------------------------------CCCccccccchHHHHHHHHhhhcC
Q 007967 160 KVLLMTIQNAPP--------------------------------------------GLDYDRDKKFSKSFKEMVAMCLVK 195 (583)
Q Consensus 160 ~~l~~~i~~~~~--------------------------------------------~~~~~~~~~~S~~lkdLI~~cL~~ 195 (583)
+ +...+..... .........++.++++||.+||.+
T Consensus 209 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 287 (331)
T cd06649 209 E-LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIK 287 (331)
T ss_pred H-HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccC
Confidence 2 2111111000 000001124688999999999999
Q ss_pred CCCCCCCHHHHHhccccccCCCC
Q 007967 196 DQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 196 DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
||.+|||+.+|++||||+.....
T Consensus 288 ~P~~Rpt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 288 NPAERADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred CcccCCCHHHHhcChHHhhcccc
Confidence 99999999999999999876543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=327.99 Aligned_cols=205 Identities=31% Similarity=0.482 Sum_probs=180.2
Q ss_pred CCCCCCCcccceEEEEEECCE-EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~-l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
++++.|||||.+++.|+.++. ++|||+||+||++.+.|....+..|+|+.+..|+.||+.|+.|||+++|+|||||+.|
T Consensus 57 is~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~N 136 (426)
T KOG0589|consen 57 LSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCAN 136 (426)
T ss_pred HHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhh
Confidence 367899999999999999988 9999999999999999988776779999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.|||+|||+|+.+.... ....+.+||++||.||++. +.+|+.|+|||||||++|||++-+++|.+.+-
T Consensus 137 ifltk~~~VkLgDfGlaK~l~~~~---~~a~tvvGTp~YmcPEil~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m- 211 (426)
T KOG0589|consen 137 IFLTKDKKVKLGDFGLAKILNPED---SLASTVVGTPYYMCPEILS-DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM- 211 (426)
T ss_pred hhccccCceeecchhhhhhcCCch---hhhheecCCCcccCHHHhC-CCCCCccCcchhhcchHHHHHhcccccCccch-
Confidence 999999999999999998764332 1334689999999999998 78999999999999999999999999998544
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
..+...+.... -.+.+..++.+++.+|+.||.++|..||++.++|.+|...
T Consensus 212 ~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 212 SELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 44444444332 2345678999999999999999999999999999997654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.41 Aligned_cols=204 Identities=27% Similarity=0.413 Sum_probs=165.3
Q ss_pred CCCCCcccceEEEEEE-----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 3 LIDHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d-----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
.++||||++++++|.+ ...+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||
T Consensus 58 ~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp 136 (288)
T cd07863 58 AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKP 136 (288)
T ss_pred hcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 4589999999999875 346899999997 5888888765455699999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
+|||++.++.+||+|||++...... .......||+.|+|||++. +..++.++||||+||++|+|++|.+||.+..
T Consensus 137 ~Nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~ 211 (288)
T cd07863 137 ENILVTSGGQVKLADFGLARIYSCQ----MALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 211 (288)
T ss_pred HHEEECCCCCEEECccCccccccCc----ccCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence 9999999999999999998654221 1122357899999999997 5678999999999999999999999998876
Q ss_pred hHHHHHHHHhcC--CCCCCc--------------------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 158 PMKVLLMTIQNA--PPGLDY--------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 158 ~~~~l~~~i~~~--~~~~~~--------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
....+....... +....+ .....++..+++||.+||++||.+|||+.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 212 EADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 655443333211 000000 0113567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.27 Aligned_cols=209 Identities=29% Similarity=0.487 Sum_probs=176.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++|||||+++++|..++.+|||||||+||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+
T Consensus 119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~ 198 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSA 198 (478)
T ss_pred HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHH
Confidence 46789999999999999999999999999999999887643 2345899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||++..+.... ........+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+...
T Consensus 199 NIll~~~~~~kL~DFgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 199 NIFLMPTGIIKLGDFGFSKQYSDSV-SLDVASSFCGTPYYLAPELWE-RKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred hEEECCCCcEEEEeCcCceecCCcc-ccccccccCCCccccCHhHhC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999987543221 112234568999999999987 56799999999999999999999999988666
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.+.+...+..... +.+..++..+++||.+||.+||.+||++.+++.|+|++..
T Consensus 277 ~~~~~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 277 REIMQQVLYGKYD----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHhCCCC----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 5555444443221 2234678999999999999999999999999999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.63 Aligned_cols=213 Identities=27% Similarity=0.469 Sum_probs=171.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++++|+|||||.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 134 (331)
T cd05597 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVL 134 (331)
T ss_pred HhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEE
Confidence 4579999999999999999999999999999999998653 456999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
++.++.+||+|||++..+..... ......+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+..
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 135 LDKNGHIRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred ECCCCCEEEEECCceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 99999999999999865432221 11123579999999999863 2457889999999999999999999998866
Q ss_pred hHHHHHHHHhcCCCCCCc-cccccchHHHHHHHHhhhcCCCCC--CCCHHHHHhccccccCCCC
Q 007967 158 PMKVLLMTIQNAPPGLDY-DRDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~-~~~~~~S~~lkdLI~~cL~~DP~k--RpTa~eIL~HpfFk~~~~~ 218 (583)
..+........ ...+.. .....++..+++||.+||+.++.. |+++.++++||||...++.
T Consensus 213 ~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 213 LVETYGKIMNH-KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred HHHHHHHHHcC-CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 54444333322 111111 122457999999999999764444 7899999999999887653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.02 Aligned_cols=206 Identities=30% Similarity=0.569 Sum_probs=172.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++++++..+|+||||++|++|.+++... ..+++..+..++.||+.||.|||+.|++||||+|+||
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 135 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 35789999999999999999999999999999999988753 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++.................|+..|+|||.+. +..++.++|||||||++|+|++|+.||.......
T Consensus 136 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 136 LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred EEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceec-cCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 999999999999999865432211111113456889999999998 4568999999999999999999999998765544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
......... .....+..++..+.++|.+||.++|.+|||+.++++|+||
T Consensus 215 ~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 215 AIFKIATQP---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhccC---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 443332221 1223345688999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.81 Aligned_cols=214 Identities=27% Similarity=0.446 Sum_probs=179.4
Q ss_pred CCCCCCCc-ccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 1 MSLIDHPN-VIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQ--DGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 1 Mk~L~HPN-IVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~~--~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
|+.|.|+| ||.+++++.+.. .+++||||+ .-+|..++..... .+++...++.+++||+.||+|||++||+
T Consensus 64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~Il 142 (323)
T KOG0594|consen 64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGIL 142 (323)
T ss_pred HHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 46789999 999999999887 899999999 5679999887643 4788899999999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 72 HRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
||||||.||||+.+|.+||+|||+|+... .+.+.....++|.||+|||++.+...|+..+||||+|||++||+++++
T Consensus 143 HRDLKPQNlLi~~~G~lKlaDFGlAra~~---ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 143 HRDLKPQNLLISSSGVLKLADFGLARAFS---IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred cccCCcceEEECCCCcEeeeccchHHHhc---CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence 99999999999999999999999998542 222334456899999999999988899999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcC--CCCCC-------------cccc----------ccchHHHHHHHHhhhcCCCCCCCCHHHH
Q 007967 152 PFSKYPPMKVLLMTIQNA--PPGLD-------------YDRD----------KKFSKSFKEMVAMCLVKDQTKRPTAEKL 206 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~--~~~~~-------------~~~~----------~~~S~~lkdLI~~cL~~DP~kRpTa~eI 206 (583)
.|.+..+.+++..+..-. +.... +..+ +..+....+++.+||+++|.+|.|+..+
T Consensus 220 LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a 299 (323)
T KOG0594|consen 220 LFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA 299 (323)
T ss_pred CCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH
Confidence 999999888876665521 11111 1111 1223478999999999999999999999
Q ss_pred HhccccccCCCC
Q 007967 207 LKHSFFKHAKPP 218 (583)
Q Consensus 207 L~HpfFk~~~~~ 218 (583)
|.||||......
T Consensus 300 l~h~yf~~~~~~ 311 (323)
T KOG0594|consen 300 LTHPYFSELPEK 311 (323)
T ss_pred hcChhhcccccc
Confidence 999999987543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.52 Aligned_cols=211 Identities=25% Similarity=0.410 Sum_probs=174.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|+||+.+++.+.+++.+|+||||+.||+|.+++.......+++..+..++.|++.||.|||++||+||||||+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05630 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133 (285)
T ss_pred HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence 35689999999999999999999999999999999988665455699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH-
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM- 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~- 159 (583)
+++.++.++|+|||++...... . ......|+..|+|||++. ...++.++||||+||++|+|++|..||......
T Consensus 134 l~~~~~~~~l~Dfg~~~~~~~~-~---~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~ 208 (285)
T cd05630 134 LLDDHGHIRISDLGLAVHVPEG-Q---TIKGRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 208 (285)
T ss_pred EECCCCCEEEeeccceeecCCC-c---cccCCCCCccccChHHHc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence 9999999999999987643211 1 112357899999999997 567899999999999999999999999864321
Q ss_pred --HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCch
Q 007967 160 --KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 160 --~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~ 220 (583)
.......... .......++..+++||.+||+.||.+||| ++++++||||+...+...
T Consensus 209 ~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05630 209 KREEVERLVKEV----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272 (285)
T ss_pred hHHHHHhhhhhh----hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHH
Confidence 1111111111 11223567889999999999999999999 999999999998765544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.06 Aligned_cols=205 Identities=32% Similarity=0.536 Sum_probs=165.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||.+|+|... ....+..+..+++||+.||.|||++||+||||||+||
T Consensus 126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 199 (353)
T PLN00034 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199 (353)
T ss_pred HHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 4578999999999999999999999999999998652 3467888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|++.++.+||+|||++..+..... .....+||..|+|||++.. +..++.++|||||||++|+|++|+.||...
T Consensus 200 ll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 200 LINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred EEcCCCCEEEcccccceecccccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999875432211 1234689999999999852 233457899999999999999999999743
Q ss_pred Ch--HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 157 PP--MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 157 ~~--~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.. ...+...+... ........++.++++||.+||..||.+|||+.++++||||.....
T Consensus 277 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 277 RQGDWASLMCAICMS---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred CCccHHHHHHHHhcc---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 22 22222222111 112233567899999999999999999999999999999998643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.27 Aligned_cols=211 Identities=23% Similarity=0.382 Sum_probs=170.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++..++.+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni 135 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 3568999999999999999999999999974 788776543 34589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+
T Consensus 136 ll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 212 (309)
T cd07872 136 LINERGELKLADFGLARAKSVPT---KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212 (309)
T ss_pred EECCCCCEEECccccceecCCCc---cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999999986432211 112235789999999998756678999999999999999999999998766544
Q ss_pred HHHHHHhcCCCC----------------CC---------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 161 VLLMTIQNAPPG----------------LD---------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 161 ~l~~~i~~~~~~----------------~~---------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.+.......... .. ......++.++++||.+||..||.+|||+.++++||||+..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 433222210000 00 01123468899999999999999999999999999999976
Q ss_pred C
Q 007967 216 K 216 (583)
Q Consensus 216 ~ 216 (583)
.
T Consensus 293 ~ 293 (309)
T cd07872 293 G 293 (309)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=297.32 Aligned_cols=212 Identities=62% Similarity=1.105 Sum_probs=180.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||+++++.+..+..+|+||||+.|++|.+++..... ..+++..++.++.||+.||.|||++|++||||+|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~n 132 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 3568999999999999999999999999999999999876543 568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCc-cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~-~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|+++.++.++|+|||++.......... .......|+..|+|||.+.....++.++|+|||||++|+|++|..||...+.
T Consensus 133 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred EEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 999999999999999987665433221 1223457899999999988555789999999999999999999999988777
Q ss_pred HHHHHHHHhcCCCCCCccc-cccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 159 MKVLLMTIQNAPPGLDYDR-DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~-~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+............+.... ...++..+.+|+.+||.+||.+|||+.+|++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred hhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 6666555555444333322 24688999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=307.62 Aligned_cols=217 Identities=45% Similarity=0.774 Sum_probs=176.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|++||||.+|+|.+++.......+++..++.+++||+.||.|||++||+||||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Ni 132 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHI 132 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceE
Confidence 45789999999999999999999999999999999999876667799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|++.++.+||+|||.+......+... .......++..|+|||++... ..|+.++||||+||++|+|++|..||..
T Consensus 133 li~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 133 LLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred EEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999876554322211 111234677889999998743 4688999999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCC-----------------------------CCccccccchHHHHHHHHhhhcCCCCCCCCHHHH
Q 007967 156 YPPMKVLLMTIQNAPPG-----------------------------LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~-----------------------------~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eI 206 (583)
..........+....+. ........++.++.+||.+||.+||.+|||++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 292 (314)
T cd08216 213 MPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292 (314)
T ss_pred CCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH
Confidence 66555444333221110 0011123456789999999999999999999999
Q ss_pred HhccccccCCC
Q 007967 207 LKHSFFKHAKP 217 (583)
Q Consensus 207 L~HpfFk~~~~ 217 (583)
|+||||+.+..
T Consensus 293 l~~p~~~~~~~ 303 (314)
T cd08216 293 LNHSFFKQCKR 303 (314)
T ss_pred hcCchHhhhcc
Confidence 99999987753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=323.00 Aligned_cols=211 Identities=26% Similarity=0.433 Sum_probs=165.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||||+++++|..+...++||||+ +++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 137 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NI 213 (391)
T PHA03212 137 LRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENI 213 (391)
T ss_pred HHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhE
Confidence 46789999999999999999999999999 4788887765 36789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh--
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP-- 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~-- 158 (583)
|++.++.+||+|||+|....... .......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.....
T Consensus 214 ll~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 214 FINHPGDVCLGDFGAACFPVDIN--ANKYYGWAGTIATNAPELLA-RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred EEcCCCCEEEEeCCccccccccc--ccccccccCccCCCChhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 99999999999999986432211 11223468999999999997 56799999999999999999999988753211
Q ss_pred -----HHHHHHHHhcC---CCCC----------------------C-----ccccccchHHHHHHHHhhhcCCCCCCCCH
Q 007967 159 -----MKVLLMTIQNA---PPGL----------------------D-----YDRDKKFSKSFKEMVAMCLVKDQTKRPTA 203 (583)
Q Consensus 159 -----~~~l~~~i~~~---~~~~----------------------~-----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa 203 (583)
...+...+... +..+ . +.....++.++.+||.+||++||.+|||+
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta 370 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA 370 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH
Confidence 11111111100 0000 0 00011346789999999999999999999
Q ss_pred HHHHhccccccCCC
Q 007967 204 EKLLKHSFFKHAKP 217 (583)
Q Consensus 204 ~eIL~HpfFk~~~~ 217 (583)
.|+|+||||+.+..
T Consensus 371 ~elL~hp~f~~~~~ 384 (391)
T PHA03212 371 EALLDFAAFQDIPD 384 (391)
T ss_pred HHHhcChhhccCCC
Confidence 99999999987653
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=302.85 Aligned_cols=208 Identities=26% Similarity=0.407 Sum_probs=168.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||+++++++.++..+|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~n 131 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQN 131 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHH
Confidence 356899999999999999999999999997 688888765433 568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.+|.++|+|||++...... ........+++.|+|||++.+...++.++|||||||++|+|++|++||.+....
T Consensus 132 il~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 132 LLIDNKGVIKLADFGLARAFGIP---VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred EEEcCCCcEEECcccceeecCCC---cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999998643211 112223467899999999875567889999999999999999999999876654
Q ss_pred HHHHHHHhcCCC------------------------CCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAPP------------------------GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~~------------------------~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
............ .........++.++++||.+||+.||.+|||+.+|+.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 209 DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 443332221100 00001123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.99 Aligned_cols=203 Identities=27% Similarity=0.487 Sum_probs=180.4
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.|+||||+++|++|.++..+||++||..+|+++..++......|+|..++.+++|++.||.|||.++||||||||+|+|
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL 156 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL 156 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence 35899999999999999999999999999999999998666678999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++..|.+||+|||-+..-. ...+.+.|||..|.+||+.. +..++..+|+|++|++.||++.|.+||.... ...
T Consensus 157 lg~~~~lkiAdfGwsV~~p-----~~kR~tlcgt~dyl~pEmv~-~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~e 229 (281)
T KOG0580|consen 157 LGSAGELKIADFGWSVHAP-----SNKRKTLCGTLDYLPPEMVE-GRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSE 229 (281)
T ss_pred cCCCCCeeccCCCceeecC-----CCCceeeecccccCCHhhcC-CCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHH
Confidence 9999999999999875321 23345789999999999998 7889999999999999999999999999877 445
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
....+... ++..+..++..++++|.+||.++|.+|++..|++.|||+...
T Consensus 230 tYkrI~k~----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 230 TYKRIRKV----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHc----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 55555543 333347899999999999999999999999999999998643
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=310.90 Aligned_cols=213 Identities=25% Similarity=0.422 Sum_probs=172.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++.+|+|||||.||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 56 ~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nil 134 (331)
T cd05624 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134 (331)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEE
Confidence 4578999999999999999999999999999999998753 357899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC----CCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG----SGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~----~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
++.++.+||+|||++........ ......+||+.|+|||++... ..++.++|||||||++|+|++|+.||....
T Consensus 135 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 135 LDMNGHIRLADFGSCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred EcCCCCEEEEeccceeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 99999999999999865432211 111235799999999998631 457889999999999999999999998866
Q ss_pred hHHHHHHHHhcCCCCCCccc-cccchHHHHHHHHhhhcCCCCC--CCCHHHHHhccccccCCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDR-DKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~-~~~~S~~lkdLI~~cL~~DP~k--RpTa~eIL~HpfFk~~~~~ 218 (583)
..+....... ....+.++. ...+++.++++|.+||+.++.+ |++++++++||||+..+|.
T Consensus 213 ~~~~~~~i~~-~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 213 LVETYGKIMN-HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred HHHHHHHHHc-CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 5544433332 222222211 2357899999999999976654 4689999999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.41 Aligned_cols=212 Identities=27% Similarity=0.447 Sum_probs=184.2
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
-.|+||++|+++|+++..+|||||-|.||.|+..|... ..|+|.++.++++.|+.||.|||.+||.||||||+|||..
T Consensus 133 qgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 133 QGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCE 210 (463)
T ss_pred cCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeec
Confidence 47999999999999999999999999999999887764 7799999999999999999999999999999999999996
Q ss_pred CCC---cEEEEecCCccccccCCCC----ccccccccCCCCCCCccccc----CCCCCCccccccchhhHHhhhhhCCCC
Q 007967 84 TNG---VVKLADFGVSACMFDTGDR----QRSRNTFVGTPCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 84 ~~g---~IKL~DFGlA~~~~~~~~~----~~~~~~~~GT~~Y~APEil~----~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
... .||||||.+..-+....+. .....+.+|+..|||||+.. ....|+.++|.||||||+|.||+|++|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 554 5899999886543222221 12234679999999999974 356799999999999999999999999
Q ss_pred CCCCCh--------------HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 153 FSKYPP--------------MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 153 F~~~~~--------------~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
|.+... ...+++.|+.+...++-..|..+|.+++++|..+|..|+..|.++.++++|||+..+..
T Consensus 291 FvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 291 FVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred ccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 965321 45788999999888888889999999999999999999999999999999999987753
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=303.32 Aligned_cols=216 Identities=27% Similarity=0.386 Sum_probs=177.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|+||+.++++|.+++.+|+||||+.+|+|.+++.......+++..+..++.|++.||.|||++||+||||||+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05632 54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133 (285)
T ss_pred HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence 45789999999999999999999999999999999887665445799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++...... .......|++.|+|||.+. +..++.++|+|||||++|+|++|..||.+.....
T Consensus 134 li~~~~~~kl~Dfg~~~~~~~~----~~~~~~~g~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 134 LLDDYGHIRISDLGLAVKIPEG----ESIRGRVGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred EECCCCCEEEecCCcceecCCC----CcccCCCCCcCccChHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999988643211 1112457899999999997 5678999999999999999999999998765433
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSV 222 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~ 222 (583)
......... ..........++..+.+|+.+||+.||.+||+ +.+++.|+||+...+.....
T Consensus 209 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 274 (285)
T cd05632 209 KREEVDRRV-LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEA 274 (285)
T ss_pred HHHHHHHhh-hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhc
Confidence 222211111 11112234568889999999999999999999 89999999999987654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.03 Aligned_cols=219 Identities=30% Similarity=0.494 Sum_probs=183.4
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+.+-|++++-.|+|+.++|+|||||+||+|..+|... +.++|..+++|+.+|+.||.-||+.|+|||||||+|||||.
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc
Confidence 4567899999999999999999999999999999875 37999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC---C-CCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP---G-SGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~---~-~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
.|+|||+|||.+..+-..|. ......+|||.|++||+++. + ..|+..+||||+||++|||+.|..||....-.+
T Consensus 211 ~GHikLADFGsClkm~~dG~--V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve 288 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADGT--VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE 288 (1317)
T ss_pred cCcEeeccchhHHhcCCCCc--EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH
Confidence 99999999998765543332 33356799999999999973 3 569999999999999999999999998755444
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC---HHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT---AEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT---a~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
... .|.+....+.++....+|+++++||+++|+ +|..|+. ++++..||||.+++|. .++...+++.|
T Consensus 289 TY~-KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~--~iR~~~pP~vP 358 (1317)
T KOG0612|consen 289 TYG-KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD--NIRESVPPVVP 358 (1317)
T ss_pred HHH-HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh--hhhhcCCCCCC
Confidence 443 333444456666566799999999999987 5899998 9999999999999994 33444444433
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.05 Aligned_cols=206 Identities=43% Similarity=0.729 Sum_probs=168.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+.+|+|||||.+|+|.+++... +.+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 137 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANI 137 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 35679999999999999999999999999999999988653 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc--CCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ--PGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~--~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+++.++.++|+|||++...... ........|+..|+|||.+. ....++.++|+|||||++|+|++|..||.....
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 138 LLTDNGHVKLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred EECCCCCEEECcceeeeEccCc---ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 9999999999999997654221 11223457899999999874 234588899999999999999999999976555
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hpf 211 (583)
......................++..++++|.+||..+|.+|||++++++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 215 MRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred hhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 44433322221111111112357889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.15 Aligned_cols=204 Identities=29% Similarity=0.545 Sum_probs=173.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+..|+||||++|++|.+++.......+++..++.++.||+.||.|||++|++|+||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~ni 132 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNL 132 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 35789999999999999999999999999999999998876556799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......|++.|+|||++. ...++.++|+|||||++|+|++|..||.......
T Consensus 133 li~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 208 (256)
T cd08529 133 FLDAYDNVKIGDLGVAKLLSDNT---NFANTIVGTPYYLSPELCE-DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208 (256)
T ss_pred EEeCCCCEEEcccccceeccCcc---chhhccccCccccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999876543221 1123457899999999998 5568899999999999999999999998876554
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
..........+.+ ...++..+.++|.+||+.+|++||++.++++|||+
T Consensus 209 ~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 209 LILKIIRGVFPPV----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHcCCCCCC----ccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 4444433322221 23678899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.41 Aligned_cols=209 Identities=27% Similarity=0.422 Sum_probs=172.9
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
..+||||+.++++|..++.+|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~ 130 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE
Confidence 35799999999999999999999999999999988764 3669999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh--HH
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP--MK 160 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~--~~ 160 (583)
+.++.++|+|||++...... ......|++.|+|||.+..+..++.++||||+||++|+|++|..||..... ..
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 205 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205 (279)
T ss_pred CCCCCEEEccCCcceecccc-----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH
Confidence 99999999999998643211 112357899999999986556789999999999999999999999975432 12
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSV 222 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~ 222 (583)
.+..... ......+..++.+++++|.+||..||.+|+ |+.++++||||+...+.....
T Consensus 206 ~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~ 268 (279)
T cd05633 206 EIDRMTL----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYL 268 (279)
T ss_pred HHHHHhh----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhc
Confidence 2211111 122233456889999999999999999999 699999999999987655433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.22 Aligned_cols=204 Identities=33% Similarity=0.636 Sum_probs=168.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+++.+|+|||||.||+|.+++... +.+++..+..++.||+.||.|||+. +|+||||||+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~N 134 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 134 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhh
Confidence 35689999999999999999999999999999999998753 5689999999999999999999985 79999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.+||+|||++...... ......|+..|+|||.+. +..++.++|||||||++|+|++|+.||......
T Consensus 135 ili~~~~~~kL~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 135 ILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred EEEcCCCCEEEeeCCcchhhhhh-----ccccCCCCccccCHHHhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99999999999999998644221 123457899999999997 567899999999999999999999999764332
Q ss_pred HHHHHHHh---------------------------------------------cCCCCCCccccccchHHHHHHHHhhhc
Q 007967 160 KVLLMTIQ---------------------------------------------NAPPGLDYDRDKKFSKSFKEMVAMCLV 194 (583)
Q Consensus 160 ~~l~~~i~---------------------------------------------~~~~~~~~~~~~~~S~~lkdLI~~cL~ 194 (583)
... ..+. ...+.. ....++.++++||.+||+
T Consensus 209 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~L~ 284 (333)
T cd06650 209 ELE-LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL---PSGVFGAEFQDFVNKCLI 284 (333)
T ss_pred HHH-HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccC---CCCCcCHHHHHHHHHhcc
Confidence 211 1110 000000 012367889999999999
Q ss_pred CCCCCCCCHHHHHhccccccCC
Q 007967 195 KDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 195 ~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+||.+|||++++++||||+...
T Consensus 285 ~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 285 KNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred CCcccCcCHHHHhhCHHHhcCc
Confidence 9999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.28 Aligned_cols=214 Identities=26% Similarity=0.349 Sum_probs=170.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.....+|+||||+. ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Ni 216 (392)
T PHA03207 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENI 216 (392)
T ss_pred HHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 467899999999999999999999999995 678888743 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh--
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP-- 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~-- 158 (583)
|++.++.++|+|||++....... .........||+.|+|||++. ...|+.++|||||||++|+|++|+.||.+...
T Consensus 217 ll~~~~~~~l~DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 294 (392)
T PHA03207 217 FLDEPENAVLGDFGAACKLDAHP-DTPQCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294 (392)
T ss_pred EEcCCCCEEEccCccccccCccc-ccccccccccccCccCHhHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC
Confidence 99999999999999986543221 112223468999999999997 56789999999999999999999999976432
Q ss_pred -HHHHHHHHh---cCCCCCC---------------------cc-----ccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 -MKVLLMTIQ---NAPPGLD---------------------YD-----RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 -~~~l~~~i~---~~~~~~~---------------------~~-----~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
...+..++. ..+..+. +. ....++.++.+||.+||..||.+|||+.++|.
T Consensus 295 ~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 295 SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111111 1000000 00 01235678899999999999999999999999
Q ss_pred ccccccCCCCc
Q 007967 209 HSFFKHAKPPE 219 (583)
Q Consensus 209 HpfFk~~~~~~ 219 (583)
||||+..++..
T Consensus 375 ~p~f~~~~~~~ 385 (392)
T PHA03207 375 LPLFTKEPINL 385 (392)
T ss_pred Cchhhccchhh
Confidence 99998876543
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.05 Aligned_cols=210 Identities=41% Similarity=0.717 Sum_probs=175.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..+...|+||||+.+|+|..++... ...+++..+..++.||+.||.|||+.|++||||||+||
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~ni 134 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence 35689999999999999999999999999999998876542 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc----CCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~----~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|++.++.+||+|||++....... .......|+..|+|||++. ....++.++|||||||++|+|++|.+||...
T Consensus 135 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 135 LFTLDGDIKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred EEccCCCEEEccccccccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 99999999999999986542211 1123457899999999984 2345788999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
................. ..+..++..+++||.+||+++|.+||+++++++||||+...
T Consensus 212 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 212 NPMRVLLKIAKSEPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred CHHHHHHHHhhcCCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 66555544444333222 23356789999999999999999999999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=299.20 Aligned_cols=213 Identities=39% Similarity=0.699 Sum_probs=175.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..+..+|+||||+.|++|..++... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Ni 141 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV 141 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceE
Confidence 35689999999999999999999999999999998876543 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
+++.++.+||+|||++....... .......+++.|+|||.+.. ...++.++|||||||++|+|++|..||...
T Consensus 142 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 142 LLTLDGDIKLADFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred EEcCCCCEEEccCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 99999999999999876432211 11234578899999999852 345788999999999999999999999876
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
..............+. ......++.++.++|.+||..+|.+||+++++++||||..+.+..
T Consensus 219 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 219 NPMRVLLKIAKSEPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred cHHHHHHHHhcCCCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 6555444433332221 223456788999999999999999999999999999998877543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.23 Aligned_cols=211 Identities=22% Similarity=0.394 Sum_probs=170.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++.+|+||||+. ++|..++... ...+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni 135 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence 356899999999999999999999999996 5888877653 45689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+
T Consensus 136 l~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 136 LINERGELKLADFGLARAKSIPT---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred EECCCCcEEECcCcchhccCCCC---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999986432211 112234678999999998755678899999999999999999999998766544
Q ss_pred HHHHHHhcC--CC--------------CCCcc---------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 161 VLLMTIQNA--PP--------------GLDYD---------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 161 ~l~~~i~~~--~~--------------~~~~~---------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
......... +. ...++ ....+++.+++||.+||+.||.+|||+.++|+||||+..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 332221110 00 00000 113468889999999999999999999999999999876
Q ss_pred C
Q 007967 216 K 216 (583)
Q Consensus 216 ~ 216 (583)
.
T Consensus 293 ~ 293 (301)
T cd07873 293 G 293 (301)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.80 Aligned_cols=211 Identities=27% Similarity=0.389 Sum_probs=159.6
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAY-------QDGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~-------~~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
|+.++||||++++++|.. +..+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv 130 (317)
T cd07867 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 456899999999999864 567999999985 57877765321 12488999999999999999999999999
Q ss_pred ccCCCCCcEEE----cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 72 HRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 72 HRDLKPeNILl----d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
||||||+|||+ +.++.+||+|||+++................||+.|+|||++.+...++.++|||||||++|+|+
T Consensus 131 H~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~ 210 (317)
T cd07867 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred cCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHH
Confidence 99999999999 45679999999998755332222222344678999999999975567899999999999999999
Q ss_pred hCCCCCCCCChH---------HHHHHHHhc--CCCCCC-------------------------------ccccccchHHH
Q 007967 148 HGHAPFSKYPPM---------KVLLMTIQN--APPGLD-------------------------------YDRDKKFSKSF 185 (583)
Q Consensus 148 tG~~PF~~~~~~---------~~l~~~i~~--~~~~~~-------------------------------~~~~~~~S~~l 185 (583)
+|.+||...... ..+...... .+.... .......+..+
T Consensus 211 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (317)
T cd07867 211 TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKV 290 (317)
T ss_pred hCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHH
Confidence 999999653211 111000000 000000 00011235668
Q ss_pred HHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 186 KEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 186 kdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+||.+||+.||.+|||+.|+|+||||
T Consensus 291 ~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 291 FLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHHHhccCcccccCHHHHhcCCCC
Confidence 899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.79 Aligned_cols=208 Identities=41% Similarity=0.746 Sum_probs=187.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|.++.|||+|.|.+||-.+...||||||| -|+-.|++... .+++-|-+|+.|+.+.+.||+|||+++.||||||.+||
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNI 157 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNI 157 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccce
Confidence 45789999999999999999999999999 57778877654 57899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++..|.|||+|||.|.... ..++|+|||+|||||++.. ...|+-++|||||||++.||...++|+-..+.
T Consensus 158 LLse~g~VKLaDFGSAsi~~-------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 158 LLSEPGLVKLADFGSASIMA-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred EecCCCeeeeccccchhhcC-------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 99999999999999876441 2467999999999999863 45699999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCch
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~ 220 (583)
+..+..+.++..+.+.. ..+|..|+.||..||++-|.+|||.+++|+|+|...-.++.+
T Consensus 231 MSALYHIAQNesPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tv 289 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTV 289 (948)
T ss_pred HHHHHHHHhcCCCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchH
Confidence 99999999998887763 568999999999999999999999999999999987766544
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.85 Aligned_cols=205 Identities=26% Similarity=0.457 Sum_probs=161.7
Q ss_pred CCCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|...+ .+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+|||
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrD 148 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 148 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 35789999999999997543 58999999965 4655543 4589999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.+|.+||+|||++...... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.
T Consensus 149 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 149 LKPSNIVVKSDCTLKILDFGLARTACTN----FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred CCHHHEEECCCCCEEEecCCCccccccC----ccCCCCcccCCCCCchhcc-CCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998643221 1223467899999999997 5679999999999999999999999998
Q ss_pred CCChHHHHHHHHhc---------------------CCCCCC----------------ccccccchHHHHHHHHhhhcCCC
Q 007967 155 KYPPMKVLLMTIQN---------------------APPGLD----------------YDRDKKFSKSFKEMVAMCLVKDQ 197 (583)
Q Consensus 155 ~~~~~~~l~~~i~~---------------------~~~~~~----------------~~~~~~~S~~lkdLI~~cL~~DP 197 (583)
+......+...+.. ..+... .......++.+++||.+||..||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 303 (359)
T cd07876 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP 303 (359)
T ss_pred CCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCc
Confidence 76543322211110 000000 00112346789999999999999
Q ss_pred CCCCCHHHHHhccccccC
Q 007967 198 TKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 198 ~kRpTa~eIL~HpfFk~~ 215 (583)
.+|||+.|+|+||||...
T Consensus 304 ~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 304 DKRISVDEALRHPYITVW 321 (359)
T ss_pred ccCCCHHHHhcCchhhhh
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.40 Aligned_cols=218 Identities=29% Similarity=0.462 Sum_probs=180.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++...|+||||+.|++|.+++.......+++..+..++.||+.||+|||+.|++|+||||+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 134 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHe
Confidence 35788999999999999999999999999999999998765456799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCC--------------------------ccccccccCCCCCCCcccccCCCCCCccc
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDR--------------------------QRSRNTFVGTPCWMAPEVLQPGSGYNSKA 134 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~--------------------------~~~~~~~~GT~~Y~APEil~~~~~ys~ks 134 (583)
+++.++.++|+|||++......... ....+.+.|+..|+|||++. +..++.++
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~ 213 (316)
T cd05574 135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAV 213 (316)
T ss_pred EEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchH
Confidence 9999999999999987643211100 01122457899999999997 56789999
Q ss_pred cccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC----HHHHHhcc
Q 007967 135 DIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT----AEKLLKHS 210 (583)
Q Consensus 135 DIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT----a~eIL~Hp 210 (583)
|||||||++|+|++|..||.+......+....... ..+.....++..++++|.+||..+|.+||| ++++|+||
T Consensus 214 Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 214 DWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE---VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC---ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 99999999999999999998766555444333222 122223347899999999999999999999 99999999
Q ss_pred ccccCCCCchhh
Q 007967 211 FFKHAKPPELSV 222 (583)
Q Consensus 211 fFk~~~~~~~~~ 222 (583)
||+..+++....
T Consensus 291 ~~~~~~~~~~~~ 302 (316)
T cd05574 291 FFRGVNWALIRH 302 (316)
T ss_pred hhhcCChhhccc
Confidence 999988776654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=291.69 Aligned_cols=207 Identities=43% Similarity=0.761 Sum_probs=172.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++.+|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 132 (262)
T cd06613 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANI 132 (262)
T ss_pred HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhE
Confidence 46789999999999999999999999999999999987653 35799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC--CCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG--SGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~--~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+++.++.+||+|||++....... .......++..|+|||.+... ..++.++|+|||||++|+|++|..||.....
T Consensus 133 ~i~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 133 LLTEDGDVKLADFGVSAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred EECCCCCEEECccccchhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999986543221 112345788999999998732 2688899999999999999999999988776
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hpf 211 (583)
......................++.++++||.+||..+|.+|||+.+++.|+|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 210 MRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 55554443332111122223457889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.01 Aligned_cols=211 Identities=26% Similarity=0.430 Sum_probs=170.0
Q ss_pred CCCCCCCcccceEEEEEECC-----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~-----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++||||+++++++...+ .+|+||||+. ++|..++.. ...+++..++.++.||+.||.|||++||+||||
T Consensus 53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dl 129 (372)
T cd07853 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDI 129 (372)
T ss_pred HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 35689999999999999877 8999999996 678777653 367999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.+||+|||+++..... .........++++|+|||++.+...|+.++||||+||++|+|++|+.||.+
T Consensus 130 kp~Nili~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 130 KPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred ChHHEEECCCCCEEeccccceeecccC--ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 999999999999999999998654221 111223457899999999998556689999999999999999999999988
Q ss_pred CChHHHHHHHHhc----------------------CCCCCC-----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 156 YPPMKVLLMTIQN----------------------APPGLD-----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 156 ~~~~~~l~~~i~~----------------------~~~~~~-----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.+....+..+... ...... +......++++.+||.+||++||.+|||+.++|+
T Consensus 208 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 208 QSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 7665443322210 000000 0112345788999999999999999999999999
Q ss_pred ccccccCC
Q 007967 209 HSFFKHAK 216 (583)
Q Consensus 209 HpfFk~~~ 216 (583)
||||+...
T Consensus 288 hp~~~~~~ 295 (372)
T cd07853 288 HPYLDEGR 295 (372)
T ss_pred CHhhCCCc
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=294.68 Aligned_cols=202 Identities=43% Similarity=0.753 Sum_probs=167.7
Q ss_pred CCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 5 DHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
+||||++++++|... ..+|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++||+||||||+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ 140 (272)
T cd06637 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 140 (272)
T ss_pred CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 799999999999863 46999999999999999987654556899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
||+++.++.++|+|||++...... ........|++.|+|||++.. ...|+.++|||||||++|+|++|..||.
T Consensus 141 nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 141 NVLLTENAEVKLVDFGVSAQLDRT---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred HEEECCCCCEEEccCCCceecccc---cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999999999999999998654221 112234678999999999862 2358889999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
............... ........++..+++|+.+||..+|.+|||+.++++||||
T Consensus 218 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 218 DMHPMRALFLIPRNP---APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ccCHHHHHHHHhcCC---CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 766544443332221 1222234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.36 Aligned_cols=208 Identities=25% Similarity=0.417 Sum_probs=166.5
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|... ..+|++|+|+ |++|.+++. ...+++..++.++.||+.||.|||++||+|||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrd 143 (343)
T cd07878 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRD 143 (343)
T ss_pred HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 4678999999999988643 3579999998 888888765 35699999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.++.+||+|||++..... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.
T Consensus 144 ikp~Nil~~~~~~~kl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 144 LKPSNVAVNEDCELRILDFGLARQADD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred CChhhEEECCCCCEEEcCCccceecCC------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999875421 12346899999999999855678999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCC----------------------CCCCc----cccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAP----------------------PGLDY----DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~----------------------~~~~~----~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+......+........ +.... ......++.+.+||.+||..||.+|||+.++|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 7654433322211100 00000 001234667899999999999999999999999
Q ss_pred ccccccCCCC
Q 007967 209 HSFFKHAKPP 218 (583)
Q Consensus 209 HpfFk~~~~~ 218 (583)
||||.....+
T Consensus 298 hp~~~~~~~~ 307 (343)
T cd07878 298 HPYFSQYHDP 307 (343)
T ss_pred CcchhccCCC
Confidence 9999876543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=296.53 Aligned_cols=210 Identities=45% Similarity=0.778 Sum_probs=175.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..+..+|+||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 134 (280)
T cd06611 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNI 134 (280)
T ss_pred HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence 35689999999999999999999999999999999987654 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
+++.++.++|+|||++....... .......|++.|+|||.+.. ...++.++|||||||++|+|++|..||...
T Consensus 135 li~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 135 LLTLDGDVKLADFGVSAKNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred EECCCCCEEEccCccchhhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999876542221 11234578999999999752 345778999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.....+........+.+ ..+..++..+.++|.+||..+|.+||++.++++||||....
T Consensus 212 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 212 NPMRVLLKILKSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred CHHHHHHHHhcCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 66554444433322222 22356889999999999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=299.22 Aligned_cols=208 Identities=30% Similarity=0.503 Sum_probs=176.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++..+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++|+||+|.||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni 132 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 45789999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... .....|++.|+|||.+. ...++.++||||||+++|+|++|..||.......
T Consensus 133 li~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 205 (290)
T cd05580 133 LLDSDGYIKITDFGFAKRVKGR------TYTLCGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205 (290)
T ss_pred EECCCCCEEEeeCCCccccCCC------CCCCCCCccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998654322 23457899999999987 4578899999999999999999999998766433
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSV 222 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~ 222 (583)
... .+..... ..+..++..++++|.+||..+|.+|+ +++++++||||+...|..+..
T Consensus 206 ~~~-~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 267 (290)
T cd05580 206 IYE-KILEGKV----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQ 267 (290)
T ss_pred HHH-HHhcCCc----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhh
Confidence 333 3332222 22345689999999999999999999 899999999999888665543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.29 Aligned_cols=215 Identities=26% Similarity=0.400 Sum_probs=176.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|...+.+|+||||++|++|.+++.......+++..+..++.||+.||.|||++|++||||+|+||
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Ni 126 (277)
T cd05577 47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENV 126 (277)
T ss_pred HHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 45789999999999999999999999999999999988765445799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++..... ........++..|+|||.+. +..++.++|||||||++|+|++|+.||.......
T Consensus 127 l~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 201 (277)
T cd05577 127 LLDDHGNVRISDLGLAVELKG----GKKIKGRAGTPGYMAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV 201 (277)
T ss_pred EECCCCCEEEccCcchhhhcc----CCccccccCCCCcCCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc
Confidence 999999999999998764422 11122356788999999987 4558999999999999999999999997654311
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELS 221 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~ 221 (583)
.. ..+...........+..+++.++++|.+||+.+|.+|| ++.++++||||+..++....
T Consensus 202 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~ 266 (277)
T cd05577 202 EK-EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLE 266 (277)
T ss_pred cH-HHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhh
Confidence 11 11111111222333456799999999999999999999 89999999999988766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=290.15 Aligned_cols=203 Identities=28% Similarity=0.507 Sum_probs=170.3
Q ss_pred CCCCCCcccceEEEEEE-CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLIDHPNVIRAYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.++||||+++++.|.. +..+|+||||+++++|.+++.......+++..+..++.+|+.||.|||++|++||||||+||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~ni 133 (257)
T cd08223 54 SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNV 133 (257)
T ss_pred HhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhE
Confidence 56799999999998874 45689999999999999998765455699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......|++.|+|||++. +..++.++||||+||++|+|++|..||...+...
T Consensus 134 l~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 209 (257)
T cd08223 134 FLTRTNIIKVGDLGIARVLENQC---DMASTLIGTPYYMSPELFS-NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209 (257)
T ss_pred EEecCCcEEEecccceEEecccC---CccccccCCcCccChhHhc-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999986543221 1223467899999999987 5678899999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
..........+ .....+++.+.+||.+||+.+|.+|||+.++++||||
T Consensus 210 ~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 210 LVYRIIEGKLP----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHhcCCC----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 43333332221 2235688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=292.22 Aligned_cols=205 Identities=31% Similarity=0.522 Sum_probs=172.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
++++||||++++++|..++.+|+||||++|++|.+++... +.+++..+..++.||+.||.|||++|++||||+|.||+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil 129 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL 129 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 3568999999999999999999999999999999988753 56899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||++..... .....|++.|+|||.+. +..++.++||||||+++|+|++|..||........
T Consensus 130 ~~~~~~~~l~dfg~~~~~~~-------~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 201 (260)
T cd05611 130 IDQTGHLKLTDFGLSRNGLE-------NKKFVGTPDYLAPETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201 (260)
T ss_pred ECCCCcEEEeecccceeccc-------cccCCCCcCccChhhhc-CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99999999999998764321 22456889999999987 44589999999999999999999999987665443
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC---HHHHHhccccccCCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT---AEKLLKHSFFKHAKP 217 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT---a~eIL~HpfFk~~~~ 217 (583)
. ..+..............++..+.++|.+||+.+|.+||+ +++++.||||++.+|
T Consensus 202 ~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 202 F-DNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred H-HHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 3 333332222222233457899999999999999999995 589999999998876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.18 Aligned_cols=205 Identities=25% Similarity=0.433 Sum_probs=162.4
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|... ..+|+|||||++ ++.+.+. ..+++..+..++.||+.||.|||++||+|||
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrD 144 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 3568999999999998754 357999999965 5666554 3589999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.++.+||+|||+++..... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.
T Consensus 145 ikp~Nill~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 145 LKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred CChHHEEECCCCCEEEeeCcccccCCCc----cccCCccccCCccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998643211 1223468899999999997 5679999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCC---------------------CCC----------------CccccccchHHHHHHHHhhhcCCC
Q 007967 155 KYPPMKVLLMTIQNAP---------------------PGL----------------DYDRDKKFSKSFKEMVAMCLVKDQ 197 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~---------------------~~~----------------~~~~~~~~S~~lkdLI~~cL~~DP 197 (583)
+....+.....+.... +.. ........+..+++||.+||..||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 299 (355)
T cd07874 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCc
Confidence 7665443322221100 000 001112345678999999999999
Q ss_pred CCCCCHHHHHhccccccC
Q 007967 198 TKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 198 ~kRpTa~eIL~HpfFk~~ 215 (583)
.+|||+.++|+||||...
T Consensus 300 ~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 300 AKRISVDEALQHPYINVW 317 (355)
T ss_pred hhcCCHHHHhcCcchhcc
Confidence 999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.88 Aligned_cols=205 Identities=25% Similarity=0.433 Sum_probs=163.4
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|... ..+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+|||
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 151 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCC
Confidence 3568999999999988643 358999999965 6766654 3588999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.++.+||+|||+++.... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||.
T Consensus 152 lkp~NIll~~~~~~kL~DfG~a~~~~~----~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 152 LKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred CCHHHEEECCCCcEEEEeCCCccccCC----CCcccCCcccCCcCCHHHHh-CCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999864421 11223467899999999997 5679999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCC---------------------CC----------------CccccccchHHHHHHHHhhhcCCC
Q 007967 155 KYPPMKVLLMTIQNAPP---------------------GL----------------DYDRDKKFSKSFKEMVAMCLVKDQ 197 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~---------------------~~----------------~~~~~~~~S~~lkdLI~~cL~~DP 197 (583)
+.+..+.....+..... .+ ........+..+++||.+||+.||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 306 (364)
T cd07875 227 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306 (364)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCc
Confidence 87665544333321100 00 000111235678999999999999
Q ss_pred CCCCCHHHHHhccccccC
Q 007967 198 TKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 198 ~kRpTa~eIL~HpfFk~~ 215 (583)
.+|||+.++|+||||...
T Consensus 307 ~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 307 SKRISVDEALQHPYINVW 324 (364)
T ss_pred ccCCCHHHHhcCcccccc
Confidence 999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.94 Aligned_cols=207 Identities=26% Similarity=0.391 Sum_probs=163.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+...+|+|||||. ++|.+++... .+.+++..++.++.||+.||.|||++|++||||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~ni 130 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL 130 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 356899999999999999999999999996 5787776543 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.+||+|||++...... ........+++.|+|||.+.+...++.++|||||||++|+|++|..||.......
T Consensus 131 l~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 131 LINKNGELKLADFGLARAFGIP---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred EEcCCCcEEECccchhhccCCC---CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 9999999999999998644221 1122335678999999998755668999999999999999999888864333322
Q ss_pred HHHHHHhc-C--------------CC-----CCC-----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQN-A--------------PP-----GLD-----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~-~--------------~~-----~~~-----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.....+.. . .. ... ......+++++++||.+||..||.+|||++++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 22111110 0 00 000 01113578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=291.92 Aligned_cols=205 Identities=33% Similarity=0.612 Sum_probs=171.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++...+..++||||+++++|.+++... +.+++..+..++.||+.||.|||++|++||||+|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~ni 137 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANI 137 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHE
Confidence 35689999999999999999999999999999999998753 6689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCC---ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDR---QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~---~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
+++.++.++|+|||++......... ........|+..|+|||.+. ...++.++|+|||||++|+|++|+.||.+..
T Consensus 138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 138 LVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred EEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 9999999999999998755321111 11112356889999999987 5678899999999999999999999998866
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.............+ ..+..++..++++|.+||+.||.+||++.++++||||
T Consensus 217 ~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 217 QLQAIFKIGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 55444333332222 2235678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=295.56 Aligned_cols=199 Identities=26% Similarity=0.460 Sum_probs=166.3
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|...+.+|+||||++||+|.+++... ..+++..+..++.||++||.|||+.|++||||||+||+++.
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC
Confidence 7999999999999999999999999999999998764 47999999999999999999999999999999999999999
Q ss_pred CC-cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 85 NG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 85 ~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
++ .++|+|||++..... .....|+..|+|||++. +..++.++||||+||++|+|++|..||..........
T Consensus 145 ~~~~~~l~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGT-------PSCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred CCCeEEEecCccceecCC-------CccCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 88 999999998764421 12346889999999997 5678999999999999999999999997644322111
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-HHHHHhcccccc
Q 007967 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-AEKLLKHSFFKH 214 (583)
Q Consensus 164 ~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-a~eIL~HpfFk~ 214 (583)
..+.... .........++..+++||.+||+.+|.+|++ ++++|+||||++
T Consensus 217 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 217 ESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 1111111 1122233468999999999999999999996 699999999974
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=297.37 Aligned_cols=208 Identities=26% Similarity=0.401 Sum_probs=173.4
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
..+||||++++++|.+.+.+|+||||+.||+|..++.. .+.+++..++.++.|++.||.|||+++|+||||||+||++
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili 130 (278)
T cd05606 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130 (278)
T ss_pred hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE
Confidence 35899999999999999999999999999999988764 3679999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH--H
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM--K 160 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~--~ 160 (583)
+.++.+||+|||++...... ......|+..|+|||.+..+..++.++||||+||++|+|++|..||...... .
T Consensus 131 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~ 205 (278)
T cd05606 131 DEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205 (278)
T ss_pred CCCCCEEEccCcCccccCcc-----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH
Confidence 99999999999998644221 1234579999999999975557899999999999999999999999765321 1
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELS 221 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~ 221 (583)
......... ....+..++..+.+++.+||..+|.+|| ++.++++||||+...+....
T Consensus 206 ~~~~~~~~~----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~ 267 (278)
T cd05606 206 EIDRMTLTM----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVF 267 (278)
T ss_pred HHHHHhhcc----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhh
Confidence 221222211 2223345789999999999999999999 99999999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=310.96 Aligned_cols=208 Identities=29% Similarity=0.383 Sum_probs=161.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|......|+||||+. |+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 111 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Ni 188 (357)
T PHA03209 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI 188 (357)
T ss_pred HHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 467899999999999999999999999995 6788877543 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC-CCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG-HAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG-~~PF~~~~~~ 159 (583)
|++.++.+||+|||++...... .......||+.|+|||++. +..|+.++|||||||++|+|+++ ..+|...+..
T Consensus 189 ll~~~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~ 263 (357)
T PHA03209 189 FINDVDQVCIGDLGAAQFPVVA----PAFLGLAGTVETNAPEVLA-RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263 (357)
T ss_pred EECCCCCEEEecCccccccccC----cccccccccccccCCeecC-CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCc
Confidence 9999999999999988632211 1123467999999999997 56799999999999999999985 4444432111
Q ss_pred ---------HHHHHHHhc---CCCCCC--------------------------ccccccchHHHHHHHHhhhcCCCCCCC
Q 007967 160 ---------KVLLMTIQN---APPGLD--------------------------YDRDKKFSKSFKEMVAMCLVKDQTKRP 201 (583)
Q Consensus 160 ---------~~l~~~i~~---~~~~~~--------------------------~~~~~~~S~~lkdLI~~cL~~DP~kRp 201 (583)
..+...+.. .+..+. ......++..+.+||.+||+.||.+||
T Consensus 264 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 343 (357)
T PHA03209 264 PEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP 343 (357)
T ss_pred HHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc
Confidence 111111110 000010 000124566788899999999999999
Q ss_pred CHHHHHhccccccC
Q 007967 202 TAEKLLKHSFFKHA 215 (583)
Q Consensus 202 Ta~eIL~HpfFk~~ 215 (583)
|+.|+|+||||+++
T Consensus 344 ta~e~l~hp~f~~~ 357 (357)
T PHA03209 344 SAEEILNYPMFAQL 357 (357)
T ss_pred CHHHHhcCchhccC
Confidence 99999999999863
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=294.29 Aligned_cols=207 Identities=28% Similarity=0.481 Sum_probs=168.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.....+|+||||++++.|..++.. ...+++..++.++.||+.||.|||++|++||||||+||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni 131 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131 (286)
T ss_pred HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence 3568999999999999999999999999999888776543 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++........ ......++..|+|||.+.+...++.++|||||||++|+|++|.+||.+....+
T Consensus 132 l~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~ 208 (286)
T cd07847 132 LITKQGQIKLCDFGFARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD 208 (286)
T ss_pred EEcCCCcEEECccccceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999999875532211 12235678999999998755668899999999999999999999998876655
Q ss_pred HHHHHHhcCCC------------------CCCc--------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPP------------------GLDY--------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~------------------~~~~--------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+......... .... .....++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 209 QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 44332211000 0000 0013467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=295.54 Aligned_cols=206 Identities=39% Similarity=0.653 Sum_probs=168.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+...+++|||||.+++|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl 130 (260)
T PF00069_consen 53 RRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENIL 130 (260)
T ss_dssp HHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccc
Confidence 356899999999999999999999999999999999883 477999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||.+.... ..........++..|+|||++.....++.++||||||+++|+|++|..||........
T Consensus 131 ~~~~~~~~l~Dfg~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~ 207 (260)
T PF00069_consen 131 LDENGEVKLIDFGSSVKLS---ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ 207 (260)
T ss_dssp ESTTSEEEESSGTTTEEST---STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH
T ss_pred ccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence 9999999999999986431 1122234567899999999987567889999999999999999999999988632222
Q ss_pred H--HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 162 L--LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 162 l--~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
. ...................+..+.++|.+||+.||.+|||+.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 208 LEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 2 11111111111111112234899999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=303.54 Aligned_cols=201 Identities=23% Similarity=0.417 Sum_probs=161.8
Q ss_pred CC-CCCcccceEEEEEEC-CEEEEEEecCCCCCHHHHHHHHh--------------------------------------
Q 007967 3 LI-DHPNVIRAYCSFVVD-SNLWVVMPFMAEGSCLHLMKIAY-------------------------------------- 42 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~-~~l~LVmEy~~GGsL~dll~~~~-------------------------------------- 42 (583)
.+ +||||++++++|... +.+|+|||||++|+|.+++....
T Consensus 66 ~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (338)
T cd05102 66 HIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVL 145 (338)
T ss_pred HhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcc
Confidence 44 899999999988764 46999999999999999887531
Q ss_pred ----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccc
Q 007967 43 ----------------------QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMF 100 (583)
Q Consensus 43 ----------------------~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~ 100 (583)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~ 225 (338)
T cd05102 146 FSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225 (338)
T ss_pred ccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccc
Confidence 1247888999999999999999999999999999999999999999999999987553
Q ss_pred cCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccc
Q 007967 101 DTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179 (583)
Q Consensus 101 ~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~ 179 (583)
.... ........+++.|+|||++. +..|+.++|||||||++|||++ |..||.+......+...+.... ....+.
T Consensus 226 ~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~ 300 (338)
T cd05102 226 KDPD-YVRKGSARLPLKWMAPESIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT---RMRAPE 300 (338)
T ss_pred cCcc-hhcccCCCCCccccCcHHhh-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC---CCCCCC
Confidence 2211 11122345678899999997 5678999999999999999997 9999987654444444443322 122235
Q ss_pred cchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 180 ~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.+++.+++||.+||..||.+|||+.++++
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 67889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=293.10 Aligned_cols=208 Identities=26% Similarity=0.453 Sum_probs=170.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.++..+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (286)
T cd07832 54 QACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131 (286)
T ss_pred HhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEE
Confidence 5678999999999999999999999999 99999988654 366999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||++........ .......|+.+|+|||.+.....++.++||||+||++|+|++|.+||.+..+...
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 209 (286)
T cd07832 132 ISADGVLKIADFGLARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ 209 (286)
T ss_pred EcCCCcEEEeeeeecccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH
Confidence 99999999999999875533221 1223457899999999987556678999999999999999999999987665544
Q ss_pred HHHHHhcCCCC----------------CCc---------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 162 LLMTIQNAPPG----------------LDY---------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 162 l~~~i~~~~~~----------------~~~---------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
+...+...... ..+ ......+..+.+||.+||.++|.+|||++++++||||.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 43332211000 000 01124578899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=294.58 Aligned_cols=202 Identities=45% Similarity=0.769 Sum_probs=167.8
Q ss_pred CCCcccceEEEEEE------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 5 DHPNVIRAYCSFVV------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 5 ~HPNIVkl~~~f~d------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
+||||++++++|.. ...+|+|||||.+|+|.+++.......+++..+..++.||+.||.|||++||+|+||+|+
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ 150 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ 150 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 79999999999863 568999999999999999987765566899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
||+++.++.++|+|||++....... .......|++.|+|||.+.. ...++.++|||||||++|+|++|..||.
T Consensus 151 nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 151 NVLLTENAEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred HEEECCCCCEEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 9999999999999999876442111 12234678999999999852 3467889999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.................. .....++..+.+||.+||..||.+|||+.+|++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 228 DMHPMRALFLIPRNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHhhhhhHhhCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 766555444333322222 1234678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=295.59 Aligned_cols=208 Identities=26% Similarity=0.410 Sum_probs=169.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++.+|+||||+. ++|..++.......+++..++.++.||+.||+|||++|++||||+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~ni 131 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 131 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 457899999999999999999999999995 6898888765556799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.+||+|||++...... ........+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.....
T Consensus 132 ll~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 208 (284)
T cd07860 132 LINTEGAIKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208 (284)
T ss_pred EECCCCCEEEeeccchhhcccC---ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999999999999987644211 1112234678899999998755567889999999999999999999998766555
Q ss_pred HHHHHHhcCCCCCC------------------------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPGLD------------------------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~~------------------------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.....+........ ......++..++++|.+||+.||.+|||++++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 44433322111000 00113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.32 Aligned_cols=208 Identities=40% Similarity=0.728 Sum_probs=173.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++.|.++.+.|+||||+.||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Ni 147 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 3567999999999999999999999999999999998753 4589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... .......|++.|+|||.+. ...++.++|||||||++|+|++|..||.......
T Consensus 148 ll~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~ 223 (296)
T cd06654 148 LLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (296)
T ss_pred EEcCCCCEEECccccchhccccc---cccCcccCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999876432211 1122357899999999987 5668899999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.+........+. ......++..+.++|.+||.++|.+|||+.++++||||.....
T Consensus 224 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 224 ALYLIATNGTPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred hHHHHhcCCCCC--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 443333322221 1223567889999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=291.85 Aligned_cols=206 Identities=40% Similarity=0.697 Sum_probs=166.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..+..+|+||||+.+|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 137 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI 137 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 3567999999999999999999999999999999998865 36789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+++.++.++|+|||++....... .......|++.|+|||.+.. ...++.++||||+||++|+|++|..||.....
T Consensus 138 ll~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 138 LLTDNGDVKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred EECCCCCEEECcCccceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 99999999999999987553211 11234578999999998852 34578899999999999999999999966544
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hpf 211 (583)
......................++..+++||.+||..+|.+|||+++|++|+|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 215 MRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 33222111111111111112357889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.18 Aligned_cols=212 Identities=32% Similarity=0.520 Sum_probs=178.6
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.-+.+-||+||-.|++++++|+||||++||++..+|.+. +-|.|..++.|++++.+|+++.|..|+|||||||+||||
T Consensus 685 EADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI 762 (1034)
T KOG0608|consen 685 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI 762 (1034)
T ss_pred hcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE
Confidence 346788999999999999999999999999999998764 779999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCcccc--------ccCCCCcc-------------------------------ccccccCCCCCCCccc
Q 007967 83 DTNGVVKLADFGVSACM--------FDTGDRQR-------------------------------SRNTFVGTPCWMAPEV 123 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~--------~~~~~~~~-------------------------------~~~~~~GT~~Y~APEi 123 (583)
|.+|+|||+|||++.-+ +..++..+ .....+||+.|+|||+
T Consensus 763 DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev 842 (1034)
T KOG0608|consen 763 DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV 842 (1034)
T ss_pred ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH
Confidence 99999999999998532 11111100 0123589999999999
Q ss_pred ccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-
Q 007967 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT- 202 (583)
Q Consensus 124 l~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT- 202 (583)
+. ..+|+..|||||.|||||||+.|++||....+.+.... +.+....+.+....++|+++.+||.++. .+++.|+.
T Consensus 843 l~-r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~k-v~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGk 919 (1034)
T KOG0608|consen 843 LA-RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYK-VINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGK 919 (1034)
T ss_pred hc-ccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceee-eeehhhccccccccccCHHHHHHHHHHh-cChhhhhcc
Confidence 98 78999999999999999999999999988766554433 3344455667777899999999999865 46899985
Q ss_pred --HHHHHhccccccCCCCc
Q 007967 203 --AEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 203 --a~eIL~HpfFk~~~~~~ 219 (583)
+++|..||||+.+++..
T Consensus 920 ng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 920 NGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred cchhhhhcCccccccchHh
Confidence 67899999999999866
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=289.67 Aligned_cols=203 Identities=44% Similarity=0.792 Sum_probs=168.3
Q ss_pred CCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 5 DHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+||||++++++|.+.. .+|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||++|++|+||+
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~ 140 (275)
T cd06608 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140 (275)
T ss_pred CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 7999999999997644 5999999999999999987654 4679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
|+||+++.++.++|+|||++....... .......|+..|+|||++.. ...++.++|||||||++|+|++|..|
T Consensus 141 p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p 217 (275)
T cd06608 141 GQNILLTKNAEVKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217 (275)
T ss_pred HHHEEEccCCeEEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence 999999999999999999876542221 12234678999999998853 23578899999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
|.................... .....++..+++||.+||..||.+|||+.++++|||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 218 LCDMHPMRALFKIPRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ccccchHHHHHHhhccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 987665555554444332222 2223478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=313.33 Aligned_cols=200 Identities=27% Similarity=0.463 Sum_probs=172.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|+|||+||++|..++.+|||||||+.|+|.++++...+..+.......++.||++|++||+++++|||||.+.||
T Consensus 255 Mk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNi 334 (468)
T KOG0197|consen 255 MKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNI 334 (468)
T ss_pred HHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhhe
Confidence 78899999999999999989999999999999999999986567799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
||+.++.+||+|||+|+.. ..+.+.. .....-...|.|||.+. ...++.|+|||||||+||||++ |+.||.+.+..
T Consensus 335 LV~~~~~vKIsDFGLAr~~-~d~~Y~~-~~~~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 335 LVDEDLVVKISDFGLARLI-GDDEYTA-SEGGKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred eeccCceEEEccccccccc-CCCceee-cCCCCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 9999999999999999843 2222211 12223355799999998 5679999999999999999998 99999998776
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHH
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL 207 (583)
+.+. .+.. ++..+.+..++.++.+++..||..+|++|||++.+.
T Consensus 412 ev~~-~le~---GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 412 EVLE-LLER---GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHH-HHhc---cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 5553 3332 466777889999999999999999999999998664
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=287.63 Aligned_cols=204 Identities=48% Similarity=0.868 Sum_probs=171.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.++..+|+||||+.+++|.+++... ...+++..+..++.||+.||.|||+.|++||||+|+||+
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~ 131 (256)
T cd06612 53 KQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNIL 131 (256)
T ss_pred HhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 5679999999999999999999999999999999988643 356899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||++....... .......|+..|+|||++. +..++.++|||||||++|+|++|+.||........
T Consensus 132 ~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~ 207 (256)
T cd06612 132 LNEEGQAKLADFGVSGQLTDTM---AKRNTVIGTPFWMAPEVIQ-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA 207 (256)
T ss_pred ECCCCcEEEcccccchhcccCc---cccccccCCccccCHHHHh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh
Confidence 9999999999999987543221 1223356888999999987 56789999999999999999999999987665444
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.......... .......++..+.++|.+||+.+|.+|||+.++|+||||
T Consensus 208 ~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 208 IFMIPNKPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhhhccCCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 4332222221 122334578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.23 Aligned_cols=210 Identities=34% Similarity=0.574 Sum_probs=170.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+++.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||+ ++++||||||+|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n 130 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence 35689999999999999999999999999999999998754 678999999999999999999997 699999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.+||+|||++...... .....+|++.|+|||.+. +..++.++|||||||++|+|++|..||......
T Consensus 131 il~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 204 (308)
T cd06615 131 ILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204 (308)
T ss_pred EEEecCCcEEEccCCCccccccc-----ccccCCCCcCccChhHhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCcchh
Confidence 99999999999999988644221 123467899999999987 567899999999999999999999999754422
Q ss_pred HHHHHHHhcCCCCCC----------------------------------ccccccchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 160 KVLLMTIQNAPPGLD----------------------------------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~----------------------------------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
. ....+........ ......++.++++||.+||..+|.+|||+.+
T Consensus 205 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 283 (308)
T cd06615 205 E-LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283 (308)
T ss_pred h-HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 2 1111111100000 0001236788999999999999999999999
Q ss_pred HHhccccccCCCCc
Q 007967 206 LLKHSFFKHAKPPE 219 (583)
Q Consensus 206 IL~HpfFk~~~~~~ 219 (583)
+++||||.....++
T Consensus 284 ll~~~~~~~~~~~~ 297 (308)
T cd06615 284 LTKHPFIKRAELEE 297 (308)
T ss_pred HhcChhhhhccccc
Confidence 99999998765443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.97 Aligned_cols=208 Identities=39% Similarity=0.726 Sum_probs=175.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.++..+|+||||+.+|+|..++.. ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Ni 146 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNV 146 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 3578999999999999999999999999999999998753 4689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.+||+|||++....... .......|+..|+|||.+. ...++.++|||||||++|+|++|..||.......
T Consensus 147 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~ 222 (296)
T cd06655 147 LLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (296)
T ss_pred EECCCCCEEEccCccchhccccc---ccCCCcCCCccccCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999876542221 1123357889999999987 5668899999999999999999999998876655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
..........+. ...+..++..+++||.+||..||.+|||+.+++.||||+....
T Consensus 223 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 223 ALYLIATNGTPE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHHhcCCcc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 544433332222 2234568889999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.26 Aligned_cols=197 Identities=18% Similarity=0.277 Sum_probs=164.6
Q ss_pred CCCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDL 75 (583)
|+.++|||||+++++|.+ ...+++|||||.||+|.+++... ..+++.....++.+++.||.|||+ .+++||||
T Consensus 72 l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdl 149 (283)
T PHA02988 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNL 149 (283)
T ss_pred HHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcC
Confidence 567899999999999987 45799999999999999998753 568999999999999999999998 49999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-CCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-GSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
||+|||++.++.+||+|||++...... .....|+..|+|||++.+ ...|+.++|||||||++|||++|..||.
T Consensus 150 kp~nill~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 150 TSVSFLVTENYKLKIICHGLEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred ChhhEEECCCCcEEEcccchHhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 999999999999999999998654221 123578899999999973 2578999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+....+.....+... ... ..+..+++.+++||.+||+.||.+|||+.++++
T Consensus 224 ~~~~~~~~~~i~~~~-~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 224 NLTTKEIYDLIINKN-NSL--KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCHHHHHHHHHhcC-CCC--CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 876555443333322 122 223457899999999999999999999999985
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=291.03 Aligned_cols=207 Identities=53% Similarity=0.923 Sum_probs=174.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.++..+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~ 130 (274)
T cd06609 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANIL 130 (274)
T ss_pred HHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 567899999999999999999999999999999998764 37899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||++....... .......|++.|+|||.+. +..++.++|||||||++|+|++|..||........
T Consensus 131 i~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~-~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~ 206 (274)
T cd06609 131 LSEEGDVKLADFGVSGQLTSTM---SKRNTFVGTPFWMAPEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206 (274)
T ss_pred ECCCCCEEEcccccceeecccc---cccccccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH
Confidence 9999999999999987653221 1223467889999999998 45589999999999999999999999987665544
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.........+.+. ...++..+.++|.+||..+|.+|||++++++||||......
T Consensus 207 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 207 LFLIPKNNPPSLE---GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHhhhcCCCCCc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 4333333222221 12278899999999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=286.12 Aligned_cols=204 Identities=32% Similarity=0.547 Sum_probs=173.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+++|||||++|+|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni 132 (256)
T cd08221 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNI 132 (256)
T ss_pred HHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhE
Confidence 45789999999999999999999999999999999998765455689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.+||+|||++........ ......|++.|+|||.+. +..++.++|||||||++|+|++|..||......+
T Consensus 133 ~~~~~~~~kl~d~~~~~~~~~~~~---~~~~~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08221 133 FLTKAGLIKLGDFGISKILGSEYS---MAETVVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208 (256)
T ss_pred EEeCCCCEEECcCcceEEcccccc---cccccCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 999999999999999865422221 223467899999999987 4568889999999999999999999998866555
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
........... .....++..++++|.+||.++|.+||++.++++|+|+
T Consensus 209 ~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 209 LVVKIVQGNYT----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcCCCC----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 44444433221 1225678999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=298.80 Aligned_cols=211 Identities=38% Similarity=0.718 Sum_probs=175.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++.|..++..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni 149 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI 149 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 3568999999999999999999999999999999987743 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|+|++|..||.......
T Consensus 150 ll~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 225 (292)
T cd06658 150 LLTSDGRIKLSDFGFCAQVSKEV---PKRKSLVGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225 (292)
T ss_pred EEcCCCCEEEccCcchhhccccc---ccCceeecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999876442211 1223467899999999987 5678999999999999999999999998766554
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~ 220 (583)
............ ......++..++++|.+||..||.+|||++++++||||.....+..
T Consensus 226 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 226 AMRRIRDNLPPR--VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred HHHHHHhcCCCc--cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 443322222211 1223457889999999999999999999999999999998876653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=288.32 Aligned_cols=207 Identities=29% Similarity=0.508 Sum_probs=173.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.++..+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nil 125 (262)
T cd05572 48 EECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL 125 (262)
T ss_pred HhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEE
Confidence 5679999999999999999999999999999999988753 56899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC--hH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP--PM 159 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~--~~ 159 (583)
++.++.++|+|||++....... ......|++.|+|||.+. ...++.++|+||+||++|+|++|..||.... ..
T Consensus 126 v~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 200 (262)
T cd05572 126 LDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200 (262)
T ss_pred EcCCCCEEEeeCCcccccCccc----ccccccCCcCccChhHhc-CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH
Confidence 9999999999999987553221 123457899999999987 5678999999999999999999999998765 33
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPP 218 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~ 218 (583)
+....... ..... ..+...+..++++|.+||..+|.+||+ ++|+++||||+...|.
T Consensus 201 ~~~~~~~~-~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 201 EIYNDILK-GNGKL--EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHHhc-cCCCC--CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 33322221 11111 223345889999999999999999999 9999999999987653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.51 Aligned_cols=215 Identities=39% Similarity=0.715 Sum_probs=170.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|..++.+|+||||+.+|+|.+++......++++..+..++.||+.||+|||++|++||||||+|||
T Consensus 54 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nil 133 (328)
T cd08226 54 HFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL 133 (328)
T ss_pred HhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 45899999999999999999999999999999999988765567999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCcccc----ccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSR----NTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~----~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
++.++.++++||+.+......+...... ....++..|+|||++.+. ..++.++||||+||++|+|++|..||...
T Consensus 134 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred EeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999998654332221111100 112345679999998743 45789999999999999999999999876
Q ss_pred ChHHHHHHHHhcCCC------------------------------------------CCCccccccchHHHHHHHHhhhc
Q 007967 157 PPMKVLLMTIQNAPP------------------------------------------GLDYDRDKKFSKSFKEMVAMCLV 194 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~------------------------------------------~~~~~~~~~~S~~lkdLI~~cL~ 194 (583)
.........+..... ....+....++..+++||.+||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 293 (328)
T cd08226 214 LRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQ 293 (328)
T ss_pred ChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHcc
Confidence 554443333221100 00111123467889999999999
Q ss_pred CCCCCCCCHHHHHhccccccCC
Q 007967 195 KDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 195 ~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.||.+|||+.++|+||||+...
T Consensus 294 ~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 294 QDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred CCcccCCCHHHHhhCHHHHHHH
Confidence 9999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.05 Aligned_cols=210 Identities=31% Similarity=0.569 Sum_probs=168.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+++||||+.|++|.+++... +.+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ni 134 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANL 134 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 35689999999999999999999999999999999988753 5789999999999999999999999999999999999
Q ss_pred EEcCCC-cEEEEecCCccccccCCCC-ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNG-VVKLADFGVSACMFDTGDR-QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g-~IKL~DFGlA~~~~~~~~~-~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+++.++ .+||+|||++......... ........|+..|+|||.+. ...++.++|+||+||++|+|++|..||.....
T Consensus 135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 998776 5999999998655322111 11122357889999999987 56789999999999999999999999975433
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
...................+..+++.+.+++.+||..+|.+|||+.++++||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 214 SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred cchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 2211111111111112233356789999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=316.83 Aligned_cols=199 Identities=29% Similarity=0.519 Sum_probs=174.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||||.+.++|...-.+|||||||..|.|...++.. ..++......|..+|+.|+.|||.+.|||||||.-||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNi 243 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNI 243 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCce
Confidence 57899999999999999999999999999999999998863 6789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||..+..|||+|||-++.+.+. .+.-.|+||..|||||+++ +...+.|+|||||||+|||||||..||.+-+...
T Consensus 244 LIs~~d~VKIsDFGTS~e~~~~----STkMSFaGTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 244 LISYDDVVKISDFGTSKELSDK----STKMSFAGTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred EeeccceEEeccccchHhhhhh----hhhhhhhhhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence 9999999999999998765332 2233589999999999999 7889999999999999999999999997755544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+++-. +...+..+.+..+++.|+-||+.||+..|..||++.+||.|
T Consensus 319 IIwGV---GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 319 IIWGV---GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred eEEec---cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 43322 22334556667899999999999999999999999999998
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=287.84 Aligned_cols=207 Identities=32% Similarity=0.593 Sum_probs=170.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+||||+.||+|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 133 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV 133 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhE
Confidence 35689999999999999999999999999999999998653 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCC---CCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTG---DRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~---~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
+++.++.++|+|||++....... ..........|+..|+|||.+. +..++.++|+|||||++|+|++|..||....
T Consensus 134 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 134 MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN-ESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred EECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhc-CCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 99999999999999876432111 1111122356899999999987 5678999999999999999999999998765
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
............ ......+..++..++++|.+||..+|.+||++.++++||||
T Consensus 213 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 213 RLAAMFYIGAHR--GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred hHHHHHHhhhcc--CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 544433222211 11122345688999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=286.78 Aligned_cols=210 Identities=34% Similarity=0.580 Sum_probs=173.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++..+...|+||||+.|++|.+++... +.+++..+..++.||+.||.|||++|++|+||+|+||+
T Consensus 48 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil 125 (265)
T cd05579 48 SQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125 (265)
T ss_pred HhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeE
Confidence 5678999999999999999999999999999999988764 47999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCC-----ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDR-----QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~-----~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
++.++.++|+|||++......... ........++..|+|||.+. ...++.++|+|||||++|+|++|..||...
T Consensus 126 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred EcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999987654322110 11223456888999999987 455889999999999999999999999876
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH---HHHHhccccccCCC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA---EKLLKHSFFKHAKP 217 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa---~eIL~HpfFk~~~~ 217 (583)
....... .+.... ...+....++..+.+||.+||+.+|.+|||+ .++|+||||+.++|
T Consensus 205 ~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 205 TPEEIFQ-NILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred CHHHHHH-HHhcCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 6544433 333221 2222222358999999999999999999999 99999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=319.09 Aligned_cols=194 Identities=29% Similarity=0.456 Sum_probs=168.6
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.-+||||++++++|.++.++|+|||++.||.|++.+... ..+. .++..|+++|+.++.|||++|||||||||+|||+
T Consensus 372 ~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 372 VRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL 448 (612)
T ss_pred hcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheee
Confidence 348999999999999999999999999999999877653 3333 7888999999999999999999999999999999
Q ss_pred -cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 83 -DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 83 -d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
+..|+|+|+|||.++..... ..+.+-|..|.|||++. ..+|++++||||||++||+||+|+.||...+....
T Consensus 449 ~~~~g~lrltyFG~a~~~~~~------~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 449 DGSAGHLRLTYFGFWSELERS------CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred cCCCCcEEEEEechhhhCchh------hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 69999999999998754222 22456788999999998 78999999999999999999999999988776645
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
+...+...... ..+|..+++||.+||+.||.+|+++.+++.||||
T Consensus 522 i~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 522 IHTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhhcCCccc------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 55555443221 6789999999999999999999999999999999
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.32 Aligned_cols=214 Identities=28% Similarity=0.494 Sum_probs=173.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..++++|+||||++||+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI 132 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence 35689999999999999999999999999999999998654 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCC------------CccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGD------------RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH 148 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~------------~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt 148 (583)
+++.++.+||+|||+++....... .........|+..|+|||.+. ...++.++|+|||||++|+|++
T Consensus 133 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~ 211 (305)
T cd05609 133 LITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLV 211 (305)
T ss_pred EECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999998763211000 000112346788999999987 5678999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC---HHHHHhccccccCCCCc
Q 007967 149 GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT---AEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 149 G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT---a~eIL~HpfFk~~~~~~ 219 (583)
|..||.+....+........ ....... ...++..+++||.+||+++|.+||+ +.++++||||...++..
T Consensus 212 g~~pf~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 212 GCVPFFGDTPEELFGQVISD-DIEWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred CCCCCCCCCHHHHHHHHHhc-ccCCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 99999876654444333322 2111111 1257899999999999999999998 79999999998876543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=285.63 Aligned_cols=204 Identities=27% Similarity=0.506 Sum_probs=173.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
++.++||||++++++|.+.+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~ni 132 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 132 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 36789999999999999999999999999999999988765445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.++|+|||++........ ......|++.|+|||++. +..++.++|+|||||++|+|++|..||......+
T Consensus 133 l~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08218 133 FLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208 (256)
T ss_pred EEcCCCCEEEeeccceeecCcchh---hhhhccCCccccCHHHhC-CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence 999999999999998865432211 112346888999999987 5568889999999999999999999998766655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.....+....+ .....++.+++++|.+||+.+|.+||++.++++||||
T Consensus 209 ~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 209 LVLKIIRGSYP----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHhcCCCC----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 55444443322 2235678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=283.53 Aligned_cols=203 Identities=30% Similarity=0.544 Sum_probs=170.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++.+..+..+++||||++|++|.+++.......+++..+..++.+++.||.|||++|++|+||+|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni 132 (256)
T cd08220 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNI 132 (256)
T ss_pred HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 46789999999999999999999999999999999998765455689999999999999999999999999999999999
Q ss_pred EEcCCC-cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 81 LLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
+++.++ .+||+|||++....... ......|+..|+|||.+. ...++.++|||||||++|+|++|..||......
T Consensus 133 l~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 207 (256)
T cd08220 133 LLDKHKMVVKIGDFGISKILSSKS----KAYTVVGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207 (256)
T ss_pred EEcCCCCEEEEccCCCceecCCCc----cccccccCCcccCchhcc-CCCCCcccchHHHHHHHHHHHhCCCCcccCchH
Confidence 998554 68999999987542211 112357889999999997 566889999999999999999999999886654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
............ .....++..++++|.+||..+|.+|||+.++++||||
T Consensus 208 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 208 ALVLKIMSGTFA----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHhcCCC----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 444333333222 2234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.11 Aligned_cols=221 Identities=27% Similarity=0.467 Sum_probs=197.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|...+.|+||++|..|.++.++|++||-|-||+|+.+++.. +.|++..++.++.-+++|++|||++|||+|||||+|+
T Consensus 474 m~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 474 MMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred HHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 34567899999999999999999999999999999998874 8899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.+|-+||.|||+|+.+.. ....+++||||.|.|||++. +.+++.++|+||||+++||||+|.+||.+.+++.
T Consensus 552 lLd~~Gy~KLVDFGFAKki~~----g~KTwTFcGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 552 LLDNRGYLKLVDFGFAKKIGS----GRKTWTFCGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred eeccCCceEEeehhhHHHhcc----CCceeeecCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 999999999999999987632 23457899999999999998 7889999999999999999999999999999888
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
....++++.. . +..+..+++.+.+||+++...+|.+|+. +.+|.+|.||...+|..+....+.+++.+
T Consensus 627 tYn~ILkGid-~--i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~ 699 (732)
T KOG0614|consen 627 TYNLILKGID-K--IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIP 699 (732)
T ss_pred HHHHHHhhhh-h--hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccc
Confidence 7766666542 2 2334788999999999999999999986 89999999999999999888877766654
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.02 Aligned_cols=213 Identities=27% Similarity=0.369 Sum_probs=172.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++.+|+||||+ +|+|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~ni 133 (298)
T cd07841 56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL 133 (298)
T ss_pred HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhE
Confidence 45789999999999999999999999999 999999887532 3699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.++|+|||++........ ......+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+..+.+
T Consensus 134 ll~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~ 210 (298)
T cd07841 134 LIASDGVLKLADFGLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210 (298)
T ss_pred EEcCCCCEEEccceeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH
Confidence 999999999999999865432211 11234568889999998755678899999999999999999998888766554
Q ss_pred HHHHHHhcCCCC--------------CC---------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPG--------------LD---------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~--------------~~---------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.+.......... .. .......+..+.+||.+||.++|.+|||+.++++|+||++...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 433332211000 00 0011345788999999999999999999999999999998654
Q ss_pred C
Q 007967 218 P 218 (583)
Q Consensus 218 ~ 218 (583)
+
T Consensus 291 ~ 291 (298)
T cd07841 291 P 291 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=291.99 Aligned_cols=215 Identities=35% Similarity=0.651 Sum_probs=181.7
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNIL 81 (583)
..+.|+||++|++|..+..++|.||.| +.+.+-+.+...+.++|..+-++..-++.||.||-. +||||||+||+|||
T Consensus 147 s~dcpyIV~c~GyFi~n~dV~IcMelM--s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNIL 224 (391)
T KOG0983|consen 147 SHDCPYIVQCFGYFITNTDVFICMELM--STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL 224 (391)
T ss_pred ccCCCeeeeeeeEEeeCchHHHHHHHH--HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceE
Confidence 346899999999999999999999998 345554444446789999999999999999999996 58999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCC-Ch
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKY-PP 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~-~~ 158 (583)
+|..|+|||||||++..+.+.. ......|-+.|||||.+.. ...|+..+||||||++++||.||..||.+. .+
T Consensus 225 lDe~GniKlCDFGIsGrlvdSk----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td 300 (391)
T KOG0983|consen 225 LDERGNIKLCDFGISGRLVDSK----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD 300 (391)
T ss_pred EccCCCEEeecccccceeeccc----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence 9999999999999998775543 2234578999999999974 356899999999999999999999999885 45
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCchhhhhh
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKL 225 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~~~~~~ 225 (583)
.+.+..++++.++.++.. ..||+.|.+|+..||.+|+.+||...++|+|||++.....+..+..+
T Consensus 301 Fe~ltkvln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~W 365 (391)
T KOG0983|consen 301 FEVLTKVLNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASW 365 (391)
T ss_pred HHHHHHHHhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHH
Confidence 667777777777666544 34999999999999999999999999999999999877665544444
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=290.73 Aligned_cols=204 Identities=35% Similarity=0.609 Sum_probs=167.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|...+..++||||+++|+|..+ ..+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 126 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM 126 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence 3568999999999999999999999999999998653 3578999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH-
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM- 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~- 159 (583)
|++.++.++|+|||++...... .....+|+..|+|||.+. +..++.++|+|||||++|+|++|..||......
T Consensus 127 ll~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~ 200 (279)
T cd06619 127 LVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200 (279)
T ss_pred EECCCCCEEEeeCCcceecccc-----cccCCCCChhhcCceeec-CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccc
Confidence 9999999999999998654221 123468899999999997 567899999999999999999999999653221
Q ss_pred -----HHHHHHHh-cCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 160 -----KVLLMTIQ-NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 160 -----~~l~~~i~-~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
......+. ...... ....++.++++||.+||+.+|.+||+++++++||||...+...
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~ 263 (279)
T cd06619 201 GSLMPLQLLQCIVDEDPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263 (279)
T ss_pred cccchHHHHHHHhccCCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence 11111111 111111 1234788999999999999999999999999999998776443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=316.85 Aligned_cols=209 Identities=29% Similarity=0.424 Sum_probs=172.9
Q ss_pred CCCCCCcccceEEEEEECC--------EEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDS--------NLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~--------~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
..++|+||+++++.|...+ .+++||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++||+
T Consensus 86 ~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~Ii 165 (496)
T PTZ00283 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMI 165 (496)
T ss_pred hcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 4678999999998886433 3789999999999999886532 34589999999999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 72 HRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
||||||+|||++.++.+||+|||+++.+.... ........+||+.|+|||++. ...|+.++|||||||++|+|++|..
T Consensus 166 HrDLKP~NILl~~~~~vkL~DFGls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~k~DVwSlGvilyeLltG~~ 243 (496)
T PTZ00283 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATV-SDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKR 243 (496)
T ss_pred cCCCCHHHEEEeCCCCEEEEecccCeeccccc-cccccccccCCcceeCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999987543221 111223568999999999998 5679999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
||.+....+.+...+..... +.+..+++++++||.+||+.||.+||++.++++|||++...
T Consensus 244 Pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 244 PFDGENMEEVMHKTLAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCCCCCHHHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 99886655544444433221 23456889999999999999999999999999999988643
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.40 Aligned_cols=208 Identities=39% Similarity=0.735 Sum_probs=173.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..++.+|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Ni 146 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNI 146 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 3568999999999999999999999999999999998753 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.++|+|||++....... .......+++.|+|||.+. +..++.++|+|||||++|+|++|..||.......
T Consensus 147 li~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~ 222 (297)
T cd06656 147 LLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (297)
T ss_pred EECCCCCEEECcCccceEccCCc---cCcCcccCCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence 99999999999999886542211 1223457899999999987 5678899999999999999999999998765544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.+........+. ...+..++..+++||.+||..+|.+||++.++++||||+....
T Consensus 223 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 223 ALYLIATNGTPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred heeeeccCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 333222222111 1223467888999999999999999999999999999997764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=287.47 Aligned_cols=206 Identities=30% Similarity=0.581 Sum_probs=166.7
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++.+ +..+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ 135 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGA 135 (266)
T ss_pred HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 356899999999999876 36799999999999999988653 56899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.+||+|||++.................++..|+|||.+. +..++.++||||+||++|+|++|..||.....
T Consensus 136 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~ 214 (266)
T cd06651 136 NILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214 (266)
T ss_pred HEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccch
Confidence 99999999999999999865422111111112346888999999987 56788999999999999999999999987655
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
........... . ....+..+++.++++| .||..+|.+||+++++++||||+
T Consensus 215 ~~~~~~~~~~~-~--~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 215 MAAIFKIATQP-T--NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHHhcCC-C--CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 44443332221 1 1122345788899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.13 Aligned_cols=203 Identities=24% Similarity=0.365 Sum_probs=159.6
Q ss_pred CCCCcccceEEEEEEC-CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEE
Q 007967 4 IDHPNVIRAYCSFVVD-SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNIL 81 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~-~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNIL 81 (583)
.+|++|++++++|..+ .++|||||++ |++|.+++... +.+++..++.|+.||+.||.|||+ .|||||||||+|||
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NIL 264 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence 4577899999999865 5799999998 78888887653 679999999999999999999998 59999999999999
Q ss_pred EcCCC----------------cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhh
Q 007967 82 LDTNG----------------VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE 145 (583)
Q Consensus 82 ld~~g----------------~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILye 145 (583)
++.++ .+||+|||.+... .......+||+.|+|||++. +..|+.++|||||||++||
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~------~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDE------RHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccC------ccccccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHH
Confidence 98765 4999999986422 11223578999999999998 5679999999999999999
Q ss_pred hhhCCCCCCCCChHHHHHHHHhcC--CC--------------------CCC-ccc--------------cccchHHHHHH
Q 007967 146 LAHGHAPFSKYPPMKVLLMTIQNA--PP--------------------GLD-YDR--------------DKKFSKSFKEM 188 (583)
Q Consensus 146 LLtG~~PF~~~~~~~~l~~~i~~~--~~--------------------~~~-~~~--------------~~~~S~~lkdL 188 (583)
|++|++||.+....+.+....... .+ .+. ... .......+.+|
T Consensus 338 lltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 417 (467)
T PTZ00284 338 LYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDL 417 (467)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHH
Confidence 999999998866544332221110 00 000 000 00114567899
Q ss_pred HHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 189 VAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 189 I~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
|.+||++||.+|||++|+|+||||....
T Consensus 418 i~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 418 IYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred HHHhCCcChhhCCCHHHHhcCccccccC
Confidence 9999999999999999999999998753
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=287.49 Aligned_cols=201 Identities=26% Similarity=0.414 Sum_probs=162.4
Q ss_pred CCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 5 DHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
+||||+++++++.++ +.+++||||+. |+|.+++... ...+++..++.++.||+.||.|||++|++||||+|+||++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l 133 (282)
T cd07831 56 PHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI 133 (282)
T ss_pred CCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence 599999999999988 89999999996 5788777643 3568999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
+. +.+||+|||++....... ......++..|+|||.+.....++.++||||+||++|+|++|.+||.+.+..+..
T Consensus 134 ~~-~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 134 KD-DILKLADFGSCRGIYSKP----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208 (282)
T ss_pred cC-CCeEEEecccccccccCC----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH
Confidence 99 999999999987553221 1123568899999998765566789999999999999999999999876654433
Q ss_pred HHHHhcC---------------CCCCCccc---------cccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 163 LMTIQNA---------------PPGLDYDR---------DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 163 ~~~i~~~---------------~~~~~~~~---------~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
....... ...+.++. ...++..+++||.+||.++|.+|||+.++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 2221100 00111110 12468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.73 Aligned_cols=210 Identities=26% Similarity=0.386 Sum_probs=164.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||||++++++..++..|+||||+. ++|..++... ...+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 214 L~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NI 291 (461)
T PHA03211 214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENV 291 (461)
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHE
Confidence 467899999999999999999999999994 7888877643 34699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC---
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP--- 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~--- 157 (583)
||+.++.+||+|||+++...... ........+||+.|+|||++. +..++.++|||||||++|||++|..|+....
T Consensus 292 Ll~~~~~vkL~DFGla~~~~~~~-~~~~~~~~~GT~~Y~APE~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 292 LVNGPEDICLGDFGAACFARGSW-STPFHYGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred EECCCCCEEEcccCCceeccccc-ccccccccCCCcCCcCHHHHc-CCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 99999999999999986542211 111223467999999999997 5679999999999999999998776543211
Q ss_pred ----hHHHHHHHHhcCCCC---C---------------------------CccccccchHHHHHHHHhhhcCCCCCCCCH
Q 007967 158 ----PMKVLLMTIQNAPPG---L---------------------------DYDRDKKFSKSFKEMVAMCLVKDQTKRPTA 203 (583)
Q Consensus 158 ----~~~~l~~~i~~~~~~---~---------------------------~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa 203 (583)
....+..++...... + .+.....++..+.+||.+||+.||.+|||+
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa 449 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA 449 (461)
T ss_pred ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH
Confidence 112222232221100 0 011112345689999999999999999999
Q ss_pred HHHHhcccccc
Q 007967 204 EKLLKHSFFKH 214 (583)
Q Consensus 204 ~eIL~HpfFk~ 214 (583)
.|||+||||+.
T Consensus 450 ~elL~hp~f~~ 460 (461)
T PHA03211 450 AELLRLPLFQS 460 (461)
T ss_pred HHHhhCcccCC
Confidence 99999999974
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=288.42 Aligned_cols=203 Identities=21% Similarity=0.392 Sum_probs=168.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
|+.++||||+++++++.+....|++|||+++|+|.+++..... ..+++..+..++.||+.||.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3568999999999999999999999999999999999876422 45889999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++|++||||||+||+++.++.++|+|||++....... .........+++.|+|||.+. ...++.++|||||||++|+|
T Consensus 142 ~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el 219 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD-YYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEI 219 (283)
T ss_pred hCCeeccccccceEEEcCCCcEEECCCcceeeccccc-cccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999987543222 111223456788999999987 56789999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+....+.. ..+..... ...+..++.++.+|+.+||+.||.+||++.+|+++
T Consensus 220 ~~~g~~p~~~~~~~~~~-~~i~~~~~---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 220 FSYGLQPYYGFSNQEVI-EMIRSRQL---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCCCCCCCCCHHHHH-HHHHcCCc---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 97 99999886665443 33332221 12245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=289.24 Aligned_cols=204 Identities=44% Similarity=0.735 Sum_probs=166.8
Q ss_pred CCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 5 DHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
+||||++++++|... ..+|+||||+.||+|.+++... ....+++..++.++.||+.||.|||++|++||||||
T Consensus 77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp 156 (291)
T cd06639 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG 156 (291)
T ss_pred CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 899999999999754 4689999999999999987642 235689999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC----CCCccccccchhhHHhhhhhCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS----GYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~----~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
+||+++.++.+||+|||++........ ......|+..|+|||.+.... .++.++|||||||++|+|++|+.||
T Consensus 157 ~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 157 NNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred HHEEEcCCCCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 999999999999999999865432211 112357889999999986322 3688999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
........+..........+ .....++..+++||.+||.++|.+||++.+|++||||+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 234 FDMHPVKTLFKIPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcHHHHHHHHhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 87666555544433322222 12345678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=289.72 Aligned_cols=209 Identities=39% Similarity=0.733 Sum_probs=173.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|...+..|+||||+.|++|.+++.. ..+++..+..++.||+.||+|||++|++||||+|+||
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Ni 146 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSI 146 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhE
Confidence 3567999999999999999999999999999999998765 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......|++.|+|||.+. ...++.++|||||||++|+|++|..||.......
T Consensus 147 l~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~ 222 (285)
T cd06648 147 LLTSDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222 (285)
T ss_pred EEcCCCcEEEcccccchhhccCC---cccccccCCccccCHHHhc-CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 99999999999999876442211 1122357899999999987 4568999999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
..........+.. .....++..+.+||.+||.++|.+|||+.++++||||+....+
T Consensus 223 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 223 AMKRIRDNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred HHHHHHhcCCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence 4333222221111 1223478899999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=290.02 Aligned_cols=211 Identities=30% Similarity=0.536 Sum_probs=170.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeN 79 (583)
+.++||||++++++|..++.+|+|||||+|++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+|
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~n 133 (286)
T cd06622 54 HKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133 (286)
T ss_pred HhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHH
Confidence 56899999999999999999999999999999988876531 2369999999999999999999997 599999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC-----CCCCccccccchhhHHhhhhhCCCCCC
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG-----SGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~-----~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|+++.++.+||+|||++..+... ......|++.|+|||.+... ..++.++|||||||++|+|++|..||.
T Consensus 134 il~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 134 VLVNGNGQVKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred EEECCCCCEEEeecCCcccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 99999999999999988654221 12235688899999998632 236889999999999999999999997
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
........ ..+...........+..++.++++||.+||..+|.+||++.+++.||||......
T Consensus 209 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 209 PETYANIF-AQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CcchhhHH-HHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 65433222 1111111111122334589999999999999999999999999999999877654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=286.18 Aligned_cols=204 Identities=43% Similarity=0.781 Sum_probs=169.9
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
.||||++++++|.++...|+||||+.|++|.++++. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~ 136 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN 136 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC
Confidence 599999999999999999999999999999998754 47899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
++.++|+|||++....... .......|+..|+|||.+..+..++.++|+|||||++|+|++|..||.+.........
T Consensus 137 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (277)
T cd06917 137 TGNVKLCDFGVAALLNQNS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213 (277)
T ss_pred CCCEEEccCCceeecCCCc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence 9999999999987553322 1223457899999999987556688999999999999999999999987654433322
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
......+.+. ...++.++.+++.+||..||.+||++.++++|+||++...
T Consensus 214 ~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 214 IPKSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred cccCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 1111111111 1237889999999999999999999999999999987653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=289.39 Aligned_cols=207 Identities=23% Similarity=0.399 Sum_probs=163.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++..|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~ni 134 (291)
T cd07844 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNL 134 (291)
T ss_pred HhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHE
Confidence 467899999999999999999999999997 5898887654 34689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||+++...... .......++..|+|||++.+...++.++||||+||++|+|++|..||.+.....
T Consensus 135 l~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 211 (291)
T cd07844 135 LISERGELKLADFGLARAKSVPS---KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211 (291)
T ss_pred EEcCCCCEEECccccccccCCCC---ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 99999999999999876432111 111223568899999998755678999999999999999999999997655222
Q ss_pred -HHHHHHhc--CCCC----------------CCc-------cccccch--HHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 -VLLMTIQN--APPG----------------LDY-------DRDKKFS--KSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 -~l~~~i~~--~~~~----------------~~~-------~~~~~~S--~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+...... .+.. ... .....++ ..+.++|.+||+++|.+|||+.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 22111110 0000 000 0001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=282.42 Aligned_cols=201 Identities=28% Similarity=0.513 Sum_probs=168.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~ni 131 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceE
Confidence 35689999999999999999999999999999999988765455689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++......+. ......|++.|+|||++. +..++.++|+||||+++|+|++|..||.......
T Consensus 132 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 207 (255)
T cd08219 132 FLTQNGKVKLGDFGSARLLTSPGA---YACTYVGTPYYVPPEIWE-NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207 (255)
T ss_pred EECCCCcEEEcccCcceeeccccc---ccccccCCccccCHHHHc-cCCcCchhhhhhhchhheehhhccCCCCCCCHHH
Confidence 999999999999999865432221 123467899999999987 5678999999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
........... ..+..++..+++||.+||+.||.+|||+.+++.-
T Consensus 208 ~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 208 LILKVCQGSYK----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhcCCCC----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 44333332221 2234578899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=284.67 Aligned_cols=209 Identities=30% Similarity=0.549 Sum_probs=171.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++...+.+++||||+.||+|.++++.. +.+++..+..++.||+.||.|||++|++||||+|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~ni 139 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL 139 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhE
Confidence 45789999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC-CCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS-GYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~-~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
+++.++.++|+|||++...... ..........|+..|+|||.+.... .++.++|+|||||++|+|++|..||......
T Consensus 140 l~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 218 (272)
T cd06629 140 LVDADGICKISDFGISKKSDDI-YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218 (272)
T ss_pred EEcCCCeEEEeecccccccccc-ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH
Confidence 9999999999999998643211 1111223456889999999987433 4889999999999999999999999765554
Q ss_pred HHHHHHHhcC-CCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNA-PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~-~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.......... ...+.......++..++++|.+||.++|.+|||+.++++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 4443322221 1222222334678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=286.70 Aligned_cols=210 Identities=36% Similarity=0.674 Sum_probs=170.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAG 78 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPe 78 (583)
+.++||||+++++++..++.+|+||||++ |+|.+++.... ...+++..++.++.||+.||.|||++ +++||||||+
T Consensus 55 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~ 133 (283)
T cd06617 55 RSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133 (283)
T ss_pred HHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 45789999999999999999999999996 67877776532 34689999999999999999999998 9999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC---CCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG---SGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~---~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|||++.++.+||+|||++....... ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||..
T Consensus 134 nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 134 NVLINRNGQVKLCDFGISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred HEEECCCCCEEEeeccccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 9999999999999999987542211 11235688999999988631 4578899999999999999999999975
Q ss_pred CC-hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 156 YP-PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 156 ~~-~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
.. ..+.+...+....+.+. ...++.+++++|.+||..+|.+|||+.++++||||.......
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 271 (283)
T cd06617 210 WKTPFQQLKQVVEEPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKN 271 (283)
T ss_pred cccCHHHHHHHHhcCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccccc
Confidence 43 23344344433322221 235789999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=287.26 Aligned_cols=206 Identities=51% Similarity=0.856 Sum_probs=172.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.++..+|+||||+.||+|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Ni 132 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhE
Confidence 3568999999999999999999999999999999998753 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......++..|+|||.+. +..++.++|+|||||++|+|++|..||.......
T Consensus 133 l~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06640 133 LLSEQGDVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208 (277)
T ss_pred EEcCCCCEEEcccccceeccCCc---cccccccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence 99999999999999986543221 1122356888999999987 5578999999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.......... ......++..+.++|.+||..+|.+||++.++++|+||.....
T Consensus 209 ~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 209 VLFLIPKNNP----PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HhhhhhcCCC----CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 4332222211 1223457888999999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=288.18 Aligned_cols=203 Identities=45% Similarity=0.754 Sum_probs=164.7
Q ss_pred CCCcccceEEEEE-----ECCEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 5 DHPNVIRAYCSFV-----VDSNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 5 ~HPNIVkl~~~f~-----d~~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
+||||++++++|. .+..+|+||||++||+|.+++... ....+++..++.++.||+.||.|||+++++||||||
T Consensus 73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 152 (286)
T cd06638 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKG 152 (286)
T ss_pred cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCH
Confidence 7999999999884 456799999999999999987642 234589999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
+||+++.++.+||+|||++....... .......|++.|+|||.+.. ...++.++||||+||++|+|++|..||
T Consensus 153 ~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 153 NNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred HhEEECCCCCEEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 99999999999999999986543211 11234578999999999852 245788999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
........+........+. ......++..+++||.+||+.||.+|||+.+|++|+||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 230 ADLHPMRALFKIPRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCchhHHHhhccccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 8766544443322222111 11223467889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=292.85 Aligned_cols=210 Identities=35% Similarity=0.681 Sum_probs=174.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..++..|+||||+++++|..++.. ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Ni 148 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSI 148 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHe
Confidence 3568999999999999999999999999999999887643 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.+||+|||++....... .......|+..|+|||.+. ...++.++|||||||++|+|++|..||.......
T Consensus 149 ll~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 224 (297)
T cd06659 149 LLTLDGRVKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 224 (297)
T ss_pred EEccCCcEEEeechhHhhccccc---ccccceecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999886442211 1123467899999999997 5578999999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
.+. .+.... .........++..+.++|.+||+.+|.+||+++++++||||.....+.
T Consensus 225 ~~~-~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 225 AMK-RLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred HHH-HHhccC-CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 443 222221 112223456788999999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=339.59 Aligned_cols=209 Identities=32% Similarity=0.553 Sum_probs=178.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
..|+|||||++|++=...+.++|.||||+||+|.+++... +..+|...+.+-.|++.|+.|||++|||||||||.|||
T Consensus 1289 E~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~ 1366 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANIL 1366 (1509)
T ss_pred HhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCcccee
Confidence 4689999999999999999999999999999999998763 55788888999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCC-CCccccccccCCCCCCCcccccCC--CCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 82 LDTNGVVKLADFGVSACMFDTG-DRQRSRNTFVGTPCWMAPEVLQPG--SGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~-~~~~~~~~~~GT~~Y~APEil~~~--~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
++.+|.||++|||.|..+.... +-....+...||+.|||||++.+. .+.+-++||||+||++.||+||+.||...+.
T Consensus 1367 Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1367 LDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred eecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 9999999999999988775442 122334567999999999999863 4677899999999999999999999987654
Q ss_pred -HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 -MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 -~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..++.....+..|.++ ..+|.+.++||.+||..||++|+++.|||.|.|-+...
T Consensus 1447 e~aIMy~V~~gh~Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1447 EWAIMYHVAAGHKPQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred hhHHHhHHhccCCCCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 4555555555555443 55999999999999999999999999999999877554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=285.99 Aligned_cols=204 Identities=38% Similarity=0.691 Sum_probs=168.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNI 80 (583)
+.++||||++++++|..+..+|+||||+.+++|.+++.... ..+++..+..++.||+.||+|||+ .|++|+||||+||
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni 132 (265)
T cd06605 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNI 132 (265)
T ss_pred HHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHE
Confidence 46789999999999999999999999999999999887642 678999999999999999999999 9999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC---
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP--- 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~--- 157 (583)
+++.++.++|+|||.+....... .....++..|+|||.+. +..++.++|||||||++|+|++|..||....
T Consensus 133 ~~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 206 (265)
T cd06605 133 LVNSRGQIKLCDFGVSGQLVNSL-----AKTFVGTSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206 (265)
T ss_pred EECCCCCEEEeecccchhhHHHH-----hhcccCChhccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc
Confidence 99999999999999876542211 11267889999999987 5688999999999999999999999997642
Q ss_pred --hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 158 --PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 158 --~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
....+........+.+.. ..++..+++||.+||..+|.+|||+.+++.||||+..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 207 DGIFELLQYIVNEPPPRLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ccHHHHHHHHhcCCCCCCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 112222222222222211 1278899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=289.75 Aligned_cols=212 Identities=24% Similarity=0.327 Sum_probs=169.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++...|+||||++ ++|..++.......+++..++.++.||+.||+|||++|++||||+|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~ni 133 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceE
Confidence 356899999999999999999999999995 5788777654344478999999999999999999999999999999999
Q ss_pred EEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 81 LLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
+++. ++.+||+|||++...... ........+++.|+|||.+.+...++.++||||+||++|+|++|.+||......
T Consensus 134 ll~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 134 LIDRRTNALKLADFGLARAFGIP---VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred EEECCCCEEEEcccccccccCCC---ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9985 557999999998643221 111223467899999999875556889999999999999999999999877665
Q ss_pred HHHHHHHhcCCCCC--------------------C----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 160 KVLLMTIQNAPPGL--------------------D----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 160 ~~l~~~i~~~~~~~--------------------~----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+.+...+....... . ......++..+.++|.+||+.+|.+||++.++++||||.+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 211 DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 55444332110000 0 00123568889999999999999999999999999999876
Q ss_pred C
Q 007967 216 K 216 (583)
Q Consensus 216 ~ 216 (583)
+
T Consensus 291 ~ 291 (294)
T PLN00009 291 G 291 (294)
T ss_pred h
Confidence 4
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=288.11 Aligned_cols=207 Identities=24% Similarity=0.372 Sum_probs=165.3
Q ss_pred CC-CCCcccceEEEEEECCE-----EEEEEecCCCCCHHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 3 LI-DHPNVIRAYCSFVVDSN-----LWVVMPFMAEGSCLHLMKIAYQ---DGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~-----l~LVmEy~~GGsL~dll~~~~~---~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
.+ +||||+++++++..... .|+|||||.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~ 134 (295)
T cd07837 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHR 134 (295)
T ss_pred HccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 44 57999999999988766 8999999985 78887765432 358999999999999999999999999999
Q ss_pred CCCCCcEEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 74 DVKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 74 DLKPeNILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
||||+||+++. ++.+||+|||++..+.... .......+++.|+|||++.+...++.++|||||||++|+|++|..|
T Consensus 135 dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 135 DLKPQNLLVDKQKGLLKIADLGLGRAFSIPV---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred CCChHHEEEecCCCeEEEeecccceecCCCc---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 99999999998 8899999999986542211 1112235788999999987556789999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCC--CCCCc---------------------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 153 FSKYPPMKVLLMTIQNAP--PGLDY---------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~--~~~~~---------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|.+......+........ ....+ ...+.++..+.+||.+||.+||.+||++.+++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 988776655544333110 00000 0013478889999999999999999999999999
Q ss_pred cccc
Q 007967 210 SFFK 213 (583)
Q Consensus 210 pfFk 213 (583)
|||+
T Consensus 292 ~~~~ 295 (295)
T cd07837 292 PYFD 295 (295)
T ss_pred CCcC
Confidence 9995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.87 Aligned_cols=212 Identities=26% Similarity=0.389 Sum_probs=169.5
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++... +.+|+||||+. ++|.+++... ...+++..+..++.||+.||.|||++|++||||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 137 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS 137 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 3578999999999999865 57999999996 5788877653 366999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.+||+|||++....... .......+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+.
T Consensus 138 nil~~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 138 NLLLTDKGCLKIADFGLARTYGLPA---KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred HEEECCCCCEEECccceeeecCCcc---CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999987553221 1112235688899999987556789999999999999999999999988776
Q ss_pred HHHHHHHHhcCCC----------------CCCcc---------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 159 MKVLLMTIQNAPP----------------GLDYD---------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 159 ~~~l~~~i~~~~~----------------~~~~~---------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
...+......... .+... ....+++.+++||.+||++||.+|||++++++||||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 5554433321100 00000 0123588899999999999999999999999999998
Q ss_pred cCCC
Q 007967 214 HAKP 217 (583)
Q Consensus 214 ~~~~ 217 (583)
....
T Consensus 295 ~~~~ 298 (309)
T cd07845 295 EKPL 298 (309)
T ss_pred cCCC
Confidence 6543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=280.23 Aligned_cols=209 Identities=33% Similarity=0.592 Sum_probs=169.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+.+++|+||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~ni 130 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANI 130 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 35689999999999999999999999999999999988653 4589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccc-cccccCCCCCCCcccccCCC--CCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRS-RNTFVGTPCWMAPEVLQPGS--GYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~-~~~~~GT~~Y~APEil~~~~--~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
+++.++.+||+|||++............ .....++..|+|||.+.... .++.++|||||||++|+|++|..||....
T Consensus 131 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 131 FLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred EECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 9999999999999998765332221111 22356788999999987432 37899999999999999999999997654
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
........+... .....+....++..+.++|.+||+.+|.+|||+.+++.|||+
T Consensus 211 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 211 NEFQIMFHVGAG-HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred chHHHHHHHhcC-CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 333322222221 112223334568899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=289.41 Aligned_cols=205 Identities=51% Similarity=0.875 Sum_probs=171.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..+..+|+||||+.+++|.+++. ...+++..++.++.||+.||.|||++|++|+||+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni 132 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANV 132 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheE
Confidence 357899999999999999999999999999999998875 35689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++..+.... .......|+..|+|||.+. +..++.++|+|||||++|+|++|..||.......
T Consensus 133 ~i~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06642 133 LLSEQGDVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIK-QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208 (277)
T ss_pred EEeCCCCEEEccccccccccCcc---hhhhcccCcccccCHHHhC-cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence 99999999999999986543221 1122356889999999987 5678999999999999999999999997655444
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..........+ .....++..+.++|.+||..+|.+||++.++++||||....
T Consensus 209 ~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 209 VLFLIPKNSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHhhhhcCCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 33322222211 12245778899999999999999999999999999997644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=292.69 Aligned_cols=211 Identities=26% Similarity=0.364 Sum_probs=164.1
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQ---DGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~---~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++||||++++++|.+. ..+|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dl 134 (316)
T cd07842 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDL 134 (316)
T ss_pred HHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCC
Confidence 3568999999999999988 88999999996 467776654322 36899999999999999999999999999999
Q ss_pred CCCcEEEcC----CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 76 KAGNILLDT----NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 76 KPeNILld~----~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
||+|||++. ++.+||+|||++.................+++.|+|||++.+...++.++|||||||++|+|++|.+
T Consensus 135 kp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 214 (316)
T cd07842 135 KPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214 (316)
T ss_pred CHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCC
Confidence 999999999 8999999999987553332222223345789999999998755678999999999999999999999
Q ss_pred CCCCCChHH---------H---HHHHHhc--------------------CCCCCCcc---------ccccchHHHHHHHH
Q 007967 152 PFSKYPPMK---------V---LLMTIQN--------------------APPGLDYD---------RDKKFSKSFKEMVA 190 (583)
Q Consensus 152 PF~~~~~~~---------~---l~~~i~~--------------------~~~~~~~~---------~~~~~S~~lkdLI~ 190 (583)
||.+..... . +...+.. ......+. .....+..+.++|.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 294 (316)
T cd07842 215 IFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294 (316)
T ss_pred CCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHH
Confidence 997643211 0 0110000 00000000 01146678999999
Q ss_pred hhhcCCCCCCCCHHHHHhcccc
Q 007967 191 MCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 191 ~cL~~DP~kRpTa~eIL~HpfF 212 (583)
+||.+||++|||+.++++||||
T Consensus 295 ~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 295 KLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhcCCcccCcCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.20 Aligned_cols=212 Identities=36% Similarity=0.590 Sum_probs=169.3
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
|+.++||||++++++|.+. +.+|+||||++|++|.+++.... ...+++..+..++.||+.||.|||+.|++|+||+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~ 132 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK 132 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 4678999999999998754 47999999999999998876432 3458999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+||+++.++.++|+|||++....... .....++..|+|||.+. ...++.++|||||||++|+|++|..||...
T Consensus 133 ~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 133 PSNILLTRKGQVKLCDFGVSGELVNSL-----AGTFTGTSFYMAPERIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred HHHEEEecCCeEEEeeccccccccccc-----cccccCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999976442211 12346788999999987 567899999999999999999999999765
Q ss_pred C----hHHHHHHHHhc-CCCCCCc--cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 157 P----PMKVLLMTIQN-APPGLDY--DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 157 ~----~~~~l~~~i~~-~~~~~~~--~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
. ........+.. ..+.+.. .....+++.+++||.+||.++|.+|||+.|+++||||+.....
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 207 GEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred cCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 2 11222222222 1111111 1113467899999999999999999999999999999877644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=288.97 Aligned_cols=207 Identities=29% Similarity=0.517 Sum_probs=167.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.++..+|+||||+.++.|..+... ...+++..+..++.||+.||.|||+.|++|+||+|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni 131 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 3568999999999999999999999999999888776543 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......++..|+|||++.+...++.++|||||||++|+|++|.+||......+
T Consensus 132 ~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~ 208 (286)
T cd07846 132 LVSQSGVVKLCDFGFARTLAAPG---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208 (286)
T ss_pred EECCCCcEEEEeeeeeeeccCCc---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 99999999999999986543322 122345788999999998755567889999999999999999999997755433
Q ss_pred HHHHHHhcCC---------------------CCCC-----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAP---------------------PGLD-----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~---------------------~~~~-----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.......... +... ....+.++..+.+|+.+||..+|.+||++.++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 3222221000 0000 00123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=288.03 Aligned_cols=206 Identities=25% Similarity=0.385 Sum_probs=166.1
Q ss_pred CCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||+++++++... +.+|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+|
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~n 136 (293)
T cd07843 59 LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSN 136 (293)
T ss_pred HhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence 567899999999999887 89999999997 5898887653 3469999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.+||+|||++....... .......+++.|+|||.+.+...++.++||||+||++|+|++|.+||......
T Consensus 137 ili~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 137 LLLNNRGILKICDFGLAREYGSPL---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred EEECCCCcEEEeecCceeeccCCc---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999887543321 11233567889999999875556789999999999999999999999887665
Q ss_pred HHHHHHHhcCCC--------------------------CCCcccccc-chHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAPP--------------------------GLDYDRDKK-FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~~--------------------------~~~~~~~~~-~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
............ .+....... +++.+++||.+||+.+|++|||+.|++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 444332221100 000000111 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=279.38 Aligned_cols=203 Identities=37% Similarity=0.663 Sum_probs=170.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++..+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni 133 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANI 133 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 35689999999999999999999999999999999988753 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.+||+|||++....... ......|+..|+|||.+.....++.++|+|||||++|+|++|..||.......
T Consensus 134 ~~~~~~~~kl~d~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~ 209 (258)
T cd06632 134 LVDTNGVVKLADFGMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA 209 (258)
T ss_pred EECCCCCEEEccCccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH
Confidence 99999999999999876542221 12346789999999998743348899999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.......... . ...+..+++.+++|+.+||..+|.+||++.+++.|||+
T Consensus 210 ~~~~~~~~~~--~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 210 AVFKIGRSKE--L-PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHhccc--C-CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 4433332111 1 12234678999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=282.49 Aligned_cols=206 Identities=30% Similarity=0.535 Sum_probs=167.5
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++.+. ..+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++|++|+||||+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 135 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 3568999999999998764 5789999999999999987653 56899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.++|+|||++.................|+..|+|||.+. +..++.++|||||||++|+|++|+.||.....
T Consensus 136 nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 214 (265)
T cd06652 136 NILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214 (265)
T ss_pred HEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccch
Confidence 99999999999999998865422111111223356889999999987 56789999999999999999999999987655
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
.......... .. ....+..++..+.++|.+||. +|.+||+++++++|||+.
T Consensus 215 ~~~~~~~~~~-~~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 215 MAAIFKIATQ-PT--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhcC-CC--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 4444332221 11 112345678889999999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.49 Aligned_cols=211 Identities=22% Similarity=0.380 Sum_probs=170.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------DGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|+.++||||+++++++.+....|+||||+.+|+|.+++..... ..++...+..++.||+.||.|||++||+|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 142 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH 142 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 4578999999999999999999999999999999999875321 22467788999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHA 151 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~ 151 (583)
|||||+|||++.++.++|+|||+++....... ........++..|+|||.+. ...++.++|||||||++|+|++ |..
T Consensus 143 ~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~-~~~~~~~~DvwslG~~l~el~~~~~~ 220 (288)
T cd05061 143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQ 220 (288)
T ss_pred CCCChheEEEcCCCcEEECcCCcccccccccc-ccccCCCcccccccCHHHhc-cCCCChHhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999875433221 11112234567899999987 5578999999999999999998 889
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh------ccccccCCC
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK------HSFFKHAKP 217 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~------HpfFk~~~~ 217 (583)
||.+....+........... .....+++.+++++.+||+.+|.+|||+.++++ ||||..++|
T Consensus 221 p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 221 PYQGLSNEQVLKFVMDGGYL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CCCCCCHHHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 99876654443333322211 223456789999999999999999999999987 999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=286.53 Aligned_cols=207 Identities=27% Similarity=0.425 Sum_probs=168.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+++..|+||||++ ++|.+++.......+++..+..++.||+.||.|||++|++||||+|+||+
T Consensus 53 ~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil 131 (283)
T cd07835 53 KELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLL 131 (283)
T ss_pred HhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEE
Confidence 56799999999999999999999999994 68998887654346999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||++...... ........++..|+|||++.+...++.++|||||||++|+|++|.+||........
T Consensus 132 ~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 208 (283)
T cd07835 132 IDREGALKLADFGLARAFGVP---VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208 (283)
T ss_pred EcCCCcEEEeecccccccCCC---ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999998644211 11112346688999999887555678999999999999999999999987665544
Q ss_pred HHHHHhcCC--------------------CCC----CccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 162 LLMTIQNAP--------------------PGL----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 162 l~~~i~~~~--------------------~~~----~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
+........ +.. .......++..+.++|.+||+.+|.+|||++++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 209 LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 433322100 000 001124567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.44 Aligned_cols=207 Identities=26% Similarity=0.465 Sum_probs=179.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||||++|.+.+....+|+||||+.+|.+++++... +.+.+..++.++.|++++++|||+++|||||||++||
T Consensus 109 mk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNi 186 (596)
T KOG0586|consen 109 MKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENI 186 (596)
T ss_pred HHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhc
Confidence 67899999999999999999999999999999999999875 7788899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+.++||+|||++..+. ......++||++.|.|||++.+....++.+|+||+|+++|-|++|.+||++..- .
T Consensus 187 lL~~~mnikIaDfgfS~~~~----~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-k 261 (596)
T KOG0586|consen 187 LLDENMNIKIADFGFSTFFD----YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-K 261 (596)
T ss_pred ccccccceeeeccccceeec----ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-c
Confidence 99999999999999987552 223446799999999999999777778999999999999999999999998443 2
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.+....... .+..+..++.+++++|+++|..+|.+|++.+++..|.|.......
T Consensus 262 ~Lr~rvl~g----k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 262 ELRPRVLRG----KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred cccchheee----eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 222222222 233445688999999999999999999999999999999865543
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=277.43 Aligned_cols=202 Identities=27% Similarity=0.478 Sum_probs=168.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-------QDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-------~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
+.++||||+++++++.+...+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++|++|||
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d 130 (262)
T cd00192 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130 (262)
T ss_pred hhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCc
Confidence 56789999999999999999999999999999999987642 35689999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPF 153 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF 153 (583)
|||+||+++.++.+||+|||.+........ ........++..|+|||.+. ...++.++|||||||++|+|++ |..||
T Consensus 131 i~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 131 LAARNCLVGEDLVVKISDFGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred cCcceEEECCCCcEEEcccccccccccccc-cccccCCCcCccccCHHHhc-cCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999876543221 12223456788999999987 4578999999999999999998 69999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.......... .+... ........++.++.+++.+||..+|.+|||+.+++++
T Consensus 209 ~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 209 PGLSNEEVLE-YLRKG---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCHHHHHH-HHHcC---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 8875544433 33321 2223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.15 Aligned_cols=207 Identities=23% Similarity=0.318 Sum_probs=162.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++..|+||||+. +++..++... ...+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 134 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 356899999999999999999999999995 6777766443 35688899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.++|+|||++....... .......+++.|+|||.+.+...++.++|||||||++|+|++|..||.+.....
T Consensus 135 l~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~ 211 (291)
T cd07870 135 LISYLGELKLADFGLARAKSIPS---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211 (291)
T ss_pred EEcCCCcEEEeccccccccCCCC---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH
Confidence 99999999999999886432221 112334678999999998755568889999999999999999999998755432
Q ss_pred HHHHHHhc---------------CCCCCC----c-------ccc--ccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQN---------------APPGLD----Y-------DRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~---------------~~~~~~----~-------~~~--~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.....+.. .+.... . ..+ ...+..+.+++.+||..||.+|||+.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 212 EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 22111110 000000 0 000 1135688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=285.70 Aligned_cols=208 Identities=24% Similarity=0.357 Sum_probs=166.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+.+.+||||||+.+ +|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~n 130 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQN 130 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence 3568999999999999999999999999975 7888776542 2458999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|+++.++.++|+|||++...... ........++..|+|||.+.+...++.++|||||||++|+|++|..||.+....
T Consensus 131 i~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 207 (284)
T cd07836 131 LLINKRGELKLADFGLARAFGIP---VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207 (284)
T ss_pred EEECCCCcEEEeecchhhhhcCC---ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999998644221 112233567889999999875567889999999999999999999999876654
Q ss_pred HHHHHHHhcCC-------------CCCC--cc---------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAP-------------PGLD--YD---------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~-------------~~~~--~~---------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
+.....+.... +.+. .+ ....++..++++|.+||+.||.+||++.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 208 DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 44333222110 0000 00 012457789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.40 Aligned_cols=206 Identities=22% Similarity=0.380 Sum_probs=162.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-----------------DGFEESAIGSILKETLKALD 63 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-----------------~~~sE~~i~~I~~QIl~gL~ 63 (583)
|+.++||||++++++|.+.+.+|+|||||.+|+|.+++..... ..+++..+..++.||+.||.
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999999999999998865311 23677889999999999999
Q ss_pred HHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHH
Q 007967 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITA 143 (583)
Q Consensus 64 yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvIL 143 (583)
|||++||+||||||+|||++.++.+||+|||+++..... ..........++..|+|||++. ...++.++|||||||++
T Consensus 153 ~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l 230 (304)
T cd05096 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG-DYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTL 230 (304)
T ss_pred HHHHCCccccCcchhheEEcCCccEEECCCccceecccC-ceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHH
Confidence 999999999999999999999999999999998754322 1111223345678899999987 55789999999999999
Q ss_pred hhhhh--CCCCCCCCChHHHHHHHH---hcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 144 LELAH--GHAPFSKYPPMKVLLMTI---QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 144 yeLLt--G~~PF~~~~~~~~l~~~i---~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|+|++ +..||........+.... ...........+..++..+.+||.+||..||.+|||+.+|.+
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 99986 678887765544332211 111111112223467889999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=284.20 Aligned_cols=208 Identities=27% Similarity=0.500 Sum_probs=167.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+||||+.++.+..++.. ...+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 131 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 3578899999999999999999999999988766655433 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.+||+|||++........ .....+.++.+|+|||++.....++.++|||||||++|+|++|.+||.+....+
T Consensus 132 ~~~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~ 209 (288)
T cd07833 132 LVSESGVLKLCDFGFARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209 (288)
T ss_pred EECCCCCEEEEeeecccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999875533221 122346788999999999854478999999999999999999999998765544
Q ss_pred HHHHHHhcC---C----------C---CCCc-----------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNA---P----------P---GLDY-----------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~---~----------~---~~~~-----------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+....... . . ...+ .....++.++++||++||..+|.+|||+.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 210 QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 433221100 0 0 0000 0112348889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=287.05 Aligned_cols=207 Identities=37% Similarity=0.692 Sum_probs=165.1
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcE
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK---IAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGNI 80 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~---~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeNI 80 (583)
+||||+++++++..+...|+||||+. +++.++.. ......+++..+..++.|++.||+|||+. |++||||||+||
T Consensus 61 ~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni 139 (288)
T cd06616 61 DCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNI 139 (288)
T ss_pred CCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHE
Confidence 59999999999999999999999985 45544432 22245699999999999999999999975 999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC--CCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG--SGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~--~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++.++.+||+|||++....... ......|++.|+|||.+... ..++.++||||+||++|+|++|+.||.....
T Consensus 140 l~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 215 (288)
T cd06616 140 LLDRNGNIKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215 (288)
T ss_pred EEccCCcEEEeecchhHHhccCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch
Confidence 99999999999999986543221 11234688899999999754 3789999999999999999999999976542
Q ss_pred H-HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 M-KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 ~-~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
. +.+........+.+.......++.++.+||.+||+++|.+|||+++|++||||+...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 216 VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 2 222222222223333333346889999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=282.95 Aligned_cols=201 Identities=30% Similarity=0.501 Sum_probs=170.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.++..+|+||||+.|++|.+++... ..+++..+..++.||+.||.|||.+|++|+||+|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni 131 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNI 131 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 35789999999999999999999999999999999988653 5799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh--
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP-- 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~-- 158 (583)
+++.++.++|+|||++....... ......|+..|+|||.+. ...++.++|+|||||++|+|++|..||.....
T Consensus 132 l~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 206 (258)
T cd05578 132 LLDEQGHVHITDFNIATKVTPDT----LTTSTSGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI 206 (258)
T ss_pred EEcCCCCEEEeecccccccCCCc----cccccCCChhhcCHHHHc-ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH
Confidence 99999999999999876543221 123456888999999987 45689999999999999999999999987653
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH--HHHHhcccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA--EKLLKHSFF 212 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa--~eIL~HpfF 212 (583)
...+....... ....+..++..+.++|.+||..||.+||++ .++++||||
T Consensus 207 ~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 207 RDQIRAKQETA----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHhccc----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 23333332221 122335678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=281.59 Aligned_cols=205 Identities=32% Similarity=0.538 Sum_probs=164.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGF--EESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~--sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||+++++++.+++.+++||||+.+++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+|
T Consensus 60 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~n 138 (268)
T cd06624 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138 (268)
T ss_pred HhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 56899999999999999999999999999999999887542 334 888999999999999999999999999999999
Q ss_pred EEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 80 ILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 80 ILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|+++. ++.++|+|||++....... .......|++.|+|||.+... ..++.++|+||+||++|+|++|..||....
T Consensus 139 il~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 139 VLVNTYSGVVKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred EEEcCCCCeEEEecchhheecccCC---CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99976 6799999999876542211 112234688999999998643 348899999999999999999999997643
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
............ ......+..+++++++|+.+||..+|.+|||+.+++.||||
T Consensus 216 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 216 EPQAAMFKVGMF--KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ChhhhHhhhhhh--ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 322211111100 11112235678899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=283.67 Aligned_cols=210 Identities=44% Similarity=0.818 Sum_probs=176.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|......|+||||++|++|.+++.... ..+++..+..++.||+.||.|||+.|++|+||+|+||
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni 147 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNI 147 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhE
Confidence 357899999999999999999999999999999999987642 3799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......++..|+|||.+. +..++.++|+|||||++|+|++|..||.......
T Consensus 148 ~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 148 LLSKDGSVKLADFGFAAQLTKEK---SKRNSVVGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred EEcCCCCEEECccchhhhhccch---hhhccccCCcccCCHhHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999876442221 1123356788999999987 5678999999999999999999999998876655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
............. .....++..+++||.+||+.+|.+|||+.++++|+||+...+
T Consensus 224 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 224 ALFLITTKGIPPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHHHHHhcCCCCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 4444333332222 222347889999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.28 Aligned_cols=204 Identities=29% Similarity=0.511 Sum_probs=170.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
++.++||||+++++.+.++...|+||||+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||||.||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni 132 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNI 132 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 35689999999999999999999999999999999988765444589999999999999999999999999999999999
Q ss_pred EEcCCC-cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 81 LLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
+++.++ .+||+|||.+........ ......|++.|+|||.+. ...++.++|+|||||++|+|++|..||......
T Consensus 133 l~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 208 (257)
T cd08225 133 FLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGTPYYLSPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH 208 (257)
T ss_pred EEcCCCCeEEecccccchhccCCcc---cccccCCCccccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 998886 469999998865432211 112346889999999987 456889999999999999999999999876554
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
+.......... ......++..++++|.+||..+|.+|||+.++++||||
T Consensus 209 ~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 209 QLVLKICQGYF----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHhcccC----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 44443333221 12234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=311.07 Aligned_cols=214 Identities=25% Similarity=0.354 Sum_probs=162.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY---QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~---~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
|+.++|||||++++++.+.+..|+||+++. ++|..++.... ........++.|+.||+.||.|||++||+||||||
T Consensus 217 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 217 LGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred HHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 456899999999999999999999999994 56777654321 12345677889999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC-CC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS-KY 156 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~-~~ 156 (583)
+|||++.+|.+||+|||++..+.... .......+||+.|+|||++. +..|+.++|||||||++|||++|..++. ..
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCccc--ccccccccCCcCCCCchhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 99999999999999999987553221 11223468999999999998 5679999999999999999999875443 22
Q ss_pred --ChHHHHHHHHhcCCC---CCC------------------------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHH
Q 007967 157 --PPMKVLLMTIQNAPP---GLD------------------------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207 (583)
Q Consensus 157 --~~~~~l~~~i~~~~~---~~~------------------------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL 207 (583)
.....+...+..... .++ ......++..+.++|.+||++||.+|||+.|+|
T Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 222333332221100 000 000123566788999999999999999999999
Q ss_pred hccccccCCCC
Q 007967 208 KHSFFKHAKPP 218 (583)
Q Consensus 208 ~HpfFk~~~~~ 218 (583)
.||||......
T Consensus 453 ~hp~f~~~~~~ 463 (501)
T PHA03210 453 ALPLFSAEEEE 463 (501)
T ss_pred hChhhhcCCch
Confidence 99999876543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=282.52 Aligned_cols=200 Identities=19% Similarity=0.382 Sum_probs=164.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++++||||+++++++..++.+|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+||
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ni 138 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV 138 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhE
Confidence 45789999999999999999999999999999999988753 35689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.++++|||.+...... .........++..|+|||.+. ...++.++|||||||++|+|++ |..||+.....
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~ 215 (266)
T cd05064 139 LVNSDLVCKISGFRRLQEDKSE--AIYTTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215 (266)
T ss_pred EEcCCCcEEECCCccccccccc--chhcccCCCCceeecCHHHHh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 9999999999999976533111 111111234567899999987 5678999999999999999775 99999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.+. .+... ...+.+..++..+.+++.+||+.+|.+||++.+|++
T Consensus 216 ~~~~-~~~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 216 DVIK-AVEDG---FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHH-HHHCC---CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 5433 33322 122334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=278.64 Aligned_cols=206 Identities=40% Similarity=0.693 Sum_probs=172.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNI 80 (583)
+.++||||++++++|.....+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+ +|++||||+|+||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni 131 (264)
T cd06623 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNL 131 (264)
T ss_pred HhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHE
Confidence 4578999999999999999999999999999999998754 679999999999999999999999 9999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC--h
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP--P 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~--~ 158 (583)
+++.++.++|+|||++........ ......++..|+|||.+. ...++.++|+||||+++|+|++|..||.... .
T Consensus 132 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 207 (264)
T cd06623 132 LINSKGEVKIADFGISKVLENTLD---QCNTFVGTVTYMSPERIQ-GESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207 (264)
T ss_pred EECCCCCEEEccCccceecccCCC---cccceeecccccCHhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCccccccC
Confidence 999999999999998875532211 112457889999999987 5578899999999999999999999997764 3
Q ss_pred HHHHHHHHhcCCCCCCcccccc-chHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKK-FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~-~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.......+..... ...... ++..+.++|.+||..+|.+|||+.++++||||+.++
T Consensus 208 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 208 FFELMQAICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHHHhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 3333333332211 112234 789999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=286.39 Aligned_cols=210 Identities=25% Similarity=0.373 Sum_probs=161.8
Q ss_pred CCCCCCCcccceEEEEEECC--------EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVVDS--------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~--------~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|+.++||||+++++++.... ..|+||||+. ++|.+++... ...+++..++.++.||+.||.|||++|++|
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H 142 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILH 142 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 35789999999999987654 4699999995 5787776542 346899999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCC-ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDR-QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~-~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
+||||+||+++.++.+||+|||++......... ........++..|+|||.+.+...++.++|||||||++|+|++|..
T Consensus 143 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~ 222 (310)
T cd07865 143 RDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222 (310)
T ss_pred cCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999998754322211 1112335678899999998755567899999999999999999999
Q ss_pred CCCCCChHHHHHHHHh--cCCCCC--------------Cccc-----------cccchHHHHHHHHhhhcCCCCCCCCHH
Q 007967 152 PFSKYPPMKVLLMTIQ--NAPPGL--------------DYDR-----------DKKFSKSFKEMVAMCLVKDQTKRPTAE 204 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~--~~~~~~--------------~~~~-----------~~~~S~~lkdLI~~cL~~DP~kRpTa~ 204 (583)
||.+............ ...+.. ..+. ....+..+++||.+||..||.+|||++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~ 302 (310)
T cd07865 223 IMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD 302 (310)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHH
Confidence 9987655433211111 100000 0000 011356788999999999999999999
Q ss_pred HHHhcccc
Q 007967 205 KLLKHSFF 212 (583)
Q Consensus 205 eIL~HpfF 212 (583)
++++||||
T Consensus 303 e~l~h~~f 310 (310)
T cd07865 303 TALNHDFF 310 (310)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.36 Aligned_cols=203 Identities=28% Similarity=0.437 Sum_probs=168.7
Q ss_pred CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCC
Q 007967 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTN 85 (583)
Q Consensus 6 HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~ 85 (583)
--|||+++++|...+++|||+|.+ +-+|.++++.+...+|+...++.|+.||+.||.+||+.||||.||||+||||...
T Consensus 247 ~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~ 325 (586)
T KOG0667|consen 247 KYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP 325 (586)
T ss_pred CeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC
Confidence 348999999999999999999999 6889999999888899999999999999999999999999999999999999643
Q ss_pred --CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 86 --GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 86 --g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
..|||+|||.|... . ....+++-+.+|+|||++. +..|+.+.||||||||++||++|.+.|.|.++.+++.
T Consensus 326 ~r~~vKVIDFGSSc~~-~-----q~vytYiQSRfYRAPEVIL-GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 326 KRSRIKVIDFGSSCFE-S-----QRVYTYIQSRFYRAPEVIL-GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred CcCceeEEeccccccc-C-----Ccceeeeeccccccchhhc-cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 37999999987532 1 1223688899999999999 7789999999999999999999999999988877765
Q ss_pred HHHh--cCCC------------CCCc-----------c----------------------cc-----------ccchHHH
Q 007967 164 MTIQ--NAPP------------GLDY-----------D----------------------RD-----------KKFSKSF 185 (583)
Q Consensus 164 ~~i~--~~~~------------~~~~-----------~----------------------~~-----------~~~S~~l 185 (583)
.++. +.++ .++. . .+ ..-...|
T Consensus 399 ~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F 478 (586)
T KOG0667|consen 399 RIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLF 478 (586)
T ss_pred HHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHH
Confidence 4432 0000 0000 0 00 0123458
Q ss_pred HHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 186 kdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.+||++||.+||.+|+|+.++|+||||....
T Consensus 479 ~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 479 IDFLKRCLEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred HHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence 9999999999999999999999999998653
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.93 Aligned_cols=207 Identities=40% Similarity=0.731 Sum_probs=172.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|......|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Ni 146 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 146 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHE
Confidence 4568999999999999999999999999999999998764 4688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......|++.|+|||.+. ...++.++|+|||||++|+|++|..||.......
T Consensus 147 li~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 147 LLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred EEcCCCCEEEccCcceecccccc---cccccccCChhhcCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 99999999999999876443221 1223457889999999987 4578899999999999999999999998765544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..........+. ...+..++..++++|.+||..+|.+||++.+++.|+||+...
T Consensus 223 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 223 ALYLIATNGTPE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred heeehhcCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 333222222222 222345788899999999999999999999999999998775
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=282.61 Aligned_cols=206 Identities=50% Similarity=0.871 Sum_probs=172.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+||||+.+|+|..++.. ..+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni 132 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhE
Confidence 3568999999999999999999999999999999988753 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......|+..|+|||.+. ...++.++|+|||||++|+|++|..||.......
T Consensus 133 ~i~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 208 (277)
T cd06641 133 LLSEHGEVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELHPMK 208 (277)
T ss_pred EECCCCCEEEeecccceecccch---hhhccccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH
Confidence 99999999999999876542211 1123357889999999987 5577889999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
..........+ .....++.++.++|.+||..+|.+||++.++++||||.....
T Consensus 209 ~~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 209 VLFLIPKNNPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HHHHHhcCCCC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 33332222211 123457889999999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=274.88 Aligned_cols=203 Identities=33% Similarity=0.562 Sum_probs=172.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||+++++.+..+...++||||+++++|.+++.... ...+++..+..++.+|+.||.|||++|++|+||+|+|
T Consensus 54 ~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~n 133 (258)
T cd08215 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133 (258)
T ss_pred HhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHH
Confidence 56789999999999999999999999999999999887653 3669999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|+++.++.++|+|||++....... .......|++.|+|||.+. ...++.++|+||+|+++|+|++|..||......
T Consensus 134 il~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 209 (258)
T cd08215 134 IFLTSNGLVKLGDFGISKVLSSTV---DLAKTVVGTPYYLSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL 209 (258)
T ss_pred eEEcCCCcEEECCccceeecccCc---ceecceeeeecccChhHhc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence 999999999999999886543222 1223457899999999987 556889999999999999999999999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
+............ .+..++..+.+++.+||..+|.+|||+.++|+||||
T Consensus 210 ~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 210 ELALKILKGQYPP----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHhcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 4444333332222 234678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=285.70 Aligned_cols=205 Identities=40% Similarity=0.736 Sum_probs=170.4
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++..|+||||+. |++.+++... ...+++..+..++.||+.||.|||++|++||||+|+||+
T Consensus 70 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl 147 (307)
T cd06607 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL 147 (307)
T ss_pred HhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEE
Confidence 56899999999999999999999999996 6677766543 356899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
++.++.++|+|||++..... .....|++.|+|||++.. ...++.++|||||||++|+|++|..||.+....
T Consensus 148 ~~~~~~~kL~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~ 220 (307)
T cd06607 148 LTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (307)
T ss_pred ECCCCCEEEeecCcceecCC-------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH
Confidence 99999999999998754311 124578889999998842 356888999999999999999999999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
...........+... ...++..++++|.+||..+|.+||++.+++.||||.....+
T Consensus 221 ~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 276 (307)
T cd06607 221 SALYHIAQNDSPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276 (307)
T ss_pred HHHHHHhcCCCCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence 554444333322221 23478899999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=281.38 Aligned_cols=205 Identities=23% Similarity=0.401 Sum_probs=163.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ---DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~---~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
+.++||||++++++|.+...+|+||||+.+|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 50 ~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~ 129 (269)
T cd05042 50 RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR 129 (269)
T ss_pred HhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHh
Confidence 567999999999999999999999999999999999876432 23567888999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC------CCCCCccccccchhhHHhhhhh-CCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP------GSGYNSKADIWSFGITALELAH-GHA 151 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~------~~~ys~ksDIWSLGvILyeLLt-G~~ 151 (583)
|||++.++.+||+|||++....... .........+++.|+|||++.. ...++.++|||||||++|+|++ |..
T Consensus 130 Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 208 (269)
T cd05042 130 NCQLTADLSVKIGDYGLALEQYPED-YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208 (269)
T ss_pred heEecCCCcEEEeccccccccccch-heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999986432221 1111123456778999999752 2356889999999999999998 889
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCcc-ccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYD-RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~-~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
||....+.+.+...+.........+ ....++..+++++..|+ .||.+|||+++|++
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 209 PYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 9987766665555555443332222 23468889999999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=279.96 Aligned_cols=201 Identities=23% Similarity=0.443 Sum_probs=165.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++..+..+++||||+++|+|.+++.......+++..+..++.|++.||+|||++|++||||||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ni 135 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 35689999999999999999999999999999999998765555689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++...... .........++..|+|||.+. +..++.++|||||||++|+|++ |..||.+....
T Consensus 136 l~~~~~~~kl~df~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 136 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred EEcCCCcEEeCCCccccccccc--eeeccCCCCCccccCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999998654221 111111223466799999887 5678999999999999999998 99999876543
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+ ....+... .....+..++..+.++|.+||..+|.+|||+.++++
T Consensus 213 ~-~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 213 Q-VYELLEKG---YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred H-HHHHHHCC---CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 3 33333332 222334668899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=276.42 Aligned_cols=204 Identities=32% Similarity=0.519 Sum_probs=168.9
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH-----HCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLH-----RQGHI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLH-----s~gIv 71 (583)
|+.++||||+++++++.. +..+|+||||+++++|.+++.... ...+++..++.++.||+.||.||| +.+++
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~ 132 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL 132 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce
Confidence 457899999999998864 456899999999999999887542 356899999999999999999999 89999
Q ss_pred ccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 72 HRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
|+||+|+||+++.++.+||+|||++........ ......|++.|+|||.+. ...++.++|+||||+++|+|++|..
T Consensus 133 h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred ecCCCHHHEEEecCCCEEEecccccccccCCcc---cccccccCCCccChhhhc-CCCCCchhHHHHHHHHHHHHHHCCC
Confidence 999999999999999999999999875532211 123457899999999987 4568899999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
||..... ..+...+..... ......++..+.+++.+||..+|.+|||+.+|++|||+
T Consensus 209 p~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 209 PFTARNQ-LQLASKIKEGKF---RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cccCcCH-HHHHHHHhcCCC---CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 9988653 333333333221 12335678999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=277.75 Aligned_cols=200 Identities=31% Similarity=0.515 Sum_probs=164.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.....+|+||||+.+|+|.+++... .+.+++..+..++.||+.||+|||++|++||||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05114 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNC 131 (256)
T ss_pred HHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceE
Confidence 45789999999999999999999999999999999987653 24689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||.++....... .......++..|+|||.+. ...++.++|||||||++|+|++ |+.||......
T Consensus 132 ~i~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 132 LVSSTGVVKVSDFGMTRYVLDDEY--TSSSGAKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred EEcCCCeEEECCCCCccccCCCce--eccCCCCCchhhCChhhcc-cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999998865432211 1112234566899999987 5678999999999999999999 99999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+........... ..+...+..+.+++.+||..+|.+||++.++++
T Consensus 209 ~~~~~i~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 209 EVVEMISRGFRL----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHCCCCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 554444333221 123446788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=295.24 Aligned_cols=216 Identities=24% Similarity=0.386 Sum_probs=169.9
Q ss_pred CCCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
|+.++||||++++++|.. ...+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||++|++|||||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 134 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLK 134 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 467899999999998863 357999999995 688887754 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCC-ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDR-QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~-~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|+||+++.+|.+||+|||++......... ........|+.+|+|||.+.....++.++|||||||++|+|++|+.||.+
T Consensus 135 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 135 PSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred HHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 99999999999999999998654332221 11123457899999999987556789999999999999999999999977
Q ss_pred CChHHHHHHHHhc-----------------------CC--CCCCc-cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQN-----------------------AP--PGLDY-DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~-----------------------~~--~~~~~-~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
......+...... .. ....+ .....++..++++|.+||+.+|.+|||+++++.|
T Consensus 215 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 215 KNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 6543332211110 00 00000 0113468899999999999999999999999999
Q ss_pred cccccCCCCc
Q 007967 210 SFFKHAKPPE 219 (583)
Q Consensus 210 pfFk~~~~~~ 219 (583)
|||.....+.
T Consensus 295 ~~~~~~~~~~ 304 (334)
T cd07855 295 PFLAQYHDPD 304 (334)
T ss_pred hhhhhccCCc
Confidence 9999776554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.32 Aligned_cols=213 Identities=23% Similarity=0.387 Sum_probs=166.2
Q ss_pred CCCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++||||+++++++... ..+|+||||+. ++|..++. ...+++..++.++.||+.||.|||++||+||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dl 132 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDL 132 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 3568899999999987654 35899999996 57777664 357999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.+||+|||++.................|++.|+|||.+.....++.++||||+||++|+|++|+.||.+
T Consensus 133 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 133 KPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred CHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999875533222222223467899999999876556789999999999999999999999977
Q ss_pred CChHHHHHHHHh--cC---------------------CCC--CCc-cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQ--NA---------------------PPG--LDY-DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~--~~---------------------~~~--~~~-~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
............ +. +.. ... .....++..+.+||.+||+.+|.+|||+.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 213 KDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 543322211111 00 000 000 0013457889999999999999999999999999
Q ss_pred cccccCCC
Q 007967 210 SFFKHAKP 217 (583)
Q Consensus 210 pfFk~~~~ 217 (583)
|||+....
T Consensus 293 p~~~~~~~ 300 (336)
T cd07849 293 PYLEQYHD 300 (336)
T ss_pred ccccccCC
Confidence 99997754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=315.90 Aligned_cols=209 Identities=44% Similarity=0.784 Sum_probs=187.7
Q ss_pred CCCCCCcccceEEEEEE-----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d-----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
..-+|||++.+|++|.- ++.+|||||||.||+.-|+++...+..+.|+.|+.|+++++.||.+||.+.++|||||
T Consensus 71 ~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDik 150 (953)
T KOG0587|consen 71 KYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIK 150 (953)
T ss_pred hccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeeccc
Confidence 34589999999999974 5679999999999999999998877779999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
-.|||++.+|.|||+|||+++.+.. ....+++++|||+|||||++.. ...|+..+|+||||++..||.-|.+|
T Consensus 151 G~NiLLT~e~~VKLvDFGvSaQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP 227 (953)
T KOG0587|consen 151 GQNVLLTENAEVKLVDFGVSAQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP 227 (953)
T ss_pred CceEEEeccCcEEEeeeeeeeeeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC
Confidence 9999999999999999999987632 2344578999999999999974 33577889999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+....++..++.+..+.++.+. .+.+++++|.+||..||.+|..+||+..++|+|||++..
T Consensus 228 l~DmHPmraLF~IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 228 LCDMHPMRALFLIPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccCcchhhhhccCCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 9999999999888888776654 467899999999999999999999999999999999843
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=276.17 Aligned_cols=203 Identities=25% Similarity=0.430 Sum_probs=166.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+ ..+++||||+++|+|.+++.......+++..++.++.||+.||.|||++|++||||||+||
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~ni 128 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNI 128 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccE
Confidence 467899999999999998 8999999999999999998765335689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||++..+..............++..|+|||.+. ...++.++|||||||++|+|++ |..||......
T Consensus 129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 207 (257)
T cd05040 129 LLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR-TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207 (257)
T ss_pred EEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhc-ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999876533222111112345778899999987 5678999999999999999998 99999876665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+........ .. .......++..+.+++.+||+.+|.+|||+.++++
T Consensus 208 ~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 208 QILKKIDKE-GE--RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHhc-CC--cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 543333321 11 12233457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=280.99 Aligned_cols=202 Identities=21% Similarity=0.372 Sum_probs=165.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY------------QDGFEESAIGSILKETLKALDYLHRQ 68 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~------------~~~~sE~~i~~I~~QIl~gL~yLHs~ 68 (583)
|+.++||||+++++++.....+|+||||+.||+|.+++.... ...+++..+..++.||+.||.|||++
T Consensus 62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 356899999999999999999999999999999999987532 13478999999999999999999999
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH 148 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt 148 (583)
|++||||||+||+++.++.+||+|||++........ ........+++.|+|||++. +..++.++|||||||++|+|++
T Consensus 142 ~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e~~~ 219 (280)
T cd05049 142 HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFT 219 (280)
T ss_pred CeeccccccceEEEcCCCeEEECCcccceecccCcc-eecCCCCcccceecChhhhc-cCCcchhhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999865432211 11112345678899999997 5679999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 149 -GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 149 -G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|..||.+....+..... ..... ......++..+++++.+||+.||.+|||+.|+++
T Consensus 220 ~g~~p~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 220 YGKQPWYGLSNEEVIECI-TQGRL---LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCCCCCCCCHHHHHHHH-HcCCc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999876655444333 32211 1223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=326.89 Aligned_cols=210 Identities=31% Similarity=0.518 Sum_probs=172.0
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-------C
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQ-------G 69 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~-------g 69 (583)
|+.|+|||||+++++|.+ ...+|||||||.+|+|.++|.... ...+++..++.|+.||+.||.|||+. +
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 457899999999999865 457999999999999999987543 25699999999999999999999985 4
Q ss_pred CcccCCCCCcEEEcC-----------------CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-CCCCC
Q 007967 70 HIHRDVKAGNILLDT-----------------NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-GSGYN 131 (583)
Q Consensus 70 IvHRDLKPeNILld~-----------------~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-~~~ys 131 (583)
||||||||+||||+. .+.+||+|||++..+... ......+||+.|+|||++.. ...++
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~----s~~~s~vGTp~YmAPEvL~ge~~~~s 221 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----SMAHSCVGTPYYWSPELLLHETKSYD 221 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc----ccccccCCCccccCHHHHhccCCCCC
Confidence 999999999999964 335899999998654211 11234579999999999863 34588
Q ss_pred ccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccc
Q 007967 132 SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211 (583)
Q Consensus 132 ~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hpf 211 (583)
.++||||||||||+|++|..||........+...+...+ .+ ....++.++.+||..||..+|.+||++.++|.|+|
T Consensus 222 ~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p-~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP-DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred chhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC-CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 999999999999999999999987776666655555432 11 12356889999999999999999999999999999
Q ss_pred cccCCCC
Q 007967 212 FKHAKPP 218 (583)
Q Consensus 212 Fk~~~~~ 218 (583)
|+.+..+
T Consensus 298 ik~i~~p 304 (1021)
T PTZ00266 298 IKNVGPP 304 (1021)
T ss_pred HhhcCCC
Confidence 9977654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=278.34 Aligned_cols=201 Identities=24% Similarity=0.463 Sum_probs=167.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+..|+||||+.+|+|.+++.......+++..+..++.||+.||+|||++|++||||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 134 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV 134 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 35689999999999999999999999999999999998776556789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.++|+|||++........ .......++..|+|||.+. ...++.++|||||||++|+|++ |..||......
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 135 LVSESLMCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred EecCCCcEEECCCccceecCCCce--eccCCCccceecCCHHHhc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 999999999999999875432111 1112234567899999987 5568899999999999999998 99999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..... +... ...+....++.++.+++.+||..+|++|||++++++
T Consensus 212 ~~~~~-~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 212 DVMSA-LQRG---YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHH-HHcC---CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 44333 3322 223334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=279.32 Aligned_cols=201 Identities=26% Similarity=0.469 Sum_probs=165.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNC 131 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceE
Confidence 46789999999999999999999999999999999988754 24689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||.++....... .......++..|+|||.+. +..++.++|||||||++|+|++ |..||......
T Consensus 132 li~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 208 (256)
T cd05113 132 LVDDQGCVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208 (256)
T ss_pred EEcCCCCEEECCCccceecCCCce--eecCCCccChhhCCHHHHh-cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 999999999999998875433211 1111234567899999987 4568999999999999999998 99999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
........... .......++.+++++.+||..+|.+|||+.+|+.+
T Consensus 209 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 209 ETVEKVSQGLR----LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 44433333221 12234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.35 Aligned_cols=208 Identities=31% Similarity=0.549 Sum_probs=177.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGF--EESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~--sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.|.|.|||++++++..++++-|.||-.+||+|.++++... +++ .|..+..+-+||++||.|||++.|||||||-+|
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDN 705 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDN 705 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCc
Confidence 46899999999999999999999999999999999998764 455 899999999999999999999999999999999
Q ss_pred EEEc-CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-CCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 80 ILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-GSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 80 ILld-~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|||+ ..|.+||+|||-++++..-. ....++.||+.|||||++.. .++|+.++|||||||++.||.||++||....
T Consensus 706 VLvNTySGvlKISDFGTsKRLAgin---P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 706 VLVNTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred EEEeeccceEEecccccchhhccCC---ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 9996 68999999999988764332 23356899999999999975 4589999999999999999999999997654
Q ss_pred hHH-HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 158 PMK-VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 158 ~~~-~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
... .++.. +-.....+.+..++.+++.||.+|+.+||.+||++.++|+.||++..+
T Consensus 783 spqAAMFkV---GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 783 SPQAAMFKV---GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred ChhHhhhhh---cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 322 22221 222233455678999999999999999999999999999999998763
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=283.54 Aligned_cols=202 Identities=21% Similarity=0.399 Sum_probs=165.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-----------QDGFEESAIGSILKETLKALDYLHRQG 69 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-----------~~~~sE~~i~~I~~QIl~gL~yLHs~g 69 (583)
|+.++||||++++++|...+.+|+||||+.+|+|.+++.... ...+++..+..++.||+.||+|||++|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 457899999999999999999999999999999999987532 124899999999999999999999999
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH- 148 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt- 148 (583)
++||||||+|||++.++.+||+|||++........ ........++..|+|||.+. ...++.++|||||||++|+|++
T Consensus 141 i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~t~ 218 (288)
T cd05093 141 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTY 218 (288)
T ss_pred eeecccCcceEEEccCCcEEeccCCccccccCCce-eecCCCCCccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875432211 11112345577899999987 5678999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 149 GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 149 G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|..||......+.......... ......++.++.+|+.+||+.||.+|||+.+++.
T Consensus 219 g~~p~~~~~~~~~~~~i~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 219 GKQPWYQLSNNEVIECITQGRV----LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCCHHHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999987665544433333221 1223457889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=285.74 Aligned_cols=209 Identities=41% Similarity=0.723 Sum_probs=173.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..++..|+||||+++++|.+++. ...+++..++.++.|++.||+|||++|++|+||+|+||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Ni 147 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI 147 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 356899999999999999999999999999999988764 35689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......|++.|+|||.+. ...++.++|+||+||++|+|++|..||.+.....
T Consensus 148 lv~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~ 223 (292)
T cd06657 148 LLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223 (292)
T ss_pred EECCCCCEEEcccccceeccccc---ccccccccCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999876442211 1123357899999999887 5668899999999999999999999998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.........+..+ .....++..+.+++.+||..+|.+||++.++++||||.....+
T Consensus 224 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 224 AMKMIRDNLPPKL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred HHHHHHhhCCccc--CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence 4333222222221 1224578889999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.24 Aligned_cols=202 Identities=21% Similarity=0.397 Sum_probs=163.3
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------------------------------
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-------------------------------------- 42 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-------------------------------------- 42 (583)
+.+ +|||||+++++|...+.+|+|||||.+|+|.+++....
T Consensus 96 ~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (374)
T cd05106 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSS 175 (374)
T ss_pred HhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccc
Confidence 345 89999999999999999999999999999999886432
Q ss_pred ------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEe
Q 007967 43 ------------------------------QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLAD 92 (583)
Q Consensus 43 ------------------------------~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~D 92 (583)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~D 255 (374)
T cd05106 176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICD 255 (374)
T ss_pred cccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEee
Confidence 12478889999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCC
Q 007967 93 FGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPP 171 (583)
Q Consensus 93 FGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~ 171 (583)
||+++....... ........+++.|+|||++. ...++.++|||||||++|+|++ |..||............+...
T Consensus 256 fGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-- 331 (374)
T cd05106 256 FGLARDIMNDSN-YVVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-- 331 (374)
T ss_pred ceeeeeccCCcc-eeeccCCCCccceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc--
Confidence 999875432211 11112234567799999987 5679999999999999999997 999998765544443444332
Q ss_pred CCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 172 GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 172 ~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
........++++++++|.+||+.||.+|||+.++++
T Consensus 332 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 332 -YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 122223456899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=282.21 Aligned_cols=203 Identities=24% Similarity=0.404 Sum_probs=164.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-----DGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-----~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++||||+++++++.+.+..|+||||+.||+|.+++..... ..+++..+..++.||+.||.|||++|++||||
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 142 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDI 142 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 3578999999999999999999999999999999999876532 24899999999999999999999999999999
Q ss_pred CCCcEEEcCCC---cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCC
Q 007967 76 KAGNILLDTNG---VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHA 151 (583)
Q Consensus 76 KPeNILld~~g---~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~ 151 (583)
||+|||++.++ .+||+|||+++....... ........++..|+|||++. +..++.++|||||||++|+|++ |..
T Consensus 143 kp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~ 220 (277)
T cd05036 143 AARNCLLTCKGPGRVAKIADFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYM 220 (277)
T ss_pred chheEEEeccCCCcceEeccCccccccCCccc-eecCCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCC
Confidence 99999998765 599999999875522211 11111233456799999997 5679999999999999999996 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
||.+....+........... ..+..++..+.+|+.+||+.+|.+|||+.++++|
T Consensus 221 pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 221 PYPGRTNQEVMEFVTGGGRL----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99887665544333332221 2235678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=284.01 Aligned_cols=210 Identities=30% Similarity=0.507 Sum_probs=170.9
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.+ +||||++++++|+.+..+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+|||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred hcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 45 6999999999999999999999999999999988753 56899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhhCCCCCCCCCh--
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSKYPP-- 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~-- 158 (583)
++.++.+||+|||++....... ........|+..|+|||.+... ..++.++|||||||++|+|++|..||.....
T Consensus 138 ~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 215 (290)
T cd05613 138 LDSNGHVVLTDFGLSKEFHEDE--VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215 (290)
T ss_pred ECCCCCEEEeeCccceeccccc--ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc
Confidence 9999999999999986542211 1122345789999999998742 3578899999999999999999999964322
Q ss_pred -HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCch
Q 007967 159 -MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 159 -~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~ 220 (583)
...+...+....+ +.+..++..+.+|+.+||..+|.+|| ++++++.||||....|...
T Consensus 216 ~~~~~~~~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 216 SQAEISRRILKSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred cHHHHHHHhhccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 1222222222221 22345788999999999999999997 8999999999999876443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.68 Aligned_cols=191 Identities=25% Similarity=0.313 Sum_probs=160.7
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
..||||+++++++.+...+|+||||+.||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~ 119 (237)
T cd05576 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119 (237)
T ss_pred cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc
Confidence 46999999999999999999999999999999988654 5699999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
.++.++++|||.+...... .....++..|+|||.+. ...++.++|+||+||++|+|++|..||......
T Consensus 120 ~~~~~~l~df~~~~~~~~~------~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---- 188 (237)
T cd05576 120 DRGHIQLTYFSRWSEVEDS------CDGEAVENMYCAPEVGG-ISEETEACDWWSLGAILFELLTGKTLVECHPSG---- 188 (237)
T ss_pred CCCCEEEecccchhccccc------cccCCcCccccCCcccC-CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----
Confidence 9999999999987543221 12245677899999986 567889999999999999999999988653321
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH-----HHHHhcccc
Q 007967 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA-----EKLLKHSFF 212 (583)
Q Consensus 164 ~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa-----~eIL~HpfF 212 (583)
+. . ......+..+++.++++|.+||+.||.+|+++ +++++||||
T Consensus 189 --~~-~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 189 --IN-T--HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred --cc-c--ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00 0 11112335678999999999999999999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=271.22 Aligned_cols=203 Identities=52% Similarity=0.908 Sum_probs=170.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..+...++||||+.|++|.+++... ...+++..+..++.|++.||.|||.+|++|+||+|+||
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni 129 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHE
Confidence 35678999999999999999999999999999999987653 25799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||.+........ .....|+..|+|||.+. ...++.++|+||||+++|+|++|..||.......
T Consensus 130 ~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 204 (253)
T cd05122 130 LLTSDGEVKLIDFGLSAQLSDTKA----RNTMVGTPYWMAPEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELPPMK 204 (253)
T ss_pred EEccCCeEEEeecccccccccccc----ccceecCCcccCHHHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999999999999998865432211 23467889999999987 4558899999999999999999999998865555
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hpf 211 (583)
............. .....++..+.++|.+||+.||.+|||+.++++|||
T Consensus 205 ~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 205 ALFKIATNGPPGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHhcCCCCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 4444433222222 222335889999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=276.00 Aligned_cols=201 Identities=23% Similarity=0.405 Sum_probs=161.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.....+|+||||+.+++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ni 125 (252)
T cd05084 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125 (252)
T ss_pred HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence 45789999999999999999999999999999999988643 34589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++..... +..........++..|+|||.+. +..++.++|||||||++|+|++ |..||......
T Consensus 126 l~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~ 203 (252)
T cd05084 126 LVTEKNVLKISDFGMSREEED-GVYASTGGMKQIPVKWTAPEALN-YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203 (252)
T ss_pred EEcCCCcEEECccccCccccc-ccccccCCCCCCceeecCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence 999999999999999864321 11110011112345699999987 5568999999999999999997 99999776654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.......... ....+..++..+.+|+.+||+.+|.+|||+.++++
T Consensus 204 ~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 204 QTREAIEQGV----RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHcCC----CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4332222221 12234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=283.02 Aligned_cols=202 Identities=22% Similarity=0.406 Sum_probs=165.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
|+.++||||+++++++......++||||+++++|.+++.... .+.+++..++.++.||+.||+|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999987532 134899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++|++||||||+|||++.++.++|+|||++........ ........++..|+|||.+. +..++.++|||||||++|+|
T Consensus 141 ~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el 218 (291)
T cd05094 141 SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEI 218 (291)
T ss_pred hCCeeecccCcceEEEccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhc-cCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999999865433211 11122345688899999987 56789999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
++ |..||......+... .+.... .......++..+.+++.+||+.+|.+|||+.++++
T Consensus 219 ~t~g~~p~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 219 FTYGKQPWFQLSNTEVIE-CITQGR---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCCCCCHHHHHH-HHhCCC---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 98 999997766544332 232221 11223457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=280.80 Aligned_cols=203 Identities=21% Similarity=0.383 Sum_probs=164.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------DGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|+.++||||+++++++.++...++||||+.+|+|.+++..... ..+++..+..++.|++.||.|||+.|++|
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH 142 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVH 142 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3568999999999999999999999999999999999865321 23577889999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHA 151 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~ 151 (583)
|||||+||+++.++.++|+|||++......... .......+++.|+|||.+. ...++.++|||||||++|+|++ |..
T Consensus 143 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~ 220 (277)
T cd05062 143 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQ 220 (277)
T ss_pred CCcchheEEEcCCCCEEECCCCCccccCCccee-ecCCCCccCHhhcChhHhh-cCCcCchhHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999998654322111 1111235577899999987 5678999999999999999998 789
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
||.+................ .....++..+++++.+||+.+|.+|||+.+++++
T Consensus 221 p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 221 PYQGMSNEQVLRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCHHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99887665444333333221 2234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=277.57 Aligned_cols=205 Identities=24% Similarity=0.349 Sum_probs=166.1
Q ss_pred CCCCCCcccceEEEEEECCE-----EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSN-----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~-----l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++||||++++++|.+.+. +|+||||+. ++|.+++.......+++..++.++.||+.||.|||++|++|+||+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~ 134 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLK 134 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 34679999999999998877 999999996 579888876544569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+||+++.++.+||+|||++....... ......++..|+|||.+. +..++.++|||||||++|+|++|.+||.+.
T Consensus 135 ~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 135 PQNILVTSDGQVKIADFGLARIYSFEM----ALTSVVVTLWYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred hhhEEEccCCCEEEeccCcceeccCCc----ccccccccccccChHHhc-cCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 999999999999999999886542221 112345788999999997 567899999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCC---------------CC-------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 157 PPMKVLLMTIQNAPPG---------------LD-------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~---------------~~-------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
...+.+...+...... +. ......++..+.++|.+||+.||.+||++.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 210 SEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 6655444333311100 00 00012356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=276.82 Aligned_cols=200 Identities=22% Similarity=0.394 Sum_probs=167.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+....|+||||+++|+|.+++.......+++..+..++.||+.||.|||++|++||||||+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~ni 135 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNI 135 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceE
Confidence 46789999999999999999999999999999999998765556689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++....... .......++..|+|||.+. ...++.++|||||||++|+|++ |..||......
T Consensus 136 lv~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 136 LVGEDLVCKVADFGLARLIKEDV---YLSSDKKIPYKWTAPEAAS-HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred EEcCCceEEEccccchhhcCCcc---ccccCCCCceEecCHHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999986542211 1112334567899999987 5678899999999999999998 89999886655
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+........ ...+....++..+.++|.+||+.+|.+|||+.+|++
T Consensus 212 ~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 212 EVYDQITAG----YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHhC----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 544433322 222334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=280.91 Aligned_cols=204 Identities=35% Similarity=0.619 Sum_probs=168.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNI 80 (583)
+.++||||+++++++.....+|+||||+++|+|.+++.. .+.+++..+..++.+++.||.|||+ +|++||||||+||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ni 135 (284)
T cd06620 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNI 135 (284)
T ss_pred HHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHE
Confidence 467999999999999999999999999999999988765 3568999999999999999999997 6999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH-
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM- 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~- 159 (583)
+++.++.++|+|||++...... ......|+..|+|||.+. ...++.++|||||||++|+|++|..||......
T Consensus 136 l~~~~~~~~l~d~gl~~~~~~~-----~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 209 (284)
T cd06620 136 LVNSRGQIKLCDFGVSGELINS-----IADTFVGTSTYMSPERIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209 (284)
T ss_pred EECCCCcEEEccCCcccchhhh-----ccCccccCcccCCHHHHc-cCCCCccchHHHHHHHHHHHHhCCCCCcccchhh
Confidence 9999999999999987644221 112457899999999987 457889999999999999999999999764431
Q ss_pred ----------HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 160 ----------KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 160 ----------~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+.....+....+.+. ...++..+.+||.+||++||.+|||+.++++|+||....
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 210 DGQDDPMGILDLLQQIVQEPPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhhhhhhHHHHHHHHHhhccCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 111122222112111 123778899999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=276.86 Aligned_cols=200 Identities=22% Similarity=0.390 Sum_probs=162.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++. ....++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||.||
T Consensus 50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~ni 126 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNV 126 (257)
T ss_pred HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhE
Confidence 35689999999999885 4577999999999999998865 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++.................++..|+|||.+. ...++.++|||||||++|||++ |..||......
T Consensus 127 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 205 (257)
T cd05116 127 LLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205 (257)
T ss_pred EEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999875533221111112234467899999987 5678899999999999999997 99999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.. ..+.... ..+.+..++.++.++|.+||+.||.+||++.+|..
T Consensus 206 ~~~-~~i~~~~---~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 206 EVT-QMIESGE---RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHH-HHHHCCC---CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 443 3333321 12234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=297.21 Aligned_cols=202 Identities=22% Similarity=0.395 Sum_probs=164.0
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh---------------------------------------
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------------------------------- 42 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------------------------------- 42 (583)
.+ +||||++++++|.+.+..|+|||||+||+|.+++....
T Consensus 94 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (375)
T cd05104 94 YLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKP 173 (375)
T ss_pred HhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCC
Confidence 45 89999999999999999999999999999999886431
Q ss_pred ----------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcE
Q 007967 43 ----------------------------------QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVV 88 (583)
Q Consensus 43 ----------------------------------~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~I 88 (583)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~ 253 (375)
T cd05104 174 GVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253 (375)
T ss_pred CcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcE
Confidence 1147888999999999999999999999999999999999999999
Q ss_pred EEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHHHHHHHHh
Q 007967 89 KLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQ 167 (583)
Q Consensus 89 KL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~~l~~~i~ 167 (583)
||+|||+++....... ........++..|+|||++. ...++.++|||||||++|+|++ |..||............+.
T Consensus 254 kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~ 331 (375)
T cd05104 254 KICDFGLARDIRNDSN-YVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331 (375)
T ss_pred EEecCccceeccCccc-ccccCCCCCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH
Confidence 9999999875432211 11112234567799999997 5679999999999999999997 9999987665555544444
Q ss_pred cCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 168 ~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
... ....+...+.++++||.+||+.||.+|||+.+|++.
T Consensus 332 ~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 332 EGY---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred hCc---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 432 112234467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.33 Aligned_cols=215 Identities=26% Similarity=0.369 Sum_probs=171.7
Q ss_pred CCCCCCCcccceEEEEEECC-----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~-----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++||||+++++++.+.. .+|+||||+. ++|..++.. ...+++..++.++.||+.||+|||++||+||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dl 129 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDL 129 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 35679999999999998875 7999999997 578887754 347999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.++|+|||++.................++.+|+|||.+.....++.++|+|||||++|+|++|.+||.+
T Consensus 130 kp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 130 KPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred CHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 99999999999999999999875533221111223457899999999998544889999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCC-------------------------C-ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQNAPPGL-------------------------D-YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~-------------------------~-~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
....+....+........ . ......++..+.+||.+||+++|.+|||++++++|
T Consensus 210 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 210 RDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 765544333222110000 0 00113467889999999999999999999999999
Q ss_pred cccccCCCC
Q 007967 210 SFFKHAKPP 218 (583)
Q Consensus 210 pfFk~~~~~ 218 (583)
|||+....+
T Consensus 290 ~~~~~~~~~ 298 (330)
T cd07834 290 PYLAQLHDP 298 (330)
T ss_pred ccHHhhccc
Confidence 999977644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=271.66 Aligned_cols=201 Identities=39% Similarity=0.704 Sum_probs=172.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.++...|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~ 131 (254)
T cd06627 54 KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL 131 (254)
T ss_pred HhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEE
Confidence 5679999999999999999999999999999999988754 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||++........ ......++..|+|||.+. ...++.++|||++|+++|+|++|..||........
T Consensus 132 i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~ 207 (254)
T cd06627 132 TTKDGVVKLADFGVATKLNDVSK---DDASVVGTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA 207 (254)
T ss_pred ECCCCCEEEeccccceecCCCcc---cccccccchhhcCHhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 99999999999999875532221 123457889999999987 44588999999999999999999999987765555
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.......... ..+..++..++++|.+||..+|++|||+.+++.||||
T Consensus 208 ~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 208 LFRIVQDDHP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHhccCCC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 5444433222 2335678999999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=280.09 Aligned_cols=203 Identities=19% Similarity=0.405 Sum_probs=165.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY---------------QDGFEESAIGSILKETLKALDYL 65 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~---------------~~~~sE~~i~~I~~QIl~gL~yL 65 (583)
|+.++||||+++++++..++..|+||||+.+|+|.+++.... ...+++..+..++.||+.||.||
T Consensus 61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999999999999999999999886432 12478899999999999999999
Q ss_pred HHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhh
Q 007967 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE 145 (583)
Q Consensus 66 Hs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILye 145 (583)
|++|++||||||+|||++.++.+||+|||++........ ........++..|+|||.+. +..++.++|||||||++|+
T Consensus 141 H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~e 218 (283)
T cd05090 141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWE 218 (283)
T ss_pred HhcCeehhccccceEEEcCCCcEEeccccccccccCCcc-eecccCCCccceecChHHhc-cCCCCchhhhHHHHHHHHH
Confidence 999999999999999999999999999999875533221 11223345677899999987 4568999999999999999
Q ss_pred hhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 146 LAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 146 LLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|++ |..||.+....... ..+.... ....+..++..+++++.+||+.||.+||++.+|+++
T Consensus 219 l~~~g~~p~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 219 IFSFGLQPYYGFSNQEVI-EMVRKRQ---LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCCCCCCCCCHHHHH-HHHHcCC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 998 99999876553333 3333221 122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=279.57 Aligned_cols=195 Identities=24% Similarity=0.389 Sum_probs=158.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++..+...++||||+++|+|..++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 136 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNI 136 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccE
Confidence 35689999999999999999999999999999998876543 35689999999999999999999999999999999999
Q ss_pred EEcCCCc-------EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh-hCCCC
Q 007967 81 LLDTNGV-------VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAP 152 (583)
Q Consensus 81 Lld~~g~-------IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL-tG~~P 152 (583)
|++.++. ++++|||++..... .....++..|+|||.+.....++.++|||||||++|+|+ .|..|
T Consensus 137 ll~~~~~~~~~~~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (262)
T cd05077 137 LLAREGIDGECGPFIKLSDPGIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209 (262)
T ss_pred EEecCCccCCCCceeEeCCCCCCccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 9987664 89999998754321 123567889999999875677899999999999999998 58899
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|......+.. ...... .......+.++++||.+||+.||.+||++.+|+++
T Consensus 210 ~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 210 LKDKTLAEKE--RFYEGQ----CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCcchhHHH--HHHhcC----ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 8765433221 111111 11123456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=280.91 Aligned_cols=202 Identities=23% Similarity=0.459 Sum_probs=163.9
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA--------------YQDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~--------------~~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
+.+ +||||++++++|..++.+|+||||+.+|+|.+++... ....+++..+..++.||+.||.|||
T Consensus 70 ~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred HhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 345 7999999999999999999999999999999998652 1345899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++||+||||||+|||++.++.+||+|||+++....... ........++..|+|||.+. ...++.++|||||||++|+|
T Consensus 150 ~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el 227 (293)
T cd05053 150 SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEI 227 (293)
T ss_pred HCCccccccceeeEEEcCCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhc-cCCcCcccceeehhhHHHHH
Confidence 99999999999999999999999999999875432211 11112233467799999987 56789999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+....+.. ..+.... ....+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 228 ~~~g~~p~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 228 FTLGGSPYPGIPVEELF-KLLKEGY---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred hcCCCCCCCCCCHHHHH-HHHHcCC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 97 99999876654433 3332221 122334678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=276.16 Aligned_cols=201 Identities=26% Similarity=0.503 Sum_probs=164.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++...+..|+||||++|++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNC 131 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhE
Confidence 35689999999999999999999999999999999988754 34689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||+++...... ........++..|+|||.+. ...++.++|||||||++|+|++ |..||......
T Consensus 132 ~i~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 132 LVGEDNVVKVSDFGLARYVLDDQ--YTSSQGTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred EECCCCcEEECCcccceeccccc--ccccCCCCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 99999999999999986543211 11111123345799999987 5678999999999999999998 89999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+... .+... .....+..++..+.+++.+||..+|.+|||+.++++.
T Consensus 209 ~~~~-~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 209 EVVE-SVSAG---YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHH-HHHcC---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 4433 33322 2223345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=278.17 Aligned_cols=202 Identities=24% Similarity=0.398 Sum_probs=165.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------DGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|+.++||||+++++++.....+|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||++|++|
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 142 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH 142 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3567999999999999999999999999999999999865321 23688899999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHA 151 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~ 151 (583)
|||||+|||++.++.+||+|||+++........ .......++..|+|||.+. ...++.++|||||||++|+|++ |..
T Consensus 143 ~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~ 220 (277)
T cd05032 143 RDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQ 220 (277)
T ss_pred cccChheEEEcCCCCEEECCcccchhhccCccc-ccCCCCCccccccCHHHHh-cCCCCcccchHHHHHHHHHhhccCCC
Confidence 999999999999999999999998755332211 1122345678899999987 5568999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
||.+........ .+.... ....+..++..+.++|.+||+.+|.+|||+.+++.
T Consensus 221 p~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 221 PYQGLSNEEVLK-FVIDGG---HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCccCCHHHHHH-HHhcCC---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 998766544433 333211 12233456899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=277.00 Aligned_cols=201 Identities=23% Similarity=0.403 Sum_probs=162.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++++ ...+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 49 l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 126 (257)
T cd05115 49 MHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNV 126 (257)
T ss_pred HHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheE
Confidence 45789999999999886 45789999999999999987643 45689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++.................++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....
T Consensus 127 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 127 LLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred EEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHc-cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 999999999999999864422211111111223357899999987 5568999999999999999996 99999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.......... ...+...++++.++|.+||..+|.+||++.+|++
T Consensus 206 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 206 EVMSFIEQGKR----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHCCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 54433333222 1233567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.60 Aligned_cols=203 Identities=30% Similarity=0.523 Sum_probs=172.7
Q ss_pred CCCCCCCcccceEEEEEECCE--EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSN--LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG--HIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~--l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHRDLK 76 (583)
|+.|.|||||++|.+|.+..+ +.+|+|+|..|+|+.|+++. +.++...++.|++||++||.|||++. |||||||
T Consensus 95 LKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLK 172 (632)
T KOG0584|consen 95 LKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLK 172 (632)
T ss_pred HccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccc
Confidence 578999999999999998765 99999999999999998876 67888999999999999999999995 9999999
Q ss_pred CCcEEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 77 AGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 77 PeNILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
.+||||+. -|.|||+|+|+|+..... .....+|||.|||||++. ..|+..+||||||+++.||+|+..||..
T Consensus 173 CDNIFinG~~G~VKIGDLGLAtl~r~s-----~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 173 CDNIFVNGNLGEVKIGDLGLATLLRKS-----HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred cceEEEcCCcCceeecchhHHHHhhcc-----ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 99999975 589999999999866322 122369999999999997 7899999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.....++...+..+.....+. +--.+++++||.+||.. .+.|+|+.|+|+||||...
T Consensus 246 C~n~AQIYKKV~SGiKP~sl~--kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 246 CTNPAQIYKKVTSGIKPAALS--KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred hCCHHHHHHHHHcCCCHHHhh--ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 766666655554433221111 12267899999999999 9999999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=287.83 Aligned_cols=215 Identities=26% Similarity=0.368 Sum_probs=171.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|..++.+|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~ni 150 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANI 150 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHe
Confidence 356899999999999999999999999996 688888764 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCC-----------CCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTG-----------DRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~-----------~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
+++.++.++|+|||++....... ..........+++.|+|||.+.+...++.++|||||||++|+|++|
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 151 FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred EECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999986543111 0011112345688999999997555689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcC--CCCCCc---------------------cccccchHHHHHHHHhhhcCCCCCCCCHHHH
Q 007967 150 HAPFSKYPPMKVLLMTIQNA--PPGLDY---------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~--~~~~~~---------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eI 206 (583)
.+||.+....+.+....... +....+ ......+..+.++|.+||+.+|.+|||++++
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 99998876655443332211 100000 0012457889999999999999999999999
Q ss_pred HhccccccCCCC
Q 007967 207 LKHSFFKHAKPP 218 (583)
Q Consensus 207 L~HpfFk~~~~~ 218 (583)
|.||||+.....
T Consensus 311 l~~~~~~~~~~~ 322 (335)
T PTZ00024 311 LKHEYFKSDPLP 322 (335)
T ss_pred hcCcccCCCCCC
Confidence 999999876543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=282.98 Aligned_cols=206 Identities=39% Similarity=0.729 Sum_probs=171.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+....|+|||||. |++.+++... ...+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ni 152 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 152 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhE
Confidence 356899999999999999999999999995 6777776543 35689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+++.++.+||+|||++.... ......|+..|+|||.+.. ...++.++|||||||++|+|++|..||.....
T Consensus 153 li~~~~~~kL~dfg~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~ 225 (313)
T cd06633 153 LLTEPGQVKLADFGSASKSS-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225 (313)
T ss_pred EECCCCCEEEeecCCCcccC-------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999875321 1234678999999999842 34588899999999999999999999988766
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
............+.. ....++..+++||.+||+++|.+||++.++++||||...+..
T Consensus 226 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 226 MSALYHIAQNDSPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred HHHHHHHHhcCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence 665554444433222 234567889999999999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=282.14 Aligned_cols=217 Identities=30% Similarity=0.493 Sum_probs=173.6
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.+ +||||++++++|..+..+|+||||+.+|+|..++.. ...+++..++.++.|++.||.|||+.|++||||+|.||+
T Consensus 60 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred hccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 44 699999999999999999999999999999988765 356899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC-CCCccccccchhhHHhhhhhCCCCCCCCCh--
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS-GYNSKADIWSFGITALELAHGHAPFSKYPP-- 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~-~ys~ksDIWSLGvILyeLLtG~~PF~~~~~-- 158 (583)
++.++.++|+|||++......... ......|+..|+|||.+.... .++.++||||||+++|+|++|..||.....
T Consensus 138 ~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 215 (288)
T cd05583 138 LDSEGHVVLTDFGLSKEFLAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN 215 (288)
T ss_pred ECCCCCEEEEECcccccccccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc
Confidence 999999999999998654332211 122356899999999987432 378899999999999999999999964322
Q ss_pred -HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC---HHHHHhccccccCCCCchhhhhhhc
Q 007967 159 -MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT---AEKLLKHSFFKHAKPPELSVKKLFA 227 (583)
Q Consensus 159 -~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT---a~eIL~HpfFk~~~~~~~~~~~~~~ 227 (583)
...+...+.... ...+..++..++++|.+||+.+|++||| +.++|+||||+...|..+......+
T Consensus 216 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 284 (288)
T cd05583 216 SQSEISRRILKSK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPA 284 (288)
T ss_pred hHHHHHHHHHccC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhccCC
Confidence 122222222221 2233457889999999999999999998 5778999999999886665444433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=274.02 Aligned_cols=200 Identities=25% Similarity=0.422 Sum_probs=162.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++. ...+++||||+.+|+|.+++... ..+++..+..++.|++.||+|||.+|++||||||+||
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~ni 126 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNV 126 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceE
Confidence 45789999999999876 45689999999999999998754 4699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++................++..|+|||.+. ...++.++|||||||++|+|++ |..||......
T Consensus 127 li~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 127 LLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN-YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred EEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhc-CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999999999875533222111111123356799999987 5678999999999999999997 99999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.. ..+.... ....+..++..++++|.+||..+|.+||++.++++
T Consensus 206 ~~~-~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 206 EVI-AMLESGE---RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHH-HHHHcCC---cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 433 3333221 12334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=279.08 Aligned_cols=206 Identities=30% Similarity=0.469 Sum_probs=167.3
Q ss_pred CCCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.+. ||||++++++|.+++..|+||||+ +|+|.+++.......+++..+..++.||+.+|.|||++|++|+||+|+||
T Consensus 52 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni 130 (283)
T cd07830 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENL 130 (283)
T ss_pred HhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence 3566 999999999999999999999999 88999888765445789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... ......++..|+|||++.....++.++|+||||+++|+|++|.+||......+
T Consensus 131 ~i~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~ 206 (283)
T cd07830 131 LVSGPEVVKIADFGLAREIRSRP----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206 (283)
T ss_pred EEcCCCCEEEeecccceeccCCC----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence 99999999999999986543221 11235688999999998756678999999999999999999999998766544
Q ss_pred HHHHHHhcCCCC------------------CC-------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPG------------------LD-------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~------------------~~-------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
............ +. .......+..+++||.+||+.+|.+|||+.+++.||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 443322211000 00 00011235789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=274.79 Aligned_cols=201 Identities=26% Similarity=0.427 Sum_probs=165.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++...+.+|+||||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 134 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNV 134 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceE
Confidence 35689999999999999999999999999999999998765445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||++....... .........+..|+|||.+. ...++.++|||||||++|+|++ |+.||.+....
T Consensus 135 l~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 135 LVGENNICKVADFGLARVIKEDI--YEAREGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred EEcCCCCEEECCcceEEEccCCc--ccccCCCcCceeccCccccc-cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999987553211 11111122345799999987 5678999999999999999998 99999886654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.......... .......++..+.+++.+||+.+|.+||++.++++
T Consensus 212 ~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 212 EVLQQVDQGY----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHcCC----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 4443332221 12233567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=277.31 Aligned_cols=202 Identities=28% Similarity=0.534 Sum_probs=168.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||+++++++.+....++||||+.+++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~n 136 (260)
T cd08222 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKN 136 (260)
T ss_pred HhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhh
Confidence 5679999999999999999999999999999999888642 23569999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|+++. +.++|+|||++........ ......|++.|+|||.+. ...++.++|+||||+++|+|++|..||......
T Consensus 137 ili~~-~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~ 211 (260)
T cd08222 137 IFLKN-NLLKIGDFGVSRLLMGSCD---LATTFTGTPYYMSPEALK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL 211 (260)
T ss_pred eEeec-CCEeecccCceeecCCCcc---cccCCCCCcCccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 99975 6799999998865533221 123456889999999986 567888999999999999999999999876554
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
...........+. .+..++.++.++|.+||..+|.+||++.++++||||
T Consensus 212 ~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 212 SVVLRIVEGPTPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHcCCCCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 4443333332222 235678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=275.96 Aligned_cols=206 Identities=22% Similarity=0.370 Sum_probs=162.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ---DGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~---~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
|+.++||||+++++++.+...+|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++|++||||||
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp 128 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLAL 128 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCc
Confidence 3578999999999999999999999999999999999875422 2467788889999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC------CCCCccccccchhhHHhhhhh-CC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG------SGYNSKADIWSFGITALELAH-GH 150 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~------~~ys~ksDIWSLGvILyeLLt-G~ 150 (583)
+||+++.++.+||+|||++....... .........|+..|+|||++... ..++.++|||||||++|+|++ |.
T Consensus 129 ~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~ 207 (269)
T cd05087 129 RNCLLTADLTVKIGDYGLSHNKYKED-YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207 (269)
T ss_pred ceEEEcCCCcEEECCccccccccCcc-eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence 99999999999999999886432221 11112235678889999998632 236789999999999999996 99
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCccc-cccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 151 APFSKYPPMKVLLMTIQNAPPGLDYDR-DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 151 ~PF~~~~~~~~l~~~i~~~~~~~~~~~-~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.||......+.....+.........+. ...+++.+++++..|+ .+|.+|||+++|+.
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 208 QPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 999876665544443433322222111 2346788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=274.52 Aligned_cols=202 Identities=25% Similarity=0.456 Sum_probs=165.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++..++.+|+||||+.+|+|.+++... .+.+++..+..++.|++.||.|||++||+|+||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 35789999999999999999999999999999999998654 34789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.++|+|||++......... .......+++.|+|||.+. ...++.++|||||||++|+|++ |..||......
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~ 215 (266)
T cd05033 138 LVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215 (266)
T ss_pred EEcCCCCEEECccchhhcccccccc-eeccCCCCCccccChhhhc-cCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence 9999999999999998765311111 1111234567899999987 5678999999999999999997 99999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.... .+... ...+....++..+.+|+.+||+.+|.+||++.+++++
T Consensus 216 ~~~~-~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 216 DVIK-AVEDG---YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHH-HHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4433 33222 1112234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=278.59 Aligned_cols=202 Identities=20% Similarity=0.392 Sum_probs=165.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-------------DGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-------------~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
|+.++||||+++++++.+.+..|+||||+.+|+|.+++..... ..+++..+..++.||+.||+|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999999999999999999875422 348899999999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
+|++||||||+|||++.++.+||+|||++....... .........+++.|+|||.+. +..++.++|||||||++|+|+
T Consensus 141 ~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~ 218 (280)
T cd05092 141 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218 (280)
T ss_pred CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCc-eeecCCCccccccccCHHHhc-cCCcCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999986543221 111122334578899999987 567899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 148 H-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 148 t-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+ |.+||................. ...+..+++.+.+||.+||+.||.+||++.+|+.
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 219 TYGKQPWYQLSNTEAIECITQGRE----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCCCCCccCCHHHHHHHHHcCcc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8 9999977665554433333322 2233567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=275.42 Aligned_cols=195 Identities=23% Similarity=0.343 Sum_probs=159.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++..+...++|||||.+|+|..++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~ni 131 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNV 131 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 35689999999999999999999999999999999988754 23689999999999999999999999999999999999
Q ss_pred EEcCCCc--------EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC-CC
Q 007967 81 LLDTNGV--------VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG-HA 151 (583)
Q Consensus 81 Lld~~g~--------IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG-~~ 151 (583)
|++.++. ++++|||++..... .....+++.|+|||.+.....++.++|||||||++|+|++| .+
T Consensus 132 li~~~~~~~~~~~~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~ 204 (258)
T cd05078 132 LLIREEDRKTGNPPFIKLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK 204 (258)
T ss_pred EEecccccccCCCceEEecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9987764 69999998754321 12356888999999998556789999999999999999998 56
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
||.......... ... .... .+...+.++.+||.+||+.+|.+|||+.+|++.
T Consensus 205 ~~~~~~~~~~~~-~~~-~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 205 PLSALDSQKKLQ-FYE-DRHQ----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ChhhccHHHHHH-HHH-cccc----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 766554433221 122 1111 223456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=291.06 Aligned_cols=212 Identities=20% Similarity=0.364 Sum_probs=165.0
Q ss_pred CCCCCCCcccceEEEEEEC--------------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVD--------------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--------------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
|+.++||||+++++++... ..+|+||||+. ++|.+++. .+.+++..++.++.||+.||.|||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH 131 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIH 131 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4578999999999877654 36899999996 58887764 356999999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhh
Q 007967 67 RQGHIHRDVKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE 145 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILye 145 (583)
++||+||||||+||+++. ++.+||+|||++.................|+..|+|||.+.....++.++|||||||++|+
T Consensus 132 ~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 211 (342)
T cd07854 132 SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 211 (342)
T ss_pred hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHH
Confidence 999999999999999974 5578999999986542211111111234678899999988755678899999999999999
Q ss_pred hhhCCCCCCCCChHHHHHHHHhcCCCCCC----------------------c---cccccchHHHHHHHHhhhcCCCCCC
Q 007967 146 LAHGHAPFSKYPPMKVLLMTIQNAPPGLD----------------------Y---DRDKKFSKSFKEMVAMCLVKDQTKR 200 (583)
Q Consensus 146 LLtG~~PF~~~~~~~~l~~~i~~~~~~~~----------------------~---~~~~~~S~~lkdLI~~cL~~DP~kR 200 (583)
|++|..||.+..+.......+...+.... . .....++.++++||.+||+.||.+|
T Consensus 212 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 291 (342)
T cd07854 212 MLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDR 291 (342)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhc
Confidence 99999999877665544433322111000 0 0013467889999999999999999
Q ss_pred CCHHHHHhccccccCC
Q 007967 201 PTAEKLLKHSFFKHAK 216 (583)
Q Consensus 201 pTa~eIL~HpfFk~~~ 216 (583)
||+.++++||||+...
T Consensus 292 ~t~~ell~h~~~~~~~ 307 (342)
T cd07854 292 LTAEEALMHPYMSCYS 307 (342)
T ss_pred cCHHHHhCCCcccccc
Confidence 9999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=279.15 Aligned_cols=203 Identities=29% Similarity=0.556 Sum_probs=170.3
Q ss_pred CCCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.+. ||||++++++|.+++.+++||||+.+++|.+++... +.+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus 56 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni 133 (280)
T cd05581 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENI 133 (280)
T ss_pred HhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 3566 999999999999999999999999999999988763 5799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCC-----------------ccccccccCCCCCCCcccccCCCCCCccccccchhhHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDR-----------------QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITA 143 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~-----------------~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvIL 143 (583)
+++.++.++|+|||++......... ........|+..|+|||.+. ...++.++|+|||||++
T Consensus 134 ~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l 212 (280)
T cd05581 134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCII 212 (280)
T ss_pred EECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHH
Confidence 9999999999999998654322210 12223457889999999987 45688899999999999
Q ss_pred hhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH----HHHHhcccc
Q 007967 144 LELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA----EKLLKHSFF 212 (583)
Q Consensus 144 yeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa----~eIL~HpfF 212 (583)
|+|++|..||............. . ..+..+..+++.+.+||.+||+.+|.+|||+ +++++||||
T Consensus 213 ~~l~~g~~p~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 213 YQMLTGKPPFRGSNEYLTFQKIL-K----LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHhCCCCCCCccHHHHHHHHH-h----cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 99999999998766444332222 2 1223345678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.32 Aligned_cols=217 Identities=28% Similarity=0.412 Sum_probs=173.8
Q ss_pred CCCCCCcccceEEEEEE-CCEEEEEEecCCCCCHHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAY---QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~---~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
+.|+|||||.|..+|.. +..+|+|+||.+ -+|+++|+... .+.++...++.|+.||+.|+.|||++-|+||||||
T Consensus 82 REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 82 RELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred HHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 56899999999999988 788999999985 67888887643 24589999999999999999999999999999999
Q ss_pred CcEEEcCC----CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 78 GNILLDTN----GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 78 eNILld~~----g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
.|||+..+ |.|||+|||+++.+..+-.+.......+-|.||+|||++.+...|+.+.|||++|||+.||++-.+.|
T Consensus 161 aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 161 ANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 99999887 89999999999877655444444556688999999999999999999999999999999999999988
Q ss_pred CCCCh---------HHHHHHHH--hcCCCCCCcccc------------------------------ccchHHHHHHHHhh
Q 007967 154 SKYPP---------MKVLLMTI--QNAPPGLDYDRD------------------------------KKFSKSFKEMVAMC 192 (583)
Q Consensus 154 ~~~~~---------~~~l~~~i--~~~~~~~~~~~~------------------------------~~~S~~lkdLI~~c 192 (583)
.+... .+++..++ .+.+..-+|+.. +.-++...+|+.+|
T Consensus 241 ~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~kl 320 (438)
T KOG0666|consen 241 KGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKL 320 (438)
T ss_pred cchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHH
Confidence 65321 11121111 111111111111 11234578999999
Q ss_pred hcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 193 LVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 193 L~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
|++||.+|.|++++|+|+||...+.+.
T Consensus 321 L~yDP~kRIta~qAleh~yF~~d~lpp 347 (438)
T KOG0666|consen 321 LTYDPIKRITAEQALEHPYFTEDPLPP 347 (438)
T ss_pred hccCchhhccHHHHhcccccccCCCCC
Confidence 999999999999999999999886553
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=279.00 Aligned_cols=207 Identities=32% Similarity=0.483 Sum_probs=167.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++..+|+||||+.+ +|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni 129 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHE
Confidence 3567899999999999999999999999964 888877653 35799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||.+....... .......++..|+|||.+.....++.++|+||+||++|+|++|+.||.+....+
T Consensus 130 li~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~ 206 (283)
T cd05118 130 LINTEGVLKLADFGLARSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID 206 (283)
T ss_pred EECCCCcEEEeeeeeeEecCCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999886553322 112234678899999998755478999999999999999999999998766554
Q ss_pred HHHHHHhcCCCCC----------------C---------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 161 VLLMTIQNAPPGL----------------D---------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~----------------~---------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
.+........... . ......++..+++||.+||.+||.+||++.+++.||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 207 QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 4333222110000 0 00123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=273.86 Aligned_cols=203 Identities=25% Similarity=0.422 Sum_probs=164.0
Q ss_pred CCCCCCCcccceEEEEEECCE------EEEEEecCCCCCHHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSN------LWVVMPFMAEGSCLHLMKIAY----QDGFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~------l~LVmEy~~GGsL~dll~~~~----~~~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
|+.++||||+++++++..... .++||||+.+|+|..++.... ...+++..+..++.||+.||.|||++|+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i 134 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF 134 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 356899999999998876554 899999999999998875532 2358999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-C
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-G 149 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G 149 (583)
+||||||+||+++.++.+||+|||+++........ .......++..|+|||.+. ...++.++|||||||++|||++ |
T Consensus 135 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred eccccchheEEECCCCeEEECCccceeeccccccc-cccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCC
Confidence 99999999999999999999999998755332211 1112234567899999986 5678999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
..||.+....+.......... ...+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 213 QTPYPGVENHEIYDYLRHGNR----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCCCHHHHHHHHHcCCC----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999987665554433333222 22345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.88 Aligned_cols=204 Identities=25% Similarity=0.465 Sum_probs=161.4
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|... ..+|+|||||. ++|.+.+.. .+++..+..++.||+.||+|||++||+|||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRD 143 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 4578999999999998754 35799999995 578777653 389999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.++.+||+|||++...... .......+++.|+|||.+. +..++.++|||||||++|+|++|+.||.
T Consensus 144 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 144 LKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCHHHEEECCCCCEEEccCccceeCCCC----CCCCCCcccccccCHHHHh-CCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999998654221 1123457889999999997 5679999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCC---------------------CCC------------Cc-----cccccchHHHHHHHHhhhcCC
Q 007967 155 KYPPMKVLLMTIQNAP---------------------PGL------------DY-----DRDKKFSKSFKEMVAMCLVKD 196 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~---------------------~~~------------~~-----~~~~~~S~~lkdLI~~cL~~D 196 (583)
..+........+.... +.. .+ ......++.+++||.+||+.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 298 (353)
T cd07850 219 GTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298 (353)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCC
Confidence 7654333222211000 000 00 001234667899999999999
Q ss_pred CCCCCCHHHHHhcccccc
Q 007967 197 QTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 197 P~kRpTa~eIL~HpfFk~ 214 (583)
|.+|||+.++|+||||+.
T Consensus 299 P~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 299 PEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhCcCHHHHhcChhHhh
Confidence 999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=281.48 Aligned_cols=207 Identities=40% Similarity=0.720 Sum_probs=171.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++...+..|+||||+. |++.+++... ...+++..+..++.|++.||.|||++|++||||+|.||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 146 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence 356899999999999999999999999996 6787776543 35689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+++.++.++|+|||++..... .....|++.|+|||.+.. ...++.++|||||||++|+|++|..||.....
T Consensus 147 l~~~~~~~kl~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 147 LLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred EECCCCcEEECCcccceeecC-------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 999999999999998764321 123578899999999752 34578899999999999999999999987665
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
............+. .....++..+++||.+||.++|.+||++.++++|||+.....+.
T Consensus 220 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~ 277 (308)
T cd06634 220 MSALYHIAQNESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277 (308)
T ss_pred HHHHHHHhhcCCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCChh
Confidence 55444444433222 12346788999999999999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=282.32 Aligned_cols=210 Identities=27% Similarity=0.427 Sum_probs=162.6
Q ss_pred CCCCCCCcccceEEEEEEC--------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVVD--------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|+.++||||+++++++.+. ..+|+||||+.+ ++...+... ...+++..+..++.||++||.|||++|++|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H 138 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILH 138 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3568999999999988643 357999999964 566655432 356999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCCc--------cccccccCCCCCCCcccccCCCCCCccccccchhhHHh
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ--------RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITAL 144 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~--------~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILy 144 (583)
|||||+|||++.++.++|+|||++.......... .......|++.|+|||.+.+...++.++|||||||++|
T Consensus 139 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~ 218 (311)
T cd07866 139 RDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFA 218 (311)
T ss_pred CCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHH
Confidence 9999999999999999999999986543221110 11123467889999999875567899999999999999
Q ss_pred hhhhCCCCCCCCChHHHHHHHHhcCC--CCCC------------------c-----cccccchHHHHHHHHhhhcCCCCC
Q 007967 145 ELAHGHAPFSKYPPMKVLLMTIQNAP--PGLD------------------Y-----DRDKKFSKSFKEMVAMCLVKDQTK 199 (583)
Q Consensus 145 eLLtG~~PF~~~~~~~~l~~~i~~~~--~~~~------------------~-----~~~~~~S~~lkdLI~~cL~~DP~k 199 (583)
+|++|.+||.+............... .... . .....+++.+.+||.+||..||.+
T Consensus 219 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 298 (311)
T cd07866 219 EMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298 (311)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCccc
Confidence 99999999988766554433222110 0000 0 001234578899999999999999
Q ss_pred CCCHHHHHhcccc
Q 007967 200 RPTAEKLLKHSFF 212 (583)
Q Consensus 200 RpTa~eIL~HpfF 212 (583)
|||+.+++.||||
T Consensus 299 R~t~~ell~~~~f 311 (311)
T cd07866 299 RLTASDALEHPYF 311 (311)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.61 Aligned_cols=212 Identities=27% Similarity=0.419 Sum_probs=168.0
Q ss_pred CCC-CCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 2 SLI-DHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
+.+ +||||++++++|... ..+|+||||+. ++|..++.. +.+++..+..++.||+.||.|||++||+||||||+
T Consensus 61 ~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ 136 (337)
T cd07852 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPS 136 (337)
T ss_pred HHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 456 999999999998754 46899999996 588887753 37889999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCC--ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDR--QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~--~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|||++.++.+||+|||++......... ......+.|+.+|+|||.+.....++.++|||||||++|+|++|+.||.+.
T Consensus 137 nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 137 NILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred HEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998765432211 112234678999999998875567889999999999999999999999876
Q ss_pred ChHHHHHHHHhcCC--------------------------CCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 157 PPMKVLLMTIQNAP--------------------------PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 157 ~~~~~l~~~i~~~~--------------------------~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
.............. ........+.++..+.++|.+||+.+|.+|||+.++++||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 55443322211110 0000111234688999999999999999999999999999
Q ss_pred ccccCCC
Q 007967 211 FFKHAKP 217 (583)
Q Consensus 211 fFk~~~~ 217 (583)
||+....
T Consensus 297 ~~~~~~~ 303 (337)
T cd07852 297 YVAQFHN 303 (337)
T ss_pred hhhhhcc
Confidence 9987753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=269.01 Aligned_cols=205 Identities=38% Similarity=0.668 Sum_probs=169.5
Q ss_pred CCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||+++++++.+. ..+++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~n 131 (260)
T cd06606 54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGAN 131 (260)
T ss_pred HHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 568899999999999998 8999999999999999988764 479999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|+++.++.++|+|||.+......... .......++..|+|||.+. ...++.++||||||+++|+|++|..||......
T Consensus 132 i~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (260)
T cd06606 132 ILVDSDGVVKLADFGCAKRLGDIETG-EGTGSVRGTPYWMAPEVIR-GEEYGRAADIWSLGCTVIEMATGKPPWSELGNP 209 (260)
T ss_pred EEEcCCCCEEEcccccEEeccccccc-ccccCCCCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence 99999999999999988755332210 0123357889999999987 455899999999999999999999999876532
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
......+... ......+..++..+++||.+||..+|.+||++.++++||||
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 210 MAALYKIGSS--GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhcccc--CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 2222222211 11122335568999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=277.28 Aligned_cols=203 Identities=18% Similarity=0.353 Sum_probs=165.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
++.++||||+++++++.+...+++++||+.+++|.+++.... ...+++..+..++.|++.||.|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999885321 234788899999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++||+||||||+|||++.++.+||+|||+++....... ........+++.|+|||.+. ...++.++|||||||++|||
T Consensus 142 ~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el 219 (283)
T cd05091 142 SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEV 219 (283)
T ss_pred HcCccccccchhheEecCCCceEecccccccccccchh-eeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHH
Confidence 99999999999999999999999999999875432221 11122345678899999987 45689999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+....+.... +..... ......++..+.+|+..||+.+|.+||++.+|+..
T Consensus 220 ~~~g~~p~~~~~~~~~~~~-i~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 220 FSYGLQPYCGYSNQDVIEM-IRNRQV---LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCCCCCCCCCHHHHHHH-HHcCCc---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 98 8899988666544433 333221 12235688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=277.68 Aligned_cols=204 Identities=23% Similarity=0.381 Sum_probs=158.4
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++... ..+|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~ 136 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAAR 136 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChh
Confidence 3578999999999988753 468999999999999998864 46999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.++|+|||++.................++..|+|||.+. ...++.++|||||||++|+|++|..||.....
T Consensus 137 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 215 (283)
T cd05080 137 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPK 215 (283)
T ss_pred eEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999999999999999875432211111112234567799999987 56789999999999999999999999865332
Q ss_pred H-HHHH----------HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 M-KVLL----------MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~-~~l~----------~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
. .... ............+....++..+.+++.+||+.+|.+|||+.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 216 KFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 0000 000000001111223567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=316.19 Aligned_cols=204 Identities=25% Similarity=0.411 Sum_probs=165.4
Q ss_pred CCCCC-CCcccceEEE-EEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 007967 1 MSLID-HPNVIRAYCS-FVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG--H 70 (583)
Q Consensus 1 Mk~L~-HPNIVkl~~~-f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g--I 70 (583)
||+|. |||||.|++. .... -.++|+||||.||.|.++|..+...+|+|.+|.+|++++++|+.+||... |
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPi 167 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPI 167 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCcc
Confidence 56674 9999999993 3321 24899999999999999999887788999999999999999999999998 9
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCcccc------ccccCCCCCCCccccc--CCCCCCccccccchhhH
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSR------NTFVGTPCWMAPEVLQ--PGSGYNSKADIWSFGIT 142 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~------~~~~GT~~Y~APEil~--~~~~ys~ksDIWSLGvI 142 (583)
||||||-|||||..+|+.||||||.|............. .....|+.|+|||++. .+...++|+|||+|||+
T Consensus 168 IHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGcl 247 (738)
T KOG1989|consen 168 IHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCL 247 (738)
T ss_pred chhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHH
Confidence 999999999999999999999999875433222110000 1125699999999975 36678999999999999
Q ss_pred HhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccc
Q 007967 143 ALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211 (583)
Q Consensus 143 LyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hpf 211 (583)
||-|+....||.+..... |.++ .+.++...+++..+++||+.||+.||.+||++.+++.+-+
T Consensus 248 LYkLCy~t~PFe~sg~la-----Ilng--~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 248 LYKLCYFTTPFEESGKLA-----ILNG--NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred HHHHHHhCCCcCcCccee-----EEec--cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 999999999998753322 2222 3445555789999999999999999999999999987533
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=275.37 Aligned_cols=202 Identities=25% Similarity=0.458 Sum_probs=164.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++..++.+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 35689999999999999999999999999999999998654 35689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.++|+|||++.................++..|+|||.+. +..++.++|+|||||++|++++ |..||......
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred EECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhc-cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 999999999999999875432221111111223356799999997 5678999999999999999886 99999886654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.... +... ...+....+++.+.+++.+||+++|.+||++.++++
T Consensus 217 ~~~~~-~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 217 DVIKA-IEEG---YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHH-HhCC---CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 44333 3322 122333457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=273.79 Aligned_cols=202 Identities=22% Similarity=0.405 Sum_probs=164.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+..|+||||+.+++|.+++... .+.+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 45789999999999999999999999999999999988653 35689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||++..................+..|+|||.+. ...++.++|||||||++|+|++ |..||......
T Consensus 139 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~ 217 (268)
T cd05063 139 LVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217 (268)
T ss_pred EEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhh-cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 999999999999999865432221111111122345799999987 5678999999999999999997 99999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.. ..+... ...+....++..+.+++.+||..+|.+||++.+|++
T Consensus 218 ~~~-~~i~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 218 EVM-KAINDG---FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHH-HHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 433 333322 122333457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=281.98 Aligned_cols=202 Identities=22% Similarity=0.423 Sum_probs=166.2
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.+ +||||++++++|...+.+|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 93 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Ni 172 (302)
T cd05055 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNV 172 (302)
T ss_pred HhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceE
Confidence 456 7999999999999999999999999999999998764444489999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.++|+|||++......... .......++..|+|||.+. ...++.++||||+||++|+|++ |..||.+....
T Consensus 173 l~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 173 LLTHGKIVKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred EEcCCCeEEECCCcccccccCCCce-eecCCCCcccccCCHhhhc-cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 9999999999999998755332211 1112345678899999987 5568999999999999999998 99999876655
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
......+... .....+...+..+.+|+.+||.++|.+|||+.++++
T Consensus 251 ~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 251 SKFYKLIKEG---YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHcC---CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4444443332 122233457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.61 Aligned_cols=201 Identities=33% Similarity=0.576 Sum_probs=169.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++.++.+..+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni 124 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENI 124 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceE
Confidence 35688999999999999999999999999999999988754 4689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+++.++.++|+|||++....... .......++..|+|||.+. +..++.++|+||||+++|+|++|..||.......
T Consensus 125 ~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 200 (250)
T cd05123 125 LLDADGHIKLTDFGLAKELSSEG---SRTNTFCGTPEYLAPEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200 (250)
T ss_pred EEcCCCcEEEeecCcceecccCC---CcccCCcCCccccChHHhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999999999999876543221 1223457888999999987 4567889999999999999999999997765533
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH---HHHHhcccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA---EKLLKHSFF 212 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa---~eIL~HpfF 212 (583)
.. ..+... ....+..++..+.++|.+||..||.+||++ +++++||||
T Consensus 201 ~~-~~~~~~----~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 201 IY-EKILKD----PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HH-HHHhcC----CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 33 333222 223345568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=277.24 Aligned_cols=195 Identities=27% Similarity=0.402 Sum_probs=158.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++...|+|||||++|+|..++... .+.+++..+..++.||+.||+|||++||+||||||.||
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Ni 148 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNI 148 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccE
Confidence 46789999999999999999999999999999998887643 45689999999999999999999999999999999999
Q ss_pred EEcCCC-------cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh-hCCCC
Q 007967 81 LLDTNG-------VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAP 152 (583)
Q Consensus 81 Lld~~g-------~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL-tG~~P 152 (583)
|++..+ .+|++|||++...... ....++..|+|||.+.....++.++|||||||++|+|+ +|..|
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred EEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 997644 4899999987533211 12357788999999875567899999999999999985 69999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|......... ...... ... +...+..+.++|.+||+.+|.+|||+.+++++
T Consensus 222 ~~~~~~~~~~-~~~~~~-~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 222 LKERTPSEKE-RFYEKK-HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ccccChHHHH-HHHHhc-cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 9876543322 122211 111 12345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=273.26 Aligned_cols=205 Identities=29% Similarity=0.536 Sum_probs=167.8
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++.+. ..+++||||+.+++|.+++... +.+++..+..++.||+.||.|||++|++|+||||+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ 135 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 3568999999999999764 5699999999999999987653 56899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.++|+|||+++................|+..|+|||.+. +..++.++|+|||||++|+|++|..||.....
T Consensus 136 ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 214 (264)
T cd06653 136 NILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214 (264)
T ss_pred HEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence 99999999999999999875422111111122457899999999987 46688999999999999999999999987665
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
........... .....+..+++.++++|.+||. +|..|||+.+++.|||.
T Consensus 215 ~~~~~~~~~~~---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 215 MAAIFKIATQP---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHcCC---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 55544333221 1122346788999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=273.86 Aligned_cols=206 Identities=19% Similarity=0.371 Sum_probs=162.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.+...+|+|||||.+|+|.+++.... ...+++..+..++.||+.||+|||+++++||||||+
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ 128 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALR 128 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccc
Confidence 356899999999999999999999999999999999887542 234677888999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC------CCCCCccccccchhhHHhhhhh-CCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP------GSGYNSKADIWSFGITALELAH-GHA 151 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~------~~~ys~ksDIWSLGvILyeLLt-G~~ 151 (583)
|||++.++.++|+|||++...... .........+|+..|+|||++.. ...++.++|||||||++|+|++ |..
T Consensus 129 nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 207 (268)
T cd05086 129 NCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQ 207 (268)
T ss_pred eEEEcCCccEEecccccccccCcc-hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCC
Confidence 999999999999999987532211 11112234578899999999852 1245789999999999999996 678
Q ss_pred CCCCCChHHHHHHHHhcCCCCCC-ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLD-YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~-~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
||......+.+...+........ ......+++.+++++..|| .+|.+||++.+|++
T Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 208 PYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 99876666655554444332221 1223457889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=276.08 Aligned_cols=207 Identities=28% Similarity=0.458 Sum_probs=165.9
Q ss_pred CCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||+++++++.+. +.+|+||||++ ++|..++... ...+++..+..++.||+.||+|||++|++|+||+|+|
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~n 130 (287)
T cd07840 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSN 130 (287)
T ss_pred HhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHH
Confidence 567899999999999988 89999999996 4788876543 2479999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|+++.++.+||+|||++........ .......++..|+|||.+.+...++.++|||||||++|+|++|..||......
T Consensus 131 il~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~ 208 (287)
T cd07840 131 ILINNDGVLKLADFGLARPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208 (287)
T ss_pred eEEcCCCCEEEccccceeeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999999999999875533221 11223466889999998875567899999999999999999999999887655
Q ss_pred HHHHHHHhcCC--CCCCcc-----------------------cccc-chHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 160 KVLLMTIQNAP--PGLDYD-----------------------RDKK-FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 160 ~~l~~~i~~~~--~~~~~~-----------------------~~~~-~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
..+........ ....+. .... ++..+.++|.+||..+|.+||+++++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 209 EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 44433322110 000000 0011 37889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=288.98 Aligned_cols=211 Identities=25% Similarity=0.375 Sum_probs=166.5
Q ss_pred CCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++||||+++++++... ..+|+||||+. ++|.+++.. .+.+++..+..++.||+.||.|||++|++|||||
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlk 135 (337)
T cd07858 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLK 135 (337)
T ss_pred HhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 567999999999988754 35899999995 788887764 3679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+||+++.++.+||+|||++....... .......++..|+|||.+.....++.++|||||||++|+|++|..||.+.
T Consensus 136 p~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 136 PSNLLLNANCDLKICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred HHHEEEcCCCCEEECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999987543221 11234578999999999875456899999999999999999999999765
Q ss_pred ChHHHHHHHHh-----------------------cCCCC--CC-ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 157 PPMKVLLMTIQ-----------------------NAPPG--LD-YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 157 ~~~~~l~~~i~-----------------------~~~~~--~~-~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
+.......... ..... .. ......++..+++||.+||+.+|.+|||++++++||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 213 DYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 43222211110 00000 00 011235788999999999999999999999999999
Q ss_pred ccccCCCC
Q 007967 211 FFKHAKPP 218 (583)
Q Consensus 211 fFk~~~~~ 218 (583)
||.....+
T Consensus 293 ~~~~~~~~ 300 (337)
T cd07858 293 YLASLHDP 300 (337)
T ss_pred chhhhcCc
Confidence 99876543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=272.72 Aligned_cols=202 Identities=25% Similarity=0.484 Sum_probs=164.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-----DGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-----~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++||||++++++|.+....|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||++|++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl 132 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDL 132 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 4678999999999999999999999999999999999875422 34788999999999999999999999999999
Q ss_pred CCCcEEEcCCC-----cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-C
Q 007967 76 KAGNILLDTNG-----VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-G 149 (583)
Q Consensus 76 KPeNILld~~g-----~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G 149 (583)
||+||+++.++ .++|+|||++....... .........++..|+|||.+. ...++.++|||||||++|+|++ |
T Consensus 133 ~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g 210 (269)
T cd05044 133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSD-YYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLG 210 (269)
T ss_pred ChheEEEecCCCCCCcceEECCccccccccccc-ccccCcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcC
Confidence 99999999877 89999999986543221 111122345678899999997 5678999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..||......+... .+... ........++..+.++|.+||..+|.+||++.++++
T Consensus 211 ~~p~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 211 QQPYPALNNQEVLQ-HVTAG---GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CCCCcccCHHHHHH-HHhcC---CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99998766544332 22221 122233567899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=279.58 Aligned_cols=208 Identities=25% Similarity=0.401 Sum_probs=163.7
Q ss_pred CCCCCCCcccceEEEEEECC----------EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS----------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~----------~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
|+.++||||+++++++.+.. .+|+||||+++ ++..++... ...+++..+..++.||+.||.|||++||
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i 137 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNF 137 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 35689999999999998755 89999999976 676665543 3469999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCC
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGH 150 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~ 150 (583)
+||||||+||+++.++.+||+|||++........ .......++..|+|||.+.....++.++|||||||++|+|++|+
T Consensus 138 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 138 LHRDIKCSNILLNNKGQIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ecCCCCHHHEEECCCCcEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999875533221 11122356788999998875556789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhc--CCCCCCc-----------------------cccccchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 151 APFSKYPPMKVLLMTIQN--APPGLDY-----------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 151 ~PF~~~~~~~~l~~~i~~--~~~~~~~-----------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
+||......+.+...... .+....+ .....++..++++|.+||..+|.+|||+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999876554433222221 1100000 012246889999999999999999999999
Q ss_pred HHhcccc
Q 007967 206 LLKHSFF 212 (583)
Q Consensus 206 IL~HpfF 212 (583)
++.||||
T Consensus 296 il~~~~~ 302 (302)
T cd07864 296 ALNSPWL 302 (302)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=279.73 Aligned_cols=198 Identities=22% Similarity=0.380 Sum_probs=160.8
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
.+ +||||+++++++...+.+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+
T Consensus 58 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 137 (297)
T cd05089 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137 (297)
T ss_pred hhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44 79999999999999999999999999999999986532 1348899999999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
+|++||||||+|||++.++.+||+|||++..... .........+..|+|||.+. ...++.++|||||||++|+|+
T Consensus 138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEV----YVKKTMGRLPVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred CCcccCcCCcceEEECCCCeEEECCcCCCccccc----eeccCCCCcCccccCchhhc-cCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999998753211 00111122345699999987 567899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 148 H-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 148 t-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+ |..||.+............. .....+..++..+++||.+||..+|.+|||++++++.
T Consensus 213 t~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 213 SLGGTPYCGMTCAELYEKLPQG----YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCCCCCCCHHHHHHHHhcC----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7 99999886655444333222 2223345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=269.84 Aligned_cols=202 Identities=29% Similarity=0.465 Sum_probs=170.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++.+....|+||||+++++|..++.... ...+++..+..++.||+.||.|||++|++|+||+|.
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ 132 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSA 132 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcc
Confidence 356789999999999999999999999999999999886532 245899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.+||+|||++...... ......++..|+|||.+. +..++.++|+||+|+++|+|++|+.||.....
T Consensus 133 ni~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 133 NILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTPHYMAPEVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred eEEEecCCcEEEeeccchhhhccC-----CcccccCCccccCHHHHC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999998655322 122356889999999997 56788999999999999999999999988665
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
............+. ....++.+++++|.+||..+|.+|||+.++++||+.
T Consensus 207 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 207 QDLRYKVQRGKYPP----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHhcCCCCC----CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 44333333222221 224678899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=279.14 Aligned_cols=205 Identities=41% Similarity=0.728 Sum_probs=171.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++..|+||||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni 156 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 156 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence 356899999999999999999999999996 5777766543 45689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+++.++.++|+|||++..... .....|++.|+|||.+.. ...++.++|||||||++|+|++|..||.....
T Consensus 157 l~~~~~~~kl~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 229 (317)
T cd06635 157 LLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229 (317)
T ss_pred EECCCCCEEEecCCCccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 999999999999998754311 123578899999999742 34688899999999999999999999988766
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
............... ....++..+++||.+||+.+|.+||++.++++|+|+.....
T Consensus 230 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 230 MSALYHIAQNESPTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHHHHhccCCCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 555555544433222 23457888999999999999999999999999999976654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=270.60 Aligned_cols=203 Identities=25% Similarity=0.426 Sum_probs=160.3
Q ss_pred CCCCCCCcccceEEEEE-ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFV-VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~-d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||+++++++. .++..|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+|
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~n 128 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcce
Confidence 46789999999999775 456789999999999999998653 3456788889999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCc-cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCC
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYP 157 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~-~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~ 157 (583)
||++.++.+||+|||+++......... .......++..|+|||.+. ...++.++|||||||++|+|++ |.+||....
T Consensus 129 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 129 CMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred EEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999986543221111 1111234577899999987 5678999999999999999999 567777655
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
............ .......++..+.+++.+||..+|.+||++.++++.
T Consensus 208 ~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 208 SFDITVYLLQGR----RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHHhcCC----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 544333332221 122234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=271.80 Aligned_cols=197 Identities=24% Similarity=0.464 Sum_probs=161.4
Q ss_pred CCCCCCCcccceEEEEE-ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFV-VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~-d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||+++++++. .+...|+||||+++|+|.+++.......+++..+..++.||+.||+|||++|++||||||+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n 132 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARN 132 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchhe
Confidence 46789999999999764 55679999999999999999876544458999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCCh
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPP 158 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~ 158 (583)
|+++.++.+||+|||++....... ....++..|+|||++. ...++.++|||||||++|+|++ |+.||.....
T Consensus 133 il~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 133 VLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred EEEcCCCcEEecCCccceeccccC------CCCccceeecCHHHHc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999876432211 1234466899999987 5678999999999999999997 9999987554
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.. +...+.... .......+++.++++|.+||..+|.+|||+.++++
T Consensus 206 ~~-~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 206 KD-VVPRVEKGY---KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HH-HHHHHhcCC---CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 33 333333321 12233567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=272.83 Aligned_cols=203 Identities=25% Similarity=0.441 Sum_probs=160.9
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAY----QDGFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~----~~~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
|+.++||||+++++++... ...++||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 133 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF 133 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3568999999999987532 25799999999999988875321 2348999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-C
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-G 149 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G 149 (583)
+||||||+|||++.++.+||+|||++....... .........+++.|+|||.+. ...++.++|||||||++|+|++ |
T Consensus 134 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 134 IHRDLAARNCMLNENMNVCVADFGLSKKIYNGD-YYRQGRIAKMPVKWIAIESLA-DRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred eccccchhheEEcCCCCEEECCCCcccccCccc-ceecCCcccCCcccCCHHHcc-CCCcChHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999987543221 111112234567899999987 5678999999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
..||.+...... ...+..... ......++..++++|.+||+.+|.+|||+.+|+++
T Consensus 212 ~~p~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 212 QTPYPGVENSEI-YDYLRQGNR---LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCHHHH-HHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999987655433 333433221 12234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=268.46 Aligned_cols=200 Identities=24% Similarity=0.411 Sum_probs=162.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++...+..|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+||
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ni 124 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheE
Confidence 35679999999999999999999999999999999987653 34689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||++....... ........++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....
T Consensus 125 li~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 125 LVGENNVLKISDFGMSRQEDDGI--YSSSGLKQIPIKWTAPEALN-YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred EEcCCCeEEECCCccceeccccc--cccCCCCCCcccccCHHHhc-cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999886432111 11111224456799999987 5668899999999999999998 99999876554
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..... +... .....+..++..+.+++.+||+.+|.+||++.++++
T Consensus 202 ~~~~~-~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 202 QAREQ-VEKG---YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHH-HHcC---CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 43332 2222 112223467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=272.92 Aligned_cols=202 Identities=29% Similarity=0.525 Sum_probs=163.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.+++..++||||+.|++|.+++.... ...+++..++.++.||+.||.|||++|++|+||||+
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ 135 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPA 135 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 356899999999999999999999999999999999887432 245899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.++|+|||++....... .......|+..|+|||.+. ...++.++|+|||||++|+|++|..||.+...
T Consensus 136 nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 136 NVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred HEEEcCCCCEEECcchhhhccccCC---cccccccCCcCccCHHHhc-CCCccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 9999999999999999876442211 1122357899999999987 56788999999999999999999999976432
Q ss_pred H-HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 M-KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~-~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
. ......+.... ........+++.++++|.+||..+|.+|||+.+|++
T Consensus 212 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 212 NLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hHHHHhhhhhcCC--CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 1 22222222111 111122457889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=281.24 Aligned_cols=198 Identities=23% Similarity=0.424 Sum_probs=160.7
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
.+ +||||+++++++.+++.+|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||+
T Consensus 63 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 142 (303)
T cd05088 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 142 (303)
T ss_pred HhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 45 89999999999999999999999999999999987532 1247899999999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
+|++||||||+|||++.++.+||+|||++..... ........++..|+|||.+. ...++.++|||||||++|+|+
T Consensus 143 ~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ell 217 (303)
T cd05088 143 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIV 217 (303)
T ss_pred CCccccccchheEEecCCCcEEeCccccCcccch----hhhcccCCCcccccCHHHHh-ccCCcccccchhhhhHHHHHH
Confidence 9999999999999999999999999998753211 01111223456799999887 566899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 148 H-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 148 t-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+ |..||.+....+.. ..+.. ......+..++..+.+||.+||+.+|.+||++.+++.+
T Consensus 218 t~g~~p~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 218 SLGGTPYCGMTCAELY-EKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCCCCcccCChHHHH-HHHhc---CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8 99999876554433 22222 11222334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=274.65 Aligned_cols=206 Identities=26% Similarity=0.400 Sum_probs=166.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+.+.+|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+
T Consensus 53 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~ 130 (282)
T cd07829 53 KELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNIL 130 (282)
T ss_pred HhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEE
Confidence 56789999999999999999999999997 58999887642 46999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||++........ ......++..|+|||.+.....++.++|||||||++|+|++|.+||.+....+.
T Consensus 131 ~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 207 (282)
T cd07829 131 INRDGVLKLADFGLARAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207 (282)
T ss_pred EcCCCCEEEecCCcccccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 99999999999998865422211 122345678899999987555889999999999999999999999987665444
Q ss_pred HHHHHhcCC--------------------CCCC----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 162 LLMTIQNAP--------------------PGLD----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 162 l~~~i~~~~--------------------~~~~----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
+........ +... ....+.++..+.++|.+||..+|.+||++++++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 208 LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 332221100 0000 01112357789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=272.54 Aligned_cols=203 Identities=28% Similarity=0.508 Sum_probs=164.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.+.+..|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ 135 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPA 135 (267)
T ss_pred HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHH
Confidence 357899999999999999999999999999999998876432 234899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.++|+|||++....... .......|++.|+|||.+. +..++.++|+||+||++|+|++|..||.....
T Consensus 136 nil~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 211 (267)
T cd08228 136 NVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred HEEEcCCCCEEECccccceeccchh---HHHhcCCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccccc
Confidence 9999999999999999876542211 1122357889999999987 56788999999999999999999999965432
Q ss_pred -HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 159 -MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 159 -~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
...+...+.... ........++..++++|.+||..+|.+||++.++++.
T Consensus 212 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 212 NLFSLCQKIEQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred cHHHHHHHHhcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 222333332211 1111123577889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=271.11 Aligned_cols=200 Identities=27% Similarity=0.450 Sum_probs=162.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++. ....|+||||+.+++|.+++.......+++..+..++.||+.||.|||++|++||||||+||
T Consensus 55 l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Ni 133 (260)
T cd05070 55 MKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI 133 (260)
T ss_pred HHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence 46789999999999885 45689999999999999998765445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.++|+|||++........ .......++..|+|||.+. ...++.++|||||||++|+|++ |.+||.+....
T Consensus 134 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 134 LVGDGLVCKIADFGLARLIEDNEY--TARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred EEeCCceEEeCCceeeeeccCccc--ccccCCCCCccccChHHHh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999865422111 1112234566799999987 5678999999999999999998 99999876655
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+........ ...+.+...+..+++|+.+||.++|.+|||+.+++.
T Consensus 211 ~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 211 EVLEQVERG----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHcC----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 444333222 122334567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=293.07 Aligned_cols=209 Identities=25% Similarity=0.400 Sum_probs=164.3
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
-.|-+||+||++=..++.+|+||||= ..+|.++|+.. ...++.-.++.|.+||+.++.++|.+||||.||||.|+|+-
T Consensus 417 kg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~-~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV 494 (677)
T KOG0596|consen 417 KGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK-KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV 494 (677)
T ss_pred cCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE
Confidence 37899999999999999999999974 57888888764 23344458999999999999999999999999999999984
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC----------CCCCccccccchhhHHhhhhhCCCCC
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG----------SGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~----------~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
.|.+||+|||+|..+... .........+||+.||+||.+... -..+.++||||||||||+|+.|+.||
T Consensus 495 -kG~LKLIDFGIA~aI~~D-TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf 572 (677)
T KOG0596|consen 495 -KGRLKLIDFGIANAIQPD-TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF 572 (677)
T ss_pred -eeeEEeeeechhcccCcc-ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence 479999999998765332 333334457999999999998631 12567899999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
......-.-+..|......+.|+.-... .++.++++.||.+||++|||+.++|+|||+.....
T Consensus 573 ~~~~n~~aKl~aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 573 GQIINQIAKLHAITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred HHHHHHHHHHHhhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 8765433333444443333444332222 23899999999999999999999999999986543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=278.32 Aligned_cols=202 Identities=25% Similarity=0.451 Sum_probs=164.3
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
+.+ +||||++++++|...+.+|+||||+.+|+|.+++..... ..++...+..++.||+.||.|||
T Consensus 75 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 154 (304)
T cd05101 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA 154 (304)
T ss_pred HhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH
Confidence 456 799999999999999999999999999999999876421 24778889999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++|++||||||+|||++.++.+||+|||++........ ........+++.|+|||++. +..++.++|||||||++|+|
T Consensus 155 ~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el 232 (304)
T cd05101 155 SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDY-YKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEI 232 (304)
T ss_pred HCCeeecccccceEEEcCCCcEEECCCccceecccccc-cccccCCCCCceeeCchhhc-cCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999999875422211 11112234567899999987 56789999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+.+..+ +...+..... ...+..++..+++||.+||..+|.+|||+.++++.
T Consensus 233 ~~~g~~p~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 233 FTLGGSPYPGIPVEE-LFKLLKEGHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HcCCCCCcccCCHHH-HHHHHHcCCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 98 889998765544 3334433221 12235678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=281.43 Aligned_cols=201 Identities=22% Similarity=0.389 Sum_probs=162.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++... ..++|+||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Ni 140 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNV 140 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence 4678999999999999764 578999999999999988754 34688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++...... .........++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....
T Consensus 141 ll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 141 LVKTPQHVKITDFGLAKLLGADE-KEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred EecCCCcEEEccccccccccCCC-cceeccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999987543221 111112234467899999987 5678999999999999999987 99999876554
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+. ...+... ...+.+..++..+.+++.+||..+|.+||++.+++.+
T Consensus 219 ~~-~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 219 EI-SSILEKG---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HH-HHHHhCC---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32 2333322 1222334578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=279.49 Aligned_cols=201 Identities=25% Similarity=0.466 Sum_probs=162.1
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
+.+ +||||++++++|.+++.+|+||||+.+|+|.+++..... ..+++..+..++.||+.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 151 (314)
T cd05099 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE 151 (314)
T ss_pred HhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 345 699999999999999999999999999999999876421 34889999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++|++||||||+|||++.++.+||+|||+++........ .......++..|+|||.+. +..++.++|||||||++|+|
T Consensus 152 ~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 152 SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred HCCeeeccccceeEEEcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHH
Confidence 999999999999999999999999999998754321111 1111223456799999987 56789999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
++ |..||.+.+..+.. ..+.... .......++.+++++|.+||..+|.+|||+.++++
T Consensus 230 ~~~g~~p~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 230 FTLGGSPYPGIPVEELF-KLLREGH---RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HhCCCCCCCCCCHHHHH-HHHHcCC---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 98 89999876654433 3333221 11223567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=285.38 Aligned_cols=202 Identities=22% Similarity=0.388 Sum_probs=163.2
Q ss_pred CC-CCCcccceEEEEEE-CCEEEEEEecCCCCCHHHHHHHHh--------------------------------------
Q 007967 3 LI-DHPNVIRAYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAY-------------------------------------- 42 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~-------------------------------------- 42 (583)
.+ +||||++++++|.. +..+++||||+.+|+|.+++....
T Consensus 66 ~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (337)
T cd05054 66 HIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASS 145 (337)
T ss_pred hhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccc
Confidence 45 89999999998875 467999999999999999886432
Q ss_pred ---------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCcccccc
Q 007967 43 ---------------------QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFD 101 (583)
Q Consensus 43 ---------------------~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~ 101 (583)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 146 GFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred ccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 12578999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Q 007967 102 TGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180 (583)
Q Consensus 102 ~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~ 180 (583)
... ........++..|+|||.+. +..++.++|||||||++|+|++ |..||.+....+.+...+..... ...+..
T Consensus 226 ~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~ 300 (337)
T cd05054 226 DPD-YVRKGDARLPLKWMAPESIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---MRAPEY 300 (337)
T ss_pred Ccc-hhhccCCCCCccccCcHHhc-CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC---CCCCcc
Confidence 221 11222345677899999987 5789999999999999999997 99999875544444444433221 122345
Q ss_pred chHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 181 ~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+++++.+++.+||+.+|.+||++.++++|
T Consensus 301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 301 ATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 78899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=273.79 Aligned_cols=200 Identities=24% Similarity=0.438 Sum_probs=161.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
++.++||||+++++++. +...++||||+.+|+|.+++... .+.+++..+..++.||+.||.|||++|++||||||+||
T Consensus 63 l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ni 140 (279)
T cd05111 63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNI 140 (279)
T ss_pred HhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceE
Confidence 35789999999999875 45688999999999999998653 35689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++..... ..........++..|+|||.+. ...++.++|||||||++|||++ |..||.+....
T Consensus 141 li~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 141 LLKSDSIVQIADFGVADLLYPD-DKKYFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred EEcCCCcEEEcCCccceeccCC-CcccccCCCCCcccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999998754322 1111223345677899999987 4578999999999999999998 99999876543
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.. ...+.... ....+..++..+.+++.+||..+|.+|||+.++++
T Consensus 219 ~~-~~~~~~~~---~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 219 EV-PDLLEKGE---RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HH-HHHHHCCC---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 32 23333221 11222346778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=276.38 Aligned_cols=202 Identities=23% Similarity=0.456 Sum_probs=165.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh----------------------cCCCCHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY----------------------QDGFEESAIGSILKET 58 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~----------------------~~~~sE~~i~~I~~QI 58 (583)
|+.++||||++++++|..++..|+||||+.+|+|.+++.... ...+++..+..++.||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 357899999999999999999999999999999999876431 1247889999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccc
Q 007967 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWS 138 (583)
Q Consensus 59 l~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWS 138 (583)
+.||.|||++|++||||||+|||++.++.+||+|||++.......... ......++..|+|||.+. +..++.++||||
T Consensus 137 ~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~-~~~~~~~~Di~s 214 (290)
T cd05045 137 SRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLF-DHIYTTQSDVWS 214 (290)
T ss_pred HHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHHc-cCCcchHhHHHH
Confidence 999999999999999999999999999999999999987553332211 112335567899999886 567899999999
Q ss_pred hhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 139 FGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 139 LGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|||++|+|++ |..||.+....+.. ..+... .....+..++..+.+|+..||+.+|.+||++.++++
T Consensus 215 lG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 215 FGVLLWEIVTLGGNPYPGIAPERLF-NLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHH-HHHhCC---CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999998 99999876654433 333321 222334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=275.50 Aligned_cols=206 Identities=23% Similarity=0.395 Sum_probs=165.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY---------QDGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~---------~~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
|+.++||||++++++|..++.+++||||+.+++|.+++.... ...+++..++.++.||+.||.|||++|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~ 152 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV 152 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 357899999999999999999999999999999999987642 12589999999999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh--C
Q 007967 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH--G 149 (583)
Q Consensus 72 HRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt--G 149 (583)
||||||+||+++.++.++|+|||++....... .........+++.|+|||.+. ...++.++|||||||++|+|++ |
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~ 230 (296)
T cd05051 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSD-YYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCR 230 (296)
T ss_pred ccccchhceeecCCCceEEccccceeecccCc-ceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCC
Confidence 99999999999999999999999987543322 112223446678899999987 4578999999999999999987 7
Q ss_pred CCCCCCCChHHHHHHHHhc---CCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 150 HAPFSKYPPMKVLLMTIQN---APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~---~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..||........+...... ............++.++.++|.+||+.||.+|||+.+|++
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 231 EQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 8898776554443322221 0111112223456789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=273.68 Aligned_cols=197 Identities=23% Similarity=0.423 Sum_probs=159.6
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
.+ +||||++++++|...+.+|+||||+.+|+|.+++.... ...+++..+..++.||+.||+|||+
T Consensus 51 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~ 130 (270)
T cd05047 51 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 130 (270)
T ss_pred hhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45 89999999999999999999999999999999987532 1247899999999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
+|++||||||+|||++.++.+||+|||++..... .........+..|+|||.+. ...++.++|||||||++|+|+
T Consensus 131 ~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~----~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~el~ 205 (270)
T cd05047 131 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIV 205 (270)
T ss_pred CCEeecccccceEEEcCCCeEEECCCCCccccch----hhhccCCCCccccCChHHHc-cCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999998752211 01111223456799999987 567899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 148 H-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 148 t-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+ |..||.+.+..+.... +.. .........++.++.+++.+||..+|.+|||+.+++.
T Consensus 206 ~~g~~pf~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 206 SLGGTPYCGMTCAELYEK-LPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCCCCccccCHHHHHHH-HhC---CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 6 9999987655443322 222 1222233457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=288.61 Aligned_cols=208 Identities=26% Similarity=0.417 Sum_probs=169.0
Q ss_pred CCCCCCCcccceEEEEEECCE------EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSN------LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~------l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||+++++++..... +|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+|||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRD 143 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 356899999999998876655 99999999 7799888763 5799999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+||+++.++.++|+|||++...... .....++..|+|||.+.....++.++|||||||++|+|++|+.||.
T Consensus 144 lkp~Nill~~~~~~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 144 LKPSNIAVNEDCELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred CCHHHeEECCCCCEEEcccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998654221 2345788999999998754578899999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCC----------------------CC---c-cccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAPPG----------------------LD---Y-DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~----------------------~~---~-~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+......+...+...... .. + .....++..+.+||.+||+.+|.+|||+.+|++
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 766554443332211100 00 0 011245889999999999999999999999999
Q ss_pred ccccccCCCC
Q 007967 209 HSFFKHAKPP 218 (583)
Q Consensus 209 HpfFk~~~~~ 218 (583)
||||.....+
T Consensus 298 h~~~~~~~~~ 307 (343)
T cd07851 298 HPYLAEYHDP 307 (343)
T ss_pred CCCccccCCC
Confidence 9999976544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=279.00 Aligned_cols=201 Identities=24% Similarity=0.456 Sum_probs=162.8
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
.+ +||||++++++|..++.+|+|||||.+|+|.+++..... ..+++..+..++.||+.||+|||+
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 45 799999999999999999999999999999999876422 247889999999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
+|++||||||+|||++.++.+||+|||++....... .........+++.|+|||.+. +..++.++|||||||++|+|+
T Consensus 159 ~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~ 236 (307)
T cd05098 159 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIF 236 (307)
T ss_pred CCcccccccHHheEEcCCCcEEECCCcccccccccc-hhhccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999986442211 111111123456899999987 567899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 148 H-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 148 t-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+ |..||.+.+. +.+...+.... ....+..++.++++||.+||..+|.+|||+.+++++
T Consensus 237 ~~g~~p~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 237 TLGGSPYPGVPV-EELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCCCCCCcCCH-HHHHHHHHcCC---CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 8 8999977554 44444444322 123345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=266.04 Aligned_cols=200 Identities=27% Similarity=0.493 Sum_probs=164.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+.+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+
T Consensus 56 ~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil 135 (258)
T smart00219 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135 (258)
T ss_pred HhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEE
Confidence 45799999999999999999999999999999999987654333999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.++|+|||++........... ....+++.|+|||.+. ...++.++||||+||++|+|++ |.+||.......
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 136 VGENLVVKISDFGLSRDLYDDDYYKK--KGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred EccCCeEEEcccCCceeccccccccc--ccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999865533211111 1123678899999986 6678999999999999999998 899998755544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
... .+..... ......++..+.+++.+||..+|.+|||+.++++
T Consensus 213 ~~~-~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 213 VLE-YLKKGYR---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHH-HHhcCCC---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 433 3332221 1223457899999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=270.08 Aligned_cols=200 Identities=28% Similarity=0.471 Sum_probs=162.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++. .+..|+||||+.+|+|.+++.......+++..+..++.||+.||.|||++|++||||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Ni 133 (260)
T cd05069 55 MKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI 133 (260)
T ss_pred HHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 35689999999999885 46689999999999999998765445589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.++|+|||++....... ........++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....
T Consensus 134 ll~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 134 LVGDNLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred EEcCCCeEEECCCccceEccCCc--ccccCCCccchhhCCHHHhc-cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999986542211 11112234567899999887 5668999999999999999998 99999886655
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.... +... .....+..++..+++++.+||.++|.+||++.++++
T Consensus 211 ~~~~~-~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 211 EVLEQ-VERG---YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHH-HHcC---CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 44433 3322 112233567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=275.77 Aligned_cols=208 Identities=38% Similarity=0.692 Sum_probs=166.3
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNIL 81 (583)
..+||||++++++|.++..+|+||||+ ++.+.+++... ...+++..+..++.||+.||.|||+ +||+||||+|+||+
T Consensus 70 ~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nil 147 (296)
T cd06618 70 SHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNIL 147 (296)
T ss_pred ccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEE
Confidence 346999999999999999999999998 45777776543 4579999999999999999999997 59999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC---CCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG---SGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~---~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
++.++.+||+|||++..+..... .....++..|+|||.+... ..++.++|||||||++|+|++|+.||.....
T Consensus 148 l~~~~~~kL~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 223 (296)
T cd06618 148 LDASGNVKLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223 (296)
T ss_pred EcCCCCEEECccccchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh
Confidence 99999999999999865432211 1224578899999998733 2478899999999999999999999976433
Q ss_pred -HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 159 -MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 159 -~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.+.+...+....+.. +....++.++++||.+||..||.+||+++++++||||......
T Consensus 224 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 224 EFEVLTKILQEEPPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred HHHHHHHHhcCCCCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence 233333333322222 2223578899999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=270.43 Aligned_cols=199 Identities=26% Similarity=0.450 Sum_probs=161.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++. ....|+||||+.+|+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil 134 (262)
T cd05071 56 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 134 (262)
T ss_pred HhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE
Confidence 5689999999999875 456899999999999999987654456899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.++|+|||.+..+..... .......++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....+
T Consensus 135 l~~~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~ 211 (262)
T cd05071 135 VGENLVCKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 211 (262)
T ss_pred EcCCCcEEeccCCceeecccccc--ccccCCcccceecCHhHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH
Confidence 99999999999999865432211 1112234677899999887 5678999999999999999999 899998766544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.... +... ........++..+.+||.+||+++|.+||++.++++
T Consensus 212 ~~~~-~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 212 VLDQ-VERG---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHH-HhcC---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4333 2221 112223567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=268.16 Aligned_cols=197 Identities=24% Similarity=0.452 Sum_probs=164.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++..|+||||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Ni 133 (256)
T cd05039 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNV 133 (256)
T ss_pred HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceE
Confidence 35689999999999999999999999999999999998765444699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||++....... ....++..|+|||.+. ...++.++|||||||++|+|++ |..||...+..
T Consensus 134 li~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 134 LVSEDLVAKVSDFGLAKEASQGQ------DSGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred EEeCCCCEEEccccccccccccc------ccCCCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999987542111 1234466799999987 5578889999999999999997 99999876544
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.. ...+.... .......+++.+.++|.+||..+|.+|||+.++++
T Consensus 207 ~~-~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 207 DV-VPHVEKGY---RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HH-HHHHhcCC---CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 33 33333221 12223567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=269.18 Aligned_cols=201 Identities=26% Similarity=0.451 Sum_probs=165.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+...+|+||||+++++|.+++.......+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~ni 134 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI 134 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheE
Confidence 35789999999999999999999999999999999998765445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||++....... ........++..|+|||.+. +..++.++||||+||++|+|++ |+.||.+....
T Consensus 135 li~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 135 LVGENLVCKIADFGLARLIEDDE--YTAREGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred EEcCCCCEEECccccceeccchh--hhhhhccCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999886542211 11111223456899999987 5678999999999999999998 99999876655
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..+...... +....+...+..+.+++.+||..+|.+||++++++.
T Consensus 212 ~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 212 EVLEQVERG----YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHcC----CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 444333332 122233456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=274.56 Aligned_cols=204 Identities=22% Similarity=0.361 Sum_probs=160.9
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++.+. ..+|+||||++|++|.+++... ...+++..+..++.||+.||.|||++|++||||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~ 138 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 138 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchh
Confidence 3578999999999999875 6799999999999999988653 245899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC-
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP- 157 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~- 157 (583)
||+++.++.++|+|||++..+..............++..|+|||.+. +..++.++|||||||++|+|+++..|+....
T Consensus 139 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred eEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 99999999999999999876533222212223456778899999987 5678999999999999999999876653211
Q ss_pred -------------hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 158 -------------PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 158 -------------~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
........+... ...+.+..++..+.+||.+||+.+|.+|||+.+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEG---KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcC---ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 011111122211 1222345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=291.42 Aligned_cols=202 Identities=19% Similarity=0.410 Sum_probs=164.2
Q ss_pred CCCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------------------------------
Q 007967 2 SLID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-------------------------------------- 42 (583)
Q Consensus 2 k~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-------------------------------------- 42 (583)
+.+. |||||+++++|.+.+.+|||||||++|+|.+++....
T Consensus 95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 4564 9999999999999999999999999999999886532
Q ss_pred --------------------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 43 --------------------------------------------------------QDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 43 --------------------------------------------------------~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
...+++..+..++.||+.||.|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 124788889999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++||+||||||+|||++.++.+||+|||+++....... ........+++.|+|||.+. +..++.++|||||||++|+|
T Consensus 255 ~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~el 332 (400)
T cd05105 255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEI 332 (400)
T ss_pred hCCeeCCCCChHhEEEeCCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999999875432221 11222345678899999987 56789999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
++ |..||........+...+... ........++..+++++.+||+.+|.+|||+.+|.+
T Consensus 333 lt~g~~P~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 333 FSLGGTPYPGMIVDSTFYNKIKSG---YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHCCCCCCcccchhHHHHHHHhcC---CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 97 999998755444444444432 122334567899999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=267.31 Aligned_cols=193 Identities=25% Similarity=0.411 Sum_probs=156.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.. ...|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 55 MSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred HHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 467899999999999988 7889999999999999988764 23689999999999999999999999999999999999
Q ss_pred EEcCCC-------cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhh-CCC
Q 007967 81 LLDTNG-------VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAH-GHA 151 (583)
Q Consensus 81 Lld~~g-------~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLt-G~~ 151 (583)
|++.++ .+||+|||++..... .....++..|+|||.+... ..++.++|||||||++|+|++ |..
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~ 205 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205 (259)
T ss_pred EEecCccccCCceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCC
Confidence 999887 799999999875422 1234567789999998743 378999999999999999998 688
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
||............... ... .......+.++|.+||..+|.+|||+.++++
T Consensus 206 p~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 206 PLSTLSSSEKERFYQDQ--HRL----PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CcccCCchhHHHHHhcC--CCC----CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 88765433222111111 111 1122378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=284.75 Aligned_cols=206 Identities=27% Similarity=0.423 Sum_probs=164.0
Q ss_pred CCCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|.... .+|+||||+. ++|..++ ...+++..+..++.||+.||.|||++|++|||
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~d 142 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRD 142 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 35689999999999997653 4799999995 4665543 35699999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.++.+||+|||++..... ......+++.|+|||.+.....++.++|||||||++|+|++|+.||.
T Consensus 143 lkp~NIll~~~~~~kL~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 143 LKPGNLAVNEDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcCCCC------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999764311 12245778999999998754568999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCC----------------------CCCCc----cccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAP----------------------PGLDY----DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~----------------------~~~~~----~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+......+...+.... +.... ...+..+..+.+||.+||+.||.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 217 GKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 8665444332222100 00000 001246778999999999999999999999999
Q ss_pred ccccccCCC
Q 007967 209 HSFFKHAKP 217 (583)
Q Consensus 209 HpfFk~~~~ 217 (583)
||||+....
T Consensus 297 h~~f~~~~~ 305 (342)
T cd07879 297 HPYFDSFRD 305 (342)
T ss_pred Ccchhhccc
Confidence 999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=269.89 Aligned_cols=202 Identities=24% Similarity=0.440 Sum_probs=163.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.++..+++||||+.+|+|.+++... .+.+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 35789999999999999999999999999999999988654 45689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccc--cCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTF--VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~--~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~ 157 (583)
+++.++.+||+|||++................ ..+..|+|||.+. ...++.++|||||||++|||++ |..||....
T Consensus 138 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred EEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhc-cCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 99999999999999876442221111111111 1245799999987 5678999999999999999886 999998866
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..+........ ...+.+..++..+.+++.+||..+|.+||++.+|+.
T Consensus 217 ~~~~~~~i~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 217 NQDVINAIEQD----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHHcC----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55443333221 222334567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=281.35 Aligned_cols=210 Identities=22% Similarity=0.343 Sum_probs=164.0
Q ss_pred CCCcccceEEEEEEC----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 5 DHPNVIRAYCSFVVD----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+||||+++++++... ..+|++|||+. ++|..++.. ...+++..++.++.||+.||.|||++|++||||||+||
T Consensus 60 ~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Ni 136 (332)
T cd07857 60 GHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNL 136 (332)
T ss_pred CCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHe
Confidence 699999999876533 46899999995 688888754 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCC-ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDR-QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~-~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|++.++.+||+|||++......... ........|++.|+|||.+.+...++.++||||+||++|+|++|.+||......
T Consensus 137 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~ 216 (332)
T cd07857 137 LVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV 216 (332)
T ss_pred EEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH
Confidence 9999999999999998754322111 111234678999999998875567899999999999999999999999875543
Q ss_pred HHHHHHHhcC-------------------------CCCCCc-cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 160 KVLLMTIQNA-------------------------PPGLDY-DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 160 ~~l~~~i~~~-------------------------~~~~~~-~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
..+...+... .+...+ ......+..+++||.+||+.||.+|||+.+++.||||.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 217 DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 3322211110 000000 11234578899999999999999999999999999998
Q ss_pred cCCC
Q 007967 214 HAKP 217 (583)
Q Consensus 214 ~~~~ 217 (583)
....
T Consensus 297 ~~~~ 300 (332)
T cd07857 297 IWHD 300 (332)
T ss_pred hhcC
Confidence 6653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=277.54 Aligned_cols=201 Identities=29% Similarity=0.521 Sum_probs=159.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.....+++|||||.+|+|.+++.......+++..+..|+.||+.||.|||+++++|++|++.|||
T Consensus 56 ~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nil 135 (259)
T PF07714_consen 56 RKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNIL 135 (259)
T ss_dssp HTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 46799999999999998888999999999999999998764567999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||++...... ..........+...|+|||.+. ...++.++||||||+++|||++ |..||......+
T Consensus 136 l~~~~~~Kl~~f~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 136 LDSNGQVKLSDFGLSRPISEK-SKYKNDSSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp EETTTEEEEESTTTGEETTTS-SSEEESTTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred ccccccccccccccccccccc-cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccc
Confidence 999999999999998755221 1112222345677899999997 4558999999999999999999 789998876544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.. ..+.... .......++..+.++|..||..+|.+|||+.+|++
T Consensus 214 ~~-~~~~~~~---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 214 II-EKLKQGQ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HH-HHHHTTE---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cc-ccccccc---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 44 3333321 12234568899999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=267.75 Aligned_cols=202 Identities=29% Similarity=0.522 Sum_probs=162.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++|+||++++++|.+++..++||||+++|+|..++.... ...+++..+..++.+|+.||.|||++|++||||+|+
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ 135 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChh
Confidence 356899999999999999999999999999999999886532 245899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.++|+|||++....... .......+++.|+|||.+. +..++.++|||||||++|+|++|..||.....
T Consensus 136 nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08224 136 NVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred hEEECCCCcEEEeccceeeeccCCC---cccceecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCc
Confidence 9999999999999999876442211 1123357889999999987 56789999999999999999999999965431
Q ss_pred -HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 -MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 -~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.......+.... ........++..++++|.+||..+|.+|||+.+|++
T Consensus 212 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 212 NLYSLCKKIEKCD--YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cHHHHHhhhhcCC--CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 112222222111 111112367889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=282.82 Aligned_cols=209 Identities=25% Similarity=0.434 Sum_probs=165.5
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|... ..+|+|++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+|||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~d 145 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRD 145 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 3567999999999998754 3478999987 7889887653 5699999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+||+++.++.+||+|||++..... ......|+..|+|||.+.....++.++|||||||++|+|++|..||.
T Consensus 146 lkp~NIll~~~~~~kl~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 146 LKPSNLAVNEDCELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred CChHHEEEcCCCCEEEecccccccccc------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999864321 12345789999999998754678899999999999999999999997
Q ss_pred CCChHHHHHHHHhcCC-------------------------CCCCc-cccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAP-------------------------PGLDY-DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~-------------------------~~~~~-~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.......+........ +...+ ......++.+++||.+||+.||.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 220 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 7554433322211100 00000 001235788999999999999999999999999
Q ss_pred ccccccCCCCc
Q 007967 209 HSFFKHAKPPE 219 (583)
Q Consensus 209 HpfFk~~~~~~ 219 (583)
||||+....+.
T Consensus 300 h~~f~~~~~~~ 310 (345)
T cd07877 300 HAYFAQYHDPD 310 (345)
T ss_pred ChhhhhcCCCC
Confidence 99999765443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=267.84 Aligned_cols=200 Identities=24% Similarity=0.476 Sum_probs=163.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++. .+.+|+||||+.+|+|.+++.......+++..+..++.|++.||+|||++|++||||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni 133 (260)
T cd05067 55 MKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANI 133 (260)
T ss_pred HHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhE
Confidence 46789999999999874 56799999999999999988765556789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.++|+|||++....... ........++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....
T Consensus 134 ~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 134 LVSETLCCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred EEcCCCCEEEccCcceeecCCCC--cccccCCcccccccCHHHhc-cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 99999999999999986542111 11112334567899999987 5568899999999999999998 99999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.... +... ...+.+..++.++.++|.+||..+|.+|||+++++.
T Consensus 211 ~~~~~-~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 211 EVIQN-LERG---YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHH-HHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44332 2222 112233557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=272.93 Aligned_cols=206 Identities=21% Similarity=0.386 Sum_probs=163.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ---------DGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~---------~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
|+.++||||+++++++.+++.+|+||||+.+|+|.+++..... ..+++..+..++.||+.||+|||++|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~ 152 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV 152 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4578999999999999999999999999999999998875321 2367889999999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh--C
Q 007967 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH--G 149 (583)
Q Consensus 72 HRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt--G 149 (583)
||||||+|||++.++.++|+|||++..+.... .........++..|+|||.+. ...++.++|||||||++|||++ |
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred cccCChheEEEcCCCCEEeccCcccccccCCc-ceeccCcCcCccccCCHHHHh-cCCccchhhhhHHHHHHHHHHHhCC
Confidence 99999999999999999999999987543221 111122234567899999876 4568999999999999999998 7
Q ss_pred CCCCCCCChHHHHHHH---HhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 150 HAPFSKYPPMKVLLMT---IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~---i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..||......+..... ..........+....+++.+.+|+.+||+.||.+||++.+|++
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8899776554433211 1111111122334567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=283.61 Aligned_cols=207 Identities=28% Similarity=0.428 Sum_probs=167.1
Q ss_pred CCCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|..+. .+|+||||+ |++|..++. ...+++..++.++.||+.||.|||++||+|||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~d 143 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRD 143 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 46789999999999998654 469999999 788888765 35799999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+||+++.++.++|+|||++..... ......+++.|+|||.+.....++.++|+|||||++|+|++|..||.
T Consensus 144 lkp~Nill~~~~~~kl~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 144 LKPGNLAVNEDCELKILDFGLARQTDS------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred CCHHHEEEcCCCCEEEeeccccccccc------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999864321 11235678999999998754568899999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCC----------------------CCC----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAPP----------------------GLD----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~----------------------~~~----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+..........+..... ... ......++..+.++|.+||..||.+|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 218 GHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 76554433322221100 000 0112356788999999999999999999999999
Q ss_pred ccccccCCC
Q 007967 209 HSFFKHAKP 217 (583)
Q Consensus 209 HpfFk~~~~ 217 (583)
||||+....
T Consensus 298 ~~~~~~~~~ 306 (343)
T cd07880 298 HPYFEEFHD 306 (343)
T ss_pred CccHhhhcC
Confidence 999997643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=272.12 Aligned_cols=202 Identities=21% Similarity=0.415 Sum_probs=162.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------------CCCCHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------------DGFEESAIGSILKETLK 60 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------------~~~sE~~i~~I~~QIl~ 60 (583)
|+.++||||+++++++.++..+|+||||+.+|+|.+++..... ..+++..+..++.||+.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 3568999999999999999999999999999999999875321 24788899999999999
Q ss_pred HHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchh
Q 007967 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFG 140 (583)
Q Consensus 61 gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLG 140 (583)
||.|||++|++||||||.|||++.++.++|+|||++........ ........++..|+|||.+. +..++.++||||||
T Consensus 142 aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG 219 (288)
T cd05050 142 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIF-YNRYTTESDVWAYG 219 (288)
T ss_pred HHHHHHhCCeecccccHhheEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHh-cCCCCchhHHHHHH
Confidence 99999999999999999999999999999999998864422211 11112234466799999987 56789999999999
Q ss_pred hHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 141 ITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 141 vILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|++|+|++ |..||.+....+.. ..+..... ...+..++..+.+||.+||+.+|.+|||+.|+++
T Consensus 220 ~il~el~~~~~~p~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 220 VVLWEIFSYGMQPYYGMAHEEVI-YYVRDGNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHH-HHHhcCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999997 88899876654443 33332211 1223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=263.71 Aligned_cols=201 Identities=23% Similarity=0.414 Sum_probs=162.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
++.++||||+++++++.+....|+||||+.|++|.+++... ...+++..+..++.+++.||.|||++|++||||||+||
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~ni 124 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNC 124 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceE
Confidence 35789999999999999999999999999999999988653 34688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.++|+|||++...... ..........++..|+|||.+. +..++.++|||||||++|+|++ |..||......
T Consensus 125 li~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~ 202 (251)
T cd05041 125 LVGENNVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEALN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202 (251)
T ss_pred EEcCCCcEEEeeccccccccCC-cceeccccCcceeccCChHhhc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence 9999999999999988643211 1111111123356799999987 5578999999999999999998 89999876654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.... .+... .....+..++..+.+|+.+||..+|.+|||+.++++
T Consensus 203 ~~~~-~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 203 QTRE-RIESG---YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHH-HHhcC---CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3332 22221 112233567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=269.23 Aligned_cols=203 Identities=19% Similarity=0.363 Sum_probs=165.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-------DGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-------~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
|+.++||||+++++++.+.+..|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||++||+||
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~ 141 (275)
T cd05046 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHR 141 (275)
T ss_pred HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccC
Confidence 3568999999999999999999999999999999999876431 158999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCC
Q 007967 74 DVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAP 152 (583)
Q Consensus 74 DLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~P 152 (583)
||||+|||++.++.++|+|||++....... ........++..|+|||.+. ...++.++|||||||++|+|++ |..|
T Consensus 142 dlkp~Nili~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p 218 (275)
T cd05046 142 DLAARNCLVSSQREVKVSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELP 218 (275)
T ss_pred cCccceEEEeCCCcEEEcccccccccCccc--ccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999876432211 11222346678899999987 4568899999999999999998 8899
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|......... ..+.... ..+.....++..+.+++.+||+.+|.+|||+.+++.+
T Consensus 219 ~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 219 FYGLSDEEVL-NRLQAGK--LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ccccchHHHH-HHHHcCC--cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 9775554433 3333222 2223345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=265.12 Aligned_cols=201 Identities=27% Similarity=0.470 Sum_probs=163.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++......|+||||+.+|+|.+++... .+.+++..+..++.|++.||+|||++|++||||||+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni 131 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNC 131 (256)
T ss_pred HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceE
Confidence 35689999999999999999999999999999999887643 34589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.++|+|||++........ .......++..|+|||.+. +..++.++|||||||++|+|++ |..||......
T Consensus 132 ~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05112 132 LVGENQVVKVSDFGMTRFVLDDQY--TSSTGTKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208 (256)
T ss_pred EEcCCCeEEECCCcceeecccCcc--cccCCCccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999999999999998865422111 1111233567899999987 5678899999999999999998 99999876554
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
... ..+.... ....+...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 209 ~~~-~~~~~~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 209 EVV-ETINAGF---RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHH-HHHhCCC---CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 433 3333221 112234468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=268.10 Aligned_cols=200 Identities=24% Similarity=0.410 Sum_probs=162.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+ ...|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+||
T Consensus 61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~ni 138 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV 138 (270)
T ss_pred HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheE
Confidence 356899999999999875 5678999999999999998653 34589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++....... ........++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....
T Consensus 139 li~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~ 215 (270)
T cd05056 139 LVSSPDCVKLGDFGLSRYLEDES--YYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215 (270)
T ss_pred EEecCCCeEEccCceeeeccccc--ceecCCCCccccccChhhhc-cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999876442221 11111233456799999986 5678999999999999999986 99999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+.......... ...+..++..+.++|.+||..+|.+|||+.+++..
T Consensus 216 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 216 DVIGRIENGER----LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54433332221 12345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=272.26 Aligned_cols=206 Identities=23% Similarity=0.372 Sum_probs=162.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ----------DGFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~----------~~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
|+.++||||++++++|.....+|+|||||.+++|.+++..... ..+++..+..++.||+.||.|||++|+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 150 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF 150 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 4678999999999999999999999999999999998864310 136888999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh--
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-- 148 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-- 148 (583)
+||||||+|||++.++.+||+|||++....... .........++..|+|||.+. ...++.++|||||||++|+|++
T Consensus 151 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD-YYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred eccccChhhEEEcCCCcEEecccccccccccCc-ceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcC
Confidence 999999999999999999999999987543221 111222345577899999987 5678999999999999999987
Q ss_pred CCCCCCCCChHHHHHHHHh---cCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 149 GHAPFSKYPPMKVLLMTIQ---NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 149 G~~PF~~~~~~~~l~~~i~---~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|..||......+.+..... .............++..+++||.+||..+|.+|||+.+|++
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7788877655443322211 11111112233457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=269.30 Aligned_cols=199 Identities=21% Similarity=0.356 Sum_probs=160.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.. ...+++|||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 64 ~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil 141 (279)
T cd05109 64 AGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141 (279)
T ss_pred HhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 56799999999999875 4578999999999999988653 356899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||+++...... .........+++.|+|||.+. ...++.++|||||||++|||++ |..||.......
T Consensus 142 ~~~~~~~kL~dfG~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 142 VKSPNHVKITDFGLARLLDIDE-TEYHADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred EcCCCcEEECCCCceeeccccc-ceeecCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999987542211 111111234467899999987 5678999999999999999998 999997755433
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+...+.... ..+.+..++..+.++|.+||..||.+||++.+++.
T Consensus 220 -~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 220 -IPDLLEKGE---RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -HHHHHHCCC---cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 223333321 12223567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=277.93 Aligned_cols=202 Identities=23% Similarity=0.451 Sum_probs=163.0
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
+++ +||||++++++|..++.+|+||||+.+|+|.+++..... ..++...+..++.||+.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 151 (334)
T cd05100 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA 151 (334)
T ss_pred HhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 455 799999999999999999999999999999999875321 23778889999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++|++||||||+|||++.++.+||+|||+++...... .........++..|+|||++. ...++.++|||||||++|+|
T Consensus 152 ~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el 229 (334)
T cd05100 152 SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID-YYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEI 229 (334)
T ss_pred HCCeeccccccceEEEcCCCcEEECCcccceeccccc-ccccccCCCcCceEcCHHHhc-cCCcCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999999986542211 111112233456799999997 56789999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+.+..+.. ..+.... .......++..+.+||.+||..+|.+|||+.+++++
T Consensus 230 ~~~g~~p~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 230 FTLGGSPYPGIPVEELF-KLLKEGH---RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HhcCCCCCCCCCHHHHH-HHHHcCC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 98 89999886654443 3333221 122334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=264.35 Aligned_cols=196 Identities=24% Similarity=0.452 Sum_probs=160.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++..+ ..|+||||+.+|+|.+++.......+++..+..++.|++.||.|||++|++||||||+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~ni 131 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNI 131 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceE
Confidence 3578999999999998754 579999999999999998765445689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||++...... ......+..|+|||.+. ...++.++|+|||||++|+|++ |..||......
T Consensus 132 li~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 132 LVSEDGVAKVSDFGLARVGSMG------VDNSKLPVKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred EEcCCCcEEECCCccceecccc------CCCCCCCceecCHHHhc-cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 9999999999999988643211 11223456799999987 5678999999999999999997 99999876554
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.. ..+... ........++..+++++.+||+.+|.+||++.+++.
T Consensus 205 ~~~-~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 205 EVK-ECVEKG---YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHH-HHHhCC---CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 333 333322 122233567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=264.59 Aligned_cols=200 Identities=23% Similarity=0.444 Sum_probs=163.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|+||+++++++.+ ...|+||||+++|+|.+++.......+++..+..++.||+.||.|||+.|++||||||+||
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 133 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 133 (260)
T ss_pred HHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence 457899999999999987 7889999999999999998765445688899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
+++.++.+||+|||.+....... ........++..|+|||.+. ...++.++|+|||||++|+|++ |+.||.+....
T Consensus 134 ~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 134 LVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred EEcCCCcEEECCCcceeeccCCC--cccccCCcccccccCHhHhc-cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999886542211 11112234567799999987 5678999999999999999998 99999876554
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
... ..+... ...+....++.++.+++.+||.++|.+||++.+++.
T Consensus 211 ~~~-~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 211 EVI-RALERG---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHH-HHHhCC---CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 433 233322 122334567889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=290.63 Aligned_cols=206 Identities=29% Similarity=0.467 Sum_probs=181.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|..++||.||.+.+.|++.+.+++|||-+. |+.++.|-....+.++|.....++.||+.||.|||-+||+|.||||+||
T Consensus 617 Lq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENV 695 (888)
T KOG4236|consen 617 LQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENV 695 (888)
T ss_pred HHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchhe
Confidence 356899999999999999999999999995 5555555555678899999999999999999999999999999999999
Q ss_pred EEcCCC---cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNG---VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g---~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|+.... ++||||||+|+.+.+.. .+...+|||.|+|||+++ +.+|+..-|+||+|||+|.-|.|..||...
T Consensus 696 LLas~~~FPQvKlCDFGfARiIgEks----FRrsVVGTPAYLaPEVLr-nkGyNrSLDMWSVGVIiYVsLSGTFPFNEd- 769 (888)
T KOG4236|consen 696 LLASASPFPQVKLCDFGFARIIGEKS----FRRSVVGTPAYLAPEVLR-NKGYNRSLDMWSVGVIIYVSLSGTFPFNED- 769 (888)
T ss_pred eeccCCCCCceeeccccceeecchhh----hhhhhcCCccccCHHHHh-hccccccccceeeeEEEEEEecccccCCCc-
Confidence 996543 79999999998774432 234579999999999998 789999999999999999999999999653
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+.+...|++....++...|..++..+.+||..+|+..-.+|.|+...|.|||+++.
T Consensus 770 --EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 770 --EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred --cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 44566788887777888899999999999999999999999999999999999865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=304.43 Aligned_cols=95 Identities=37% Similarity=0.663 Sum_probs=89.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++...+++|||||||.||+|.+++... +.+++..++.|+.||+.||.|||.+||+||||||+||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NI 135 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM 135 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHE
Confidence 35679999999999999999999999999999999998653 5689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCcc
Q 007967 81 LLDTNGVVKLADFGVSA 97 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~ 97 (583)
||+.++.+||+|||+++
T Consensus 136 Ll~~~g~vkL~DFGls~ 152 (669)
T cd05610 136 LISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEcCCCCEEEEeCCCCc
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=278.14 Aligned_cols=207 Identities=25% Similarity=0.401 Sum_probs=164.5
Q ss_pred CCCCCCCcccceEEEEEE-CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||++++++|.. ...+|+||||+ +++|..++. ...+++..+..++.||+.||.|||++||+||||+|.|
T Consensus 63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~N 138 (328)
T cd07856 63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSN 138 (328)
T ss_pred HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 356899999999999976 56799999999 678887765 3568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.++|+|||++..... ......+++.|+|||.+.+...++.++|||||||++|+|++|.+||......
T Consensus 139 ili~~~~~~~l~dfg~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 139 ILINENCDLKICDFGLARIQDP------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred EeECCCCCEEeCccccccccCC------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999998764311 1123567889999999875567899999999999999999999999775542
Q ss_pred HHHHHHHh-----------------------cCCCCCCc---cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 160 KVLLMTIQ-----------------------NAPPGLDY---DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 160 ~~l~~~i~-----------------------~~~~~~~~---~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
........ ........ .....++..++++|.+||+.+|.+|||+++++.||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 22111110 00000000 11134678999999999999999999999999999997
Q ss_pred cCCC
Q 007967 214 HAKP 217 (583)
Q Consensus 214 ~~~~ 217 (583)
....
T Consensus 293 ~~~~ 296 (328)
T cd07856 293 PYHD 296 (328)
T ss_pred cccC
Confidence 6553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=266.42 Aligned_cols=200 Identities=24% Similarity=0.411 Sum_probs=162.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.. ...++||||+.+|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ni 140 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNV 140 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceE
Confidence 456899999999999987 7899999999999999988654 34589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++........ .......++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....
T Consensus 141 l~~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 141 LVKTPQHVKITDFGLAKLLDVDEKE-YHAEGGKVPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred EEcCCCeEEECCCcccccccCcccc-eecCCCcccccccCHHHhh-cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998754322111 1111223456799999986 5678999999999999999998 99999886654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.. ..+.... ....+..++..+.+++.+||..+|.+|||+.++++
T Consensus 219 ~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 219 EIP-DLLEKGE---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHH-HHHhCCC---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 433 3333221 12233457788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=266.82 Aligned_cols=202 Identities=22% Similarity=0.411 Sum_probs=163.6
Q ss_pred CCCCCCCcccceEEEEEE-CCEEEEEEecCCCCCHHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 1 MSLIDHPNVIRAYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAYQ------DGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~~------~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
|+.++||||+++++++.. +...++++||+.+|+|.+++..... ..+++..+..++.||+.||+|||++|++||
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 141 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK 141 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 356899999999998776 5779999999999999999876432 358999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCC
Q 007967 74 DVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAP 152 (583)
Q Consensus 74 DLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~P 152 (583)
||||+||+++.++.+||+|||+++.+..... ........++..|+|||.+. ...++.++|||||||++|++++ |..|
T Consensus 142 di~p~nil~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p 219 (280)
T cd05043 142 DIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTP 219 (280)
T ss_pred ccCHhhEEEcCCCcEEECCCCCcccccCCce-EEeCCCCCcchhccCHHHHh-cCCCCchhhHHHhHHHHHHHhcCCCCC
Confidence 9999999999999999999999875533211 11112234567899999987 5678999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|......+.. ..+... ........+++.+++++.+||..+|++|||+.++++
T Consensus 220 ~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 220 YVEIDPFEMA-AYLKDG---YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCcCCHHHHH-HHHHcC---CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9876654433 333322 122233457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=268.56 Aligned_cols=203 Identities=22% Similarity=0.373 Sum_probs=156.7
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++.. ...+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ 137 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence 357899999999998754 35699999999999999988643 345899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+++.++.+||+|||++.................++..|+|||.+. +..++.++|||||||++|||++|..|+.....
T Consensus 138 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred hEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 99999999999999999875532221111111223445699999987 56789999999999999999998777643221
Q ss_pred HH---------------HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 MK---------------VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~~---------------~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.. .+...+... ...+....++..+.+||.+||..+|.+|||+.+|++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNN---GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcC---CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 10 011111111 112233567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=297.91 Aligned_cols=201 Identities=21% Similarity=0.422 Sum_probs=174.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ------------DGFEESAIGSILKETLKALDYLHRQ 68 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~------------~~~sE~~i~~I~~QIl~gL~yLHs~ 68 (583)
|..|+|||||+|+++|..++.+|+|+|||..|+|.++++...+ ..++..+...|+.||+.|++||-++
T Consensus 543 la~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~ 622 (774)
T KOG1026|consen 543 LAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH 622 (774)
T ss_pred HHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4578999999999999999999999999999999999987532 2278899999999999999999999
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH 148 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt 148 (583)
.+|||||...|+||..+..|||+|||+++.++..+.+....++ .-..+|||||.+. ..+|+.++||||+||+|||+++
T Consensus 623 ~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t-~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFs 700 (774)
T KOG1026|consen 623 HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNT-LLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFS 700 (774)
T ss_pred cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCc-eeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhc
Confidence 9999999999999999999999999999988766554433233 3367899999998 6789999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHH
Q 007967 149 -GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207 (583)
Q Consensus 149 -G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL 207 (583)
|..||.+....+.+..+ +.+.. .+.+..++.++++|+..||+..|.+||++.||-
T Consensus 701 yG~QPy~glSn~EVIe~i-~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 701 YGKQPYYGLSNQEVIECI-RAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cccCcccccchHHHHHHH-HcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 99999998887766444 43322 456678999999999999999999999999884
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=261.82 Aligned_cols=199 Identities=24% Similarity=0.468 Sum_probs=163.9
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGN 79 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeN 79 (583)
.++||||++++++|.+++..|+||||++|++|.+++... ....+++..++.++.|++.||.|||. .|++|+||+|.|
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~n 144 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNN 144 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHH
Confidence 579999999999999999999999999999999887543 23468999999999999999999996 789999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.++|+|||++....... ......|+..|+|||.+. ...++.++|+|||||++|+|++|..||......
T Consensus 145 il~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~ 219 (269)
T cd08528 145 IMLGEDDKVTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219 (269)
T ss_pred EEECCCCcEEEecccceeeccccc----ccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence 999999999999999986543221 223457899999999998 556899999999999999999999999775544
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
............. .....++..+.++|.+||+.||.+||++.++..+
T Consensus 220 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 220 SLATKIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHhhccCCc---CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 4333332222111 1123578899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=273.43 Aligned_cols=203 Identities=27% Similarity=0.444 Sum_probs=163.8
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|..++|+|||+++.+|.-. ..+|+|||||. ++|...+. ..++-..+..|++|+++|++|||+.||+|||
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRd 143 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRD 143 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecc
Confidence 5678999999999999743 35999999994 66776665 3477889999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+||++..++.+||+|||+|+.-. .....+.++.|.+|.|||++. +..|.+.+||||+||++.||++|+..|.
T Consensus 144 LkPsnivv~~~~~lKi~dfg~ar~e~----~~~~mtpyVvtRyyrapevil-~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 144 LKPSNIVVNSDCTLKILDFGLARTED----TDFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred cCcccceecchhheeeccchhhcccC----cccccCchhheeeccCchhee-ccCCcccchhhhhhhHHHHHhhceEEec
Confidence 99999999999999999999987431 223345689999999999998 5669999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCC---------------------------------CCCCc----cccccchHHHHHHHHhhhcCCC
Q 007967 155 KYPPMKVLLMTIQNAP---------------------------------PGLDY----DRDKKFSKSFKEMVAMCLVKDQ 197 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~---------------------------------~~~~~----~~~~~~S~~lkdLI~~cL~~DP 197 (583)
+.+..++...++.... +...+ +..+.-+..+++++.+||..||
T Consensus 219 g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~p 298 (369)
T KOG0665|consen 219 GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDP 298 (369)
T ss_pred CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccCh
Confidence 8766555433332110 00000 0011223558999999999999
Q ss_pred CCCCCHHHHHhccccc
Q 007967 198 TKRPTAEKLLKHSFFK 213 (583)
Q Consensus 198 ~kRpTa~eIL~HpfFk 213 (583)
++|.++.++|+||||+
T Consensus 299 e~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 299 EKRISVDDALRHPYIK 314 (369)
T ss_pred hhcccHHHHhcCCeee
Confidence 9999999999999998
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=264.40 Aligned_cols=202 Identities=25% Similarity=0.432 Sum_probs=160.7
Q ss_pred CCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.+.||||+++++++.. ....|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+|
T Consensus 61 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n 139 (284)
T cd05038 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARN 139 (284)
T ss_pred HhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 56899999999999987 56899999999999999998653 3359999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|+++.++.++|+|||++.................++..|+|||.+. ...++.++|||||||++|+|++|..||......
T Consensus 140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 218 (284)
T cd05038 140 ILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218 (284)
T ss_pred EEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc-cCCCCcccchHHHhhhhheeeccCCCcccccch
Confidence 9999999999999999876532221111112234556799999987 557889999999999999999999998653221
Q ss_pred --------------HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 --------------KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 --------------~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..+...+... ...+....++.++.+|+.+||..+|.+|||+.+|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 219 FLRMIGIAQGQMIVTRLLELLKEG---ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred hccccccccccccHHHHHHHHHcC---CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122222221 122333456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=281.81 Aligned_cols=203 Identities=20% Similarity=0.388 Sum_probs=165.1
Q ss_pred CCCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-------------------------------------
Q 007967 2 SLID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ------------------------------------- 43 (583)
Q Consensus 2 k~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~------------------------------------- 43 (583)
..+. |||||+++++|...+.+|+|||||.+|+|.+++.....
T Consensus 95 ~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (401)
T cd05107 95 SHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES 174 (401)
T ss_pred HhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence 4565 99999999999999999999999999999999865321
Q ss_pred -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 007967 44 -----------------------------------------------------------DGFEESAIGSILKETLKALDY 64 (583)
Q Consensus 44 -----------------------------------------------------------~~~sE~~i~~I~~QIl~gL~y 64 (583)
..+++..+..|+.||+.||.|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 254 (401)
T cd05107 175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF 254 (401)
T ss_pred CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 136777889999999999999
Q ss_pred HHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHh
Q 007967 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITAL 144 (583)
Q Consensus 65 LHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILy 144 (583)
||+.|++||||||+|||++.++.+||+|||+++........ .......+++.|+|||.+. ...++.++|||||||++|
T Consensus 255 LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~ 332 (401)
T cd05107 255 LASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIF-NNLYTTLSDVWSFGILLW 332 (401)
T ss_pred HhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhc-CCCCCcHhHHHHHHHHHH
Confidence 99999999999999999999999999999998754322211 1122346788899999997 567899999999999999
Q ss_pred hhhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 145 ELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 145 eLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
||++ |..||......+.....+.... ....+..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 333 e~l~~g~~P~~~~~~~~~~~~~~~~~~---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQFYNAIKRGY---RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCCCCCCCchHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9998 8999987665555444444321 122334678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=304.40 Aligned_cols=202 Identities=25% Similarity=0.496 Sum_probs=177.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-----QDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-----~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++|||||++.+++.+....+|++|||+||+|+.+|+..+ ...++..+...++.+|++|+.||+++++|||||
T Consensus 749 m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL 828 (1025)
T KOG1095|consen 749 MSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL 828 (1025)
T ss_pred HhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence 788999999999999999999999999999999999998753 345889999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFS 154 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~ 154 (583)
...|+|++....+||+|||+|+.++....+... ....-...|||||.+. ...++.|+|||||||++||+++ |..||.
T Consensus 829 AaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~-d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 829 AARNCLLDERRVVKIADFGLARDIYDKDYYRKH-GEAMLPVKWMPPESLK-DGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred hhhheeecccCcEEEcccchhHhhhhchheecc-CccccceecCCHHHHh-hcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999966554433322 2223346799999998 5789999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+....+.+....... ..+.+..++..+.+++..||..+|++||++..|++
T Consensus 907 ~~~n~~v~~~~~~gg----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 907 SRSNFEVLLDVLEGG----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CcchHHHHHHHHhCC----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 988888877666665 44556789999999999999999999999999987
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=302.91 Aligned_cols=206 Identities=22% Similarity=0.377 Sum_probs=162.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY---------QDGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~---------~~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
|+.++||||+++++++.+++..|+|||||+||+|.+++.... ...++...+..++.||+.||+|||++||+
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GII 135 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL 135 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 356899999999999999999999999999999999886432 12356677889999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEEecCCccccccCCCC---------------ccccccccCCCCCCCcccccCCCCCCccccc
Q 007967 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR---------------QRSRNTFVGTPCWMAPEVLQPGSGYNSKADI 136 (583)
Q Consensus 72 HRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~---------------~~~~~~~~GT~~Y~APEil~~~~~ys~ksDI 136 (583)
||||||+|||++.+|.+||+|||++......... .......+||+.|+|||.+. +..++.++||
T Consensus 136 HRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-g~~~S~kSDI 214 (932)
T PRK13184 136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDI 214 (932)
T ss_pred ccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-CCCCCcHhHH
Confidence 9999999999999999999999998754111100 01112357999999999987 5678999999
Q ss_pred cchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 137 WSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 137 WSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|||||++|+|++|..||......+.........+ ........+++.+.+++.+||..||.+|++..+.+.+
T Consensus 215 WSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P--~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 215 YALGVILYQMLTLSFPYRRKKGRKISYRDVILSP--IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhhhhhhhccCh--hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999987554433322111111 1112234678899999999999999999887665544
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.65 Aligned_cols=201 Identities=21% Similarity=0.398 Sum_probs=160.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|... ..++||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 63 ~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Ni 140 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNV 140 (303)
T ss_pred HHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeecccccccee
Confidence 3568999999999998754 578999999999999987653 34689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++...... .........++..|+|||.+. +..++.++|||||||++|+|++ |..||.+....
T Consensus 141 ll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~ 218 (303)
T cd05110 141 LVKSPNHVKITDFGLARLLEGDE-KEYNADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218 (303)
T ss_pred eecCCCceEEccccccccccCcc-cccccCCCccccccCCHHHhc-cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999987543211 111122345577899999987 5678999999999999999997 99999876543
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
. ....+.... ..+.+..++..+.+++..||..+|.+||++.++++.
T Consensus 219 ~-~~~~~~~~~---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 219 E-IPDLLEKGE---RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred H-HHHHHHCCC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 223333221 122234567889999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.07 Aligned_cols=202 Identities=23% Similarity=0.390 Sum_probs=159.4
Q ss_pred CC-CCCcccceEEEEEEC-CEEEEEEecCCCCCHHHHHHHHh--------------------------------------
Q 007967 3 LI-DHPNVIRAYCSFVVD-SNLWVVMPFMAEGSCLHLMKIAY-------------------------------------- 42 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~-~~l~LVmEy~~GGsL~dll~~~~-------------------------------------- 42 (583)
.+ +||||++++++|... ..+++|||||.+|+|.+++....
T Consensus 66 ~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (343)
T cd05103 66 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQ 145 (343)
T ss_pred hccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccc
Confidence 45 789999999988654 56899999999999999886431
Q ss_pred ---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCC
Q 007967 43 ---------------------------QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGV 95 (583)
Q Consensus 43 ---------------------------~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGl 95 (583)
...+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~ 225 (343)
T cd05103 146 SSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL 225 (343)
T ss_pred ccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEeccc
Confidence 12367888899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 007967 96 SACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLD 174 (583)
Q Consensus 96 A~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~ 174 (583)
+.......... ......++..|+|||.+. ...++.++|||||||++|+|++ |..||............+.... .
T Consensus 226 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~ 300 (343)
T cd05103 226 ARDIYKDPDYV-RKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---R 300 (343)
T ss_pred ccccccCcchh-hcCCCCCCcceECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---C
Confidence 87543222111 112234567799999987 5678999999999999999996 9999977544333333333322 1
Q ss_pred ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 175 ~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
...+..+++.+.+++..||..+|.+|||+.+|++|
T Consensus 301 ~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12233467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=252.21 Aligned_cols=203 Identities=40% Similarity=0.668 Sum_probs=170.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++|+||+++++++......++||||+.+++|.+++... ..+++..+..++.+++.+|.|||+.|++|+||+|.||+
T Consensus 42 ~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~ 119 (244)
T smart00220 42 KKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENIL 119 (244)
T ss_pred HhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeE
Confidence 4679999999999999999999999999999999988753 33899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.++|+|||.+....... ......++..|++||.+. ...++.++|||+||+++|+|++|..||........
T Consensus 120 ~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~ 194 (244)
T smart00220 120 LDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEYMAPEVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE 194 (244)
T ss_pred ECCCCcEEEccccceeeecccc----ccccccCCcCCCCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999987553321 223457888999999987 56788899999999999999999999987444455
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
....+........ .....++..+.+++.+||..+|.+||++.++++||||
T Consensus 195 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 195 LFKKIGKPKPPFP-PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHhccCCCCc-cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 5444444332221 1111278899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=251.38 Aligned_cols=211 Identities=25% Similarity=0.384 Sum_probs=173.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.+.|.|||+++++...+..+-+|+|||. .+|..+.... .+.++.+.++.++.|+++||.|||++++.||||||.|+
T Consensus 55 lkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnl 132 (292)
T KOG0662|consen 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNL 132 (292)
T ss_pred HHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceE
Confidence 467899999999999999999999999994 5677776554 57799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
||+.+|.+|++|||+++-+ +.+.+.....+-|.||++|.++.+..-|+...|+||.|||+.|+.. |++.|.+.+-.
T Consensus 133 lin~ngelkladfglaraf---gipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 133 LINRNGELKLADFGLARAF---GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred EeccCCcEEecccchhhhc---CCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 9999999999999999754 2233333445779999999999988899999999999999999986 89999987766
Q ss_pred HHHHHHHhcC--CCCCCc------------cc----------cccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 160 KVLLMTIQNA--PPGLDY------------DR----------DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 160 ~~l~~~i~~~--~~~~~~------------~~----------~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+++..+.... +....+ +. -+++...-+++++++|.-+|..|++++++++||||.+.
T Consensus 210 dqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred HHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 6665554321 111111 10 02234456899999999999999999999999999865
Q ss_pred C
Q 007967 216 K 216 (583)
Q Consensus 216 ~ 216 (583)
.
T Consensus 290 s 290 (292)
T KOG0662|consen 290 S 290 (292)
T ss_pred C
Confidence 3
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=285.95 Aligned_cols=200 Identities=29% Similarity=0.464 Sum_probs=169.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++++|||||++|++...+..++||||+|.||+|.++|+.. ++.++..+...++.+.++||+|||++++|||||...|+
T Consensus 215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNc 293 (474)
T KOG0194|consen 215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNC 293 (474)
T ss_pred HHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHh
Confidence 67899999999999999999999999999999999999875 33699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++.-. ..........-...|+|||.+. ...|++++|||||||++||+++ |..||.+....
T Consensus 294 L~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~-~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 294 LYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLN-TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred eecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhc-cCccccccchhheeeeEEeeeccCCCCCCCCCHH
Confidence 99999999999999986431 1111110112356899999998 4589999999999999999998 89999998877
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+....++.+. +....+...+..+..++..|+..+|.+|||+.++.+
T Consensus 370 ~v~~kI~~~~---~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 370 EVKAKIVKNG---YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHhcC---ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 6665554543 333444577889999999999999999999998865
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=264.94 Aligned_cols=201 Identities=20% Similarity=0.310 Sum_probs=154.6
Q ss_pred CCCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
..++|+||+++++++.... ..+++|+++ ..++.+++... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp 154 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKP 154 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 4578999999999876544 457889987 44666665542 3468899999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
+|||++.++.++|+|||+|+.+...+... .......||+.|+|||++. +..++.++|||||||++|+|++|..||
T Consensus 155 ~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-~~~~~~~~DiwSlG~~l~el~~g~~P~ 233 (294)
T PHA02882 155 ENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-GACVTRRGDLESLGYCMLKWAGIKLPW 233 (294)
T ss_pred HHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999987654322111 1123357999999999987 667999999999999999999999999
Q ss_pred CCCChHHHHHH-----HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 154 SKYPPMKVLLM-----TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 154 ~~~~~~~~l~~-----~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.+......... .+...... .......++.+.+++..|+..+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 234 KGFGHNGNLIHAAKCDFIKRLHEG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CccccchHHHHHhHHHHHHHhhhh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 87633222111 11111100 0112345788999999999999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=262.40 Aligned_cols=222 Identities=24% Similarity=0.374 Sum_probs=172.0
Q ss_pred CCCCCCcccceEEEEEE--------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 2 SLIDHPNVIRAYCSFVV--------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d--------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
.+|.|+|++.++++|.. ...+|+||++|+ -+|.-++.. ....|+..+|..++.+++.||.|+|++.|+||
T Consensus 71 ~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHR 148 (376)
T KOG0669|consen 71 QLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHR 148 (376)
T ss_pred HHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhh
Confidence 46789999999988754 234999999995 557666643 23569999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCccccccCCCCccc-cccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 74 DVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS-RNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 74 DLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~-~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
|+|+.|+||+.+|.+||+|||+++.+......... .+..+-|+||++||.+.+.+.|+++.|||..|||+.||++|.+.
T Consensus 149 DmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 149 DMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred cccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc
Confidence 99999999999999999999999765433222221 12356799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHh--cCCCCCCccc------c-------------cc---------chHHHHHHHHhhhcCCCCCCCC
Q 007967 153 FSKYPPMKVLLMTIQ--NAPPGLDYDR------D-------------KK---------FSKSFKEMVAMCLVKDQTKRPT 202 (583)
Q Consensus 153 F~~~~~~~~l~~~i~--~~~~~~~~~~------~-------------~~---------~S~~lkdLI~~cL~~DP~kRpT 202 (583)
|.+.++...+..+-. +......|+. + .. -.+++.+|+.+||..||.+|++
T Consensus 229 mqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 229 MQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID 308 (376)
T ss_pred ccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc
Confidence 998777655432211 1111100100 0 00 1346889999999999999999
Q ss_pred HHHHHhccccccCCCCchhhhhh
Q 007967 203 AEKLLKHSFFKHAKPPELSVKKL 225 (583)
Q Consensus 203 a~eIL~HpfFk~~~~~~~~~~~~ 225 (583)
+.++|+|.||+.-..+...+...
T Consensus 309 ad~alnh~~F~kdp~pqanl~~m 331 (376)
T KOG0669|consen 309 ADQALNHDFFWKDPMPQANLQDM 331 (376)
T ss_pred hHhhhchhhhhcCCcchhhHHHH
Confidence 99999999999876664444443
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=257.19 Aligned_cols=203 Identities=24% Similarity=0.418 Sum_probs=159.8
Q ss_pred CCCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQ----DGFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~~----~~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
|+.++||||+++++++.... ..++++||+.+|+|.+++..... ..+++..+..++.||+.||+|||++||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i 134 (273)
T cd05074 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNF 134 (273)
T ss_pred HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 46789999999999987542 24789999999999887754321 247899999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-C
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-G 149 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G 149 (583)
+||||||+||+++.++.+||+|||+++...... .........+++.|++||.+. ...++.++|||||||++|+|++ |
T Consensus 135 ~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~-~~~~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 135 IHRDLAARNCMLNENMTVCVADFGLSKKIYSGD-YYRQGCASKLPVKWLALESLA-DNVYTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred eecccchhhEEEcCCCCEEECcccccccccCCc-ceecCCCccCchhhcCHhHHh-cCccchhhhhHHHHHHHHHHhhCC
Confidence 999999999999999999999999987543211 111112334567899999987 5678899999999999999998 8
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.+||.+....+.......... ......++..+.+++.+||+.+|.+||++.+++++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 213 QTPYAGVENSEIYNYLIKGNR----LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCCCHHHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999987655443333332221 12224577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=286.53 Aligned_cols=205 Identities=23% Similarity=0.378 Sum_probs=167.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+++-+|-||+-+.++|..... .||+-+|+|-+|..++... ...|.....+.|++||++|+.|||.++|||||||..||
T Consensus 442 lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNI 519 (678)
T KOG0193|consen 442 LKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNI 519 (678)
T ss_pred HhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccce
Confidence 467799999999999987777 9999999999999988765 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|+.+++.|||+|||++..-.... ........-|...|||||+++. ...|++.+|||||||++|||++|..||.....
T Consensus 520 Fl~~~~kVkIgDFGLatvk~~w~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 520 FLHEDLKVKIGDFGLATVKTRWS-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred EEccCCcEEEecccceeeeeeec-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 99999999999999986432111 1112234578889999999874 56799999999999999999999999996555
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..+++++-++.-..-........++++++|+..||.+++++||.+.+||.
T Consensus 599 dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 599 DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 55555544442111122233567889999999999999999999999986
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=260.48 Aligned_cols=206 Identities=26% Similarity=0.413 Sum_probs=160.6
Q ss_pred CCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Q 007967 2 SLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQD--GFEESAIGSILKETLKALDYLHRQG--HIH 72 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~--~~sE~~i~~I~~QIl~gL~yLHs~g--IvH 72 (583)
++++||||++++++...+ ...|||++|...|+|.+.+.....+ .++|.++..|+.+|++||++||+.. ++|
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence 578999999999877543 3499999999999999998865433 4899999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccC--CCCc----cccccccCCCCCCCcccccC--CCCCCccccccchhhHHh
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDT--GDRQ----RSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITAL 144 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~--~~~~----~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILy 144 (583)
|||||.|||+..++.++|.|||.+....-. +... .....-..|..|+|||.+.- +...+.++|||||||++|
T Consensus 153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 999999999999999999999987543111 1000 00012346899999999863 345688999999999999
Q ss_pred hhhhCCCCCCCCChHH-HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 145 ELAHGHAPFSKYPPMK-VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 145 eLLtG~~PF~~~~~~~-~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.|+.|..||...-... -+...+.+ ..+.++....+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 233 a~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 233 AMMFGESPFERIYQQGGSLALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHcCCcchHHhhcCCeEEEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999996421100 01111112 234455556799999999999999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=269.58 Aligned_cols=204 Identities=26% Similarity=0.378 Sum_probs=155.9
Q ss_pred CCCCCCCcccceEEEEEECC-EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS-NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG---HIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~-~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g---IvHRDLK 76 (583)
|..++|||||+|++||.+.+ ..+||+|||++|+|.+.+.......++|....+|+.++++||+|||... |||||||
T Consensus 125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK 204 (361)
T KOG1187|consen 125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK 204 (361)
T ss_pred HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence 46789999999999999998 5999999999999999887542227899999999999999999999864 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccc-cCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF-VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~-~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
+.|||+|.+.+.||+|||+|+..... .....+. .||.+|+|||.+. ....+.++|||||||++.||++|+.+...
T Consensus 205 ssNILLD~~~~aKlsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~-~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 205 SSNILLDEDFNAKLSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYAS-TGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred HHHeeECCCCCEEccCccCcccCCcc---ccceeeecCCCCccCChhhhc-cCCcCcccccccchHHHHHHHhCCcccCC
Confidence 99999999999999999999543211 1111122 8999999999997 45789999999999999999999988764
Q ss_pred CC---h---HHHHHHHHhcCC--CCCCcccc-cc-----chHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 156 YP---P---MKVLLMTIQNAP--PGLDYDRD-KK-----FSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 156 ~~---~---~~~l~~~i~~~~--~~~~~~~~-~~-----~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.. . .+.....+.... .-++.... .. .-..+..+..+|+..+|.+||+..++++
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 32 1 111111222210 01111100 11 2334678888999999999999998754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=280.48 Aligned_cols=200 Identities=23% Similarity=0.286 Sum_probs=142.2
Q ss_pred EECCEEEEEEecCCCCCHHHHHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 17 VVDSNLWVVMPFMAEGSCLHLMKIAYQ------------------DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 17 ~d~~~l~LVmEy~~GGsL~dll~~~~~------------------~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
..+..+||||||+.+++|.+++..... ....+..+..++.||+.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 356679999999999999998864210 01224457789999999999999999999999999
Q ss_pred cEEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC---------------------CCCCccccc
Q 007967 79 NILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG---------------------SGYNSKADI 136 (583)
Q Consensus 79 NILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~---------------------~~ys~ksDI 136 (583)
|||++. ++.+||+|||+|+.+..... .....++|++.|+|||.+... ..++.++||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 999985 58999999999875432211 122457899999999976421 124556799
Q ss_pred cchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCC-----------CC------ccccccchHHHHHHHHhhhcCCCCC
Q 007967 137 WSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG-----------LD------YDRDKKFSKSFKEMVAMCLVKDQTK 199 (583)
Q Consensus 137 WSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~-----------~~------~~~~~~~S~~lkdLI~~cL~~DP~k 199 (583)
|||||++|||+++..++.. ....+...+...... .. +.........+.+||.+||++||.+
T Consensus 363 wSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999997766533 222222222211000 00 0000112334569999999999999
Q ss_pred CCCHHHHHhccccccCCCCch
Q 007967 200 RPTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 200 RpTa~eIL~HpfFk~~~~~~~ 220 (583)
|||+.++|+||||........
T Consensus 441 R~ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 441 RISAKAALAHPYFDREGLLGL 461 (566)
T ss_pred CCCHHHHhCCcCcCCCCcccc
Confidence 999999999999998766433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-31 Score=260.71 Aligned_cols=210 Identities=35% Similarity=0.646 Sum_probs=174.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKI---AYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~---~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLK 76 (583)
|+.-+.||||++|+....++..|+.||+|+ .+|..+.+. ..+..++|..+..|..-.+.||.||-.. .|||||+|
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK 195 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK 195 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence 445578999999999999999999999994 555444333 3356799999999999999999999965 89999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC-CCCccccccchhhHHhhhhhCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS-GYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~-~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|+|||++..|.|||||||++..+..+- ..+.-.|-..|||||.+.... +|+.++|+||||++|||+.+|+.|+.+
T Consensus 196 PSNILldr~G~vKLCDFGIcGqLv~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 196 PSNILLDRHGDVKLCDFGICGQLVDSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred hhheEEecCCCEeeecccchHhHHHHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 999999999999999999987664332 222347888999999998644 599999999999999999999999988
Q ss_pred CCh-HHHHHHHHhcCCCCCCcccc-ccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 156 YPP-MKVLLMTIQNAPPGLDYDRD-KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 156 ~~~-~~~l~~~i~~~~~~~~~~~~-~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+.. .+++.....+.++.+..... .+++..++.||.-||.+|-..||...+++++||++..
T Consensus 272 w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 272 WDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 765 44555555666665554433 5689999999999999999999999999999999854
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=266.23 Aligned_cols=211 Identities=24% Similarity=0.381 Sum_probs=171.9
Q ss_pred CCCCCCcccceEEEEE-ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCC
Q 007967 2 SLIDHPNVIRAYCSFV-VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ--GHIHRDVKAG 78 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~-d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~--gIvHRDLKPe 78 (583)
+.|+||-||++|++|. +.+.+|-|+|||+|.+|..+++.. +-++|.+++.|+.||+.||.||.+. -|||-||||.
T Consensus 522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPg 599 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPG 599 (775)
T ss_pred hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCc
Confidence 4689999999999998 557799999999999999888764 6699999999999999999999987 4999999999
Q ss_pred cEEEc---CCCcEEEEecCCccccccCCCC----ccccccccCCCCCCCcccccC---CCCCCccccccchhhHHhhhhh
Q 007967 79 NILLD---TNGVVKLADFGVSACMFDTGDR----QRSRNTFVGTPCWMAPEVLQP---GSGYNSKADIWSFGITALELAH 148 (583)
Q Consensus 79 NILld---~~g~IKL~DFGlA~~~~~~~~~----~~~~~~~~GT~~Y~APEil~~---~~~ys~ksDIWSLGvILyeLLt 148 (583)
|||+- .-|.|||+|||+++.+...... ........||.||++||.+.- ....+.++||||+|||+|.++.
T Consensus 600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 99994 4578999999999866433221 122345789999999999863 2457889999999999999999
Q ss_pred CCCCCCCCChHHHHH-HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 149 GHAPFSKYPPMKVLL-MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 149 G~~PF~~~~~~~~l~-~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
|+.||........++ ....-....+.++..+-++.++++||++||.+.-++|..+.++-.||||..
T Consensus 680 GrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 999997654433332 211111223455566779999999999999999999999999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=284.87 Aligned_cols=205 Identities=26% Similarity=0.384 Sum_probs=161.5
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH-hcCCC-CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA-YQDGF-EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~-~~~~~-sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
+|||||++||.=.+.+.+||..|.| ..+|.+++... ..... .....+.++.|+++||++||+.+||||||||.||||
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI 639 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILI 639 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEE
Confidence 7999999999999999999999999 68899998763 11111 114568899999999999999999999999999999
Q ss_pred cC---CC--cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCC
Q 007967 83 DT---NG--VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKY 156 (583)
Q Consensus 83 d~---~g--~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~ 156 (583)
.. ++ .++|+|||+++++...........+..||-+|+|||++.. ..-..++||||+||++|+.++ |..||...
T Consensus 640 ~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 640 SVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred EccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCch
Confidence 76 34 6899999999887554444444567889999999999984 445669999999999999988 59999764
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
...+. .++.+...-......... ++++||.+||+++|..||+|.++|.||||...
T Consensus 719 ~~R~~--NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 719 LERQA--NILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHhhh--hhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 43322 223332222222212222 89999999999999999999999999999754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=299.17 Aligned_cols=205 Identities=14% Similarity=0.161 Sum_probs=150.6
Q ss_pred CCCCC-CcccceEEEE-------EECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 2 SLIDH-PNVIRAYCSF-------VVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 2 k~L~H-PNIVkl~~~f-------~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
+.+.| +||++++++| .....++++|||+ +++|.+++... ...+++..++.|++||++||+|||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 45677 7999999988 3345688889987 67999998643 3569999999999999999999999999999
Q ss_pred CCCCCcEEEcCC-------------------CcEEEEecCCccccccCCC-------------CccccccccCCCCCCCc
Q 007967 74 DVKAGNILLDTN-------------------GVVKLADFGVSACMFDTGD-------------RQRSRNTFVGTPCWMAP 121 (583)
Q Consensus 74 DLKPeNILld~~-------------------g~IKL~DFGlA~~~~~~~~-------------~~~~~~~~~GT~~Y~AP 121 (583)
||||+||||+.. +.+||+|||+++....... ........+||++||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999654 4456666666543210000 00011224789999999
Q ss_pred ccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC
Q 007967 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP 201 (583)
Q Consensus 122 Eil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp 201 (583)
|++. +..|+.++|||||||+||||++|.+||..... ....+.... ++ +..........+++.+||.++|.+||
T Consensus 185 E~~~-~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~L~~~P~~Rp 257 (793)
T PLN00181 185 EEDN-GSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRV--LP-PQILLNWPKEASFCLWLLHPEPSCRP 257 (793)
T ss_pred hhhc-cCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhh--cC-hhhhhcCHHHHHHHHHhCCCChhhCc
Confidence 9987 56789999999999999999999988754221 111111111 01 00111234567899999999999999
Q ss_pred CHHHHHhccccccC
Q 007967 202 TAEKLLKHSFFKHA 215 (583)
Q Consensus 202 Ta~eIL~HpfFk~~ 215 (583)
++.++++||||...
T Consensus 258 s~~eil~h~~~~~~ 271 (793)
T PLN00181 258 SMSELLQSEFINEP 271 (793)
T ss_pred ChHHHhhchhhhhh
Confidence 99999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=276.97 Aligned_cols=210 Identities=40% Similarity=0.700 Sum_probs=183.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+..+|||||.|++.|...+.+|++||||.||+|.++... .+.++|.++..++++.++||+|||++|-+|||||-.||
T Consensus 66 ~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGani 143 (829)
T KOG0576|consen 66 LRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANI 143 (829)
T ss_pred eecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccce
Confidence 4567999999999999999999999999999999997543 47799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc--CCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ--PGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~--~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++..|.+|++|||.+..+.. ....+..+.||++|||||+-. ...+|...+|||++|++..|+..-++|--...+
T Consensus 144 lltd~gDvklaDfgvsaqita---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp 220 (829)
T KOG0576|consen 144 LLTDEGDVKLADFGVSAQITA---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP 220 (829)
T ss_pred eecccCceeecccCchhhhhh---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch
Confidence 999999999999999887633 233445789999999999853 356799999999999999999998998777788
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+..++..-+............++++.|.+|++.+|.++|++|||++.+|.|||....
T Consensus 221 mr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 221 MRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 887776666554444445557889999999999999999999999999999998765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=259.45 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=159.1
Q ss_pred ccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC----
Q 007967 9 VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT---- 84 (583)
Q Consensus 9 IVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~---- 84 (583)
+|++.++|...++.|||+|.+ |-+++++|..+.-..|+...++.+.+|++.+++|||+.+++|-||||+|||+.+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 567788899999999999998 779999998766677999999999999999999999999999999999999832
Q ss_pred ----------------CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh
Q 007967 85 ----------------NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH 148 (583)
Q Consensus 85 ----------------~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt 148 (583)
+..|+|+|||.|+.... ...+.+.|..|+|||++. +-+++..+||||+||||+||.+
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e------~hs~iVsTRHYRAPEViL-gLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE------HHSTIVSTRHYRAPEVIL-GLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceecc------CcceeeeccccCCchhee-ccCcCCccCceeeeeEEEEeec
Confidence 23589999998864311 224678899999999999 6789999999999999999999
Q ss_pred CCCCCCCCChHHHH--HHHHhcCCC----------------CCCccc-------------cc----------cchHHHHH
Q 007967 149 GHAPFSKYPPMKVL--LMTIQNAPP----------------GLDYDR-------------DK----------KFSKSFKE 187 (583)
Q Consensus 149 G~~PF~~~~~~~~l--~~~i~~~~~----------------~~~~~~-------------~~----------~~S~~lkd 187 (583)
|...|..-...+.+ .+.+.+..+ .++|+. +. .....+.+
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 99999886654433 122211110 111110 00 01234789
Q ss_pred HHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 188 MVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 188 LI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
||++||.+||.+|+|+.|+|.||||+...
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred HHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 99999999999999999999999998653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=268.54 Aligned_cols=201 Identities=25% Similarity=0.455 Sum_probs=171.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||+|+|+++|..+-.+|||+|||..|+|+++++...+..++.-....++.||..|++||..+++|||||...|.
T Consensus 317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNC 396 (1157)
T KOG4278|consen 317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 396 (1157)
T ss_pred HHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhc
Confidence 78899999999999999999999999999999999999988777788888889999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|+..+..||++|||+++.+. ++.........-..-|.|||-+. ...++.|+|||+|||+|||+.+ |-.||.+.+-
T Consensus 397 LVgEnhiVKvADFGLsRlMt--gDTYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl- 472 (1157)
T KOG4278|consen 397 LVGENHIVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL- 472 (1157)
T ss_pred cccccceEEeeccchhhhhc--CCceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccH-
Confidence 99999999999999998653 23222222223356799999998 5678999999999999999998 9999988543
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.+....+.+ ++....+..+++...+|++.||+++|.+||++.||-+
T Consensus 473 SqVY~LLEk---gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 473 SQVYGLLEK---GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHhc---cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 333333333 4667778889999999999999999999999988844
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=270.21 Aligned_cols=199 Identities=26% Similarity=0.432 Sum_probs=169.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|. +...|||||++.-|.|.++++.+ ...++......+++||+.+|.|||+..+|||||...||
T Consensus 445 MrnfdHphIikLIGv~~-e~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNi 522 (974)
T KOG4257|consen 445 MRNFDHPHIIKLIGVCV-EQPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNI 522 (974)
T ss_pred HHhCCCcchhheeeeee-ccceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhe
Confidence 78999999999999997 46899999999999999999875 46689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|+.+...|||+|||+++.+.+...+... ...-..-|||||-+. -+.++.++|||-|||++||++. |..||.+-...
T Consensus 523 LVsSp~CVKLaDFGLSR~~ed~~yYkaS--~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 523 LVSSPQCVKLADFGLSRYLEDDAYYKAS--RGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred eecCcceeeecccchhhhccccchhhcc--ccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 9999999999999999876544333222 222355699999998 6789999999999999999886 99999987665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.+..+- .+...+.++.+++.+..|+.+||.++|.+||++.+|..
T Consensus 600 DVI~~iE----nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 600 DVIGHIE----NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ceEEEec----CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 5543222 23445667889999999999999999999999988864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=276.08 Aligned_cols=203 Identities=24% Similarity=0.426 Sum_probs=176.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|-+++||||++|.++......+.||+|||++|+|..+++.+ .+.|+..++.-+++.|+.|++||.++|+|||||...||
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNI 762 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNI 762 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhe
Confidence 67899999999999999999999999999999999999876 57799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.+-.+|++|||+++.+.+..+.......-.-..+|.|||.+. .++++.++||||+||+|||.++ |..|||.....
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchH
Confidence 999999999999999986644332221111112246899999998 6789999999999999999886 99999999988
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+.+..+.++ +..+.+..++..+.+|+..||++|-..||.+.+|+.+
T Consensus 842 dVIkaIe~g----yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 842 DVIKAIEQG----YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHhc----cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 877655553 5566677899999999999999999999999999863
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=265.68 Aligned_cols=206 Identities=24% Similarity=0.412 Sum_probs=170.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|.+|+|||||+++++|..++.+++|||||+.|+|.+++..........+....|+.||+.|++||.+.++|||||.+.|+
T Consensus 589 LsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc 668 (807)
T KOG1094|consen 589 LSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNC 668 (807)
T ss_pred HhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence 56889999999999999999999999999999999998876434445556677999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh--hCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA--HGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL--tG~~PF~~~~~ 158 (583)
|++.++++||+|||+++.++. ++..+.....+-...|||+|.+. ..+++.++|+|+||+++||++ |...||....+
T Consensus 669 Lv~~e~~iKiadfgmsR~lys-g~yy~vqgr~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 669 LVDGEFTIKIADFGMSRNLYS-GDYYRVQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred eecCcccEEecCccccccccc-CCceeeecceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 999999999999999987654 44445555567788999999988 678999999999999999975 68899988766
Q ss_pred HHHHH---HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 MKVLL---MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~~~l~---~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.+... ..........-...+.-++..+.+++.+||..+..+||+++++..
T Consensus 747 e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 747 EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 44332 122222223334455678899999999999999999999999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=277.55 Aligned_cols=189 Identities=28% Similarity=0.460 Sum_probs=146.7
Q ss_pred CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCcccc
Q 007967 20 SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACM 99 (583)
Q Consensus 20 ~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~ 99 (583)
..+||-||||+...+.++++.+.... ....++++++||+.||.|+|++|||||||||.|||++.++.|||+|||+|...
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDL 747 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhh
Confidence 56899999999988888887642111 37789999999999999999999999999999999999999999999999762
Q ss_pred cc---------------CCCCccccccccCCCCCCCcccccCCC--CCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 100 FD---------------TGDRQRSRNTFVGTPCWMAPEVLQPGS--GYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 100 ~~---------------~~~~~~~~~~~~GT~~Y~APEil~~~~--~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
.. .+......+..+||.-|+|||++.... .|+.|+|+||||||+|||+. ||...-++...
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i 824 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI 824 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH
Confidence 20 011222335679999999999998544 69999999999999999996 57544343444
Q ss_pred HHHHhcCCCCCCcc--ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 163 LMTIQNAPPGLDYD--RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 163 ~~~i~~~~~~~~~~--~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
...++.. .++.+ .+..--+.-+.+|++||+.||.+||||.|+|++.||-.
T Consensus 825 L~~LR~g--~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 825 LTNLRKG--SIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHhcccC--CCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 4444433 33333 12222344568999999999999999999999999873
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=225.91 Aligned_cols=164 Identities=31% Similarity=0.441 Sum_probs=130.2
Q ss_pred CCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCcccccc
Q 007967 32 GSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111 (583)
Q Consensus 32 GsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~ 111 (583)
|+|.+++... ...+++..++.|++||+.||.|||+++ ||+|||++.++.+|+ ||++..... ..
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~--------~~ 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP--------EQ 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc--------cc
Confidence 7899988753 456999999999999999999999998 999999999999999 998764321 12
Q ss_pred ccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCC-Cc--cccccchH--HHH
Q 007967 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL-DY--DRDKKFSK--SFK 186 (583)
Q Consensus 112 ~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~-~~--~~~~~~S~--~lk 186 (583)
..||+.|||||++. +..|+.++|||||||++|||++|..||............+....... .. .....++. .++
T Consensus 64 ~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (176)
T smart00750 64 SRVDPYFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA 142 (176)
T ss_pred CCCcccccChHHhc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence 36899999999998 56799999999999999999999999976544333333332221111 10 11233444 699
Q ss_pred HHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 187 EMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 187 dLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
++|.+||..+|.+||++.++++|+|+.
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=282.94 Aligned_cols=195 Identities=18% Similarity=0.324 Sum_probs=150.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH---RQGHIHRDVKA 77 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH---s~gIvHRDLKP 77 (583)
|+.++|||||+++++|.+.+..|+|||||++|+|.++++ .+++..+..|+.||++||+||| +.+|+||||||
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp 811 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence 467899999999999999999999999999999999885 3789999999999999999999 66999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
+||+++.++..+++ ||....... .....||+.|+|||++. ...|+.++|||||||++|||++|+.||....
T Consensus 812 ~Nil~~~~~~~~~~-~~~~~~~~~-------~~~~~~t~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 812 EKIIIDGKDEPHLR-LSLPGLLCT-------DTKCFISSAYVAPETRE-TKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred HhEEECCCCceEEE-ecccccccc-------CCCccccccccCccccc-CCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 99999998887775 665432211 12346889999999987 5679999999999999999999999985422
Q ss_pred h----HHHHHHHHh-cC------CCCC--CccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 158 P----MKVLLMTIQ-NA------PPGL--DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 158 ~----~~~l~~~i~-~~------~~~~--~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
. ......... .. .+.. ..........++.+++.+||+.||.+|||+.++++.
T Consensus 883 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 883 GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1 111111000 00 0001 011112234467899999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=263.95 Aligned_cols=207 Identities=25% Similarity=0.410 Sum_probs=174.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|..|+|||+|+||++..+ ..+.+|||+|..|+|++.++...+..|-......|+.||+.|+.||-++++|||||...||
T Consensus 165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNl 243 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNL 243 (1039)
T ss_pred HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhh
Confidence 568999999999999887 8899999999999999999886677799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|+-....|||||||+.+-+....+.........-...|+|||.++ ...++.++|+|++||++|||++ |..||.+....
T Consensus 244 llasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~ 322 (1039)
T KOG0199|consen 244 LLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI 322 (1039)
T ss_pred eecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHH
Confidence 999999999999999886644333222212223345699999998 6789999999999999999998 89999998876
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
.++. .+. .+...+.++.+++++.+++..||..+|.+|||+..|...-+..
T Consensus 323 qIL~-~iD---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 323 QILK-NID---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHH-hcc---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 6553 333 3445667788999999999999999999999999887544443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=267.55 Aligned_cols=197 Identities=28% Similarity=0.491 Sum_probs=152.5
Q ss_pred CCCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~-~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
|++++|||||+++++=++.. .-.+|||||.||+|+..++... ..+++|.++..++..+..||.|||++||+||
T Consensus 65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHR 144 (732)
T KOG4250|consen 65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHR 144 (732)
T ss_pred HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceec
Confidence 67899999999999866544 4789999999999999987532 3569999999999999999999999999999
Q ss_pred CCCCCcEEEc--CCC--cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 74 DVKAGNILLD--TNG--VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 74 DLKPeNILld--~~g--~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
||||+||++- .+| ..||+|||.|+.+.+. .....++||+.|.+||++.....|+..+|.|||||++|+++||
T Consensus 145 DlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG 220 (732)
T KOG4250|consen 145 DLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATG 220 (732)
T ss_pred cCCCCcEEEeecCCCceEEeeecccccccCCCC----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhcc
Confidence 9999999983 334 4799999999866322 2456789999999999998557899999999999999999999
Q ss_pred CCCCCCCChH----HHHHHHHhcCCCC----------------CCccccccchH----HHHHHHHhhhcCCCCCCC
Q 007967 150 HAPFSKYPPM----KVLLMTIQNAPPG----------------LDYDRDKKFSK----SFKEMVAMCLVKDQTKRP 201 (583)
Q Consensus 150 ~~PF~~~~~~----~~l~~~i~~~~~~----------------~~~~~~~~~S~----~lkdLI~~cL~~DP~kRp 201 (583)
..||...-.. +.....+...+.. ...+.+..++. .+-..+..+|..+|.+|.
T Consensus 221 ~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 221 ELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 9999543222 2333333222111 11122223333 345778889999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=260.71 Aligned_cols=205 Identities=20% Similarity=0.295 Sum_probs=149.0
Q ss_pred cccceEEEEEE--------CCEEEEEEecCCCCCHHHHHHHHh----------------------cCCCCHHHHHHHHHH
Q 007967 8 NVIRAYCSFVV--------DSNLWVVMPFMAEGSCLHLMKIAY----------------------QDGFEESAIGSILKE 57 (583)
Q Consensus 8 NIVkl~~~f~d--------~~~l~LVmEy~~GGsL~dll~~~~----------------------~~~~sE~~i~~I~~Q 57 (583)
++++++++|.. .+..||||||+.+|+|.+++.... ...+++..++.++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 34666666653 356899999999999999886421 112456788999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCC--------
Q 007967 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSG-------- 129 (583)
Q Consensus 58 Il~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~-------- 129 (583)
|+.||.|||+++|+||||||+|||++.++.+||+|||++...... .. .......+++.|+|||.+.....
T Consensus 318 l~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~ 395 (507)
T PLN03224 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-IN-FNPLYGMLDPRYSPPEELVMPQSCPRAPAPA 395 (507)
T ss_pred HHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-Cc-cCccccCCCcceeChhhhcCCCCCCccchhh
Confidence 999999999999999999999999999999999999998644221 11 11112345789999999863211
Q ss_pred -----------C--CccccccchhhHHhhhhhCCC-CCCCCChHHHHHHH--------HhcCCCCCCccccccchHHHHH
Q 007967 130 -----------Y--NSKADIWSFGITALELAHGHA-PFSKYPPMKVLLMT--------IQNAPPGLDYDRDKKFSKSFKE 187 (583)
Q Consensus 130 -----------y--s~ksDIWSLGvILyeLLtG~~-PF~~~~~~~~l~~~--------i~~~~~~~~~~~~~~~S~~lkd 187 (583)
| ..+.||||+||++|+|++|.. ||............ .......+.+..+...++.+++
T Consensus 396 ~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~d 475 (507)
T PLN03224 396 MAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWD 475 (507)
T ss_pred hhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHH
Confidence 2 234799999999999999875 77543211111000 0111123345556678999999
Q ss_pred HHHhhhcCCC---CCCCCHHHHHhcccccc
Q 007967 188 MVAMCLVKDQ---TKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 188 LI~~cL~~DP---~kRpTa~eIL~HpfFk~ 214 (583)
|+.+||.++| .+|+|+.|+|+||||..
T Consensus 476 Li~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 476 LACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 9999999876 68999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=247.87 Aligned_cols=208 Identities=25% Similarity=0.397 Sum_probs=163.9
Q ss_pred CCCCCcccceEEEEEECC-----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 3 LIDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~-----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
.++|.||+..++..+-.+ .+|+|+|+|. -+|..+|.. +..++...++.+++||++||+|||+.||.||||||
T Consensus 108 fFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKP 184 (449)
T KOG0664|consen 108 SFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKP 184 (449)
T ss_pred hhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCC
Confidence 468999999888876543 3788999884 456555443 56799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
+|+|++++..+||||||+++.... +.....+..+-|.+|+|||++.+.+.|+.++||||+|||+.||+..+..|....
T Consensus 185 GNLLVNSNCvLKICDFGLARvee~--d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 185 GNLLVNSNCILKICDFGLARTWDQ--RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred ccEEeccCceEEecccccccccch--hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 999999999999999999985422 222233445779999999999999999999999999999999999999998887
Q ss_pred hHHHHHHHHhc----------------------CCC-CCCccc------cccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 158 PMKVLLMTIQN----------------------APP-GLDYDR------DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 158 ~~~~l~~~i~~----------------------~~~-~~~~~~------~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.+.+..++.- ... .-.... ...-..+...++..+|..||.+|.+.++++.
T Consensus 263 PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 263 PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 77666443321 000 000000 1122345788999999999999999999999
Q ss_pred ccccccC
Q 007967 209 HSFFKHA 215 (583)
Q Consensus 209 HpfFk~~ 215 (583)
|++....
T Consensus 343 ~~~~~e~ 349 (449)
T KOG0664|consen 343 HRYLEEG 349 (449)
T ss_pred ccccccc
Confidence 9998764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=261.83 Aligned_cols=201 Identities=26% Similarity=0.495 Sum_probs=167.3
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh------c--------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY------Q--------DGFEESAIGSILKETLKALDYLHRQG 69 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~------~--------~~~sE~~i~~I~~QIl~gL~yLHs~g 69 (583)
..|||||.+.+++...+.+++|+|||..|+|.++++..+ . ..++..+...+++||+.|++||++..
T Consensus 359 g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~ 438 (609)
T KOG0200|consen 359 GKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP 438 (609)
T ss_pred cCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC
Confidence 379999999999999999999999999999999998764 0 13888999999999999999999999
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH- 148 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt- 148 (583)
+|||||...|||+..+..+||+|||+|+................-...|||||.+. ...|+.++|||||||+|||+++
T Consensus 439 ~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-~~~ft~kSDVWSfGI~L~EifsL 517 (609)
T KOG0200|consen 439 CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-DRVFTSKSDVWSFGILLWEIFTL 517 (609)
T ss_pred ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-cCcccccchhhHHHHHHHHHhhC
Confidence 99999999999999999999999999986544433321111101234599999999 4889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 149 GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 149 G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|..||.+......+...+.. +.....+..++.++.++++.||+.+|.+||++.++..
T Consensus 518 G~~PYp~~~~~~~l~~~l~~---G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 518 GGTPYPGIPPTEELLEFLKE---GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCCCcHHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99999886534444444444 3455667788999999999999999999999998875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=227.93 Aligned_cols=202 Identities=23% Similarity=0.395 Sum_probs=159.3
Q ss_pred CCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 5 DHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.|||||+++++..+. ....||+||+++.+...+. ..++..+++.+++|+++||.|||++||+|||+||.|++|
T Consensus 91 gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI 165 (338)
T KOG0668|consen 91 GGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI 165 (338)
T ss_pred CCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence 599999999999875 4588999999988876654 347889999999999999999999999999999999999
Q ss_pred cCC-CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC-CCCChHH
Q 007967 83 DTN-GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF-SKYPPMK 160 (583)
Q Consensus 83 d~~-g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF-~~~~~~~ 160 (583)
|.. ..++|+|+|+|..+ .++.. -+..+.+.+|--||++..-..|+.+-|+|||||+++.|+..+.|| .|.+..+
T Consensus 166 dh~~rkLrlIDWGLAEFY-Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D 241 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFY-HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 241 (338)
T ss_pred chhhceeeeeecchHhhc-CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence 864 46999999998644 33322 234577899999999987788999999999999999999988887 4444444
Q ss_pred HHHHHHh------------cC----CCCC----------Ccc-----ccc-cchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 161 VLLMTIQ------------NA----PPGL----------DYD-----RDK-KFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~------------~~----~~~~----------~~~-----~~~-~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
++..+.+ .- .+.+ .+. ... -.++++.+|+.++|.+|-.+|+|+.|++.
T Consensus 242 QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 242 QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 4432221 00 1100 000 011 13689999999999999999999999999
Q ss_pred ccccccC
Q 007967 209 HSFFKHA 215 (583)
Q Consensus 209 HpfFk~~ 215 (583)
||||...
T Consensus 322 HpyF~~~ 328 (338)
T KOG0668|consen 322 HPYFAPV 328 (338)
T ss_pred CchHHHH
Confidence 9999754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=249.80 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=159.2
Q ss_pred CcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCC
Q 007967 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTN 85 (583)
Q Consensus 7 PNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~ 85 (583)
-|+|+|+..|...+++|||+|-+ .-+|.++++... ..++....++.|+.|++.||..|-..||+|.||||+|||++..
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 36788999999999999999988 577898887652 3468899999999999999999999999999999999999864
Q ss_pred -CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH--
Q 007967 86 -GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL-- 162 (583)
Q Consensus 86 -g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l-- 162 (583)
..+||||||.|...... ..+.+.-+..|.|||++. +..|+...|+||+||+||||.+|+..|.+.+....+
T Consensus 573 k~iLKLCDfGSA~~~~en-----eitPYLVSRFYRaPEIiL-G~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASEN-----EITPYLVSRFYRAPEIIL-GLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred cceeeeccCccccccccc-----cccHHHHHHhccCcceee-cCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 57899999987544221 112356678899999999 778999999999999999999999999998765544
Q ss_pred HHHHhcCCCC------------CC------c-------------------c----------------ccccchHHHHHHH
Q 007967 163 LMTIQNAPPG------------LD------Y-------------------D----------------RDKKFSKSFKEMV 189 (583)
Q Consensus 163 ~~~i~~~~~~------------~~------~-------------------~----------------~~~~~S~~lkdLI 189 (583)
++.+++..+. ++ + + .....-..|++|+
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 2322221110 00 0 0 0011224589999
Q ss_pred HhhhcCCCCCCCCHHHHHhcccccc
Q 007967 190 AMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 190 ~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.+||..||.+|.|+.++|+||||..
T Consensus 727 dkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHhccChhhcCCHHHHhcCCcccC
Confidence 9999999999999999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=224.05 Aligned_cols=169 Identities=32% Similarity=0.633 Sum_probs=139.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKA 77 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKP 77 (583)
|+....|++|++|+.+.++..+||.||.| ..+|..+.+... ++.++|..+-+|+..|+.||.|||++ .+||||+||
T Consensus 99 ~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKP 177 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKP 177 (282)
T ss_pred ccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCc
Confidence 56678999999999999999999999999 466665554432 45589999999999999999999987 899999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC---CCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP---GSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~---~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
+||||+.+|++|+||||.+-.+.++- ..+.-.|--.|||||.+.. ..+|+.++||||||++++||.+++.||.
T Consensus 178 sNiLIn~~GqVKiCDFGIsG~L~dSi----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 178 SNILINYDGQVKICDFGISGYLVDSI----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred ceEEEccCCcEEEcccccceeehhhh----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 99999999999999999987764432 1122457778999999874 3479999999999999999999999997
Q ss_pred CC-ChHHHHHHHHhcCCCCCC
Q 007967 155 KY-PPMKVLLMTIQNAPPGLD 174 (583)
Q Consensus 155 ~~-~~~~~l~~~i~~~~~~~~ 174 (583)
.+ ++.+++........+.++
T Consensus 254 ~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 254 SWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred ccCCHHHHHHHHhcCCCCCCc
Confidence 65 566666666666555544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=204.97 Aligned_cols=170 Identities=42% Similarity=0.707 Sum_probs=147.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.+.|++|+++++++......++||||+.|++|.+++.... ..+++..+..++.+++.+|.|||++|++|+||+|.||
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni 123 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENI 123 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhE
Confidence 356789999999999999999999999999999999877531 4689999999999999999999999999999999999
Q ss_pred EEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 81 LLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
+++. ++.++|+|||.+........ ......+...|++||.+.....++.+.|+|++|+++++|
T Consensus 124 ~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------- 187 (215)
T cd00180 124 LLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------- 187 (215)
T ss_pred EEeCCCCcEEEecCCceEEccCCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------
Confidence 9999 89999999998765432211 122356788899999987433788999999999999999
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
..+.+++..|+..+|.+||++.++++|+
T Consensus 188 -----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5789999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=228.44 Aligned_cols=208 Identities=30% Similarity=0.432 Sum_probs=158.1
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
..+-||+++.+++..++.+.+||||++.....++.. .++-.+++.+++.++.||.++|.+|||||||||+|||++
T Consensus 92 gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n 166 (418)
T KOG1167|consen 92 GGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN 166 (418)
T ss_pred ccchhhhcchhhhccCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc
Confidence 368899999999999999999999999988887754 477899999999999999999999999999999999997
Q ss_pred C-CCcEEEEecCCccccc-----------------c-CC-----------------------CCccccccccCCCCCCCc
Q 007967 84 T-NGVVKLADFGVSACMF-----------------D-TG-----------------------DRQRSRNTFVGTPCWMAP 121 (583)
Q Consensus 84 ~-~g~IKL~DFGlA~~~~-----------------~-~~-----------------------~~~~~~~~~~GT~~Y~AP 121 (583)
. -+.-.|+|||+|.... . .+ .+........||++|+||
T Consensus 167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP 246 (418)
T KOG1167|consen 167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP 246 (418)
T ss_pred cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence 4 5678899999986110 0 00 000011224699999999
Q ss_pred ccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh-HHHHHHHHh--------------cC----C------------
Q 007967 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP-MKVLLMTIQ--------------NA----P------------ 170 (583)
Q Consensus 122 Eil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~-~~~l~~~i~--------------~~----~------------ 170 (583)
|++......++++||||.|||+.-+++++.||-...+ ...+.++.. +. .
T Consensus 247 EvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~ 326 (418)
T KOG1167|consen 247 EVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRV 326 (418)
T ss_pred HHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHh
Confidence 9998777889999999999999999999999854321 111100000 00 0
Q ss_pred --CCC--------Cc------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 171 --PGL--------DY------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 171 --~~~--------~~------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..+ +. .....++..+.+|+.+||..||.+|.|++++|+||||...+
T Consensus 327 ~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 327 NFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred chhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 000 00 00123455789999999999999999999999999999554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=249.53 Aligned_cols=213 Identities=23% Similarity=0.343 Sum_probs=169.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.+.||||+.....+.+....+-+||||++ +|+.++... +.++..++..+++|++.|+.|||.+||.|||||++|++
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll 452 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLL 452 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEE
Confidence 357999998888777777666666999999 999988753 57899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCC-ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDR-QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~-~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+..+|.+||+|||.+.++....+. .......+|+..|+|||++.+...-...+||||+|++++.|.+|+.||......+
T Consensus 453 ~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 453 VTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred EecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 999999999999998766544432 1334568999999999999854444567899999999999999999997654433
Q ss_pred HHHHHHhcCC-CCC---CccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAP-PGL---DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~-~~~---~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
..+....... ... ....+..++...+.+|.+||+.+|.+|.|+++|++.+||+.+..
T Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 533 NSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred cchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 3221111111 111 11223456788999999999999999999999999999998753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=241.90 Aligned_cols=200 Identities=25% Similarity=0.427 Sum_probs=167.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|..++||||++|++++.... +-||++||++|.|.++++.. +..+-......|.+||++||.|||.++++||||...||
T Consensus 752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNV 829 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNV 829 (1177)
T ss_pred HhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhe
Confidence 67899999999999998766 99999999999999999875 57788999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|+..-.++||.|||+++.+..... ........-.+-|||-|.+. ...|+.++|||||||++||++| |..|+.+.+..
T Consensus 830 LVksP~hvkitdfgla~ll~~d~~-ey~~~~gK~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 830 LVKSPNHVKITDFGLAKLLAPDEK-EYSAPGGKVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred eecCCCeEEEEecchhhccCcccc-cccccccccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 999999999999999976543322 22222233456799999988 7789999999999999999998 99999987654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
++- ..+... .....++.++-++..++.+||..|+..||+++++..
T Consensus 908 eI~-dlle~g---eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 908 EIP-DLLEKG---ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred Hhh-HHHhcc---ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 432 233322 234566788999999999999999999999988754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=227.63 Aligned_cols=78 Identities=31% Similarity=0.496 Sum_probs=70.7
Q ss_pred CCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCc
Q 007967 5 DHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGN 79 (583)
Q Consensus 5 ~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeN 79 (583)
.-..||+|++.|.. +.++|+|+|++ |.+|+.+|+...-++++...++.|++||+.||.|||.+ ||||-||||+|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 34579999999985 56899999999 89999999988778899999999999999999999965 99999999999
Q ss_pred EEEc
Q 007967 80 ILLD 83 (583)
Q Consensus 80 ILld 83 (583)
||+.
T Consensus 219 vLl~ 222 (590)
T KOG1290|consen 219 VLLC 222 (590)
T ss_pred eeee
Confidence 9983
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=229.21 Aligned_cols=200 Identities=24% Similarity=0.371 Sum_probs=151.9
Q ss_pred CCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------C
Q 007967 3 LIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ---------G 69 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~---------g 69 (583)
.+.|+||++++++-.... .+|||++|.+.|+|.++++. ..+++....+++.-|++||+|||+. .
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~ 336 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPP 336 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCc
Confidence 478999999999877665 79999999999999999985 5789999999999999999999984 4
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCC-----ccccccchhhHHh
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYN-----SKADIWSFGITAL 144 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys-----~ksDIWSLGvILy 144 (583)
|+|||||..||||..|++..|+|||+|..+. .+.........+||.+|||||++.+...+. ...||||+|.+||
T Consensus 337 IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~-p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW 415 (534)
T KOG3653|consen 337 IAHRDLKSKNVLVKNDLTCCIADFGLALRLE-PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW 415 (534)
T ss_pred cccccccccceEEccCCcEEeeccceeEEec-CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999997664 344444444579999999999998654444 4689999999999
Q ss_pred hhhhCCCC------------CCC----CChHHHHHHHHh--cCCCCCCcc-ccccchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 145 ELAHGHAP------------FSK----YPPMKVLLMTIQ--NAPPGLDYD-RDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 145 eLLtG~~P------------F~~----~~~~~~l~~~i~--~~~~~~~~~-~~~~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
||++...- |.. .+..+.+....- +..+.++.. .....-..+++.++.||..||+-|+|+.=
T Consensus 416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 99874332 221 111222222111 222222211 11223456899999999999999999854
Q ss_pred H
Q 007967 206 L 206 (583)
Q Consensus 206 I 206 (583)
+
T Consensus 496 v 496 (534)
T KOG3653|consen 496 V 496 (534)
T ss_pred H
Confidence 3
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-25 Score=236.67 Aligned_cols=143 Identities=29% Similarity=0.513 Sum_probs=127.9
Q ss_pred CCCcccceEEEEEECCEEEEEEecC-CCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFM-AEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~-~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.|+||++++++|++++++||+||-- +|.+|+++|... ..++|.++..|++||+.|+++||++||||||||-+|+.++
T Consensus 627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd 704 (772)
T KOG1152|consen 627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD 704 (772)
T ss_pred CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEe
Confidence 3999999999999999999999975 466899998764 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
.+|-+||+|||.|... ..+ ....++||..|.|||++.+....+..-|||++|++||.++....||.
T Consensus 705 ~~g~~klidfgsaa~~-ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYT-KSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCeEEEeeccchhhh-cCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999987643 222 23468999999999999977777888999999999999998888874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=221.75 Aligned_cols=202 Identities=25% Similarity=0.402 Sum_probs=153.1
Q ss_pred CCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CC
Q 007967 3 LIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ--------GH 70 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~--------gI 70 (583)
+|+|+||+.+++.-..+. .+|||++|.+.|+|+|++.+ ..++...+.+++.-++.||+|||-. .|
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaI 337 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAI 337 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchh
Confidence 589999999998866443 59999999999999999986 6799999999999999999999974 49
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccC-CCCccccccccCCCCCCCcccccCCCCC-----CccccccchhhHHh
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDT-GDRQRSRNTFVGTPCWMAPEVLQPGSGY-----NSKADIWSFGITAL 144 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~-~~~~~~~~~~~GT~~Y~APEil~~~~~y-----s~ksDIWSLGvILy 144 (583)
.|||||..|||+.++|.+.|+|+|+|...... +.-....+..+||-+|||||++...-.. -..+||||||.++|
T Consensus 338 AHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlW 417 (513)
T KOG2052|consen 338 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLW 417 (513)
T ss_pred hccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHH
Confidence 99999999999999999999999999765433 3334455778999999999999732211 13589999999999
Q ss_pred hhhhC----------CCCCCCCCh----HHHHHHHHh--cCCCCCCccccc--cchHHHHHHHHhhhcCCCCCCCCHHHH
Q 007967 145 ELAHG----------HAPFSKYPP----MKVLLMTIQ--NAPPGLDYDRDK--KFSKSFKEMVAMCLVKDQTKRPTAEKL 206 (583)
Q Consensus 145 eLLtG----------~~PF~~~~~----~~~l~~~i~--~~~~~~~~~~~~--~~S~~lkdLI~~cL~~DP~kRpTa~eI 206 (583)
|++.. ++||.+..+ .+.+...+- +..+.++ ..|. ..-..+..+++.||..+|.-|.|+-.|
T Consensus 418 EiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ip-nrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 418 EIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIP-NRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred HHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCC-cccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 99752 578865433 333322221 1122221 1121 122346788999999999999998766
Q ss_pred Hh
Q 007967 207 LK 208 (583)
Q Consensus 207 L~ 208 (583)
.+
T Consensus 497 KK 498 (513)
T KOG2052|consen 497 KK 498 (513)
T ss_pred HH
Confidence 53
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=196.73 Aligned_cols=165 Identities=36% Similarity=0.604 Sum_probs=138.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~-~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.++|+||+++++++......+++|||+.+++|.+++... .. +++..+..++.+++.+|.|||++|++|+||+|.||
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni 129 (225)
T smart00221 52 KKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENI 129 (225)
T ss_pred HhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 4568999999999999999999999999999999988764 33 89999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC-CChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK-YPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~-~~~~ 159 (583)
+++.++.++|+|||.+........ .......++..|++||.+.....++.++|+|+||+++|+|++|+.||.. ....
T Consensus 130 ~v~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 130 LLGMDGLVKLADFGLARFIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred EEcCCCCEEEeeCceeeEecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 999999999999998876533220 0123457888999999984356788899999999999999999999977 4555
Q ss_pred HHHHHHHhcCC
Q 007967 160 KVLLMTIQNAP 170 (583)
Q Consensus 160 ~~l~~~i~~~~ 170 (583)
..+...+....
T Consensus 208 ~~~~~~~~~~~ 218 (225)
T smart00221 208 SLLSDVWSFGV 218 (225)
T ss_pred HHHHHHHhcCC
Confidence 55555555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=209.43 Aligned_cols=187 Identities=25% Similarity=0.378 Sum_probs=142.8
Q ss_pred CCCCcccceEE-EEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 4 IDHPNVIRAYC-SFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 4 L~HPNIVkl~~-~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
-.|.|||.-|+ .|++.+.++++||||+.|+|..-+. ..++-|.....++.|+++||.|+|++++||||||.+||||
T Consensus 78 s~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 78 SPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI 154 (378)
T ss_pred ccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE
Confidence 36999998776 4888899999999999999987554 4789999999999999999999999999999999999999
Q ss_pred c--CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 83 D--TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 83 d--~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
- +..+|||||||+.+.. +.... ..--+..|.|||++.. .....+..|||.||+++|.+|+|.+||...
T Consensus 155 f~~df~rvKlcDFG~t~k~---g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 155 FDADFYRVKLCDFGLTRKV---GTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ecCCccEEEeeeccccccc---Cceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 4 2348999999987643 11111 1123456899998753 223567899999999999999999999753
Q ss_pred ChH----HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCC
Q 007967 157 PPM----KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR 200 (583)
Q Consensus 157 ~~~----~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kR 200 (583)
..+ -......++..+..+ .....+++.+..+.++-|..++++|
T Consensus 229 ~~~d~~Y~~~~~w~~rk~~~~P-~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 229 SIMDKPYWEWEQWLKRKNPALP-KKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hccCchHHHHHHHhcccCccCc-hhhcccCHHHHHHHHHhcCCccccc
Confidence 222 122222222222222 2346789999999999999999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-24 Score=231.22 Aligned_cols=210 Identities=28% Similarity=0.437 Sum_probs=180.3
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
.||++|+++..|+.+..+|++++|..||+|+..+.. ...+.+...+.+..+++.+++++|+.||+|||+|++||+++.
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~ 132 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL 132 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc
Confidence 499999999999999999999999999999876554 366899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
+|++++.|||+++...+.. ..|||.-|||||++. ++..++|+||+|+++|+|++|..||.+ +.. .
T Consensus 133 ~Ghi~~tdfglske~v~~~-------~~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~-~ 197 (612)
T KOG0603|consen 133 EGHIKLTDFGLSKEAVKEK-------IACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTM-K 197 (612)
T ss_pred cCccccCCchhhhHhHhhh-------hcccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHH-H
Confidence 9999999999987653321 229999999999997 678899999999999999999999987 222 2
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCchHHH
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPPLWNR 235 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~~r 235 (583)
.|.... ...+..++..+++++..++..+|.+|.. +.++++|+||..++|..+..++...++.+....
T Consensus 198 ~Il~~~----~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~ 269 (612)
T KOG0603|consen 198 RILKAE----LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSIT 269 (612)
T ss_pred HHhhhc----cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccc
Confidence 333222 2334678899999999999999999975 589999999999999988888887777776543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=208.86 Aligned_cols=200 Identities=25% Similarity=0.387 Sum_probs=166.5
Q ss_pred CCCCCcccceEEEEEEC-CEEEEEEecCCCCCHHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 3 LIDHPNVIRAYCSFVVD-SNLWVVMPFMAEGSCLHLMKIAYQ------DGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~-~~l~LVmEy~~GGsL~dll~~~~~------~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
-+.|||++.+.+++..+ ..-++++.++.-|+|..++...+. ..++..++..++.|+..|++|||++||||.||
T Consensus 343 ~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDi 422 (563)
T KOG1024|consen 343 GASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDI 422 (563)
T ss_pred cCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchh
Confidence 46799999999998754 567888999999999999885432 23667778889999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFS 154 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~ 154 (583)
...|.+|++.-++||+|=.+++.++..+......+ ......||+||.+. ...|+.++|+|||||++|||++ |+.|+.
T Consensus 423 AaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDn-EnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 423 AARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDN-ENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred hhhcceehhheeEEeccchhccccCcccccccCCC-CCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 99999999999999999999998776543322222 23466799999998 7789999999999999999998 999998
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.-++.+....... ++....+.++++++..++..||...|++||+++++..
T Consensus 501 eIDPfEm~~ylkd----GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 501 EIDPFEMEHYLKD----GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ccCHHHHHHHHhc----cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8887666544333 2445566789999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=192.05 Aligned_cols=213 Identities=38% Similarity=0.548 Sum_probs=167.7
Q ss_pred CCCCC-cccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 3 LIDHP-NVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 3 ~L~HP-NIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
.+.|+ +|+++++++......+++++|+.++++.+++..... ..+.+..+..++.|++.++.|+|+.|++|||+||+||
T Consensus 53 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~ni 132 (384)
T COG0515 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENI 132 (384)
T ss_pred HccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 46677 799999999888889999999999999976654321 2699999999999999999999999999999999999
Q ss_pred EEcCCC-cEEEEecCCccccccCCCCc---cccccccCCCCCCCcccccCC--CCCCccccccchhhHHhhhhhCCCCCC
Q 007967 81 LLDTNG-VVKLADFGVSACMFDTGDRQ---RSRNTFVGTPCWMAPEVLQPG--SGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 81 Lld~~g-~IKL~DFGlA~~~~~~~~~~---~~~~~~~GT~~Y~APEil~~~--~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
+++..+ .++++|||++.......... ......+|+..|+|||.+... ..+....|+|++|+++++++.|..||.
T Consensus 133 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 133 LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred eecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999988 79999999987443322221 123567999999999999843 578899999999999999999999987
Q ss_pred CCCh---HHHHHHHHhcCCCC-CCccccccc----hHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 155 KYPP---MKVLLMTIQNAPPG-LDYDRDKKF----SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 155 ~~~~---~~~l~~~i~~~~~~-~~~~~~~~~----S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.... .......+...... ......... ...+.+++..|+..+|..|.+..+...++|....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 213 GEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred CCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 7653 34444444433322 222222222 2678999999999999999999999888666544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-20 Score=213.88 Aligned_cols=165 Identities=28% Similarity=0.463 Sum_probs=134.9
Q ss_pred HHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCC------------CccccccccCCCCCCCccccc
Q 007967 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD------------RQRSRNTFVGTPCWMAPEVLQ 125 (583)
Q Consensus 58 Il~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~------------~~~~~~~~~GT~~Y~APEil~ 125 (583)
++.+++|||+.||+|||+||+|++|..=|++|++|||++........ ........|||+.|+|||++.
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 38899999999999999999999999999999999998765432211 111123459999999999998
Q ss_pred CCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC---C
Q 007967 126 PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP---T 202 (583)
Q Consensus 126 ~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp---T 202 (583)
..+|+.-+|||++|+|+|+.+.|..||.+.++.+.+...+..... + .+....+.++++++|..+|..+|..|. .
T Consensus 232 -rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~-w-pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 232 -RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-W-PEEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred -hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc-c-cccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 788999999999999999999999999998887666555554322 1 122567889999999999999999995 4
Q ss_pred HHHHHhccccccCCCCchhhhhh
Q 007967 203 AEKLLKHSFFKHAKPPELSVKKL 225 (583)
Q Consensus 203 a~eIL~HpfFk~~~~~~~~~~~~ 225 (583)
+-++.+|+||+..+|..+..++.
T Consensus 309 a~evk~h~ff~~LDw~~llRqka 331 (1205)
T KOG0606|consen 309 ALEVKQHGFFQLLDWKSLLRQKA 331 (1205)
T ss_pred hhhhhhccceeecccchhhhhhc
Confidence 78899999999999987665554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.1e-19 Score=184.31 Aligned_cols=197 Identities=28% Similarity=0.385 Sum_probs=144.4
Q ss_pred CCCCcccceEEEEEE---------------------------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHH
Q 007967 4 IDHPNVIRAYCSFVV---------------------------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56 (583)
Q Consensus 4 L~HPNIVkl~~~f~d---------------------------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~ 56 (583)
-.|||||+++.+|.+ ...+|+||.-+ ..+|..++-. ...+....+-++.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~la 348 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILA 348 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHH
Confidence 479999999998865 22489999977 4678887764 5577788899999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCcEEE--cCCC--cEEEEecCCccccccCCC-----CccccccccCCCCCCCcccccCC
Q 007967 57 ETLKALDYLHRQGHIHRDVKAGNILL--DTNG--VVKLADFGVSACMFDTGD-----RQRSRNTFVGTPCWMAPEVLQPG 127 (583)
Q Consensus 57 QIl~gL~yLHs~gIvHRDLKPeNILl--d~~g--~IKL~DFGlA~~~~~~~~-----~~~~~~~~~GT~~Y~APEil~~~ 127 (583)
|+++|+.|||.+||.|||+|.+|||+ +.|+ .+.|+|||.+ +.+... ........-|....||||+....
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc--LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC--LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee--eeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999999999999999999 4444 5889999964 222211 11111234578889999998632
Q ss_pred CC-----CCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC
Q 007967 128 SG-----YNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT 202 (583)
Q Consensus 128 ~~-----ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT 202 (583)
.+ .-.++|.|++|.+.||+++...||.+..++..-....+... + ...+..+++.++++|..+|+.||++|++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q--L-Palp~~vpp~~rqlV~~lL~r~pskRvs 503 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ--L-PALPSRVPPVARQLVFDLLKRDPSKRVS 503 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh--C-CCCcccCChHHHHHHHHHhcCCccccCC
Confidence 22 12479999999999999999999987444322222222211 1 1234578899999999999999999998
Q ss_pred H---HHHHhc
Q 007967 203 A---EKLLKH 209 (583)
Q Consensus 203 a---~eIL~H 209 (583)
+ ..+|+-
T Consensus 504 p~iAANvl~L 513 (598)
T KOG4158|consen 504 PNIAANVLNL 513 (598)
T ss_pred ccHHHhHHHH
Confidence 4 556653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3e-18 Score=179.58 Aligned_cols=200 Identities=23% Similarity=0.274 Sum_probs=153.0
Q ss_pred CcccceEEEE-EECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCC
Q 007967 7 PNVIRAYCSF-VVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTN 85 (583)
Q Consensus 7 PNIVkl~~~f-~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~ 85 (583)
+++..+++.+ ..+..-|+||+.+ |.+|.++......+.|+...+..|+.|++.+|++||+.|++||||||.|+++...
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~ 158 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQS 158 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCC
Confidence 5888899999 5888999999998 8999998766655789999999999999999999999999999999999999765
Q ss_pred -----CcEEEEecCCcc--ccccCCC----Cccc-cccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 86 -----GVVKLADFGVSA--CMFDTGD----RQRS-RNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 86 -----g~IKL~DFGlA~--~~~~~~~----~~~~-~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
..+.|.|||+++ .+..... ..+. ...+.||..|.++.... +...+.+.|+||++.++.+|+.|..||
T Consensus 159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-GIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhC-CCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 369999999998 4332221 1111 23467999999999887 678899999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCcc-ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 154 SKYPPMKVLLMTIQNAPPGLDYD-RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~~~~~~~~-~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.+............. ....... .....+..+..+...+-..+...+|....+...
T Consensus 238 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 238 EALEMTDLKSKFEKD-PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccccccchHHHHHHH-hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 775532221111111 1111111 223456778888888887888888888776553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-18 Score=187.21 Aligned_cols=182 Identities=24% Similarity=0.355 Sum_probs=136.7
Q ss_pred CEEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccc
Q 007967 20 SNLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSAC 98 (583)
Q Consensus 20 ~~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~ 98 (583)
.++||.|++|...+|.++|++... ...+...+..++.|+..|++| +|.+|||+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 368999999999999999975432 336778899999999999999 9999999999999999999999999998754
Q ss_pred cccCC---CCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCC
Q 007967 99 MFDTG---DRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLD 174 (583)
Q Consensus 99 ~~~~~---~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~ 174 (583)
..... .........+||.+||+||.+. +..|+.++||||||+|||||+. -..+| +.......++.... +
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~~f~T~~----er~~t~~d~r~g~i--p 478 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIR-GQQYSEKVDIYALGLILAELLIQFSTQF----ERIATLTDIRDGII--P 478 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHh-hhhhhhhcchhhHHHHHHHHHHHhccHH----HHHHhhhhhhcCCC--C
Confidence 42221 0122334578999999999998 7889999999999999999997 22222 11222233333221 1
Q ss_pred ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 175 ~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
...... -+.-..|+.+||.+.|.+||++.+.-.|.|.
T Consensus 479 ~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 001111 1334689999999999999988888777764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.5e-17 Score=177.97 Aligned_cols=206 Identities=24% Similarity=0.388 Sum_probs=157.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-cccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGH-IHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gI-vHRDLKPeN 79 (583)
|+.+.|.|+.++++.+.++..+++|.+||..|+|++.+.. ..-.++.-....+++.|+.||.|||.--| +|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 7889999999999999999999999999999999999876 34568888999999999999999998755 999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC--C----CCccccccchhhHHhhhhhCCCCC
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS--G----YNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~--~----ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
.+++..-.+||+|||+........... ......-..-|.|||+++... . .+.+.||||+|++++|+++...||
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~-~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPE-AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred ceeeeeEEEEechhhhccccccccccc-ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999876442211111 111122345699999998421 1 466799999999999999999999
Q ss_pred CCCCh---HHHHHHHHhc-CCCCCCccc--cccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 154 SKYPP---MKVLLMTIQN-APPGLDYDR--DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 154 ~~~~~---~~~l~~~i~~-~~~~~~~~~--~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..... ...+...+.. ....+.... ...+.+++..+++.||..+|.+||+++++..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 76321 1233333333 222121111 1245667999999999999999999988864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-18 Score=195.86 Aligned_cols=209 Identities=22% Similarity=0.336 Sum_probs=173.5
Q ss_pred CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEcC
Q 007967 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH-RQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 6 HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH-s~gIvHRDLKPeNILld~ 84 (583)
|+|++++++.....+..+++++|..||+++..+......+.+...+..++.|+..++.|+| ..++.||||||+|.+++.
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~ 159 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE 159 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc
Confidence 9999999999999999999999999999998763221226888899999999999999999 999999999999999999
Q ss_pred CC-cEEEEecCCccccccCCCCccccccccC-CCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 85 NG-VVKLADFGVSACMFDTGDRQRSRNTFVG-TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 85 ~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~G-T~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
.+ .+++.|||+|..+.............+| ++.|+|||...+....++..|+||+|+++.-+++|..|+.........
T Consensus 160 s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~ 239 (601)
T KOG0590|consen 160 SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR 239 (601)
T ss_pred CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc
Confidence 99 9999999999877652334444556788 999999999985456788999999999999999999998664433322
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 163 ~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
...............+..++....+++.++|..+|..|.+.+++..++|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 2222222222345567788999999999999999999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-18 Score=197.88 Aligned_cols=201 Identities=23% Similarity=0.281 Sum_probs=144.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
++++|||++.+.-+-+.+...|||-+|. .-+|.|.+..+ .-+...+.+-|+.||+.||..||..||+|+|||.+|||
T Consensus 76 ~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENIL 152 (1431)
T KOG1240|consen 76 ALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENIL 152 (1431)
T ss_pred HhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEE
Confidence 3568999999888888888899999998 56788866532 22566777889999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCcccccccc----CCCCCCCcccccCCC----------CCCccccccchhhHHhhhh
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFV----GTPCWMAPEVLQPGS----------GYNSKADIWSFGITALELA 147 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~----GT~~Y~APEil~~~~----------~ys~ksDIWSLGvILyeLL 147 (583)
|+.=+=+.|+||..-+..+-+.+......-+. .-.+|+|||.+.... ..+++-||||+||+++||+
T Consensus 153 iTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 153 ITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred EeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 99988899999975443332222222222222 234799999986321 1567899999999999998
Q ss_pred h-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 148 H-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 148 t-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+ |++||.- .+++..-.+.......-...--+..+++||..|++.||.+|.++++.|+.
T Consensus 233 ~Eg~PlF~L----SQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 233 LEGRPLFTL----SQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hcCCCcccH----HHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 7 8999842 22222222210000000001113368999999999999999999999975
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.6e-17 Score=172.59 Aligned_cols=131 Identities=19% Similarity=0.263 Sum_probs=95.1
Q ss_pred CCCCCCCcccc-eEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCC
Q 007967 1 MSLIDHPNVIR-AYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV-KAG 78 (583)
Q Consensus 1 Mk~L~HPNIVk-l~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL-KPe 78 (583)
|+.++|+||+. +++ .+..|||||||.|++|... . . .. ...++.|++.+|.|||++||+|||| ||+
T Consensus 75 L~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~---~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~ 141 (365)
T PRK09188 75 LKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R---P--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQ 141 (365)
T ss_pred HHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C---c--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcc
Confidence 46789999995 443 2468999999999999632 1 1 11 1468899999999999999999999 999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccc-----cccccCCCCCCCcccccCC-----CCCCcccccc-chhhHHh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRS-----RNTFVGTPCWMAPEVLQPG-----SGYNSKADIW-SFGITAL 144 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~-----~~~~~GT~~Y~APEil~~~-----~~ys~ksDIW-SLGvILy 144 (583)
|||++.++.+||+|||+|+.+...+..... .....+++.|+|||.+... ...+..+|.| .-|=+.+
T Consensus 142 NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW~~TGDlg~ 218 (365)
T PRK09188 142 NWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIWLATGKKVY 218 (365)
T ss_pred eEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcEEeCCCEEE
Confidence 999999999999999999866443322111 1346788899999998742 1233446666 3344333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.2e-17 Score=162.08 Aligned_cols=193 Identities=22% Similarity=0.390 Sum_probs=153.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG--HIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHRDLKPe 78 (583)
|+-+.||||+.+++.|....++.++..||+.|+|+..+.....--.+..++.+++..|++|++|||+.. |.---|...
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~ 320 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSK 320 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccc
Confidence 456789999999999999999999999999999999987643334788899999999999999999975 344458889
Q ss_pred cEEEcCCCcEEE--EecCCccccccCCCCccccccccCCCCCCCcccccCCCC--CCccccccchhhHHhhhhhCCCCCC
Q 007967 79 NILLDTNGVVKL--ADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSG--YNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 79 NILld~~g~IKL--~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~--ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
.++||.+-+.+| +|--++. .. ......|.||+||.+..... .-.++|+|||.+++|||.+...||.
T Consensus 321 hvmidedltarismad~kfsf---qe-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa 390 (448)
T KOG0195|consen 321 HVMIDEDLTARISMADTKFSF---QE-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA 390 (448)
T ss_pred eEEecchhhhheecccceeee---ec-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc
Confidence 999999876655 3433221 10 12345788999999974322 2357999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHH
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eI 206 (583)
..++++.-..+... ++....++.++.....|+.-|++.||.+||.+..|
T Consensus 391 dlspmecgmkiale---glrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 391 DLSPMECGMKIALE---GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred cCCchhhhhhhhhc---cccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 99988765444333 34555668899999999999999999999987655
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.5e-16 Score=158.94 Aligned_cols=194 Identities=19% Similarity=0.287 Sum_probs=148.7
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
..++|...|-+-+.+-+-.||||++ |-+|.|++... .+.|+...++.++.|++.-++|+|++.+|+|||||+|+||..
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGr 159 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGR 159 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecC
Confidence 5688999998888999999999998 89999988765 688999999999999999999999999999999999999965
Q ss_pred CC-----cEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 85 NG-----VVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 85 ~g-----~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
.+ .|.|+|||+|+.+.++.... +......||..||+--... ++..+...|+-|||-++++.|.|.+||.+
T Consensus 160 p~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl-GrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 160 PGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccc-cchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 43 58999999998876654332 2234568999999998887 67788899999999999999999999988
Q ss_pred CCh--HHHHHHHHhcCCCCC-CccccccchHHHHHHHHhhhcCCCCCCC
Q 007967 156 YPP--MKVLLMTIQNAPPGL-DYDRDKKFSKSFKEMVAMCLVKDQTKRP 201 (583)
Q Consensus 156 ~~~--~~~l~~~i~~~~~~~-~~~~~~~~S~~lkdLI~~cL~~DP~kRp 201 (583)
... .+...+.|....... .......++.+|...++-.-..+-.+-|
T Consensus 239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~P 287 (449)
T KOG1165|consen 239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETP 287 (449)
T ss_pred ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCC
Confidence 642 333334443322111 1122345666666666644443333333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-16 Score=164.27 Aligned_cols=163 Identities=26% Similarity=0.407 Sum_probs=106.0
Q ss_pred EEEEEecCCCCCHHHHHHHHh---cCCCCHHH-H-HHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCc
Q 007967 22 LWVVMPFMAEGSCLHLMKIAY---QDGFEESA-I-GSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS 96 (583)
Q Consensus 22 l~LVmEy~~GGsL~dll~~~~---~~~~sE~~-i-~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA 96 (583)
.+++|+-+ .++|.+++.... ........ + ..+..|+++.+++||..|++|+||+|+|||++.+|.++|+||+..
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 57788887 677877765322 12112222 2 334589999999999999999999999999999999999999865
Q ss_pred cccccCCCCccccccccCCCCCCCcccccCC-------CCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcC
Q 007967 97 ACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG-------SGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA 169 (583)
Q Consensus 97 ~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~-------~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~ 169 (583)
... +..... ...+..|.+||..... ..++.+.|.|+||+++|.|+||..||.......
T Consensus 193 ~r~---g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~--------- 257 (288)
T PF14531_consen 193 VRA---GTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEA--------- 257 (288)
T ss_dssp EET---TEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGS---------
T ss_pred eec---Cceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccc---------
Confidence 432 222111 2345779999987532 247889999999999999999999997643211
Q ss_pred CCCCCccccccchHHHHHHHHhhhcCCCCCC
Q 007967 170 PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR 200 (583)
Q Consensus 170 ~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kR 200 (583)
....++....++++.++.||..+|+++|.+|
T Consensus 258 ~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 258 DPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 1111344445889999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.4e-16 Score=153.03 Aligned_cols=144 Identities=13% Similarity=0.127 Sum_probs=105.7
Q ss_pred CCCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCC
Q 007967 1 MSLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV-KAG 78 (583)
Q Consensus 1 Mk~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL-KPe 78 (583)
|++| +|++|++++++ +..|++|||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+
T Consensus 55 L~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~ 121 (218)
T PRK12274 55 LRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEA 121 (218)
T ss_pred HHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcc
Confidence 3456 45889999885 457999999999998653211 1 1357889999999999999999999 799
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCC----c-cc-----cccccCCCCCCCcccccCCCCCC-ccccccchhhHHhhhh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDR----Q-RS-----RNTFVGTPCWMAPEVLQPGSGYN-SKADIWSFGITALELA 147 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~----~-~~-----~~~~~GT~~Y~APEil~~~~~ys-~ksDIWSLGvILyeLL 147 (583)
|||++.+|.++|+|||+|......+.- . +. ..-...++.|+.|+...--...+ ...+|++.|+-+|.++
T Consensus 122 NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~ 201 (218)
T PRK12274 122 NWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFV 201 (218)
T ss_pred eEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHH
Confidence 999999999999999998743222210 0 00 00123577888887654222333 4678899999999999
Q ss_pred hCCCCCCCCC
Q 007967 148 HGHAPFSKYP 157 (583)
Q Consensus 148 tG~~PF~~~~ 157 (583)
|+..++++..
T Consensus 202 ~~~~~~~~~~ 211 (218)
T PRK12274 202 TRRVLHWEDN 211 (218)
T ss_pred hccCCccccC
Confidence 9999987743
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=149.39 Aligned_cols=195 Identities=19% Similarity=0.248 Sum_probs=150.6
Q ss_pred CcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCC-
Q 007967 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTN- 85 (583)
Q Consensus 7 PNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~- 85 (583)
..|..++.++.+.++-.+|||++ |.+|.+++... .+.|+-..+.-++-|++.-++|+|.+++|||||||+|+|..-+
T Consensus 71 ~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr 148 (341)
T KOG1163|consen 71 VGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR 148 (341)
T ss_pred CCCchhhhhccccccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc
Confidence 45666777888899999999998 89999988765 5779999999999999999999999999999999999999643
Q ss_pred --CcEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 86 --GVVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 86 --g~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
..+.++|||+|+.+.+..... +......||..|.+--... +...+...|+-|+|.+|.++..|..||.+....
T Consensus 149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~-g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHL-GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhh-hhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 468999999998876543322 2223467999999877665 455677899999999999999999999987543
Q ss_pred HH--HHHHHhcCCCCCC-ccccccchHHHHHHHHhhhcCCCCCCCCHH
Q 007967 160 KV--LLMTIQNAPPGLD-YDRDKKFSKSFKEMVAMCLVKDQTKRPTAE 204 (583)
Q Consensus 160 ~~--l~~~i~~~~~~~~-~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~ 204 (583)
.. -.+.|........ ....+.++.+|.-.+.-|-..--.+-|...
T Consensus 228 tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 228 TKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred hHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 32 2233332222111 122467889999999999888888888753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.8e-16 Score=154.19 Aligned_cols=119 Identities=13% Similarity=0.267 Sum_probs=91.1
Q ss_pred CCCCCCcccceEEEEEEC--------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 2 SLIDHPNVIRAYCSFVVD--------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~--------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
..+.||+|..+..++.+. +..+|||||++|.+|.++.. +++ ..+.+|+.+|..||.+|++||
T Consensus 90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~ 159 (232)
T PRK10359 90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSG 159 (232)
T ss_pred HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccC
Confidence 356899999999987754 35899999999999987632 333 246699999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 74 DVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 74 DLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
|+||+||+++.+| ++|+|||......... . + ..++. .+.|+.++|+|+||+++..+.
T Consensus 160 Dikp~Nili~~~g-i~liDfg~~~~~~e~~--a------~-------d~~vl-er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 160 DPHKGNFIVSKNG-LRIIDLSGKRCTAQRK--A------K-------DRIDL-ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCChHHEEEeCCC-EEEEECCCcccccchh--h------H-------HHHHH-HhHhcccccccceeEeehHHH
Confidence 9999999999988 9999999765431110 0 0 00222 345778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=9.3e-15 Score=142.54 Aligned_cols=90 Identities=14% Similarity=0.184 Sum_probs=70.3
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCcEEE
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL-HRQGHIHRDVKAGNILL 82 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yL-Hs~gIvHRDLKPeNILl 82 (583)
+.|++|...+.+.. . ..+|||||++|+++...+.. ...+++..+..++.||+.+|.|| |+.||+||||||+|||+
T Consensus 76 l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 76 LVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred HHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 34555543332222 2 23899999998877654322 36799999999999999999999 79999999999999999
Q ss_pred cCCCcEEEEecCCccc
Q 007967 83 DTNGVVKLADFGVSAC 98 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~ 98 (583)
+ ++.++|+|||+|..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 57899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.8e-14 Score=143.08 Aligned_cols=87 Identities=22% Similarity=0.230 Sum_probs=71.7
Q ss_pred CCCcccceEEEEEECC---E-EEEEEec--CCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCcccCCCC
Q 007967 5 DHPNVIRAYCSFVVDS---N-LWVVMPF--MAEGSCLHLMKIAYQDGFEESAIGSILKETLKAL-DYLHRQGHIHRDVKA 77 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~---~-l~LVmEy--~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL-~yLHs~gIvHRDLKP 77 (583)
+||||+++|++++++. . +.+|||| +.+|+|.+++.. ..+++. ..++.+++.++ +|||+++|+||||||
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp 133 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKP 133 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 7899999999999874 4 3478999 558999999864 347666 46788888888 999999999999999
Q ss_pred CcEEEcC----CCcEEEEecCCc
Q 007967 78 GNILLDT----NGVVKLADFGVS 96 (583)
Q Consensus 78 eNILld~----~g~IKL~DFGlA 96 (583)
+|||++. ++.++|+||+.+
T Consensus 134 ~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 134 QNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHEEEeccCCCCCcEEEEECCCC
Confidence 9999974 337999995433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.7e-14 Score=138.62 Aligned_cols=92 Identities=16% Similarity=0.194 Sum_probs=73.3
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNIL 81 (583)
.+.|++|.....+... ..||||||+.|+++...... ...+++..+..++.|++.+|.+||. +||+||||||+|||
T Consensus 75 ~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 75 RLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred HHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 4567777554444333 24899999998865443222 3568899999999999999999999 99999999999999
Q ss_pred EcCCCcEEEEecCCcccc
Q 007967 82 LDTNGVVKLADFGVSACM 99 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~ 99 (583)
++ ++.++|+|||++...
T Consensus 151 l~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 151 YH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EE-CCCEEEEEcccceec
Confidence 98 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-14 Score=167.43 Aligned_cols=215 Identities=27% Similarity=0.423 Sum_probs=169.5
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
.||.++...-.|.-...++|||+|+.|++|...+... +..+++.++.++..++.+++|||...+.|||++|.|+|+..
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY 939 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcc
Confidence 4577777666666778899999999999999987653 56888889999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccC-------CC---------------------CccccccccCCCCCCCcccccCCCCCCccccc
Q 007967 85 NGVVKLADFGVSACMFDT-------GD---------------------RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADI 136 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~-------~~---------------------~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDI 136 (583)
+|+.++.|||........ +. ..+.....+||+.|.+||.+. +...+..+||
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~ 1018 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADW 1018 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCCcchh
Confidence 999999999843221100 00 001123467999999999998 6778899999
Q ss_pred cchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHH---HHHhccccc
Q 007967 137 WSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE---KLLKHSFFK 213 (583)
Q Consensus 137 WSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~---eIL~HpfFk 213 (583)
|++|+++++.++|.+||....+.+.. ..+.+...... ......+..+.+++..+|..+|.+|..+. ++..|+||+
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~f-~ni~~~~~~~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~ 1096 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIF-ENILNRDIPWP-EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQ 1096 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhhh-hccccCCCCCC-CCccccChhhhhhhhhhhccCchhccCcccccccccCCccC
Confidence 99999999999999999987765554 33333322211 12345788999999999999999999876 999999999
Q ss_pred cCCCCchhhhh
Q 007967 214 HAKPPELSVKK 224 (583)
Q Consensus 214 ~~~~~~~~~~~ 224 (583)
..+|..+....
T Consensus 1097 ~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1097 DVDWENLALQK 1107 (1205)
T ss_pred CCCcccccccc
Confidence 99987665433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.7e-13 Score=139.74 Aligned_cols=208 Identities=22% Similarity=0.330 Sum_probs=146.7
Q ss_pred CCCCCcccceEEEEEECC-----EEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--Cccc
Q 007967 3 LIDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQG--HIHR 73 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~-----~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHR 73 (583)
++.|-|||++|.+|.+.. .+.+++|||..|++..++++.. +..+......+|+-||+.||.|||+.. |+|+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 467999999999997654 4899999999999999988643 345888999999999999999999984 9999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCccc--cccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 74 DVKAGNILLDTNGVVKLADFGVSAC--MFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 74 DLKPeNILld~~g~IKL~DFGlA~~--~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
.+..+-|++..+|-|||+----... ..... .........+-++|.|||.=. ....+.++|||+||....+|..|..
T Consensus 203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~-~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNST-REAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred CcchhheeecCCceEEecccCccccchhhhhh-hHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHhee
Confidence 9999999999999888753211110 00000 001111234578899999654 3456678999999999999988754
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
--......-.....+.+....+... .-++++.+||+-.|..||++.+++.||..-++....
T Consensus 281 q~tnseS~~~~ee~ia~~i~~len~-------lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslk 341 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIANVIIGLENG-------LQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLK 341 (458)
T ss_pred ccCCCcceeehhhhhhhheeeccCc-------cccCcCcccccCCCCCCcchhhhhcCceeeecchHH
Confidence 3211111011112222222222111 135789999999999999999999999988776543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1e-12 Score=153.05 Aligned_cols=138 Identities=23% Similarity=0.340 Sum_probs=115.7
Q ss_pred CcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC--
Q 007967 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT-- 84 (583)
Q Consensus 7 PNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~-- 84 (583)
+-|+.++.++.-.+.-+||+||.+.|+|++++.. .+.++|..+..++.|++..+++||.+||||+||||+|+||..
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREI 831 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeeccc
Confidence 4455566666677788999999999999999883 477999999999999999999999999999999999999942
Q ss_pred -----CCcEEEEecCCcccc--ccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCC
Q 007967 85 -----NGVVKLADFGVSACM--FDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGH 150 (583)
Q Consensus 85 -----~g~IKL~DFGlA~~~--~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~ 150 (583)
.--++|+|||.+-.+ +..+ ......++|-.+-.+|++. ++.++..+|.|.++.+++-||.|+
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~lfp~~---~~F~~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKLFPDG---TKFKAVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred CCCCcccceEEEecccceeeeEcCCC---cEEeeeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHH
Confidence 235999999987533 2222 2334578899999999988 789999999999999999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.2e-13 Score=130.17 Aligned_cols=88 Identities=24% Similarity=0.346 Sum_probs=77.6
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.+.|++|.....++.+....++||||++|++|.+++... .. ....++.+|+.+|.+||+.|++|+|++|.|||+
T Consensus 55 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~ 128 (211)
T PRK14879 55 RARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL 128 (211)
T ss_pred HHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE
Confidence 457888888888888888999999999999999987542 12 788999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCcc
Q 007967 83 DTNGVVKLADFGVSA 97 (583)
Q Consensus 83 d~~g~IKL~DFGlA~ 97 (583)
+ ++.++|+|||.+.
T Consensus 129 ~-~~~~~liDf~~a~ 142 (211)
T PRK14879 129 S-GGKIYLIDFGLAE 142 (211)
T ss_pred E-CCCEEEEECCccc
Confidence 9 7899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-12 Score=126.74 Aligned_cols=86 Identities=21% Similarity=0.303 Sum_probs=72.0
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.+.|++|....-++......++||||++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||++
T Consensus 53 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~ 123 (199)
T TIGR03724 53 RARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV 123 (199)
T ss_pred HHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE
Confidence 4567776666656667778899999999999998765321 1 789999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccc
Q 007967 83 DTNGVVKLADFGVSAC 98 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~ 98 (583)
+ ++.++++|||++..
T Consensus 124 ~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 124 R-DDKLYLIDFGLGKY 138 (199)
T ss_pred E-CCcEEEEECCCCcC
Confidence 9 88999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.3e-12 Score=143.13 Aligned_cols=87 Identities=17% Similarity=0.287 Sum_probs=77.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.+.|++|+..+.++.+....++||||++|++|.+++. ....++.+|+.+|.|||++|++||||||+||
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NI 459 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNF 459 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHE
Confidence 346789999988888888888999999999999998775 3467899999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccc
Q 007967 81 LLDTNGVVKLADFGVSAC 98 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~ 98 (583)
|+ .++.++|+|||+++.
T Consensus 460 Ll-~~~~~~liDFGla~~ 476 (535)
T PRK09605 460 IV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EE-ECCcEEEEeCccccc
Confidence 99 678999999999863
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.1e-12 Score=125.88 Aligned_cols=89 Identities=21% Similarity=0.271 Sum_probs=70.1
Q ss_pred CCCCCcc--cceEEEEEECCE----EEEEEecCCC-CCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 3 LIDHPNV--IRAYCSFVVDSN----LWVVMPFMAE-GSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 3 ~L~HPNI--Vkl~~~f~d~~~----l~LVmEy~~G-GsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
.|.|++| ++.+++...... .++||||++| .+|.+++.. ..+++. .+.+|+.+|.+||++||+||||
T Consensus 96 ~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDl 168 (239)
T PRK01723 96 QLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADL 168 (239)
T ss_pred HHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCC
Confidence 4567664 677776544322 3599999997 688887653 445654 3678999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccc
Q 007967 76 KAGNILLDTNGVVKLADFGVSAC 98 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~ 98 (583)
||+|||++.++.++|+|||.+..
T Consensus 169 kp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 169 NAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.2e-12 Score=127.58 Aligned_cols=75 Identities=23% Similarity=0.242 Sum_probs=64.1
Q ss_pred EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCCcEEEcCCCcEEEEecCCccc
Q 007967 21 NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG-HIHRDVKAGNILLDTNGVVKLADFGVSAC 98 (583)
Q Consensus 21 ~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g-IvHRDLKPeNILld~~g~IKL~DFGlA~~ 98 (583)
..||||||+.|++|...+.. ...+.+..+..++.||+.+|.+||.+| ++||||||+||+++ ++.++|+|||.+..
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 35899999999888665322 245667778899999999999999999 99999999999999 88999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9e-12 Score=137.03 Aligned_cols=200 Identities=21% Similarity=0.216 Sum_probs=155.4
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHH----HHHHHHHCCCcccCCCCCcE
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK----ALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~----gL~yLHs~gIvHRDLKPeNI 80 (583)
-|+|.++.+..|+..+.+|+-+|+| |.+|..+.... ..-+++..++.++.+... ||.++|..+++|-|+||.||
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i 253 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANI 253 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhhe
Confidence 5999999999999999999999999 57777765432 234889999999999999 99999999999999999999
Q ss_pred EEcCC-CcEEEEecCCccccccCCCCcccc--ccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC-
Q 007967 81 LLDTN-GVVKLADFGVSACMFDTGDRQRSR--NTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY- 156 (583)
Q Consensus 81 Lld~~-g~IKL~DFGlA~~~~~~~~~~~~~--~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~- 156 (583)
+...+ ..++++|||+...+-......... ....|...|++||.++ .-++.+.|||++|.++.+..+|..++...
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 99999 889999999877664333211111 1225777899999997 56899999999999999988876665432
Q ss_pred -ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 157 -PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 157 -~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.... .+.+. .++.+.....+.++...+..|+..+|..|+++..+++|++...
T Consensus 332 ~~~W~----~~r~~--~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 332 NSSWS----QLRQG--YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CCCcc----ccccc--cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 1111 11111 1223334456677777999999999999999999999999873
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-10 Score=130.31 Aligned_cols=136 Identities=18% Similarity=0.301 Sum_probs=105.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH-RQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH-s~gIvHRDLKPeN 79 (583)
||.++||||++|++.++.++.+|||+|-+ -.|..+++. +....+.--++||+.||.||| ..+++|++|.-..
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~S 135 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDS 135 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeee
Confidence 67899999999999999999999999987 345555544 237778888999999999998 6689999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
|+|+..|..||++|-++......+. ......---.|..|+.+... +...|.|-|||++++++.|
T Consensus 136 VfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 136 VFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred EEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence 9999999999999987643321111 01112222347777766522 2568999999999999998
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.6e-11 Score=118.06 Aligned_cols=72 Identities=21% Similarity=0.254 Sum_probs=62.0
Q ss_pred CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCcccc
Q 007967 20 SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACM 99 (583)
Q Consensus 20 ~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~ 99 (583)
+..++||||++|++|..+.. ......++.+|+.++.++|..||+||||||+||+++.++.++|+|||++...
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 45699999999999876532 1345778999999999999999999999999999999999999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-10 Score=103.61 Aligned_cols=82 Identities=21% Similarity=0.282 Sum_probs=71.8
Q ss_pred CcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCcEEEc
Q 007967 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ---GHIHRDVKAGNILLD 83 (583)
Q Consensus 7 PNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~---gIvHRDLKPeNILld 83 (583)
+++.+++.++...+..|++|||+.|+.+..+ +......++.+++.+|++||.. +++|+|++|+||+++
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~ 123 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE
Confidence 5888999988888899999999998876543 4456677899999999999985 799999999999999
Q ss_pred CCCcEEEEecCCcc
Q 007967 84 TNGVVKLADFGVSA 97 (583)
Q Consensus 84 ~~g~IKL~DFGlA~ 97 (583)
..+.++++|||.++
T Consensus 124 ~~~~~~l~Df~~~~ 137 (155)
T cd05120 124 DGKILGIIDWEYAG 137 (155)
T ss_pred CCcEEEEEeccccc
Confidence 98999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-09 Score=104.82 Aligned_cols=74 Identities=23% Similarity=0.303 Sum_probs=59.4
Q ss_pred EEEEEEecCCCCCHHH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEcCCCcEEEEecCCccc
Q 007967 21 NLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNILLDTNGVVKLADFGVSAC 98 (583)
Q Consensus 21 ~l~LVmEy~~GGsL~d-ll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNILld~~g~IKL~DFGlA~~ 98 (583)
..++||||+.|+.+.. .+... .. ...++.++.+++.++.++|. +||+||||||+||+++ ++.++|+|||.+..
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccc
Confidence 4699999999864421 11111 01 16788999999999999999 9999999999999999 89999999998864
Q ss_pred c
Q 007967 99 M 99 (583)
Q Consensus 99 ~ 99 (583)
.
T Consensus 164 ~ 164 (187)
T cd05119 164 I 164 (187)
T ss_pred c
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-09 Score=121.76 Aligned_cols=159 Identities=21% Similarity=0.315 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHHHC-CCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCcccc------ccccCCCCCCCcccccCC
Q 007967 55 LKETLKALDYLHRQ-GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSR------NTFVGTPCWMAPEVLQPG 127 (583)
Q Consensus 55 ~~QIl~gL~yLHs~-gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~------~~~~GT~~Y~APEil~~~ 127 (583)
+.+++.||.|+|.. ++||+.|.|++|.++..|..||+.|+++.......+..... ....-...|.|||++. .
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~-~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL-G 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc-c
Confidence 44566899999976 89999999999999999999999999765432211110000 1123456799999998 4
Q ss_pred CCCCccccccchhhHHhhhh-hCCCCCCCCChHHH-HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 128 SGYNSKADIWSFGITALELA-HGHAPFSKYPPMKV-LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 128 ~~ys~ksDIWSLGvILyeLL-tG~~PF~~~~~~~~-l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
...+.++|+||+||++|.+. .|+..|........ -.......-. .......++.++++=+.++|..++..||++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~--~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG--AFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc--cccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 67789999999999999999 56666544321111 1111111111 11223678899999999999999999999999
Q ss_pred HHhccccccCC
Q 007967 206 LLKHSFFKHAK 216 (583)
Q Consensus 206 IL~HpfFk~~~ 216 (583)
++.-|||.+..
T Consensus 262 l~~~~ff~D~~ 272 (700)
T KOG2137|consen 262 LLSIPFFSDPG 272 (700)
T ss_pred hhcccccCCch
Confidence 99999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.3e-10 Score=123.27 Aligned_cols=194 Identities=24% Similarity=0.258 Sum_probs=147.4
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.-|.+++.++..|....+.|+=-|||+++++...+.. ...+.+...+++..|++.++.++|+..++|+|+||+||++.
T Consensus 323 ~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~ 400 (524)
T KOG0601|consen 323 GSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS 400 (524)
T ss_pred hcccccCCCCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec
Confidence 4689999999999999999999999999988665432 35588999999999999999999999999999999999998
Q ss_pred CC-CcEEEEecCCccccccCCCCccccccccCCCCCC-CcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 84 TN-GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM-APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 84 ~~-g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~-APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
.+ +..++.|||.+..+.. ........-+++ ..|++.....+..++|++|||..+++.++|.+.=+....
T Consensus 401 ~~~~~~~~~~~~~~t~~~~------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--- 471 (524)
T KOG0601|consen 401 NDGFFSKLGDFGCWTRLAF------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--- 471 (524)
T ss_pred cchhhhhccccccccccce------ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---
Confidence 76 7889999998753211 111223344455 366666577889999999999999999998654322111
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
...+... .++.......++..+.+.++..++..|+.+.++..|.=|.
T Consensus 472 -~~~i~~~----~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 -SLTIRSG----DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred -ceeeecc----cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1122211 1222344557889999999999999999999998887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.4e-08 Score=111.49 Aligned_cols=77 Identities=19% Similarity=0.389 Sum_probs=60.0
Q ss_pred CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHH-HHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 19 DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK-ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 19 ~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~-gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
....+|||||++|++|.++.... ..++. ...++..++. .+..+|..|++|+|+||+||+++.+|.++++|||++.
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~-~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~ 305 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALD-EAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVG 305 (437)
T ss_pred cCCceEEEEeECCcccccHHHHH-hcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCee
Confidence 44579999999999998876532 12332 2345555555 4788999999999999999999999999999999876
Q ss_pred cc
Q 007967 98 CM 99 (583)
Q Consensus 98 ~~ 99 (583)
.+
T Consensus 306 ~l 307 (437)
T TIGR01982 306 RL 307 (437)
T ss_pred EC
Confidence 44
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.2e-08 Score=96.05 Aligned_cols=84 Identities=17% Similarity=0.225 Sum_probs=63.8
Q ss_pred cccceEEEEEECCEEEEEEecCCCCCHHH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCcEEEcCC
Q 007967 8 NVIRAYCSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILKETLKALDYL-HRQGHIHRDVKAGNILLDTN 85 (583)
Q Consensus 8 NIVkl~~~f~d~~~l~LVmEy~~GGsL~d-ll~~~~~~~~sE~~i~~I~~QIl~gL~yL-Hs~gIvHRDLKPeNILld~~ 85 (583)
++.+++.+ ..-+|||||+.++.+.. .++ ...+++..+..++.+++.+|..| |..|+||+||++.|||+. +
T Consensus 89 ~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~ 160 (197)
T cd05146 89 PCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-D 160 (197)
T ss_pred CCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-C
Confidence 34445543 46789999997654422 222 23466677888899999999999 899999999999999996 5
Q ss_pred CcEEEEecCCcccc
Q 007967 86 GVVKLADFGVSACM 99 (583)
Q Consensus 86 g~IKL~DFGlA~~~ 99 (583)
+.+.|+|||.+...
T Consensus 161 ~~v~iIDF~qav~~ 174 (197)
T cd05146 161 GKVWFIDVSQSVEP 174 (197)
T ss_pred CcEEEEECCCceeC
Confidence 78999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-07 Score=96.64 Aligned_cols=78 Identities=14% Similarity=0.110 Sum_probs=66.0
Q ss_pred CEEEEEEecCCCC-CHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC-------CCcEEEE
Q 007967 20 SNLWVVMPFMAEG-SCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT-------NGVVKLA 91 (583)
Q Consensus 20 ~~l~LVmEy~~GG-sL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~-------~g~IKL~ 91 (583)
..-+||||++++- +|.+++........++.....++.+|+..+.-||.+||+|+|+++.|||++. ++.+.++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3578999999876 7888876433355677888899999999999999999999999999999975 4679999
Q ss_pred ecCCcc
Q 007967 92 DFGVSA 97 (583)
Q Consensus 92 DFGlA~ 97 (583)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.5e-07 Score=102.89 Aligned_cols=175 Identities=18% Similarity=0.234 Sum_probs=128.1
Q ss_pred CCCCCCcccceEEEEEE----CCEEEEEEecCCC-CCHHHHHHHH-------------hcCCCCHHHHHHHHHHHHHHHH
Q 007967 2 SLIDHPNVIRAYCSFVV----DSNLWVVMPFMAE-GSCLHLMKIA-------------YQDGFEESAIGSILKETLKALD 63 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d----~~~l~LVmEy~~G-GsL~dll~~~-------------~~~~~sE~~i~~I~~QIl~gL~ 63 (583)
+++.|+|||.+.++|.. +..++||++|.++ ++|.++.-.. .+.+.+|+.+|.|+.|+..||.
T Consensus 328 kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~ 407 (655)
T KOG3741|consen 328 KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALY 407 (655)
T ss_pred HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHH
Confidence 56889999999999984 4569999999876 5676653221 1234789999999999999999
Q ss_pred HHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHH
Q 007967 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITA 143 (583)
Q Consensus 64 yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvIL 143 (583)
++|+.|+.-+-|.|.+||++.+.+|+|...|....+.... . |.+. --.+-|.=.||.++
T Consensus 408 sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------------~--~~le----~~Qq~D~~~lG~ll 466 (655)
T KOG3741|consen 408 SIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---------------T--EPLE----SQQQNDLRDLGLLL 466 (655)
T ss_pred HHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC---------------C--cchh----HHhhhhHHHHHHHH
Confidence 9999999999999999999999899998777654332211 0 1122 12246777899999
Q ss_pred hhhhhCCCCCCCCC-hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 144 LELAHGHAPFSKYP-PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 144 yeLLtG~~PF~~~~-~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+.|.+|..-=+..+ ..+.....+ ...++.+++++|.-+...++.+ -++.+++.|
T Consensus 467 ~aLAt~~~ns~~~d~~~~s~~~~I-----------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 467 LALATGTENSNRTDSTQSSHLTRI-----------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHhhcccccccccchHHHHHHHh-----------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999965422211 111111111 1457889999999999999987 788888875
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.6e-08 Score=90.56 Aligned_cols=75 Identities=24% Similarity=0.282 Sum_probs=57.8
Q ss_pred cceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----cccCCCCCcEEEcC
Q 007967 10 IRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGH-----IHRDVKAGNILLDT 84 (583)
Q Consensus 10 Vkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gI-----vHRDLKPeNILld~ 84 (583)
.+++.++ ...-++||||++|.++... ......++.+++.+|..||..++ +|+|++|.||+++
T Consensus 56 P~~~~~~--~~~~~lv~e~i~G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~- 122 (170)
T cd05151 56 PKLYYFD--PETGVLITEFIEGSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD- 122 (170)
T ss_pred CceEEEe--CCCCeEEEEecCCCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-
Confidence 3455543 3345899999999877542 01123467899999999999985 9999999999999
Q ss_pred CCcEEEEecCCcc
Q 007967 85 NGVVKLADFGVSA 97 (583)
Q Consensus 85 ~g~IKL~DFGlA~ 97 (583)
++.++++|||.+.
T Consensus 123 ~~~~~liDf~~a~ 135 (170)
T cd05151 123 DGRLWLIDWEYAG 135 (170)
T ss_pred CCeEEEEeccccc
Confidence 6789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.4e-08 Score=111.85 Aligned_cols=74 Identities=20% Similarity=0.301 Sum_probs=55.8
Q ss_pred CCEEEEEEecCCCCCHHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCC----cEEE
Q 007967 19 DSNLWVVMPFMAEGSCLHLMKIAYQD----GFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNG----VVKL 90 (583)
Q Consensus 19 ~~~l~LVmEy~~GGsL~dll~~~~~~----~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g----~IKL 90 (583)
....+||||||.|+.+.++-.....+ .+.+..+..++.||+ ..|++|+|+||+||+++.+| .+++
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~l 305 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIA 305 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence 45577999999999998753222112 244555556666654 58999999999999999888 9999
Q ss_pred EecCCcccc
Q 007967 91 ADFGVSACM 99 (583)
Q Consensus 91 ~DFGlA~~~ 99 (583)
+|||++..+
T Consensus 306 lDFGivg~l 314 (537)
T PRK04750 306 LDFGIVGSL 314 (537)
T ss_pred EecceEEEC
Confidence 999987654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.7e-07 Score=89.74 Aligned_cols=73 Identities=25% Similarity=0.372 Sum_probs=61.9
Q ss_pred EEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecC
Q 007967 15 SFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFG 94 (583)
Q Consensus 15 ~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFG 94 (583)
++.+.+...|+|||++|-.|.+++... ...+++.|-.-+.-||..||+|+||.++||++..++ +.++|||
T Consensus 67 ~dvD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 67 YDVDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred EEEcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECC
Confidence 455677889999999998888887653 256788888888999999999999999999997765 9999999
Q ss_pred Ccc
Q 007967 95 VSA 97 (583)
Q Consensus 95 lA~ 97 (583)
++.
T Consensus 137 Lg~ 139 (204)
T COG3642 137 LGE 139 (204)
T ss_pred ccc
Confidence 975
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=86.36 Aligned_cols=86 Identities=16% Similarity=0.188 Sum_probs=70.1
Q ss_pred cceEEEEEEC----CEEEEEEecCCCC-CHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 10 IRAYCSFVVD----SNLWVVMPFMAEG-SCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 10 Vkl~~~f~d~----~~l~LVmEy~~GG-sL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
.+.+++.+.. ...+||||+++|. +|.+++.... ..+......++.++...+.-||.+||+|+|+++.|||++.
T Consensus 76 P~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~ 153 (206)
T PF06293_consen 76 PEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDP 153 (206)
T ss_pred CcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeC
Confidence 3455555542 2468999999884 7888877532 2677788899999999999999999999999999999988
Q ss_pred CC---cEEEEecCCcc
Q 007967 85 NG---VVKLADFGVSA 97 (583)
Q Consensus 85 ~g---~IKL~DFGlA~ 97 (583)
++ .+.++||+-++
T Consensus 154 ~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 154 DDGQYRFYLIDLDRMR 169 (206)
T ss_pred CCCceeEEEEcchhce
Confidence 87 89999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=8.6e-07 Score=86.20 Aligned_cols=83 Identities=24% Similarity=0.400 Sum_probs=67.8
Q ss_pred EEEECCEEEEEEecCCC-CCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCC---cEEE
Q 007967 15 SFVVDSNLWVVMPFMAE-GSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNG---VVKL 90 (583)
Q Consensus 15 ~f~d~~~l~LVmEy~~G-GsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g---~IKL 90 (583)
+|.+...-.|+|||++| -++.+++...............+++.|-+.|.-||.++|||+||..+||++..+| .+.+
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEE
Confidence 46677778899999987 3677777766555555555588999999999999999999999999999997665 3589
Q ss_pred EecCCcc
Q 007967 91 ADFGVSA 97 (583)
Q Consensus 91 ~DFGlA~ 97 (583)
+|||++.
T Consensus 158 Idfgls~ 164 (229)
T KOG3087|consen 158 IDFGLSS 164 (229)
T ss_pred Eeecchh
Confidence 9999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.8e-08 Score=106.70 Aligned_cols=202 Identities=28% Similarity=0.379 Sum_probs=141.5
Q ss_pred CCCCCCc-ccceEEEEEECCEEEEEEecCCCC-CHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPN-VIRAYCSFVVDSNLWVVMPFMAEG-SCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPN-IVkl~~~f~d~~~l~LVmEy~~GG-sL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
.+.+||| .+.+++.++.+.+++++|+||.+| +....+... .-.+.+-....+.+.-+++|++||+.--+||| |
T Consensus 288 dK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~ 362 (829)
T KOG0576|consen 288 DKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----N 362 (829)
T ss_pred HHccCCCCcccccccCCcccccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----c
Confidence 4678999 888889999999999999999888 222211110 12244555667788888999999998778998 7
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|+... +..+..||+....+... ...++..+++.|+|||+.. ...+..+.|.|++|+-..+|.-|.+|-.. +.
T Consensus 363 ~l~s~-~~~~~~~~~v~~~L~~~----~~~~t~~~~~~~~~pev~~-~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~ 434 (829)
T KOG0576|consen 363 ILGSE-EEVKLLDFAVPPQLTRT----MKPRTAIGTPEPLAPEVIQ-ENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PP 434 (829)
T ss_pred ccccc-cccccccccCCcccCcc----cccccCCCCCCCCCchhhc-ccccccCCCccCCCcchhhcCCCCCCCCC--Cc
Confidence 76644 67899999987655222 2456789999999999887 56788999999999988888888877544 11
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHH-HHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFK-EMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lk-dLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
..... +.+.+..........++..+. ++...|+..-|..|+....++.|.+|..++.
T Consensus 435 ~~~~~-~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 435 AVLPM-IGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred cccCC-CCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 11111 111110000000011122222 5889999999999999999999999998764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.3e-06 Score=87.65 Aligned_cols=179 Identities=19% Similarity=0.272 Sum_probs=120.9
Q ss_pred EEEEEecCCCCCH-HHHHHHH-hc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCc
Q 007967 22 LWVVMPFMAEGSC-LHLMKIA-YQ---DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS 96 (583)
Q Consensus 22 l~LVmEy~~GGsL-~dll~~~-~~---~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA 96 (583)
+.++|+.+.|..= ..+++-. ++ -.+.+..+.++++.|+.+.+.||.+|.+-+|+.++|||+.+++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 7889999887632 2222111 11 12678889999999999999999999999999999999999999999886521
Q ss_pred cccccCCCCccccccccCCCCCCCccccc----CCCCCCccccccchhhHHhhhhhC-CCCCCCCC-------hHH-HH-
Q 007967 97 ACMFDTGDRQRSRNTFVGTPCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHG-HAPFSKYP-------PMK-VL- 162 (583)
Q Consensus 97 ~~~~~~~~~~~~~~~~~GT~~Y~APEil~----~~~~ys~ksDIWSLGvILyeLLtG-~~PF~~~~-------~~~-~l- 162 (583)
.+...+ ......+|...|.+||.-. .+.+-+...|.|-||+++|++|.| +.||.+.. +.+ .+
T Consensus 165 -qi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 165 -QINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred -eeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 222222 2233568999999999865 133456789999999999998875 99997642 111 11
Q ss_pred ---HHHHhcCCCCC-C---ccccccchHHHHHHHHhhhcCC--CCCCCCHH
Q 007967 163 ---LMTIQNAPPGL-D---YDRDKKFSKSFKEMVAMCLVKD--QTKRPTAE 204 (583)
Q Consensus 163 ---~~~i~~~~~~~-~---~~~~~~~S~~lkdLI~~cL~~D--P~kRpTa~ 204 (583)
+..-.....++ + ...+.-+++++..|..+|+... +.-|||++
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 00000111111 1 1112346788889999998753 56899864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.7e-06 Score=84.83 Aligned_cols=82 Identities=26% Similarity=0.340 Sum_probs=53.0
Q ss_pred cccceEEEEEECCEEEEEEecCC--CCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccCCCCCcEEEcC
Q 007967 8 NVIRAYCSFVVDSNLWVVMPFMA--EGSCLHLMKIAYQDGFEESAIGSILKETLKALDY-LHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 8 NIVkl~~~f~d~~~l~LVmEy~~--GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~y-LHs~gIvHRDLKPeNILld~ 84 (583)
++.+++.+. .-+|||||+. |..+..+.. ..++......++.+++..+.. +|..||+|+||.+.|||++.
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~----~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKD----VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD 142 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHH----CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHh----ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec
Confidence 344555432 3479999998 555444322 222345667788888885555 57999999999999999987
Q ss_pred CCcEEEEecCCccc
Q 007967 85 NGVVKLADFGVSAC 98 (583)
Q Consensus 85 ~g~IKL~DFGlA~~ 98 (583)
+ .+.|+|||.+..
T Consensus 143 ~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 143 G-KVYIIDFGQAVD 155 (188)
T ss_dssp T-CEEE--GTTEEE
T ss_pred c-eEEEEecCccee
Confidence 7 899999998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.5e-06 Score=81.69 Aligned_cols=67 Identities=22% Similarity=0.447 Sum_probs=52.8
Q ss_pred CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 20 SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 20 ~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
...+|||||++|..|.++.. +++ .+...|..++.-||..|++|+|++|+|+++..++ ++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 45678999999988766432 233 2445677889999999999999999999998655 9999998543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.6e-06 Score=80.44 Aligned_cols=88 Identities=17% Similarity=0.212 Sum_probs=65.2
Q ss_pred CcccceEEEEEEC---CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------
Q 007967 7 PNVIRAYCSFVVD---SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR---------------- 67 (583)
Q Consensus 7 PNIVkl~~~f~d~---~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs---------------- 67 (583)
.++.+++.+.... +..|+||||++|+++.+.+.. ..+++.....++.+++++|.+||+
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~ 133 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGG 133 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCc
Confidence 4466777776654 367899999999887664321 346666777777777777777774
Q ss_pred ----------------------------------------CCCcccCCCCCcEEEcC--CCcEEEEecCCcc
Q 007967 68 ----------------------------------------QGHIHRDVKAGNILLDT--NGVVKLADFGVSA 97 (583)
Q Consensus 68 ----------------------------------------~gIvHRDLKPeNILld~--~g~IKL~DFGlA~ 97 (583)
..++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 134 YLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred hHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23689999999999988 6678999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.84 E-value=3.1e-05 Score=91.76 Aligned_cols=193 Identities=22% Similarity=0.281 Sum_probs=133.7
Q ss_pred CCCCCCcccceEEEEEECCE----EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSN----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~----l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
..+.|+|++.++.+-...-. +.+.-+||.+-++..++... +..+...++.+..++++||.|+|+....|.-|..
T Consensus 237 ~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~ 314 (1351)
T KOG1035|consen 237 SKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSA 314 (1351)
T ss_pred HhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhccceeEEec
Confidence 46789999999988665433 34456789999999887764 6688899999999999999999999666665555
Q ss_pred C---cEEEcCCCcEEEE--ecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCc--cccccchhhHHhhhhhCC
Q 007967 78 G---NILLDTNGVVKLA--DFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNS--KADIWSFGITALELAHGH 150 (583)
Q Consensus 78 e---NILld~~g~IKL~--DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~--ksDIWSLGvILyeLLtG~ 150 (583)
. +...+..+.+.++ ||+.+......... .....+.-|.|+|... ...+.. ..|+|.+|..+..+..|.
T Consensus 315 s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~-~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 315 SSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLK-ENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred ccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccc-cccchhhhhhHHHHHHHHHhhhhhcC
Confidence 4 4444566667766 88876654322211 1234456688888876 333333 369999999999998875
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 151 APFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 151 ~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.+-.. ......+. +..+.....+++.+|+.-++++|+++.+++.|+|.+.-
T Consensus 390 ~i~~~----~~~~~~~l----------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 390 DISEK----SAVPVSLL----------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred ccccc----ccchhhhh----------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 44211 00100111 01111267889999999999999999999999998754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00021 Score=71.45 Aligned_cols=77 Identities=18% Similarity=0.143 Sum_probs=63.8
Q ss_pred EEEEEEecCCC-CCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCc--EEEEecCCcc
Q 007967 21 NLWVVMPFMAE-GSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGV--VKLADFGVSA 97 (583)
Q Consensus 21 ~l~LVmEy~~G-GsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~--IKL~DFGlA~ 97 (583)
..+||+|-+.| -+|.+++....-...++.....++.+|+..|.-||..|+.|+|+.+.|||++.+|. ++++||.-++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 47899997754 57877765432345678888899999999999999999999999999999987777 9999997654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0003 Score=72.51 Aligned_cols=71 Identities=23% Similarity=0.310 Sum_probs=56.5
Q ss_pred CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCc
Q 007967 19 DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS 96 (583)
Q Consensus 19 ~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA 96 (583)
.+.-.+||||++|-.|... .++.+.+..++..|++-+.-+-..|+||+|+.+-||+++.+|.+.++||=-+
T Consensus 179 ~nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 179 WNRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred cccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccc
Confidence 3457899999998766542 2245556667777777777777999999999999999999999999999543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=2e-05 Score=94.95 Aligned_cols=202 Identities=13% Similarity=0.093 Sum_probs=135.5
Q ss_pred CCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC-----CcccC
Q 007967 4 IDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKETLKALDYLHRQG-----HIHRD 74 (583)
Q Consensus 4 L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~--~sE~~i~~I~~QIl~gL~yLHs~g-----IvHRD 74 (583)
..|+++...+.-... ....|.+|+||.+|.+++.|....... ..+..+.....+.+.+..-+|+.. .+|++
T Consensus 1286 ~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~ 1365 (2724)
T KOG1826|consen 1286 AKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKS 1365 (2724)
T ss_pred hhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhh
Confidence 467777766654442 345899999999999999887542221 344445555555577777777652 78999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
||+-|.+|..+.++|++++|+.+.. . .........++++.|+.|++.. .-.++.++|+|..|+.+|.+..|..+|-
T Consensus 1366 Lkf~lpmIVtny~v~~gk~gLdKIk-n--p~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1366 LKFTLPMIVTNYNVKLGKGGLDKIK-N--PVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhhhccceecCCccccccccccccc-C--chHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999999999999999998622 1 1112234568899999999887 4567778999999999999999887763
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
... ...+...+.+. -......-.+.++-.....+|-+.-..||.-..++.-+.|-
T Consensus 1442 ~fl-q~~Lkgiidn~---tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1442 FFL-QPALKGIIDNH---TFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHH-HHHHcCccccc---ccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 311 11111111111 11222233345555566666667777888888777766654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0011 Score=74.48 Aligned_cols=81 Identities=22% Similarity=0.444 Sum_probs=59.0
Q ss_pred EEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCC
Q 007967 16 FVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGV 95 (583)
Q Consensus 16 f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGl 95 (583)
++..+.-.|+|||++|-.+.++.... ..+++...+...+.++. +..+=..|++|.|.+|+||+++.+|.+.+.|||+
T Consensus 235 we~t~~~VLtmE~i~Gi~i~d~~~l~-~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi 311 (517)
T COG0661 235 WEYTTRRVLTMEWIDGIKISDIAALK-SAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGI 311 (517)
T ss_pred hhccCCcEEEEEeeCCEecccHHHHH-hcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcc
Confidence 33456789999999999888874433 25666554444333322 2333348999999999999999999999999998
Q ss_pred cccc
Q 007967 96 SACM 99 (583)
Q Consensus 96 A~~~ 99 (583)
...+
T Consensus 312 ~g~l 315 (517)
T COG0661 312 VGRL 315 (517)
T ss_pred eecC
Confidence 7544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0013 Score=64.36 Aligned_cols=84 Identities=18% Similarity=0.130 Sum_probs=68.1
Q ss_pred CcccceEEEEEECCEEEEEEecCCCCCHHHH---HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCCCcE
Q 007967 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHL---MKIAYQDGFEESAIGSILKETLKALDYLHR---QGHIHRDVKAGNI 80 (583)
Q Consensus 7 PNIVkl~~~f~d~~~l~LVmEy~~GGsL~dl---l~~~~~~~~sE~~i~~I~~QIl~gL~yLHs---~gIvHRDLKPeNI 80 (583)
+++.+++++|- -++|.||...+++... +.. -...++....+|+.+++..+++|+. ..+.-.|++++||
T Consensus 20 ~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nf 93 (188)
T PF12260_consen 20 EPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNF 93 (188)
T ss_pred CCCCCeeeECC----CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHe
Confidence 58999999983 3668999987766421 111 1336889999999999999999998 4588899999999
Q ss_pred EEcCCCcEEEEecCCc
Q 007967 81 LLDTNGVVKLADFGVS 96 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA 96 (583)
-++.+|++|++|....
T Consensus 94 gv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 94 GVNDDGRLKLIDLDDV 109 (188)
T ss_pred EEeCCCcEEEEechhc
Confidence 9999999999999864
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0026 Score=71.52 Aligned_cols=77 Identities=23% Similarity=0.319 Sum_probs=56.2
Q ss_pred CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC----CCcEEEEecCC
Q 007967 20 SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT----NGVVKLADFGV 95 (583)
Q Consensus 20 ~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~----~g~IKL~DFGl 95 (583)
..-.|+||||+|.-+.++-.. ...+++...+...+.+...-+ |=..|++|.|-+|+||+++. ++.+.+.|||+
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~~q--If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl 351 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYLEQ--IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGL 351 (538)
T ss_pred cceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHHHH--HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccc
Confidence 467999999999877655322 246677776655555544333 33468999999999999984 66899999999
Q ss_pred cccc
Q 007967 96 SACM 99 (583)
Q Consensus 96 A~~~ 99 (583)
...+
T Consensus 352 ~~~i 355 (538)
T KOG1235|consen 352 YAVI 355 (538)
T ss_pred cccc
Confidence 7654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0047 Score=61.88 Aligned_cols=29 Identities=24% Similarity=0.274 Sum_probs=25.7
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998778899998653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0069 Score=60.88 Aligned_cols=28 Identities=25% Similarity=0.440 Sum_probs=24.9
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0031 Score=64.46 Aligned_cols=75 Identities=20% Similarity=0.323 Sum_probs=56.0
Q ss_pred EEEEEEecCCCCCH-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEcCCCcEEEEecCCccc
Q 007967 21 NLWVVMPFMAEGSC-LHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNILLDTNGVVKLADFGVSAC 98 (583)
Q Consensus 21 ~l~LVmEy~~GGsL-~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNILld~~g~IKL~DFGlA~~ 98 (583)
+-.|||||+..... .-.|+ .-++...++..+..++++.+.-|-. .|+||+||..-|||+. ++.+.|+|||-|..
T Consensus 140 ~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 45899999954311 00111 1234444788889999999988887 8999999999999999 88999999998754
Q ss_pred c
Q 007967 99 M 99 (583)
Q Consensus 99 ~ 99 (583)
.
T Consensus 216 ~ 216 (268)
T COG1718 216 I 216 (268)
T ss_pred c
Confidence 3
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.036 Score=54.93 Aligned_cols=83 Identities=22% Similarity=0.335 Sum_probs=62.4
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCC--C----CHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAE--G----SCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~G--G----sL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
...+.+|.++|++.+++..+.+|+|.+.. | +|.+++. .+.+++ .+ ...+-.-..||-.++|+.+||+
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~ 145 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-EL---RQALDEFKRYLLDHHIVIRDLN 145 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HH---HHHHHHHHHHHHHcCCeecCCC
Confidence 34688999999999999999999998643 2 5777774 356766 33 3444455678899999999999
Q ss_pred CCcEEEcCC--C--cEEEEe
Q 007967 77 AGNILLDTN--G--VVKLAD 92 (583)
Q Consensus 77 PeNILld~~--g--~IKL~D 92 (583)
|.||++... + .+.|+|
T Consensus 146 ~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cccEEEEecCCCceEEEEEe
Confidence 999999532 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.013 Score=69.74 Aligned_cols=29 Identities=21% Similarity=0.512 Sum_probs=23.9
Q ss_pred CCcccCCCCCcEEEcCC-Cc-EEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTN-GV-VKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~-g~-IKL~DFGlA~ 97 (583)
.+||+|+++.|||++.+ +. +-|.||+++.
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~ 256 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELST 256 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccc
Confidence 49999999999999853 33 5799999875
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.015 Score=64.88 Aligned_cols=157 Identities=19% Similarity=0.264 Sum_probs=96.1
Q ss_pred CCCCCCCcccceEEEEEEC-CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVD-SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~-~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
++.+.|+|+-.+.++-... ....+|||++ +.+|.+++.... +-.. +++ .+|+.|-
T Consensus 36 lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~-------s~~-------~~~~~~~------ 91 (725)
T KOG1093|consen 36 LKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDE-------SLL-------AHGVLHL------ 91 (725)
T ss_pred HHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchh-------hhc-------cccccee------
Confidence 3567899999988887654 3488899999 788998876531 1111 111 2232222
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
+.++++|- ++. . | |- ..++|+|||++|.++.++..|...|......
T Consensus 92 ------~~~~~td~-~~t----~---------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s 137 (725)
T KOG1093|consen 92 ------NIIYITDH-FLT----K---------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAELTES 137 (725)
T ss_pred ------hhhhcccc-ccc----c---------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHHHHH
Confidence 12333431 000 0 0 11 1124999999999999999998877655444
Q ss_pred HHHHHHHhcCCCCCCc-------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 160 KVLLMTIQNAPPGLDY-------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~-------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+.+............. .....+++.+..+..+|+-..|..||...++.+++-|..+
T Consensus 138 ~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 138 EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 4332222211100000 0112345667899999999999999999999999998765
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.048 Score=52.79 Aligned_cols=30 Identities=37% Similarity=0.643 Sum_probs=21.0
Q ss_pred CCCcccCCCCCcEEEc-CCCcEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLD-TNGVVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld-~~g~IKL~DFGlA~ 97 (583)
..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3599999999999999 66777899998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.06 Score=58.06 Aligned_cols=72 Identities=24% Similarity=0.273 Sum_probs=56.2
Q ss_pred CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 19 DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 19 ~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
..++|++|++- |+.+.- + ..-..+++..|+++.+..++-+..+ ..-||++..+||||+ +|+|-|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 34688889985 554432 2 2235677888999988888777765 688999999999999 9999999999887
Q ss_pred c
Q 007967 98 C 98 (583)
Q Consensus 98 ~ 98 (583)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 3
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.023 Score=60.33 Aligned_cols=69 Identities=17% Similarity=0.228 Sum_probs=54.5
Q ss_pred ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecC
Q 007967 18 VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFG 94 (583)
Q Consensus 18 d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFG 94 (583)
+.+.-++|||++.|-.|...-. ...+..+...+..-+.-|-.+|+||+|..--||++..++.++++||-
T Consensus 179 D~~RH~Vvmelv~g~Pl~~v~~--------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 179 DHNRHCVVMELVDGYPLRQVRH--------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFP 247 (465)
T ss_pred cccceeeHHHhhcccceeeeee--------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeech
Confidence 3456789999998887755311 12344566677777888999999999999999999999999999995
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=92.57 E-value=0.2 Score=52.28 Aligned_cols=39 Identities=38% Similarity=0.616 Sum_probs=31.1
Q ss_pred HHHHHHHHH-------CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 59 LKALDYLHR-------QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 59 l~gL~yLHs-------~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
...++++.. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 171 DKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 345555543 589999999999999988877899999753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.19 E-value=0.28 Score=50.73 Aligned_cols=28 Identities=36% Similarity=0.500 Sum_probs=24.7
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVS 96 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA 96 (583)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67899999854
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.73 E-value=0.32 Score=50.77 Aligned_cols=30 Identities=27% Similarity=0.492 Sum_probs=25.6
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.|+||+|++|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999876556899999763
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=91.49 E-value=0.16 Score=50.73 Aligned_cols=29 Identities=28% Similarity=0.526 Sum_probs=24.7
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
+++|+|+.++|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 58999999999999876556799999753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=91.39 E-value=0.47 Score=47.39 Aligned_cols=75 Identities=23% Similarity=0.319 Sum_probs=51.7
Q ss_pred CCCCCCcc--cceEEEEEEC------------------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 007967 2 SLIDHPNV--IRAYCSFVVD------------------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKA 61 (583)
Q Consensus 2 k~L~HPNI--Vkl~~~f~d~------------------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~g 61 (583)
+.+++.++ |++|+++.-. ....||.||..... .+. ..-+.+|++-
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~d 176 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRD 176 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHH
Confidence 34455566 7777776321 12577888876553 122 2335678888
Q ss_pred HHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCc
Q 007967 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS 96 (583)
Q Consensus 62 L~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA 96 (583)
|..+|..||+-+|+++.|.. + -||+|||.+
T Consensus 177 l~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHHHHCCeeeccCcccccc---C--CEEEecccC
Confidence 89999999999999999985 3 389999853
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.09 E-value=0.66 Score=48.54 Aligned_cols=26 Identities=15% Similarity=0.259 Sum_probs=20.6
Q ss_pred CCcccCCCCCcEEEcCC-Cc-EEEEecC
Q 007967 69 GHIHRDVKAGNILLDTN-GV-VKLADFG 94 (583)
Q Consensus 69 gIvHRDLKPeNILld~~-g~-IKL~DFG 94 (583)
.++|+|+.++||+++.+ +. +.|+|..
T Consensus 194 sLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 194 VLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred eeEeCCCCcccEEECCCCCceEEEECch
Confidence 47999999999999865 43 5677764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.00 E-value=0.22 Score=49.42 Aligned_cols=29 Identities=28% Similarity=0.508 Sum_probs=25.7
Q ss_pred CCcccCCCCCcEEEcC-CCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDT-NGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~-~g~IKL~DFGlA~ 97 (583)
+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999997 5789999998653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=91.00 E-value=0.34 Score=49.84 Aligned_cols=30 Identities=30% Similarity=0.514 Sum_probs=26.3
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.86 E-value=0.36 Score=49.15 Aligned_cols=63 Identities=21% Similarity=0.221 Sum_probs=45.1
Q ss_pred ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCCcEEEcCCCcEEEEecCC
Q 007967 18 VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ--GHIHRDVKAGNILLDTNGVVKLADFGV 95 (583)
Q Consensus 18 d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~--gIvHRDLKPeNILld~~g~IKL~DFGl 95 (583)
++..+.++.|+|......- ..++.-=+..|.-.|+. +.+|+|..|+||+-|+.|.+||.|-+.
T Consensus 125 n~~~yGvIlE~Cy~~~i~~---------------~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 125 NNYKYGVILERCYKIKINF---------------SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCceeEEEEeeccCcccch---------------hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 3445889999995432110 11222225678888943 799999999999999999999999873
|
The function of this family is unknown. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.49 E-value=0.39 Score=51.08 Aligned_cols=37 Identities=19% Similarity=0.469 Sum_probs=31.1
Q ss_pred HHHHHHHC--------CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 61 ALDYLHRQ--------GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 61 gL~yLHs~--------gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
-..||+.+ .++|+|+.+.||+|+.++.+=+.||+++.
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 45666654 37999999999999999889999999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.35 E-value=0.53 Score=48.72 Aligned_cols=29 Identities=34% Similarity=0.464 Sum_probs=25.8
Q ss_pred CCcccCCCCCcEEEcCC----CcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTN----GVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~----g~IKL~DFGlA~ 97 (583)
+++|+|+.+.|||++.+ +.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999875 889999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.94 E-value=0.42 Score=47.05 Aligned_cols=27 Identities=33% Similarity=0.673 Sum_probs=24.2
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.+|+|+.|+||++..+| ++|+||+.|.
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCccc
Confidence 69999999999998877 9999999764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=87.11 E-value=0.43 Score=48.28 Aligned_cols=28 Identities=32% Similarity=0.572 Sum_probs=24.7
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.++|+|+.|.||+++.++ +.|+||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 589999999999999877 7899998653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.26 E-value=0.87 Score=48.71 Aligned_cols=27 Identities=30% Similarity=0.485 Sum_probs=24.7
Q ss_pred CcccCCCCCcEEEcCCCc-EEEEecCCc
Q 007967 70 HIHRDVKAGNILLDTNGV-VKLADFGVS 96 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~-IKL~DFGlA 96 (583)
+||+|+.|+|||++.+.. +.++|||-+
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccc
Confidence 999999999999998875 889999965
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=85.97 E-value=0.82 Score=44.87 Aligned_cols=29 Identities=41% Similarity=0.701 Sum_probs=20.8
Q ss_pred CCcccCCCCCcEEE-cCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILL-DTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILl-d~~g~IKL~DFGlA~ 97 (583)
.++|+|+.+.|||+ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=85.75 E-value=1.1 Score=46.87 Aligned_cols=29 Identities=14% Similarity=0.188 Sum_probs=26.6
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
+++|+|+.+.|||++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=85.70 E-value=1.3 Score=43.40 Aligned_cols=30 Identities=33% Similarity=0.381 Sum_probs=24.9
Q ss_pred CCCcccCCCCCcEEEcCCC-----cEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTNG-----VVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g-----~IKL~DFGlA~ 97 (583)
..++|||+.+.||++..++ .+.++||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4689999999999997543 58999998753
|
subfamily of choline kinases |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=85.53 E-value=0.83 Score=48.85 Aligned_cols=29 Identities=28% Similarity=0.655 Sum_probs=25.2
Q ss_pred CCcccCCCCCcEEEcC-CCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDT-NGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~-~g~IKL~DFGlA~ 97 (583)
.++|+|+++.|||++. ++.+.++||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4789999998653
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=84.98 E-value=1.2 Score=46.16 Aligned_cols=44 Identities=32% Similarity=0.468 Sum_probs=33.0
Q ss_pred HHHHHHHHHHHHHHHC--CCcccCCCCCcEEEcCCCcEEEEecCCc
Q 007967 53 SILKETLKALDYLHRQ--GHIHRDVKAGNILLDTNGVVKLADFGVS 96 (583)
Q Consensus 53 ~I~~QIl~gL~yLHs~--gIvHRDLKPeNILld~~g~IKL~DFGlA 96 (583)
..+..+-.++.-.|.. -++|+|+.|+|+|++..|.++|+||--|
T Consensus 136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyA 181 (269)
T COG0510 136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYA 181 (269)
T ss_pred HHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccC
Confidence 3444444444444443 4899999999999999999999999765
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.77 E-value=2.7 Score=45.19 Aligned_cols=64 Identities=17% Similarity=0.195 Sum_probs=37.9
Q ss_pred CEEEEEEecC--CCCCHHHHHHHHhcCCCC--HHHHHHHHHHHHHHHHHHH----HCCCcccCCCCCcEEEcCC
Q 007967 20 SNLWVVMPFM--AEGSCLHLMKIAYQDGFE--ESAIGSILKETLKALDYLH----RQGHIHRDVKAGNILLDTN 85 (583)
Q Consensus 20 ~~l~LVmEy~--~GGsL~dll~~~~~~~~s--E~~i~~I~~QIl~gL~yLH----s~gIvHRDLKPeNILld~~ 85 (583)
..-.+|+++. ....+...... ..+|. .+-++.++.||+.-.-.+- ..+++|.||||+|||+-..
T Consensus 248 rGnIIIfPLArcSadkv~~~~~~--e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 248 RGNIIIFPLARCSADKVTEENAA--ELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred CCcEEEEehhhcccccCCHHHHH--HcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 3456777764 33333221111 23332 3457778888876553442 3469999999999999443
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=84.20 E-value=1.9 Score=44.18 Aligned_cols=28 Identities=11% Similarity=0.224 Sum_probs=23.4
Q ss_pred CcccceEEEEEECCEEEEEEecCCCCCH
Q 007967 7 PNVIRAYCSFVVDSNLWVVMPFMAEGSC 34 (583)
Q Consensus 7 PNIVkl~~~f~d~~~l~LVmEy~~GGsL 34 (583)
-.|.+++++-.+.++.|+||||++-|.+
T Consensus 71 i~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 71 ITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccccceEEecCCCCeeEEEEeeccCCCC
Confidence 4577888888899999999999987544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=82.64 E-value=0.89 Score=47.12 Aligned_cols=29 Identities=28% Similarity=0.487 Sum_probs=24.3
Q ss_pred CCcccCCCCCcEEEcCCCc-EEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGV-VKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~-IKL~DFGlA~ 97 (583)
.++|+|++|.|||++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999987565 4699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=81.93 E-value=3.1 Score=44.14 Aligned_cols=28 Identities=29% Similarity=0.608 Sum_probs=24.4
Q ss_pred CcccCCCCCcEEEcC-CCcEEEEecCCcc
Q 007967 70 HIHRDVKAGNILLDT-NGVVKLADFGVSA 97 (583)
Q Consensus 70 IvHRDLKPeNILld~-~g~IKL~DFGlA~ 97 (583)
++|+|+.+.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999974 5789999998753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=81.89 E-value=1.7 Score=53.25 Aligned_cols=30 Identities=37% Similarity=0.563 Sum_probs=25.6
Q ss_pred CCCcccCCCCCcEEEcCCC--cEE-EEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTNG--VVK-LADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g--~IK-L~DFGlA~ 97 (583)
+++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999998875 565 99999764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 583 | ||||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-70 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-69 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-53 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-53 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-53 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-53 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-52 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-51 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-47 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-44 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-40 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-40 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-40 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-40 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-40 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-40 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-39 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-39 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-39 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-39 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-39 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-37 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-37 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-37 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-37 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-37 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-36 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-36 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-36 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-35 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-34 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-34 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-34 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-33 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-31 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-26 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-26 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-26 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-25 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-24 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-23 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-23 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-22 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-22 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-22 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-21 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-21 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-21 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-21 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-19 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-15 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-08 |
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 414 bits (1067), Expect = e-143
Identities = 127/237 (53%), Positives = 164/237 (69%), Gaps = 13/237 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG------FEESAIGSI 54
MS HPN++ Y SFVV LW+VM ++ GS L ++K G +ES I +I
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTF 112
L+E L+ L+YLH+ G IHRDVKAGNILL +G V++ADFGVSA + GD R + R TF
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
VGTPCWMAPEV++ GY+ KADIWSFGITA+ELA G AP+ KYPPMKVL++T+QN PP
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 173 L-----DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKK 224
L D + KK+ KSF++M+++CL KD KRPTA +LL+H FF+ AK E +K
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 387 bits (996), Expect = e-131
Identities = 101/320 (31%), Positives = 139/320 (43%), Gaps = 56/320 (17%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
L +HPN++ +F+ D+ LWVV FMA GS L+ + DG E AI IL+ LK
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT----FVGTP 116
ALDY+H G++HR VKA +IL+ +G V L+ + M G RQR + V
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 117 CWMAPEVL-QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL-- 173
W++PEVL Q GY++K+DI+S GITA ELA+GH PF P ++LL + P L
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 174 ---------------------------------------DYDRDKKFSKSFKEMVAMCLV 194
+ + FS F V CL
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 195 KDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQLKDAAQLALKKMPS 254
++ RP+A LL HSFFK K LP L V + + +Q
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEA------LPELLRPVTPITNFEGSQSQDHSGIF 373
Query: 255 AEQEAISQSEYQRGVSAWNF 274
+ + E V W F
Sbjct: 374 GLVTNLEELE----VDDWEF 389
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 351 bits (903), Expect = e-118
Identities = 106/225 (47%), Positives = 143/225 (63%), Gaps = 11/225 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S D P V + Y S++ D+ LW++M ++ GS L L++ +E+ I +IL+E LK
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILK 130
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
LDYLH + IHRD+KA N+LL +G VKLADFGV+ + DT + RNTFVGTP WMA
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWMA 187
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV++ S Y+SKADIWS GITA+ELA G P S+ PMKVL + +N PP L +
Sbjct: 188 PEVIK-QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL----EGN 242
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKL 225
+SK KE V CL K+ + RPTA++LLKH F + +L
Sbjct: 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-102
Identities = 82/251 (32%), Positives = 129/251 (51%), Gaps = 17/251 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ D P +++ + +F+ ++++++ M M G+C +K Q E +G + +K
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 61 ALDYLHRQ-GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL YL + G IHRDVK NILLD G +KL DFG+S + D ++++ G +M
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD----KAKDRSAGCAAYM 191
Query: 120 APEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTIQNAPPGLD 174
APE + P Y+ +AD+WS GI+ +ELA G P+ +VL +Q PP L
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL- 250
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWN 234
FS F+ V CL KD KRP KLL+HSF K + E+ V F D +
Sbjct: 251 -PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKD---VMA 306
Query: 235 RVKALQLKDAA 245
+ ++ + ++
Sbjct: 307 KTESPRSGPSS 317
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 2e-98
Identities = 80/223 (35%), Positives = 127/223 (56%), Gaps = 10/223 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++ DHP +++ ++ D LW+++ F G+ +M G E I + ++ L+
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLE 128
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL++LH + IHRD+KAGN+L+ G ++LADFGVSA T + R++F+GTP WMA
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK---RDSFIGTPYWMA 185
Query: 121 PEVL----QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
PEV+ + Y+ KADIWS GIT +E+A P + PM+VLL ++ PP L
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL--L 243
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
K+S F++ + + L K+ RP+A +LL+H F +
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 1e-97
Identities = 92/235 (39%), Positives = 129/235 (54%), Gaps = 16/235 (6%)
Query: 1 MSLIDHPNVIRAYCSFV------VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
H N+ Y +F+ +D LW+VM F GS L+K + +E I I
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
+E L+ L +LH+ IHRD+K N+LL N VKL DFGVSA + T R RNTF+G
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIG 191
Query: 115 TPCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAP 170
TP WMAPEV+ P + Y+ K+D+WS GITA+E+A G P PM+ L + +N
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKL 225
P L + KK+SK F+ + CLVK+ ++RP E+L+KH F + +L
Sbjct: 252 PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQL 303
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 2e-97
Identities = 79/237 (33%), Positives = 121/237 (51%), Gaps = 13/237 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY---QDGFEESAIGSILKE 57
M D P +++ Y + + + W+ M M+ S K Y D E +G I
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 58 TLKALDYLHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
T+KAL++L I HRD+K NILLD +G +KL DFG+S + D+ ++ G
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS----IAKTRDAGCR 189
Query: 117 CWMAPEVLQP---GSGYNSKADIWSFGITALELAHGHAPFSKYPPM-KVLLMTIQNAPPG 172
+MAPE + P GY+ ++D+WS GIT ELA G P+ K+ + L ++ PP
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADL 229
L +++FS SF V +CL KD++KRP ++LLKH F + + V +
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKI 306
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 5e-97
Identities = 96/219 (43%), Positives = 134/219 (61%), Gaps = 7/219 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M D P+V++ Y S+ +++LW+VM + GS ++++ E I +IL+ TLK
Sbjct: 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLK 136
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+YLH IHRD+KAGNILL+T G KLADFGV+ + DT + RNT +GTP WMA
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMA 193
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+Q GYN ADIWS GITA+E+A G P++ PM+ + M N PP + +
Sbjct: 194 PEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF--RKPEL 250
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
+S +F + V CLVK +R TA +LL+H F + AK
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 2e-95
Identities = 91/261 (34%), Positives = 125/261 (47%), Gaps = 22/261 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + HPN I+ ++ + W+VM + GS L+++ ++ +E I ++ L+
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQ 165
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L YLH IHRDVKAGNILL G+VKL DFG ++ M N+FVGTP WMA
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSFVGTPYWMA 218
Query: 121 PEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
PEV+ Y+ K D+WS GIT +ELA P M L QN P L +
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---QS 275
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKA 238
+S+ F+ V CL K RPT+E LLKH F +PP + + L R K
Sbjct: 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV--------IMDLIQRTKD 327
Query: 239 LQLKDAAQLALKKMPSAEQEA 259
+ K QEA
Sbjct: 328 AVRELDNLQYRKMKKILFQEA 348
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 4e-95
Identities = 84/219 (38%), Positives = 122/219 (55%), Gaps = 9/219 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +PN++ S++V LWVVM ++A GS ++ + +E I ++ +E L+
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQ 127
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL++LH IHRD+K+ NILL +G VKL DFG A + + R+T VGTP WMA
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMA 184
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+ Y K DIWS GI A+E+ G P+ P++ L + N P L +K
Sbjct: 185 PEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL--QNPEK 241
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
S F++ + CL D KR +A++LL+H F K AKP
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 2e-93
Identities = 80/219 (36%), Positives = 117/219 (53%), Gaps = 9/219 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M H NV+ Y S++V LWV+M F+ G+ ++ Q E I ++ + L+
Sbjct: 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQ 152
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL YLH QG IHRD+K+ +ILL +G VKL+DFG A + + R + VGTP WMA
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMA 209
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+ S Y ++ DIWS GI +E+ G P+ P++ + + PP L K
Sbjct: 210 PEVIS-RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--KNSHK 266
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
S ++ + LV+D +R TA++LL H F PE
Sbjct: 267 VSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 7e-87
Identities = 73/235 (31%), Positives = 112/235 (47%), Gaps = 15/235 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
M +D P + Y + + ++W+ M M S K G E +G I
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 59 LKALDYLHRQGH-IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+KAL++LH + IHRDVK N+L++ G VK+ DFG+S + D +++ G
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD----VAKDIDAGCKP 174
Query: 118 WMAPEVLQP---GSGYNSKADIWSFGITALELAHGHAPFSKY-PPMKVLLMTIQNAPPGL 173
+MAPE + P GY+ K+DIWS GIT +ELA P+ + P + L ++ P L
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234
Query: 174 DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFAD 228
KFS F + + CL K+ +RPT +L++H FF + V
Sbjct: 235 P---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKL 286
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 4e-80
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 10/224 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
+ + P ++ Y + + + M + GS L+K Q G E L + L
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALYYLGQAL 160
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGV-VKLADFGVSACMFDTGDRQ--RSRNTFVGTP 116
+ L+YLH + +H DVKA N+LL ++G L DFG + C+ G + + + GT
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
MAPEV+ G ++K DIWS L + +G P+++Y + L PP +
Sbjct: 221 THMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI- 278
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
+ + + L K+ R +A +L + + L
Sbjct: 279 -PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-73
Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 12/230 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
+ H N+++ SF + + + M + GS L++ + E IG K+ L
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 60 KALDYLHRQGHIHRDVKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+ L YLH +HRD+K N+L++T +GV+K++DFG S + TF GT +
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQY 189
Query: 119 MAPEVL-QPGSGYNSKADIWSFGITALELAHGHAPFSKYP-PMKVLLM-TIQNAPPGLDY 175
MAPE++ + GY ADIWS G T +E+A G PF + P + + P +
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI-- 247
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKL 225
+ S K + C D KR A LL F K + + + KL
Sbjct: 248 --PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 3e-72
Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 54/267 (20%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + P ++ Y +F D + + M M GS ++K A E +G + +K
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIK 142
Query: 61 ALDYLHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
L YL + I HRDVK NIL+++ G +KL DFGVS + D+ N+FVGT +M
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYM 197
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP---------------------- 157
+PE LQ G+ Y+ ++DIWS G++ +E+A G P
Sbjct: 198 SPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 158 --------------------PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQ 197
++L + PP L FS F++ V CL+K+
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNP 313
Query: 198 TKRPTAEKLLKHSFFKHAKPPELSVKK 224
+R ++L+ H+F K + E+
Sbjct: 314 AERADLKQLMVHAFIKRSDAEEVDFAG 340
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 2e-71
Identities = 49/237 (20%), Positives = 91/237 (38%), Gaps = 35/237 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
L H +V+R + ++ D ++ + + GS + Y+ F+E+ + +L +
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGV-------------------VKLADFGVSACM 99
+ L Y+H +H D+K NI + + K+ D G +
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 100 FDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159
S G ++A EVLQ + KADI++ +T + A
Sbjct: 185 -------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216
+ Q P + + S+ F E++ + + D +RP+A L+KHS A
Sbjct: 238 HEI---RQGRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-69
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 14/214 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HP +R ++ L++ S + A+ E+ + L++TL
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCE-AWGASLPEAQVWGYLRDTLL 168
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL +LH QG +H DVK NI L G KL DFG+ + G + G P +MA
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG----AGEVQEGDPRYMA 224
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+LQ Y + AD++S G+T LE+A + L PP
Sbjct: 225 PELLQ--GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY--LPPEF----TAG 276
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214
S + ++ M L D R TAE LL +
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-66
Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 1 MSLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56
+ + HPN++R Y S+ + +V M G+ +K ++ + + S +
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKV-MKIKVLRSWCR 136
Query: 57 ETLKALDYLHRQGH--IHRDVKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFV 113
+ LK L +LH + IHRD+K NI + G VK+ D G++ R +
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVI 191
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQN--APP 171
GTP +MAPE+ + Y+ D+++FG+ LE+A P+S+ + + + P
Sbjct: 192 GTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249
Query: 172 GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214
DK KE++ C+ +++ +R + + LL H+FF+
Sbjct: 250 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 5e-66
Identities = 61/249 (24%), Positives = 110/249 (44%), Gaps = 28/249 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-------------LWVVMPFMAEGSCLHLMKIAYQDGFE 47
++ ++H V+R Y +++ N L++ M + G+ L+ + +
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQ 114
Query: 48 ESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQR 107
+ ++ L+AL Y+H QG IHRD+K NI +D + VK+ DFG++ + + D +
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 108 S-----------RNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156
+ +GT ++A EVL YN K D++S GI E+ + PFS
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216
+L +++ D D K K+++ + + D KRP A LL +
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
Query: 217 PPELSVKKL 225
E+ + L
Sbjct: 292 QDEVIKEAL 300
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-65
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 11/223 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILKET 58
+ ++HPNVI+ Y SF+ D+ L +V+ G ++K + E + +
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
AL+++H + +HRD+K N+ + GVVKL D G+ ++ VGTP +
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYY 202
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF-SKYPPMKVLLMTIQNA-PPGLDYD 176
M+PE + +GYN K+DIWS G E+A +PF + L I+ P L D
Sbjct: 203 MSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
+S+ +++V MC+ D KRP + + HA
Sbjct: 262 H---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-63
Identities = 62/267 (23%), Positives = 118/267 (44%), Gaps = 14/267 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++ + HPN+++ SF + +L++VM + G + F+E I +
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL ++H + +HRD+K+ NI L +G V+L DFG++ + T + +GTP +++
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL---ARACIGTPYYLS 193
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+ + YN+K+DIW+ G EL F ++L I + P +
Sbjct: 194 PEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV----SLH 248
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQ 240
+S + +V+ ++ RP+ +L+ F ++K +
Sbjct: 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR------IEKFLSPQLIAEEFCLKTF 302
Query: 241 LKDAAQLALKKMPSAEQEAISQSEYQR 267
K +Q K P++ Q +IS Q+
Sbjct: 303 SKFGSQPIPAKRPASGQNSISVMPAQK 329
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-62
Identities = 45/233 (19%), Positives = 89/233 (38%), Gaps = 30/233 (12%)
Query: 1 MSLIDHPNVIRAYCSFV----------------VDSNLWVVMPFMAEGSCLHLMKIAYQD 44
++ +DH N++ + L++ M F +G+ ++ +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 45 GFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD 104
++ + ++ K +DY+H + I+RD+K NI L VK+ DFG+ + + G
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 105 RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164
R GT +M+PE + Y + D+++ G+ EL H +
Sbjct: 178 ----RTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFT 229
Query: 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
+++ F K K ++ L K RP ++L+ P
Sbjct: 230 DLRDGII------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-56
Identities = 57/278 (20%), Positives = 114/278 (41%), Gaps = 22/278 (7%)
Query: 1 MSLIDHPN--VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKE 57
++ + + +IR Y + D +++VM L + + S K
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID---LNSWLKKKKSIDPWERKSYWKN 116
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
L+A+ +H+ G +H D+K N L+ +G++KL DFG++ M +++ VGT
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVN 174
Query: 118 WMAPEVLQ----------PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ 167
+M PE ++ S + K+D+WS G + +G PF + L I
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK-HAKPPELSVKKLF 226
+ P + + K ++++ CL +D +R + +LL H + + P K
Sbjct: 235 D--PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 292
Query: 227 ADLPPLWNRVKALQLKDAAQLALKKMPSAEQEAISQSE 264
++ + ++ L ++ A K + S +
Sbjct: 293 EEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-56
Identities = 53/237 (22%), Positives = 102/237 (43%), Gaps = 21/237 (8%)
Query: 1 MSLIDHPN--VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKE 57
++ + + +IR Y + D +++VM L + + S K
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID---LNSWLKKKKSIDPWERKSYWKN 135
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
L+A+ +H+ G +H D+K N L+ +G++KL DFG++ M +++ VGT
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVN 193
Query: 118 WMAPEVLQ----------PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ 167
+M PE ++ S + K+D+WS G + +G PF + L I
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKK 224
+ P + + K ++++ CL +D +R + +LL H + + P + K
Sbjct: 254 D--PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 9e-56
Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 29/241 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN------------LWVVMPFMAEGSCLHLMKIA-YQDGFE 47
++ ++HP ++R + +++ + L++ M + + M + E
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 48 ESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQR 107
S I + +A+++LH +G +HRD+K NI + VVK+ DFG+ M + Q
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 108 ---------SRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158
VGT +M+PE + G+ Y+ K DI+S G+ EL + PFS
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---PFSTQME 232
Query: 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
L ++N + + MV L +RP A +++++ F+ P
Sbjct: 233 RVRTLTDVRNLKFPPLFTQ---KYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289
Query: 219 E 219
Sbjct: 290 G 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 52/237 (21%), Positives = 101/237 (42%), Gaps = 21/237 (8%)
Query: 1 MSLIDHPN--VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKE 57
++ + + +IR Y + D +++VM L + + S K
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID---LNSWLKKKKSIDPWERKSYWKN 163
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
L+A+ +H+ G +H D+K N L+ +G++KL DFG++ M +++ VG
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM-QPDTTSVVKDSQVGAVN 221
Query: 118 WMAPEVLQ----------PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ 167
+M PE ++ S + K+D+WS G + +G PF + L I
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKK 224
+ P + + K ++++ CL +D +R + +LL H + + P + K
Sbjct: 282 D--PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 8e-53
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 19/223 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN--LWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILK 56
+ + HPN++R Y + +N L++VM + G ++ ++ +E + ++
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 57 ETLKALDYLHRQGH-----IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
+ AL HR+ +HRD+K N+ LD VKL DFG++ + T
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKT 175
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPP 171
FVGTP +M+PE + YN K+DIWS G EL PF+ K L I+
Sbjct: 176 FVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGK- 232
Query: 172 GLDYDRD-KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ R ++S E++ L RP+ E++L++
Sbjct: 233 ---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 50/235 (21%), Positives = 92/235 (39%), Gaps = 19/235 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN----LWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSI 54
L +HPN++R + + W+++PF G+ + ++ G E I +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRN---- 110
L + L+ +H +G+ HRD+K NILL G L D G + R
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 111 --TFVGTPCWMAPEV--LQPGSGYNSKADIWSFGITALELAHGHAPF-SKYPPMKVLLMT 165
T + APE+ +Q + + D+WS G + G P+ + + +
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 166 IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH-SFFKHAKPPE 219
+QN L + + S + +++ + D +RP LL + P +
Sbjct: 260 VQN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 55/258 (21%), Positives = 103/258 (39%), Gaps = 19/258 (7%)
Query: 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKAL 62
+HPNVIR +C+ ++ + + ++ ++L++T L
Sbjct: 74 SDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQTTSGL 131
Query: 63 DYLHRQGHIHRDVKAGNILLDTNG-----VVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+LH +HRD+K NIL+ ++DFG+ + R+ GT
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 118 WMAPEVLQ--PGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQNAPPGLD 174
W+APE+L DI+S G ++ G PF K + ++ + L
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWN 234
++ +E++ + D KRP+A+ +LKH FF S++K + +
Sbjct: 252 PEKH--EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW-------SLEKQLQFFQDVSD 302
Query: 235 RVKALQLKDAAQLALKKM 252
R++ L L++
Sbjct: 303 RIEKESLDGPIVKQLERG 320
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-48
Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 21/226 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK-IAYQDGFEESAIGSILKETL 59
M N + L++ M + + M + E I +
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS---------RN 110
+A+++LH +G +HRD+K NI + VVK+ DFG+ M + Q
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 111 TFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA- 169
VGT +M+PE + G+ Y+ K DI+S G+ EL + FS ++ ++N
Sbjct: 235 GQVGTKLYMSPEQIH-GNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLK 290
Query: 170 -PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214
P + MV L T+RP A +++++ F++
Sbjct: 291 FPLLFT-----QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 53/225 (23%), Positives = 103/225 (45%), Gaps = 14/225 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
S + HPN++R Y F + +++++ + G+ ++ F+E + + E
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR--ELQKLSKFDEQRTATYITELAN 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL Y H + IHRD+K N+LL + G +K+ADFG S R GT ++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLP 175
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+++ G ++ K D+WS G+ E G PF + I ++
Sbjct: 176 PEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRV----EFTFPDF 229
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF-KHAKPPELSVKK 224
++ +++++ L + ++RP ++L+H + ++ P K
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNK 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-46
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 14/234 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ H +V+ + F + ++VV+ S L + E L++ +
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVL 126
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
YLHR IHRD+K GN+ L+ + VK+ DFG++ + G+R + GTP ++A
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIA 183
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVL G++ + D+WS G L G PF +K + I+ +Y K
Sbjct: 184 PEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN----EYSIPKH 237
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF-KHAKPPELSVKKLFADLPPLW 233
+ ++ L D T RPT +LL FF P L + L +PP +
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCL--TIPPRF 289
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 14/234 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ H +V+ + F + ++VV+ S L + E L++ +
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVL 152
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
YLHR IHRD+K GN+ L+ + VK+ DFG++ + G+R + GTP ++A
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIA 209
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVL G++ + D+WS G L G PF +K + I+ +Y K
Sbjct: 210 PEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN----EYSIPKH 263
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF-KHAKPPELSVKKLFADLPPLW 233
+ ++ L D T RPT +LL FF P L + L +PP +
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCL--TIPPRF 315
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 10/219 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HP+++ Y F + +++V+ G +K F E+ + + +
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQIIT 123
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YLH G +HRD+ N+LL N +K+ADFG++ + ++ T GTP +++
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK---HYTLCGTPNYIS 180
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+ S + ++D+WS G L G PF +K L + A DY+
Sbjct: 181 PEIAT-RSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLA----DYEMPSF 234
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
S K+++ L ++ R + +L H F +
Sbjct: 235 LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-44
Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 28/243 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEG------SCLHLMKIAYQDGFEESAIGSI 54
++ I + + ++++ +M ++ Y I I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 55 LKETLKALDYLHRQGHI-HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
+K L + Y+H + +I HRDVK NIL+D NG VKL+DFG S M D
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSR 211
Query: 114 GTPCWMAPEVLQPGSGY-NSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA--- 169
GT +M PE S Y +K DIWS GI + + PFS + L I+
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 170 -PPGLDYDRDKK-----------FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
P ++ S + + + L K+ +R T+E LKH +
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331
Query: 218 PEL 220
+L
Sbjct: 332 EDL 334
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 13/220 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
S + HPN++R Y F +++++ F G ++ F+E + ++E
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYK--ELQKHGRFDEQRSATFMEELAD 125
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL Y H + IHRD+K N+L+ G +K+ADFG S R R T GT ++
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLR---RRTMCGTLDYLP 180
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+++ G ++ K D+W G+ E G PF + I N D
Sbjct: 181 PEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIVNV----DLKFPPF 234
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
S K++++ L +R + +++H + K L
Sbjct: 235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 17/219 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVD----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56
+ +DHPNV++ V+D +L++V + +G +M++ E +
Sbjct: 90 LKKLDHPNVVKLVE--VLDDPNEDHLYMVFELVNQGP---VMEVPTLKPLSEDQARFYFQ 144
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
+ +K ++YLH Q IHRD+K N+L+ +G +K+ADFGVS F D S VGTP
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKGSDALLS--NTVGTP 201
Query: 117 CWMAPEVLQPGS-GYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLD 174
+MAPE L ++ D+W+ G+T G PF + L I++ L+
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQA--LE 258
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ ++ K+++ L K+ R ++ H +
Sbjct: 259 FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 28/232 (12%)
Query: 1 MSLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILK 56
M + HPN++ + NL +V +++ GS L+ L K ++ +E S+
Sbjct: 88 MKRLRHPNIVLFMGAVT--QPPNLSIVTEYLSRGS-LYRLLHKSGAREQLDERRRLSMAY 144
Query: 57 ETLKALDYLHRQGH--IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
+ K ++YLH + +HR++K+ N+L+D VK+ DFG+S T S + G
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL---SSKSAAG 201
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQN-----A 169
TP WMAPEVL+ N K+D++SFG+ ELA P+ P +V+
Sbjct: 202 TPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 170 PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH--SFFKHAKPPE 219
P L+ ++ C + KRP+ ++ K A PP
Sbjct: 261 PRNLN--------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 12/215 (5%)
Query: 1 MSLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ H N++ Y + L +V + S H + + + FE + I ++T
Sbjct: 74 LRKTRHVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQT 129
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+ +DYLH + IHRD+K+ NI L + VK+ DFG+ A G+ W
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL-ATEKSRWSGSHQFEQLSGSILW 188
Query: 119 MAPEVL--QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI--QNAPPGLD 174
MAPEV+ Q + Y+ ++D+++FGI EL G P+S ++ + + P L
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
R K K ++A CL K + +RP+ ++L
Sbjct: 249 KVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-42
Identities = 49/256 (19%), Positives = 92/256 (35%), Gaps = 43/256 (16%)
Query: 1 MSLIDHPNVIRAYCSF--VVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKE 57
+ ++H N+++ + + ++M F GS L + + G ES +L++
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 58 TLKALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
+ +++L G +HR++K GNI+ D V KL DFG + + + +
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQFVSLY 176
Query: 114 GTPCWMAPEVLQ-------PGSGYNSKADIWSFGITALELAHGHAPFS------------ 154
GT ++ P++ + Y + D+WS G+T A G PF
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 155 ------KYPPMKVLLMTIQNAPPGLDYDRD------KKFSKSFKEMVAMCLVKDQTKRPT 202
K + +N P D + ++A L DQ K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 203 AEKLLKHS-FFKHAKP 217
++ + H
Sbjct: 297 FDQFFAETSDILHRGN 312
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 39/213 (18%), Positives = 80/213 (37%), Gaps = 27/213 (12%)
Query: 1 MSLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ + HPNV+ C + ++ +M GS +++ ++S +
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 59 LKALDYLHRQGH--IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
+ + +LH + + ++++D + +++ V + P
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK--------FSFQSPGRMYAP 172
Query: 117 CWMAPEVLQ--PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQN-----A 169
W+APE LQ P AD+WSF + EL PF+ M++ +
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232
Query: 170 PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT 202
PPG+ +++ +C+ +D KRP
Sbjct: 233 PPGIS--------PHVSKLMKICMNEDPAKRPK 257
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 63/242 (26%), Positives = 103/242 (42%), Gaps = 37/242 (15%)
Query: 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM-KIAYQDGFEESAIG-------SI 54
DHPNVIR YCS D L++ + + L + ++ +E+ S+
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELC-NLN---LQDLVESKNVSDENLKLQKEYNPISL 120
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDT-------------NGVVKLADFGVSACMFD 101
L++ + +LH IHRD+K NIL+ T N + ++DFG+ D
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-KKLD 179
Query: 102 TGDR--QRSRNTFVGTPCWMAPEVLQ------PGSGYNSKADIWSFG-ITALELAHGHAP 152
+G + + N GT W APE+L+ DI+S G + L+ G P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 153 F-SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
F KY ++ I + + D+ ++++ + D KRPTA K+L+H
Sbjct: 240 FGDKYSRESNIIRGIFSLDE-MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 212 FK 213
F
Sbjct: 299 FW 300
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 30/233 (12%), Positives = 65/233 (27%), Gaps = 32/233 (13%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM------KIAYQDGFEESAIGSI 54
+ +IR L + S L + A +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
+ ++ L LH G +H ++ +I+LD G V L F R +R
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-------RDGARVVSSV 264
Query: 115 TPCWMAPEVLQP----------GSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164
+ + PE+ + D W+ G+ + P +K +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS-- 322
Query: 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
+ K + + ++ L + R + ++ ++ +
Sbjct: 323 -------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 47/222 (21%), Positives = 88/222 (39%), Gaps = 21/222 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGS---CLHLMKIAYQDGFEESAIGSILKE 57
H NV+ + + +L ++ + + KI + + I +E
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV----LDVNKTRQIAQE 138
Query: 58 TLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRN--TFVGT 115
+K + YLH +G +H+D+K+ N+ D NG V + DFG+ + +R G
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 116 PCWMAPEVL--------QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ 167
C +APE++ + ++ +D+++ G EL PF P ++
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
P L K +++ C +Q +RPT KL+
Sbjct: 258 GMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-41
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 37/255 (14%)
Query: 2 SLIDHPNVIRAYCSFVVD-------SNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGS 53
L HPN+++ + + ++++ + +G + L K+ + +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 54 ILKETLKALDYLHRQGH--IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSR-- 109
I +T +A+ ++HRQ IHRD+K N+LL G +KL DFG + + D S
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 110 -------NTFVGTPCWMAPEVLQPGSG--YNSKADIWSFGITALELAHGHAPFSKYPPMK 160
T TP + PE++ S K DIW+ G L PF ++
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 161 VLLMTIQNA----PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216
I N PP F ++ L + +R + +++ + A
Sbjct: 261 -----IVNGKYSIPPHDTQ------YTVFHSLIRAMLQVNPEERLSIAEVVHQ-LQEIAA 308
Query: 217 PPELSVKKLFADLPP 231
++ K +L
Sbjct: 309 ARNVNPKSPITELLE 323
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-40
Identities = 66/268 (24%), Positives = 124/268 (46%), Gaps = 25/268 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ +DHPN+++ Y F ++V G +I + F E I+++ L
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD--EIISRKRFSEVDAARIIRQVLS 137
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+ Y+H+ +HRD+K N+LL++ + +++ DFG+S F+ + + +GT
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMK---DKIGTAY 193
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
++APEVL Y+ K D+WS G+ L G PF+ +L ++ + +
Sbjct: 194 YIAPEVLH--GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK-VEKGKYTFELPQ 250
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVK 237
KK S+S K+++ L + R +A L H + + ++S D+P L N +
Sbjct: 251 WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS-----VDVPSLDNAIL 305
Query: 238 ALQ-------LKDAAQLAL-KKMPSAEQ 257
++ L AA L + K+ S ++
Sbjct: 306 NIRQFQGTQKLAQAALLYMGSKLTSQDE 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 28/229 (12%), Positives = 64/229 (27%), Gaps = 19/229 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDS--NLWVVMPFMAEGSCLHLMK-----IAYQDGFEESAIGS 53
+++ P + + N ++MP L ++ A+
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHI 198
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
+ + ++ L +G +H N+ + +G + L D G R
Sbjct: 199 LTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---KVGTR---GPASS 252
Query: 114 GTPCWMAPEVLQP-GSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV----LLMTIQN 168
+ E L + + + W G++ + PF P
Sbjct: 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP 312
Query: 169 APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
L + K ++ L D+ +R + ++ F +
Sbjct: 313 GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-40
Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 12/216 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ L+DHPN+++ Y F N ++VM G +I ++ F E I+K+ L
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD--EIIHRMKFNEVDAAVIIKQVLS 147
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+ YLH+ +HRD+K N+LL++ + ++K+ DFG+S +F+ + + +GT
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKMK---ERLGTAY 203
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
++APEVL+ Y+ K D+WS G+ L G+ PF ++L ++ D
Sbjct: 204 YIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK-VEKGKYTFDSPE 260
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
K S+ K+++ L D +R +A++ L+H + K
Sbjct: 261 WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 49/248 (19%), Positives = 93/248 (37%), Gaps = 42/248 (16%)
Query: 1 MSLIDHPNVIRAYCSF--VVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKE 57
+ ++H N+++ + + ++M F GS L + + G ES +L++
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 58 TLKALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
+ +++L G +HR++K GNI+ D V KL DFG + + + +
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL----EDDEQFVSLY 176
Query: 114 GTPCWMAPEVLQ-------PGSGYNSKADIWSFGITALELAHGHAPFS------------ 154
GT ++ P++ + Y + D+WS G+T A G PF
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 155 ------KYPPMKVLLMTIQNAPPGLDYD--RDKKFSKSFKEMV----AMCLVKDQTKRPT 202
K + +N P D S+ + ++ A L DQ K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 203 AEKLLKHS 210
++ +
Sbjct: 297 FDQFFAET 304
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-38
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 12/216 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ +DHPN+I+ + F ++V F G +I + F+E +I+K+ L
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE--QIINRHKFDECDAANIMKQILS 157
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+ YLH+ +HRD+K NILL+ +K+ DFG+S F + +GT
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDYKL---RDRLGTAY 213
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
++APEVL+ YN K D+WS G+ L G+ PF ++ ++ D++
Sbjct: 214 YIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK-VEKGKYYFDFND 270
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
K S KE++ + L D KR TAE+ L + K
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-38
Identities = 75/337 (22%), Positives = 132/337 (39%), Gaps = 42/337 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ +DHPN+++ + S+ ++V G +I + F E I+K+
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD--EIIKRKRFSEHDAARIIKQVFS 132
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+ Y+H+ +HRD+K NILL++ + +K+ DFG+S F + +GT
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKM---KDRIGTAY 188
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
++APEVL+ Y+ K D+WS G+ L G PF +L ++ D +
Sbjct: 189 YIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR-VETGKYAFDLPQ 245
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVK 237
+ S K+++ L + R TA + L+H + + S +DLP L + +
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS----SETPTISDLPSLESAMT 301
Query: 238 ALQ-------LKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQ-ASLVRDD 289
++ L Q AL M A + + L L ++
Sbjct: 302 NIRQFQAEKKLA---QAALLYM------ASKLTTLDE--------TKQLTEIFRKLDTNN 344
Query: 290 DDMLETKEENESVKSSVGFKAGTGFQFSLGKSNSIAE 326
D ML ++E G + S E
Sbjct: 345 DGML-DRDELVRGYHEFMRLKGVDSNSLIQNEGSTIE 380
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 17/220 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
M ++HPNV++ D L + ++ G+ ++K D + S S K+
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIA 118
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR-----------QRS 108
+ YLH IHRD+ + N L+ N V +ADFG++ M D + ++
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 109 RNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQN 168
R T VG P WMAPE++ G Y+ K D++SFGI E+ Y P +
Sbjct: 179 RYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237
Query: 169 APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
LD SF + C D KRP+ KL
Sbjct: 238 G--FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 45/231 (19%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGS---CLH--------LMKIAYQDGFEES 49
+++ HPN+I + + NL +VM F G L L+ A Q
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------ 113
Query: 50 AIGSILKETLKALDYLHRQGH---IHRDVKAGNILLD--------TNGVVKLADFGVSAC 98
+ ++YLH + IHRD+K+ NIL+ +N ++K+ DFG++
Sbjct: 114 --------IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
Query: 99 MFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158
T ++ + G WMAPEV++ S ++ +D+WS+G+ EL G PF
Sbjct: 166 WHRT-----TKMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219
Query: 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ V N L + F +++ C D RP+ +L
Sbjct: 220 LAVAYGVAMN---KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 12/220 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +DHPN+IR Y +F ++++++VM G ++ ++ F ES I+K+ L
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESDAARIMKDVLS 117
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
A+ Y H+ HRD+K N L T + +KL DFG++A F G T VGTP
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM---RTKVGTPY 173
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
+++P+VL+ Y + D WS G+ L G+ PFS P +++ I+
Sbjct: 174 YVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKD 230
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
S + ++ L K +R T+ + L+H +F+
Sbjct: 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 18/219 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S ++H N+I+ F +VM G L I +E I ++ +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL-FAFIDRHPRLDEPLASYIFRQLVS 141
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A+ YL + IHRD+K NI++ + +KL DFG +A + G TF GT + A
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLF---YTFCGTIEYCA 197
Query: 121 PEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PEVL G+ Y + ++WS G+T L PF + A
Sbjct: 198 PEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFCELE-------ETVEA----AIHPPY 245
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
SK +V+ L +R T EKL+ +
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-38
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILKET 58
+S ++HPN+++ Y + + +VM + GS L+ L + + S +
Sbjct: 55 LSRVNHPNIVKLYG--ACLNPVCLVMEYAEGGS-LYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 59 LKALDYLHRQGH---IHRDVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVG 114
+ + YLH IHRD+K N+LL G V+K+ DFG + D Q G
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKG 165
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY--PPMKVLLMTIQNAPPG 172
+ WMAPEV + GS Y+ K D++S+GI E+ PF + P +++ P
Sbjct: 166 SAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
L K K + ++ C KD ++RP+ E+++K
Sbjct: 225 L----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-38
Identities = 54/239 (22%), Positives = 96/239 (40%), Gaps = 14/239 (5%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ + H NVI+ +++VM + ++ + F +
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-CVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+ L+YLH QG +H+D+K GN+LL T G +K++ GV+ + R T G+P +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQGSPAF 177
Query: 119 MAPEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
PE+ ++ K DIWS G+T + G PF + L I Y
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKG----SYAI 232
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRV 236
+++ L + KR + ++ +HS+F+ PP +PP +
Sbjct: 233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE----APVPIPPSPDTK 287
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 15/221 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILKET 58
+ +DHPN+I+ + F N+++VM G L + A E + ++K+
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
+ AL Y H Q +H+D+K NIL + +K+ DFG++ +F + + GT
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS---TNAAGT 189
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY 175
+MAPEV + K DIWS G+ L G PF+ ++ + +Y
Sbjct: 190 ALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKE--PNY 244
Query: 176 DRD-KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215
+ + + +++ L KD +RP+A ++L H +FK A
Sbjct: 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 16/227 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HPN+I+ ++ ++ ++V M +G + + E I++ L+
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD--YLTEKVTLSEKETRKIMRALLE 135
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ LH+ +HRD+K NILLD + +KL DFG S C D G++ R GTP ++A
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLR---EVCGTPSYLA 191
Query: 121 PEVLQPGS-----GYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY 175
PE+++ GY + D+WS G+ L G PF M +L M I + +
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-IMSGN--YQF 248
Query: 176 DRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
+S + K++V+ LV KR TAE+ L H FF+ E+
Sbjct: 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 49/225 (21%), Positives = 94/225 (41%), Gaps = 15/225 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+++H NV++ Y + ++ + + + G +I G E + +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIGMPEPDAQRFFHQLMA 116
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YLH G HRD+K N+LLD +K++DFG++ +F +R+R N GT ++A
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVA 175
Query: 121 PEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA----PPGLDY 175
PE+L+ ++ D+WS GI + G P+ + + P
Sbjct: 176 PELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP---- 230
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
KK + ++ LV++ + R T + K ++
Sbjct: 231 --WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 16/224 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ +DHPN+++ + S+ ++V G +I + F E I+K+
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD--EIIKRKRFSEHDAARIIKQVFS 132
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
+ Y+H+ +HRD+K NILL++ + +K+ DFG+S F + +GT
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM---KDRIGTAY 188
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
++APEVL+ Y+ K D+WS G+ L G PF +L ++ +D
Sbjct: 189 YIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGK--YAFDL 243
Query: 178 D--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
+ S K+++ L + R TA + L+H + + E
Sbjct: 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-37
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 14/219 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM-KIAYQDGFEESAIGSILKETL 59
+ ++HP +I+ F + ++V+ M G L K+ +E+ + L
Sbjct: 194 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGE---LFDKVVGNKRLKEATCKLYFYQML 249
Query: 60 KALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
A+ YLH G IHRD+K N+LL + + ++K+ DFG S + R T GTP
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTP 305
Query: 117 CWMAPEVLQPGS--GYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLD 174
++APEVL GYN D WS G+ G+ PFS++ L I +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ + S+ ++V LV D R T E+ L+H + +
Sbjct: 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 6e-37
Identities = 29/230 (12%), Positives = 69/230 (30%), Gaps = 24/230 (10%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFM----AEGSCLHLMKIAYQDG-----FEESAI 51
L+ P + + + ++WV+ F + + ++ A
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 52 GSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
+ + ++ L LH G +H ++ +I+LD G V L F + D
Sbjct: 214 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH--LVRDGASAVSPIGR 271
Query: 112 FVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ 167
P A +L + D W+ G+ + P + +
Sbjct: 272 GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----- 326
Query: 168 NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
+ K + + ++ L + R + ++ ++ +
Sbjct: 327 ----EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-37
Identities = 57/242 (23%), Positives = 86/242 (35%), Gaps = 34/242 (14%)
Query: 1 MSLIDHPNVIRAY------CSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGS 53
M ++HPNV+ A + + M + G +L + G +E I +
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNG---VVKLADFGVSACMFDTGDRQRSRN 110
+L + AL YLH IHRD+K NI+L + K+ D G + D G+
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCT--- 181
Query: 111 TFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAP 170
FVGT ++APE+L+ Y D WSFG A E G PF ++
Sbjct: 182 EFVGTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 171 PGLDYDRDK---------------KFSKSFKEMV----AMCLVKDQTKRPTAEKLLKHSF 211
D S + L+ Q +R T +
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 212 FK 213
F+
Sbjct: 301 FQ 302
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 15/227 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HPN++R + S +S ++V + G I ++ + E+ +++ L+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--DIVAREFYSEADASHCIQQILE 116
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
++ Y H G +HR++K N+LL + VKLADFG++ + + + F GTP
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEA---WHGFAGTPG 172
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
+++PEVL+ Y+ DIW+ G+ L G+ PF + L I+ DY
Sbjct: 173 YLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGA--YDYPS 228
Query: 178 D--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSV 222
+ K ++ L + KR TA++ LK + + + ++
Sbjct: 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 15/223 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEESAIGSILKETL 59
+ D + + +F D+NL++VM + G L L K ++D E L E +
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMV 185
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
A+D +H+ ++HRD+K NIL+D NG ++LADFG C+ D + VGTP ++
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS--CLKLMEDGTVQSSVAVGTPDYI 243
Query: 120 APEVLQ----PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY 175
+PE+LQ Y + D WS G+ E+ +G PF ++ I N +
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKERFQF 302
Query: 176 DRD-KKFSKSFKEMVAMCLVKDQTKR---PTAEKLLKHSFFKH 214
S++ K+++ L+ + R E KH FF
Sbjct: 303 PTQVTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSG 344
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 13/220 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ + P V++ + +F D L++VM +M G ++LM E E +
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVL 179
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
ALD +H G IHRDVK N+LLD +G +KLADFG CM + +T VGTP +++
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT--CMKMNKEGMVRCDTAVGTPDYIS 237
Query: 121 PEVLQ---PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
PEVL+ Y + D WS G+ E+ G PF + I N L +
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKNSLTFPD 296
Query: 178 DKKFSKSFKEMVAMCLVKDQTKR---PTAEKLLKHSFFKH 214
D SK K ++ + D+ R E++ +H FFK+
Sbjct: 297 DNDISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFFKN 335
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 49/233 (21%), Positives = 97/233 (41%), Gaps = 15/233 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+++H NV++ Y + ++ + + + G +I G E + +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD--RIEPDIGMPEPDAQRFFHQLMA 116
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YLH G HRD+K N+LLD +K++DFG++ +F +R+R N GT ++A
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVA 175
Query: 121 PEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA----PPGLDY 175
PE+L+ ++ D+WS GI + G P+ + + P
Sbjct: 176 PELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP---- 230
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFAD 228
KK + ++ LV++ + R T + K ++ ++ +
Sbjct: 231 --WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSG 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 13/221 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +++HPN+++ + + L+++M + A G + + +E S ++ +
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEY-ASGGEV-FDYLVAHGRMKEKEARSKFRQIVS 125
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A+ Y H++ +HRD+KA N+LLD + +K+ADFG S F G + F G P + A
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN-EFTVGGKLD---AFCGAPPYAA 181
Query: 121 PEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PE+ Q G Y+ + D+WS G+ L G PF +K L + Y
Sbjct: 182 PELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRG----KYRIPF 235
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
S + ++ LV + KR T E+++K + +
Sbjct: 236 YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 48/232 (20%)
Query: 1 MSLIDHPNVIRAYCSF--VVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
MS ++HPN+++ ++ + +VM F+ G H + + S ++ +
Sbjct: 77 MSNLNHPNIVK----LYGLMHNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDI 131
Query: 59 LKALDYLHRQGH--IHRDVKAGNILLDTNG-----VVKLADFGVSACMFDTGDRQRSRNT 111
++Y+ Q +HRD+++ NI L + K+ADFG+S +Q +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--------QQSVHSV 183
Query: 112 --FVGTPCWMAPEVLQPGSG-YNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM---- 164
+G WMAPE + Y KAD +SF + + G PF +Y K+ +
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 165 ------TI-QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
TI ++ PP L + ++ +C D KRP ++K
Sbjct: 244 EEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 20/265 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM-KIAYQDGFEESAIGSILKETL 59
+ ++HP +I+ F + ++V+ M G L K+ +E+ + L
Sbjct: 69 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGE---LFDKVVGNKRLKEATCKLYFYQML 124
Query: 60 KALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
A+ YLH G IHRD+K N+LL + + ++K+ DFG S + R T GTP
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTP 180
Query: 117 CWMAPEVLQPGS--GYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLD 174
++APEVL GYN D WS G+ G+ PFS++ L I +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240
Query: 175 YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWN 234
+ + S+ ++V LV D R T E+ L+H + + + +K+ F DL N
Sbjct: 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQDLLSEEN 295
Query: 235 RVKALQLKDAAQLALKKMPSAEQEA 259
AL + AQ + + E EA
Sbjct: 296 ESTALP-QVLAQPSTSRKRPREGEA 319
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 70/241 (29%), Positives = 110/241 (45%), Gaps = 37/241 (15%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCL-HLMKIAYQDGFEE------SAIGS 53
MS +DHP ++ Y +F D L+ + + G L ++ KI F+E +A
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTA--- 137
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
E + AL+YLH +G IHRD+K NILL+ + +++ DFG + + + R+ N+FV
Sbjct: 138 ---EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFV 193
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL 173
GT +++PE+L +D+W+ G +L G PF + I
Sbjct: 194 GTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLE--- 248
Query: 174 DYDRDKKFSKSFKEMVAMCLVKDQTKRPT------AEKLLKHSFFK--------HAKPPE 219
YD +KF +++V LV D TKR L H FF+ PP+
Sbjct: 249 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPK 307
Query: 220 L 220
L
Sbjct: 308 L 308
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 13/221 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ L HP++I+ Y ++ ++VM + G L I EE + ++ L
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEY-VSGGEL-FDYICKHGRVEEMEARRLFQQILS 122
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A+DY HR +HRD+K N+LLD + K+ADFG+S M G+ R T G+P + A
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLR---TSCGSPNYAA 178
Query: 121 PEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PEV+ G Y + DIWS G+ L G PF + L I+ + +
Sbjct: 179 PEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGG----VFYIPE 232
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
++S ++ L D KR T + + +H +FK P L
Sbjct: 233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 15/220 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILKET 58
++ HP+++ ++ D L++V FM + + + E+ +++
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
L+AL Y H IHRDVK +LL + + VKL FGV+ + ++G VGT
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGT 196
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY 175
P +MAPEV++ Y D+W G+ L G PF Y + L I
Sbjct: 197 PHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPF--YGTKERLFEGIIKGK--YKM 251
Query: 176 DRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ S+S K++V L+ D +R T + L H + K
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 17/220 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
M ++HP ++ + SF + ++++V+ + G L Q+ F+E + + E +
Sbjct: 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKEETVKLFICELV 125
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
ALDYL Q IHRD+K NILLD +G V + DF + A M + T GT +M
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI-AAMLPRETQI---TTMAGTKPYM 181
Query: 120 APEVL--QPGSGYNSKADIWSFGITALELAHGHAPF--SKYPPMKVLLMTIQNAPPGLDY 175
APE+ + G+GY+ D WS G+TA EL G P+ K ++ T +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY-- 239
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKR-PTAEKLLKHSFFKH 214
+S+ ++ L + +R + +
Sbjct: 240 --PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 72/269 (26%), Positives = 114/269 (42%), Gaps = 22/269 (8%)
Query: 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKAL 62
HPN+I + ++VV M G L KI Q F E ++L K +
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLD--KILRQKFFSEREASAVLFTITKTV 129
Query: 63 DYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+YLH QG +HRD+K NIL +++ DFG + + T T +
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANF 186
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM--KVLLMTIQNAPPGLDYD 176
+APEVL+ GY++ DIWS G+ + G+ PF+ P + +L I +
Sbjct: 187 VAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--FSLS 243
Query: 177 RD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWN 234
S + K++V+ L D +R TA +L+H + H +L +L + +
Sbjct: 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD--QLPQYQL--NRQDAPH 299
Query: 235 RVKALQLKDAAQLALKKMPSAEQEAISQS 263
VK A AL + S E + +S
Sbjct: 300 LVKGAM--AATYSALNRNQSPVLEPVGRS 326
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 18/221 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HP++I S+ S +++V M +G + + E SI++ L+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD--YLTEKVALSEKETRSIMRSLLE 211
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A+ +LH +HRD+K NILLD N ++L+DFG S C + G++ GTP ++A
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEK---LRELCGTPGYLA 267
Query: 121 PEVLQPGS-----GYNSKADIWSFG-ITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLD 174
PE+L+ GY + D+W+ G I LA G PF + +L M I
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILMLRM-IMEG--QYQ 323
Query: 175 YDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ S + K++++ L D R TAE+ L+H FF+
Sbjct: 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 61/265 (23%), Positives = 101/265 (38%), Gaps = 45/265 (16%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEG---------------------------- 32
M + HPN+ R Y + + + +VM G
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 33 ----------SCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82
+H + + E I +I+++ AL YLH QG HRD+K N L
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 83 DT--NGVVKLADFGVSACMFDTGDRQRSR-NTFVGTPCWMAPEVLQPGS-GYNSKADIWS 138
T + +KL DFG+S + + + T GTP ++APEVL + Y K D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 139 FGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQT 198
G+ L G PF + + N + S +++++ L ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQ-VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
Query: 199 KRPTAEKLLKHSFFK--HAKPPELS 221
+R A + L+H + K ++S
Sbjct: 321 ERFDAMRALQHPWISQFSDKIYKMS 345
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 15/224 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ D + + + +F ++ L++VM + G L L+ + + L E +
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVM 173
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A+D +HR G++HRD+K NILLD G ++LADFG C+ D VGTP +++
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS--CLKLRADGTVRSLVAVGTPDYLS 231
Query: 121 PEVLQ------PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLD 174
PE+LQ Y + D W+ G+ A E+ +G PF + I + L
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYKEHLS 290
Query: 175 Y-DRDKKFSKSFKEMVAMCLVKDQTKR---PTAEKLLKHSFFKH 214
D+ + ++ + L+ R A H FF
Sbjct: 291 LPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFFFG 333
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 68/310 (21%), Positives = 126/310 (40%), Gaps = 37/310 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HPN++R + S +S ++V + G I ++ + E+ +++ L+
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--DIVAREFYSEADASHCIQQILE 139
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
++ Y H G +HR++K N+LL + VKLADFG++ + + + F GTP
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEA---WHGFAGTPG 195
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
+++PEVL+ Y+ DIW+ G+ L G+ PF + L I+ DY
Sbjct: 196 YLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGA--YDYPS 251
Query: 178 D--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNR 235
+ K ++ L + KR TA++ LK + + + A +
Sbjct: 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV--------ASAIHRQDT 303
Query: 236 VKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLET 295
V L+ K A+ LK ++ +L ++
Sbjct: 304 VDCLK-KFNARRKLKGAILT-------------TMIATRNLSNLGRNLLNKKEQGPPSTI 349
Query: 296 KEENESVKSS 305
KE +ES ++
Sbjct: 350 KESSESSQTI 359
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 54/248 (21%), Positives = 104/248 (41%), Gaps = 23/248 (9%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HPN+++ + F + ++VM + G +I + F E+ I+++ + A+ ++
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 66 HRQGHIHRDVKAGNILL---DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
H G +HRD+K N+L + N +K+ DFG + + T T + APE
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK---TPCFTLHYAAPE 179
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGHAPF------SKYPPMKVLLMTIQNAPPGLDYD 176
+L +GY+ D+WS G+ + G PF ++ I+ ++
Sbjct: 180 LLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--FSFE 236
Query: 177 RD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP----PELSVKKLFADLP 230
+ K S+ K+++ L D KR L + + + P ++ L +
Sbjct: 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGA 296
Query: 231 PLWNRVKA 238
+ VKA
Sbjct: 297 AVHTCVKA 304
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 14/218 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + HPN+I+ F + + +V+ + G +I + + E +K+ L+
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD--RIVEKGYYSERDAADAVKQILE 159
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
A+ YLH G +HRD+K N+L T + +K+ADFG+S + + + T GTP
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCGTPG 215
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
+ APE+L+ G Y + D+WS GI L G PF + + I N +
Sbjct: 216 YCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE--YYFIS 272
Query: 178 D--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ S + K++V +V D KR T + L+H +
Sbjct: 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 56/247 (22%), Positives = 88/247 (35%), Gaps = 46/247 (18%)
Query: 1 MSLIDHPNVIR--AYCSFVVDS--NLWVVMPFMAEGS---CLHLMKIAYQDGFEESAIGS 53
++ H N++ A S LW++ + GS L L +
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------R 109
Query: 54 ILKETLKALDYLHRQGH--------IHRDVKAGNILLDTNGVVKLADFGVSACMFD--TG 103
I+ L +LH + HRD+K+ NIL+ NG +AD G+ A M T
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL-AVMHSQSTN 168
Query: 104 DRQRSRNTFVGTPCWMAPEVLQ-----PGSGYNSKADIWSFGITALELAHGHA------- 151
N VGT +MAPEVL + DIW+FG+ E+A
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 152 ---PFSKYPPMKVLLMTIQNA-------PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP 201
PF P ++ P + S +++ C ++ + R
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 202 TAEKLLK 208
TA ++ K
Sbjct: 289 TALRIKK 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 62/262 (23%), Positives = 110/262 (41%), Gaps = 23/262 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ I HPNVI + + +++ +++ +A G +A ++ E LK+ L
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLKQILN 125
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT----NGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
+ YLH H D+K NI+L +K+ DFG++ D G+ + GTP
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-HKIDFGNEFK---NIFGTP 181
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
++APE++ +AD+WS G+ L G +PF + L + +++
Sbjct: 182 EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAV--NYEFE 237
Query: 177 RD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK-HAKPPELSVKKLFADLPPLW 233
+ S K+ + LVKD KR T + L+H + K LS K ++
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFK 297
Query: 234 N---RVKALQLKDAAQLALKKM 252
R K+ + + L +
Sbjct: 298 KFAARKKS---NNGSGGGLNDI 316
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
+S D P ++ +F L ++ M G L Q G F E+ + E +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEII 302
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
L+++H + ++RD+K NILLD +G V+++D G+ AC F + VGT +M
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL-ACDFSKK----KPHASVGTHGYM 357
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMT--IQNAPPGLDYDR 177
APEVLQ G Y+S AD +S G +L GH+PF ++ + L
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---- 413
Query: 178 DKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKH 214
FS + ++ L +D +R A+++ + FF+
Sbjct: 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 67/299 (22%), Positives = 124/299 (41%), Gaps = 41/299 (13%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
L+ HPN++R + S + + +++ + G I ++ + E+ +++ L+
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE--DIVAREYYSEADASHCIQQILE 121
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
A+ + H+ G +HR++K N+LL + VKLADFG++ + Q++ F GTP
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI-EVEGE--QQAWFGFAGTPG 178
Query: 118 WMAPEVLQPGSGYNSKADIWSFG-ITALELAHGHAPFSKYPP-----MKVLLMTIQNAPP 171
+++PEVL+ Y D+W+ G I + L YPP L I+
Sbjct: 179 YLSPEVLR-KDPYGKPVDLWACGVILYILL-------VGYPPFWDEDQHRLYQQIKAGA- 229
Query: 172 GLDYDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE--------LS 221
D+ + K+++ L + +KR TA + LKH + H +
Sbjct: 230 -YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVD 288
Query: 222 VKKLFADLPPLWNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLK 280
K F ++K L + + S ++ I + Q + N D E
Sbjct: 289 CLKKFNAR----RKLKGAILT---VMLATRNFSVRKQEIIKVTEQLIEAISNGDFESYT 340
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ I HPN+I + F +++ +++ ++ G +A ++ E LK+ L
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFD--FLAEKESLTEDEATQFLKQILD 119
Query: 61 ALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
+ YLH + H D+K NI+L N +KL DFG++ + G+ + GTP
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-HKIEAGNEFK---NIFGTP 175
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGL 173
++APE++ +AD+WS G+ L G +PF +K + L I
Sbjct: 176 EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAV--NY 228
Query: 174 DYDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216
D+D + S+ K+ + LVKD +R T + L+HS+ K +
Sbjct: 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 59/240 (24%), Positives = 100/240 (41%), Gaps = 27/240 (11%)
Query: 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKAL 62
H NV+ F + ++V M GS L I + F E ++++ AL
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS--HIHKRRHFNELEASVVVQDVASAL 124
Query: 63 DYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRN----TFVGT 115
D+LH +G HRD+K NIL + VK+ DF + + + GD T G+
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 116 PCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQN 168
+MAPEV++ S Y+ + D+WS G+ L G+ PF
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 169 APPGL---------DYDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
L ++ S + K++++ LV+D +R +A ++L+H + + P
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 55/230 (23%), Positives = 105/230 (45%), Gaps = 16/230 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + H NVI + + +++ +++ ++ G +A ++ E S +K+ L
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILD 126
Query: 61 ALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
++YLH + H D+K NI+L +KL DFG++ + G + GTP
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFK---NIFGTP 182
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
++APE++ +AD+WS G+ L G +PF + L I + D+D
Sbjct: 183 EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-ITSV--SYDFD 238
Query: 177 RD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKK 224
+ S+ K+ + LVK+ KR T ++ L+H + + V++
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 36/227 (15%), Positives = 69/227 (30%), Gaps = 25/227 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM---KIAYQDGFEESAIGSILKE 57
+ ++ Y + + + +V + G+ L+ + K + + + S
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 58 TLKALDYLHRQGHIHRDVKAGNILL-----------DTNGVVKLADFGVSACMFDTGDRQ 106
L ++ +H IH D+K N +L D + + L D G S M
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 107 RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI 166
T + E+L +N + D + T + G K + +
Sbjct: 241 I-FTAKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 167 QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
P LD + E + L + LL+ K
Sbjct: 299 FRRLPHLDM---------WNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 53/247 (21%), Positives = 92/247 (37%), Gaps = 46/247 (18%)
Query: 1 MSLIDHPNVIR--AYC--SFVVDSNLWVVMPFMAEGS---CLHLMKIAYQDGFEESAIGS 53
+ + H N+++ VD +LW++ F +GS L +++ +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELC------H 125
Query: 54 ILKETLKALDYLHRQGH----------IHRDVKAGNILLDTNGVVKLADFGVSACMFDTG 103
I + + L YLH HRD+K+ N+LL N +ADFG+ A F+ G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL-ALKFEAG 184
Query: 104 DRQRSRNTFVGTPCWMAPEVLQPG----SGYNSKADIWSFGITALELAHGHAPFSKYPP- 158
+ VGT +MAPEVL+ + D+++ G+ ELA
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 159 -----------------MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP 201
M+ +++ + P DY + E + C D R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 202 TAEKLLK 208
+A + +
Sbjct: 305 SAGCVGE 311
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-33
Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 21/253 (8%)
Query: 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSC-LHLMKIAYQDG-FEESAIGSILKETL 59
+ + ++ +F ++L +VM M G H+ + + F+E + +
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
L++LH++ I+RD+K N+LLD +G V+++D G+ + + ++ + GTP +M
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL--AVELKAGQTKT-KGYAGTPGFM 356
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLDYD 176
APE+L G Y+ D ++ G+T E+ PF + K L +
Sbjct: 357 APELLL-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--- 412
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
KFS + K+ L KD KR + + L H F+ +L L PP
Sbjct: 413 -PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGML---TPP 468
Query: 232 LWNRVKALQLKDA 244
+ + K+
Sbjct: 469 FVPDSRTVYAKNI 481
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 22/235 (9%)
Query: 1 MSLIDH--PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ + VIR F + +++ E I + +E S +
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTN-GVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
L+A+ + H G +HRD+K NIL+D N G +KL DFG A + DT F GT
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRV 213
Query: 118 WMAPEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
+ PE ++ Y+ A +WS GI ++ G PF + I
Sbjct: 214 YSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEE-----IIRG----QVF 261
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
++ S + ++ CL + RPT E++ H + + P+ + + L P
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 51/244 (20%), Positives = 91/244 (37%), Gaps = 40/244 (16%)
Query: 1 MSLIDHPNVIR--AYC--SFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56
L+ H N++ A + L+++ + GS +K + ++ +
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAY 141
Query: 57 ETLKALDYLHRQGH--------IHRDVKAGNILLDTNGVVKLADFGVSACMFD--TGDRQ 106
++ L +LH + HRD+K+ NIL+ NG +AD G+ A F T +
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-AVKFISDTNEVD 200
Query: 107 RSRNTFVGTPCWMAPEVLQPGSG-----YNSKADIWSFGITALELAHG----------HA 151
NT VGT +M PEVL AD++SFG+ E+A
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
Query: 152 PFSKYPPMKVLLMTIQNA-------PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE 204
P+ P ++ P + + + +++ C + R TA
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
Query: 205 KLLK 208
++ K
Sbjct: 321 RVKK 324
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-33
Identities = 49/254 (19%), Positives = 91/254 (35%), Gaps = 49/254 (19%)
Query: 1 MSLIDHPNVIR--AYC---SFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
+ L++H N+ R + +VM + GS L K + + +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS---LXKYLSLHTSDWVSSCRLA 117
Query: 56 KETLKALDYLHRQGH---------IHRDVKAGNILLDTNGVVKLADFGVS-----ACMFD 101
+ L YLH + HRD+ + N+L+ +G ++DFG+S +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 102 TGDRQRSRNTFVGTPCWMAPEVL------QPGSGYNSKADIWSFGITALELAHG---HAP 152
G+ + + VGT +MAPEVL + + D+++ G+ E+ P
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 153 FSKYPPMKVLLMTIQNAPPGLD------------------YDRDKKFSKSFKEMVAMCLV 194
P ++ T P + + + +S KE + C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 195 KDQTKRPTAEKLLK 208
+D R TA+ +
Sbjct: 298 QDAEARLTAQXAEE 311
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-33
Identities = 52/216 (24%), Positives = 80/216 (37%), Gaps = 20/216 (9%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65
HP VIR F +V+ L I + E + + A+ +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDL-FDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 66 HRQGHIHRDVKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
H +G +HRD+K NIL+D G KL DFG A + D F GT + PE +
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-----PYTDFDGTRVYSPPEWI 210
Query: 125 QPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
Y+ A +WS GI ++ G PF + I A + S
Sbjct: 211 S-RHQYHALPATVWSLGILLYDMVCGDIPFERD-------QEILEA----ELHFPAHVSP 258
Query: 184 SFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
++ CL + RP+ E++L + +
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 14/221 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ L+ HP++I+ Y +++ +V+ + A G I + E ++ +
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFD--YIVEKKRMTEDEGRRFFQQIIC 119
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A++Y HR +HRD+K N+LLD N VK+ADFG+S + G+ + T G+P + A
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLK---TSCGSPNYAA 175
Query: 121 PEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PEV+ G Y + D+WS GI + G PF + L + + Y
Sbjct: 176 PEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSC----VYVMPD 229
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
S + ++ +V D +R T +++ + +F P L
Sbjct: 230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 26/275 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+++ H N++ + SF L ++ F++ + E I S + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLD-IFERINTSAFELNEREIVSYVHQVCE 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
AL +LH H D++ NI+ T + +K+ +FG + GD R P +
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNFR---LLFTAPEY 169
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLDY 175
APEV Q ++ D+WS G L G PF + + ++ I NA +
Sbjct: 170 YAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAE--YTF 222
Query: 176 DRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE----LSVKKLFADL 229
D + K+ S + V LVK++ R TA + L+H + K + K
Sbjct: 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282
Query: 230 PPLWN---RVKALQLKDAAQLALKKMPSAEQEAIS 261
L + + + A++ +
Sbjct: 283 HTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVK 317
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 17/221 (7%)
Query: 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKA 61
++ V+ ++ L +V+ M G + Q GF E+ E
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
L+ LHR+ ++RD+K NILLD +G ++++D G+ A G VGT +MAP
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTI---KGRVGTVGYMAP 354
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLDYDRD 178
EV++ Y D W+ G E+ G +PF K + + ++ P
Sbjct: 355 EVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY----S 409
Query: 179 KKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKH 214
++FS + + + L KD +R +A ++ +H FK
Sbjct: 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 69/306 (22%), Positives = 118/306 (38%), Gaps = 35/306 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HPN++R + ++L ++M + + G +I F E ++ L
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARFFFQQLLS 127
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGV--VKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+ Y H HRD+K N LLD + +K+ DFG S + + VGTP +
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAY 183
Query: 119 MAPEVLQPGSGYN-SKADIWSFGITALELAHGHAPF--SKYPPM-KVLLMTIQNAPPGLD 174
+APEVL Y+ AD+WS G+T + G PF + P + + I +
Sbjct: 184 IAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV----K 238
Query: 175 YD--RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPL 232
Y D + S +++ V D R + ++ HS+F P + L
Sbjct: 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPAD---------LMNE 289
Query: 233 WNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDM 292
N Q + +L + EA + N ++D + DD D
Sbjct: 290 SNTGSQFQEPEQPMQSLDTIMQIISEATIP-------AVRNRCLDDFMTDNLDLDDDMDD 342
Query: 293 LETKEE 298
+++ E
Sbjct: 343 FDSESE 348
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 59/265 (22%), Positives = 100/265 (37%), Gaps = 29/265 (10%)
Query: 3 LIDHPNVIRAYCSF----VVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
P+++ + L ++M M G ++ F E I+++
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 59 LKALDYLHRQGHIHRDVKAGNILL---DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
A+ +LH HRDVK N+L + + V+KL DFG + Q T T
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQ----TPCYT 192
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPG 172
P ++APEVL P Y+ D+WS G+ L G PF + + I+
Sbjct: 193 PYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-- 249
Query: 173 LDYDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLP 230
+ + S+ K+++ + L D T+R T + + H + +
Sbjct: 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV---------VPQT 300
Query: 231 PLWNRVKALQLKDAAQLALKKMPSA 255
PL + KD ++M SA
Sbjct: 301 PLHTARVLQEDKDHWDEVKEEMTSA 325
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 54/289 (18%), Positives = 109/289 (37%), Gaps = 26/289 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ + HP +I + +F + +++ F++ G L A E+ + + +++ +
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE-LFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
L ++H +H D+K NI+ +T VK+ DFG++ + + + T +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVK---VTTATAEF 216
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLDY 175
APE++ D+W+ G+ L G +PF L ++ ++
Sbjct: 217 AAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRC--DWEF 269
Query: 176 DRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH---AKPPELSVKKLFADLP 230
D D S K+ + L K+ KR T L+H + K + +
Sbjct: 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329
Query: 231 PLWNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDL 279
+ + A + S + EYQ + FD ++
Sbjct: 330 KIKEKYADWPAPQPAIGRIANFSSLRK--HRPQEYQ--IYDSYFDRKEA 374
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-32
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 13/221 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ L HP++I+ Y S++++VM + G L I +E + ++ L
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEY-VSGGEL-FDYICKNGRLDEKESRRLFQQILS 127
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+DY HR +HRD+K N+LLD + K+ADFG+S M D G+ R T G+P + A
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR---TSCGSPNYAA 183
Query: 121 PEVLQPGSGYN-SKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PEV+ G Y + DIWS G+ L G PF + L I + + +
Sbjct: 184 PEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDG----IFYTPQ 237
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
+ S ++ L D KR T + + +H +FK P L
Sbjct: 238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYL 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 28/230 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ I H N++ + ++ ++VM ++ G +I + + E ++++ L
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD--RILERGVYTEKDASLVIQQVLS 117
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
A+ YLH G +HRD+K N+L T N + + DFG+S M G +T GTP
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNG----IMSTACGTPG 172
Query: 118 WMAPEVLQPGSGYNSKADIWSFG-ITALELAHGHAPFSKYPP-----MKVLLMTIQNAPP 171
++APEVL Y+ D WS G IT + L YPP L I+
Sbjct: 173 YVAPEVLA-QKPYSKAVDCWSIGVITYILL-------CGYPPFYEETESKLFEKIKEGY- 223
Query: 172 GLDYDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
+++ S+S K+ + L KD +R T EK L H +
Sbjct: 224 -YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 58/298 (19%), Positives = 124/298 (41%), Gaps = 19/298 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + HPN+I + + +++ +++ ++ G +A ++ E S +K+ L
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILD 126
Query: 61 ALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
++YLH + H D+K NI+L +KL DFG++ + G + GTP
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFK---NIFGTP 182
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
++APE++ +AD+WS G+ L G +PF + L I D+D
Sbjct: 183 EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-ITAV--SYDFD 238
Query: 177 RD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK-HAKPPELSVKKLFADLPPL- 232
+ + S+ K+ + LVK+ KR T ++ L+H + + ++ +L
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFK 298
Query: 233 -WNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDD 289
+ +L + + + + + + + + E++ + +L
Sbjct: 299 KQYVRRRWKLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRR 356
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/261 (23%), Positives = 107/261 (40%), Gaps = 22/261 (8%)
Query: 1 MSLIDH-PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
+ L P VI + + S + +++ + A G L + E+ + ++K+ L
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 60 KALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
+ + YLH+ +H D+K NILL + G +K+ DFG+S R +GTP
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELR---EIMGTP 197
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
++APE+L + D+W+ GI A L +PF + L I +DY
Sbjct: 198 EYLAPEILN-YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-ISQVN--VDYS 253
Query: 177 RD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWN 234
+ S+ + + LVK+ KRPTAE L HS+ + P
Sbjct: 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE--------NLFHPEET 305
Query: 235 RVKALQLKDAAQLALKKMPSA 255
+ + + + K +
Sbjct: 306 SSSSQTQDHSVRSSEDKTSKS 326
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 18/220 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
+ ++HP +++ + +F + L++++ F+ G L ++ F E + L E
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
ALD+LH G I+RD+K NILLD G +KL DFG+S D + +F GT +M
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYM 193
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
APEV+ G+ AD WSFG+ E+ G PF K + I A G+ +
Sbjct: 194 APEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGM----PQ 247
Query: 180 KFSKSFKEMVAMCLVKDQTKR----PT-AEKLLKHSFFKH 214
S + ++ M ++ R P E++ +HSFF
Sbjct: 248 FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
+ ++ P +++ SF +SNL++VM ++A G + + G F E + +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG---EMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+YLH I+RD+K N+L+D G +++ DFG F + R+ T GTP +
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG-----FAKRVKGRT-WTLCGTPEAL 205
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
APE++ GYN D W+ G+ E+A G+ PF P++ + I + + +
Sbjct: 206 APEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGK--VRFPSH- 260
Query: 180 KFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKH 214
FS K+++ L D TKR + H +F
Sbjct: 261 -FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-31
Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 21/226 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
MS++ HP ++ + +F D+ + ++ FM+ G K+A + E +++
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVC 265
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGV--VKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
K L ++H ++H D+K NI+ T +KL DFG++ D + GT
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSVK---VTTGTAE 321
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLD 174
+ APEV + G D+WS G+ + L G +PF + L +++ +
Sbjct: 322 FAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCD--WN 374
Query: 175 YDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
D S+ K+ + L+ D R T + L+H + P
Sbjct: 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 49/244 (20%), Positives = 90/244 (36%), Gaps = 40/244 (16%)
Query: 1 MSLIDHPNVIRAYCS----FVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56
++ H N++ + + LW+V + GS + + + +
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLAL 146
Query: 57 ETLKALDYLHRQGH--------IHRDVKAGNILLDTNGVVKLADFGVSACMFDTG--DRQ 106
T L +LH + HRD+K+ NIL+ NG +AD G+ A D+
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-AVRHDSATDTID 205
Query: 107 RSRNTFVGTPCWMAPEVLQPGSG-----YNSKADIWSFGITALELAHG----------HA 151
+ N VGT +MAPEVL +ADI++ G+ E+A
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
Query: 152 PFSKYPPMKVLLMTIQNA-------PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE 204
P+ P + ++ P + + + + +++ C + R TA
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
Query: 205 KLLK 208
++ K
Sbjct: 326 RIKK 329
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
+ + HP ++ +F L++++ +++ G L ++G F E L E
Sbjct: 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG---ELFMQLEREGIFMEDTACFYLAEIS 131
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL +LH++G I+RD+K NI+L+ G VKL DFG+ G +TF GT +M
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYM 188
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
APE+L SG+N D WS G ++ G PF+ K + I L
Sbjct: 189 APEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNL----PP 242
Query: 180 KFSKSFKEMVAMCLVKDQTKR----PT-AEKLLKHSFFKH 214
++ ++++ L ++ R P A ++ H FF+H
Sbjct: 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 58/233 (24%), Positives = 108/233 (46%), Gaps = 20/233 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ +DH N+I+ Y +F +++ +VM ++ G L I E +K+ +
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE-LFDRIIDESYNLTELDTILFMKQICE 198
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
+ ++H+ +H D+K NIL +K+ DFG++ + ++ + GTP +
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKLK---VNFGTPEF 254
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLDY 175
+APEV+ + D+WS G+ A L G +PF + L I D
Sbjct: 255 LAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACR--WDL 307
Query: 176 DRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK-HAKPPELSVKKL 225
+ + + S+ KE ++ L+K+++ R +A + LKH + H LS +K
Sbjct: 308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 59/265 (22%), Positives = 101/265 (38%), Gaps = 28/265 (10%)
Query: 3 LIDHPNVIRAYCSF----VVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
P+++R + L +VM + G ++ F E I+K
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 59 LKALDYLHRQGHIHRDVKAGNILL---DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
+A+ YLH HRDVK N+L N ++KL DFG + + + T T
Sbjct: 171 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLT---TPCYT 226
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPG 172
P ++APEVL P Y+ D+WS G+ L G+ PF + I+
Sbjct: 227 PYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-- 283
Query: 173 LDYDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLP 230
++ + S+ K ++ L + T+R T + + H + +
Sbjct: 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK---------VPQT 334
Query: 231 PLWNRVKALQLKDAAQLALKKMPSA 255
PL + K+ + ++M SA
Sbjct: 335 PLHTSRVLKEDKERWEDVKEEMTSA 359
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 21/220 (9%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALDY 64
P ++ + +F ++ L +++ ++ G L Q F E + + E + AL++
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGG---ELFTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVS-ACMFDTGDRQRSRNTFVGTPCWMAPEV 123
LH+ G I+RD+K NILLD+NG V L DFG+S + D +R F GT +MAP++
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA---YDFCGTIEYMAPDI 231
Query: 124 LQPGS-GYNSKADIWSFGITALELAHGHAPFSKYPP---MKVLLMTIQNAPPGLDYDRDK 179
++ G G++ D WS G+ EL G +PF+ + I + P +
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--- 288
Query: 180 KFSKSFKEMVAMCLVKDQTKR----PT-AEKLLKHSFFKH 214
S K+++ L+KD KR P A+++ +H FF+
Sbjct: 289 -MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 33/226 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEE------SAIGS 53
+S++ HP +IR + +F ++++M ++ G L + + F +A
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG---ELFSLLRKSQRFPNPVAKFYAA--- 113
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
E AL+YLH + I+RD+K NILLD NG +K+ DFG + + D T
Sbjct: 114 ---EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YTLC 164
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL 173
GTP ++APEV+ YN D WSFGI E+ G+ PF MK I NA L
Sbjct: 165 GTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAE--L 220
Query: 174 DYDRDKKFSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKH 214
+ F++ K++++ + +D ++R E + H +FK
Sbjct: 221 RFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 18/220 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETL 59
+ HP + +F L VM + G L ++ F E E +
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIV 115
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
AL+YLH + ++RD+K N++LD +G +K+ DFG+ G TF GTP ++
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYL 172
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
APEVL+ + Y D W G+ E+ G PF + L I +
Sbjct: 173 APEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRF----PR 226
Query: 180 KFSKSFKEMVAMCLVKDQTKR----PT-AEKLLKHSFFKH 214
S K ++A L KD +R P+ A+++++H FF
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 26/225 (11%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALD 63
+HP ++ + F +S L+ V+ ++ G LM + E E AL+
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLH +G I+RD+K N+LLD+ G +KL D+G+ C + +TF GTP ++APE+
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTT-STFCGTPNYIAPEI 181
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM--------KVLLMTIQNAPPGLDY 175
L+ G Y D W+ G+ E+ G +PF L I +
Sbjct: 182 LR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-- 238
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKR------PTAEKLLKHSFFKH 214
+ S ++ L KD +R + H FF++
Sbjct: 239 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 8/205 (3%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ P+V+ + +D L+V M + G L M + Q +I+++ ALD
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLI-NGVDLAAM-LRRQGPLAPPRAVAIVRQIGSALD 148
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
H G HRDVK NIL+ + L DFG+++ D Q VGT +MAPE
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMAPER 206
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
S +ADI++ E G P+ + V+ I A P
Sbjct: 207 FS-ESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPS-TVRPGIPV 263
Query: 184 SFKEMVAMCLVKDQTKR-PTAEKLL 207
+F ++A + K+ R T L
Sbjct: 264 AFDAVIARGMAKNPEDRYVTCGDLS 288
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-29
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 17/216 (7%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKAL 62
+ HP ++ + SF L+ V+ ++ G L ++ F E E AL
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASAL 152
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
YLH ++RD+K NILLD+ G + L DFG+ + +TF GTP ++APE
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT---STFCGTPEYLAPE 209
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFS 182
VL Y+ D W G E+ +G PF + I N P L +
Sbjct: 210 VLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQL----KPNIT 263
Query: 183 KSFKEMVAMCLVKDQTKR----PTAEKLLKHSFFKH 214
S + ++ L KD+TKR ++ H FF
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALD 63
+HP + + +C F L+ VM F+ G LM + F+E+ E + AL
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
+LH +G I+RD+K N+LLD G KLADFG+ C + + TF GTP ++APE+
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM--CKEGICNGVTT-ATFCGTPDYIAPEI 195
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
LQ Y D W+ G+ E+ GHAPF L I N +
Sbjct: 196 LQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVY----PTWLHE 249
Query: 184 SFKEMVAMCLVKDQTKR------PTAEKLLKHSFFKH 214
++ + K+ T R +L+H FFK
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSC-LHLMKIAYQDGFEESAIGSILKETLKAL 62
+HP + +C+F NL+ VM ++ G H+ F+ S E + L
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGL 131
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPE 122
+LH +G ++RD+K NILLD +G +K+ADFG+ C + ++ NTF GTP ++APE
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM--CKENMLGDAKT-NTFCGTPDYIAPE 188
Query: 123 VLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFS 182
+L G YN D WSFG+ E+ G +PF + L +I+ P +
Sbjct: 189 ILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFY----PRWLE 242
Query: 183 KSFKEMVAMCLVKDQTKR-PTAEKLLKHSFFKH 214
K K+++ V++ KR + +H F+
Sbjct: 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM-KIAYQDGFEESAIGSILKETLKALD 63
P + + + F L+ VM ++ G LM I F+E E L
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
+L +G I+RD+K N++LD+ G +K+ADFG+ C + D + TF GTP ++APE+
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM--CKENIWDGVTT-KTFCGTPDYIAPEI 513
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
+ Y D W+FG+ E+ G APF L +I K SK
Sbjct: 514 IA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAY----PKSMSK 567
Query: 184 SFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKH 214
+ + K KR + +H+FF++
Sbjct: 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 19/221 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLM-KIAYQDGFEESAIGSILKETL 59
+ HP + SF L VM + G L ++ + F E E +
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIV 258
Query: 60 KALDYLH-RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
ALDYLH + ++RD+K N++LD +G +K+ DFG+ G TF GTP +
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEY 315
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
+APEVL+ + Y D W G+ E+ G PF + L I
Sbjct: 316 LAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRF----P 369
Query: 179 KKFSKSFKEMVAMCLVKDQTKR----PT-AEKLLKHSFFKH 214
+ K +++ L KD +R A+++++H FF
Sbjct: 370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 26/225 (11%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALD 63
+HP ++ + F +S L+ V+ ++ G LM + E E AL+
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLH +G I+RD+K N+LLD+ G +KL D+G+ C + +TF GTP ++APE+
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTT-STFCGTPNYIAPEI 224
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM--------KVLLMTIQNAPPGLDY 175
L+ G Y D W+ G+ E+ G +PF L I +
Sbjct: 225 LR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI-- 281
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKR------PTAEKLLKHSFFKH 214
+ S ++ L KD +R + H FF++
Sbjct: 282 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGSILKETLKALDY 64
P + + + F L+ VM ++ G LM Q G F+E E L +
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
L +G I+RD+K N++LD+ G +K+ADFG+ C + D + TF GTP ++APE++
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGM--CKENIWDGVTT-KTFCGTPDYIAPEII 193
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS 184
Y D W+FG+ E+ G APF L +I K SK
Sbjct: 194 A-YQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAY----PKSMSKE 247
Query: 185 FKEMVAMCLVKDQTKR----PT-AEKLLKHSFFKH 214
+ + K KR P + +H+FF++
Sbjct: 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 61/257 (23%), Positives = 98/257 (38%), Gaps = 61/257 (23%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ HPN++ F L +V + + + LH + YQ G E + SI +TL+A++
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELD-RYQRGVPEHLVKSITWQTLQAVN 116
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM-APE 122
+ H+ IHRDVK NIL+ + V+KL DFG A + + V T W +PE
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGF-ARLL--TGPSDYYDDEVAT-RWYRSPE 172
Query: 123 VLQPGSGYNSKADIWSFG---------------------------------------ITA 143
+L + Y D+W+ G +
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 144 LELAHGHAPFSKYPPMKVLLMTIQNAPP-GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT 202
+ G M+ L + N L ++ CL D T+R T
Sbjct: 233 NQYFSGV-KIPDPEDMEPLELKFPNISYPALG-------------LLKGCLHMDPTERLT 278
Query: 203 AEKLLKHSFFKHAKPPE 219
E+LL H +F++ + E
Sbjct: 279 CEQLLHHPYFENIREIE 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 6/204 (2%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
H N++ D ++VM ++ EG L I + + L + +
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEY-IESHGPLSVDTAINFTNQILDGIKH 126
Query: 65 LHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVL 124
H +HRD+K NIL+D+N +K+ DFG++ + +T Q N +GT + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFSPEQA 184
Query: 125 QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS 184
+ G + DI+S GI E+ G PF+ + + + IQ++ P + D K +S
Sbjct: 185 K-GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 185 FKEMVAMCLVKDQTKRP-TAEKLL 207
++ KD+ R T +++
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMK 267
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 3/156 (1%)
Query: 53 SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF 112
++ + +AL++ H+ G IHRDVK NI++ VK+ DFG++ + D+G+
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPG 172
+GT +++PE + G ++++D++S G E+ G PF+ P+ V ++ P
Sbjct: 180 IGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRP-TAEKLL 207
R + S +V L K+ R TA ++
Sbjct: 239 PS-ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/257 (20%), Positives = 85/257 (33%), Gaps = 61/257 (23%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ H N++ ++V F+ + + L ++ + +G + + L + + +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLE-LFPNGLDYQVVQKYLFQIINGIG 138
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM-APE 122
+ H IHRD+K NIL+ +GVVKL DFG A + V T W APE
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGF-ARTL--AAPGEVYDDEVAT-RWYRAPE 194
Query: 123 VLQPGSGYNSKADIWSFG-ITALELAHGHA------------------------------ 151
+L Y D+W+ G + E+ G
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVT-EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253
Query: 152 --------PFSKYPPMKVLLMTIQNAPP-GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT 202
+ + L +D + CL D KRP
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVID-------------LAKKCLHIDPDKRPF 300
Query: 203 AEKLLKHSFFKHAKPPE 219
+LL H FF+ E
Sbjct: 301 CAELLHHDFFQMDGFAE 317
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 56/253 (22%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ H N++R + D L +V F + + + + S L + LK L
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
+ H + +HRD+K N+L++ NG +KLA+FG+ A F G R + V T + P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGL-ARAF--GIPVRCYSAEVVTLWYRPPDV 172
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAP------------------------------- 152
L Y++ D+WS G ELA+ P
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 153 ------FSKYPPMKVLLMTIQNAPP-GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205
+ YP L+ + G D ++ L + +R +AE+
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRD-------------LLQNLLKCNPVQRISAEE 279
Query: 206 LLKHSFFKHAKPP 218
L+H +F PP
Sbjct: 280 ALQHPYFSDFCPP 292
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 33/179 (18%)
Query: 1 MSLIDHPNVIRAY-CSFVVDSNLWVVMPFMAEGSCLH-------------LMKIAYQDGF 46
M HPNV+ + + VV+P+M G + L+ Q
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ--- 136
Query: 47 EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ 106
+ + YL + +HRD+ A N +LD VK+ADFG++ M+D +
Sbjct: 137 ----VAK-------GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EYY 184
Query: 107 RSRNTFVGT-PC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVL 162
N P WMA E LQ + +K+D+WSFG+ EL G P+ +
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M+ +D+P+V R C S + ++ M G L ++ ++D + + +
Sbjct: 71 MASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQI 126
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
K ++YL + +HRD+ A N+L+ T VK+ DFG++ + + V P
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIK 184
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVL 162
WMA E + Y ++D+WS+G+T EL G P+ P ++
Sbjct: 185 WMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M I HPN+++ C+ + +++ FM G+ L ++ + + + +
Sbjct: 63 MKEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
A++YL ++ IHRD+ A N L+ N +VK+ADFG+S M + F P
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIK 177
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ--------N 168
W APE L ++ K+D+W+FG+ E+A +G +P+ +V + +
Sbjct: 178 WTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 169 APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
P + Y E++ C + + RP+ ++ +
Sbjct: 237 CPEKV-Y-----------ELMRACWQWNPSDRPSFAEIHQA 265
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 36/223 (16%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ HPN++R C+ +++VM + G L ++ + ++ +
Sbjct: 166 LKQYSHPNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLR-TEGARLRVKTLLQMVGDA 222
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
++YL + IHRD+ A N L+ V+K++DFG+S D V P
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVK 280
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK---VLLMTIQ------ 167
W APE L G Y+S++D+WSFGI E G +P YP + +
Sbjct: 281 WTAPEALNYGR-YSSESDVWSFGILLWETFSLGASP---YPNLSNQQTREFVEKGGRLPC 336
Query: 168 --NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
P + ++ C + +RP+ + +
Sbjct: 337 PELCPDAV------------FRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 53/265 (20%), Positives = 91/265 (34%), Gaps = 49/265 (18%)
Query: 3 LIDHPNVIRAYCSF----VVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
P+++R + L +VM + G ++ F E I+K
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
+A+ YLH HRDVK N+L + N ++KL DFG
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------- 165
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPG 172
A E G Y+ D+WS G+ L G+ PF + I+
Sbjct: 166 ---FAKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-- 218
Query: 173 LDYDRD--KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLP 230
++ + S+ K ++ L + T+R T + + H + +
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK---------VPQT 269
Query: 231 PLWNRVKALQLKDAAQLALKKMPSA 255
PL + K+ + ++M SA
Sbjct: 270 PLHTSRVLKEDKERWEDVKEEMTSA 294
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 37/181 (20%)
Query: 1 MSLIDHPNVIRAY-CSFVVDSNLWVVMPFMAEGSCLH-------------LMKIAYQDGF 46
M ++HPNV+ + V++P+M G L L+ Q
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ--- 132
Query: 47 EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDT---G 103
+ ++YL Q +HRD+ A N +LD + VK+ADFG++ + D
Sbjct: 133 ----VAR-------GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181
Query: 104 DRQRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKV 161
+Q P W A E LQ + +K+D+WSFG+ EL G P+ P +
Sbjct: 182 VQQHRHARL---PVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237
Query: 162 L 162
Sbjct: 238 T 238
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 39/246 (15%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKI--AYQDGFEESAIGSILKETLKA 61
+ HPN++ + L +V FM L K+ + G ++S I L + L+
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
+ + H+ +HRD+K N+L++++G +KLADFG+ A F G RS V T + AP
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGL-ARAF--GIPVRSYTHEVVTLWYRAP 188
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPF---------------------------S 154
+VL Y++ DIWS G E+ G F
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214
+ P K T Q F + ++++ L D KR +A + H +FK
Sbjct: 249 ELPLWK--QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 215 AKPPEL 220
P++
Sbjct: 307 L-DPQI 311
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 25/229 (10%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +DH N+IR Y V+ + +V GS L ++ +Q F + + +
Sbjct: 75 MHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAE 132
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT--PC- 117
+ YL + IHRD+ A N+LL T +VK+ DFG+ + D + P
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHRKVPFA 189
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQN-----APP 171
W APE L+ + ++ +D W FG+T E+ +G P+ ++L + P
Sbjct: 190 WCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
Query: 172 GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
+ ++ C RPT L F A+P ++
Sbjct: 249 DC--------PQDIYNVMVQCWAHKPEDRPTFVAL--RDFLLEAQPTDM 287
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 7/166 (4%)
Query: 1 MSLIDHPNVIRAY-CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M HPNV+ + + VV+P+M G + ++ + +
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVA 202
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT-PC- 117
K + +L + +HRD+ A N +LD VK+ADFG++ M+D + N P
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVK 261
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVL 162
WMA E LQ + +K+D+WSFG+ EL G P+ +
Sbjct: 262 WMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 38/163 (23%), Positives = 74/163 (45%), Gaps = 13/163 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M +DHP++++ +++ W++M G H ++ ++ + + +
Sbjct: 67 MKNLDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQIC 123
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-W 118
KA+ YL +HRD+ NIL+ + VKL DFG+S + D + S P W
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL---PIKW 180
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK 160
M+PE + + + +D+W F + E+ G P + ++
Sbjct: 181 MSPESINFRR-FTTASDVWMFAVCMWEILSFGKQP---FFWLE 219
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 41/240 (17%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKI--AYQDGFEESAIGSILKETLKA 61
+ H N+++ Y L +V + L K+ + G E S L + L
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 62 LDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
+ Y H + +HRD+K N+L++ G +K+ADFG+ A F G R + T + AP
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGL-ARAF--GIPVRKYTHEIVTLWYRAP 169
Query: 122 EVLQPGSGYNSKADIWSFG-ITALELAHGHAPF--------------------------- 153
+VL Y++ DIWS G I A E+ +G F
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFA-EMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
++ P P K +S ++++ L D +R TA++ L+H++FK
Sbjct: 229 TELPKYDP---NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M DHP++++ + ++ +W++M G ++ + + +++ +
Sbjct: 70 MRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQL 125
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
AL YL + +HRD+ A N+L+ +N VKL DFG+S M D+ + S+ P
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PIK 182
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK 160
WMAPE + + S +D+W FG+ E+ HG P + +K
Sbjct: 183 WMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKP---FQGVK 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 54/256 (21%), Positives = 94/256 (36%), Gaps = 53/256 (20%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMA---EGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ H N++R Y ++ L +V FM + G E + + + L+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L + H +HRD+K N+L++ G +KL DFG+ A F G + ++ V T + A
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL-ARAF--GIPVNTFSSEVVTLWYRA 176
Query: 121 PEVLQPGSGYNSKADIWSFG-ITALELAHG------------------------------ 149
P+VL Y++ DIWS G I A E+ G
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILA-EMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 150 -------HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT 202
+ + PP + + + LD + + + L + R +
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNL--------MDFLHGLLQLNPDMRLS 287
Query: 203 AEKLLKHSFFKHAKPP 218
A++ L H +F
Sbjct: 288 AKQALHHPWFAEYYHH 303
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 25/227 (11%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + H +++ Y S + +++V +M++GS L +K + + +
Sbjct: 233 MKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ Y+ R ++HRD++A NIL+ N V K+ADFG++ + D R F P
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIK 346
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQN----APPG 172
W APE G + K+D+WSFGI EL G P+ +VL + PP
Sbjct: 347 WTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 405
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH--SFFKHAKP 217
+S +++ C K+ +RPT E L +F +P
Sbjct: 406 --------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 74/286 (25%), Positives = 112/286 (39%), Gaps = 63/286 (22%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ HPN+I +F SN+ +V FM E ++K S I + + TL+ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLE 126
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
YLH+ +HRD+K N+LLD NGV+KLADFG+ A F + +R + V T + APE+
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGL-AKSFGSPNRAYTHQ--VVTRWYRAPEL 183
Query: 124 LQPGSGYNSKADIWSFG-ITALELAHGHA------------------------------- 151
L Y D+W+ G I A EL
Sbjct: 184 LFGARMYGVGVDMWAVGCILA-ELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242
Query: 152 -----PFSKYPPMKVLLMTIQNAPP-GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205
F +P + L A LD ++ + + R TA +
Sbjct: 243 LPDYVTFKSFPGIP-LHHIFSAAGDDLLD-------------LIQGLFLFNPCARITATQ 288
Query: 206 LLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQLKDAAQLALKK 251
LK +F + P LP V+ L+ + LA+K+
Sbjct: 289 ALKMKYFSNRPGP-----TPGCQLPRPNCPVETLKEQSNPALAIKR 329
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + H ++R Y + ++++ +M GS + +K + + + +
Sbjct: 62 MKQLQHQRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ + ++ + +IHRD++A NIL+ K+ADFG++ + D R F P
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---PIK 175
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPM 159
W APE + G+ + K+D+WSFGI E+ HG P YP M
Sbjct: 176 WTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIP---YPGM 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M DHPN+IR + +V +M GS ++ + F + +L+
Sbjct: 104 MGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGV 160
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ YL G++HRD+ A N+L+D+N V K++DFG+S + D D + G
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT---GGKIP 217
Query: 118 --WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK 160
W APE + + ++S +D+WSFG+ E+ +G P Y M
Sbjct: 218 IRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERP---YWNMT 259
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 15/165 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M +D+P ++R V + L +VM G + ++ S + +L +
Sbjct: 64 MHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVS 120
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT--PC 117
+ YL + +HRD+ A N+LL K++DFG+S + +R P
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPL 177
Query: 118 -WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK 160
W APE + ++S++D+WS+G+T E +G P Y MK
Sbjct: 178 KWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKP---YKKMK 218
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 50/231 (21%)
Query: 1 MSLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCL--HL--------------MKIAY 42
M+ H N++ + +L +V +M GS L L KIA
Sbjct: 84 MAKCQHENLVELLGFS--SDGDDLCLVYVYMPNGS-LLDRLSCLDGTPPLSWHMRCKIA- 139
Query: 43 QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDT 102
G +++LH HIHRD+K+ NILLD K++DFG+ A +
Sbjct: 140 --------QG-----AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL-ARASEK 185
Query: 103 GDRQRSRNTFVGTPCWMAPEVLQPGSGY-NSKADIWSFGITALELAHGHAPFSKYPPMKV 161
+ + VGT +MAPE L G K+DI+SFG+ LE+ G ++ ++
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEAL---RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
Query: 162 LL---MTIQNAPPGLDYDRDKKF----SKSFKEMVA---MCLVKDQTKRPT 202
LL I++ ++ DKK S S + M + CL + + KRP
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 7/164 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ +D+P+V R + S + ++ M G L ++ ++D + + + K
Sbjct: 71 MASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAK 128
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC-WM 119
++YL + +HRD+ A N+L+ T VK+ DFG++ + + V P WM
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWM 186
Query: 120 APEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVL 162
A E + Y ++D+WS+G+T EL G P+ P ++
Sbjct: 187 ALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M +D+P ++R + ++ +VM G ++ ++ I ++ +
Sbjct: 72 MQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVS 127
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT--PC 117
+ YL +HRD+ A N+LL T K++DFG+S + + +++ P
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGKWPV 184
Query: 118 -WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK 160
W APE + ++SK+D+WSFG+ E +G P Y MK
Sbjct: 185 KWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKP---YRGMK 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-24
Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M I HPN+++ C+ + +++ FM G+ L ++ + + + +
Sbjct: 270 MKEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
A++YL ++ IHR++ A N L+ N +VK+ADFG+S M + F P
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIK 384
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQN----APPG 172
W APE L ++ K+D+W+FG+ E+A +G +P+ +V + ++ P G
Sbjct: 385 WTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ E++ C + + RP+ ++ +
Sbjct: 444 --------CPEKVYELMRACWQWNPSDRPSFAEIHQA 472
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 50/233 (21%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M H N+IR S + ++ +M G+ ++ F + +L+
Sbjct: 100 MGQFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGI 156
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ YL ++HRD+ A NIL+++N V K++DFG+S + D + + + G
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS---GGKIP 213
Query: 118 --WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ------- 167
W APE + + S +D+WSFGI E+ +G P+ + +V+
Sbjct: 214 IRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272
Query: 168 -NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
+ P + ++ M+ C +++ +RP + K + P+
Sbjct: 273 MDCPSAI-----------YQLMM-QCWQQERARRPKFAD-IVSILDKLIRAPD 312
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + HP +++ Y CS + +++V +++ G L+ ++ ++ G E S + + +
Sbjct: 57 MMKLSHPKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDV 113
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ + +L IHRD+ A N L+D + VK++DFG++ + D F P
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF---PVK 170
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ--------N 168
W APEV Y+SK+D+W+FGI E+ G P+ Y +V+L Q
Sbjct: 171 WSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL 229
Query: 169 APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
A + Y +++ C + KRPT ++LL
Sbjct: 230 ASDTI-Y-----------QIMYSCWHELPEKRPTFQQLLS 257
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 53/255 (20%), Positives = 96/255 (37%), Gaps = 41/255 (16%)
Query: 1 MSLIDHPNVIRAY--CS----FVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGS 53
M DHP+V + V++PFM G L+ + + +
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 54 ILKETL---KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRS 108
+++ + ++YL + IHRD+ A N +L + V +ADFG+S ++ D RQ
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG-DYYRQGC 197
Query: 109 RNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTI 166
+ P W+A E L Y +D+W+FG+T E+ G P++ ++ I
Sbjct: 198 ASKL---PVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253
Query: 167 Q--------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH--SFFKHAK 216
+ Y +++ C D +RP+ L + H
Sbjct: 254 GGNRLKQPPECMEEV-Y-----------DLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 217 PPELSVKKLFADLPP 231
S L+ ++
Sbjct: 302 VLSTSQDPLYINIER 316
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 57/265 (21%), Positives = 92/265 (34%), Gaps = 73/265 (27%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
+ +HPNV+R + +V + + + A G I ++
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
++ L+ LD+LH +HRD+K NIL+ + G VKLADFG+ A ++ + T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL-ARIYS------YQMAL--T 177
Query: 116 PC----WM-APEVLQPGSGYNSKADIWSFG-ITALELAHG-------------------- 149
P W APEVL S Y + D+WS G I A E+
Sbjct: 178 PVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFA-EMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 150 ---------------HAPFSKYPPMKVLLMTIQNAPP-GLDYDRDKKFSKSFKEMVAMCL 193
F P + + G ++ L
Sbjct: 236 GLPPEDDWPRDVSLPRGAFPPRGPRP-VQSVVPEMEESGAQ-------------LLLEML 281
Query: 194 VKDQTKRPTAEKLLKHSFFKHAKPP 218
+ KR +A + L+HS+ +
Sbjct: 282 TFNPHKRISAFRALQHSYLHKDEGN 306
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 31/210 (14%)
Query: 4 IDHPNVIRAY-----CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ HP++++ + D ++VM ++ G L K + + + L E
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSL---KRSKGQKLPVAEAIAYLLEI 191
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
L AL YLH G ++ D+K NI+L +KL D G + + G GTP +
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG-------YLYGTPGF 243
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE +G DI++ G T L + + + P L
Sbjct: 244 QAPE--IVRTGPTVATDIYTVGRTLAALTLDLPTRN-----GRYVDGLPEDDPVLK---- 292
Query: 179 KKFSKSFKEMVAMCLVKDQTKRP-TAEKLL 207
S+ ++ + D +R TAE++
Sbjct: 293 --TYDSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 49/226 (21%), Positives = 94/226 (41%), Gaps = 43/226 (19%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M+ + H N+++ L++V +MA+GS + ++ + + +
Sbjct: 68 MTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+A++YL +HRD+ A N+L+ + V K++DFG+ ++
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL------------TKEASSTQDTG 174
Query: 118 -----WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ---- 167
W APE L+ +++K+D+WSFGI E+ G P+ + P V+ +
Sbjct: 175 KLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 233
Query: 168 ----NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
PP + Y E++ C D RP+ +L +
Sbjct: 234 DAPDGCPPAV-Y-----------EVMKNCWHLDAAMRPSFLQLREQ 267
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ +DH +++R C S+L +V ++ GS L ++ ++ + + +
Sbjct: 69 IGSLDHAHIVRLLGLCP---GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQI 124
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT--P 116
K + YL G +HR++ A N+LL + V++ADFGV+ + D+Q + P
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL-PPDDKQLLYS---EAKTP 180
Query: 117 C-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVL 162
WMA E + G Y ++D+WS+G+T EL G P++ +V
Sbjct: 181 IKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + HP +++ Y C + + +V FM G ++ + F + + +
Sbjct: 57 MMKLSHPKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDV 113
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ + YL IHRD+ A N L+ N V+K++DFG++ + D + F P
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF---PVK 170
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPM 159
W +PEV Y+SK+D+WSFG+ E+ G P Y
Sbjct: 171 WASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIP---YENR 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 38/230 (16%)
Query: 1 MSLIDHPNVIRAY--CSF---VVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSI 54
M HPNVIR C V++PFM G L+ + G + + ++
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 55 LKETL---KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSR 109
LK + ++YL + +HRD+ A N +L + V +ADFG+S ++ D RQ
Sbjct: 150 LKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG-DYYRQGRI 208
Query: 110 NTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ 167
P W+A E L Y SK+D+W+FG+T E+A G P+ ++ +
Sbjct: 209 AKM---PVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
Query: 168 --------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ L Y E++ C D RPT L
Sbjct: 265 GHRLKQPEDCLDEL-Y-----------EIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 34/162 (20%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCL-----------HLMKIAYQDGFE 47
+ + H ++I+ C ++L +VM ++ GS L+ A Q
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---- 142
Query: 48 ESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--R 105
I + + YLH Q +IHRD+ A N+LLD + +VK+ DFG++ + + + R
Sbjct: 143 ---IC-------EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 192
Query: 106 QRSRNTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALEL 146
R P W APE L+ + +D+WSFG+T EL
Sbjct: 193 VREDGDS---PVFWYAPECLKEYK-FYYASDVWSFGVTLYEL 230
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + H +++ + + ++++ FMA+GS L +K + +
Sbjct: 237 MKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ + ++ ++ +IHRD++A NIL+ + V K+ADFG++ + D R F P
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF---PIK 350
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPM 159
W APE + GS + K+D+WSFGI +E+ +G P YP M
Sbjct: 351 WTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIP---YPGM 389
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M DHP++++ + ++ +W++M G ++ + + +++ +
Sbjct: 445 MRQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQL 500
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
AL YL + +HRD+ A N+L+ +N VKL DFG+S M D+ + S+ P
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL---PIK 557
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ--------N 168
WMAPE + + S +D+W FG+ E+ HG PF V+ N
Sbjct: 558 WMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616
Query: 169 APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206
PP L Y ++ C D ++RP +L
Sbjct: 617 CPPTL-Y-----------SLMTKCWAYDPSRRPRFTEL 642
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 62/264 (23%), Positives = 105/264 (39%), Gaps = 48/264 (18%)
Query: 1 MSLIDHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
+ +HPNV+R + V ++ L +V + + + + G I ++
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
+ L+ LD+LH +HRD+K NIL+ ++G +KLADFG+ A ++ + T
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYS------FQMAL--T 177
Query: 116 PC----WM-APEVLQPGSGYNSKADIWSFG-ITALELAHGHAPF---------------- 153
W APEVL S Y + D+WS G I A E+ F
Sbjct: 178 SVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFA-EMFRRKPLFRGSSDVDQLGKILDVI 235
Query: 154 -----SKYPPMKVL-LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207
+P L + + K+++ CL + KR +A L
Sbjct: 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 208 KHSFFKHAKPPELSVKKLFADLPP 231
H +F+ + + + L + LPP
Sbjct: 296 SHPYFQDLERCK---ENLDSHLPP 316
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 46/242 (19%), Positives = 87/242 (35%), Gaps = 34/242 (14%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
+ H N++ + + +L +V ++ + + + + L + L+ L
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLD-DCGNIINMHNVKLFLFQLLRGLA 114
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
Y HRQ +HRD+K N+L++ G +KLADFG+ A ++ + V T + P++
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGL-ARAK--SIPTKTYDNEVVTLWYRPPDI 171
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPF---------------------------SKY 156
L + Y+++ D+W G E+A G F
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216
K + +++ L + R +AE +KH FF
Sbjct: 232 EEFK--TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 217 PP 218
Sbjct: 290 ER 291
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 25/235 (10%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + H +++ Y S + +++V +M++GS L +K + + +
Sbjct: 316 MKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+ Y+ R ++HRD++A NIL+ N V K+ADFG++ + D R F P
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---PIK 429
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQN----APPG 172
W APE G + K+D+WSFGI EL G P+ +VL + PP
Sbjct: 430 WTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 488
Query: 173 LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH--SFFKHAKPPELSVKKL 225
+S +++ C K+ +RPT E L +F +P + L
Sbjct: 489 --------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 14/163 (8%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + H +++ Y C+ ++++ +MA G L+ ++ + F+ + + K+
Sbjct: 73 MMNLSHEKLVQLYGVCT--KQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDV 129
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+A++YL + +HRD+ A N L++ GVVK++DFG+S + D + F P
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---PVR 186
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPM 159
W PEVL ++SK+DIW+FG+ E+ G P Y
Sbjct: 187 WSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMP---YERF 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M DHPN+IR + +V +M GS ++ + F + +L+
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIAS 158
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC--- 117
+ YL G++HRD+ A NIL+++N V K++DFG+ + D + + G
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR---GGKIPIR 215
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK 160
W +PE + + S +D+WS+GI E+ +G P Y M
Sbjct: 216 WTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERP---YWEMS 255
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 60/284 (21%), Positives = 97/284 (34%), Gaps = 59/284 (20%)
Query: 5 DHPNVIR--------AYCSFVVDSNLWVVMPFMAEGSCLH-LMKIA--YQDGFEESAIGS 53
H NV+ A ++++V F H L + F S I
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-----HDLAGLLSNVLVKFTLSEIKR 128
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
+++ L L Y+HR +HRD+KA N+L+ +GV+KLADFG+ A F +
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL-ARAFSLAKNSQPNRY-- 185
Query: 114 GTPC----WM-APEVLQPGSGYNSKADIWSFG-ITALELAHGHAPF-------------- 153
T W PE+L Y D+W G I A E+
Sbjct: 186 -TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA-EMWTRSPIMQGNTEQHQLALISQ 243
Query: 154 -------------SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFK--EMVAMCLVKDQT 198
Y + + + DR K + + +++ LV D
Sbjct: 244 LCGSITPEVWPNVDNYELYE--KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301
Query: 199 KRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQLK 242
+R ++ L H FF + P +K + + A +
Sbjct: 302 QRIDSDDALNHDFFW-SDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ + H N+++ C NL ++M ++ GS ++ +++ + + +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQI 123
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT--P 116
K ++YL + +IHRD+ NIL++ VK+ DFG++ + + + + P
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE---PGESP 180
Query: 117 -CWMAPEVLQPGSGYNSKADIWSFGITALEL 146
W APE L ++ +D+WSFG+ EL
Sbjct: 181 IFWYAPESLTESK-FSVASDVWSFGVVLYEL 210
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 38/181 (20%), Positives = 74/181 (40%), Gaps = 18/181 (9%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ + +++ +L +VM ++ G ++ ++ + S + +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQI 136
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
K ++YL + +HRD+ A NIL+++ VK+ADFG++ + D R P
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR-----EPGQ 191
Query: 118 ----WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQNAPPG 172
W APE L ++ ++D+WSFG+ EL + P L +
Sbjct: 192 SPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKS---CSPSAEFLRMMGCERDV 247
Query: 173 L 173
Sbjct: 248 P 248
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 36/164 (21%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCL-------------HLMKIAYQDG 45
+ + H N+++ C+ + + ++M F+ GS +K A Q
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ-- 134
Query: 46 FEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
I K +DYL + ++HRD+ A N+L+++ VK+ DFG++ + +
Sbjct: 135 -----IC-------KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 182
Query: 106 QRSRNTFVGT--P-CWMAPEVLQPGSGYNSKADIWSFGITALEL 146
++ P W APE L + +D+WSFG+T EL
Sbjct: 183 YTVKD---DRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHEL 222
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+ + H N+++ C NL ++M ++ GS ++ +++ + + +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQI 154
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT--P 116
K ++YL + +IHRD+ NIL++ VK+ DFG++ + + + + P
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE---PGESP 211
Query: 117 -CWMAPEVLQPGSGYNSKADIWSFGITALEL 146
W APE L ++ +D+WSFG+ EL
Sbjct: 212 IFWYAPESLTESK-FSVASDVWSFGVVLYEL 241
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 37/229 (16%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M+ + H N+++ L++V +MA+GS + ++ + + +
Sbjct: 240 MTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC- 117
+A++YL +HRD+ A N+L+ + V K++DFG+ ++
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL------------TKEASSTQDTG 346
Query: 118 -----WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQN--- 168
W APE L+ +++K+D+WSFGI E+ G P+ + P V+ +
Sbjct: 347 KLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 405
Query: 169 -APPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH--SFFKH 214
AP G + +++ C D RPT +L + H
Sbjct: 406 DAPDGC--------PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 15/165 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M +D+P ++R V + L +VM G + ++ S + +L +
Sbjct: 390 MHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVS 446
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTFVGTPC 117
+ YL + +HR++ A N+LL K++DFG+S + RS + P
Sbjct: 447 MGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW---PL 503
Query: 118 -WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK 160
W APE + ++S++D+WS+G+T E +G P Y MK
Sbjct: 504 KWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKP---YKKMK 544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 65/275 (23%), Positives = 108/275 (39%), Gaps = 55/275 (20%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN------LWVVMPFMAEGSCLH-LMKIAYQDG--FEESAI 51
M +DH N++R F L +V+ ++ E ++ + + + +
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYV 158
Query: 52 GSILKETLKALDYLHRQGHIHRDVKAGNILLDTN-GVVKLADFGVSACMFDTGDRQRSRN 110
+ + ++L Y+H G HRD+K N+LLD + V+KL DFG SA G+ S
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVS-- 215
Query: 111 TFVGTPCWMAPEVLQPGSGYNSKADIWSFG-ITALELAHGHAPFSKYPP----------- 158
++ + + APE++ + Y S D+WS G + A EL G F P
Sbjct: 216 -YICSRYYRAPELIFGATDYTSSIDVWSAGCVLA-ELLLGQPIF----PGDSGVDQLVEI 269
Query: 159 MKVL---------LMTIQNAPPGLDYDRDKKFSKSFK--------EMVAMCLVKDQTKRP 201
+KVL M + ++K F+ + + L T R
Sbjct: 270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329
Query: 202 TAEKLLKHSFFK--HAKPPELSVKKLFADLPPLWN 234
T + HSFF +L + D P L+N
Sbjct: 330 TPLEACAHSFFDELRDPNVKLPNGR---DTPALFN 361
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 47/230 (20%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
M + +V+R S V+M M G ++ +
Sbjct: 82 MKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 59 L--------KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD-RQRSR 109
+ + YL+ +HRD+ A N ++ + VK+ DFG++ +++T R+ +
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 110 NTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ 167
P WM+PE L+ G + + +D+WSFG+ E+A P+ +VL ++
Sbjct: 200 GLL---PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 168 --------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
N P L + E++ MC + RP+ +++
Sbjct: 256 GGLLDKPDNCPDML-F-----------ELMRMCWQYNPKMRPSFLEIISS 293
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 71/276 (25%), Positives = 115/276 (41%), Gaps = 57/276 (20%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN------LWVVMPFMAEGSCLH-LMK--IAYQDGFEESAI 51
M ++ HPNV+ F + + L +V+ ++ E ++ + + I
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE--TVYRASRHYAKLKQTMPMLLI 143
Query: 52 GSILKETLKALDYLHRQGHIHRDVKAGNILLDTN-GVVKLADFGVSACMFDTGDRQRSRN 110
+ + L++L Y+H G HRD+K N+LLD GV+KL DFG SA + G+ N
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SAKILIAGE----PN 198
Query: 111 T-FVGTPCWMAPEVLQPGSGYNSKADIWSFG-ITALELAHGHAPFSKYPP---------- 158
++ + + APE++ + Y + DIWS G + A EL G F P
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA-ELMQGQPLF----PGESGIDQLVE 253
Query: 159 -MKVL---------LMTIQNAPPGLDYDRDKKFSKSFK--------EMVAMCLVKDQTKR 200
+KVL M R FSK F+ ++++ L + R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 201 PTAEKLLKHSFFK--HAKPPELSVKKLFADLPPLWN 234
TA + L H FF + + +LPPL+N
Sbjct: 314 LTAIEALCHPFFDELRTGEARMPNGR---ELPPLFN 346
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 51/249 (20%), Positives = 86/249 (34%), Gaps = 44/249 (17%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK-IAYQDGFEESAIGSILKETLKAL 62
+ H N+I + L ++ + L K + I S L + + +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 63 DYLHRQGHIHRDVKAGNILLDTN-----GVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
++ H + +HRD+K N+LL + V+K+ DFG+ A F G R + T
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL-ARAF--GIPIRQFTHEIITLW 202
Query: 118 WMAPEVLQPGSGYNSKADIWSFG-ITALELAHGHAPF----------------------- 153
+ PE+L Y++ DIWS I A E+ F
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWA-EMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 154 ----SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ P K + L +++ L D KR +A+ L+H
Sbjct: 262 WPGVTALPDWKQSFP--KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 210 SFFKHAKPP 218
+F H
Sbjct: 320 PYFSHNDFD 328
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 40/170 (23%), Positives = 65/170 (38%), Gaps = 22/170 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MS + H +++ Y V +V F+ GS +K ++ + K+
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAA 124
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT--------NGVVKLADFGVSACMFDTGD-RQRSRNT 111
A+ +L IH +V A NILL +KL+D G+S + ++R
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-- 182
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMK 160
W+ PE ++ N D WSFG T E+ G P +
Sbjct: 183 ------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALD 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 63/293 (21%), Positives = 101/293 (34%), Gaps = 68/293 (23%)
Query: 5 DHPNVIRAYCSFVVDSNLWV----VMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++++ F V V + E + L L+K G + I K+ L
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 61 ALDYLHRQGH-IHRDVKAGNILLD------TNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
LDY+HR+ IH D+K N+L++ +K+AD G +AC +D +
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYD-----EHYTNSI 196
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS------------------- 154
T + +PEVL G+ + ADIWS EL G F
Sbjct: 197 QTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 155 --KYPPMKVLLMTIQNA-----------------PPGLD-----YDRDKKFSKSFKEMVA 190
P +L P D Y K +K + ++
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 191 MCLVKDQTKRPTAEKLLKHSFFK------HAKPPELSVKKLFADLPPLWNRVK 237
L D KR A L+ H + K + P+ + +D+P + V+
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVR 368
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 50/248 (20%), Positives = 83/248 (33%), Gaps = 47/248 (18%)
Query: 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKI---AYQDGFEESAIGSILKETL 59
L PN+I + + F H+ + I + E L
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFE------HVNNTDFKQLYQTLTDYDIRFYMYEIL 140
Query: 60 KALDYLHRQGHIHRDVKAGNILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
KALDY H G +HRDVK N+++D + ++L D+G++ + + N V + +
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYF 196
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLDY 175
PE+L Y+ D+WS G + PF V + + DY
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 176 ------DRDKKFSKSFKEMVAM------------------------CLVKDQTKRPTAEK 205
+ D +F+ L D R TA +
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 206 LLKHSFFK 213
++H +F
Sbjct: 317 AMEHPYFY 324
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 69/324 (21%), Positives = 110/324 (33%), Gaps = 63/324 (19%)
Query: 4 IDHPNVIRAYCSFV--VDSNLWVVMPFMAEGSCLHLMKIAYQDG-------FEESAIGSI 54
+ HPNVI F+ D +W++ + E H++K + S+
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRN 110
L + L + YLH +HRD+K NIL+ G VK+AD G A +F++ + +
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSPLKPLADL 192
Query: 111 TFVGTPCWM-APEVLQPGSGYNSKADIWSFG-ITALELAHGHAPF--------------- 153
V W APE+L Y DIW+ G I A EL F
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA-ELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 154 ---------------------SKYPPMKVLLMTIQNAP---PGLDYDRDKKFSKSFKEMV 189
K P L+ + L +K K +
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311
Query: 190 AM---CLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKALQLKDAAQ 246
+ L D KR T+E+ ++ +F P V FA + + + L ++
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDV---FAGCQIPYPKREFLTEEEPDD 368
Query: 247 LALKKMPSAEQEAISQSEYQRGVS 270
KK +Q + +
Sbjct: 369 KGDKKNQQQQQGNNHTNGTGHPGN 392
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 24/179 (13%)
Query: 1 MSLID-HPNVIRAY-CSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILKE 57
+ I H NV+ L V++ F G+ L + + A + K+
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 58 TLKALD-------------YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD 104
L +L + IHRD+ A NILL VVK+ DFG++ ++ D
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 105 RQRSRNTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKV 161
R + + P WMAPE + Y ++D+WSFG+ E+ G +P YP +K+
Sbjct: 204 YVRKGDARL--PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP---YPGVKI 256
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 52/250 (20%), Positives = 95/250 (38%), Gaps = 48/250 (19%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
++ HPN++ FV L++V M + L + + I +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFM 140
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF--- 112
L L LH G +HRD+ GNILL N + + DF ++ R+ + +
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA--------REDTADANKTH 192
Query: 113 -VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY------------P 157
V + APE++ G+ D+WS G E+ + A F S +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 158 PMKVLLMTIQNAPPGLDYDRD---KKFSKSFKEMVAM-----------CLVKDQTKRPTA 203
P ++ + P DY R+ ++++ +V L + +R +
Sbjct: 253 PKIEDVVMFSS-PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311
Query: 204 EKLLKHSFFK 213
E+ L+H +F+
Sbjct: 312 EQALRHPYFE 321
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 50/229 (21%), Positives = 85/229 (37%), Gaps = 37/229 (16%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIG-----S 53
+S +H N++R +++M MA G ++ + S++
Sbjct: 87 ISKFNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNG---VVKLADFGVSACMFDTGDRQRSRN 110
+ ++ YL IHRD+ A N LL G V K+ DFG++ ++ ++
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 111 TFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ- 167
+ P WM PE G + SK D WSFG+ E+ G+ P+ +VL
Sbjct: 205 AML--PVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
Query: 168 -------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
N P + Y ++ C RP +L+
Sbjct: 262 GRMDPPKNCPGPV-Y-----------RIMTQCWQHQPEDRPNFAIILER 298
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 37/229 (16%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIG-----S 53
+S +H N++R ++++ MA G ++ + S++
Sbjct: 128 ISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNG---VVKLADFGVSACMFDTGDRQRSRN 110
+ ++ YL IHRD+ A N LL G V K+ DFG++ ++ G ++
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 111 TFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQ- 167
+ P WM PE G + SK D WSFG+ E+ G+ P+ +VL
Sbjct: 246 AML--PVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302
Query: 168 -------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
N P + Y ++ C RP +L+
Sbjct: 303 GRMDPPKNCPGPV-Y-----------RIMTQCWQHQPEDRPNFAIILER 339
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 57/250 (22%), Positives = 96/250 (38%), Gaps = 52/250 (20%)
Query: 1 MSLIDHPNVI------RAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
+ + H NVI S +++++V M G+ L+ I + + +
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLN--NIVKCQKLTDDHVQFL 137
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF-- 112
+ + L+ L Y+H IHRD+K N+ ++ + +K+ DFG++ R
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----------RHTADEMT 187
Query: 113 --VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY------------ 156
V T + APE++ YN DIWS G EL G F + +
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 157 PPMKVLLMTIQNAPPGLDYDRD--KKFSKSFKEMVAM-----------CLVKDQTKRPTA 203
P LL I + +Y + + +F + LV D KR TA
Sbjct: 248 TPGAELLKKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 306
Query: 204 EKLLKHSFFK 213
+ L H++F
Sbjct: 307 AQALAHAYFA 316
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 46/236 (19%), Positives = 90/236 (38%), Gaps = 46/236 (19%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
++++ H +++R + C+ L +V +M G ++ D + +
Sbjct: 97 LTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 59 LKALD-------------YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD- 104
L YL +HRD+ N L+ VVK+ DFG+S ++ T D
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-DY 213
Query: 105 -RQRSRNTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKV 161
R R P WM PE + + +++D+WSFG+ E+ +G P+ + +
Sbjct: 214 YRVGGRTML---PIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269
Query: 162 LLMTIQ--------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ Q PP + Y ++ C ++ +R + + +
Sbjct: 270 IDCITQGRELERPRACPPEV-Y-----------AIMRGCWQREPQQRHSIKDVHAR 313
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 54/259 (20%), Positives = 96/259 (37%), Gaps = 58/259 (22%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-------LWVVMPFMAEGSCLH-LMKIAYQDG--FEESA 50
++++ HPN+++ F L VVM ++ + LH + Y+
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD--TLHRCCRNYYRRQVAPPPIL 130
Query: 51 IGSILKETLKALDYLHRQGH--IHRDVKAGNILLD-TNGVVKLADFGVSACMFDTGDRQR 107
I L + ++++ LH HRD+K N+L++ +G +KL DFG SA +
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPSEP-- 187
Query: 108 SRNT-FVGTPCWMAPEVLQPGSGYNSKADIWSFG-ITALELAHGHAPFSKYPP------- 158
N ++ + + APE++ Y + DIWS G I A E+ G F
Sbjct: 188 --NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA-EMMLGEPIF----RGDNSAGQ 240
Query: 159 ----MKVL---------LMTIQNAPPGLDYDRDKKFSKSFKEMVAM-----------CLV 194
++VL + + L + +S F + L
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 195 KDQTKRPTAEKLLKHSFFK 213
+R + L H +F
Sbjct: 301 YLPEERMKPYEALCHPYFD 319
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 52/250 (20%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN------LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
+ + H NVI F D ++VMPFM G+ L K+ + E I +
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLG--KLMKHEKLGEDRIQFL 133
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF-- 112
+ + LK L Y+H G IHRD+K GN+ ++ + +K+ DFG++ R ++
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----------RQADSEMT 183
Query: 113 --VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY------------ 156
V T + APEV+ Y DIWS G E+ G F S +
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243
Query: 157 PPMKVLLMTIQNAPPGLDY-----DRDKK-FSKSFKEM-------VAMCLVKDQTKRPTA 203
P + +Q+ +Y + +KK F+ + LV D +R TA
Sbjct: 244 TPPAEFVQRLQS-DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 302
Query: 204 EKLLKHSFFK 213
+ L H +F+
Sbjct: 303 GEALAHPYFE 312
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 65/250 (26%), Positives = 99/250 (39%), Gaps = 53/250 (21%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN------LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
+ + H NVI F S+ ++VMPFM + L KI F E I +
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQ--KIMGLK-FSEEKIQYL 131
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT--- 111
+ + LK L Y+H G +HRD+K GN+ ++ + +K+ DFG++ R +
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----------RHADAEMT 181
Query: 112 -FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY------------ 156
+V T + APEV+ YN DIWS G E+ G F Y
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241
Query: 157 PPMKVLLMTIQNAPPGLDYDRD--KKFSKSFKEMVAM-----------CLVKDQTKRPTA 203
P + + + Y + + K F ++ L D KR TA
Sbjct: 242 VPGTEFVQKLND-KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 300
Query: 204 EKLLKHSFFK 213
+ L H FF+
Sbjct: 301 AQALTHPFFE 310
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 41/183 (22%), Positives = 76/183 (41%), Gaps = 29/183 (15%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILK 56
+ + HPNV+ + D L ++ + + G LH L+ + + +K
Sbjct: 66 RARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGD-LHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 57 ETLKALD-------------YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTG 103
L+ D YL +H+D+ N+L+ VK++D G+ ++
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA- 181
Query: 104 D--RQRSRNTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPM 159
D + + P WMAPE + G ++ +DIWS+G+ E+ +G P+ Y
Sbjct: 182 DYYKLLGNSLL---PIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237
Query: 160 KVL 162
V+
Sbjct: 238 DVV 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 43/183 (23%), Positives = 74/183 (40%), Gaps = 29/183 (15%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILK 56
++ + H ++++ Y C L +V +M G L+ L K
Sbjct: 71 LTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGD-LNKFLRAHGPDAMILVDGQPRQAK 127
Query: 57 ETLKALD-------------YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTG 103
L YL Q +HRD+ N L+ N +VK+ DFG+S ++ T
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST- 186
Query: 104 D--RQRSRNTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPM 159
D R P WM PE + + +++D+WSFG+ E+ +G P+ +
Sbjct: 187 DYYRVGGHTML---PIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242
Query: 160 KVL 162
+V+
Sbjct: 243 EVI 245
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 62/254 (24%), Positives = 101/254 (39%), Gaps = 47/254 (18%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
+ H N+I + DS ++++ M + LH ++ + I +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLH--RVISTQMLSDDHIQYFI 118
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT---- 111
+TL+A+ LH IHRD+K N+L+++N +K+ DFG+ A + D S T
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL-ARIIDESAADNSEPTGQQS 177
Query: 112 ----FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY--------- 156
FV T + APEV+ + Y+ D+WS G EL F Y
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 157 ----PPMKVLLMTIQNAPPGLDY-----DRDKK-FSKSFKEM-------VAMCLVKDQTK 199
P L I++ P +Y K F + + LV D K
Sbjct: 238 IIGTPHSDNDLRCIES-PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 200 RPTAEKLLKHSFFK 213
R TA++ L+H + +
Sbjct: 297 RITAKEALEHPYLQ 310
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 54/245 (22%), Positives = 92/245 (37%), Gaps = 37/245 (15%)
Query: 1 MSLIDHPNVIRAY-----CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
+ H N+I + ++++V M + L+ K+ I L
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLY--KLLKTQHLSNDHICYFL 134
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
+ L+ L Y+H +HRD+K N+LL+T +K+ DFG++ D +V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY------------PPMKV 161
+ APE++ GY DIWS G E+ F Y P +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254
Query: 162 LLMTIQNAPPGLDY-----DRDKK-FSKSFKEM-------VAMCLVKDQTKRPTAEKLLK 208
L I N +Y ++K +++ F + L + KR E+ L
Sbjct: 255 DLNCIIN-LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 209 HSFFK 213
H + +
Sbjct: 314 HPYLE 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 54/234 (23%)
Query: 2 SLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCL--HL---------------MKIAY 42
S HP+++ +C + + ++ +M G+ L HL ++I
Sbjct: 90 SFCRHPHLVSLIGFC--DERNEMILIYKYMENGN-LKRHLYGSDLPTMSMSWEQRLEIC- 145
Query: 43 QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDT 102
IG+ + L YLH + IHRDVK+ NILLD N V K+ DFG+S +
Sbjct: 146 --------IGAA-----RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 103 GDRQRSRNTFV-GTPCWMAPEVLQPGSGY-NSKADIWSFGITALELAHGHAPFSKYPPM- 159
S T V GT ++ PE G K+D++SFG+ E+ + + P
Sbjct: 193 DQTHLS--TVVKGTLGYIDPEYFI--KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 160 --------KVLL---MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT 202
Q P L + + F + CL RP+
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 53/174 (30%), Positives = 76/174 (43%), Gaps = 42/174 (24%)
Query: 2 SLIDHPNVIR--AYCSFVVDSNLWVVMPFMAEGS---CLHL-------------MKIAYQ 43
S+ H N++R +C + + +V P+MA GS CL +IA
Sbjct: 82 SMAVHRNLLRLRGFC--MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-- 137
Query: 44 DGFEESAIGSILKETLKALDYLHRQGH---IHRDVKAGNILLDTNGVVKLADFGVSACMF 100
+G + + L YLH IHRDVKA NILLD + DFG+ A +
Sbjct: 138 -------LG-----SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL-AKLM 184
Query: 101 DTGDRQRSRNTFVGTPCWMAPEVLQPGSGY-NSKADIWSFGITALELAHGHAPF 153
D D + GT +APE L +G + K D++ +G+ LEL G F
Sbjct: 185 DYKDTHVT-TAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 45/182 (24%), Positives = 75/182 (41%), Gaps = 29/182 (15%)
Query: 1 MSLI-DHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMK-----IAYQDGFEESAIG 52
+S + +H N++ C+ + V+ + G L+ ++
Sbjct: 80 LSYLGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 53 SILKETLKAL-----------DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFD 101
L L+ L +L + IHRD+ A NILL + K+ DFG++ + +
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 102 TGDRQRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPM 159
+ N + P WMAPE + Y ++D+WS+GI EL G +P YP M
Sbjct: 198 DSNYVVKGNARL--PVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP---YPGM 251
Query: 160 KV 161
V
Sbjct: 252 PV 253
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 2 SLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKE-- 57
+ H N+I C+ D L+V++ + ++G+ ++ G E S + + E
Sbjct: 96 MIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 58 -TLKAL-----------DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
T K L +YL Q IHRD+ A N+L+ N V+K+ADFG++ + +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 106 QRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLL 163
+++ N + P WMAPE L Y ++D+WSFG+ E+ G +P+ P ++
Sbjct: 214 KKTTNGRL--PVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 164 MTIQ--------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ + N L Y M+ C ++RPT ++L++
Sbjct: 271 LLKEGHRMDKPANCTNEL-YM-----------MMRDCWHAVPSQRPTFKQLVED 312
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 44/185 (23%), Positives = 74/185 (40%), Gaps = 34/185 (18%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLH-----------LMKIAYQDGFE 47
+ ++HP+VI+ Y CS D L +++ + GS +
Sbjct: 80 LKQVNHPHVIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 48 ESAIGSILKETLKAL-----------DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS 96
T+ L YL +HRD+ A NIL+ +K++DFG+S
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 97 ACMFDTGDRQRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFS 154
+++ + + P WMA E L Y +++D+WSFG+ E+ G P
Sbjct: 198 RDVYEEDSYVKRSQGRI--PVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP-- 252
Query: 155 KYPPM 159
YP +
Sbjct: 253 -YPGI 256
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 50/180 (27%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 3 LIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILKETL 59
L HPN+I C L++ + + G+ L L K + AI + TL
Sbjct: 82 LGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 60 KALD-------------YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ 106
+ YL ++ IHRD+ A NIL+ N V K+ADFG+S
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---------- 189
Query: 107 RSRNTFVGTPC------WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPM 159
R + +V WMA E L Y + +D+WS+G+ E+ G P Y M
Sbjct: 190 RGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTP---YCGM 245
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 31/204 (15%), Positives = 47/204 (23%), Gaps = 39/204 (19%)
Query: 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALD 63
ID P V R + VV ++ G L + ++ A D
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWI-RGGSLQEV---ADTSPSPVGAIRAMQSLAAAAD 143
Query: 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
HR G + + +G V LA M
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-----------------------MPDA- 179
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPF---SKYPPMKVLLMTIQNAPPGLDYDRDKK 180
N + DI G + L P + P D D+
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA-DIDRD 231
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAE 204
+ A + D R +
Sbjct: 232 IPFQISAVAARSVQGDGGIRSAST 255
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 43/191 (22%), Positives = 84/191 (43%), Gaps = 37/191 (19%)
Query: 1 MSLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLH----------LMKIAYQDGFEE 48
M+ D+PN+++ C+ V + ++ +MA G L+ + +++ D
Sbjct: 104 MAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGD-LNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 49 SAIGSILKETLKALD-------------YLHRQGHIHRDVKAGNILLDTNGVVKLADFGV 95
+ + S L + YL + +HRD+ N L+ N VVK+ADFG+
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 96 SACMFDTGD--RQRSRNTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHA 151
S ++ D + + P WM PE + Y +++D+W++G+ E+ +G
Sbjct: 221 SRNIYSA-DYYKADGNDAI---PIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQ 275
Query: 152 PFSKYPPMKVL 162
P+ +V+
Sbjct: 276 PYYGMAHEEVI 286
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 54/260 (20%), Positives = 103/260 (39%), Gaps = 61/260 (23%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN------LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
M ++H N+I F + +++VM M + L ++ + + + +
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLC--QVIQME-LDHERMSYL 132
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF-- 112
L + L + +LH G IHRD+K NI++ ++ +K+ DFG++ R +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGTSFMMT 184
Query: 113 --VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY------------ 156
V T + APEV+ G GY DIWS G E+ G F + +
Sbjct: 185 PYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243
Query: 157 PPMKVLLMTIQ-----------------------NAPPGLDYDRDKKFSKSFKEMVAMCL 193
P + +Q + D + +K + +++++ L
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303
Query: 194 VKDQTKRPTAEKLLKHSFFK 213
V D +KR + ++ L+H +
Sbjct: 304 VIDASKRISVDEALQHPYIN 323
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 44/236 (18%)
Query: 1 MSLI-DHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILK 56
M +I H N+I C+ D L+V++ + ++G+ L I + +
Sbjct: 140 MKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 57 ETLKALD-------------YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTG 103
E + D YL Q IHRD+ A N+L+ N V+K+ADFG++ + +
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 104 DRQRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKV 161
+++ N + P WMAPE L Y ++D+WSFG+ E+ G +P+ P ++
Sbjct: 258 YYKKTTNGRL--PVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314
Query: 162 LLMTIQ--------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ + N L Y M+ C ++RPT ++L++
Sbjct: 315 FKLLKEGHRMDKPANCTNEL-YM-----------MMRDCWHAVPSQRPTFKQLVED 358
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 46/254 (18%), Positives = 95/254 (37%), Gaps = 46/254 (18%)
Query: 1 MSLIDHPNVIRAY--------------CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGF 46
+ +DH N+++ + S +++++V +M + L + Q
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLA--NVLEQGPL 117
Query: 47 EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT-NGVVKLADFGVSACMFDTGDR 105
E + + L+ L Y+H +HRD+K N+ ++T + V+K+ DFG++ M
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 106 QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFG-ITALELAHGHAPF--SKY------ 156
+ + + T + +P +L + Y D+W+ G I A E+ G F +
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA-EMLTGKTLFAGAHELEQMQL 236
Query: 157 ------PPMKVLLMTIQNAPP----GLDYDRDKKFSKSFKEM-------VAMCLVKDQTK 199
+ + + P + K ++ + + L
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 200 RPTAEKLLKHSFFK 213
R TAE+ L H +
Sbjct: 297 RLTAEEALSHPYMS 310
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 58/248 (23%), Positives = 105/248 (42%), Gaps = 45/248 (18%)
Query: 2 SLIDHPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKE-- 57
+ H N+I C+ D L+V++ + ++G+ ++ G E S S E
Sbjct: 130 MIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 58 -TLKAL-----------DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
+ K L +YL + IHRD+ A N+L+ + V+K+ADFG++ +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 106 QRSRNTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLL 163
+++ N + P WMAPE L Y ++D+WSFG+ E+ G +P+ P ++
Sbjct: 248 KKTTNGRL--PVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304
Query: 164 MTIQ--------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH--SFFK 213
+ + N L Y M+ C ++RPT ++L++
Sbjct: 305 LLKEGHRMDKPSNCTNEL-Y-----------MMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352
Query: 214 HAKPPELS 221
E+
Sbjct: 353 LTSNQEMG 360
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 34/187 (18%)
Query: 1 MSLI-DHPNVIR--AYCSFVVDSNLWVVMPFMAEGSCLH----------LMKIAYQDGFE 47
M+ + H N++ C+ + ++++ + G L+ +I Y++
Sbjct: 102 MTQLGSHENIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 48 ESAIGSILKETLKAL-----------DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVS 96
+ T + L ++L + +HRD+ A N+L+ VVK+ DFG++
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 97 ACMFDTGDRQRSRNTFVGTP-CWMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFS 154
+ + N + P WMAPE L G Y K+D+WS+GI E+ G P
Sbjct: 220 RDIMSDSNYVVRGNARL--PVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP-- 274
Query: 155 KYPPMKV 161
YP + V
Sbjct: 275 -YPGIPV 280
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 25/178 (14%)
Query: 1 MSLID-HPNVIRAY--CSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILK 56
MS + H N++ C+ + V+ + G L+ L + + + + +
Sbjct: 103 MSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 57 ETLKAL-----------DYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR 105
+ + L +L + IHRDV A N+LL V K+ DFG++ + + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 106 QRSRNTFVGTPC-WMAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKV 161
N + P WMAPE + Y ++D+WS+GI E+ G P YP + V
Sbjct: 221 IVKGNARL--PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP---YPGILV 272
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 50/312 (16%), Positives = 94/312 (30%), Gaps = 88/312 (28%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET-- 58
M ++DH N+I+ F + P + K + +S I + +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 59 -------------------------------------LKALDYLHRQGHIHRDVKAGNIL 81
+A+ ++H G HRD+K N+L
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 82 LDTN-GVVKLADFGVSACMFDTGDRQRSRNT-FVGTPCWMAPEVLQPGSGYNSKADIWSF 139
+++ +KL DFG SA + + ++ + + APE++ + Y D+WS
Sbjct: 174 VNSKDNTLKLCDFG-SAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 140 G-ITALELAHGHAPFSKYPP-----------MKVL---------LMTIQNAPPGLDYDRD 178
G + EL G F ++++ M +
Sbjct: 229 GCVFG-ELILGKPLF----SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283
Query: 179 KKFSKSFKEM--------VAMCLVKDQTKRPTAEKLLKHSFFK--HAKPPELSVKKLF-- 226
K + K E + L + R + + H FF
Sbjct: 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFP 343
Query: 227 ----ADLPPLWN 234
++P L+N
Sbjct: 344 HGVNQNIPQLFN 355
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 8e-18
Identities = 55/260 (21%), Positives = 95/260 (36%), Gaps = 61/260 (23%)
Query: 1 MSLIDHPNVI------RAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
M ++H N+I + ++++VM M + L ++ + + + +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLC--QVIQME-LDHERMSYL 169
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF-- 112
L + L + +LH G IHRD+K NI++ ++ +K+ DFG++ R +
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------RTAGTSFMMT 221
Query: 113 --VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF--SKY------------ 156
V T + APEV+ G GY DIWS G E+ F Y
Sbjct: 222 PYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280
Query: 157 -PPMKVL-------LMTIQNAPPGLDYDRDKKFSKSFKEMVAM---------------CL 193
P + + ++N P K F S + L
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340
Query: 194 VKDQTKRPTAEKLLKHSFFK 213
V D KR + + L+H +
Sbjct: 341 VIDPAKRISVDDALQHPYIN 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 52/271 (19%), Positives = 88/271 (32%), Gaps = 70/271 (25%)
Query: 8 NVIRAYCSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILKETLKALDYL 65
++ F ++ +V + G + + + + F I + + K++++L
Sbjct: 78 RCVQMLEWFEHHGHICIVFELL--GLSTYDFIKENGFL-PFRLDHIRKMAYQICKSVNFL 134
Query: 66 HRQGHIHRDVKAGNILLDTNGV-------------------VKLADFGVSACMFDTGDRQ 106
H H D+K NIL + +K+ DFG SA +D
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SAT-YD----D 188
Query: 107 RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS------------ 154
+T V T + APEV+ G++ D+WS G +E G F
Sbjct: 189 EHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 155 ---KYPPMKVLLMTIQN---APPGLDYDRDKKFSKSFKE--------------------- 187
P ++ T + LD+D +
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 188 MVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
++ L D KR T + LKH FF K
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 59/277 (21%), Positives = 98/277 (35%), Gaps = 66/277 (23%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILKETLKALD 63
+ NVI +F +++ + + L+ L+K GF + L+ LD
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL--SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 64 YLHRQGHIHRDVKAGNILLDTNG--VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAP 121
LH+ IH D+K NILL G +K+ DFG S+C + T++ + + AP
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEH-----QRVYTYIQSRFYRAP 268
Query: 122 EVLQPGSGYNSKADIWSFGITALELAHGHAPF---------------------------- 153
EV+ G+ Y D+WS G EL G+
Sbjct: 269 EVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 154 -------SKYPPMKVLLMTIQNAPPGLDYDRDKKFS-------------------KSFKE 187
SK P + T+ + L+ R ++ F +
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 188 MVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKK 224
+ CL D R T + L+H + + P + +K
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEK 424
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 53/272 (19%), Positives = 84/272 (30%), Gaps = 70/272 (25%)
Query: 8 NVIRAYCSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILKETLKALDYL 65
+ F ++ + + G L + +Q + + + + AL +L
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELL--GKNTFEFLKENNFQ-PYPLPHVRHMAYQLCHALRFL 139
Query: 66 HRQGHIHRDVKAGNILLDTNGV-------------------VKLADFGVSACMFDTGDRQ 106
H H D+K NIL + +++ADFG SA FD
Sbjct: 140 HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SAT-FD----H 193
Query: 107 RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS------------ 154
T V T + PEV+ G+ D+WS G E G F
Sbjct: 194 EHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252
Query: 155 ---KYPPMKVLLMTIQN---APPGLDYDRDKKFSKSFKE--------------------- 187
P ++ T + GL +D + + KE
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312
Query: 188 MVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
++ L D +R T + L H FF P E
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 56/274 (20%), Positives = 92/274 (33%), Gaps = 68/274 (24%)
Query: 3 LIDHPNVIRAYCSFVVDSN--LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
L H N++ D++ +++V +M + LH + + E ++ + +K
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLH--AVIRANILEPVHKQYVVYQLIK 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM- 119
+ YLH G +HRD+K NILL+ VK+ADFG+S + + +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 120 -----------------APEVLQPGSGYNSKADIWSFG-ITALELAHGHAPF--SKY--- 156
APE+L + Y D+WS G I E+ G F S
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSSTMNQ 239
Query: 157 ---------PPMKVLLMTIQN---------------APPGLDYDRDKKFSKSFKEMVAM- 191
P + +IQ+ D K+ ++
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 192 ------------CLVKDQTKRPTAEKLLKHSFFK 213
L + KR +A LKH F
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 54/273 (19%), Positives = 87/273 (31%), Gaps = 73/273 (26%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH-LMKIAYQDGFEESAIGSILKETLKALD 63
++ F+ ++L +V + L+ L++ G + ++ AL
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML--SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 64 YLHRQ--GHIHRDVKAGNILL--DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+L IH D+K NILL +K+ DFG S+C + ++ + +
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLG-----QRIYQYIQSRFYR 225
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFS---------------KYPPMKVL-- 162
+PEVL G Y+ D+WS G +E+ G FS PP +L
Sbjct: 226 SPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284
Query: 163 ---------------------------------------LMTIQNAPPGLDY---DRDKK 180
L P G
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
FK+++ L D R L+HSFFK
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 61/283 (21%), Positives = 88/283 (31%), Gaps = 103/283 (36%)
Query: 25 VMPFMAEGSCLHLMKIAYQD-GFEESAIGSILKETLKALDYLHRQGH-IHRDVKAGNILL 82
V + G L I G + I+++ L+ LDYLH + IH D+K NILL
Sbjct: 123 VFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180
Query: 83 -------------------------------------------------DTNGVVKLADF 93
VK+AD
Sbjct: 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240
Query: 94 GVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153
G +AC + + T + + EVL GSGYN+ ADIWS A ELA G F
Sbjct: 241 G-NACWVH-----KHFTEDIQTRQYRSLEVLI-GSGYNTPADIWSTACMAFELATGDYLF 293
Query: 154 SKY---------------------PPMKVL---------------LMTIQNAPPGL---- 173
+ P K++ L I P
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 174 ---DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
Y+ ++ + F + + L KR TA + L+H +
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/277 (22%), Positives = 97/277 (35%), Gaps = 78/277 (28%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLH--LMKIAYQDGFEESAIGSILKETLKAL 62
++ N+++ + F+ ++ ++ + G L+ + + Y GF I E LKAL
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL--GPSLYEIITRNNYN-GFHIEDIKLYCIEILKAL 150
Query: 63 DYLHRQGHIHRDVKAGNILLDTNGV-------------------------VKLADFGVSA 97
+YL + H D+K NILLD +KL DFG A
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CA 209
Query: 98 CMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF---- 153
F + + T + APEV+ G++ +D+WSFG EL G F
Sbjct: 210 T-FK----SDYHGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263
Query: 154 ----------------------------SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKS- 184
SKY L + ++ + K
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323
Query: 185 --------FKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
F + + L D T RP+ +LLKH F +
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 8/104 (7%)
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP-CW 118
K +++L + IHRD+ A NILL VVK+ DFG++ ++ D R + + P W
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKW 261
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKV 161
MAPE + Y ++D+WSFG+ E+ G +P YP +K+
Sbjct: 262 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP---YPGVKI 301
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 38/164 (23%), Positives = 61/164 (37%), Gaps = 27/164 (16%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
++ + +IR Y + D L++V+ S L + E I +IL
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKL-FKTPIFLTEEHIKTIL 135
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
L +++H G IHRD+K N LL+ + VK+ DFG++ + D +
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 116 PCWM-------------------APEVLQPGSGYNSKADIWSFG 140
APE++ Y DIWS G
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 32/169 (18%), Positives = 59/169 (34%), Gaps = 32/169 (18%)
Query: 1 MSLIDHPNVIRAY-----CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
++ ++H +V++ L+VV+ S + E I ++L
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKL-FRTPVYLTELHIKTLL 162
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
L + Y+H G +HRD+K N L++ + VK+ DFG++ + +
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 116 PCWM------------------------APEVLQPGSGYNSKADIWSFG 140
APE++ Y D+WS G
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 6e-09
Identities = 41/214 (19%), Positives = 67/214 (31%), Gaps = 30/214 (14%)
Query: 19 DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHI-HRDVKA 77
D L++V+ F G L M+ SIL + +L HRD+
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLAT---AKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 78 GNILLDTNGVVKLAD-----------FGVSACMFDTGDRQRSRNTFVGTPCWM---APEV 123
GN+LL + KL G+ + D SR G + E
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT---LSRLERDGIVVFCDVSMDED 247
Query: 124 LQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVL---LMTIQNAPPGLDYDRDK 179
L G + + DI+ + P+S + L ++ + K
Sbjct: 248 LFTGD-GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMK 306
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+ + +E L + L +HS FK
Sbjct: 307 QIKRKIQEFHRTML----NFSSATDLLCQHSLFK 336
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 60/430 (13%), Positives = 113/430 (26%), Gaps = 120/430 (27%)
Query: 219 ELSVKKLFADLPPLWNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIED 278
+ K + + V KD + + +S+ E I
Sbjct: 15 QYQYKDILSVFED--AFVDNFDCKD--------VQDMPKSILSKEEID--------HIIM 56
Query: 279 LKAQASLVRDDDDMLETKEENESVKSSVGFKAGTGFQFSLGKSNSIAELSQAESRGPTNQ 338
K S L +K+E V+ V ++F + + E R P+
Sbjct: 57 SKDAVSGTLRLFWTLLSKQEE-MVQKFVEEVLRINYKF-------LMSPIKTEQRQPSMM 108
Query: 339 LQLYES----LNKKGKALEGDSLDRNQENIALRKN------------------GSSTEEM 376
++Y L + ++ R Q + LR+ G + +
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW--V 166
Query: 377 ASTSEKDTMQTKAKA-----VKSRHTQSGPLMPGMLLSHSSSERARNSERCEIESQPP-- 429
A + ++ S + ML + R + S
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 430 TEKSNREVRRAPSFSGPLMLPNRASANSL-------SAPIKSSAGYRDSMD--------- 473
E+RR +L ++ N L +A ++ +
Sbjct: 227 IHSIQAELRR--------LLKSKPYENCLLVLLNVQNAKAW------NAFNLSCKILLTT 272
Query: 474 -DKSKANLVQIKGRFSVT----------SENLDL---VKDIPLSTVPRR-SQGSPLRKS- 517
K + + ++ E L D +PR +P R S
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 518 --ASVGDWIFESKQVPTSPSSKDLNNCSVPASV--LMPH-LQNLFQQTS-FQQDL-IMNL 570
S+ D + K L + +S+ L P + +F + S F I
Sbjct: 333 IAESIRDGLATWDNWKHVNCDK-LTT-IIESSLNVLEPAEYRKMFDRLSVFPPSAHI--- 387
Query: 571 LNSLQPAEVL 580
P +L
Sbjct: 388 -----PTILL 392
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 19/67 (28%), Positives = 32/67 (47%), Gaps = 6/67 (8%)
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTN--GVVKLADFGVSACMFDTGD----RQRSRNTF 112
L AL++LH ++H +V A NI +D V LA +G + +G + SR+
Sbjct: 169 LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPH 228
Query: 113 VGTPCWM 119
G ++
Sbjct: 229 EGDLEFI 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 22/108 (20%), Positives = 43/108 (39%), Gaps = 10/108 (9%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNG-----VVKLADFGVSACMFDTGDRQ-- 106
K+ L + +H + ++RD+K N L+ ++ + DFG+ D +Q
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170
Query: 107 --RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152
R + GT +M+ G + + D+ + G + G P
Sbjct: 171 PYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 61/400 (15%), Positives = 124/400 (31%), Gaps = 60/400 (15%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNG---VVKLADFGVSACMFDTGDRQ---- 106
+ + + ++++H + +HRD+K N L+ V + DFG++ DT Q
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Query: 107 RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI 166
R GT + + G + + D+ S G + G P+ +
Sbjct: 168 RENKNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQG----------L 216
Query: 167 QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH------SFFKHA----- 215
+ Y++ + K T + E L + S+F +
Sbjct: 217 KAGTKKQKYEK-------------ISEKKVAT---SIEALCRGYPTEFASYFHYCRSLRF 260
Query: 216 --KPPELSVKKLFADLPPL----------WNRVKALQLKDAAQLALKKMPSAEQEAISQS 263
KP +K+LF DL W +K Q + A+ A ++
Sbjct: 261 DDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPP 320
Query: 264 EYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKSSVGFKAGTGFQFSLGKSNS 323
Q + + + R + + K+ VG A + + SN
Sbjct: 321 ALQNDRQSGVDEGRTSGWSSMDRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNF 380
Query: 324 IAELSQAESRGPTNQLQLYESLNKKGKALEGDSLDRNQENIALRKNGSSTEEMASTSEKD 383
+ S + R + + ++ + + + A R+ + S +
Sbjct: 381 LGRSSGSSRRPAVSSSRDVMPID---TSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEP 437
Query: 384 TMQTKAKAVKSRHTQSGPLMPGMLLSHSSSERARNSERCE 423
+ A+ + L L+ ER + + E
Sbjct: 438 KHSSSARHSSNVKNYESALKGIEGLNFDGDERVQYAAALE 477
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 21/64 (32%), Positives = 32/64 (50%), Gaps = 6/64 (9%)
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTN--GVVKLADFGVSACMFDTGD----RQRSRNTF 112
L L+Y+H ++H D+KA N+LL V LAD+G+S G+ ++ R
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 113 VGTP 116
GT
Sbjct: 221 NGTI 224
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 7/100 (7%)
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTN--GVVKLADFGVSACMFDTGDRQ----RSRNTF 112
L L+Y+H ++H D+KA N+LL+ V L D+G++ G + +
Sbjct: 162 LDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152
GT + + + G + + D+ G ++ GH P
Sbjct: 222 DGTIEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 25/106 (23%), Positives = 43/106 (40%), Gaps = 8/106 (7%)
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILL---DTNGVVKLADFGVSACMFDTGDRQ---- 106
+ + + ++Y+H + IHRDVK N L+ +V + DFG++ D Q
Sbjct: 110 LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169
Query: 107 RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152
R GT + + G + + D+ S G + G P
Sbjct: 170 RENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 23/103 (22%), Positives = 44/103 (42%), Gaps = 10/103 (9%)
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDTNG-----VVKLADFGVSACMFDTGDRQ----RSR 109
+ ++Y+H + I+RDVK N L+ G V+ + DF ++ D ++ R
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 110 NTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152
+ GT +M+ G + + D+ + G + G P
Sbjct: 175 KSLTGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLP 216
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 583 | |||
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.82 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.6 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.31 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.01 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.56 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.26 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.57 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.44 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.57 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 91.31 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 89.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 88.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 87.98 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 84.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 84.11 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 82.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 81.55 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 80.12 |
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=427.48 Aligned_cols=219 Identities=28% Similarity=0.484 Sum_probs=189.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++.+|||||||+||+|.+++... +.++|..++.|++||+.||+|||++||+||||||+||
T Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 157 (304)
T 3ubd_A 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157 (304)
T ss_dssp CCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHe
Confidence 67899999999999999999999999999999999998764 7799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|++||+|||+|+...... ....+.+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 158 Ll~~~g~vKl~DFGla~~~~~~~---~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 233 (304)
T 3ubd_A 158 LLDEEGHIKLTDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233 (304)
T ss_dssp EECTTSCEEEESSEEEEC--------CCCCSCCCCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEcCCCCEEecccccceeccCCC---ccccccccCcccCCHHHhc-cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH
Confidence 99999999999999997543322 2234679999999999998 6789999999999999999999999999977766
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLP 230 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~ 230 (583)
.+..+... .. ..+..+|+++++||.+||++||.+||| ++|+++||||+.++|..+..+++.+++.
T Consensus 234 ~~~~i~~~-~~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~ 303 (304)
T 3ubd_A 234 TMTMILKA-KL----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFK 303 (304)
T ss_dssp HHHHHHHC-CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSC
T ss_pred HHHHHHcC-CC----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcC
Confidence 65555443 22 234578999999999999999999998 5899999999999987776666655554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=428.44 Aligned_cols=212 Identities=31% Similarity=0.522 Sum_probs=185.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++++|||||||+||+|.++++.. +.++|..++.|++||+.||+|||++||+||||||+||
T Consensus 86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNI 163 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 163 (311)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 57899999999999999999999999999999999999764 7799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|++||+|||+|+.+... .......+++||+.|||||++. +..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 164 Ll~~~g~vKl~DFGla~~~~~~-~~~~~~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 241 (311)
T 4aw0_A 164 LLNEDMHIQITDFGTAKVLSPE-SKQARANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241 (311)
T ss_dssp EECTTSCEEECCCTTCEECCTT-TTCCCBCCCCSCGGGCCHHHHH-HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEcCCCCEEEEEcCCceecCCC-CCcccccCcccCcccCCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999865322 2223345689999999999998 6789999999999999999999999999877655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHH------HHhccccccCCCCchh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK------LLKHSFFKHAKPPELS 221 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~e------IL~HpfFk~~~~~~~~ 221 (583)
.+..+.. ... ..+..+++++++||.+||++||.+|||++| |++||||++++|..+.
T Consensus 242 ~~~~i~~-~~~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 242 IFAKIIK-LEY----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp HHHHHHH-TCC----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHHc-CCC----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 5544444 332 234578999999999999999999999876 6899999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=428.93 Aligned_cols=209 Identities=40% Similarity=0.709 Sum_probs=184.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++.+|||||||+||+|.+++.. +.++|..++.|++||+.||+|||++|||||||||+||
T Consensus 125 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 201 (346)
T 4fih_A 125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 201 (346)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 4578999999999999999999999999999999998864 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||+.+|++||+|||+|+.+.... ....+.+||++|||||++. +..|+.++|||||||++|||++|.+||.+.+..+
T Consensus 202 Ll~~~g~vKl~DFGla~~~~~~~---~~~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 277 (346)
T 4fih_A 202 LLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 277 (346)
T ss_dssp EECTTCCEEECCCTTCEECCSSS---CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EECCCCCEEEecCcCceecCCCC---CcccccccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 99999999999999998653322 2234689999999999997 6789999999999999999999999999988777
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.+..+.....+. ...+..+++++++||.+||++||.+|||++|+|+||||++...+
T Consensus 278 ~~~~i~~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 278 AMKMIRDNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HHHHHHHSSCCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHHcCCCCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 665555544333 33456799999999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=432.02 Aligned_cols=209 Identities=41% Similarity=0.715 Sum_probs=185.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++|++|++++.+|||||||+||+|.+++.. +.++|..++.|++||+.||+|||++|||||||||+||
T Consensus 202 l~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NI 278 (423)
T 4fie_A 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI 278 (423)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTE
T ss_pred HHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence 4678999999999999999999999999999999998864 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||+.+|.+||+|||+|+.+.... ....+.+||++|||||++. +..|+.++|||||||++|||++|.+||.+.+..+
T Consensus 279 Ll~~~g~vKl~DFGla~~~~~~~---~~~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 279 LLTHDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp EECTTCCEEECCCTTCEECCSSC---CCBCCCEECTTTCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EEcCCCCEEEecCccceECCCCC---ccccccccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 99999999999999998653322 2235689999999999998 6789999999999999999999999999988777
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.+..+.....+.+ ..+..+++++++||.+||++||.+|||+.|||+||||+....+
T Consensus 355 ~~~~i~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 355 AMKMIRDNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HHHHHHHSCCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHHHcCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 7665555544333 3456789999999999999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=426.50 Aligned_cols=206 Identities=26% Similarity=0.491 Sum_probs=182.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.|+|||||+++++|++++.+|||||||+||+|.++|.......++|..++.|++||+.||+|||++|||||||||+||
T Consensus 77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 156 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156 (350)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence 45789999999999999999999999999999999999876556689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||+.+|.+||+|||+|+.+... .....+.+||+.|||||++. +..|+.++|||||||++|||++|+.||.+.+..+
T Consensus 157 Ll~~~g~vKl~DFGla~~~~~~---~~~~~~~~GT~~YmAPE~l~-~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 232 (350)
T 4b9d_A 157 FLTKDGTVQLGDFGIARVLNST---VELARACIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232 (350)
T ss_dssp EECTTCCEEECSTTEESCCCHH---HHHHHHHHSCCTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EECCCCCEEEcccccceeecCC---cccccccCCCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 9999999999999999755221 11224578999999999998 6789999999999999999999999999988777
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.+..++....+ +.+..+++++++||.+||++||.+|||++|+|+||||+.
T Consensus 233 ~~~~i~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 233 LVLKIISGSFP----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred HHHHHHcCCCC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 76666665433 234578999999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=406.75 Aligned_cols=203 Identities=27% Similarity=0.501 Sum_probs=175.2
Q ss_pred CCCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccC
Q 007967 1 MSLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG--HIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHRD 74 (583)
|+.|+|||||+++++|++ +..+|||||||+||+|.+++... +.+++..++.|++||+.||+|||++| |||||
T Consensus 79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRD 156 (290)
T 3fpq_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156 (290)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCC
T ss_pred HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecc
Confidence 467899999999999986 35699999999999999999764 67999999999999999999999999 99999
Q ss_pred CCCCcEEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 75 VKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 75 LKPeNILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
|||+||||+. +|.+||+|||+|+.... ....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||
T Consensus 157 lKp~NILl~~~~g~vKl~DFGla~~~~~-----~~~~~~~GTp~YmAPE~~~--~~y~~~~DiwSlGvilyelltg~~Pf 229 (290)
T 3fpq_A 157 LKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CCGGGEEESSTTSCEEECCTTGGGGCCT-----TSBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cChhheeEECCCCCEEEEeCcCCEeCCC-----CccCCcccCccccCHHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999984 79999999999964311 1234679999999999987 36999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.+......+...+..... +...+..+++++++||.+||.+||.+|||+.++|+||||++
T Consensus 230 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 230 SECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp TTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCcHHHHHHHHHcCCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 887766666666665432 22334567899999999999999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=404.77 Aligned_cols=202 Identities=25% Similarity=0.431 Sum_probs=167.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++.+||||||| +|+|.+++.. .+.+++..++.+++||+.||+|||++||+||||||+||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NI 143 (275)
T 3hyh_A 67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL 143 (275)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHe
Confidence 45689999999999999999999999999 7899998875 47799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|++||+|||+|+..... ....+.+||+.|||||++.+...++.++||||+||++|+|++|+.||.+.+...
T Consensus 144 Ll~~~~~vkl~DFGla~~~~~~----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~ 219 (275)
T 3hyh_A 144 LLDEHLNVKIADFGLSNIMTDG----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV 219 (275)
T ss_dssp EECTTCCEEECCSSCC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EECCCCCEEEeecCCCeecCCC----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999999999999999754221 123457999999999999854445789999999999999999999998866544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
+...+...... .+..+++++++||.+||++||.+|||++|+|+||||+.
T Consensus 220 -~~~~i~~~~~~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 220 -LFKNISNGVYT----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -HHHHHHHTCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -HHHHHHcCCCC----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 44445444332 34578999999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=413.19 Aligned_cols=213 Identities=27% Similarity=0.418 Sum_probs=179.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++|++|++++.+|||||||+||+|.++|+.. +.+++..++.|++||+.||+|||++|||||||||+||
T Consensus 104 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 181 (336)
T 4g3f_A 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181 (336)
T ss_dssp TTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHE
Confidence 67899999999999999999999999999999999999764 6799999999999999999999999999999999999
Q ss_pred EEcCCC-cEEEEecCCccccccCCCC--ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNG-VVKLADFGVSACMFDTGDR--QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g-~IKL~DFGlA~~~~~~~~~--~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
||+.+| ++||+|||+|+.+...+.. .......+||+.|||||++. +..|+.++|||||||++|||++|+.||.+..
T Consensus 182 Ll~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp EECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred EEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 999988 6999999999866433221 11234568999999999998 6789999999999999999999999998876
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHH-------------HhccccccCCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL-------------LKHSFFKHAKPP 218 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eI-------------L~HpfFk~~~~~ 218 (583)
....+..+.....+ . ...+..+++.+++||.+||++||.+|||+.|+ |+|||+.....|
T Consensus 261 ~~~~~~~i~~~~~~-~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 261 RGPLCLKIASEPPP-I-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp CSCCHHHHHHSCCG-G-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred HHHHHHHHHcCCCC-c-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 65555444443321 1 23456789999999999999999999999998 579999877654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=429.76 Aligned_cols=220 Identities=26% Similarity=0.386 Sum_probs=190.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++|||||+++++|++.+++|||||||+||+|+++|... +.|+|..++.|++||+.||+|||++|||||||||+|||
T Consensus 247 ~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNIL 324 (689)
T 3v5w_A 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324 (689)
T ss_dssp SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred hhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeE
Confidence 5679999999999999999999999999999999998764 77999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC--hH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP--PM 159 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~--~~ 159 (583)
|+.+|+|||+|||+|+.+.. ....+.+||+.|||||++..+..|+.++|||||||++|||++|.+||.+.. ..
T Consensus 325 ld~~G~vKL~DFGlA~~~~~-----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~ 399 (689)
T 3v5w_A 325 LDEHGHVRISDLGLACDFSK-----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399 (689)
T ss_dssp ECTTSCEEECCCTTCEECSS-----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH
T ss_pred EeCCCCEEecccceeeecCC-----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 99999999999999976522 123467999999999999756789999999999999999999999997642 22
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCch
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPPL 232 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p~ 232 (583)
..+...+..... ..+..+|+++++||.+||++||.+|++ +++|++||||++++|..+..+++.+++.|.
T Consensus 400 ~~i~~~i~~~~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~ 473 (689)
T 3v5w_A 400 HEIDRMTLTMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 473 (689)
T ss_dssp HHHHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHhhcCCCC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCC
Confidence 233333433332 234678999999999999999999998 799999999999999888777777776553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=398.77 Aligned_cols=207 Identities=27% Similarity=0.426 Sum_probs=166.0
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+|||||+++++|++++++|||||||+||+|.+++ +.+++.+++.|++||+.||+|||++||+||||||+|||++.
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~ 152 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR 152 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC
Confidence 7999999999999999999999999999999987 35999999999999999999999999999999999999987
Q ss_pred C-CcEEEEecCCccccccCCC-------------------------CccccccccCCCCCCCcccccCCCCCCccccccc
Q 007967 85 N-GVVKLADFGVSACMFDTGD-------------------------RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWS 138 (583)
Q Consensus 85 ~-g~IKL~DFGlA~~~~~~~~-------------------------~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWS 138 (583)
+ +.+||+|||+|+....... ......+.+||++|||||++.+...|+.++||||
T Consensus 153 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS 232 (361)
T 4f9c_A 153 RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232 (361)
T ss_dssp TTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred CCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh
Confidence 6 8999999999975432211 0111235689999999999986667999999999
Q ss_pred hhhHHhhhhhCCCCCCCCC-hHHHHHHHHh-------------------------------------cCC----------
Q 007967 139 FGITALELAHGHAPFSKYP-PMKVLLMTIQ-------------------------------------NAP---------- 170 (583)
Q Consensus 139 LGvILyeLLtG~~PF~~~~-~~~~l~~~i~-------------------------------------~~~---------- 170 (583)
+|||+|+|++|+.||.... +.+.+..+.. ...
T Consensus 233 lG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~ 312 (361)
T 4f9c_A 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDI 312 (361)
T ss_dssp HHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------
T ss_pred hHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccc
Confidence 9999999999999996543 3333322211 000
Q ss_pred --CCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 171 --PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 171 --~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.......+..+++++++||.+||++||.+|+|++|+|+||||+++.
T Consensus 313 ~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 313 QGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred ccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0001123456789999999999999999999999999999999763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=386.51 Aligned_cols=212 Identities=25% Similarity=0.425 Sum_probs=160.2
Q ss_pred CCCCCCCcccceEEEEEECC------------EEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDS------------NLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~------------~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
|+.|+|||||+++++|.+.+ ++|||||||+||+|.+++..... ...++..++.|+.||+.||+|||+
T Consensus 57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~ 136 (299)
T 4g31_A 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS 136 (299)
T ss_dssp HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH
Confidence 57899999999999998654 48999999999999999875311 124567789999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCC---------ccccccccCCCCCCCcccccCCCCCCccccccc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR---------QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWS 138 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~---------~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWS 138 (583)
+|||||||||+||||+.+|.+||+|||+|+.+...... .....+.+||+.|||||++. +..|+.++||||
T Consensus 137 ~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwS 215 (299)
T 4g31_A 137 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFS 215 (299)
T ss_dssp TTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT-TCCCCTHHHHHH
T ss_pred CcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc-CCCCCCHHHHHH
Confidence 99999999999999999999999999999765332111 11224568999999999998 678999999999
Q ss_pred hhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 139 FGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 139 LGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
|||++|||++ ||.+..+.......+.... ++ +.....++.+++||.+||++||.+|||+.++|+||||++.+++
T Consensus 216 lGvilyell~---Pf~~~~~~~~~~~~~~~~~--~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 216 LGLILFELLY---PFSTQMERVRTLTDVRNLK--FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHHS---CCSSHHHHHHHHHHHHTTC--CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHHHHHHcc---CCCCccHHHHHHHHHhcCC--CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 9999999996 8865333222233333221 11 2234556778999999999999999999999999999998765
Q ss_pred c
Q 007967 219 E 219 (583)
Q Consensus 219 ~ 219 (583)
.
T Consensus 290 ~ 290 (299)
T 4g31_A 290 G 290 (299)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=400.74 Aligned_cols=216 Identities=21% Similarity=0.328 Sum_probs=176.5
Q ss_pred CCCCCCCcccceEEEEEE------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVV------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++|||||+++++|.. .+++|||||||+ |+|++++.. .+.+++..++.|++||+.||.|||++||||||
T Consensus 107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRD 183 (398)
T 4b99_A 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRD 183 (398)
T ss_dssp HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCC
Confidence 456899999999999864 367999999995 679988764 46799999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCC-CccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGD-RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~-~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
|||+|||++.+|.+||+|||+|+.+..... ......+++||++|||||++.+...|+.++||||+|||+|||++|++||
T Consensus 184 lKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 184 LKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp CCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred cCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence 999999999999999999999976543221 2223456899999999999986667899999999999999999999999
Q ss_pred CCCChHHHHHHHHhcC--CCC---------------------CCc---cccccchHHHHHHHHhhhcCCCCCCCCHHHHH
Q 007967 154 SKYPPMKVLLMTIQNA--PPG---------------------LDY---DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~--~~~---------------------~~~---~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL 207 (583)
.+.+..+.+..++... +.. ... ...+.+++++++||.+||++||.+|||+.|+|
T Consensus 264 ~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 264 PGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 9988777665444321 100 000 01134688999999999999999999999999
Q ss_pred hccccccCCCCc
Q 007967 208 KHSFFKHAKPPE 219 (583)
Q Consensus 208 ~HpfFk~~~~~~ 219 (583)
+||||+....+.
T Consensus 344 ~Hp~f~~~~~p~ 355 (398)
T 4b99_A 344 RHPFLAKYHDPD 355 (398)
T ss_dssp TSGGGTTTCCGG
T ss_pred cCHhhCcCCCCc
Confidence 999999876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=379.16 Aligned_cols=206 Identities=25% Similarity=0.423 Sum_probs=168.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++++++. ++.+|||||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||
T Consensus 86 l~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NI 163 (307)
T 3omv_A 86 LRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNI 163 (307)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSE
T ss_pred HHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHE
Confidence 57899999999999875 56789999999999999998643 45799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+.++.+||+|||+|+...... ......+.+||+.|||||++.. ...|+.++|||||||++|||++|+.||.+...
T Consensus 164 Ll~~~~~~Ki~DFGla~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 164 FLHEGLTVKIGDFGLATVKSRWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp EEETTEEEEECCCSSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EECCCCcEEEeeccCceecccCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 99999999999999997543221 2222345799999999999963 34589999999999999999999999998777
Q ss_pred HHHHHHHHhcCCCC-CCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 159 MKVLLMTIQNAPPG-LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 159 ~~~l~~~i~~~~~~-~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
...+...+...... .....+..+++.+++||.+||++||.+|||+.+|+++
T Consensus 243 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 243 RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 66665555543221 1123346789999999999999999999999988654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=411.03 Aligned_cols=212 Identities=25% Similarity=0.401 Sum_probs=184.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++.+|||||||+||+|+++|... .+.++|.+++.|++||+.||+|||++||+||||||+||
T Consensus 208 l~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Ni 286 (573)
T 3uto_A 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 286 (573)
T ss_dssp HHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhc
Confidence 45789999999999999999999999999999999987532 35799999999999999999999999999999999999
Q ss_pred EEcCC--CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTN--GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~--g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++.+ |.+||+|||+|+.+... ....+.+||++|||||++. +..|+.++|||||||++|+|++|.+||.+...
T Consensus 287 ll~~~~~~~vKl~DFG~a~~~~~~----~~~~~~~GT~~y~APEv~~-~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 287 MFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361 (573)
T ss_dssp EESSSSCCCEEECCCSSCEECCTT----SEEEEECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cccCCCCCCEEEeeccceeEccCC----CceeeeEECccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 99854 89999999999865321 2234579999999999998 67899999999999999999999999999777
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
.+.+. .+......+....+..+|+++++||.+||++||.+|||+.|+|+||||+...++.
T Consensus 362 ~~~~~-~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 362 DETLR-NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHHH-HHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred HHHHH-HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 65554 4444444455555678999999999999999999999999999999999877654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=377.23 Aligned_cols=205 Identities=21% Similarity=0.413 Sum_probs=175.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-----------QDGFEESAIGSILKETLKALDYLHRQG 69 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-----------~~~~sE~~i~~I~~QIl~gL~yLHs~g 69 (583)
|+.++|||||+++++|.+++.+|||||||+||+|.++++... ...+++..+..|+.||+.||.|||+++
T Consensus 69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T 4asz_A 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH 148 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999999999999999999999999997532 246999999999999999999999999
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH- 148 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt- 148 (583)
||||||||+|||++.++.+||+|||+|+...... ........+||+.|||||++. ...|+.++|||||||++|||++
T Consensus 149 iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~-~~~~~~k~DVwS~Gvvl~Ellt~ 226 (299)
T 4asz_A 149 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTY 226 (299)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CEEETTTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCccCHhhEEECCCCcEEECCcccceecCCCC-ceeecCceecChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999997553322 222223457999999999998 5689999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 149 GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 149 G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
|+.||.+.+..+.+..+.....+ +.+..+++++++||.+||+.||.+|||+.+| |+|++
T Consensus 227 G~~Pf~~~~~~~~~~~i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 227 GKQPWYQLSNNEVIECITQGRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp TCCTTTTSCHHHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 99999998876666555544322 3346789999999999999999999999999 44554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=378.37 Aligned_cols=203 Identities=19% Similarity=0.381 Sum_probs=167.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-------------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-------------QDGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-------------~~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
|+.++|||||+++++|.+.+.+|||||||+||+|.++++... .+.+++..+..|+.||+.||+|||+
T Consensus 97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 578999999999999999999999999999999999986532 2459999999999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
++||||||||+||||+.++.+||+|||+|+...... ........+||+.|||||++. +..|+.++|||||||++|||+
T Consensus 177 ~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~-~~~~~~~sDvwS~Gvvl~Ell 254 (329)
T 4aoj_A 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 254 (329)
T ss_dssp TTCCCSCCCGGGEEEETTTEEEECCCC-----------------CCCCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHH
T ss_pred CCeecccccHhhEEECCCCcEEEcccccceeccCCC-cceecCcccccccccChhhhc-CCCCCccccccchHHHHHHHH
Confidence 999999999999999999999999999997653322 222234568999999999998 678999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 148 H-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 148 t-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+ |+.||.+....+.+..+..... .+.+..+++++.+||.+||++||.+|||+.+|+++
T Consensus 255 t~G~~Pf~~~~~~~~~~~i~~g~~----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 255 TYGKQPWYQLSNTEAIDCITQGRE----LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TTSCCTTCSSCHHHHHHHHHHTCC----CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCC----CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8 9999999877666655544432 23446789999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=373.92 Aligned_cols=203 Identities=18% Similarity=0.356 Sum_probs=174.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
|+.++|||||+++++|.+++.+|||||||++|+|.++|.... ...+++..+..|+.||+.||+|||
T Consensus 83 l~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 162 (308)
T 4gt4_A 83 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 162 (308)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 456899999999999999999999999999999999986432 245899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
+++||||||||+||||+.++.+||+|||+|+...... ........+||+.|||||++. ...|+.++|||||||++|||
T Consensus 163 ~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El 240 (308)
T 4gt4_A 163 SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEV 240 (308)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCccccceEECCCCCEEECCcccceeccCCC-ceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHH
Confidence 9999999999999999999999999999998654332 222334568999999999998 56899999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+....+.+..+..... .+.+..++..+.+|+.+||+.||.+|||+.+|+++
T Consensus 241 ~t~g~~Pf~~~~~~~~~~~i~~~~~----~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 241 FSYGLQPYCGYSNQDVVEMIRNRQV----LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTTCCTTTTCCHHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 98 8999999877665544443322 23346789999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=375.93 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=203.8
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|++.+.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~ 159 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECC
Confidence 7999999999999999999999999999999998764 67999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
+|++||+|||+|+...... ....+.+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+....+....
T Consensus 160 ~g~ikL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~ 235 (353)
T 3txo_A 160 EGHCKLADFGMCKEGICNG---VTTATFCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 235 (353)
T ss_dssp TSCEEECCCTTCBCSCC------------CCGGGCCHHHHH-HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCEEEccccceeecccCC---ccccccCCCcCeEChhhcC-CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999987432222 2234578999999999997 56799999999999999999999999998776655544
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH------HHHHhccccccCCCCchhhhhhhcCCCchHHHHhH
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA------EKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKA 238 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa------~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~~r~~~ 238 (583)
+... ... .+..++..+++||.+||.+||.+||++ ++|++||||+.++|..+..+++.+++.|...
T Consensus 236 i~~~-~~~----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~---- 306 (353)
T 3txo_A 236 ILND-EVV----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK---- 306 (353)
T ss_dssp HHHC-CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC----
T ss_pred HHcC-CCC----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC----
Confidence 4443 222 235689999999999999999999998 9999999999998877666665555543211
Q ss_pred HHHHHHHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccce
Q 007967 239 LQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENES 301 (583)
Q Consensus 239 ~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Ef 301 (583)
......+||.+++.+.+.+...+......+++.+|
T Consensus 307 ----------------------------~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f 341 (353)
T 3txo_A 307 ----------------------------SREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEF 341 (353)
T ss_dssp ----------------------------STTCCTTSCHHHHTSCCCCCCCCTTSGGGSCGGGG
T ss_pred ----------------------------CcccccccCcccccCCCcCCCccccccCccccccc
Confidence 11234578888888877777766555544444444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=375.69 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=208.6
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.+|||||+++++|++.+.+|||||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 110 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~ 187 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 187 (396)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC
Confidence 48999999999999999999999999999999988764 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC------
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP------ 157 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~------ 157 (583)
.+|++||+|||+|+.....+ ....+.+||+.|+|||++. +..|+.++|||||||++|+|++|..||....
T Consensus 188 ~~g~ikL~DFGla~~~~~~~---~~~~~~~gt~~Y~aPE~l~-~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~ 263 (396)
T 4dc2_A 188 SEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263 (396)
T ss_dssp TTSCEEECCCTTCBCCCCTT---CCBCCCCBCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----
T ss_pred CCCCEEEeecceeeecccCC---CccccccCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc
Confidence 99999999999987533222 2234679999999999998 6789999999999999999999999996431
Q ss_pred --hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH------HHHHhccccccCCCCchhhhhhhcCC
Q 007967 158 --PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA------EKLLKHSFFKHAKPPELSVKKLFADL 229 (583)
Q Consensus 158 --~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa------~eIL~HpfFk~~~~~~~~~~~~~~~~ 229 (583)
....+...+...... .+..++.++++||.+||++||.+||++ ++|++||||+.++|..+..+++.+++
T Consensus 264 ~~~~~~~~~~i~~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~ 339 (396)
T 4dc2_A 264 QNTEDYLFQVILEKQIR----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 339 (396)
T ss_dssp -CCHHHHHHHHHHCCCC----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSC
T ss_pred hhhHHHHHHHHhccccC----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCC
Confidence 223344444444332 235689999999999999999999984 89999999999998877766666665
Q ss_pred CchHHHHhHHHHHHHHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCcccccccccee
Q 007967 230 PPLWNRVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESV 302 (583)
Q Consensus 230 ~p~~~r~~~~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv 302 (583)
.|... ......+||.+++.+.+.+..++.+.....+..+|.
T Consensus 340 ~p~~~--------------------------------~~~d~~~fd~~~~~~~~~~~~~~~~~~~~~~~~~f~ 380 (396)
T 4dc2_A 340 KPNIS--------------------------------GEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFE 380 (396)
T ss_dssp CCCCC--------------------------------SSTTGGGSCHHHHTSCCCCCCCCHHHHTTSCGGGGT
T ss_pred cCCCC--------------------------------CccchhhcChhhccCCCccCCCcchhhccccccccC
Confidence 44321 112345788888887777777766655555555553
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=380.85 Aligned_cols=299 Identities=24% Similarity=0.390 Sum_probs=232.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+...+|+|||||.||+|.+++... ..+++..++.+++||+.||.|||++||+||||||+||
T Consensus 90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 167 (494)
T 3lij_A 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167 (494)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhE
Confidence 46789999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EEcC---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|++. ++.+||+|||++...... ......+||++|+|||++. ..|+.++|||||||++|+|++|.+||.+..
T Consensus 168 l~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 168 LLESKEKDALIKIVDFGLSAVFENQ----KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp EESCSSTTCCEEECCCTTCEECBTT----BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeCCCCCCcEEEEECCCCeECCCC----ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9976 455999999998755322 1223568999999999987 469999999999999999999999999877
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC--------ch-hhhhhhcC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP--------EL-SVKKLFAD 228 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~--------~~-~~~~~~~~ 228 (583)
..+.+ ..+......+..+.+..+++.+++||.+||++||.+|||+.++|+||||+..... .. ........
T Consensus 242 ~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (494)
T 3lij_A 242 DQEIL-RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320 (494)
T ss_dssp HHHHH-HHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHT
T ss_pred HHHHH-HHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHH
Confidence 65554 4444444455556667899999999999999999999999999999999864211 00 00000011
Q ss_pred CC---chHHH--------HhHHHHHHHHHHHHhcCCchhhhhcchhhhhcCccccCC--------ChhhHHhhcccccCC
Q 007967 229 LP---PLWNR--------VKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNF--------DIEDLKAQASLVRDD 289 (583)
Q Consensus 229 ~~---p~~~r--------~~~~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~nf--------d~~d~~~~~~l~~~d 289 (583)
+. .+... +.........+..|..++.+.++.|+.+|+...+...+. .....+.+..+..-|
T Consensus 321 ~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D 400 (494)
T 3lij_A 321 FQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAAD 400 (494)
T ss_dssp TTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHC
T ss_pred HHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhC
Confidence 11 11100 001112234457788899999999999999887755432 444555677788888
Q ss_pred CCccccccccceeeeecCc
Q 007967 290 DDMLETKEENESVKSSVGF 308 (583)
Q Consensus 290 dd~~~~~d~~Efv~as~~~ 308 (583)
.|.++.+++.||+++....
T Consensus 401 ~d~~G~I~~~EF~~~~~~~ 419 (494)
T 3lij_A 401 FDRNGYIDYSEFVTVAMDR 419 (494)
T ss_dssp TTCSSSEEHHHHHHHHSCH
T ss_pred CCCCCcCcHHHHHHHHHhh
Confidence 8899999999998775443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=381.27 Aligned_cols=299 Identities=22% Similarity=0.402 Sum_probs=227.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+|+|||||.||+|.+++... +.+++..++.+++||+.||.|||++||+||||||+||
T Consensus 75 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 152 (486)
T 3mwu_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152 (486)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence 35679999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EEc---CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLD---TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld---~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|++ .++.+||+|||++...... ......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+..
T Consensus 153 l~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 153 LLESKEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp EESSSSTTCCEEECSCSCTTTBCCC--------CCTTGGGGCCGGGGG--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEecCCCCCCEEEEECCcCeECCCC----CccCCCcCCCCCCCHHHhC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 995 4567999999998755322 1223468999999999997 359999999999999999999999999877
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCchhh------hhhhcCC--
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSV------KKLFADL-- 229 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~~~------~~~~~~~-- 229 (583)
..+.+. .+......+..+.+..+++.+++||.+||.+||.+|||+.++|+||||+......... ......+
T Consensus 227 ~~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (486)
T 3mwu_A 227 EYDILK-RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQ 305 (486)
T ss_dssp HHHHHH-HHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHH
T ss_pred HHHHHH-HHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHH
Confidence 655554 4444444555666778999999999999999999999999999999999765432111 0000000
Q ss_pred ----CchHH--------HHhHHHHHHHHHHHHhcCCchhhhhcchhhhhcCccc----cCCChh----------hHHhhc
Q 007967 230 ----PPLWN--------RVKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSA----WNFDIE----------DLKAQA 283 (583)
Q Consensus 230 ----~p~~~--------r~~~~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~----~nfd~~----------d~~~~~ 283 (583)
..+.. .+............|..+|.+.++.|+.+|+..++.. .+.+.. +.....
T Consensus 306 ~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 385 (486)
T 3mwu_A 306 FQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDS 385 (486)
T ss_dssp HHHSCHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHH
Confidence 00000 0000111233456778889999999999999654422 122222 444566
Q ss_pred ccccCCCCccccccccceeeeecCc
Q 007967 284 SLVRDDDDMLETKEENESVKSSVGF 308 (583)
Q Consensus 284 ~l~~~ddd~~~~~d~~Efv~as~~~ 308 (583)
.+..-|.|.++.+++.||+++....
T Consensus 386 ~~~~~D~d~dG~I~~~Ef~~~~~~~ 410 (486)
T 3mwu_A 386 LMPLLDMDGSGSIEYSEFIASAIDR 410 (486)
T ss_dssp HHHHHCTTCCSSBCHHHHHHHHSCT
T ss_pred HHHHhcCCCCCcCcHHHHHHHHHhh
Confidence 6777788899999999998765543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=383.84 Aligned_cols=298 Identities=22% Similarity=0.376 Sum_probs=227.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+|||||.||+|.+++.. ...+++..++.+++||+.||.|||++||+||||||+||
T Consensus 80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 157 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 157 (484)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 4678999999999999999999999999999999998764 46799999999999999999999999999999999999
Q ss_pred EE---cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LL---DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Ll---d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|+ +.++.+||+|||++...... ......+||++|+|||++.+ .|+.++|||||||++|+|++|.+||.+..
T Consensus 158 l~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 158 LLESKSKDANIRIIDFGLSTHFEAS----KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp EESSSSTTCCEEECCTTHHHHBCCC----CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEecCCCCCcEEEEeeeeeEEcccc----cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 99 56789999999998755222 12234689999999999973 69999999999999999999999999877
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCchhhh-----hhhcCCCch
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVK-----KLFADLPPL 232 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~~~~-----~~~~~~~p~ 232 (583)
..+.+. .+......+..+.+..+++.+++||.+||++||.+|||+.++|+||||+.......... .....+...
T Consensus 232 ~~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (484)
T 3nyv_A 232 EYDILK-KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQF 310 (484)
T ss_dssp HHHHHH-HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHH
T ss_pred HHHHHH-HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHH
Confidence 665554 44444445556667789999999999999999999999999999999986543221110 000000000
Q ss_pred --HHHHh------------HHHHHHHHHHHHhcCCchhhhhcchhhhhcCc----cccCCChh-------hHHhhccccc
Q 007967 233 --WNRVK------------ALQLKDAAQLALKKMPSAEQEAISQSEYQRGV----SAWNFDIE-------DLKAQASLVR 287 (583)
Q Consensus 233 --~~r~~------------~~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~----~~~nfd~~-------d~~~~~~l~~ 287 (583)
.++++ ...........|..+|.+.++.++.+|+..++ ...+++.. +.+....+..
T Consensus 311 ~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 390 (484)
T 3nyv_A 311 QGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDA 390 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHHHHHhccCcHHHHHHHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHH
Confidence 00000 01111233466788899999999999995433 33344443 4455677777
Q ss_pred CCCCccccccccceeeeecC
Q 007967 288 DDDDMLETKEENESVKSSVG 307 (583)
Q Consensus 288 ~ddd~~~~~d~~Efv~as~~ 307 (583)
-|.|.++.+++.||+++...
T Consensus 391 ~D~d~~g~i~~~Ef~~~~~~ 410 (484)
T 3nyv_A 391 VDFDKNGYIEYSEFVTVAMD 410 (484)
T ss_dssp HTCCTTSEEEHHHHHHHHHH
T ss_pred hCCCCCCeEeHHHHHHHHHh
Confidence 78889999999999876443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=381.73 Aligned_cols=298 Identities=24% Similarity=0.391 Sum_probs=233.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+|||||||.||+|.+++... ..+++..++.+++||+.||.|||++||+||||||+||
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 177 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence 35689999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EEcCCC---cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTNG---VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g---~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|++.++ .+||+|||++...... ......+||+.|+|||++. ..|+.++||||+||++|+|++|..||.+..
T Consensus 178 l~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 178 LLENKNSLLNIKIVDFGLSSFFSKD----YKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp EESSTTCCSSEEECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEecCCCCccEEEEECCCCEEcCCC----CccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998776 6999999998754221 1223568999999999987 468999999999999999999999999877
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCch--h---hhhh---hcCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL--S---VKKL---FADL 229 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~--~---~~~~---~~~~ 229 (583)
..+.+ ..+......+....+..+++++++||.+||++||.+|||+.++|+||||+....... . .... ...+
T Consensus 252 ~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (504)
T 3q5i_A 252 DQDII-KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKF 330 (504)
T ss_dssp HHHHH-HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHC
T ss_pred HHHHH-HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHH
Confidence 65544 444444444555556788999999999999999999999999999999987653211 0 0000 0011
Q ss_pred C---chHHH--------HhHHHHHHHHHHHHhcCCchhhhhcchhhhhcCcccc--------CCChhhHHhhcccccCCC
Q 007967 230 P---PLWNR--------VKALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAW--------NFDIEDLKAQASLVRDDD 290 (583)
Q Consensus 230 ~---p~~~r--------~~~~~~~~~a~~~~~~~~~~~~~~is~~e~~~g~~~~--------nfd~~d~~~~~~l~~~dd 290 (583)
. .+... +-..+........|..+|.+.++.++.+|+...+... ++.....+....+..-|.
T Consensus 331 ~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 410 (504)
T 3q5i_A 331 EGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDF 410 (504)
T ss_dssp CCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCC
Confidence 1 01000 0011222334577888999999999999998765433 445555666777888888
Q ss_pred CccccccccceeeeecC
Q 007967 291 DMLETKEENESVKSSVG 307 (583)
Q Consensus 291 d~~~~~d~~Efv~as~~ 307 (583)
|.++.+++.||+++...
T Consensus 411 d~dG~I~~~EF~~~~~~ 427 (504)
T 3q5i_A 411 DKNGYIEYSEFISVCMD 427 (504)
T ss_dssp TCSSSEEHHHHHHHHSC
T ss_pred CCCCcEeHHHHHHHHHh
Confidence 89999999999876544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=373.40 Aligned_cols=202 Identities=23% Similarity=0.386 Sum_probs=170.9
Q ss_pred CC-CCCcccceEEEEEE-CCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 3 LI-DHPNVIRAYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
.+ +|||||+++++|.. ++.+|||||||++|+|.++|+... ...+++..+..|+.||++||+|||
T Consensus 123 ~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH 202 (353)
T 4ase_A 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 202 (353)
T ss_dssp HHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH
T ss_pred HcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh
Confidence 45 45999999999976 467999999999999999997642 234899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
+++||||||||+|||++.++.+||+|||+|+.+...... ....+.+||+.|||||++. +..|+.++|||||||++|||
T Consensus 203 ~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El 280 (353)
T 4ase_A 203 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEI 280 (353)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHH
T ss_pred hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHH
Confidence 999999999999999999999999999999865433222 2234578999999999998 57899999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+....+.+...+.... ....+..+++++++||.+||+.||.+|||+.+|++|
T Consensus 281 ~t~G~~Pf~~~~~~~~~~~~i~~g~---~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 281 FSLGASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHHcCC---CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 98 9999998765555555555432 223346689999999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=359.27 Aligned_cols=220 Identities=27% Similarity=0.470 Sum_probs=187.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|++.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 136 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHE
Confidence 35689999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|++||+|||+++.....+ ....+.+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+.....
T Consensus 137 ll~~~g~vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 212 (337)
T 1o6l_A 137 MLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp EECTTSCEEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EECCCCCEEEeeccchhhcccCC---CcccccccChhhCChhhhc-CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999987533222 2234578999999999998 5679999999999999999999999998866554
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
....+.. .... .+..+++++++||.+||.+||.+|| ++++|++||||+.++|..+..+++.+++.|
T Consensus 213 ~~~~i~~-~~~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p 283 (337)
T 1o6l_A 213 LFELILM-EEIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283 (337)
T ss_dssp HHHHHHH-CCCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHc-CCCC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCC
Confidence 4433333 3222 2356899999999999999999999 899999999999998877665555555543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.45 Aligned_cols=217 Identities=30% Similarity=0.544 Sum_probs=183.8
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
++||||++++++|++.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 152 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC
Confidence 48999999999999999999999999999999998764 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
.+|++||+|||+++...... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+....+...
T Consensus 153 ~~g~vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 228 (345)
T 1xjd_A 153 KDGHIKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228 (345)
T ss_dssp TTSCEEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCEEEeEChhhhhcccCC---CcccCCCCCcccCChhhhc-CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999987532221 1234579999999999998 5679999999999999999999999999876655444
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHH-HHHhccccccCCCCchhhhhhhcCCCc
Q 007967 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE-KLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 164 ~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~-eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
.+......+ +..+++++++||.+||..||.+||++. +|++||||+.++|..+..+++.+++.|
T Consensus 229 -~i~~~~~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p 292 (345)
T 1xjd_A 229 -SIRMDNPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRP 292 (345)
T ss_dssp -HHHHCCCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC----
T ss_pred -HHHhCCCCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCC
Confidence 333333222 356899999999999999999999998 999999999999877666555554433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=360.02 Aligned_cols=218 Identities=28% Similarity=0.491 Sum_probs=182.6
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.+||||++++++|.+.+.+|+|||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 67 ~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 144 (345)
T 3a8x_A 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 144 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC
Confidence 38999999999999999999999999999999988764 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC-------
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY------- 156 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~------- 156 (583)
.+|++||+|||+++.....+ ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||...
T Consensus 145 ~~g~~kL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 220 (345)
T 3a8x_A 145 SEGHIKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220 (345)
T ss_dssp TTSCEEECCGGGCBCSCCTT---CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----
T ss_pred CCCCEEEEeccccccccCCC---CcccccCCCccccCccccC-CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc
Confidence 99999999999987543222 1234578999999999998 568999999999999999999999999652
Q ss_pred -ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH------HHHHhccccccCCCCchhhhhhhcCC
Q 007967 157 -PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA------EKLLKHSFFKHAKPPELSVKKLFADL 229 (583)
Q Consensus 157 -~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa------~eIL~HpfFk~~~~~~~~~~~~~~~~ 229 (583)
.....+...+...... .+..++..+++||.+||++||.+||++ .+|++||||+.++|..+..+...+++
T Consensus 221 ~~~~~~~~~~i~~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~ 296 (345)
T 3a8x_A 221 QNTEDYLFQVILEKQIR----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 296 (345)
T ss_dssp --CHHHHHHHHHHCCCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred cccHHHHHHHHHcCCCC----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCc
Confidence 1223333444443322 235689999999999999999999995 89999999999988766555555444
Q ss_pred Cc
Q 007967 230 PP 231 (583)
Q Consensus 230 ~p 231 (583)
.|
T Consensus 297 ~p 298 (345)
T 3a8x_A 297 KP 298 (345)
T ss_dssp CC
T ss_pred CC
Confidence 33
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=353.66 Aligned_cols=217 Identities=29% Similarity=0.514 Sum_probs=188.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+...+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 61 ~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp HSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred hhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 5689999999999999999999999999999999998763 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|.+||+|||+++.... ...+.+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+......
T Consensus 139 l~~~g~~kL~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 211 (318)
T 1fot_A 139 LDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211 (318)
T ss_dssp ECTTSCEEECCCSSCEECSS------CBCCCCSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EcCCCCEEEeecCcceecCC------ccccccCCccccCHhHhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999875421 123568999999999998 66799999999999999999999999988776655
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCCCch
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPPL 232 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p~ 232 (583)
...++.. .. ..+..++.++++||.+||..||.+|| +++++++||||+.++|..+..+...+++.|.
T Consensus 212 ~~~i~~~-~~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~ 282 (318)
T 1fot_A 212 YEKILNA-EL----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 282 (318)
T ss_dssp HHHHHHC-CC----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHhC-CC----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCC
Confidence 5444443 22 22356899999999999999999999 8999999999999998777666665555443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=370.72 Aligned_cols=224 Identities=31% Similarity=0.496 Sum_probs=189.4
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++|||||+++++|.+++.+|||||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 124 ~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL 200 (410)
T 3v8s_A 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200 (410)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHee
Confidence 457999999999999999999999999999999998864 57999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC---CCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS---GYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~---~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
++.+|++||+|||+|+.....+ .....+.+||+.|+|||++.... .|+.++|||||||++|+|++|..||.+...
T Consensus 201 l~~~g~ikL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 201 LDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp ECTTSCEEECCCTTCEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ECCCCCEEEeccceeEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 9999999999999987543221 11234678999999999997422 178999999999999999999999998776
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCC--CCCHHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~k--RpTa~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
......++.. ...+.++.+..+++++++||.+||+.+|.+ |+++++|++||||++++|.....++..+++.|
T Consensus 279 ~~~~~~i~~~-~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p 352 (410)
T 3v8s_A 279 VGTYSKIMNH-KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 352 (410)
T ss_dssp HHHHHHHHTH-HHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCC
T ss_pred hhHHHHHHhc-cccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCC
Confidence 5555444332 112334445678999999999999999988 99999999999999999988777777666654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.78 Aligned_cols=219 Identities=28% Similarity=0.450 Sum_probs=188.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|++.+.+|||||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 94 ~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl 171 (373)
T 2r5t_A 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 171 (373)
T ss_dssp CCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred HhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 5689999999999999999999999999999999998764 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|++||+|||+++...... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+....+.
T Consensus 172 l~~~g~ikL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 247 (373)
T 2r5t_A 172 LDSQGHIVLTDFGLCKENIEHN---STTSTFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247 (373)
T ss_dssp ECTTSCEEECCCCBCGGGBCCC---CCCCSBSCCCCCCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH
T ss_pred ECCCCCEEEeeCccccccccCC---CccccccCCccccCHHHhC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999987543222 2234579999999999998 66799999999999999999999999988766555
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH----HHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA----EKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa----~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
...++.. ... .+..++..+++||.+||++||.+||++ .+|++||||+.++|..+..+++.+++.|
T Consensus 248 ~~~i~~~-~~~----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p 316 (373)
T 2r5t_A 248 YDNILNK-PLQ----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNP 316 (373)
T ss_dssp HHHHHHS-CCC----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHhc-ccC----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCC
Confidence 4444433 222 235689999999999999999999986 7999999999999887776666666554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=356.67 Aligned_cols=216 Identities=26% Similarity=0.421 Sum_probs=186.4
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|++.+.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~ 156 (353)
T 2i0e_A 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 156 (353)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC
Confidence 8999999999999999999999999999999998764 67999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~ 164 (583)
+|++||+|||+++.....+ ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+....+....
T Consensus 157 ~g~vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~ 232 (353)
T 2i0e_A 157 EGHIKIADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 232 (353)
T ss_dssp TSCEEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCcEEEEeCCcccccccCC---cccccccCCccccChhhhc-CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 9999999999987532222 1234578999999999998 66799999999999999999999999998766555444
Q ss_pred HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 165 ~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
+.. .... .+..++.++++||.+||.+||.+||+ +++|++||||+.++|..+..+++.+++.|
T Consensus 233 i~~-~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p 299 (353)
T 2i0e_A 233 IME-HNVA----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP 299 (353)
T ss_dssp HHH-CCCC----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHh-CCCC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCC
Confidence 443 3222 23568999999999999999999994 79999999999999887776666666654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=352.43 Aligned_cols=206 Identities=24% Similarity=0.455 Sum_probs=177.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NI 145 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHE
Confidence 35679999999999999999999999999999999998764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... ......+||++|+|||++.+...++.++|||||||++|+|++|..||.+.....
T Consensus 146 ll~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 221 (328)
T 3fe3_A 146 LLDADMNIKIADFGFSNEFTVG----GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221 (328)
T ss_dssp EECTTSCEEECSTTCCGGGSSS----CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEcCCCCEEEeeccCceecCCC----CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998754322 123457899999999999854445689999999999999999999999876655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
........ .. ..+..+++++.+||.+||..||.+|||++++++||||+....
T Consensus 222 ~~~~i~~~-~~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 222 LRERVLRG-KY----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHHHHHHC-CC----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred HHHHHHhC-CC----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 54444433 22 223467899999999999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.59 Aligned_cols=207 Identities=40% Similarity=0.733 Sum_probs=181.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++.+|+|||||.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 72 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil 148 (297)
T 3fxz_A 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148 (297)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred hcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence 467999999999999999999999999999999998864 56999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++....... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+......
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 224 (297)
T 3fxz_A 149 LGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (297)
T ss_dssp ECTTCCEEECCCTTCEECCSTT---CCBCCCCSCGGGCCHHHHH-CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ECCCCCEEEeeCCCceecCCcc---cccCCccCCcCccChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999987553222 2234568999999999998 56799999999999999999999999998877766
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.........+.. ..+..++..+++||.+||+.||.+|||+.++++||||+....
T Consensus 225 ~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 225 LYLIATNGTPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHHHCSCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHhCCCCCC--CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 665555544333 334678999999999999999999999999999999997654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.29 Aligned_cols=210 Identities=25% Similarity=0.423 Sum_probs=181.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI 146 (361)
T 2yab_A 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146 (361)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 4678999999999999999999999999999999998864 46799999999999999999999999999999999999
Q ss_pred EEcCCC----cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNG----VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g----~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|++.++ .+||+|||++...... ......+||+.|+|||++. ...|+.++|||||||++|+|++|..||.+.
T Consensus 147 ll~~~~~~~~~vkl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 147 MLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp EESCTTSSSCCEEECCCSSCEECCTT----CCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred EEeCCCCCccCEEEEecCCceEcCCC----CccccCCCCccEECchHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 998777 7999999998755321 1224568999999999998 567999999999999999999999999987
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
...+.+ ..+......+....+..+++.+++||.+||.+||.+|||+.++|+||||+..++.
T Consensus 222 ~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 282 (361)
T 2yab_A 222 TKQETL-ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282 (361)
T ss_dssp SHHHHH-HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred CHHHHH-HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence 665544 4444444444444456789999999999999999999999999999999977643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=354.30 Aligned_cols=217 Identities=27% Similarity=0.467 Sum_probs=186.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 172 (350)
T 1rdq_E 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceE
Confidence 46789999999999999999999999999999999998764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||+++.... .....+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+.....
T Consensus 173 ll~~~g~~kL~DFg~a~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 245 (350)
T 1rdq_E 173 LIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp EECTTSCEEECCCTTCEECSS------CBCCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EECCCCCEEEcccccceeccC------CcccccCCccccCHHHhc-CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence 999999999999999875421 123568999999999998 5679999999999999999999999999876655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
....+... ... .+..++..+++||.+||+.||.+||+ +++|++||||+.++|..+..+...+++.|
T Consensus 246 ~~~~i~~~-~~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p 316 (350)
T 1rdq_E 246 IYEKIVSG-KVR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIP 316 (350)
T ss_dssp HHHHHHHC-CCC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHcC-CCC----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCC
Confidence 54444433 222 23568999999999999999999998 99999999999998876655555554433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.94 Aligned_cols=221 Identities=28% Similarity=0.462 Sum_probs=184.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++.+|+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 76 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nil 153 (327)
T 3a62_A 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIM 153 (327)
T ss_dssp HHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred HhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeE
Confidence 4678999999999999999999999999999999998764 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|.+||+|||+++...... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+......
T Consensus 154 l~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 229 (327)
T 3a62_A 154 LNHQGHVKLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229 (327)
T ss_dssp ECTTSCEEECCCSCC-------------CTTSSCCTTSCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ECCCCcEEEEeCCcccccccCC---ccccccCCCcCccCHhhCc-CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999999986543222 1223568999999999997 56789999999999999999999999998776555
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCCCchH
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPPLW 233 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p~~ 233 (583)
...+... .. ..+..++..+++||.+||..||.+|| ++.++++||||+..+|..+......+++.|..
T Consensus 230 ~~~i~~~-~~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~ 301 (327)
T 3a62_A 230 IDKILKC-KL----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLL 301 (327)
T ss_dssp HHHHHHT-CC----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-
T ss_pred HHHHHhC-CC----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCc
Confidence 5444433 22 22356889999999999999999999 89999999999999887776666666665543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=360.00 Aligned_cols=220 Identities=28% Similarity=0.456 Sum_probs=186.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+.+.+|||||||+||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|
T Consensus 202 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~N 279 (446)
T 4ejn_A 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 279 (446)
T ss_dssp CCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGG
T ss_pred HHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHH
Confidence 56789999999999999999999999999999999988764 679999999999999999999998 999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.+||+|||+|+...... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+....
T Consensus 280 Ill~~~~~~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 355 (446)
T 4ejn_A 280 LMLDKDGHIKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355 (446)
T ss_dssp EEECSSSCEEECCCCCCCTTCC--------CCSSSCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCCCCEEEccCCCceeccCCC---cccccccCCccccCHhhcC-CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 999999999999999987533222 2234578999999999997 567999999999999999999999999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
.....+... ... .+..+++++++||.+||.+||.+|| |++++++||||+.+.+..+..+.+.+++.|
T Consensus 356 ~~~~~i~~~-~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p 427 (446)
T 4ejn_A 356 KLFELILME-EIR----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKP 427 (446)
T ss_dssp HHHHHHHHC-CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHhC-CCC----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccC
Confidence 544444333 222 2356889999999999999999999 999999999999998877666666555544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=348.99 Aligned_cols=206 Identities=23% Similarity=0.336 Sum_probs=158.6
Q ss_pred CCCCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------
Q 007967 1 MSLIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-------- 68 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-------- 68 (583)
|+.++|||||+++++|.+++ .+|||||||+||+|.++++. .++++..+..++.|++.||+|||++
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~ 127 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 45789999999999998764 68999999999999999864 6799999999999999999999987
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCc-cccccccCCCCCCCcccccCCC-----CCCccccccchhhH
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCWMAPEVLQPGS-----GYNSKADIWSFGIT 142 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~-~~~~~~~GT~~Y~APEil~~~~-----~ys~ksDIWSLGvI 142 (583)
+||||||||+||||+.++++||+|||+|+......... ......+||++|||||++.+.. .|+.++|||||||+
T Consensus 128 ~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvv 207 (303)
T 3hmm_A 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp CEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred CEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHH
Confidence 99999999999999999999999999997654332221 1223468999999999997421 36789999999999
Q ss_pred HhhhhhCCCCCCCC--------------ChHHHHHHHHhcCC--CCCCcc-ccccchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 143 ALELAHGHAPFSKY--------------PPMKVLLMTIQNAP--PGLDYD-RDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 143 LyeLLtG~~PF~~~--------------~~~~~l~~~i~~~~--~~~~~~-~~~~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
+|||++|.+||... .....+...+.... +.++.. .....+..+.+|+.+||..||.+|||+.+
T Consensus 208 l~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 287 (303)
T 3hmm_A 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 99999998766321 11233333332221 112111 11234567899999999999999999999
Q ss_pred HHhc
Q 007967 206 LLKH 209 (583)
Q Consensus 206 IL~H 209 (583)
|++.
T Consensus 288 i~~~ 291 (303)
T 3hmm_A 288 IKKT 291 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=383.69 Aligned_cols=218 Identities=26% Similarity=0.407 Sum_probs=189.7
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.+||||++++++|++.+.+|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||||+
T Consensus 399 ~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~ 476 (674)
T 3pfq_A 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476 (674)
T ss_dssp TCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC
T ss_pred cCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc
Confidence 38999999999999999999999999999999998764 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
.+|++||+|||+|+.....+ ....+.+||+.|+|||++. ...|+.++|||||||++|||++|..||.+....+...
T Consensus 477 ~~g~ikL~DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~ 552 (674)
T 3pfq_A 477 SEGHIKIADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552 (674)
T ss_dssp SSSCEEECCCTTCEECCCTT---CCBCCCCSCSSSCCHHHHT-CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCcEEEeecceeeccccCC---cccccccCCCcccCHhhhc-CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 99999999999987543322 2234679999999999997 6789999999999999999999999999877655554
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCH-----HHHHhccccccCCCCchhhhhhhcCCCch
Q 007967 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA-----EKLLKHSFFKHAKPPELSVKKLFADLPPL 232 (583)
Q Consensus 164 ~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa-----~eIL~HpfFk~~~~~~~~~~~~~~~~~p~ 232 (583)
.++. ... ..+..+++++++||.+||++||.+||++ ++|++||||+.++|..+..+++.+++.|.
T Consensus 553 ~i~~-~~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~ 621 (674)
T 3pfq_A 553 SIME-HNV----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621 (674)
T ss_dssp HHHS-SCC----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCB
T ss_pred HHHh-CCC----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCc
Confidence 4443 322 2235789999999999999999999997 99999999999999888777777666553
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=365.65 Aligned_cols=215 Identities=27% Similarity=0.453 Sum_probs=181.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++.+|||||||.||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 207 (437)
T 4aw2_A 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207 (437)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHee
Confidence 4579999999999999999999999999999999998652 467999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc----CCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~----~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
++.+|.+||+|||+|+....... ......+||+.|+|||++. +...|+.++|||||||++|||++|..||.+..
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EcCCCCEEEcchhhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999875533221 2223468999999999986 24568999999999999999999999999877
Q ss_pred hHHHHHHHHhcCCCCCCccc-cccchHHHHHHHHhhhcCCCCC--CCCHHHHHhccccccCCCCch
Q 007967 158 PMKVLLMTIQNAPPGLDYDR-DKKFSKSFKEMVAMCLVKDQTK--RPTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~-~~~~S~~lkdLI~~cL~~DP~k--RpTa~eIL~HpfFk~~~~~~~ 220 (583)
..+....++... ..+.++. ...+++++++||.+||+.+|.+ |++++++++||||+.++|..+
T Consensus 286 ~~~~~~~i~~~~-~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 286 LVETYGKIMNHK-ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp HHHHHHHHHTHH-HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred hhHHHHhhhhcc-ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 666554444321 1111221 2458999999999999998888 999999999999999999876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=354.29 Aligned_cols=218 Identities=41% Similarity=0.707 Sum_probs=174.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NI 159 (389)
T 3gni_B 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159 (389)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 35689999999999999999999999999999999999876557799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|++.++.+||+|||.+......+... ......+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+
T Consensus 160 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999876543322211 112235899999999999843 5799999999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCC-----------------------------------------CCccccccchHHHHHHHHhhhc
Q 007967 156 YPPMKVLLMTIQNAPPG-----------------------------------------LDYDRDKKFSKSFKEMVAMCLV 194 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~-----------------------------------------~~~~~~~~~S~~lkdLI~~cL~ 194 (583)
......+...+....+. ...+.+..+++.+++||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 66544443322211100 0111234578899999999999
Q ss_pred CCCCCCCCHHHHHhccccccCCCC
Q 007967 195 KDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 195 ~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
+||.+|||+.++|+||||+.....
T Consensus 320 ~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 320 RNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp SCTTTSCCHHHHTTSGGGGGC---
T ss_pred cCcccCCCHHHHhcCHHHHHHhhc
Confidence 999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.51 Aligned_cols=221 Identities=27% Similarity=0.470 Sum_probs=186.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+.+.+|+|||||.||+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 146 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI 146 (384)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence 3568999999999999999999999999999999998875 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCC-
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYP- 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~- 157 (583)
|++.+|.+||+|||++...... ......+||+.|+|||++.. +..|+.++|||||||++|+|++|..||....
T Consensus 147 ll~~~g~vkL~DFG~a~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 147 LLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp EECTTSCEEECCCTTCEECCTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred EECCCCCEEEeccceeeeccCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999998754221 22345789999999999974 3468999999999999999999999997532
Q ss_pred -hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-HHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 158 -PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-AEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 158 -~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-a~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
....+...+...... .+..++..+.+||.+||.+||.+||+ ++++++||||+.++|..+..+.+.+++.|
T Consensus 223 ~~~~~~~~~~~~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p 294 (384)
T 4fr4_A 223 TSSKEIVHTFETTVVT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIP 294 (384)
T ss_dssp SCHHHHHHHHHHCCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCC
T ss_pred ccHHHHHHHHhhcccC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCC
Confidence 233343444443222 23568999999999999999999998 99999999999999887766666555544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=360.20 Aligned_cols=207 Identities=25% Similarity=0.448 Sum_probs=179.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NI 141 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141 (444)
T ss_dssp HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTE
T ss_pred HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 3568999999999999999999999999999999998875 36799999999999999999999999999999999999
Q ss_pred EEc---CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLD---TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld---~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|++ .++.+||+|||++....... ......+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+..
T Consensus 142 ll~~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 142 LLASKLKGAAVKLADFGLAIEVEGEQ---QAWFGFAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp EESBSSTTCCEEECCCSSCBCCCTTC---CBCCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEeccCCCCcEEEccCceeEEecCCC---ceeecccCCcccCCHHHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 998 46789999999987543221 2234578999999999998 5679999999999999999999999999876
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
..... ..+......+..+.+..+++++++||.+||+.||.+|||+.++|+||||+.
T Consensus 218 ~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 218 QHRLY-QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHH-HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHH-HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 65544 444444445555556789999999999999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.82 Aligned_cols=208 Identities=25% Similarity=0.368 Sum_probs=177.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NI 133 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence 34679999999999999999999999999999999987542 34699999999999999999999999999999999999
Q ss_pred EEcC--CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~--~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++. ++.+||+|||++...... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+...
T Consensus 134 l~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 134 IYQTRRSSTIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTT----CEEEEEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred EEccCCCCCEEEEECCCCeECCCC----CccccccCChhhcCcHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 9987 789999999998754221 1223468999999999998 55689999999999999999999999998776
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
...+.. +......+....+..++.++++||.+||..||.+|||+.++|+||||+..
T Consensus 209 ~~~~~~-i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 209 QQIIEN-IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHH-HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHH-HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 555444 44444444444456789999999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.55 Aligned_cols=211 Identities=26% Similarity=0.417 Sum_probs=172.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.++..+|+|||||.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 74 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl 151 (311)
T 3niz_A 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLL 151 (311)
T ss_dssp HHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEE
Confidence 467999999999999999999999999975 788776543 456999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++...... .......+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+....+.
T Consensus 152 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 228 (311)
T 3niz_A 152 INSDGALKLADFGLARAFGIP---VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228 (311)
T ss_dssp ECTTCCEEECCCTTCEETTSC---CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH
T ss_pred ECCCCCEEEccCcCceecCCC---cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999998754221 12223468899999999998667799999999999999999999999987665444
Q ss_pred HHHHHh--cCCCCCCcc-----------------------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 162 LLMTIQ--NAPPGLDYD-----------------------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 162 l~~~i~--~~~~~~~~~-----------------------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+..... ..+....+. ....+++++++||.+||++||.+|||+.++|+||||++++
T Consensus 229 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 229 LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 433322 111111100 1134678999999999999999999999999999999876
Q ss_pred C
Q 007967 217 P 217 (583)
Q Consensus 217 ~ 217 (583)
+
T Consensus 309 ~ 309 (311)
T 3niz_A 309 P 309 (311)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=360.07 Aligned_cols=214 Identities=27% Similarity=0.410 Sum_probs=178.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|++.+.+|||||||+||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 194 (412)
T 2vd5_A 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL 194 (412)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHee
Confidence 3578999999999999999999999999999999998754 357999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC------CCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP------GSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~------~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
++.+|++||+|||+++....... ......+||+.|+|||++.. ...|+.++|||||||++|||++|+.||.+
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ecCCCCEEEeechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99999999999999876532221 12234689999999999862 34689999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCcc-ccccchHHHHHHHHhhhcCCCCCC---CCHHHHHhccccccCCCCch
Q 007967 156 YPPMKVLLMTIQNAPPGLDYD-RDKKFSKSFKEMVAMCLVKDQTKR---PTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~-~~~~~S~~lkdLI~~cL~~DP~kR---pTa~eIL~HpfFk~~~~~~~ 220 (583)
....+....++.... .+..+ ....+++++++||.+||+ +|.+| +++++|++||||+.++|..+
T Consensus 273 ~~~~~~~~~i~~~~~-~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 273 DSTAETYGKIVHYKE-HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp SSHHHHHHHHHTHHH-HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CCHHHHHHHHHhccc-CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 776655544443210 01111 135689999999999999 99998 58999999999999998876
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.99 Aligned_cols=208 Identities=28% Similarity=0.446 Sum_probs=174.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||++++++|.+++.+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~N 160 (351)
T 3c0i_A 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160 (351)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHH
Confidence 467999999999999999999999999999999887765432 348999999999999999999999999999999999
Q ss_pred EEEcCCCc---EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 80 ILLDTNGV---VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 80 ILld~~g~---IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
||++.++. +||+|||++....... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+.
T Consensus 161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 161 VLLASKENSAPVKLGGFGVAIQLGESG---LVAGGRVGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp EEECSSSTTCCEEECCCTTCEECCTTS---CBCCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eEEecCCCCCcEEEecCcceeEecCCC---eeecCCcCCcCccCHHHHc-CCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 99986654 9999999987653321 1233568999999999998 567899999999999999999999999874
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
. ..+...+...........+..++..+++||.+||.+||.+|||+.++|+||||+..
T Consensus 237 ~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 237 K--ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp H--HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred H--HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 3 23333444333333333446789999999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.81 Aligned_cols=205 Identities=26% Similarity=0.455 Sum_probs=176.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++.+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIl 160 (362)
T 2bdw_A 83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL 160 (362)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEE
Confidence 467999999999999999999999999999999998764 366999999999999999999999999999999999999
Q ss_pred EcCC---CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 82 LDTN---GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 82 ld~~---g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
++.+ +.+||+|||++...... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+...
T Consensus 161 l~~~~~~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 161 LASKAKGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp ESCSSTTCCEEECCCTTCBCCTTC----CSCCCSCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EecCCCCCCEEEeecCcceEecCC----cccccCCCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9765 45999999998754321 1223568999999999998 56799999999999999999999999998766
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.... ..+......+....+..+++++++||.+||.+||.+|||+.++|+||||+.
T Consensus 236 ~~~~-~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 236 HRLY-AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHH-HHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHH-HHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 4444 444444444455556788999999999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=334.26 Aligned_cols=210 Identities=25% Similarity=0.437 Sum_probs=170.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+||||+.+ +|.+++... .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 131 (288)
T 1ob3_A 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (288)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4678999999999999999999999999975 888887643 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... .......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+
T Consensus 132 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (288)
T 1ob3_A 132 LINREGELKIADFGLARAFGIP---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (288)
T ss_dssp EECTTSCEEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEcCCCCEEEeECccccccCcc---ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998654221 1122345789999999999855679999999999999999999999999877666
Q ss_pred HHHHHHhc--CCCCCCc----------------------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 161 VLLMTIQN--APPGLDY----------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 161 ~l~~~i~~--~~~~~~~----------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.+...... ......+ .....+++.+++||.+||..||.+|||+.++|+||||++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 55444331 1100000 0123578999999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=334.20 Aligned_cols=211 Identities=24% Similarity=0.362 Sum_probs=169.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||.+ ++.+++... .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Ni 132 (292)
T 3o0g_A 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132 (292)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 4678999999999999999999999999975 566655442 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC-CCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF-SKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF-~~~~~~ 159 (583)
|++.++.+||+|||++...... .......+||+.|+|||++.+...++.++|||||||++|+|++|..|| .+....
T Consensus 133 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~ 209 (292)
T 3o0g_A 133 LINRNGELKLANFGLARAFGIP---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp EECTTSCEEECCCTTCEECCSC---CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred EEcCCCCEEEeecccceecCCc---cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 9999999999999998754221 222344688999999999985566899999999999999999877775 444443
Q ss_pred HHHHHHHhc--CCCCCC----------------------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 160 KVLLMTIQN--APPGLD----------------------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 160 ~~l~~~i~~--~~~~~~----------------------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
..+...... .+.... ......++..+++||.+||++||.+|||++++|+||||++.
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 333333221 111000 01123578999999999999999999999999999999876
Q ss_pred C
Q 007967 216 K 216 (583)
Q Consensus 216 ~ 216 (583)
.
T Consensus 290 ~ 290 (292)
T 3o0g_A 290 C 290 (292)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.38 Aligned_cols=208 Identities=26% Similarity=0.407 Sum_probs=162.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||.||+|.+++... +.+++..++.+++||+.||.|||++||+||||||+|||
T Consensus 71 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil 148 (361)
T 3uc3_A 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148 (361)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred HhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 4679999999999999999999999999999999988764 67999999999999999999999999999999999999
Q ss_pred EcCCCc--EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 82 LDTNGV--VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 82 ld~~g~--IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
++.++. +||+|||+++..... ......+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+....
T Consensus 149 l~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 149 LDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp ECSSSSCCEEECCCCCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred EcCCCCceEEEeecCcccccccc----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 987765 999999998643211 12234689999999999984433345599999999999999999999875432
Q ss_pred ---HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 160 ---KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 160 ---~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
......+.... ...+....+++.+++||.+||.+||.+|||+.+|++||||.....
T Consensus 225 ~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 225 RDYRKTIQRILSVK--YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp CCHHHHHHHHHTTC--CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHHhcCC--CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 22222333222 233344568999999999999999999999999999999976543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.33 Aligned_cols=208 Identities=25% Similarity=0.394 Sum_probs=177.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+...+|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 69 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl 146 (326)
T 2y0a_A 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146 (326)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEE
Confidence 467899999999999999999999999999999998864 467999999999999999999999999999999999999
Q ss_pred EcCCC----cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 82 LDTNG----VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 82 ld~~g----~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
++.++ .+||+|||++....... .....+||+.|+|||++. ...|+.++|||||||++|+|++|..||.+..
T Consensus 147 l~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 147 LLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp ESCSSSSSCCEEECCCTTCEECCTTS----CCCCCCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EecCCCCCCCEEEEECCCCeECCCCC----ccccccCCcCcCCceeec-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 98887 89999999987552211 223468999999999997 5679999999999999999999999998876
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
..+.+.. +......+....+..++..+++||.+||..||.+|||+.++|+||||+....
T Consensus 222 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 222 KQETLAN-VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp HHHHHHH-HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred HHHHHHH-HHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 6554433 3333333333344578899999999999999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=336.63 Aligned_cols=214 Identities=23% Similarity=0.352 Sum_probs=176.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ----DGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~----~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
|+.++||||++++++|.+++.+|+|||||. |+|.+++..... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk 135 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK 135 (317)
T ss_dssp HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 467899999999999999999999999997 689998876532 458999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+|||++.+|.+||+|||++...... .......+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+.
T Consensus 136 p~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 136 PQNLLINKRGQLKLGDFGLARAFGIP---VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTSC---CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hHHeEEcCCCCEEECcCccceecCCC---cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998754221 112234688999999999985567899999999999999999999999987
Q ss_pred ChHHHHHHHHhc--CCCCCC---------------------------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHH
Q 007967 157 PPMKVLLMTIQN--APPGLD---------------------------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207 (583)
Q Consensus 157 ~~~~~l~~~i~~--~~~~~~---------------------------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL 207 (583)
...+.+..+... .+.... ......++.++++||.+||+.||.+|||+.++|
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp SHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 766555433321 110000 001125788999999999999999999999999
Q ss_pred hccccccCCCC
Q 007967 208 KHSFFKHAKPP 218 (583)
Q Consensus 208 ~HpfFk~~~~~ 218 (583)
+||||++....
T Consensus 293 ~hp~f~~~~~~ 303 (317)
T 2pmi_A 293 HHPWFAEYYHH 303 (317)
T ss_dssp TSGGGGGGCC-
T ss_pred CChhhhcccch
Confidence 99999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.22 Aligned_cols=209 Identities=25% Similarity=0.391 Sum_probs=168.1
Q ss_pred CCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 3 LIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
.++||||++++++|.. ..++|||||||.||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 190 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence 4589999999999986 677999999999999999987543446999999999999999999999999999999999
Q ss_pred cEEEcC---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 79 NILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 79 NILld~---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|||++. ++.+||+|||+++..... ......+||+.|+|||++. ...|+.++|||||||++|+|++|..||.+
T Consensus 191 Nill~~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 191 NLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECC---------------CTTCCGGGSC-CCCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eEEEecCCCCccEEEEecccccccCCC----CccccCCCCCCccCHhhcC-CCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 999987 789999999998754221 1234578999999999997 67899999999999999999999999977
Q ss_pred CChHH---HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 156 YPPMK---VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 156 ~~~~~---~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..... .....+......+....+..++.++++||.+||..||.+|||+.++++||||....
T Consensus 266 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 266 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 54321 12233333333444444567899999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=342.93 Aligned_cols=210 Identities=28% Similarity=0.439 Sum_probs=172.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+...+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 103 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 180 (349)
T 2w4o_A 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180 (349)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred HhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEE
Confidence 467899999999999999999999999999999998764 356999999999999999999999999999999999999
Q ss_pred EcC---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 82 LDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 82 ld~---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
++. ++.+||+|||+++..... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 181 l~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 181 YATPAPDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGYCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp ESSSSTTCCEEECCCC--------------------CGGGSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred EecCCCCCCEEEccCccccccCcc----cccccccCCCCccCHHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 975 889999999998754221 1223468999999999998 56799999999999999999999999988766
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
...+...+.........+.+..++..+++||.+||..||.+|||+.++|+||||......
T Consensus 256 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp HHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred cHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 665555565554444444456789999999999999999999999999999999976644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.68 Aligned_cols=207 Identities=28% Similarity=0.405 Sum_probs=170.2
Q ss_pred CCCCcccceEEEEEECC-----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 4 IDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~-----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
++||||++++++|.+.. .+++||||+. |+|.+++.......+++..++.++.||+.||+|||++||+||||||+
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 149 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 46999999999999866 5999999996 69999987654455999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||++..... .......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+...
T Consensus 150 Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 150 NILVTSGGTVKLADFGLARIYSY----QMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp TEEECTTSCEEECSCSCTTTSTT----CCCSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred HEEEcCCCCEEEeeCccccccCC----CcccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999875422 12234568999999999998 56799999999999999999999999998877
Q ss_pred HHHHHHHHhcC--CCCCCcc--------------------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 MKVLLMTIQNA--PPGLDYD--------------------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 ~~~l~~~i~~~--~~~~~~~--------------------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
...+....... .+...++ ....+++.+.+||.+||++||.+|||+.++|+||||+...
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 66654444321 1111110 1235789999999999999999999999999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.84 Aligned_cols=210 Identities=38% Similarity=0.691 Sum_probs=180.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|...+.+|+|||||+||+|.+++. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 467899999999999999999999999999999999875 35799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.....
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~ 248 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVIS-RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 248 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSS---CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EECCCCcEEEeeeeeeeecccCc---cccccccCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999987553221 1223568999999999997 5678999999999999999999999998877665
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
..........+.+ .....+++.+++||.+||..||.+|||+.++++||||.....++
T Consensus 249 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 305 (321)
T 2c30_A 249 AMKRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305 (321)
T ss_dssp HHHHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred HHHHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence 5544444333222 23456889999999999999999999999999999998776543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=337.46 Aligned_cols=212 Identities=21% Similarity=0.333 Sum_probs=170.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|||||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 467899999999999999999999999997 5899988753 5699999999999999999999999999999999999
Q ss_pred EEc-----CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 81 LLD-----TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 81 Lld-----~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|++ ..+.+||+|||++...... .......+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+
T Consensus 164 ll~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 164 LLSVSDASETPVLKIGDFGLARAFGIP---IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp EEEC-----CCEEEECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEecCCCCccceEEECcCCCccccCCc---ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 994 4556999999998754221 12223467899999999998656789999999999999999999999998
Q ss_pred CChHHHHHHHHhcC--CCCCCcc-----------------------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 156 YPPMKVLLMTIQNA--PPGLDYD-----------------------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 156 ~~~~~~l~~~i~~~--~~~~~~~-----------------------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
....+.+....... +....+. ....+++++++||.+||.+||.+|||+.++|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 241 DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 87766665554321 1111000 0112678999999999999999999999999999
Q ss_pred ccccCCCC
Q 007967 211 FFKHAKPP 218 (583)
Q Consensus 211 fFk~~~~~ 218 (583)
||++.++.
T Consensus 321 ~f~~~~~~ 328 (329)
T 3gbz_A 321 YFSHNDFD 328 (329)
T ss_dssp GGSSSCSC
T ss_pred ccCCCCCC
Confidence 99988753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=347.37 Aligned_cols=210 Identities=26% Similarity=0.420 Sum_probs=169.4
Q ss_pred CCCcccceEEEEEECC--EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 5 DHPNVIRAYCSFVVDS--NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~--~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
+||||++++++|...+ .+|+|||||. |+|..++.. ..+++..+..+++||+.||+|||++||+||||||+|||+
T Consensus 67 ~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 67 GHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142 (388)
T ss_dssp TCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence 4999999999998654 7999999997 688888764 579999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCC------------------CCccccccccCCCCCCCcccccCCCCCCccccccchhhHHh
Q 007967 83 DTNGVVKLADFGVSACMFDTG------------------DRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITAL 144 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~------------------~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILy 144 (583)
+.++.+||+|||+|+.+.... ........++||++|+|||++.+...|+.++|||||||++|
T Consensus 143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 222 (388)
T 3oz6_A 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222 (388)
T ss_dssp CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence 999999999999987543211 01112345689999999999986578999999999999999
Q ss_pred hhhhCCCCCCCCChHHHHHHHHhcCCCCC----------------------------C----c----------cccccch
Q 007967 145 ELAHGHAPFSKYPPMKVLLMTIQNAPPGL----------------------------D----Y----------DRDKKFS 182 (583)
Q Consensus 145 eLLtG~~PF~~~~~~~~l~~~i~~~~~~~----------------------------~----~----------~~~~~~S 182 (583)
+|++|++||.+......+..++....... . + .....++
T Consensus 223 ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (388)
T 3oz6_A 223 EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302 (388)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCC
Confidence 99999999999877666544432111000 0 0 0012568
Q ss_pred HHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 183 KSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 183 ~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
+++++||.+||++||.+|||++++|+||||+....+
T Consensus 303 ~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338 (388)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCG
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCC
Confidence 899999999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.65 Aligned_cols=212 Identities=28% Similarity=0.452 Sum_probs=168.4
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
++||||++++++|.+++.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE 145 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEc
Confidence 58999999999999999999999999999999998764 6799999999999999999999999999999999999998
Q ss_pred CCCc---EEEEecCCccccccCCC----CccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCC
Q 007967 84 TNGV---VKLADFGVSACMFDTGD----RQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 84 ~~g~---IKL~DFGlA~~~~~~~~----~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
.++. +||+|||++......+. ........+||+.|+|||++.. ...++.++|||||||++|+|++|..|
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence 8775 99999999875432211 1111234579999999999862 13578999999999999999999999
Q ss_pred CCCCCh--------------HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 153 FSKYPP--------------MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 153 F~~~~~--------------~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
|.+... ...+...+......++...+..++..+++||.+||..||.+|||+.++|+||||+...+
T Consensus 226 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp CCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred CcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 977532 23344445544444433334568999999999999999999999999999999997654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=368.61 Aligned_cols=221 Identities=25% Similarity=0.406 Sum_probs=187.4
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++|||||+++++|++.+.+|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 239 ~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL 318 (576)
T 2acx_A 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318 (576)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE
Confidence 46799999999999999999999999999999999887654455999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh---
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP--- 158 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~--- 158 (583)
++.+|++||+|||++...... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+...
T Consensus 319 ld~~g~vKL~DFGla~~~~~~----~~~~~~~GT~~Y~APEvl~-~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~ 393 (576)
T 2acx_A 319 LDDHGHIRISDLGLAVHVPEG----QTIKGRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 393 (576)
T ss_dssp ECTTSCEEECCCTTCEECCTT----CCEECCCSCGGGCCHHHHT-TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC
T ss_pred EeCCCCeEEEecccceecccC----ccccccCCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCcccccchh
Confidence 999999999999998754221 1223468999999999998 56799999999999999999999999987532
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
...+...+......+ +..+++++++||.+||++||.+|| ++++|++||||+.++|..+......+++.|
T Consensus 394 ~~~i~~~i~~~~~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p 467 (576)
T 2acx_A 394 REEVERLVKEVPEEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKP 467 (576)
T ss_dssp HHHHHHHHHHCCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHhhcccccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCC
Confidence 334444444443322 357899999999999999999999 799999999999999877766665555554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.48 Aligned_cols=204 Identities=25% Similarity=0.420 Sum_probs=171.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+|+||||| +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 139 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhE
Confidence 46789999999999999999999999999 78999988764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.....
T Consensus 140 ll~~~~~~kl~DFG~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 140 LLDDNLNVKIADFGLSNIMTDG----NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp EECTTCCEEECCSSCTBTTTTS----BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred EEcCCCCEEEEEeccceeccCC----cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 9999999999999998754221 123456899999999999844444789999999999999999999997743221
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
. ........+..+..+++.+++||.+||..||.+|||+.++++||||+...
T Consensus 216 ~-----~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 216 L-----FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp C-----BCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred H-----HHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 1 11111122334456899999999999999999999999999999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=340.04 Aligned_cols=206 Identities=23% Similarity=0.418 Sum_probs=157.5
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|.++..+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 64 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~ 141 (325)
T 3kn6_A 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTD 141 (325)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC
T ss_pred CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEec
Confidence 499999999999999999999999999999999876 367999999999999999999999999999999999999987
Q ss_pred CC---cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh---
Q 007967 85 NG---VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP--- 158 (583)
Q Consensus 85 ~g---~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~--- 158 (583)
++ .+||+|||++....... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+...
T Consensus 142 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 217 (325)
T 3kn6_A 142 ENDNLEIKIIDFGFARLKPPDN---QPLKTPCFTLHYAAPELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT 217 (325)
T ss_dssp ----CEEEECCCTTCEECCC--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------
T ss_pred CCCcccEEEeccccceecCCCC---CcccccCCCcCccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc
Confidence 66 89999999987542221 2224568899999999997 66799999999999999999999999976432
Q ss_pred ---HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 ---MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 ---~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
...+...+......+....+..+++++++||.+||..||.+|||+.++++||||++..
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 218 CTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 2334455555544444455567899999999999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=333.06 Aligned_cols=213 Identities=27% Similarity=0.420 Sum_probs=170.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil 134 (311)
T 4agu_A 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENIL 134 (311)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEE
Confidence 467899999999999999999999999999998887654 467999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++....... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.
T Consensus 135 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 211 (311)
T 4agu_A 135 ITKHSVIKLCDFGFARLLTGPS---DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ 211 (311)
T ss_dssp ECTTSCEEECCCTTCEECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EcCCCCEEEeeCCCchhccCcc---cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999987543222 1223468899999999998657789999999999999999999999998776555
Q ss_pred HHHHHhcCCC------------------CCCc--------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 162 LLMTIQNAPP------------------GLDY--------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 162 l~~~i~~~~~------------------~~~~--------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.......... .... .....++..+.+||.+||.+||.+|||++++++||||+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 212 LYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp HHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 4332221000 0000 0114578899999999999999999999999999999988
Q ss_pred CCCc
Q 007967 216 KPPE 219 (583)
Q Consensus 216 ~~~~ 219 (583)
....
T Consensus 292 ~~~~ 295 (311)
T 4agu_A 292 REIE 295 (311)
T ss_dssp C---
T ss_pred cCHH
Confidence 7543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.39 Aligned_cols=206 Identities=29% Similarity=0.426 Sum_probs=174.4
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.+||||++++++|.+++.+|+|||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 73 ~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV 150 (342)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred cCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEe
Confidence 3799999999999999999999999999999998864 36799999999999999999999999999999999999984
Q ss_pred CC----CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC--C
Q 007967 84 TN----GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY--P 157 (583)
Q Consensus 84 ~~----g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~--~ 157 (583)
.+ +.+||+|||++....... ....+.+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+. .
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 226 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAEN---GLLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTT---CCBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS
T ss_pred cCCCCcCeEEEEECCCcccCcCCC---CceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC
Confidence 33 359999999987553322 1224578999999999997 456899999999999999999999999863 2
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
....+...+......+....+..+++.+++||.+||..||.+|||+.++++||||.+.
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 227 TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 3344555555555444445567899999999999999999999999999999999653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=332.44 Aligned_cols=204 Identities=26% Similarity=0.495 Sum_probs=170.0
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.+ ...+|+|||||++|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 356899999999999997 678999999999999887543 357999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCC--CCccccccchhhHHhhhhhCCCCCCCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSG--YNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~--ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|||++.++.+||+|||++....... ......+||+.|+|||++..... ++.++|||||||++|+|++|..||.+.
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999987553221 12234689999999999974332 478899999999999999999999886
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
...... ..+.... ..++....+++.+++||.+||..||.+|||+.++++||||+
T Consensus 244 ~~~~~~-~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 244 RIMCLH-SKIKSQA--LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SHHHHH-HHHHHCC--CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred cHHHHH-HHHhccc--CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 654433 3333322 22333457899999999999999999999999999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=353.46 Aligned_cols=217 Identities=24% Similarity=0.362 Sum_probs=165.5
Q ss_pred CCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++|||||+++++|... ..+|+||||| +|+|.+++.. ...+++..++.|++||+.||+|||++||+|||||
T Consensus 107 ~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlK 183 (458)
T 3rp9_A 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK 183 (458)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred HhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 467999999999999543 5799999998 5789888764 3669999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCC------------------------ccccccccCCCCCCCcccccCCCCCCc
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDR------------------------QRSRNTFVGTPCWMAPEVLQPGSGYNS 132 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~------------------------~~~~~~~~GT~~Y~APEil~~~~~ys~ 132 (583)
|+||||+.++.+||+|||+|+........ .......+||++|+|||++.....|+.
T Consensus 184 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 263 (458)
T 3rp9_A 184 PANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263 (458)
T ss_dssp GGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCT
T ss_pred hhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCc
Confidence 99999999999999999999765322110 012345789999999998765678999
Q ss_pred cccccchhhHHhhhhh-----------CCCCCCCCCh--------------------HHHHHHHHh--cCC---------
Q 007967 133 KADIWSFGITALELAH-----------GHAPFSKYPP--------------------MKVLLMTIQ--NAP--------- 170 (583)
Q Consensus 133 ksDIWSLGvILyeLLt-----------G~~PF~~~~~--------------------~~~l~~~i~--~~~--------- 170 (583)
++||||||||+|||++ |.++|.+... ...+..++. +.+
T Consensus 264 ~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 343 (458)
T 3rp9_A 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343 (458)
T ss_dssp HHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSS
T ss_pred HhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcC
Confidence 9999999999999998 7777766431 111111110 000
Q ss_pred ------------CC---CCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCchh
Q 007967 171 ------------PG---LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELS 221 (583)
Q Consensus 171 ------------~~---~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~~ 221 (583)
.. ........+++++.+||.+||.+||.+|||++|+|+||||+...++...
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp CHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred CHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence 00 0011234568999999999999999999999999999999998876554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.69 Aligned_cols=219 Identities=57% Similarity=1.010 Sum_probs=174.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY------QDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~------~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|...+.+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 67 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 146 (303)
T 2vwi_A 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRD 146 (303)
T ss_dssp CCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 567899999999999999999999999999999999987532 34589999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCC--CccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGD--RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~--~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
|||+|||++.++.+||+|||++........ .........||+.|+|||++.....++.++|||||||++|+|++|..|
T Consensus 147 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 226 (303)
T 2vwi_A 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226 (303)
T ss_dssp CSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999998865432211 111223468999999999987435689999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCc-----cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDY-----DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~-----~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
|............+......... .....++..+++||.+||..||.+|||+.++++||||+.....+
T Consensus 227 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 227 YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp TTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred CccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence 99887766665555554333221 22356789999999999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=323.61 Aligned_cols=208 Identities=25% Similarity=0.442 Sum_probs=178.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++..|+|||||.||+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 137 (284)
T 3kk8_A 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL 137 (284)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEE
Confidence 4679999999999999999999999999999999887764 67999999999999999999999999999999999999
Q ss_pred EcCCCc---EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 82 LDTNGV---VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 82 ld~~g~---IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
++.++. +||+|||++...... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.+...
T Consensus 138 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 138 LASKAKGAAVKLADFGLAIEVNDS----EAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp ESSSSTTCCEEECCCTTCEECCSS----CBCCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EecCCCCCcEEEeeceeeEEcccC----ccccCCCCCcCCcCchhhc-CCCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 986655 999999998654221 1223468999999999998 56789999999999999999999999988766
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.... ..+.........+.+..+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus 213 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 213 HRLY-AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHH-HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred hHHH-HHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 5444 344444444444455678999999999999999999999999999999997654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=323.49 Aligned_cols=206 Identities=30% Similarity=0.479 Sum_probs=175.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni 137 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 137 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHE
Confidence 35689999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EE---cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LL---DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Ll---d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|+ +.++.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||....
T Consensus 138 l~~~~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 138 LFLTDSPDSPLKLIDFGLAARFKPG----KMMRTKVGTPYYVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp EESSSSTTCCEEECCCTTCEECCTT----SCBCCCCSCTTTCCHHHHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEecCCCCCcEEEEecccceeccCc----cchhccCCCCCccChHHhc--ccCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 99 78889999999998754322 1223468999999999987 348999999999999999999999999877
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
..+...... ..........+..+++.+.+||.+||..||.+|||+.++|+||||++.
T Consensus 212 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 212 DSEVMLKIR-EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHH-HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHH-hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 655554443 333333333334689999999999999999999999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.58 Aligned_cols=222 Identities=26% Similarity=0.398 Sum_probs=185.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||++++++|++...+|||||||+||+|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 240 ~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~N 319 (543)
T 3c4z_A 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319 (543)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHH
Confidence 46799999999999999999999999999999999887532 3469999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC--
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP-- 157 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~-- 157 (583)
||++.+|++||+|||++..+.... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+..
T Consensus 320 ILl~~~g~vkL~DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~ 395 (543)
T 3c4z_A 320 VLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMAPELLL-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395 (543)
T ss_dssp EEECTTSCEEECCCTTCEECCTTC---CCBCCCCSCTTTSCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC
T ss_pred EEEeCCCCEEEeecceeeeccCCC---cccccccCCccccChhhhc-CCCCChHHhcCcchHHHHHHHhCCCCCCCCccc
Confidence 999999999999999987653221 1223468999999999998 5689999999999999999999999998753
Q ss_pred -hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 158 -PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 158 -~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
....+...+...... .+..++..+++||.+||++||.+||+ +++|++||||+.++|..+......+++.|
T Consensus 396 ~~~~~~~~~i~~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P 471 (543)
T 3c4z_A 396 VENKELKQRVLEQAVT----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVP 471 (543)
T ss_dssp CCHHHHHHHHHHCCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred hhHHHHHHHHhhcccC----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCC
Confidence 223344444433322 23578999999999999999999996 58999999999998877666555555544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=325.09 Aligned_cols=207 Identities=29% Similarity=0.506 Sum_probs=169.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.+...+|+|||||+||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~ 153 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE 153 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHH
Confidence 357899999999999999999999999999999999886542 366999999999999999999999999999999999
Q ss_pred cEEE---cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 79 NILL---DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 79 NILl---d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|||+ +.++.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+
T Consensus 154 NIl~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 154 NILFQDTSPHSPIKIIDFGLAELFKSD----EHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp GEEESSSSTTCCEEECCCCCCCC--------------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HEEEecCCCCCCEEEEeeecceecCCc----ccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 9999 45678999999998654221 1123467999999999986 4689999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
............. ...... ....+++.+.+||.+||..||.+|||+.++|+||||+++
T Consensus 228 ~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 228 TSLEEVQQKATYK-EPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp SSHHHHHHHHHHC-CCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred CCHHHHHhhhccC-Cccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 7655544333332 222221 224578999999999999999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.52 Aligned_cols=212 Identities=22% Similarity=0.370 Sum_probs=171.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NI 131 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131 (324)
T ss_dssp HSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGE
T ss_pred HHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHE
Confidence 467899999999999999999999999997 5888887654 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... .......+||+.|+|||++.+...|+.++|||||||++|+|++|..||.+....+
T Consensus 132 l~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 208 (324)
T 3mtl_A 132 LINERGELKLADFGLARAKSIP---TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208 (324)
T ss_dssp EECTTCCEEECSSSEEECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EECCCCCEEEccCcccccccCC---ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998644221 1222346789999999999866789999999999999999999999999877666
Q ss_pred HHHHHHhc--CCCCCCc-----------------------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 161 VLLMTIQN--APPGLDY-----------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 161 ~l~~~i~~--~~~~~~~-----------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.+...... .+....+ .....+++++++||.+||++||.+|||++|+|+||||...
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 55443331 1111111 1123568899999999999999999999999999999987
Q ss_pred CC
Q 007967 216 KP 217 (583)
Q Consensus 216 ~~ 217 (583)
..
T Consensus 289 ~~ 290 (324)
T 3mtl_A 289 GE 290 (324)
T ss_dssp CS
T ss_pred cc
Confidence 54
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.18 Aligned_cols=209 Identities=25% Similarity=0.371 Sum_probs=178.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|||||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 140 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 218 (373)
T 2x4f_A 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENI 218 (373)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 46789999999999999999999999999999999987653 35699999999999999999999999999999999999
Q ss_pred EE--cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LL--DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Ll--d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|+ +.++.+||+|||+++..... ......+||+.|+|||++. ...++.++|||||||++|+|++|..||.+...
T Consensus 219 ll~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 219 LCVNRDAKQIKIIDFGLARRYKPR----EKLKVNFGTPEFLAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp EEEETTTTEEEECCCSSCEECCTT----CBCCCCCSSCTTCCHHHHT-TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred EEecCCCCcEEEEeCCCceecCCc----cccccccCCCcEeChhhcc-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99 56789999999998755322 1223457999999999997 56789999999999999999999999998777
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.+.+..++.. ...+....+..+++++++||.+||++||.+|||+.++|+||||+..+
T Consensus 294 ~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 294 AETLNNILAC-RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHHHHHT-CCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHHhc-cCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 6655544443 33333344567899999999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=340.40 Aligned_cols=210 Identities=22% Similarity=0.367 Sum_probs=176.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+++.+|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 60 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl 137 (323)
T 3tki_A 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137 (323)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEE
Confidence 467999999999999999999999999999999998754 356999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++..+.... ........+||+.|+|||++.+...++.++|||||||++|+|++|..||........
T Consensus 138 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 138 LDERDNLKISDFGLATVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp ECTTCCEEECCCTTCEECEETT-EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred EeCCCCEEEEEeeccceeccCC-cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 9999999999999987543222 222234578999999999998544458899999999999999999999987655433
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
......... .....+..++..+.+||.+||..||.+|||+.|+++||||+...
T Consensus 217 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 217 EYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHTTC--TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHhccc--ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 333333322 22233467899999999999999999999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.34 Aligned_cols=210 Identities=21% Similarity=0.369 Sum_probs=178.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+...+|+|||||.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI 180 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 180 (387)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHe
Confidence 46789999999999999999999999999999999987542 34699999999999999999999999999999999999
Q ss_pred EEcC--CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~--~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++. ++.+||+|||++...... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+...
T Consensus 181 ll~~~~~~~vkL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 255 (387)
T 1kob_A 181 MCETKKASSVKIIDFGLATKLNPD----EIVKVTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255 (387)
T ss_dssp EESSTTCCCEEECCCTTCEECCTT----SCEEEECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred EEecCCCCceEEEecccceecCCC----cceeeeccCCCccCchhcc-CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence 9974 578999999998755221 1123458999999999998 56789999999999999999999999998776
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.+.+... ......+....+..+++++++||.+||..||.+|||+.++|+||||+....
T Consensus 256 ~~~~~~i-~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 256 LETLQNV-KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHH-HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHH-HhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 5555433 333333444445678999999999999999999999999999999987643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=334.45 Aligned_cols=203 Identities=29% Similarity=0.423 Sum_probs=168.0
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.++||||++++++|...+.+|+||||| +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 170 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEE
Confidence 346999999999999999999999999 9999999987655679999999999999999999999999999999999999
Q ss_pred cC-------------------------CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCcccccc
Q 007967 83 DT-------------------------NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIW 137 (583)
Q Consensus 83 d~-------------------------~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIW 137 (583)
+. ++.+||+|||++..... .....+||+.|+|||++. +..|+.++|||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~Diw 243 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------YHGSIINTRQYRAPEVIL-NLGWDVSSDMW 243 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS------CCCSCCSCGGGCCHHHHT-TCCCCTTHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCC------CCcCccCcccccCcHHHc-CCCCCCccchH
Confidence 75 78999999999864321 123468999999999998 56799999999
Q ss_pred chhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCC-----------------------Cccc-----------------
Q 007967 138 SFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL-----------------------DYDR----------------- 177 (583)
Q Consensus 138 SLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~-----------------------~~~~----------------- 177 (583)
||||++|+|++|..||.+....+.+........+.. .++.
T Consensus 244 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 323 (360)
T 3llt_A 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323 (360)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc
Confidence 999999999999999988776554433322111000 0000
Q ss_pred -cccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 178 -DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 178 -~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
....++.+.+||.+||++||.+|||+.++|+||||+
T Consensus 324 ~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 011237788999999999999999999999999996
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.48 Aligned_cols=210 Identities=25% Similarity=0.406 Sum_probs=178.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+...+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl 147 (321)
T 2a2a_A 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147 (321)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEE
Confidence 467899999999999999999999999999999999864 467999999999999999999999999999999999999
Q ss_pred EcCCC----cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 82 LDTNG----VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 82 ld~~g----~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
++.++ .+||+|||++...... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.+..
T Consensus 148 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 148 LLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp ESCTTSSSCCEEECCCTTCEECCTT----CCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred EecCCCCcCCEEEccCccceecCcc----ccccccCCCCCccCccccc-CCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 99888 7999999998754322 1223467999999999997 5678999999999999999999999998876
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
..+.+. .+..............++..+++||.+||..||.+|||+.++++||||+...+..
T Consensus 223 ~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~ 283 (321)
T 2a2a_A 223 KQETLA-NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283 (321)
T ss_dssp HHHHHH-HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHH
T ss_pred HHHHHH-HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCccc
Confidence 655443 3343333333333456889999999999999999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.35 Aligned_cols=216 Identities=25% Similarity=0.392 Sum_probs=173.4
Q ss_pred CCCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKI-AYQDGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~-~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
|+.++||||++++++|...+ .+|+|||||.++.+..+... .....+++..++.+++||+.||+|||++||+||
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr 165 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 45789999999999997544 38999999977544333222 224679999999999999999999999999999
Q ss_pred CCCCCcEEEc-CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 74 DVKAGNILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 74 DLKPeNILld-~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
||||+|||++ .++.+||+|||+|+...... .....+||++|+|||++.+...|+.++|||||||++|+|++|+.|
T Consensus 166 Dlkp~Nill~~~~~~~kL~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 241 (394)
T 4e7w_A 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241 (394)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCcEEEeeCCCcccccCCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999 79999999999987553221 223568899999999998666799999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCC----------------CCCC--------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 153 FSKYPPMKVLLMTIQNAP----------------PGLD--------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~----------------~~~~--------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|.+....+.+..++.... ..+. ......+++++.+||.+||++||.+|||+.++++
T Consensus 242 f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 999887766655543210 0000 0012347889999999999999999999999999
Q ss_pred ccccccCCCCch
Q 007967 209 HSFFKHAKPPEL 220 (583)
Q Consensus 209 HpfFk~~~~~~~ 220 (583)
||||+...+...
T Consensus 322 hp~f~~~~~~~~ 333 (394)
T 4e7w_A 322 HPFFDELRTGEA 333 (394)
T ss_dssp SGGGSTTTSSCC
T ss_pred Chhhhhhccccc
Confidence 999998876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=335.85 Aligned_cols=220 Identities=30% Similarity=0.503 Sum_probs=180.3
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|.++..+|||||||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS 194 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 6999999999999999999999999999999998764 67999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhhCCCCCCCCC---hHH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSKYP---PMK 160 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLtG~~PF~~~~---~~~ 160 (583)
++.+||+|||+++.+.... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... ...
T Consensus 195 ~~~~kl~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 272 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272 (355)
T ss_dssp TSCEEESCSSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred CCcEEEeeCCCCeecccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH
Confidence 9999999999987543221 1122356899999999999842 457899999999999999999999997532 223
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCCCch
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPPL 232 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p~ 232 (583)
.+...+....+ ..+..++..+++||.+||..||.+|| |+.++++||||+...+..+..+....++.|.
T Consensus 273 ~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~ 345 (355)
T 1vzo_A 273 EISRRILKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 345 (355)
T ss_dssp HHHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHHhccCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCc
Confidence 33333333222 22356889999999999999999999 9999999999999887776666655555443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=343.17 Aligned_cols=218 Identities=25% Similarity=0.387 Sum_probs=162.7
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQ-------DGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~-------~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
|+.++|||||+++++|.. +..+|||||||. |+|.+++..... ..+++..++.|++||+.||.|||++||+
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 150 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 150 (405)
T ss_dssp HHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 356899999999999965 678999999996 578887764321 2499999999999999999999999999
Q ss_pred ccCCCCCcEEE----cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 72 HRDVKAGNILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 72 HRDLKPeNILl----d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
||||||+|||| +.++.+||+|||+|+...............+||++|+|||++.+...|+.++|||||||++|+|+
T Consensus 151 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 230 (405)
T 3rgf_A 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230 (405)
T ss_dssp CCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH
Confidence 99999999999 67789999999998765332222233345789999999999985567999999999999999999
Q ss_pred hCCCCCCCCCh---------HHHHHHHHh--cCCCCCCcccc-------------------------------ccchHHH
Q 007967 148 HGHAPFSKYPP---------MKVLLMTIQ--NAPPGLDYDRD-------------------------------KKFSKSF 185 (583)
Q Consensus 148 tG~~PF~~~~~---------~~~l~~~i~--~~~~~~~~~~~-------------------------------~~~S~~l 185 (583)
+|.+||.+... .+.+..++. ..+....+... ...+..+
T Consensus 231 ~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (405)
T 3rgf_A 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310 (405)
T ss_dssp HSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHH
T ss_pred hCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHH
Confidence 99999976543 122222221 11111111100 1126788
Q ss_pred HHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 186 kdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
.+||.+||.+||.+|||++++|+||||+....+.
T Consensus 311 ~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 311 FHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred HHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 9999999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.89 Aligned_cols=215 Identities=27% Similarity=0.446 Sum_probs=175.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------------------------------c
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------------------------------Q 43 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------------------------------~ 43 (583)
+.++||||++++++|.+.+.+|+|||||+||+|.+++.... .
T Consensus 83 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (345)
T 3hko_A 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLD 162 (345)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECC
T ss_pred HhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 46789999999999999999999999999999999874110 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCC--cEEEEecCCccccccCCC-CccccccccCCCCCCC
Q 007967 44 DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNG--VVKLADFGVSACMFDTGD-RQRSRNTFVGTPCWMA 120 (583)
Q Consensus 44 ~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g--~IKL~DFGlA~~~~~~~~-~~~~~~~~~GT~~Y~A 120 (583)
..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+..... .........||+.|+|
T Consensus 163 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~a 242 (345)
T 3hko_A 163 FVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCC
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccC
Confidence 1246888999999999999999999999999999999998776 899999999876533221 1112345689999999
Q ss_pred cccccC-CCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCC
Q 007967 121 PEVLQP-GSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK 199 (583)
Q Consensus 121 PEil~~-~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~k 199 (583)
||++.. ...++.++|||||||++|+|++|..||.+....+.....+.. ...+..+....+++.+++||.+||..||.+
T Consensus 243 PE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK-KLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred chhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-ccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 999974 367899999999999999999999999987776666555543 333444455668999999999999999999
Q ss_pred CCCHHHHHhccccccCCC
Q 007967 200 RPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 200 RpTa~eIL~HpfFk~~~~ 217 (583)
|||+.++|+||||++..+
T Consensus 322 Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 322 RFDAMRALQHPWISQFSD 339 (345)
T ss_dssp SCCHHHHHHSHHHHTTSS
T ss_pred CCCHHHHhcChhhccChH
Confidence 999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=321.30 Aligned_cols=203 Identities=25% Similarity=0.491 Sum_probs=172.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Ni 140 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGE
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhE
Confidence 36789999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... ......|++.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 141 li~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 141 LLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp EECTTSCEEECSCCEESCC-------------CCCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred EEcCCCCEEEEeccccccCCcc-----cccccCCCCCccCHhHhc-cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 9999999999999987543211 123468999999999997 5678999999999999999999999998866544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
... .+..... ..+..++..+++||.+||..||.+|||+.++++||||+...
T Consensus 215 ~~~-~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 215 TYK-RISRVEF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHH-HHHHTCC----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHH-HHHhCCC----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 443 3333222 22356889999999999999999999999999999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=319.64 Aligned_cols=203 Identities=27% Similarity=0.503 Sum_probs=173.1
Q ss_pred CCCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccC
Q 007967 1 MSLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG--HIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHRD 74 (583)
|+.++||||++++++|.. ...+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++| |+|||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~d 156 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSC
T ss_pred HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECC
Confidence 467899999999999986 46699999999999999998764 67999999999999999999999999 99999
Q ss_pred CCCCcEEEc-CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 75 VKAGNILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 75 LKPeNILld-~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
|||+|||++ .++.+||+|||++..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 157 ikp~Nil~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf 229 (290)
T 1t4h_A 157 LKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CCGGGEEESSTTSCEEECCTTGGGGCCT-----TSBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHEEEECCCCCEEEeeCCCcccccc-----cccccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCC
Confidence 999999997 789999999999864321 1123467999999999987 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
............+..... ....+...++.+.+||.+||..||.+|||+.++++||||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 230 SECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp TTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCcCcHHHHHHHHhccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 887666666555554332 22334567789999999999999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=322.61 Aligned_cols=212 Identities=45% Similarity=0.828 Sum_probs=181.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+.+|+|||||.+|+|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Ni 156 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHE
Confidence 35689999999999999999999999999999999998643 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 157 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 157 LLNTEGHAKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp EECTTCCEEECCCTTCEECBTT---BSCBCCCCSCGGGCCHHHHS-SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EECCCCCEEEeecccchhhhhh---ccccCccCCCCCccChhhcC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999998654322 11223468999999999998 5678999999999999999999999999877766
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
............+ .....++..+.+||.+||..||.+|||+.++++||||+......
T Consensus 233 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 233 AIFMIPTNPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp HHHHHHHSCCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred HHHHHhcCCCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 6555444433322 33456899999999999999999999999999999999876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=332.89 Aligned_cols=210 Identities=27% Similarity=0.419 Sum_probs=176.7
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|.+.+.+|+|||||.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 166 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESC
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEec
Confidence 67999999999999999999999999999999875444467999999999999999999999999999999999999987
Q ss_pred ---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 85 ---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 85 ---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+||+|||++....... .....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+......
T Consensus 167 ~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 167 IYPLGDIKIVDFGMSRKIGHAC----ELREIMGTPEYLAPEILN-YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp BTTBCCEEECCGGGCEEC-------------CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCCcEEEeeCccccccCCcc----ccccccCCcCccCCeeec-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 7899999999987542221 123468999999999997 56789999999999999999999999988776555
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCch
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~ 220 (583)
... +..............+++.+++||.+||..||.+|||++++|+||||+..++...
T Consensus 242 ~~~-i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 242 YLN-ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHH-HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred HHH-HHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 443 3333334444555678999999999999999999999999999999998876544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.51 Aligned_cols=217 Identities=24% Similarity=0.339 Sum_probs=172.5
Q ss_pred CCCCCCcccceEEEEEE--------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 2 SLIDHPNVIRAYCSFVV--------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d--------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
+.++||||++++++|.+ .+.+|+|||||.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~ 148 (351)
T 3mi9_A 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHR 148 (351)
T ss_dssp HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence 46789999999999987 4579999999975 777766533 3569999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCccccccCCC-CccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 74 DVKAGNILLDTNGVVKLADFGVSACMFDTGD-RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 74 DLKPeNILld~~g~IKL~DFGlA~~~~~~~~-~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
||||+|||++.++.+||+|||++..+..... ........+||+.|+|||++.+...|+.++|||||||++|+|++|..|
T Consensus 149 Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 228 (351)
T 3mi9_A 149 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 228 (351)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999875532211 112223468899999999998556789999999999999999999999
Q ss_pred CCCCChHHHHHHHHh--cCCCCCCccccc-------------------------cchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 153 FSKYPPMKVLLMTIQ--NAPPGLDYDRDK-------------------------KFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 153 F~~~~~~~~l~~~i~--~~~~~~~~~~~~-------------------------~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
|.+......+..... ...+...++... ..++.+++||.+||++||.+|||+.+
T Consensus 229 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 229 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 998776555433332 111111111100 12678999999999999999999999
Q ss_pred HHhccccccCCCCch
Q 007967 206 LLKHSFFKHAKPPEL 220 (583)
Q Consensus 206 IL~HpfFk~~~~~~~ 220 (583)
+|+||||+....+..
T Consensus 309 ~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 309 ALNHDFFWSDPMPSD 323 (351)
T ss_dssp HHTSGGGGSSSCCCC
T ss_pred HhCCCCcCCCCCccc
Confidence 999999998766543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=333.92 Aligned_cols=212 Identities=27% Similarity=0.384 Sum_probs=175.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 144 (346)
T 1ua2_A 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL 144 (346)
T ss_dssp HHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred hhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEE
Confidence 457899999999999999999999999976 788776542 346899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|.+||+|||++....... ......+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+....+.
T Consensus 145 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~ 221 (346)
T 1ua2_A 145 LDENGVLKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 221 (346)
T ss_dssp ECTTCCEEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EcCCCCEEEEecccceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999999987543221 2233468999999999997556789999999999999999999999998877666
Q ss_pred HHHHHhcC--CCCCCcc---------------------ccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 162 LLMTIQNA--PPGLDYD---------------------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 162 l~~~i~~~--~~~~~~~---------------------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
+..+.... +....++ ....++..+++||.+||..||.+|||+.++|+||||++...+
T Consensus 222 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 222 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 55444321 1111000 014567899999999999999999999999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=351.04 Aligned_cols=204 Identities=28% Similarity=0.465 Sum_probs=175.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI 147 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence 4678999999999999999999999999999999998764 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++...... ....+.+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.....
T Consensus 148 ll~~~~~vkL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 223 (476)
T 2y94_A 148 LLDAHMNAKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223 (476)
T ss_dssp EECTTCCEEECCCSSCEECCTT----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH
T ss_pred EEecCCCeEEEeccchhhcccc----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999998754221 123456899999999999854445789999999999999999999998866544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
... .+..... ..+..+++.+++||.+||..||.+|||+.++++||||+..
T Consensus 224 ~~~-~i~~~~~----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 224 LFK-KICDGIF----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHH-HHHTTCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHH-HHhcCCc----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 443 3333322 2235688999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.41 Aligned_cols=208 Identities=29% Similarity=0.494 Sum_probs=176.5
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|.+++.+|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC
Confidence 5999999999999999999999999999999998764 67999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc-----CCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ-----PGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~-----~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
++.+||+|||++...... .......|++.|+|||++. ....++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 235 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235 (298)
T ss_dssp TCCEEECCCTTCEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCcEEEecccchhhcCCC----cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence 999999999998654221 1223467999999999985 2456889999999999999999999999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
...... .........+.+..++..+.+||.+||..||.+|||+.++++||||++....+
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 236 LMLRMI-MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294 (298)
T ss_dssp HHHHHH-HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred HHHHHH-hcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence 544333 33333344444567899999999999999999999999999999999876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=322.41 Aligned_cols=206 Identities=27% Similarity=0.447 Sum_probs=176.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+...+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl 138 (304)
T 2jam_A 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLL 138 (304)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCE
T ss_pred HhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 4679999999999999999999999999999999988764 67999999999999999999999999999999999999
Q ss_pred E---cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 82 L---DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 82 l---d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
+ +.++.+||+|||++..... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+...
T Consensus 139 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 212 (304)
T 2jam_A 139 YLTPEENSKIMITDFGLSKMEQN-----GIMSTACGTPGYVAPEVLA-QKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212 (304)
T ss_dssp ESSSSTTCCEEBCSCSTTCCCCC-----BTTHHHHSCCCBCCTTTBS-SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EecCCCCCCEEEccCCcceecCC-----CccccccCCCCccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9 7788999999999864311 1123457999999999998 56789999999999999999999999988666
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.... ..+...........+..++..+++||.+||..||.+|||+.++++||||+...
T Consensus 213 ~~~~-~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 213 SKLF-EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHH-HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHH-HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 5444 44444433344444567899999999999999999999999999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.61 Aligned_cols=197 Identities=24% Similarity=0.372 Sum_probs=163.6
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
+||||++++++|.+.+.+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 148 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence 899999999999999999999999999999999876533 669999999999999999999999999999999999999
Q ss_pred cCC-------------------CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHH
Q 007967 83 DTN-------------------GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITA 143 (583)
Q Consensus 83 d~~-------------------g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvIL 143 (583)
+.+ ..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (289)
T 1x8b_A 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTV 221 (289)
T ss_dssp C--------------------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHH
T ss_pred cCCCCCcccccccccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHH
Confidence 844 47999999998754221 2346899999999998555777899999999999
Q ss_pred hhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 144 LELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 144 yeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
|+|++|.+||..... .........+ ..+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 222 ~~l~~~~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 222 VCAAGAEPLPRNGDQ---WHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHTTCCCCCSSSHH---HHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHhcCCCCCcchhH---HHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 999999988755332 2222222221 2235689999999999999999999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.16 Aligned_cols=202 Identities=26% Similarity=0.454 Sum_probs=174.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 69 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146 (284)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred hcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 5689999999999999999999999999999999998764 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++...... ......|++.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 220 (284)
T 2vgo_A 147 MGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220 (284)
T ss_dssp ECTTCCEEECCCTTCEECSSS-----CBCCCCSCGGGCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EcCCCCEEEecccccccCccc-----ccccccCCCCcCCHHHhc-cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH
Confidence 999999999999988643211 123468999999999998 56789999999999999999999999988665544
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.... ..... ..+..++..+++||.+||..||.+|||+.++++||||+...
T Consensus 221 ~~~~-~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 221 HRRI-VNVDL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHH-HTTCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHH-hcccc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 4333 33222 23356889999999999999999999999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.32 Aligned_cols=202 Identities=30% Similarity=0.524 Sum_probs=173.7
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||++++++|.....+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 7999999999999999999999999999999998754 67999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-----CCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 85 NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-----GSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 85 ~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
+|.+||+|||++..+... ......+||+.|+|||++.+ ...|+.++|||||||++|+|++|..||.+....
T Consensus 236 ~~~ikl~DfG~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPG----EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp TCCEEECCCTTCEECCTT----CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCEEEEecCcccccCCC----cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999998755321 12234689999999999862 235889999999999999999999999886665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
..+.. +.........+.+..++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 312 ~~~~~-i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 312 LMLRM-IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHH-HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHH-HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 54433 333333333344567889999999999999999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.33 Aligned_cols=217 Identities=25% Similarity=0.369 Sum_probs=166.8
Q ss_pred CCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++||||+++++++... ..+|+|||||. |+|.+++.. ...+++..++.+++||+.||.|||++||+|||||
T Consensus 80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk 156 (432)
T 3n9x_A 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLK 156 (432)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 467899999999999876 57999999995 699998764 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCC-------------------ccccccccCCCCCCCcccccCCCCCCcccccc
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDR-------------------QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIW 137 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~-------------------~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIW 137 (583)
|+|||++.++.+||+|||+|+........ .......+||++|+|||++.....|+.++|||
T Consensus 157 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Diw 236 (432)
T 3n9x_A 157 PANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236 (432)
T ss_dssp GGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHH
T ss_pred HHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccc
Confidence 99999999999999999999765332111 01235679999999999976567899999999
Q ss_pred chhhHHhhhhhC-----------CCCCCCCCh-----------------HHHHHHH-----------------------H
Q 007967 138 SFGITALELAHG-----------HAPFSKYPP-----------------MKVLLMT-----------------------I 166 (583)
Q Consensus 138 SLGvILyeLLtG-----------~~PF~~~~~-----------------~~~l~~~-----------------------i 166 (583)
||||++|||++| .++|.+... ...+..+ +
T Consensus 237 SlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~ 316 (432)
T 3n9x_A 237 STGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316 (432)
T ss_dssp HHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHH
T ss_pred hHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHH
Confidence 999999999984 444544321 1111111 1
Q ss_pred hcCCCCCCc---cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCchh
Q 007967 167 QNAPPGLDY---DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELS 221 (583)
Q Consensus 167 ~~~~~~~~~---~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~~~ 221 (583)
...+..... ...+.+++++++||.+||.+||.+|||++++|+||||+...++...
T Consensus 317 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE 374 (432)
T ss_dssp HTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC
T ss_pred HhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccC
Confidence 111111000 1124578999999999999999999999999999999998876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.03 Aligned_cols=207 Identities=29% Similarity=0.421 Sum_probs=172.5
Q ss_pred CCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 2 SLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
+.++||||++++++|.... .+|+||||| |++|.+++.. ..+++..++.+++||+.||.|||++||+||||
T Consensus 79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dl 154 (367)
T 1cm8_A 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDL 154 (367)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 4678999999999998763 469999999 8999998864 67999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.+||+|||+++.... .....+||++|+|||++.+...|+.++||||+||++|+|++|+.||.+
T Consensus 155 kp~NIll~~~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 155 KPGNLAVNEDCELKILDFGLARQADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEEcCCCCEEEEeeeccccccc------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999875421 123568999999999998557899999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCC----------------------C---CC-ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQNAPP----------------------G---LD-YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~----------------------~---~~-~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
......+..++..... . .. ......+++.+.+||.+||..||.+|||++++|+|
T Consensus 229 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 229 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 7766555443321100 0 00 01124568999999999999999999999999999
Q ss_pred cccccCCCC
Q 007967 210 SFFKHAKPP 218 (583)
Q Consensus 210 pfFk~~~~~ 218 (583)
|||+....+
T Consensus 309 p~f~~~~~~ 317 (367)
T 1cm8_A 309 PYFESLHDT 317 (367)
T ss_dssp GGGTTTC--
T ss_pred hHHHhhcCC
Confidence 999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=324.11 Aligned_cols=197 Identities=28% Similarity=0.376 Sum_probs=164.4
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
..||||++++++|.+++.+||||||| +|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 48999999999999999999999999 77898887664 45699999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHH
Q 007967 84 TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLL 163 (583)
Q Consensus 84 ~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~ 163 (583)
.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....
T Consensus 192 ~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---- 261 (311)
T 3p1a_A 192 PRGRCKLGDFGLLVELGTA----GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---- 261 (311)
T ss_dssp GGGCEEECCCTTCEECC----------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----
T ss_pred CCCCEEEccceeeeecccC----CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----
Confidence 9999999999998654221 12234579999999999973 6899999999999999999997777553222
Q ss_pred HHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 164 MTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 164 ~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
..+.... ........+++.+.+||.+||++||.+|||+.++|+||||++
T Consensus 262 ~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 262 QQLRQGY--LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHTTTC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHhccC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 2222221 222334568899999999999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.36 Aligned_cols=210 Identities=22% Similarity=0.387 Sum_probs=172.0
Q ss_pred CCCCCCCcccceEEEEEE--------------------------------------CCEEEEEEecCCCCCHHHHHHHH-
Q 007967 1 MSLIDHPNVIRAYCSFVV--------------------------------------DSNLWVVMPFMAEGSCLHLMKIA- 41 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--------------------------------------~~~l~LVmEy~~GGsL~dll~~~- 41 (583)
|+.++|||||+++++|.. +.++++|||||+ |+|.+.+...
T Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 132 (383)
T 3eb0_A 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI 132 (383)
T ss_dssp HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHH
T ss_pred HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH
Confidence 467899999999999954 345999999997 5787776642
Q ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc-CCCcEEEEecCCccccccCCCCccccccccCCCCCC
Q 007967 42 -YQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119 (583)
Q Consensus 42 -~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld-~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~ 119 (583)
....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...... .....+||+.|+
T Consensus 133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~ 208 (383)
T 3eb0_A 133 RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYR 208 (383)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCcc
Confidence 346699999999999999999999999999999999999998 68899999999987553221 223568899999
Q ss_pred CcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCC--------------CCCc----------
Q 007967 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPP--------------GLDY---------- 175 (583)
Q Consensus 120 APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~--------------~~~~---------- 175 (583)
|||++.+...|+.++||||+||++|+|++|..||.+....+.+..++..... ...+
T Consensus 209 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (383)
T 3eb0_A 209 APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288 (383)
T ss_dssp CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHH
T ss_pred CHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHh
Confidence 9999986567999999999999999999999999998877766555431100 0000
Q ss_pred cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 176 ~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
..+..+++.+++||.+||.+||.+|||+.++|+||||+..
T Consensus 289 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred hCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 0123478899999999999999999999999999999865
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=318.64 Aligned_cols=210 Identities=22% Similarity=0.369 Sum_probs=174.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 137 (276)
T 2yex_A 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137 (276)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEE
Confidence 568999999999999999999999999999999988753 356999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++....... .........||+.|+|||++.....++.++|||||||++|+|++|..||........
T Consensus 138 ~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 216 (276)
T 2yex_A 138 LDERDNLKISDFGLATVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (276)
T ss_dssp ECTTCCEEECCCTTCEECEETT-EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH
T ss_pred EccCCCEEEeeCCCccccCCCc-chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 9999999999999987543221 112234568999999999998444457899999999999999999999987654333
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
....+..... ....+..++..+++||.+||..||.+|||+.++++||||+...
T Consensus 217 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 217 EYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHhhhccc--ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 3333333222 2233467899999999999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=325.78 Aligned_cols=188 Identities=24% Similarity=0.397 Sum_probs=147.4
Q ss_pred EEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCcccc
Q 007967 21 NLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACM 99 (583)
Q Consensus 21 ~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~ 99 (583)
.+|+|||||+||+|.+++..... ...++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence 38999999999999999875321 22567789999999999999999999999999999999999999999999998765
Q ss_pred ccCCCC---------ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCC
Q 007967 100 FDTGDR---------QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAP 170 (583)
Q Consensus 100 ~~~~~~---------~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~ 170 (583)
...... .......+||+.|+|||++. +..++.++|||||||++|+|++|..|+.. .......+....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~ 290 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH-GNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLK 290 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHH-CCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTC
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhc-CCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccC
Confidence 332211 11223468999999999998 56799999999999999999998776422 222222222221
Q ss_pred CCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 171 ~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
. .......++.+++||.+||+.||.+|||+.++++||||+++
T Consensus 291 --~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 291 --F-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp --C-CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred --C-CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 1 11234567889999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.70 Aligned_cols=206 Identities=24% Similarity=0.419 Sum_probs=162.5
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++|||||+++++|... ..+|||||||.++ |.+.+. ..+++..++.+++||+.||+|||++||+|||
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrD 189 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 189 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 3567999999999999754 4689999999765 555543 4699999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.++.+||+|||+|+.... .......+||++|+|||++. +..|+.++|||||||++|+|++|++||.
T Consensus 190 lkp~NIll~~~~~~kl~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 190 LKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp CCGGGEEECTTSCEEECCCCCC---------CCCC----CCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEeCCCCEEEEEEEeeeecCC----CcccCCCcccccccCHHHHc-CCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999875422 12234578999999999998 5689999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCC---------------------C---CCccc-------------cccchHHHHHHHHhhhcCCC
Q 007967 155 KYPPMKVLLMTIQNAPP---------------------G---LDYDR-------------DKKFSKSFKEMVAMCLVKDQ 197 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~---------------------~---~~~~~-------------~~~~S~~lkdLI~~cL~~DP 197 (583)
+.+..+.+..++..... . ..++. ....++++++||.+||.+||
T Consensus 265 g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 344 (464)
T 3ttj_A 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344 (464)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCCh
Confidence 98776655444332110 0 00000 01126789999999999999
Q ss_pred CCCCCHHHHHhccccccCC
Q 007967 198 TKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 198 ~kRpTa~eIL~HpfFk~~~ 216 (583)
.+|||++|+|+||||+...
T Consensus 345 ~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 345 AKRISVDDALQHPYINVWY 363 (464)
T ss_dssp TTSCCHHHHHTSTTTGGGC
T ss_pred hhCCCHHHHhcChhhhhcc
Confidence 9999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.08 Aligned_cols=198 Identities=26% Similarity=0.401 Sum_probs=168.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCC-CHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEG-SCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GG-sL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+.+.+|+||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 160 (335)
T 3dls_A 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN 160 (335)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHH
Confidence 46789999999999999999999999999776 99998764 3579999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||......
T Consensus 161 Ill~~~~~~kL~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 236 (335)
T 3dls_A 161 IVIAEDFTIKLIDFGSAAYLERG----KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET 236 (335)
T ss_dssp EEECTTSCEEECCCTTCEECCTT----CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG
T ss_pred EEEcCCCcEEEeecccceECCCC----CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH
Confidence 99999999999999998754322 12235689999999999985444588999999999999999999999763221
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
. ......+..+++++++||.+||.+||.+|||+.++++||||+..
T Consensus 237 ------~-----~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 ------V-----EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ------T-----TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ------H-----hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0 11122334589999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=320.31 Aligned_cols=210 Identities=26% Similarity=0.403 Sum_probs=174.7
Q ss_pred CCCCcccceEEEEE-----ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 4 IDHPNVIRAYCSFV-----VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 4 L~HPNIVkl~~~f~-----d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
++||||++++++|. ....+|+||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+
T Consensus 71 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~ 149 (326)
T 1blx_A 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149 (326)
T ss_dssp TCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred cCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH
Confidence 48999999999998 5567999999997 69999988765556999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||.+...
T Consensus 150 Nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 150 NILVTSSGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp GEEECTTCCEEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HeEEcCCCCEEEecCcccccccCC----CCccccccccceeCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999999999998654211 1223468899999999998 56789999999999999999999999998777
Q ss_pred HHHHHHHHhcC--CCCCC--------------------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 MKVLLMTIQNA--PPGLD--------------------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 ~~~l~~~i~~~--~~~~~--------------------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
...+...+... +.... ......++..+++||.+||..||.+|||+.++++||||+...
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 66554444311 00000 011245789999999999999999999999999999999887
Q ss_pred CCc
Q 007967 217 PPE 219 (583)
Q Consensus 217 ~~~ 219 (583)
...
T Consensus 305 ~~~ 307 (326)
T 1blx_A 305 RCK 307 (326)
T ss_dssp CCC
T ss_pred hhh
Confidence 543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.40 Aligned_cols=206 Identities=24% Similarity=0.442 Sum_probs=151.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 143 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGE
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 35789999999999999999999999999999999988642 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 144 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 219 (278)
T 3cok_A 144 LLTRNMNIKIADFGLATQLKMPH---EKHYTLCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219 (278)
T ss_dssp EECTTCCEEECCCTTCEECC--------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-
T ss_pred EEcCCCCEEEEeecceeeccCCC---CcceeccCCCCcCCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH
Confidence 99999999999999987543221 1123467999999999987 5678999999999999999999999998755433
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.+... . ...+..+..++.++++||.+||..||.+|||+.++++||||....
T Consensus 220 ~~~~~-~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 220 TLNKV-V----LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ----C-C----SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHH-h----hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 22111 1 112233456889999999999999999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=327.64 Aligned_cols=211 Identities=21% Similarity=0.452 Sum_probs=170.3
Q ss_pred CCCCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
|+.++||||+++++++.... ..|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+|||||
T Consensus 66 l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 143 (311)
T 3ork_A 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 143 (311)
T ss_dssp CCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 56789999999999998654 359999999999999998764 679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+|||++.++.+||+|||++................+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.
T Consensus 144 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp GGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876543332222334467999999999998 567999999999999999999999999987
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.........+..... ........++..+.+||.+||..||.+||++.+++.|+|++..
T Consensus 223 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 223 SPVSVAYQHVREDPI-PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp SHHHHHHHHHHCCCC-CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ChHHHHHHHhcCCCC-CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 776666555554322 2222335689999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.36 Aligned_cols=205 Identities=41% Similarity=0.744 Sum_probs=176.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++.+|||||||. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 186 (348)
T 1u5q_A 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186 (348)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred HhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 46799999999999999999999999997 6788877643 467999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
++.++.+||+|||++..... ....+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+....
T Consensus 187 l~~~~~~kL~DfG~a~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 259 (348)
T 1u5q_A 187 LSEPGLVKLGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259 (348)
T ss_dssp EETTTEEEECCCTTCBSSSS-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ECCCCCEEEeeccCceecCC-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999865421 234689999999999852 457899999999999999999999999988777
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
..+........+.. ....+++.+++||.+||..||.+|||++++++||||.....+
T Consensus 260 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 260 SALYHIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 76666655543322 235678999999999999999999999999999999876544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.87 Aligned_cols=211 Identities=38% Similarity=0.708 Sum_probs=176.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||
T Consensus 71 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 149 (302)
T 2j7t_A 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVL 149 (302)
T ss_dssp HHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred hcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEE
Confidence 4579999999999999999999999999999999987654 467999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc----CCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~----~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
++.++.+||+|||++....... .......||+.|+|||++. ....++.++|||||||++|+|++|..||....
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 150 MTLEGDIRLADFGVSAKNLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp ECTTSCEEECCCHHHHHHHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ECCCCCEEEEECCCCccccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9999999999999875432111 1123467999999999984 35678999999999999999999999999877
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.............+.. ..+..++..+.+||.+||..||.+|||+.++++||||+...+.
T Consensus 227 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 227 PMRVLLKIAKSDPPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp HHHHHHHHHHSCCCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred HHHHHHHHhccCCccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 7666655555443322 2346789999999999999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.84 Aligned_cols=209 Identities=28% Similarity=0.463 Sum_probs=167.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|. ...+|+|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 194 l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI 270 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV 270 (419)
T ss_dssp HHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 35679999999999985 5568999999999999887654 46799999999999999999999999999999999999
Q ss_pred EEcCCC---cEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 81 LLDTNG---VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 81 Lld~~g---~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|++.++ .+||+|||+++.... .......+||+.|+|||++.. ...|+.++|||||||++|+|++|..||..
T Consensus 271 ll~~~~~~~~~kl~DFG~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 271 LLSSQEEDCLIKITDFGHSKILGE----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp EESSSSSSCCEEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEecCCCcceEEEeecccceecCC----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 997544 599999999875422 122235789999999999863 35688999999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
......+...+...........+..+++.+++||.+||++||.+|||+.++|+||||++.+
T Consensus 347 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 347 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp CSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred CcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 6554444455555444433344467899999999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.14 Aligned_cols=210 Identities=35% Similarity=0.625 Sum_probs=172.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+++.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++ ||+||||||+|
T Consensus 85 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~N 162 (360)
T 3eqc_A 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 162 (360)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred HHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHH
Confidence 46789999999999999999999999999999999998764 6799999999999999999999996 99999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.+||+|||++...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 163 il~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 236 (360)
T 3eqc_A 163 ILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236 (360)
T ss_dssp EEECTTCCEEECCCCCCHHHHHH-----C----CCCCTTCCHHHHT-TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred EEECCCCCEEEEECCCCcccccc-----cccCCCCCCCeECHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999998654221 123468999999999998 567999999999999999999999999875543
Q ss_pred HHHHH-----------------------------------------HHhcCCCCCCccccccchHHHHHHHHhhhcCCCC
Q 007967 160 KVLLM-----------------------------------------TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQT 198 (583)
Q Consensus 160 ~~l~~-----------------------------------------~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~ 198 (583)
..... .+..... .......++.++.+||.+||.+||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~ 314 (360)
T 3eqc_A 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPA 314 (360)
T ss_dssp HHHHHHC------------------------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTT
T ss_pred HHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChh
Confidence 32111 0111100 1111234788999999999999999
Q ss_pred CCCCHHHHHhccccccCCCCch
Q 007967 199 KRPTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 199 kRpTa~eIL~HpfFk~~~~~~~ 220 (583)
+|||+.++|+||||+...+..+
T Consensus 315 ~Rpt~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 315 ERADLKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp TSCCHHHHHTSHHHHHHHHSCC
T ss_pred hCCCHHHHhhChHhhcchHhhh
Confidence 9999999999999997665444
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.39 Aligned_cols=207 Identities=27% Similarity=0.429 Sum_probs=174.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 63 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 140 (283)
T 3bhy_A 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIM 140 (283)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEE
Confidence 4678999999999999999999999999999999998753 67999999999999999999999999999999999999
Q ss_pred EcCCC----cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 82 LDTNG----VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 82 ld~~g----~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
++.++ .+||+|||++....... ......|++.|+|||++. ...++.++|||||||++|+|++|..||.+..
T Consensus 141 ~~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 141 LLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp ESCSSSSSCCEEECCCTTCEECC------------CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EecCCCCCCceEEEecccceeccCCC----cccccCCCcCccCcceec-CCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 98877 89999999987542211 123457899999999997 5678999999999999999999999998876
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
....+ ..+..............++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 216 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 216 KQETL-TNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHH-HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred hHHHH-HHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 65444 33443333333334457889999999999999999999999999999998653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=314.05 Aligned_cols=204 Identities=28% Similarity=0.462 Sum_probs=165.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+.+.+|+|||||.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 143 (276)
T 2h6d_A 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143 (276)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEE
T ss_pred hcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEE
Confidence 5689999999999999999999999999999999998764 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++...... .......|++.|+|||++.+...++.++|||||||++|+|++|..||........
T Consensus 144 ~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 219 (276)
T 2h6d_A 144 LDAHMNAKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219 (276)
T ss_dssp ECTTSCEEECCCCGGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ECCCCCEEEeecccccccCCC----cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH
Confidence 999999999999998654221 1123457899999999998444447899999999999999999999988655443
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
. ..+...... .+..++..+.++|.+||+.||.+|||+.++++||||++..
T Consensus 220 ~-~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 220 F-KKIRGGVFY----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp H-HHHHHCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred H-HHhhcCccc----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 3 344433222 2355789999999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.86 Aligned_cols=206 Identities=33% Similarity=0.614 Sum_probs=163.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAG 78 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPe 78 (583)
+.++||||++++++|.+++.+|+|||||+ |+|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+
T Consensus 61 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~ 139 (290)
T 3fme_A 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139 (290)
T ss_dssp TTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGG
T ss_pred HhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 56899999999999999999999999997 5887776643 245699999999999999999999998 9999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc---CCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ---PGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~---~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|||++.++.+||+|||++...... .......||+.|+|||++. ....++.++|||||||++|+|++|..||..
T Consensus 140 Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 140 NVLINALGQVKMCDFGISGYLVDD----VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp GCEECTTCCEEBCCC-------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred HEEECCCCCEEEeecCCccccccc----ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 999999999999999998654322 1223357999999999973 356789999999999999999999999986
Q ss_pred CC-hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 156 YP-PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 156 ~~-~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.. ....+...+....+.. ....+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 216 WGTPFQQLKQVVEEPSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CSCHHHHHHHHHHSCCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCchHHHHHHHhccCCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 43 3444444444433322 234688999999999999999999999999999999854
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=330.30 Aligned_cols=210 Identities=26% Similarity=0.438 Sum_probs=169.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 79 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil 156 (331)
T 4aaa_A 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156 (331)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred hhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEE
Confidence 467899999999999999999999999999988876543 467999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++....... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+......
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (331)
T 4aaa_A 157 VSQSGVVKLCDFGFARTLAAPG---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ 233 (331)
T ss_dssp ECTTSCEEECCCTTC---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EcCCCcEEEEeCCCceeecCCc---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999987543222 1223467999999999998555789999999999999999999999998776655
Q ss_pred HHHHHhcCCC----------------CCCc----------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 162 LLMTIQNAPP----------------GLDY----------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 162 l~~~i~~~~~----------------~~~~----------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
+......... .... .....+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 234 LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 5433321100 0000 0123578999999999999999999999999999999864
Q ss_pred C
Q 007967 216 K 216 (583)
Q Consensus 216 ~ 216 (583)
.
T Consensus 314 ~ 314 (331)
T 4aaa_A 314 G 314 (331)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.20 Aligned_cols=207 Identities=43% Similarity=0.767 Sum_probs=170.3
Q ss_pred CCCcccceEEEEEE------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 5 DHPNVIRAYCSFVV------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 5 ~HPNIVkl~~~f~d------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
+||||++++++|.. ...+|+|||||.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 158 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 158 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence 79999999999987 568999999999999999998765567999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----CCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----GSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||++.++.+||+|||++....... .......||+.|+|||++.. ...++.++|||||||++|+|++|..||.
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp GEEECTTCCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred HEEEcCCCCEEEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999986542211 12234689999999999863 3568899999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
+...............+.. ....++..+++||.+||..||.+|||+.++++||||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 236 DMHPMRALFLIPRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp TSCHHHHHHHHHHSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred CCcHHHHHHHhhcCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 8777666655554433222 23568899999999999999999999999999999987653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.46 Aligned_cols=213 Identities=24% Similarity=0.387 Sum_probs=170.8
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|+.++|||||+++++|... .++++|||||.+ +|.+++... ....+++..++.++.||+.||.|||++||+|
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 179 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 179 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4578999999999998642 247899999975 566665532 2466999999999999999999999999999
Q ss_pred cCCCCCcEEEcCC-CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 73 RDVKAGNILLDTN-GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 73 RDLKPeNILld~~-g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
|||||+||||+.+ +.+||+|||+++.+.... .....+||++|+|||++.+...|+.++|||||||++|||++|+.
T Consensus 180 rDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCChhhEEEeCCCCeEEeccchhhhhcccCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 9999999999965 578999999997553221 22346899999999999855689999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCC--------------CCCCcc----------ccccchHHHHHHHHhhhcCCCCCCCCHHHHH
Q 007967 152 PFSKYPPMKVLLMTIQNAP--------------PGLDYD----------RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~--------------~~~~~~----------~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL 207 (583)
||.+....+.+..++.... ..+.++ ....++.++++||.+||.+||.+|||+.+++
T Consensus 256 pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 9999877666655443210 011111 1234688999999999999999999999999
Q ss_pred hccccccCCCC
Q 007967 208 KHSFFKHAKPP 218 (583)
Q Consensus 208 ~HpfFk~~~~~ 218 (583)
+||||+....+
T Consensus 336 ~hp~f~~~~~~ 346 (420)
T 1j1b_A 336 AHSFFDELRDP 346 (420)
T ss_dssp TSGGGGGGGCT
T ss_pred CCHhhcccccc
Confidence 99999876544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=317.06 Aligned_cols=206 Identities=29% Similarity=0.456 Sum_probs=176.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+++.+|+|||||.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil 147 (294)
T 2rku_A 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 147 (294)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence 5689999999999999999999999999999999987754 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||......+.
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 148 LNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp ECTTCCEEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHT-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EcCCCCEEEEeccCceecccCcc---ccccccCCCCcCCcchhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999875432221 223467999999999997 56789999999999999999999999988665554
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.... ..... ..+..++..+.+||.+||..||.+|||+.++++||||.....+
T Consensus 224 ~~~~-~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 224 YLRI-KKNEY----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HHHH-HTTCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHHH-hhccC----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 4333 33222 2335688999999999999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=324.91 Aligned_cols=206 Identities=29% Similarity=0.458 Sum_probs=177.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+|||||.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 96 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 173 (335)
T 2owb_A 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173 (335)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEE
Confidence 5689999999999999999999999999999999987764 67999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||......+.
T Consensus 174 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 174 LNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp ECTTCCEEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHH-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EcCCCCEEEeeccCceecccCcc---cccccCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 99999999999999875532221 123468999999999998 56789999999999999999999999988665554
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
....... .. ..+..++..+.+||.+||..||.+|||+.++++||||.....+
T Consensus 250 ~~~~~~~-~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 250 YLRIKKN-EY----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp HHHHHHT-CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHHHhcC-CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 4433332 22 2235688999999999999999999999999999999976543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=319.78 Aligned_cols=210 Identities=22% Similarity=0.375 Sum_probs=174.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni 142 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 46789999999999999999999999999999999998764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... .......+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.....
T Consensus 143 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 219 (294)
T 4eqm_A 143 LIDSNKTLKIFDFGIAKALSETS--LTQTNHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219 (294)
T ss_dssp EECTTSCEEECCCSSSTTC---------------CCSSCCHHHHH-TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH
T ss_pred EECCCCCEEEEeCCCcccccccc--ccccCccccCccccCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999999987542221 11223467999999999998 5678999999999999999999999999988777
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.....+....+.........++..+.++|.+||.+||.+||+..+.+.+.|..-.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 220 IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 7666666655444344456789999999999999999999976666666665543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=315.34 Aligned_cols=212 Identities=28% Similarity=0.468 Sum_probs=166.9
Q ss_pred CCCCCCCcccceEEEEEE-------------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVV-------------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d-------------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
|+.++||||++++++|.+ ...+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~ 134 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHS 134 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHh
Confidence 467899999999999876 35799999999999999998753 3458899999999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCC-----------CccccccccCCCCCCCcccccCCCCCCccccc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD-----------RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADI 136 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~-----------~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDI 136 (583)
+||+||||||+|||++.++.+||+|||++........ .........||+.|+|||++.+...++.++||
T Consensus 135 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 214 (303)
T 1zy4_A 135 QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214 (303)
T ss_dssp TTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHH
T ss_pred CCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhH
Confidence 9999999999999999999999999999875432110 01122346799999999999855578999999
Q ss_pred cchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 137 WSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 137 WSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
|||||++|+|++ ||............+......++.......+..+++||.+||..||.+|||+.++++||||+...
T Consensus 215 ~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 215 YSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 999999999998 66543333444455554444444444566788899999999999999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.09 Aligned_cols=213 Identities=29% Similarity=0.442 Sum_probs=177.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHH------HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHL------MKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHR 73 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dl------l~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHR 73 (583)
|+.++||||++++++|.+.+.+|+|||||+||+|.++ +.......+++..++.++.||+.||.|||+ +||+||
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 4678999999999999999999999999999999887 544334679999999999999999999999 999999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCc-cccccchhhHHhhhhhCCCC
Q 007967 74 DVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNS-KADIWSFGITALELAHGHAP 152 (583)
Q Consensus 74 DLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~-ksDIWSLGvILyeLLtG~~P 152 (583)
||||+|||++.++.+||+|||++...... ......|++.|+|||++.+...++. ++|||||||++|+|++|..|
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCChHhEEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999998754221 2234689999999999985446666 99999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccc---------------cccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDR---------------DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~---------------~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
|........+...+......++... ...++..+.+||.+||+.||.+|||+.++++||||+...+
T Consensus 252 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 252 FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp SCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred CCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 9887664445555554433322110 1568899999999999999999999999999999997764
Q ss_pred C
Q 007967 218 P 218 (583)
Q Consensus 218 ~ 218 (583)
.
T Consensus 332 ~ 332 (348)
T 2pml_X 332 E 332 (348)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.67 Aligned_cols=212 Identities=22% Similarity=0.344 Sum_probs=173.0
Q ss_pred CCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++||||++++++|... ..+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 155 (364)
T 3qyz_A 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLK 155 (364)
T ss_dssp HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 467999999999999765 47999999996 589888764 679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+|||++.++.+||+|||++................+||+.|+|||++.....++.++|||||||++|+|++|..||.+.
T Consensus 156 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999998765333222222345689999999999875667999999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCC-------------------------CCCc-cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 157 PPMKVLLMTIQNAPP-------------------------GLDY-DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~-------------------------~~~~-~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
...+.+..+...... ...+ .....++.++.+||.+||++||.+|||+.++|+||
T Consensus 236 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 665544333221000 0000 01245688999999999999999999999999999
Q ss_pred ccccCCC
Q 007967 211 FFKHAKP 217 (583)
Q Consensus 211 fFk~~~~ 217 (583)
||+....
T Consensus 316 ~~~~~~~ 322 (364)
T 3qyz_A 316 YLEQYYD 322 (364)
T ss_dssp GGTTTCC
T ss_pred chhhccC
Confidence 9998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.80 Aligned_cols=207 Identities=29% Similarity=0.459 Sum_probs=170.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++..++ +|+|||||.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 70 ~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl 146 (322)
T 2ycf_A 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146 (322)
T ss_dssp HHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 4679999999999997655 8999999999999998754 367999999999999999999999999999999999999
Q ss_pred EcCCCc---EEEEecCCccccccCCCCccccccccCCCCCCCccccc--CCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 82 LDTNGV---VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ--PGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 82 ld~~g~---IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~--~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
++.++. +||+|||++...... .......||+.|+|||++. ....++.++|||||||++|+|++|..||...
T Consensus 147 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 147 LSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp ESSSSSSCCEEECCCTTCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred EecCCCCCeEEEccCccceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 987664 999999998754211 1123467999999999974 2467899999999999999999999999875
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.....+...+...........+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 223 RTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp TCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred chHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 54333334444433332223345688999999999999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.37 Aligned_cols=215 Identities=20% Similarity=0.343 Sum_probs=171.0
Q ss_pred CCCCCCCcccceEEEEE--------------ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFV--------------VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~--------------d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
|+.++||||+++++++. +...+|+||||+. |+|.+++. .+.+++..++.++.||+.||+|||
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH 137 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIH 137 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHH
Confidence 35689999999999883 4578999999997 68988875 367999999999999999999999
Q ss_pred HCCCcccCCCCCcEEEc-CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhh
Q 007967 67 RQGHIHRDVKAGNILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE 145 (583)
Q Consensus 67 s~gIvHRDLKPeNILld-~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILye 145 (583)
++||+||||||+|||++ .++.+||+|||++.................+|+.|+|||++.....++.++|||||||++|+
T Consensus 138 ~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~e 217 (320)
T 2i6l_A 138 SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217 (320)
T ss_dssp HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHH
T ss_pred hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHH
Confidence 99999999999999997 56799999999987543221112222345789999999998755789999999999999999
Q ss_pred hhhCCCCCCCCChHHHHHHHHhcCCCCC------------------------C-ccccccchHHHHHHHHhhhcCCCCCC
Q 007967 146 LAHGHAPFSKYPPMKVLLMTIQNAPPGL------------------------D-YDRDKKFSKSFKEMVAMCLVKDQTKR 200 (583)
Q Consensus 146 LLtG~~PF~~~~~~~~l~~~i~~~~~~~------------------------~-~~~~~~~S~~lkdLI~~cL~~DP~kR 200 (583)
|++|..||.+..............+... . ......++..+++||.+||+.||.+|
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 218 MLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence 9999999998776655544433221100 0 01124578999999999999999999
Q ss_pred CCHHHHHhccccccCCCCc
Q 007967 201 PTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 201 pTa~eIL~HpfFk~~~~~~ 219 (583)
||+.++|+||||+...++.
T Consensus 298 pt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 298 LTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCHHHHHTSHHHHTTCC--
T ss_pred CCHHHHhCCcccccccCcc
Confidence 9999999999999876653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=323.51 Aligned_cols=206 Identities=23% Similarity=0.322 Sum_probs=166.1
Q ss_pred CCC-CCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 3 LID-HPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 3 ~L~-HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
.+. ||||+++++++.+ ....++|||||.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N 160 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 160 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 344 9999999999998 678999999999999988763 48999999999999999999999999999999999
Q ss_pred EEEcCCC-cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 80 ILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 80 ILld~~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||++.++ .+||+|||++....... .....+||+.|+|||++.....++.++|||||||++|+|++|..||.....
T Consensus 161 il~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 236 (330)
T 3nsz_A 161 VMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236 (330)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred EEEcCCCCEEEEEeCCCceEcCCCC----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 9999777 89999999987542221 223468999999999998557799999999999999999999999954332
Q ss_pred -HHHHHHHH------------hcCCCCC--------------------CccccccchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 159 -MKVLLMTI------------QNAPPGL--------------------DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 159 -~~~l~~~i------------~~~~~~~--------------------~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
...+.... ....... .......+++++++||.+||++||.+|||+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 316 (330)
T 3nsz_A 237 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316 (330)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred hHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 22221111 1111000 11112337899999999999999999999999
Q ss_pred HHhccccccCCC
Q 007967 206 LLKHSFFKHAKP 217 (583)
Q Consensus 206 IL~HpfFk~~~~ 217 (583)
+|+||||+.+.+
T Consensus 317 ~l~hp~f~~~~~ 328 (330)
T 3nsz_A 317 AMEHPYFYTVVK 328 (330)
T ss_dssp HHTSGGGTTCC-
T ss_pred HhcCccHhhhcc
Confidence 999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=317.64 Aligned_cols=205 Identities=51% Similarity=0.875 Sum_probs=177.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.++..+|+|||||.|++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 75 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 151 (303)
T 3a7i_A 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVL 151 (303)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEE
Confidence 45799999999999999999999999999999999875 367999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.++.+||+|||++....... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 152 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 227 (303)
T 3a7i_A 152 LSEHGEVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227 (303)
T ss_dssp ECTTSCEEECCCTTCEECBTTB---CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred ECCCCCEEEeecccceecCccc---cccCccCCCcCccCHHHHh-cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH
Confidence 9999999999999987553221 2224568999999999998 56789999999999999999999999988777665
Q ss_pred HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 162 LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 162 l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.........+. ....++..+.+||.+||..||.+|||+.++++||||.....
T Consensus 228 ~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 228 LFLIPKNNPPT----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHHHHHSCCCC----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHHhhcCCCCC----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 55444443322 23568899999999999999999999999999999976543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.08 Aligned_cols=208 Identities=26% Similarity=0.506 Sum_probs=176.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+.+|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI 152 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhE
Confidence 35689999999999999999999999999999999987654 6799999999999999999999999999999999999
Q ss_pred EEcCC---CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLDTN---GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld~~---g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|++.+ +.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+..
T Consensus 153 lv~~~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 153 LLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp EESCSSTTCCEEECSTTGGGTBCCCS----SCSCHHHHHTTCCHHHHT--TCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEecCCCcccEEEeccCcceeecCCC----ccccccCcccccChHHhc--CCCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99754 479999999987543221 123457899999999987 348999999999999999999999998876
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
..... ..+.........+.+..++..+.+||.+||..||.+|||+.++++||||++..+
T Consensus 227 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 227 EYDIL-KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHH-HHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred HHHHH-HHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 65544 344444444444555678999999999999999999999999999999986543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=326.74 Aligned_cols=213 Identities=23% Similarity=0.347 Sum_probs=169.1
Q ss_pred CCCCCCcccceEEEEEECCE-------EEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH--HCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSN-------LWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLH--RQGH 70 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~-------l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLH--s~gI 70 (583)
+.++||||++++++|...+. +|+|||||.+ +|...+... ....+++..++.++.||+.||.||| ++||
T Consensus 74 ~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i 152 (360)
T 3e3p_A 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV 152 (360)
T ss_dssp HHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC
T ss_pred HhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence 34689999999999976443 8999999976 455444332 2456899999999999999999999 9999
Q ss_pred cccCCCCCcEEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 71 IHRDVKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 71 vHRDLKPeNILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
+||||||+|||++. ++.+||+|||++....... .....+||+.|+|||++.+...++.++|||||||++|+|++|
T Consensus 153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g 228 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228 (360)
T ss_dssp BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999996 8999999999987553221 223468899999999997566689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCC--------------CCC-------------ccccccchHHHHHHHHhhhcCCCCCCCC
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPP--------------GLD-------------YDRDKKFSKSFKEMVAMCLVKDQTKRPT 202 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~--------------~~~-------------~~~~~~~S~~lkdLI~~cL~~DP~kRpT 202 (583)
..||.+......+......... ... .......+..+++||.+||++||.+|||
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 308 (360)
T 3e3p_A 229 EPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308 (360)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC
Confidence 9999987766555444331100 000 0011225789999999999999999999
Q ss_pred HHHHHhccccccCCCCc
Q 007967 203 AEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 203 a~eIL~HpfFk~~~~~~ 219 (583)
+.++|+||||+....+.
T Consensus 309 ~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 309 PYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHHTTSGGGGGGGCTT
T ss_pred HHHHhcCccccccCCcc
Confidence 99999999999876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=324.53 Aligned_cols=207 Identities=24% Similarity=0.422 Sum_probs=163.7
Q ss_pred CCCC--CcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 3 LIDH--PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 3 ~L~H--PNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
.+.| |||+++++++.++..+||||| +.+|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 63 ~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NI 139 (343)
T 3dbq_A 63 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 139 (343)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred hhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 3444 999999999999999999999 458899999876 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----------CCCCCccccccchhhHHhhhhhCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----------GSGYNSKADIWSFGITALELAHGH 150 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----------~~~ys~ksDIWSLGvILyeLLtG~ 150 (583)
|++ ++.+||+|||+++...... ........+||+.|+|||++.. ...|+.++|||||||++|+|++|.
T Consensus 140 ll~-~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 217 (343)
T 3dbq_A 140 LIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217 (343)
T ss_dssp EEE-TTEEEECCCSSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSS
T ss_pred EEE-CCcEEEeecccccccCccc-ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 996 6889999999987553221 1122335689999999999852 256899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 151 APFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 151 ~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.||............+..... ....+...+..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 218 ~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 218 TPFQQIINQISKLHAIIDPNH--EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CTTTTCCSHHHHHHHHHCTTS--CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CcchhhhhHHHHHHHHhcCCc--ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 999875543333333332222 2233355678999999999999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.02 Aligned_cols=206 Identities=25% Similarity=0.369 Sum_probs=169.6
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
..+||||++++++|.....+|+|||||. |+|.+++......++++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl 233 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 3589999999999999999999999995 689999887655679999999999999999999999999999999999999
Q ss_pred cCCCc--EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 83 DTNGV--VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 83 d~~g~--IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+.++. +||+|||++.... ....+.+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+....+
T Consensus 234 ~~~~~~~vkL~DFG~a~~~~------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 234 KQQGRSGIKVIDFGSSCYEH------QRVYTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp SSTTSCCEEECCCTTCEETT------CCCCSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccCCCcceEEeecccceecC------CcccccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99887 9999999986431 1123568999999999998 5679999999999999999999999999887766
Q ss_pred HHHHHHhcCCCCC-----------------Cc-------------------------------------cccccchHHHH
Q 007967 161 VLLMTIQNAPPGL-----------------DY-------------------------------------DRDKKFSKSFK 186 (583)
Q Consensus 161 ~l~~~i~~~~~~~-----------------~~-------------------------------------~~~~~~S~~lk 186 (583)
.+...+....... .+ ......++.++
T Consensus 307 ~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 386 (429)
T 3kvw_A 307 QLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386 (429)
T ss_dssp HHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHH
T ss_pred HHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHH
Confidence 5544332110000 00 00012377899
Q ss_pred HHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 187 EMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 187 dLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+||.+||++||.+|||+.|+|+||||+...
T Consensus 387 dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred HHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 999999999999999999999999998753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.32 Aligned_cols=205 Identities=25% Similarity=0.343 Sum_probs=167.8
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
..|++|++++++|.+.+.+|+||||| +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 74 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 152 (339)
T 1z57_A 74 NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFV 152 (339)
T ss_dssp TCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 35667999999999999999999999 89999998876445799999999999999999999999999999999999998
Q ss_pred C-------------------CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHh
Q 007967 84 T-------------------NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITAL 144 (583)
Q Consensus 84 ~-------------------~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILy 144 (583)
. ++.+||+|||++..... .....+||+.|+|||++. +..++.++|||||||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ 225 (339)
T 1z57_A 153 QSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE------HHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILI 225 (339)
T ss_dssp CCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS------CCCSSCSCGGGCCHHHHT-TSCCCTHHHHHHHHHHHH
T ss_pred ccccccccCCccccccccccCCCceEeeCcccccCcc------ccccccCCccccChHHhh-CCCCCcchhhHHHHHHHH
Confidence 7 67899999999864321 123468999999999998 567999999999999999
Q ss_pred hhhhCCCCCCCCChHHHHHHHHh--cCCCC----------------CC---------------------ccccccchHHH
Q 007967 145 ELAHGHAPFSKYPPMKVLLMTIQ--NAPPG----------------LD---------------------YDRDKKFSKSF 185 (583)
Q Consensus 145 eLLtG~~PF~~~~~~~~l~~~i~--~~~~~----------------~~---------------------~~~~~~~S~~l 185 (583)
+|++|..||......+....... ...+. .. .......++.+
T Consensus 226 el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (339)
T 1z57_A 226 EYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305 (339)
T ss_dssp HHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence 99999999988766544322211 10000 00 00112346789
Q ss_pred HHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 186 KEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 186 kdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.+||.+||..||.+|||+.++++||||+...
T Consensus 306 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 306 FDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 9999999999999999999999999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.51 Aligned_cols=211 Identities=24% Similarity=0.436 Sum_probs=172.1
Q ss_pred CCCCCCCcccceEEEEE--ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFV--VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~--d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++. +...+|+|||||.+| |.+++.......+++..+..++.||+.||.|||++||+||||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 138 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcc
Confidence 46789999999999994 456899999999877 777777655677999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC-CCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS-GYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~-~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|||++.++.+||+|||++....... .........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+..
T Consensus 139 NIl~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 139 NLLLTTGGTLKISALGVAEALHPFA-ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTC-SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cEEEcCCCcEEeeccccccccCccc-cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 9999999999999999987543211 112223467999999999987422 34779999999999999999999998866
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
..... ..+..... ..+..++..+.+||.+||..||.+|||+.++++||||+....+
T Consensus 218 ~~~~~-~~i~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 218 IYKLF-ENIGKGSY----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHH-HHHHHCCC----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred HHHHH-HHHhcCCC----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 54443 33333322 2335688999999999999999999999999999999977643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=325.74 Aligned_cols=212 Identities=22% Similarity=0.321 Sum_probs=164.8
Q ss_pred CCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++||||++++++|... ..+|+|||||. |+|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 161 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH 161 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCC
Confidence 467999999999999653 46999999997 6788877632 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTAD----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp GGGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hHHEEEcCCCCEEEEecCcccccccc----cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998643221 12234688999999999985577999999999999999999999999987
Q ss_pred ChHHHHHHHHhcC-----------------------CCCCC----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 157 PPMKVLLMTIQNA-----------------------PPGLD----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 157 ~~~~~l~~~i~~~-----------------------~~~~~----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.....+....... ..... ......+++.+.+||.+||..||.+|||+.++|+|
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 238 TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 7655543333210 00000 01123568889999999999999999999999999
Q ss_pred cccccCCCCc
Q 007967 210 SFFKHAKPPE 219 (583)
Q Consensus 210 pfFk~~~~~~ 219 (583)
|||+....+.
T Consensus 318 p~f~~~~~~~ 327 (362)
T 3pg1_A 318 PYFESLFDPL 327 (362)
T ss_dssp GGGTTTCCGG
T ss_pred chhhhccCcc
Confidence 9999876443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.99 Aligned_cols=204 Identities=24% Similarity=0.419 Sum_probs=164.4
Q ss_pred CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCC
Q 007967 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTN 85 (583)
Q Consensus 6 HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~ 85 (583)
||||+++++++..++.+||||| |.+|+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++ +
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~ 190 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D 190 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S
T ss_pred CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C
Confidence 6999999999999999999999 5689999998763 5799999999999999999999999999999999999995 5
Q ss_pred CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----------CCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 86 GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----------GSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 86 g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----------~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
+.+||+|||+++.+... .........+||+.|+|||++.. ...|+.++|||||||++|+|++|..||..
T Consensus 191 ~~~kl~DFG~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 191 GMLKLIDFGIANQMQPD-TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp SCEEECCCSSSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CeEEEEecCccccccCC-CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 89999999998755322 11122345689999999999863 13689999999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..........+....... ..+...+..+++||.+||..||.+|||+.++|+||||+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 270 IINQISKLHAIIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCHHHHHHHHHCTTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hhHHHHHHHHHhCccccC--CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 654333333333322222 23345688999999999999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=331.93 Aligned_cols=208 Identities=25% Similarity=0.424 Sum_probs=160.3
Q ss_pred CCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 2 SLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
+.++||||++++++|... ..+|+||||+ +++|.+++.. ..+++..++.+++||+.||.|||++||+||||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dl 158 (367)
T 2fst_X 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDL 158 (367)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 467899999999999764 5689999999 7889888764 67999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.+||+|||+++.... .....+||++|+|||++.+...|+.++|||||||++|+|++|+.||.+
T Consensus 159 kp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 159 KPSNLAVNEDCELKILDFGLARHTAD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp CGGGEEECTTCCEEECC---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CHhhEEECCCCCEEEeeccccccccc------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999875421 123468999999999998557899999999999999999999999998
Q ss_pred CChHHHHHHHHhcCC----------------------CCC---Cc-cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQNAP----------------------PGL---DY-DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~----------------------~~~---~~-~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
......+..++.... +.. .+ ......++.+++||.+||..||.+|||+.++|+|
T Consensus 233 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 776655544332110 000 00 0113467889999999999999999999999999
Q ss_pred cccccCCCCc
Q 007967 210 SFFKHAKPPE 219 (583)
Q Consensus 210 pfFk~~~~~~ 219 (583)
|||+....+.
T Consensus 313 p~~~~~~~~~ 322 (367)
T 2fst_X 313 AYFAQYHDPD 322 (367)
T ss_dssp GGGTTTCCGG
T ss_pred hhhhhccCCC
Confidence 9999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=328.28 Aligned_cols=205 Identities=24% Similarity=0.413 Sum_probs=159.9
Q ss_pred CCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 2 SLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
+.++||||++++++|.... .+|+|||||.+ +|.+++. ..+++..++.++.||+.||.|||++||+||||
T Consensus 79 ~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 153 (371)
T 2xrw_A 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 153 (371)
T ss_dssp HHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 4679999999999998765 79999999975 6777764 56999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.+||+|||+++..... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+
T Consensus 154 kp~NIl~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 154 KPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp CGGGEEECTTSCEEECCCCC--------------------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEEcCCCCEEEEEeecccccccc----cccCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998754221 1223468999999999998 56799999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCC---------------------CCc----------------cccccchHHHHHHHHhhhcCCCC
Q 007967 156 YPPMKVLLMTIQNAPPG---------------------LDY----------------DRDKKFSKSFKEMVAMCLVKDQT 198 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~---------------------~~~----------------~~~~~~S~~lkdLI~~cL~~DP~ 198 (583)
......+...+...... +.. ......+..+++||.+||..||.
T Consensus 229 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 308 (371)
T 2xrw_A 229 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308 (371)
T ss_dssp SSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGG
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChh
Confidence 77766554444321110 000 00012367899999999999999
Q ss_pred CCCCHHHHHhccccccCC
Q 007967 199 KRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 199 kRpTa~eIL~HpfFk~~~ 216 (583)
+|||++++|+||||+...
T Consensus 309 ~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 309 KRISVDEALQHPYINVWY 326 (371)
T ss_dssp GSCCHHHHHHSHHHHTTC
T ss_pred hCCCHHHHhCCcchhhhc
Confidence 999999999999998643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.55 Aligned_cols=209 Identities=31% Similarity=0.532 Sum_probs=169.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+.+.+++|||||++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 152 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhh
Confidence 3568999999999999999999999999999999999876422 346799999999999999999999999999999999
Q ss_pred EEEcC-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC-CCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 80 ILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 80 ILld~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~-~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
||++. ++.+||+|||++....... .......||+.|+|||++... ..++.++|||||||++|+|++|..||....
T Consensus 153 il~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 153 VLINTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp EEEETTTCCEEECCTTTCEESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred EEEECCCCCEEEeecccccccCCCC---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 99987 8999999999987543211 112346799999999998732 248899999999999999999999997654
Q ss_pred hHHHHHHH--HhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 158 PMKVLLMT--IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 158 ~~~~l~~~--i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
........ ..... ...+..++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 230 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 230 EPQAAMFKVGMFKVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp SHHHHHHHHHHHCCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred chhHHHHhhcccccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 33322111 11211 223456889999999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=327.99 Aligned_cols=208 Identities=25% Similarity=0.414 Sum_probs=149.8
Q ss_pred CCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
+.+.||||++++++|.. +..+|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp 156 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP 156 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 35689999999999987 55699999999999999998765445799999999999999999999999999999999
Q ss_pred CcEEEcC---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 78 GNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 78 eNILld~---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
+|||++. ++.+||+|||++..... ......+||+.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 157 ENLLYTSKEKDAVLKLTDFGFAKETTQ-----NALQTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred HHEEEEecCCCceEEEeccccceeccc-----cccccCCCCcCccChhhhC-CCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999976 45699999999865421 1223467899999999986 5678999999999999999999999997
Q ss_pred CCChHHHH---HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 155 KYPPMKVL---LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 155 ~~~~~~~l---~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
........ ...+......+....+..++..+++||.+||..||.+|||+.++++||||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 231 SNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp --------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 65443221 12222222233334456789999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.83 Aligned_cols=214 Identities=24% Similarity=0.379 Sum_probs=171.4
Q ss_pred CCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++||||+++++++... ..+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+|||||
T Consensus 64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk 139 (353)
T 2b9h_A 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLK 139 (353)
T ss_dssp HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 467999999999998764 67999999996 689888764 679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCC-------ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDR-------QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~-------~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
|+|||++.++.+||+|||++......... .......+||+.|+|||++.....++.++|||||||++|+|++|
T Consensus 140 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 219 (353)
T 2b9h_A 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219 (353)
T ss_dssp GGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHS
T ss_pred HHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhC
Confidence 99999999999999999998755322111 01123468999999999987567899999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhc--CCC---------------------CCC----ccccccchHHHHHHHHhhhcCCCCCCCC
Q 007967 150 HAPFSKYPPMKVLLMTIQN--APP---------------------GLD----YDRDKKFSKSFKEMVAMCLVKDQTKRPT 202 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~--~~~---------------------~~~----~~~~~~~S~~lkdLI~~cL~~DP~kRpT 202 (583)
..||.+......+...... .+. ... ......+++.+.+||.+||..||.+|||
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (353)
T 2b9h_A 220 RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299 (353)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC
Confidence 9999987765544333221 110 000 0112367899999999999999999999
Q ss_pred HHHHHhccccccCCCCc
Q 007967 203 AEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 203 a~eIL~HpfFk~~~~~~ 219 (583)
+.++++||||+....+.
T Consensus 300 ~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 300 AKEALEHPYLQTYHDPN 316 (353)
T ss_dssp HHHHHTSGGGTTTCCTT
T ss_pred HHHHhcCccccccCCcc
Confidence 99999999999876543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.57 Aligned_cols=207 Identities=30% Similarity=0.451 Sum_probs=168.2
Q ss_pred CCCCCCcccceEEEEEECCEE------EEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l------~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
+.++||||++++++|...+.. |+|||||. |+|.+++ ...+++..++.++.||+.||+|||++||+||||
T Consensus 96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 170 (371)
T 4exu_A 96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDL 170 (371)
T ss_dssp HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCc
Confidence 457899999999999987765 99999997 6777765 356999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.+||+|||+++.... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+
T Consensus 171 kp~NIll~~~~~~kL~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 171 KPGNLAVNEDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp CGGGEEECTTCCEEECSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CHHHeEECCCCCEEEEecCccccccc------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999864421 123468899999999998557899999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCC-------------------------CC-ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQNAPPG-------------------------LD-YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~-------------------------~~-~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
....+.+...+...... .. ......+++.+++||.+||++||.+|||+.++|+|
T Consensus 245 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 77655554443211000 00 01123568999999999999999999999999999
Q ss_pred cccccCCCCc
Q 007967 210 SFFKHAKPPE 219 (583)
Q Consensus 210 pfFk~~~~~~ 219 (583)
|||+....+.
T Consensus 325 p~f~~~~~~~ 334 (371)
T 4exu_A 325 PFFEPFRDPE 334 (371)
T ss_dssp GGGTTTCCGG
T ss_pred cccccCCCcc
Confidence 9999776543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.01 Aligned_cols=207 Identities=22% Similarity=0.331 Sum_probs=167.2
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE--
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL-- 82 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl-- 82 (583)
.|++|+.++++|...+.+||||||| +|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158 (355)
T ss_dssp SCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESC
T ss_pred CceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 3445999999999999999999999 7778887776544579999999999999999999999999999999999999
Q ss_pred -----------------cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhh
Q 007967 83 -----------------DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE 145 (583)
Q Consensus 83 -----------------d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILye 145 (583)
+.++.+||+|||++..... .....+||+.|+|||++. +..++.++|||||||++|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE------HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFE 231 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS------CCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccCCCcEEEeecCccccccc------cccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHH
Confidence 5678999999999864321 123468999999999998 5679999999999999999
Q ss_pred hhhCCCCCCCCChHHHHHHHHhc--CCCC----------------C---------------------CccccccchHHHH
Q 007967 146 LAHGHAPFSKYPPMKVLLMTIQN--APPG----------------L---------------------DYDRDKKFSKSFK 186 (583)
Q Consensus 146 LLtG~~PF~~~~~~~~l~~~i~~--~~~~----------------~---------------------~~~~~~~~S~~lk 186 (583)
|++|..||.+......+...... ..+. . ........+..+.
T Consensus 232 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 99999999887665443222211 1000 0 0001122356899
Q ss_pred HHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 187 EMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 187 dLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
+||.+||..||.+|||+.++|+||||+...+.+
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 344 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHHH
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcCCChhh
Confidence 999999999999999999999999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.81 Aligned_cols=211 Identities=22% Similarity=0.393 Sum_probs=161.0
Q ss_pred CCCCCCCcccceEEEEEECCEE------EEEEecCCCCCHHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNL------WVVMPFMAEGSCLHLMKIAYQD----GFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l------~LVmEy~~GGsL~dll~~~~~~----~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
|+.++||||+++++++.+.... |+|||||.+|+|.+++...... .+++..++.++.||+.||.|||++||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 158 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF 158 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 4678999999999999987665 9999999999999998765322 59999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-C
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-G 149 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G 149 (583)
+||||||+|||++.++.+||+|||++....... .........+++.|+|||++. +..++.++|||||||++|+|++ |
T Consensus 159 vH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g 236 (323)
T 3qup_A 159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-YYRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMTRG 236 (323)
T ss_dssp CCSCCSGGGEEECTTSCEEECCCCC------------------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCCCcceEEEcCCCCEEEeeccccccccccc-cccccccccCcccccCchhhc-CCCCCCccchhhHHHHHHHHHhCC
Confidence 999999999999999999999999987543222 112223346788999999997 5679999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-------HHHHHhccccccCCC
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-------AEKLLKHSFFKHAKP 217 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-------a~eIL~HpfFk~~~~ 217 (583)
..||.+....+.......... ......+++.+.+||.+||..||.+||| +++++.|+|+.....
T Consensus 237 ~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 237 QTPYAGIENAEIYNYLIGGNR----LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp CCTTTTCCGGGHHHHHHTTCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CCCccccChHHHHHHHhcCCC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 999998776655544444332 2234578899999999999999999999 788889999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.97 Aligned_cols=202 Identities=28% Similarity=0.441 Sum_probs=161.6
Q ss_pred CCCcccceEEEEE----ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCc
Q 007967 5 DHPNVIRAYCSFV----VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGN 79 (583)
Q Consensus 5 ~HPNIVkl~~~f~----d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeN 79 (583)
+||||++++++|. +...+||||||| +|+|.+++.......+++..++.|+.||+.||.|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 4899999999998 456899999999 77787777665446799999999999999999999999 99999999999
Q ss_pred EEEcCCC-------------------------------------------------cEEEEecCCccccccCCCCccccc
Q 007967 80 ILLDTNG-------------------------------------------------VVKLADFGVSACMFDTGDRQRSRN 110 (583)
Q Consensus 80 ILld~~g-------------------------------------------------~IKL~DFGlA~~~~~~~~~~~~~~ 110 (583)
||++.++ .+||+|||++..... ...
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------~~~ 251 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------HFT 251 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------CSC
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------cCc
Confidence 9998775 799999999865421 123
Q ss_pred cccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh------HHHHHHHHh--cCCCC----------
Q 007967 111 TFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP------MKVLLMTIQ--NAPPG---------- 172 (583)
Q Consensus 111 ~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~------~~~l~~~i~--~~~~~---------- 172 (583)
..+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+... ...+..... ...+.
T Consensus 252 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 252 EDIQTRQYRSLEVLI-GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp SCCSCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred cCCCCCcccCChhhc-CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 458999999999998 56799999999999999999999999976442 122211111 10000
Q ss_pred -----------C--------------CccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 173 -----------L--------------DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 173 -----------~--------------~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
+ .+......+..+++||.+||++||.+|||+.+||+||||+.
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 00112345678999999999999999999999999999973
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.88 Aligned_cols=202 Identities=25% Similarity=0.427 Sum_probs=168.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|||||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 104 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 182 (325)
T 3kul_A 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNV 182 (325)
T ss_dssp HTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceE
Confidence 46789999999999999999999999999999999998643 45799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++.................+|+.|+|||++. +..++.++|||||||++|+|++ |..||.+....
T Consensus 183 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 261 (325)
T 3kul_A 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261 (325)
T ss_dssp EECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred EECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999999999876543322222223346688899999997 5678999999999999999998 99999987766
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+......... ..+.+..++..+.+||.+||..||.+|||+.+|++
T Consensus 262 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 262 DVISSVEEGY----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCC----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 6554444332 22334678999999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.67 Aligned_cols=202 Identities=24% Similarity=0.446 Sum_probs=169.0
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
+.+ +||||++++++|.+.+.+|+|||||.||+|.+++..... ..+++..+..++.||+.||.|||
T Consensus 141 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 220 (370)
T 2psq_A 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 220 (370)
T ss_dssp HHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 345 899999999999999999999999999999999876431 34899999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++||+||||||+|||++.+|.+||+|||+++...... .........+|+.|+|||++. +..|+.++|||||||++|+|
T Consensus 221 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~el 298 (370)
T 2psq_A 221 SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEI 298 (370)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCC-TTCTTTTTTSCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHH
T ss_pred hCCeeccccchhhEEECCCCCEEEccccCCcccCccc-ceecccCCCcccceECHhHhc-CCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999987553322 112223456788999999998 56799999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+....+.......... ...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 299 lt~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 299 FTLGGSPYPGIPVEELFKLLKEGHR----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98 9999988766544433333221 23345688999999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.75 Aligned_cols=207 Identities=27% Similarity=0.485 Sum_probs=170.8
Q ss_pred CCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-----Ccc
Q 007967 2 SLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQ--DGFEESAIGSILKETLKALDYLHRQG-----HIH 72 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~--~~~sE~~i~~I~~QIl~gL~yLHs~g-----IvH 72 (583)
+.++||||++++++|.+ +..+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++| |+|
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH 139 (279)
T 2w5a_A 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139 (279)
T ss_dssp HHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred HhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence 46799999999998865 5789999999999999999876432 34999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
|||||+|||++.++.+||+|||++...... ........|++.|+|||++. +..++.++|||||||++|+|++|..|
T Consensus 140 ~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p 215 (279)
T 2w5a_A 140 RDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKTFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPP 215 (279)
T ss_dssp CCCSGGGEEECSSSCEEECCCCHHHHC------CHHHHHHHSCCTTCCHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eccchhhEEEcCCCCEEEecCchheeeccc---cccccccCCCccccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999998654221 11122457899999999998 56789999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
|.................. ..+..++..+.+||.+||..||.+|||+.++++|+|+..-.
T Consensus 216 ~~~~~~~~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 216 FTAFSQKELAGKIREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp SCCSSHHHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CcccCHHHHHHHHhhcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 9887665444333333222 22356889999999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.10 Aligned_cols=196 Identities=14% Similarity=0.143 Sum_probs=158.4
Q ss_pred CCCCCCCcccceE-------EEEEECCE-----------------EEEEEecCCCCCHHHHHHHHhcCCCCH-------H
Q 007967 1 MSLIDHPNVIRAY-------CSFVVDSN-----------------LWVVMPFMAEGSCLHLMKIAYQDGFEE-------S 49 (583)
Q Consensus 1 Mk~L~HPNIVkl~-------~~f~d~~~-----------------l~LVmEy~~GGsL~dll~~~~~~~~sE-------~ 49 (583)
|+.++|||||+++ +++++.+. .||||||| +|+|.+++... +.+++ .
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~ 206 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHH 206 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHH
Confidence 4567999999998 77776543 89999999 68999998865 23444 8
Q ss_pred HHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC--
Q 007967 50 AIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG-- 127 (583)
Q Consensus 50 ~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~-- 127 (583)
.+..|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+... . .....+| +.|+|||++...
T Consensus 207 ~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~---~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---A---RVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT---C---EEECCCC-TTCCCHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC---C---cccCCCC-cCccChhhhccccc
Confidence 888899999999999999999999999999999999999999999987421 1 2234678 999999999833
Q ss_pred --------CCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCC
Q 007967 128 --------SGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTK 199 (583)
Q Consensus 128 --------~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~k 199 (583)
..|+.++|||||||++|+|++|..||.+........ ........+++.+++||.+||..||.+
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE---------WIFRSCKNIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG---------GGGSSCCCCCHHHHHHHHHHTCSSGGG
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh---------hhhhhccCCCHHHHHHHHHHcCCCchh
Confidence 269999999999999999999999997643221110 111223568899999999999999999
Q ss_pred CCCHHHHHhccccccC
Q 007967 200 RPTAEKLLKHSFFKHA 215 (583)
Q Consensus 200 RpTa~eIL~HpfFk~~ 215 (583)
|||+.++++||||+.+
T Consensus 351 Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 351 RLLPLQAMETPEYEQL 366 (377)
T ss_dssp CCCHHHHHTSHHHHHH
T ss_pred CCCHHHHhhChHHHHH
Confidence 9999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=312.53 Aligned_cols=207 Identities=37% Similarity=0.663 Sum_probs=162.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCcE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeNI 80 (583)
+.++||||++++++|.+++.+|+||||+ ++.+..+... ....+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 79 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156 (318)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred HhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence 4679999999999999999999999999 5666555443 357799999999999999999999995 999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc----CCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~----~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|++.++.+||+|||++....... ......||+.|+|||++. ....++.++|||||||++|+|++|..||...
T Consensus 157 l~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 157 LLDERGQIKLCDFGISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp EECTTSCEEECCCTTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EECCCCCEEEEECCCchhccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999986543221 123457999999999985 2456889999999999999999999999875
Q ss_pred Ch-HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 157 PP-MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 157 ~~-~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.. ...+...+....+.+ +....++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 233 KTDFEVLTKVLQEEPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp CSHHHHHHHHHHSCCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CccHHHHHHHhccCCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 43 344444444433222 23346899999999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=315.60 Aligned_cols=206 Identities=23% Similarity=0.425 Sum_probs=166.7
Q ss_pred CCCCCCcccceEEEEEECC--EEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDS--NLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~--~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
+.++||||+++++++.... .+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 141 (319)
T 4euu_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG 141 (319)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHH
Confidence 4678999999999998765 89999999999999999876433 23999999999999999999999999999999999
Q ss_pred cEEE----cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-------CCCCCccccccchhhHHhhhh
Q 007967 79 NILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-------GSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 79 NILl----d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-------~~~ys~ksDIWSLGvILyeLL 147 (583)
|||+ +.++.+||+|||++....... .....+||+.|+|||++.. ...++.++|||||||++|+|+
T Consensus 142 NIll~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~ 217 (319)
T 4euu_A 142 NIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (319)
T ss_dssp GEEEEECTTSCEEEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred HEEEeccCCCCceEEEccCCCceecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence 9999 778889999999987553221 2234679999999999852 467899999999999999999
Q ss_pred hCCCCCCCCCh----HHHHHHHHhcCCCC--------------------CCccccccchHHHHHHHHhhhcCCCCCCCCH
Q 007967 148 HGHAPFSKYPP----MKVLLMTIQNAPPG--------------------LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTA 203 (583)
Q Consensus 148 tG~~PF~~~~~----~~~l~~~i~~~~~~--------------------~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa 203 (583)
+|..||..... .+.+...+...+.. ........++..+.+||.+||++||.+|||+
T Consensus 218 ~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~ 297 (319)
T 4euu_A 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297 (319)
T ss_dssp HSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred hCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH
Confidence 99999975432 23333343332211 1112234567889999999999999999999
Q ss_pred HHHHhccc
Q 007967 204 EKLLKHSF 211 (583)
Q Consensus 204 ~eIL~Hpf 211 (583)
.|+|+||-
T Consensus 298 ~ell~h~~ 305 (319)
T 4euu_A 298 DQFFAETS 305 (319)
T ss_dssp HHHHHHHH
T ss_pred HHhhhccH
Confidence 99999973
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=329.67 Aligned_cols=204 Identities=14% Similarity=0.160 Sum_probs=151.7
Q ss_pred CCCcccceE-------EEEEEC-----------------CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHH------HHH
Q 007967 5 DHPNVIRAY-------CSFVVD-----------------SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAI------GSI 54 (583)
Q Consensus 5 ~HPNIVkl~-------~~f~d~-----------------~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i------~~I 54 (583)
+||||++++ +++... .++|||||||+ |+|.+++.... ..+.+..+ ..+
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i 199 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHIL 199 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHH
Confidence 699988765 555544 34899999998 89999998652 33455555 577
Q ss_pred HHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-CCCCCcc
Q 007967 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-GSGYNSK 133 (583)
Q Consensus 55 ~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-~~~ys~k 133 (583)
+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... . .....+|+.|+|||++.. ...|+.+
T Consensus 200 ~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 273 (371)
T 3q60_A 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---R---GPASSVPVTYAPREFLNASTATFTHA 273 (371)
T ss_dssp HHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC---E---EEGGGSCGGGCCHHHHTCSEEECCHH
T ss_pred HHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC---C---ccCccCCcCCcChhhccCCCCCcCcc
Confidence 79999999999999999999999999999999999999999875421 1 113467799999999973 1578999
Q ss_pred ccccchhhHHhhhhhCCCCCCCCChHHHH-HH---HHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 134 ADIWSFGITALELAHGHAPFSKYPPMKVL-LM---TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 134 sDIWSLGvILyeLLtG~~PF~~~~~~~~l-~~---~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+|||||||++|+|++|+.||.+....... .. ..........++.+..+++.+++||.+||.+||.+|||+.++|+|
T Consensus 274 ~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred ccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999999875331100 00 001111223334446789999999999999999999999999999
Q ss_pred cccccCC
Q 007967 210 SFFKHAK 216 (583)
Q Consensus 210 pfFk~~~ 216 (583)
|||++..
T Consensus 354 p~f~~~~ 360 (371)
T 3q60_A 354 PEFLQLQ 360 (371)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=315.18 Aligned_cols=206 Identities=27% Similarity=0.481 Sum_probs=163.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETLKALDYLHRQG--HIHRDVKAG 78 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHRDLKPe 78 (583)
+.++||||++++++|.+...+|+|||||+||+|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+
T Consensus 89 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~ 168 (309)
T 3p86_A 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSP 168 (309)
T ss_dssp HHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGG
T ss_pred HhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChh
Confidence 56799999999999999999999999999999999887431 123999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||+++..... ........||+.|+|||++. +..++.++|||||||++|+|++|..||.+...
T Consensus 169 NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 169 NLLVDKKYTVKVCDFGLSRLKAST---FLSSKSAAGTPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp GEEECTTCCEEECCCC--------------------CCTTSCHHHHT-TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred hEEEeCCCcEEECCCCCCcccccc---ccccccCCCCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999998643221 11223468999999999998 56789999999999999999999999998776
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh--cccccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK--HSFFKH 214 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~--HpfFk~ 214 (583)
........... . ....+..+++.+.+||.+||..||.+|||+.++++ .++++.
T Consensus 245 ~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 245 AQVVAAVGFKC-K--RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHSC-C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhcC-C--CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 55544333222 1 22334678999999999999999999999999987 455543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.28 Aligned_cols=207 Identities=23% Similarity=0.402 Sum_probs=173.6
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-----DGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-----~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++|||||+++++|.+....|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 129 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 208 (367)
T 3l9p_A 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208 (367)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 457999999999999999999999999999999999987532 358999999999999999999999999999999
Q ss_pred CCcEEEcCCC---cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCC
Q 007967 77 AGNILLDTNG---VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAP 152 (583)
Q Consensus 77 PeNILld~~g---~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~P 152 (583)
|+|||++.+| .+||+|||+++....... ........||+.|+|||++. +..|+.++|||||||++|+|++ |..|
T Consensus 209 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~p 286 (367)
T 3l9p_A 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMP 286 (367)
T ss_dssp GGGEEESCSSTTCCEEECCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred hhhEEEecCCCCceEEECCCccccccccccc-cccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999655 599999999875433221 12233467899999999997 5679999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
|.+....+.......... ...+..++..+.+||.+||+.||.+|||+.+|++|.++..
T Consensus 287 f~~~~~~~~~~~i~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 287 YPSKSNQEVLEFVTSGGR----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp STTCCHHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC----CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 998776655544444332 2234568899999999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=305.66 Aligned_cols=201 Identities=24% Similarity=0.446 Sum_probs=169.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 137 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 137 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheE
Confidence 35789999999999999999999999999999999998643 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++...... .........+|+.|+|||++. ...++.++|||||||++|+|++ |..||......
T Consensus 138 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 138 LVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp EECGGGCEEECCTTGGGGBCCH--HHHSTTSTTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EEcCCCCEEecccccccccccc--ccccccCcccccccCCHHHhc-CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998654221 111223356788899999997 5679999999999999999999 99999987765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+......... ....+..++..+.+||.+||..||.+|||+.++++|
T Consensus 215 ~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 215 EVVEDISTGF----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHTTC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCc----cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 5544443332 222345678999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.68 Aligned_cols=204 Identities=23% Similarity=0.320 Sum_probs=165.0
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCCCcEEE
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH--RQGHIHRDVKAGNILL 82 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH--s~gIvHRDLKPeNILl 82 (583)
.|++|++++++|...+.+|||||||. |+|.+++.......+++..++.++.||+.||.||| ..||+||||||+|||+
T Consensus 114 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192 (382)
T ss_dssp GGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEE
T ss_pred cceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEE
Confidence 45579999999999999999999995 59999988765567999999999999999999999 5799999999999999
Q ss_pred c--CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 83 D--TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 83 d--~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
+ .++.+||+|||++..... .....+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+....+
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~------~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQ------RIYQYIQSRFYRSPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTC------CCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecCCCCcEEEEeccCceeccc------ccccccCCccccChHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4 478899999999875421 123468999999999998 5679999999999999999999999999877766
Q ss_pred HHHHHHhcCCCCC--------------------Cc--------------ccc-------------------------ccc
Q 007967 161 VLLMTIQNAPPGL--------------------DY--------------DRD-------------------------KKF 181 (583)
Q Consensus 161 ~l~~~i~~~~~~~--------------------~~--------------~~~-------------------------~~~ 181 (583)
.+..++....... .+ +.. ...
T Consensus 266 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (382)
T 2vx3_A 266 QMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 345 (382)
T ss_dssp HHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHH
T ss_pred HHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchh
Confidence 5544433110000 00 000 001
Q ss_pred hHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 182 SKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 182 S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
++.+++||.+||++||.+|||+.++|+||||+...
T Consensus 346 ~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred hHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence 24789999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=311.15 Aligned_cols=203 Identities=24% Similarity=0.454 Sum_probs=169.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc----------------------CCCCHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ----------------------DGFEESAIGSILKET 58 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~----------------------~~~sE~~i~~I~~QI 58 (583)
|+.++||||++++++|.+.+.+|+|||||.||+|.+++..... ..+++..++.++.||
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999876432 238999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccc
Q 007967 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWS 138 (583)
Q Consensus 59 l~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWS 138 (583)
+.||.|||++||+||||||+|||++.++.+||+|||++....... .........+|+.|+|||++. +..++.++||||
T Consensus 160 ~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~s 237 (314)
T 2ivs_A 160 SQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED-SYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWS 237 (314)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTS-CEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHH
T ss_pred HHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccc-cceeccCCCCcccccChhhhc-CCCcCchhhHHH
Confidence 999999999999999999999999999999999999987553322 112223456788999999997 567899999999
Q ss_pred hhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 139 FGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 139 LGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|||++|+|++ |..||.+....... ..+.... ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 238 lG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 238 FGVLLWEIVTLGGNPYPGIPPERLF-NLLKTGH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHH-HHhhcCC---cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999 99999887664443 3333321 123345789999999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=317.90 Aligned_cols=206 Identities=30% Similarity=0.441 Sum_probs=166.7
Q ss_pred CCCCCCcccceEEEEEECCE------EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSN------LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~------l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
+.++||||++++++|..... +|+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||
T Consensus 78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dl 152 (353)
T 3coi_A 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDL 152 (353)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred HhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 45789999999999987654 599999997 57776653 46999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.+||+|||++..... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+
T Consensus 153 kp~NIl~~~~~~~kl~Dfg~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 153 KPGNLAVNEDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp CGGGEEECTTCCEEECSTTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CHHHEeECCCCcEEEeecccccCCCC------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999864321 123468899999999998557899999999999999999999999998
Q ss_pred CChHHHHHHHHhcC-----------------------C---CCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQNA-----------------------P---PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~~-----------------------~---~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
....+.+....... + ..........++..+++||.+||..||.+|||+.++|+|
T Consensus 227 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 77655443332210 0 000011224678999999999999999999999999999
Q ss_pred cccccCCCC
Q 007967 210 SFFKHAKPP 218 (583)
Q Consensus 210 pfFk~~~~~ 218 (583)
|||+....+
T Consensus 307 p~f~~~~~~ 315 (353)
T 3coi_A 307 PFFEPFRDP 315 (353)
T ss_dssp GGGTTTCCG
T ss_pred cchhhccCc
Confidence 999977644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=315.21 Aligned_cols=210 Identities=36% Similarity=0.643 Sum_probs=152.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA---YQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~---~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKP 77 (583)
+.++||||++++++|.+.+.+|+|||||.+ +|.+++... ....+++..+..++.||+.||.|||++ ||+||||||
T Consensus 76 ~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp 154 (327)
T 3aln_A 76 RSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKP 154 (327)
T ss_dssp SSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCG
T ss_pred HcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCH
Confidence 568999999999999999999999999975 787776642 246799999999999999999999999 999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc---CCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ---PGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~---~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
+|||++.++.+||+|||++....... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.
T Consensus 155 ~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (327)
T 3aln_A 155 SNILLDRSGNIKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230 (327)
T ss_dssp GGEEEETTTEEEECCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred HHEEEcCCCCEEEccCCCceeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999987543221 122347999999999984 24568999999999999999999999998
Q ss_pred CCChHHH-HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 155 KYPPMKV-LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 155 ~~~~~~~-l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+...... +........+.+.......++..+.+||.+||..||.+|||+.++++||||....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 231 KWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 7543221 1111112222233333456899999999999999999999999999999997543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=304.16 Aligned_cols=200 Identities=27% Similarity=0.469 Sum_probs=169.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.++..+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 136 (268)
T 3sxs_A 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136 (268)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEE
T ss_pred HhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEE
Confidence 4578999999999999999999999999999999998764 356999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||++....... ........+|+.|+|||++. +..++.++|||||||++|+|++ |..||.......
T Consensus 137 ~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (268)
T 3sxs_A 137 VDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSAPEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213 (268)
T ss_dssp ECTTCCEEECCTTCEEECCTTC--EEECCSCCCCGGGCCHHHHH-HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred ECCCCCEEEccCccceecchhh--hhcccCCCcCcccCCHHHHh-ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence 9999999999999987543221 11223345678899999997 5678999999999999999998 999998877666
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.......... ...+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 214 ~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 214 VVLKVSQGHR----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHTTCC----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCC----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5544444322 22235578899999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=329.67 Aligned_cols=208 Identities=25% Similarity=0.347 Sum_probs=159.2
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+|||||++++++.+...+|||||||. |+|.+++... ...+.+..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 76 ~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~ 153 (432)
T 3p23_A 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153 (432)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECC
T ss_pred CCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEec
Confidence 79999999999999999999999995 6999988643 334666678899999999999999999999999999999953
Q ss_pred ---C--CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhh-CCCCCCCC
Q 007967 85 ---N--GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAH-GHAPFSKY 156 (583)
Q Consensus 85 ---~--g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~ 156 (583)
+ ..+||+|||+|+...............+||+.|+|||++.. ...++.++|||||||++|+|++ |..||...
T Consensus 154 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp CBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 2 35889999998765332222223345789999999999974 3567789999999999999999 99999764
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
...... .+...............+..+++||.+||+.||.+|||+.++++||||+...
T Consensus 234 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 234 LQRQAN--ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp TTHHHH--HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred hHHHHH--HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 433222 2222211112222345677899999999999999999999999999997643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.63 Aligned_cols=203 Identities=22% Similarity=0.391 Sum_probs=170.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------DGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|+.++||||+++++++.+.+.+|+|||||.||+|.+++..... ..+++..+..++.||+.||.|||++||+|
T Consensus 82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 161 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 161 (322)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 4678999999999999999999999999999999999876432 45799999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHA 151 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~ 151 (583)
|||||+|||++.++.+||+|||++........ ........||+.|+|||++. +..++.++|||||||++|+|++ |..
T Consensus 162 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~ 239 (322)
T 1p4o_A 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQ 239 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred CCCccceEEEcCCCeEEECcCccccccccccc-cccccCCCCCCCccChhhhc-cCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999875533221 11223356789999999997 5678999999999999999999 899
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
||.+............... ......++..+.+||.+||..||.+|||+.++++|
T Consensus 240 p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 240 PYQGLSNEQVLRFVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTTTSCHHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCCHHHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9988766555444433322 12345788999999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=314.01 Aligned_cols=203 Identities=20% Similarity=0.386 Sum_probs=169.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh----------------------cCCCCHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY----------------------QDGFEESAIGSILKET 58 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~----------------------~~~~sE~~i~~I~~QI 58 (583)
|+.++||||++++++|.+++.+|+|||||++|+|.+++.... ...+++..++.++.||
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 356899999999999999999999999999999999987632 1569999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccc
Q 007967 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWS 138 (583)
Q Consensus 59 l~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWS 138 (583)
+.||.|||++||+||||||+|||++.++.+||+|||++....... .........||+.|+|||++. ...++.++||||
T Consensus 184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~s 261 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWA 261 (343)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHH-HCCCCHHHHHHH
T ss_pred HHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCc-cccccCCCcccceecChhhhc-cCCcCcccccHH
Confidence 999999999999999999999999999999999999987543221 112223457899999999987 567999999999
Q ss_pred hhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 139 FGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 139 LGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|||++|+|++ |..||.+....+........... ..+..++..+.+||.+||..||.+|||+.+++++
T Consensus 262 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 262 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999999998 99999987765555444333222 2335688999999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.10 Aligned_cols=208 Identities=27% Similarity=0.391 Sum_probs=156.4
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG-----FEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~-----~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
.+|||||++++++.+++.+|||||||. |+|.+++....... .++..++.++.||+.||.|||++||+||||||+
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 489999999999999999999999995 69999987432111 133456789999999999999999999999999
Q ss_pred cEEEcCC-------------CcEEEEecCCccccccCCCCc-cccccccCCCCCCCcccccC------CCCCCccccccc
Q 007967 79 NILLDTN-------------GVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCWMAPEVLQP------GSGYNSKADIWS 138 (583)
Q Consensus 79 NILld~~-------------g~IKL~DFGlA~~~~~~~~~~-~~~~~~~GT~~Y~APEil~~------~~~ys~ksDIWS 138 (583)
|||++.+ +.+||+|||++.......... ......+||+.|+|||++.+ ...++.++||||
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 9999754 489999999987653322111 11234689999999999974 256899999999
Q ss_pred hhhHHhhhhh-CCCCCCCCChHHHHHHHHhcC--CCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 139 FGITALELAH-GHAPFSKYPPMKVLLMTIQNA--PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 139 LGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~--~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
|||++|+|++ |..||........ ..+... ...........++.++++||.+||+.||.+|||+.++++||||+.
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHhCCCCCCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 9999999998 9999976544332 222221 111222223467889999999999999999999999999999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.03 Aligned_cols=201 Identities=26% Similarity=0.478 Sum_probs=169.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+|||||.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 151 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 151 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceE
Confidence 35689999999999999999999999999999999998653 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++....... ........+|+.|+|||++. ...++.++|||||||++|+|++ |..||......
T Consensus 152 li~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 152 LVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp EECTTSCEEECSTTGGGGBCCHH--HHSTTSTTSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred EEcCCCCEEEccccccccccccc--cccccCCccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence 99999999999999986542211 11122346788899999998 5678999999999999999998 99999987765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.......... ....+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 229 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 229 ETAEHIAQGL----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccc----CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 5544443332 222345678999999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.64 Aligned_cols=200 Identities=24% Similarity=0.429 Sum_probs=157.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++ .++.+|+|||||.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 70 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 147 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 147 (281)
T ss_dssp HHTCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHE
Confidence 3568999999999998 456789999999999999998753 34699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++........ .......+++.|+|||++. ...++.++|||||||++|+|++ |..||.+....
T Consensus 148 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~ 224 (281)
T 1mp8_A 148 LVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224 (281)
T ss_dssp EEEETTEEEECC---------------------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred EECCCCCEEECccccccccCcccc--cccccCCCcccccChhhcc-cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence 999999999999999875532211 1122346778999999997 5678999999999999999996 99999887765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+.......... ...+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 225 ~~~~~i~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 225 DVIGRIENGER----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp GHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55444433322 22346789999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=318.07 Aligned_cols=200 Identities=23% Similarity=0.386 Sum_probs=166.6
Q ss_pred CCCcccceEEEEEECCE-EEEEEecCCCCCHHHHHHHHhc----------------------------------------
Q 007967 5 DHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQ---------------------------------------- 43 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~-l~LVmEy~~GGsL~dll~~~~~---------------------------------------- 43 (583)
+||||++++++|.+.+. +|+|||||.||+|.+++.....
T Consensus 84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (359)
T 3vhe_A 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163 (359)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence 79999999999987654 9999999999999999875421
Q ss_pred ------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCcccc
Q 007967 44 ------------------------DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACM 99 (583)
Q Consensus 44 ------------------------~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~ 99 (583)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 12899999999999999999999999999999999999999999999999998755
Q ss_pred ccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Q 007967 100 FDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178 (583)
Q Consensus 100 ~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~ 178 (583)
..... ........||+.|+|||++. +..|+.++|||||||++|+|++ |..||.+......+...+.... ....+
T Consensus 244 ~~~~~-~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 318 (359)
T 3vhe_A 244 YKDPD-YVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---RMRAP 318 (359)
T ss_dssp TSCTT-CEEC--CEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC---CCCCC
T ss_pred ccccc-chhccccCCCceeEChhhhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC---CCCCC
Confidence 33222 22233467899999999998 5679999999999999999998 9999988765555555554432 12234
Q ss_pred ccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 179 ~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
..+++.+.++|.+||..||.+|||+.++++|
T Consensus 319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 5688999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.13 Aligned_cols=200 Identities=24% Similarity=0.387 Sum_probs=163.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|. +..+++|||||.+|+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 70 ~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 147 (325)
T 3kex_A 70 GSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147 (325)
T ss_dssp HTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEE
T ss_pred hcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEE
Confidence 4679999999999986 56799999999999999988643 356999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||+++...... .........||+.|+|||++. ...++.++|||||||++|+|++ |..||.+.....
T Consensus 148 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 148 LKSPSQVQVADFGVADLLPPDD-KQLLYSEAKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp ESSSSCEEECSCSGGGGSCCCT-TCCC-----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH
T ss_pred ECCCCeEEECCCCcccccCccc-ccccccCCCCcccccChHHhc-cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH
Confidence 9999999999999987653322 222234467888999999997 5679999999999999999999 999998866544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
......... ....+..++..+.+||.+||..||.+|||+.++++|
T Consensus 226 ~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 226 VPDLLEKGE----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHHHTTC----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHcCC----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 443333222 122234577889999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.54 Aligned_cols=204 Identities=26% Similarity=0.392 Sum_probs=162.3
Q ss_pred CCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCc
Q 007967 5 DHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-GHIHRDVKAGN 79 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-gIvHRDLKPeN 79 (583)
.||||++++++|...+ .+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 162 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence 4999999999998765 799999999 99999999876566799999999999999999999998 99999999999
Q ss_pred EEEcC------CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 80 ILLDT------NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 80 ILld~------~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
||++. .+.+||+|||++..... .....+||+.|+|||++. +..++.++|||||||++|+|++|..||
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred eEEeccCCCcCcceEEEcccccccccCC------CCCCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 99953 34799999999865422 123458999999999998 567899999999999999999999999
Q ss_pred CCCCh------HHHHHHHHh--cCCCC------------------------C-----------CccccccchHHHHHHHH
Q 007967 154 SKYPP------MKVLLMTIQ--NAPPG------------------------L-----------DYDRDKKFSKSFKEMVA 190 (583)
Q Consensus 154 ~~~~~------~~~l~~~i~--~~~~~------------------------~-----------~~~~~~~~S~~lkdLI~ 190 (583)
.+... ...+...+. ...+. . .......++..+.+||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 76431 122211111 00000 0 01122456788999999
Q ss_pred hhhcCCCCCCCCHHHHHhccccccCC
Q 007967 191 MCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 191 ~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+||+.||.+|||+.++|+||||++..
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHhccCccccCCHHHHhhChhhhccc
Confidence 99999999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=314.73 Aligned_cols=203 Identities=23% Similarity=0.406 Sum_probs=170.0
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc---------------------CCCCHHHHHHHHHHHHH
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ---------------------DGFEESAIGSILKETLK 60 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~---------------------~~~sE~~i~~I~~QIl~ 60 (583)
.+ +||||++++++|.+.+.+|+|||||+||+|.+++..... ..+++..++.++.||+.
T Consensus 104 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 183 (344)
T 1rjb_A 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183 (344)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred hhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHH
Confidence 45 899999999999999999999999999999999875422 23799999999999999
Q ss_pred HHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchh
Q 007967 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFG 140 (583)
Q Consensus 61 gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLG 140 (583)
||.|||++||+||||||+|||++.++.+||+|||++....... .........||+.|+|||++. +..++.++||||||
T Consensus 184 aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG 261 (344)
T 1rjb_A 184 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYG 261 (344)
T ss_dssp HHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHH
T ss_pred HHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCc-cceeccCccCccCccCHHHhc-cCCCChhHhHHHHH
Confidence 9999999999999999999999999999999999987553322 222223456788999999987 56799999999999
Q ss_pred hHHhhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 141 ITALELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 141 vILyeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
|++|+|++ |..||.+..........+... .....+..+++.+.+||.+||..||.+|||+.++++|-
T Consensus 262 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQNG---FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCCCCcccCCcHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99999998 999998876555555555443 22233456789999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=311.99 Aligned_cols=199 Identities=30% Similarity=0.477 Sum_probs=163.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||.||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni 139 (310)
T 3s95_A 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNC 139 (310)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeE
Confidence 46789999999999999999999999999999999998753 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCc-----------cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQ-----------RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~-----------~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
|++.++.+||+|||++.......... ......+||+.|+|||++. +..++.++|||||||++|+|++|
T Consensus 140 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g 218 (310)
T 3s95_A 140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGR 218 (310)
T ss_dssp EECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHT
T ss_pred EECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHhcC
Confidence 99999999999999987553322111 1112468999999999998 67899999999999999999999
Q ss_pred CCCCCCCChHHH-----HHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 150 HAPFSKYPPMKV-----LLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 150 ~~PF~~~~~~~~-----l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..||........ ....... ..+..+++.+.+||.+||..||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 219 VNADPDYLPRTMDFGLNVRGFLDR-------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp CCSSTTTSCBCTTSSBCHHHHHHH-------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhHHHHhhhhhccccc-------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999876432110 0111111 112457788999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.18 Aligned_cols=204 Identities=17% Similarity=0.241 Sum_probs=161.9
Q ss_pred CCCCCCcccceEEEEEEC----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVD----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
+.++||||+++++++... .++||||||| ||+|.+++... ...+++..++.|+.||+.||.|||++||+||||||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp 180 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKA 180 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCH
Confidence 567899999999999875 5699999999 99999998763 46799999999999999999999999999999999
Q ss_pred CcEEEc--CCCcEEEEecCCccccccCCCC----ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 78 GNILLD--TNGVVKLADFGVSACMFDTGDR----QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 78 eNILld--~~g~IKL~DFGlA~~~~~~~~~----~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
+|||++ .++.+||+|||+++.+...... .......+||+.|+|||++. +..++.++|||||||++|+|++|..
T Consensus 181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-CCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999 8899999999999765332211 11123456999999999998 5679999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhc-CCCCCC-----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 152 PFSKYPPMKVLLMTIQN-APPGLD-----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~-~~~~~~-----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
||.+............. ....+. ......++.++.+||..||..||.+||++.+|++
T Consensus 260 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 260 PWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 99864322221111110 000000 0011456899999999999999999999998875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=317.07 Aligned_cols=199 Identities=23% Similarity=0.449 Sum_probs=168.4
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
+||||++++++|.+++.+|+|||||.||+|.+++..... ..+++..++.|+.||+.||.|||++||
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 212 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 212 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 899999999999999999999999999999999987532 359999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-C
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-G 149 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G 149 (583)
+||||||+|||++.++.+||+|||+++...... .........||+.|+|||++. +..++.++|||||||++|+|++ |
T Consensus 213 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt~g 290 (382)
T 3tt0_A 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLG 290 (382)
T ss_dssp CCSCCCGGGEEECTTCCEEECSCSCCCCSSCCC-TTCCCTTCCCGGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ecCCCCcceEEEcCCCcEEEcccCccccccccc-ccccccCCCCCcceeCHHHhc-CCCCCchhHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999987543221 112223456788999999998 5679999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
..||.+....+... .+.... ....+..++.++.+||.+||..||.+|||+.+++++
T Consensus 291 ~~p~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 291 GSPYPGVPVEELFK-LLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCSSTTCCHHHHHH-HHHTTC---CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHH-HHHcCC---CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99998876554443 333321 222345789999999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.64 Aligned_cols=195 Identities=23% Similarity=0.358 Sum_probs=161.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++..|+|||||.||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 144 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNI 144 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceE
Confidence 35789999999999999999999999999999999998764 34499999999999999999999999999999999999
Q ss_pred EEcCCCc--------EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC-CC
Q 007967 81 LLDTNGV--------VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG-HA 151 (583)
Q Consensus 81 Lld~~g~--------IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG-~~ 151 (583)
|++.++. +||+|||++..... .....||+.|+|||++.....++.++|||||||++|+|++| .+
T Consensus 145 ll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 145 LLIREEDRKTGNPPFIKLSDPGISITVLP-------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp EEEECCBGGGTBCCEEEECCCCSCTTTSC-------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEecCCcccccccceeeeccCcccccccC-------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 9998887 99999999864311 12356899999999998546799999999999999999995 55
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
||..... .......... . ..+..++..+.+||.+||..||.+|||+.++++|
T Consensus 218 ~~~~~~~-~~~~~~~~~~-~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 218 PLSALDS-QRKLQFYEDR-H----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TTTTSCH-HHHHHHHHTT-C----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred Cccccch-HHHHHHhhcc-C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5555443 3333333321 1 1224457789999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.82 Aligned_cols=203 Identities=17% Similarity=0.277 Sum_probs=163.0
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.+ +||||+++++++.+++.+|+||||| ||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 59 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 136 (330)
T 2izr_A 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENF 136 (330)
T ss_dssp HHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 345 8999999999999999999999999 99999998764 46799999999999999999999999999999999999
Q ss_pred EEcCCCc-----EEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 81 LLDTNGV-----VKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 81 Lld~~g~-----IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
|++.++. +||+|||++..+....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..
T Consensus 137 ll~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~ 215 (330)
T 2izr_A 137 LIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSL 215 (330)
T ss_dssp EECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHc-CCCCCchhHHHHHHHHHHHHhcCCC
Confidence 9998887 9999999997654332211 1124578999999999998 5779999999999999999999999
Q ss_pred CCCCCCh--HHHHHHHHhcCCCCCCcc-ccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 152 PFSKYPP--MKVLLMTIQNAPPGLDYD-RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 152 PF~~~~~--~~~l~~~i~~~~~~~~~~-~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
||.+... .......+.......... ....++ ++.+||..||..||.+||++.+|++
T Consensus 216 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 216 PWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp TTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9987532 222222221111011111 112345 9999999999999999999988875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.42 Aligned_cols=202 Identities=22% Similarity=0.389 Sum_probs=169.7
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHH
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ----------------DGFEESAIGSILKETLKALDYL 65 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~----------------~~~sE~~i~~I~~QIl~gL~yL 65 (583)
.+ +||||++++++|.+++..|+|||||++|+|.+++..... ..+++..++.++.||+.||.||
T Consensus 82 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 161 (313)
T 1t46_A 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (313)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred hcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 45 899999999999999999999999999999999876432 1489999999999999999999
Q ss_pred HHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhh
Q 007967 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE 145 (583)
Q Consensus 66 Hs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILye 145 (583)
|++||+||||||+|||++.++.+||+|||++....... .........||+.|+|||++. +..++.++|||||||++|+
T Consensus 162 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e 239 (313)
T 1t46_A 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWE 239 (313)
T ss_dssp HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHH
T ss_pred HHCCeecCCCccceEEEcCCCCEEEccccccccccccc-cceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHH
Confidence 99999999999999999999999999999987553322 112223456788999999987 5679999999999999999
Q ss_pred hhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 146 LAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 146 LLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|++ |..||.+..........+..... ...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 240 llt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 240 LFSLGSSPYPGMPVDSKFYKMIKEGFR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCcccchhHHHHHhccCCC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 998 99999887655555555544322 22345688999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.57 Aligned_cols=196 Identities=26% Similarity=0.416 Sum_probs=167.0
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCC-CCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAE-GSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~G-GsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.||||++++++|.+.+.+++||||+.+ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe
Confidence 479999999999999999999999986 8999998764 6799999999999999999999999999999999999999
Q ss_pred -CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 84 -TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 84 -~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
.++.+||+|||++...... ......||+.|+|||++.....++.++|||||||++|+|++|..||.....
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---- 254 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---- 254 (320)
T ss_dssp TTTTEEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred CCCCCEEEeeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----
Confidence 7899999999998754321 123467999999999987544457889999999999999999999976321
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCC
Q 007967 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218 (583)
Q Consensus 163 ~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~ 218 (583)
.... . ......+++.+.+||.+||..||.+|||++++++||||++...+
T Consensus 255 --~~~~-~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 255 --IIRG-Q----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp --HHHC-C----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred --hhcc-c----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 1121 1 12235688999999999999999999999999999999987654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=297.08 Aligned_cols=197 Identities=18% Similarity=0.337 Sum_probs=166.0
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG--HIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHRDLK 76 (583)
|+.++||||++++++|.+. ..+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++| |+|||||
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik 140 (271)
T 3kmu_A 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140 (271)
T ss_dssp GCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred HHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence 4678999999999999987 78999999999999999987643335999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC--CCCccccccchhhHHhhhhhCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS--GYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~--~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|+|||++.++.++|+|||++... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.
T Consensus 141 p~Nil~~~~~~~~l~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 141 SRSVMIDEDMTARISMADVKFSF--------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp GGGEEECTTSCEEEEGGGSCCTT--------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred cceEEEcCCcceeEEeccceeee--------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999886432 112357899999999997321 23347999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+............... ....+..++..+.++|.+||..||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 213 DLSNMEIGMKVALEGL---RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TSCHHHHHHHHHHSCC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccChHHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8777666555544432 22334678999999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.24 Aligned_cols=196 Identities=27% Similarity=0.513 Sum_probs=160.4
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG---HIHRDVKAG 78 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g---IvHRDLKPe 78 (583)
+.++||||++++++|.+++.+|+|||||+||+|.+++. ...+++..++.++.||+.||.|||++| |+||||||+
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~ 137 (271)
T 3dtc_A 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137 (271)
T ss_dssp HHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGG
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchH
Confidence 45789999999999999999999999999999998874 467999999999999999999999999 899999999
Q ss_pred cEEEcC--------CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCC
Q 007967 79 NILLDT--------NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGH 150 (583)
Q Consensus 79 NILld~--------~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~ 150 (583)
|||++. ++.+||+|||++...... ......||+.|+|||++. +..++.++|||||||++|+|++|.
T Consensus 138 Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 138 NILILQKVENGDLSNKILKITDFGLAREWHRT-----TKMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp GEEESSCCSSSCCSSCCEEECCCCC------------------CCGGGSCHHHHH-HCCCSHHHHHHHHHHHHHHHHHCC
T ss_pred HEEEecccccccccCcceEEccCCcccccccc-----cccCCCCccceeCHHHhc-cCCCCchhhHHHHHHHHHHHHhCC
Confidence 999985 778999999998654221 112457899999999997 567899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 151 APFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 151 ~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.||.+.............. .....+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 212 ~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 212 VPFRGIDGLAVAYGVAMNK---LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTTTSCHHHHHHHHHTSC---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHhhhcCC---CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999877665554444332 2223346788999999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=301.09 Aligned_cols=201 Identities=15% Similarity=0.208 Sum_probs=162.8
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+||||+++++++.+....|+||||+ ||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 141 (298)
T 1csn_A 64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 141 (298)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECC
T ss_pred cCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecc
Confidence 8999999999999999999999999 99999998754 356999999999999999999999999999999999999987
Q ss_pred CCc-----EEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 85 NGV-----VKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 85 ~g~-----IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
++. +||+|||++.......... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.+
T Consensus 142 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 142 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 776 9999999987654322211 1234568999999999997 56789999999999999999999999987
Q ss_pred CCh---HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 156 YPP---MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 156 ~~~---~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
... ......................+++.+.+||.+||..||.+|||+.+|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 221 LKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 432 22222111111001111122467899999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.31 Aligned_cols=202 Identities=24% Similarity=0.440 Sum_probs=157.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+.+.+|+|||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 178 (373)
T 2qol_A 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 178 (373)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceE
Confidence 46789999999999999999999999999999999998643 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++................+++.|+|||++. ...++.++|||||||++|+|++ |..||......
T Consensus 179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~ 257 (373)
T 2qol_A 179 LINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257 (373)
T ss_dssp EECTTCCEEECCC----------------------CTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH
T ss_pred EEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhc-cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999876533222221222234578899999997 5679999999999999999997 99999987765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+........ ...+....++..+.+||.+||..||.+||++.++++
T Consensus 258 ~~~~~i~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 258 DVIKAVDEG----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHTT----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcC----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 544333322 122234568899999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.91 Aligned_cols=202 Identities=21% Similarity=0.383 Sum_probs=167.9
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++ ..+.+|+|||||.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 65 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 142 (287)
T 1u59_A 65 HQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 142 (287)
T ss_dssp HHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEE
Confidence 457999999999999 566799999999999999987532 456999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||++.................||+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+
T Consensus 143 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 221 (287)
T 1u59_A 143 LVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221 (287)
T ss_dssp EEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred EcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999876533222222223456789999999997 5678999999999999999998 999998876655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
.......... ...+..+++.+.++|.+||..||.+|||+.++++|.
T Consensus 222 ~~~~i~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 222 VMAFIEQGKR----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHTTCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCc----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 4433333322 223457899999999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.15 Aligned_cols=203 Identities=22% Similarity=0.398 Sum_probs=163.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+.+.+|||||||.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 178 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 178 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheE
Confidence 35689999999999999999999999999999999998753 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++.................+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....
T Consensus 179 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 257 (333)
T 1mqb_A 179 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257 (333)
T ss_dssp EECTTCCEEECCCCC-----------------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcc-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999999999876533222222222345688999999997 5679999999999999999998 99999887765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+......... ..+.+..++..+.+||.+||..||.+||++.+++++
T Consensus 258 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 258 EVMKAINDGF----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHTTC----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHCCC----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5443333321 223345688999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.29 Aligned_cols=200 Identities=22% Similarity=0.387 Sum_probs=164.8
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.++. .++||||+.+|+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||
T Consensus 72 ~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl 149 (327)
T 3poz_A 72 ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp HHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEE
Confidence 4679999999999998754 78999999999999998753 467999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||+++...... .........||+.|+|||++. +..|+.++|||||||++|+|++ |..||.+.....
T Consensus 150 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 150 VKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp EEETTEEEECCTTHHHHHTTTC-C-------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred ECCCCCEEEccCcceeEccCCc-ccccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 9999999999999987553222 222223456788999999998 5679999999999999999999 999998876644
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
... .+.... ....+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus 228 ~~~-~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 228 ISS-ILEKGE---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHH-HHHTTC---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHH-HHHcCC---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 433 333221 223345688999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=307.76 Aligned_cols=199 Identities=22% Similarity=0.410 Sum_probs=165.2
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLH 66 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLH 66 (583)
+.+ +||||++++++|.+.+.+|+|||||++|+|.+++.... ...+++..++.++.||+.||.|||
T Consensus 80 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 159 (327)
T 1fvr_A 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 159 (327)
T ss_dssp TTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 566 89999999999999999999999999999999987531 236999999999999999999999
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhh
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALEL 146 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeL 146 (583)
++||+||||||+|||++.++.+||+|||++..... ........+++.|+|||++. ...++.++|||||||++|+|
T Consensus 160 ~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el 234 (327)
T 1fvr_A 160 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEI 234 (327)
T ss_dssp HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE----ECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHH
T ss_pred hCCccCCCCccceEEEcCCCeEEEcccCcCccccc----cccccCCCCCccccChhhhc-cccCCchhcchHHHHHHHHH
Confidence 99999999999999999999999999999863211 11122346788999999997 56789999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 Lt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++ |..||.+........ .+... .....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 235 lt~g~~pf~~~~~~~~~~-~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 235 VSLGGTPYCGMTCAELYE-KLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HTTSCCTTTTCCHHHHHH-HGGGT---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCCCcHHHHHH-HhhcC---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 98 999998876544433 33322 2223345788999999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.56 Aligned_cols=200 Identities=24% Similarity=0.438 Sum_probs=169.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.++..+|+|||||.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 64 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil 143 (288)
T 3kfa_A 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143 (288)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEE
T ss_pred HhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEE
Confidence 46789999999999999999999999999999999998755566999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||++...... .........+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+.....
T Consensus 144 ~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~ 220 (288)
T 3kfa_A 144 VGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220 (288)
T ss_dssp ECGGGCEEECCCCGGGTSCSS--SSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EcCCCCEEEccCccceeccCC--ccccccCCccccCcCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999998754322 122223456788999999997 5678999999999999999999 999998866544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
........ .....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 221 ~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 221 VYELLEKD----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcc----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 43333222 122334678999999999999999999999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=297.18 Aligned_cols=200 Identities=24% Similarity=0.437 Sum_probs=167.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||++++++|.+.+.+|+||||++||+|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 136 (267)
T 3t9t_A 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 136 (267)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred HhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEE
Confidence 5679999999999999999999999999999999998753 456999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||++...... .........|++.|+|||++. ...++.++|||||||++|+|++ |..||.......
T Consensus 137 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (267)
T 3t9t_A 137 VGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213 (267)
T ss_dssp ECGGGCEEECCTTGGGGBCCH--HHHSTTSTTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ECCCCCEEEcccccccccccc--cccccccccccccccChhhhc-CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence 999999999999998654221 111122346788999999997 5678999999999999999999 999998876655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
......... ....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 214 ~~~~i~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 214 VVEDISTGF----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTTC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCC----cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 443333322 122335678999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=317.36 Aligned_cols=201 Identities=22% Similarity=0.403 Sum_probs=167.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||+||+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 166 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 244 (377)
T 3cbl_A 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNC 244 (377)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHE
Confidence 46789999999999999999999999999999999998754 34699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++..... ..........+++.|+|||++. ...++.++|||||||++|||++ |..||.+....
T Consensus 245 l~~~~~~~kl~DfG~s~~~~~~-~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~ 322 (377)
T 3cbl_A 245 LVTEKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322 (377)
T ss_dssp EECTTCCEEECCGGGCEECTTS-EEECCSSCCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred EEcCCCcEEECcCCCceecCCC-ceeecCCCCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998753221 1111111234577899999997 5578999999999999999998 99999887765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.......... ..+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 323 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 323 QTREFVEKGG----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCC----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5443333322 22334568899999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=307.13 Aligned_cols=204 Identities=22% Similarity=0.302 Sum_probs=161.5
Q ss_pred CCCCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------
Q 007967 1 MSLIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-------- 68 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-------- 68 (583)
|+.++|||||+++++|.+.. .+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~ 148 (322)
T 3soc_A 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148 (322)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEE
T ss_pred HhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhcccccccc
Confidence 56789999999999999844 48999999999999999864 5699999999999999999999999
Q ss_pred --CCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCC----CCCCccccccchhhH
Q 007967 69 --GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPG----SGYNSKADIWSFGIT 142 (583)
Q Consensus 69 --gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~----~~ys~ksDIWSLGvI 142 (583)
||+||||||+|||++.++.+||+|||+++...... ........+||+.|+|||++.+. ..++.++|||||||+
T Consensus 149 ~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 227 (322)
T 3soc_A 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227 (322)
T ss_dssp ECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTS-CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHH
T ss_pred CCCEEeCCCChHhEEECCCCeEEEccCCccccccccc-CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHH
Confidence 99999999999999999999999999987553322 22223346899999999999842 345668899999999
Q ss_pred HhhhhhCCCCCCCCCh---------------HHHHHHHHhcCCCCCCcc---ccccchHHHHHHHHhhhcCCCCCCCCHH
Q 007967 143 ALELAHGHAPFSKYPP---------------MKVLLMTIQNAPPGLDYD---RDKKFSKSFKEMVAMCLVKDQTKRPTAE 204 (583)
Q Consensus 143 LyeLLtG~~PF~~~~~---------------~~~l~~~i~~~~~~~~~~---~~~~~S~~lkdLI~~cL~~DP~kRpTa~ 204 (583)
+|+|++|..||.+... ...+...+.......... .....++.+.+||.+||+.||.+|||+.
T Consensus 228 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (322)
T 3soc_A 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307 (322)
T ss_dssp HHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHH
Confidence 9999999999975321 222222222211111111 1123466799999999999999999999
Q ss_pred HHHh
Q 007967 205 KLLK 208 (583)
Q Consensus 205 eIL~ 208 (583)
++++
T Consensus 308 ell~ 311 (322)
T 3soc_A 308 CVGE 311 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=303.88 Aligned_cols=203 Identities=21% Similarity=0.339 Sum_probs=165.4
Q ss_pred CCCCCCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.+. ..+|+|||||++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 155 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 155 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchh
Confidence 3568999999999999877 6799999999999999998654 466999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC--
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY-- 156 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~-- 156 (583)
|||++.++.+||+|||++.................||..|+|||++. +..++.++|||||||++|+|++|..||...
T Consensus 156 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 234 (302)
T 4e5w_A 156 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234 (302)
T ss_dssp GEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred eEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCcchhh
Confidence 99999999999999999876543332222334567889999999997 567889999999999999999999886321
Q ss_pred ------------ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 157 ------------PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 157 ------------~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.....+...+... .....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 235 LFLKMIGPTHGQMTVTRLVNTLKEG---KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHCSCCGGGHHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHhhccCCcccccCHHHHHHHHhcc---CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1122222222222 223345678999999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=301.88 Aligned_cols=200 Identities=22% Similarity=0.372 Sum_probs=165.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++ ..+.+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 72 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni 148 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 148 (291)
T ss_dssp HHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceE
Confidence 3568999999999999 67789999999999999999876 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++.................+++.|+|||++. ...++.++|||||||++|+|++ |..||.+....
T Consensus 149 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 227 (291)
T 1xbb_A 149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227 (291)
T ss_dssp EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc-cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999875533322222222345678899999997 5568899999999999999999 99999987765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
............ ..+..+++.+.++|.+||..||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 228 EVTAMLEKGERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 544333333222 234568999999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=305.33 Aligned_cols=194 Identities=25% Similarity=0.444 Sum_probs=160.2
Q ss_pred CCCcccceEEEEEECCEEEEEEec-CCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPF-MAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy-~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
+||||++++++|.+.+..++|||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID 173 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe
Confidence 899999999999999999999999 7899999998764 6799999999999999999999999999999999999999
Q ss_pred -CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 84 -TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 84 -~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
.++.+||+|||++...... ......|++.|+|||++.....++.++|||||||++|+|++|+.||.....
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 244 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDE-----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---- 244 (312)
T ss_dssp TTTTEEEECCCSSCEECCSS-----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred CCCCeEEEEEcchhhhcccC-----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----
Confidence 8899999999998755321 123467999999999987444445689999999999999999999976321
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 163 ~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
... .. ......++..+++||.+||..||.+|||+.++++||||+...
T Consensus 245 --~~~-~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 245 --ILE-AE----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp --HHH-TC----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred --Hhh-hc----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 111 11 122356889999999999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=297.54 Aligned_cols=199 Identities=22% Similarity=0.390 Sum_probs=167.2
Q ss_pred CCCCCCcccceEEEEEE----------------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 007967 2 SLIDHPNVIRAYCSFVV----------------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d----------------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yL 65 (583)
+.++||||++++++|.. ...+|+|||||++|+|.+++.......+++..++.++.||+.||.||
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 138 (284)
T 2a19_B 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI 138 (284)
T ss_dssp HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 46799999999999875 45689999999999999999876667899999999999999999999
Q ss_pred HHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhh
Q 007967 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE 145 (583)
Q Consensus 66 Hs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILye 145 (583)
|++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||++. +..++.++|||||||++|+
T Consensus 139 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ 213 (284)
T 2a19_B 139 HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAE 213 (284)
T ss_dssp HHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHH-CSCCCTHHHHHHHHHHHHH
T ss_pred HhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc----cccccCCcccccChhhhc-cCCCcchhhhHHHHHHHHH
Confidence 99999999999999999999999999999987553321 123457999999999998 5678999999999999999
Q ss_pred hhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 146 LAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 146 LLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
|++|..||.. .......+.... ....++..+++||.+||..||.+|||+.++++|.+...
T Consensus 214 l~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 214 LLHVCDTAFE---TSKFFTDLRDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHSCCSSHHH---HHHHHHHHHTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHhcCCcchh---HHHHHHHhhccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9999988743 122223333221 12457889999999999999999999999999987654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.19 Aligned_cols=204 Identities=25% Similarity=0.423 Sum_probs=161.2
Q ss_pred CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCC
Q 007967 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTN 85 (583)
Q Consensus 6 HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~ 85 (583)
||||+++++++.++..+|+||| +.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ +
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~ 162 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D 162 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T
T ss_pred CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-C
Confidence 6999999999999999999999 568999999875 36799999999999999999999999999999999999996 4
Q ss_pred CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC----------CCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 86 GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP----------GSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 86 g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~----------~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
+.+||+|||++....... .........||+.|+|||++.. ...++.++|||||||++|+|++|..||..
T Consensus 163 ~~~kL~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp TEEEECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CeEEEeeccccccccCcc-ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 899999999987543221 1112234679999999999873 14688899999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..........+..... ....+...+..+.+||.+||..||.+|||+.++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 242 IINQISKLHAIIDPNH--EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCSHHHHHHHHHCTTS--CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHHHHHHHHHhccc--ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 6543333333332222 2223345688999999999999999999999999999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.77 Aligned_cols=203 Identities=21% Similarity=0.362 Sum_probs=159.6
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.. ...+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~ 143 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 143 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHh
Confidence 357899999999999865 35699999999999999998764 345999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||++.................++..|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 144 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 222 (295)
T 3ugc_A 144 NILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222 (295)
T ss_dssp GEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH
T ss_pred hEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChH
Confidence 99999999999999999876533322222223456788899999998 56799999999999999999999999865221
Q ss_pred HH---------------HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 MK---------------VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~~---------------~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.. .+...+.. ....+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 223 EFMRMIGNDKQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhcCccccchhHHHHHHHHhc---cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 10 11111111 1223345678999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.66 Aligned_cols=202 Identities=20% Similarity=0.374 Sum_probs=168.8
Q ss_pred CC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007967 3 LI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY------------QDGFEESAIGSILKETLKALDYLHRQG 69 (583)
Q Consensus 3 ~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~------------~~~~sE~~i~~I~~QIl~gL~yLHs~g 69 (583)
.+ +||||++++++|.+.+.+|+|||||++|+|.+++.... ...+++..+..++.||+.||.|||++|
T Consensus 105 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 184 (333)
T 2i1m_A 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184 (333)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 45 89999999999999999999999999999999987643 245899999999999999999999999
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH- 148 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt- 148 (583)
|+||||||+|||++.++.+||+|||++........ ........||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 185 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~ 262 (333)
T 2i1m_A 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSL 262 (333)
T ss_dssp EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTT
T ss_pred cccCCcccceEEECCCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999875533221 11223456788999999987 5678999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 149 GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 149 G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|..||.+..........+.... ....+..++..+.+||.+||..||.+|||+.+++++
T Consensus 263 g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 263 GLNPYPGILVNSKFYKLVKDGY---QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp SCCSSTTCCSSHHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccchhHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 9999988765555544444432 222335578999999999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.40 Aligned_cols=205 Identities=26% Similarity=0.471 Sum_probs=159.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++ .....+++|||||.|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 74 l~~l~h~~iv~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Ni 151 (289)
T 3og7_A 74 LRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI 151 (289)
T ss_dssp HTTCCCTTBCCEEEE-ECSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCcEEEEEee-ccCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 467899999999995 4667799999999999999987543 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc--CCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ--PGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~--~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++.++.+||+|||++....... .........||+.|+|||++. ....++.++|||||||++|+|++|..||.+...
T Consensus 152 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 152 FLHEDNTVKIGDFGLATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp EEETTTEEEECCCC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred EECCCCCEEEccceecccccccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 99999999999999986442211 112223467999999999986 245688899999999999999999999988777
Q ss_pred HHHHHHHHhcCCCCCC-ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 MKVLLMTIQNAPPGLD-YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~-~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
...+...+........ ......+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 231 RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6666555554432222 1223568899999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=308.02 Aligned_cols=207 Identities=22% Similarity=0.386 Sum_probs=170.2
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-----DGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-----~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
+.++||||+++++++.+...+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlk 167 (327)
T 2yfx_A 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167 (327)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCC
Confidence 457999999999999999999999999999999999886532 348999999999999999999999999999999
Q ss_pred CCcEEEcC---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCC
Q 007967 77 AGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAP 152 (583)
Q Consensus 77 PeNILld~---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~P 152 (583)
|+|||++. ++.+||+|||++....... .........||+.|+|||++. ...++.++|||||||++|+|++ |..|
T Consensus 168 p~NIli~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p 245 (327)
T 2yfx_A 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRAS-YYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMP 245 (327)
T ss_dssp GGGEEESCSSTTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred HhHEEEecCCCcceEEECcccccccccccc-ccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999984 4469999999986543222 112223457899999999997 5678999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 153 FSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
|................. ......++..+.+||.+||..||.+|||+.++++|.|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 246 YPSKSNQEVLEFVTSGGR----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp STTCCHHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 988766554433333322 2234568899999999999999999999999999988653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.90 Aligned_cols=204 Identities=20% Similarity=0.245 Sum_probs=162.2
Q ss_pred CCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
+.++||||+++++++.+ ...+|+||||| ||+|.+++... +.+++..++.++.||+.||.|||++||+||||||
T Consensus 103 ~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 179 (345)
T 2v62_A 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKA 179 (345)
T ss_dssp HTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred ccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCH
Confidence 45799999999999998 78899999999 99999987654 4799999999999999999999999999999999
Q ss_pred CcEEEcCCC--cEEEEecCCccccccCCCC----ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 78 GNILLDTNG--VVKLADFGVSACMFDTGDR----QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 78 eNILld~~g--~IKL~DFGlA~~~~~~~~~----~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
+|||++.++ .+||+|||+++.+...... ........||+.|+|||++. +..++.++|||||||++|+|++|..
T Consensus 180 ~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~ 258 (345)
T 2v62_A 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-GVALSRRSDVEILGYCMLRWLCGKL 258 (345)
T ss_dssp GGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999998877 9999999999765332211 11123468999999999998 5679999999999999999999999
Q ss_pred CCCCCCh-HHHHHHHHhcCCCCCCc-----cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 152 PFSKYPP-MKVLLMTIQNAPPGLDY-----DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 152 PF~~~~~-~~~l~~~i~~~~~~~~~-----~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
||.+... ..............+.. .....++..+++||.+||..||.+|||+.+|++.
T Consensus 259 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 259 PWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 9965322 11111111111011110 0112688899999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=300.48 Aligned_cols=202 Identities=24% Similarity=0.410 Sum_probs=166.1
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+.. .++||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 76 ~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 153 (291)
T 1u46_A 76 HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 153 (291)
T ss_dssp HHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEE
Confidence 4578999999999998765 89999999999999998764 456999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||++.................+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+.....
T Consensus 154 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 232 (291)
T 1u46_A 154 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232 (291)
T ss_dssp EEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH
Confidence 99999999999999876533322222223456788999999997 5668899999999999999999 999999877655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
......... . .......++..+.++|.+||..||.+|||+.+++++
T Consensus 233 ~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 233 ILHKIDKEG-E--RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHTSC-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccC-C--CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 554443332 1 223345789999999999999999999999999873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=322.34 Aligned_cols=200 Identities=23% Similarity=0.433 Sum_probs=168.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++++++. ...+|||||||.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+||
T Consensus 237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 57889999999999986 67799999999999999999865445789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++...... ........+++.|+|||++. ...++.++|||||||++|||++ |..||.+....
T Consensus 316 ll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 316 LVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp EECTTCCEEECSTTGGGGBCCHH--HHTTCSSSSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EECCCCcEEEeeCCCceEcCCCc--eeccCCCcccccccCHHHhc-cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999987542211 11122345678899999997 5679999999999999999999 99999987766
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+........ ...+.+..+++.+.+||.+||..||.+|||+.+|+.
T Consensus 393 ~~~~~i~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 393 EVIRALERG----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcC----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 655444333 223344678999999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.91 Aligned_cols=201 Identities=24% Similarity=0.322 Sum_probs=158.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.+++.+|+|||||+|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI 165 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence 46789999999999999999999999999999999998764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... ........|++.|+|||++. +..++.++|||||||++|+|++|..||.+....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 241 (309)
T 2h34_A 166 LVSADDFAYLVDFGIASATTDEK--LTQLGNTVGTLYYMAPERFS-ESHATYRADIYALTCVLYECLTGSPPYQGDQLS- 241 (309)
T ss_dssp EECTTSCEEECSCCC------------------CCGGGCCGGGTC-C----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-
T ss_pred EEcCCCCEEEecCccCccccccc--cccccccCCCcCccCHHHHc-CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-
Confidence 99999999999999986543221 11223467999999999997 567899999999999999999999999875443
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-CHHHHHh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-TAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-Ta~eIL~ 208 (583)
.+...+..... ........++..+.+||.+||..||.+|| |++++++
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 242 VMGAHINQAIP-RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHSCCC-CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCC-CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 33344443322 22233467889999999999999999999 7888775
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.00 Aligned_cols=200 Identities=22% Similarity=0.385 Sum_probs=161.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||++++++|.++. .++||+|+.+|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 148 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 148 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHE
Confidence 46789999999999998755 88999999999999998764 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||++....... .........||+.|+|||++. +..|+.++|||||||++|+|++ |..||.+....
T Consensus 149 l~~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 149 LVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp EEEETTEEEECCTTC-----------------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred EEcCCCCEEEccCcceeEccCcc-ccccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 99999999999999987543222 122223356788999999998 5679999999999999999999 99999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.......... ..+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 227 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 227 EISSILEKGE----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp GHHHHHHTTC----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCC----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5443333322 22334568899999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.81 Aligned_cols=208 Identities=23% Similarity=0.345 Sum_probs=165.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.+.+.+|+|||||+||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~ 168 (321)
T 2qkw_B 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSI 168 (321)
T ss_dssp GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCST
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHH
Confidence 467899999999999999999999999999999998875432 124899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||++....... .........||+.|+|||++. +..++.++|||||||++|+|++|+.||.+..+
T Consensus 169 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 169 NILLDENFVPKITDFGISKKGTELD-QTHLSTVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp TEEECTTCCEEECCCTTCEECSSSS-CCCCBCCCEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred HEEECCCCCEEEeeccccccccccc-ccccccccCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 9999999999999999987543221 112223457899999999987 45789999999999999999999999976433
Q ss_pred HHH------HHHHHhcCC------CCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 159 MKV------LLMTIQNAP------PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 159 ~~~------l~~~i~~~~------~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
... ......... +.........++..+.+++.+||..||.+|||+.++++|.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 111 111111110 1111122345778899999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=298.47 Aligned_cols=203 Identities=23% Similarity=0.387 Sum_probs=158.9
Q ss_pred CCCCCcccceEEEEEEC----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CC
Q 007967 3 LIDHPNVIRAYCSFVVD----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ--------GH 70 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~--------gI 70 (583)
.++||||+++++++.+. ..+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++ ||
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 46999999999999988 789999999999999999864 5799999999999999999999999 99
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCC-ccccccccCCCCCCCcccccCCCCCCcc------ccccchhhHH
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDR-QRSRNTFVGTPCWMAPEVLQPGSGYNSK------ADIWSFGITA 143 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~-~~~~~~~~GT~~Y~APEil~~~~~ys~k------sDIWSLGvIL 143 (583)
+||||||+|||++.++.+||+|||++......... .......+||+.|+|||++.+ ..+... +|||||||++
T Consensus 164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il 242 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLIL 242 (337)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHH
Confidence 99999999999999999999999998655332211 111234689999999999973 334443 8999999999
Q ss_pred hhhhhC----------CCCCCCCC----hHHHHHHHHhcCCCCCCccc---cccchHHHHHHHHhhhcCCCCCCCCHHHH
Q 007967 144 LELAHG----------HAPFSKYP----PMKVLLMTIQNAPPGLDYDR---DKKFSKSFKEMVAMCLVKDQTKRPTAEKL 206 (583)
Q Consensus 144 yeLLtG----------~~PF~~~~----~~~~l~~~i~~~~~~~~~~~---~~~~S~~lkdLI~~cL~~DP~kRpTa~eI 206 (583)
|+|++| ..||.... ........+.........+. ...+++.+.+||.+||..||.+|||+.++
T Consensus 243 ~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 999999 77775532 22223222222211111111 23577889999999999999999999999
Q ss_pred Hhc
Q 007967 207 LKH 209 (583)
Q Consensus 207 L~H 209 (583)
++|
T Consensus 323 l~~ 325 (337)
T 3mdy_A 323 KKT 325 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.51 Aligned_cols=199 Identities=21% Similarity=0.376 Sum_probs=162.7
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+ +..|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 68 ~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 145 (281)
T 3cc6_A 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145 (281)
T ss_dssp HHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred HhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence 45789999999999875 4578999999999999998764 456999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||++....... ........+++.|+|||++. ...++.++|||||||++|+|++ |+.||.......
T Consensus 146 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~ 222 (281)
T 3cc6_A 146 VASPECVKLGDFGLSRYIEDED--YYKASVTRLPIKWMSPESIN-FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222 (281)
T ss_dssp EEETTEEEECCCCGGGCC-----------CCCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred ECCCCcEEeCccCCCccccccc--ccccccCCCCcceeCchhhc-cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence 9999999999999987543221 11122346788999999997 5678999999999999999998 999998766554
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.......... ...+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 223 ~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 223 VIGVLEKGDR----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCC----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 4433333222 22335688999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.02 Aligned_cols=197 Identities=25% Similarity=0.467 Sum_probs=166.0
Q ss_pred CCCCCCCcccceEEEEEECC-EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDS-NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~-~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++|||||++++++.... .+|||||||.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|
T Consensus 240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 319 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 319 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence 46789999999999988765 79999999999999999987644458999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCCh
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPP 158 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~ 158 (583)
||++.++.+||+|||+++..... .....+++.|+|||++. ...++.++|||||||++|||++ |..||.+...
T Consensus 320 ill~~~~~~kl~DfG~a~~~~~~------~~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 320 VLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp EEECTTSCEEECCCTTCEECC------------CCCTTTSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred EEECCCCCEEEeeCCCccccccc------ccCCCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999998743211 12246788999999998 5679999999999999999998 9999988766
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.+........ .....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 393 ~~~~~~i~~~----~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 393 KDVVPRVEKG----YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TTHHHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcC----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5544333332 223345678999999999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.79 Aligned_cols=202 Identities=26% Similarity=0.445 Sum_probs=163.8
Q ss_pred CCCCCCCcccceEEEEEECCEE-EEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNL-WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l-~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||++++++|.+.+.. ++||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N 154 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARN 154 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 3568999999999999877665 9999999999999998652 4668999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCC-CccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCC
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGD-RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYP 157 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~-~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~ 157 (583)
||++.++.+||+|||++........ .........+++.|+|||.+. +..++.++|||||||++|+|++ |.+||....
T Consensus 155 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 155 CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ-TYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp EEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT-TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred EEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhc-cCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 9999999999999999875432211 112223457889999999998 6678999999999999999999 555555544
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..... ..+.... ....+..++..+.+||.+||..||.+|||+.++++
T Consensus 234 ~~~~~-~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 234 PFDLT-HFLAQGR---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp GGGHH-HHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHH-HHhhcCC---CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 44433 3333322 12234568899999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.06 Aligned_cols=203 Identities=25% Similarity=0.402 Sum_probs=161.2
Q ss_pred CCCCCCCcccceEEEEEECC-----EEEEEEecCCCCCHHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIAY----QDGFEESAIGSILKETLKALDYLHRQGHI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~-----~l~LVmEy~~GGsL~dll~~~~----~~~~sE~~i~~I~~QIl~gL~yLHs~gIv 71 (583)
|+.++||||++++++|.+.. ..|+|||||.+|+|.+++.... ...+++..++.++.||+.||.|||++||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 169 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL 169 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 35689999999999998765 3599999999999999986432 35599999999999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CC
Q 007967 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GH 150 (583)
Q Consensus 72 HRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~ 150 (583)
||||||+|||++.++.+||+|||++....... .........+++.|+|||++. ...++.++|||||||++|+|++ |.
T Consensus 170 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~ 247 (313)
T 3brb_A 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-YYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGM 247 (313)
T ss_dssp CCCCSGGGEEECTTSCEEECSCSCC-----------------CCGGGSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCCCcceEEEcCCCcEEEeecCcceeccccc-ccCcccccCCCccccCchhhc-CCCccchhhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999987543221 112223356788999999998 5679999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 151 APFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 151 ~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.||.+............... ...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 248 TPYPGVQNHEMYDYLLHGHR----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CSSTTCCGGGHHHHHHTTCC----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHcCCC----CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99988766555444443322 22345688999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.70 Aligned_cols=202 Identities=25% Similarity=0.421 Sum_probs=164.0
Q ss_pred CCCCCCCcccceEEEEE-ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFV-VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~-d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||+++++++. .++..|+|||||.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N 158 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN 158 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 35789999999999864 567899999999999999998642 4568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCC-CccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCC
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGD-RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYP 157 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~-~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~ 157 (583)
||++.++.+||+|||++........ .........||+.|+|||++. +..++.++|||||||++|+|++ |.+||.+..
T Consensus 159 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp EEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred EEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 9999999999999999875533221 111223457788999999997 5678999999999999999999 677777766
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..+........... ..+..++..+.++|.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 238 TFDITVYLLQGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTTHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55544444443221 223567899999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=304.43 Aligned_cols=200 Identities=23% Similarity=0.384 Sum_probs=165.9
Q ss_pred CCCcccceEEEEEECC-EEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007967 5 DHPNVIRAYCSFVVDS-NLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLHRQG 69 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~-~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLHs~g 69 (583)
+||||++++++|...+ .+|+|||||.||+|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 168 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 7999999999998754 59999999999999999875421 12899999999999999999999999
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH- 148 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt- 148 (583)
|+||||||+|||++.++.+||+|||++........ ........||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccccCccceEEECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875533221 12223457889999999997 5678999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 149 GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 149 G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|..||.+..........+.... ....+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 247 g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 247 GASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccchhHHHHHHhccCc---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999988765555544444432 122335678999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.38 Aligned_cols=203 Identities=24% Similarity=0.404 Sum_probs=159.3
Q ss_pred CCCCCcccceEEEEEEC----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCC
Q 007967 3 LIDHPNVIRAYCSFVVD----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH--------RQGH 70 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH--------s~gI 70 (583)
.++||||+++++++.+. ..+|+|||||++|+|.++++ ...+++..+..++.||+.||.||| ++||
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 47999999999997653 46999999999999999984 367999999999999999999999 9999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCc-cccccccCCCCCCCcccccCCC-----CCCccccccchhhHHh
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCWMAPEVLQPGS-----GYNSKADIWSFGITAL 144 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~-~~~~~~~GT~~Y~APEil~~~~-----~ys~ksDIWSLGvILy 144 (583)
+||||||+|||++.++.+||+|||+++......... ......+||+.|+|||++.+.. .++.++|||||||++|
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~ 214 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH
Confidence 999999999999999999999999987543322211 1123458999999999998432 3447899999999999
Q ss_pred hhhhC----------CCCCCCCCh----HHHHHHHHhcCCCCCCcc---ccccchHHHHHHHHhhhcCCCCCCCCHHHHH
Q 007967 145 ELAHG----------HAPFSKYPP----MKVLLMTIQNAPPGLDYD---RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207 (583)
Q Consensus 145 eLLtG----------~~PF~~~~~----~~~l~~~i~~~~~~~~~~---~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL 207 (583)
+|++| ..||..... .................+ ....++..+.+||.+||+.||.+|||+.+++
T Consensus 215 el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 99999 889865322 223322222221111111 1234678899999999999999999999998
Q ss_pred h
Q 007967 208 K 208 (583)
Q Consensus 208 ~ 208 (583)
+
T Consensus 295 ~ 295 (301)
T 3q4u_A 295 K 295 (301)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.32 Aligned_cols=204 Identities=21% Similarity=0.333 Sum_probs=166.6
Q ss_pred CCCCCCCcccceEEEEE--ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFV--VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~--d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++. +...+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~ 156 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 156 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChh
Confidence 35689999999999987 456799999999999999998764 346999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||++.................||+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 157 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 157 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp GEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred hEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc-cCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 99999999999999999876533332222334457889999999997 56789999999999999999999999865322
Q ss_pred H--------------HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 159 M--------------KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 159 ~--------------~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
. ..+...+... .....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLEEG---QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhhcccccccccHHHHHHHhhcc---cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 1222222221 2233356789999999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.52 Aligned_cols=199 Identities=24% Similarity=0.441 Sum_probs=166.0
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------------DGFEESAIGSILKETLKALDYLHRQGH 70 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------------~~~sE~~i~~I~~QIl~gL~yLHs~gI 70 (583)
+||||++++++|.+.+.+|+|||||.+|+|.+++..... ..+++..++.++.||+.||.|||++||
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 178 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 899999999999999999999999999999999875421 248999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-C
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-G 149 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G 149 (583)
+||||||+|||++.++.+||+|||++....... .........+|+.|+|||++. +..++.++|||||||++|+|++ |
T Consensus 179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g 256 (334)
T 2pvf_A 179 IHRDLAARNVLVTENNVMKIADFGLARDINNID-YYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLG 256 (334)
T ss_dssp ECSCCSGGGEEECTTCCEEECCCTTCEECTTTS-SEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTS
T ss_pred eCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999987543221 111223356788999999987 5678999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
..||.+....+.......... ...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 257 GSPYPGIPVEELFKLLKEGHR----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCSSTTCCHHHHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcCcCCHHHHHHHHhcCCC----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999988765544433333322 22345688999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.15 Aligned_cols=209 Identities=24% Similarity=0.336 Sum_probs=165.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--DGFEESAIGSILKETLKALDYLHRQ---GHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--~~~sE~~i~~I~~QIl~gL~yLHs~---gIvHRDL 75 (583)
|+.++||||++++++|.+....|+|||||.+|+|.+++..... ..+++..+..++.||+.||.|||++ ||+||||
T Consensus 81 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dl 160 (326)
T 3uim_A 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDV 160 (326)
T ss_dssp GGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCC
T ss_pred HHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Confidence 4678999999999999999999999999999999999875422 2399999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.++.+||+|||++....... ........||+.|+|||++. +..++.++|||||||++|+|++|..||..
T Consensus 161 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (326)
T 3uim_A 161 KAANILLDEEFEAVVGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDL 237 (326)
T ss_dssp SGGGEEECTTCCEEECCCSSCEECCSSS--SCEECCCCSCGGGCCHHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred chhhEEECCCCCEEeccCccccccCccc--ccccccccCCcCccCHHHhc-cCCCCccccchhHHHHHHHHHhCCCcccc
Confidence 9999999999999999999987543221 12223457999999999997 45689999999999999999999999952
Q ss_pred C----ChHHHHHHHHhcCC----------CCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 156 Y----PPMKVLLMTIQNAP----------PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 156 ~----~~~~~l~~~i~~~~----------~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
. .........+.... ...........+..+.+++.+||+.||.+|||+.++++|-.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1 00001111111110 011112234456889999999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.21 Aligned_cols=201 Identities=23% Similarity=0.442 Sum_probs=169.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+...+|||||||.+|+|.++++......+++..+..++.||+.||+|||++||+||||||+||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 349 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNC 349 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 45689999999999999999999999999999999999875556699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++..... .........+++.|+|||++. ...|+.++|||||||++|||++ |..||.+....
T Consensus 350 ll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 350 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp EECGGGCEEECCTTCEECCTTC--CEECCTTCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EECCCCcEEEeecccceeccCC--ceeecCCCcCCcceeCHhHHh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998754321 111223345678899999997 5678999999999999999998 99999887654
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
... ..+... .....+..+++.+.+||.+||..||.+|||+.+|++
T Consensus 427 ~~~-~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 427 QVY-ELLEKD---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp GHH-HHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH-HHHHcC---CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 443 333322 223345678999999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=295.50 Aligned_cols=197 Identities=26% Similarity=0.470 Sum_probs=161.3
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG--HIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHRDLKPe 78 (583)
|+.++||||++++++|.+.. ++|||||.+|+|.+++... ...+++..+..++.||+.||.|||++| |+||||||+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~ 153 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSP 153 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGG
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcc
Confidence 45789999999999997665 7999999999999887543 456999999999999999999999999 999999999
Q ss_pred cEEEcCCCc-----EEEEecCCccccccCCCCccccccccCCCCCCCcccccC-CCCCCccccccchhhHHhhhhhCCCC
Q 007967 79 NILLDTNGV-----VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-GSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 79 NILld~~g~-----IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
|||++.++. +||+|||++..... ......||+.|+|||++.. ...++.++|||||||++|+|++|..|
T Consensus 154 Nil~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 227 (287)
T 4f0f_A 154 NIFLQSLDENAPVCAKVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227 (287)
T ss_dssp GEEESCCCTTCSCCEEECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred eEEEeccCCCCceeEEeCCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 999988776 99999999864321 2234689999999999842 44578999999999999999999999
Q ss_pred CCCCChHHHH-HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 153 FSKYPPMKVL-LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 153 F~~~~~~~~l-~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|......... ...+.... .....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 228 f~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 228 FDEYSYGKIKFINMIREEG--LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp TTTCCCCHHHHHHHHHHSC--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CccccccHHHHHHHHhccC--CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9876543321 22222221 222334678999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=298.52 Aligned_cols=203 Identities=23% Similarity=0.394 Sum_probs=163.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+...+|+|||||.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NI 161 (319)
T 2y4i_B 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV 161 (319)
T ss_dssp GTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTE
T ss_pred HhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhE
Confidence 46789999999999999999999999999999999988642 34699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCC--CCccccccccCCCCCCCcccccC--------CCCCCccccccchhhHHhhhhhCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTG--DRQRSRNTFVGTPCWMAPEVLQP--------GSGYNSKADIWSFGITALELAHGH 150 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~--~~~~~~~~~~GT~~Y~APEil~~--------~~~ys~ksDIWSLGvILyeLLtG~ 150 (583)
|++ ++.+||+|||++....... ..........|++.|+|||++.. ...++.++|||||||++|+|++|.
T Consensus 162 l~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 240 (319)
T 2y4i_B 162 FYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240 (319)
T ss_dssp EEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 998 6899999999876432111 11122234568999999999873 345789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 151 APFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 151 ~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.||.................+.. ....++..+.+||.+||..||.+|||+.++++
T Consensus 241 ~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 241 WPFKTQPAEAIIWQMGTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CSSSSCCHHHHHHHHHTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHhccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99988776555544433322221 22357889999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=295.33 Aligned_cols=199 Identities=22% Similarity=0.424 Sum_probs=165.3
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++. .+.+|+|||||.||+|.+++.......+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 63 ~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 141 (279)
T 1qpc_A 63 KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (279)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE
Confidence 4679999999999986 456899999999999999987544447999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMK 160 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~~ 160 (583)
++.++.+||+|||++....... ........+++.|+|||++. ...++.++|||||||++|+|++ |..||.+....+
T Consensus 142 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 218 (279)
T 1qpc_A 142 VSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (279)
T ss_dssp ECTTSCEEECCCTTCEECSSSC--EECCTTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred EcCCCCEEECCCcccccccCcc--cccccCCCCccCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH
Confidence 9999999999999987543221 11223346788999999997 5678999999999999999999 999998876655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
......... ....+..++..+.+||.+||..||.+|||+.++++
T Consensus 219 ~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 219 VIQNLERGY----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccc----CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 443333321 22334578899999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=294.88 Aligned_cols=197 Identities=25% Similarity=0.479 Sum_probs=160.0
Q ss_pred CCCCCCCcccceEEEEEEC-CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVD-SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~-~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||+++++++.+. +.+|+|||||++|+|.+++.......+++..+..++.||+.||.|||++|++||||||+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 147 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcce
Confidence 4678999999999997654 579999999999999999886544458999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCCh
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPP 158 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~ 158 (583)
||++.++.+||+|||++...... .....+++.|+|||++. ...++.++|||||||++|+|++ |..||.....
T Consensus 148 il~~~~~~~~l~Dfg~~~~~~~~------~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 148 VLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp EEECTTSCEEECCCCC------------------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred EEEeCCCcEEEeecccccccccc------ccCCCccccccCHHHhC-CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999998643221 12346788999999997 5678999999999999999998 9999988665
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.... ..+... .....+..+++.+.++|.+||..||.+|||+.++++
T Consensus 221 ~~~~-~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 221 KDVV-PRVEKG---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp GGHH-HHHTTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH-HHHhcC---CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 4443 333322 223334678999999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=296.42 Aligned_cols=203 Identities=29% Similarity=0.528 Sum_probs=157.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||++++++|.+.+.+|+||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++|++||||||+
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~ 165 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPA 165 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHH
Confidence 356899999999999999999999999999999999987532 355999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||++....... .......|++.|+|||++. ...++.++|||||||++|+|++|..||.+...
T Consensus 166 NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 241 (310)
T 2wqm_A 166 NVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241 (310)
T ss_dssp GEEECTTSCEEECCC---------------------CCSSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTC---C
T ss_pred HEEEcCCCCEEEEeccceeeecCCC---ccccccCCCeeEeChHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 9999999999999999986543221 1123457899999999998 56789999999999999999999999976432
Q ss_pred -HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 159 -MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 159 -~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
...+...+.... ........++..+.+||.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 242 NLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHTTC--SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhhccc--CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 222333333221 1112235688999999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.43 Aligned_cols=203 Identities=24% Similarity=0.416 Sum_probs=157.7
Q ss_pred CCCCCCCcccceEEEEE-ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFV-VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~-d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|+.++||||+++++++. .++..|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 144 l~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 222 (373)
T 3c1x_A 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222 (373)
T ss_dssp STTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchhe
Confidence 57889999999999875 456889999999999999998643 4568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCC-ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCC
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDR-QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYP 157 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~-~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~ 157 (583)
||++.++.+||+|||+++........ ........+|+.|+|||++. ...++.++|||||||++|+|++ |.+||.+..
T Consensus 223 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp EEECTTCCEEECCC---------------------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred EEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhc-CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 99999999999999998755332211 11123356788999999997 5679999999999999999999 788887765
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
..+.......... ...+..++..+.++|.+||..||.+|||+.+++++
T Consensus 302 ~~~~~~~~~~~~~----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 302 TFDITVYLLQGRR----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp SSCHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5444433333321 22235688999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=318.39 Aligned_cols=207 Identities=26% Similarity=0.443 Sum_probs=167.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++.+ ..+|||||||.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+||
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 456899999999999876 7799999999999999999765556799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++...... ........+++.|+|||++. ...++.++|||||||++|+|++ |..||.+....
T Consensus 312 ll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 312 LVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp EECGGGCEEECCCCTTC----------------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EECCCCCEEECCCccceecCCCc--eecccCCcccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999987543221 11122345788999999997 5679999999999999999999 99999987766
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh--ccccccC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK--HSFFKHA 215 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~--HpfFk~~ 215 (583)
+.+...... ...+.+..+++.+.+||.+||..||.+|||+++|++ ..+|...
T Consensus 389 ~~~~~i~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 389 EVLDQVERG----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHHTT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHcC----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 555444332 223334678999999999999999999999999987 3555443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.14 Aligned_cols=189 Identities=23% Similarity=0.374 Sum_probs=152.5
Q ss_pred CCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
+.++||||++++++|.+ ...+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 145 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 145 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 34689999999999987 77899999999999999999875455799999999999999999999999999999999
Q ss_pred CcEEEcC---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 78 GNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 78 eNILld~---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
+|||++. ++.+||+|||++.... +..|+.++|||||||++|+|++|..||.
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred HHEEEecCCCCCcEEEeccccccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999998 7899999999875321 2357889999999999999999999997
Q ss_pred CCChHHHHHHHHh---cCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 155 KYPPMKVLLMTIQ---NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 155 ~~~~~~~l~~~i~---~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+............ ..........+..+++++++||.+||+.||.+|||+.++++||||++..
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 200 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp C-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 7543221100000 1111111111246899999999999999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.03 Aligned_cols=205 Identities=25% Similarity=0.390 Sum_probs=164.5
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~-~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.++||||+++++++.+.+.+|+|||||++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 85 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni 164 (307)
T 2nru_A 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164 (307)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHE
Confidence 46799999999999999999999999999999999987543 34599999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||++....... .........||+.|+|||++. ..++.++|||||||++|+|++|..||.......
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFA-QTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCS-SCEECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred EEcCCCcEEEeeccccccccccc-ccccccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999987543221 111223467999999999987 358899999999999999999999997654321
Q ss_pred ---HHHHHHhcCCCC-------CCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 161 ---VLLMTIQNAPPG-------LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 161 ---~l~~~i~~~~~~-------~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.+...+...... ........++..+.+++.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111222211110 0111234567889999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=327.78 Aligned_cols=201 Identities=21% Similarity=0.390 Sum_probs=163.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+ +.+|||||||.||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 390 l~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 467 (613)
T 2ozo_A 390 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNV 467 (613)
T ss_dssp HTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHE
Confidence 567899999999999976 5699999999999999988543 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
||+.++.+||+|||+++................+++.|+|||++. ...|+.++|||||||++|||++ |..||.+....
T Consensus 468 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp EEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred EEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 999999999999999875532222111222345678999999997 5679999999999999999998 99999987776
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+....+.... ....+..+++.+.+||.+||..||.+|||+.+|++
T Consensus 547 ~~~~~i~~~~----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 547 EVMAFIEQGK----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCC----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6554443332 22334578999999999999999999999998854
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.77 Aligned_cols=205 Identities=19% Similarity=0.300 Sum_probs=163.6
Q ss_pred CCCCCCcccc---------------eEEEEEE-CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 007967 2 SLIDHPNVIR---------------AYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYL 65 (583)
Q Consensus 2 k~L~HPNIVk---------------l~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yL 65 (583)
+.++||||++ +++++.. +..+|+||||| ||+|.+++.......+++..++.++.||+.||.||
T Consensus 97 ~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L 175 (352)
T 2jii_A 97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL 175 (352)
T ss_dssp HHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3467888776 7788877 78999999999 99999999865456799999999999999999999
Q ss_pred HHCCCcccCCCCCcEEEcCCC--cEEEEecCCccccccCCCC----ccccccccCCCCCCCcccccCCCCCCccccccch
Q 007967 66 HRQGHIHRDVKAGNILLDTNG--VVKLADFGVSACMFDTGDR----QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSF 139 (583)
Q Consensus 66 Hs~gIvHRDLKPeNILld~~g--~IKL~DFGlA~~~~~~~~~----~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSL 139 (583)
|++||+||||||+|||++.++ .+||+|||+++.+...... ........||+.|+|||++. +..++.++|||||
T Consensus 176 H~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~sl 254 (352)
T 2jii_A 176 HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-GCGPSRRSDLQSL 254 (352)
T ss_dssp HHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-TCCCCHHHHHHHH
T ss_pred HhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-cCCCCchhhHHHH
Confidence 999999999999999999998 9999999998755332211 11123458999999999998 5679999999999
Q ss_pred hhHHhhhhhCCCCCCCCC-hHHHHHHHH---hcCCCCC--CccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 140 GITALELAHGHAPFSKYP-PMKVLLMTI---QNAPPGL--DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 140 GvILyeLLtG~~PF~~~~-~~~~l~~~i---~~~~~~~--~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
||++|+|++|..||.... ....+.... ......+ ....+..++..+.+||.+||..||.+|||+.++++
T Consensus 255 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 255 GYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 999999999999998754 222222222 2222111 11123467899999999999999999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.14 Aligned_cols=200 Identities=26% Similarity=0.394 Sum_probs=162.9
Q ss_pred CCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 2 SLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
+.++||||++++++|.+ ...+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~N 164 (318)
T 3lxp_A 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARN 164 (318)
T ss_dssp HHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 46789999999999998 4689999999999999998753 569999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
||++.++.+||+|||++.................||+.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 165 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~ 243 (318)
T 3lxp_A 165 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243 (318)
T ss_dssp EEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred EEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCcccccchh
Confidence 9999999999999999876533322222233457888999999998 567889999999999999999999999653211
Q ss_pred --------------HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 --------------KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 --------------~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..+...+.. ......+..++..+.+||.+||..||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 244 FLELIGIAQGQMTVLRLTELLER---GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhcccccchhHHHHHHHHhc---ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 011122222 1223345678999999999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=330.08 Aligned_cols=200 Identities=22% Similarity=0.375 Sum_probs=163.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|. .+.++||||||.+|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 424 l~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NI 500 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 500 (635)
T ss_dssp HHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhE
Confidence 35689999999999996 4568999999999999999865 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
||+.++.+||+|||+++.+..............||+.|+|||++. ...|+.++|||||||++|||++ |..||.+....
T Consensus 501 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 501 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp EEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999876533322222223346788999999997 5679999999999999999998 99999987776
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.......... ...+..++.++.+||.+||..||.+|||+.+|++
T Consensus 580 ~~~~~i~~~~~----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 580 EVTAMLEKGER----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 55544443322 2334578999999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=300.77 Aligned_cols=211 Identities=20% Similarity=0.330 Sum_probs=157.7
Q ss_pred CCCCCCcccceEEEEEE-----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------
Q 007967 2 SLIDHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-------- 68 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d-----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-------- 68 (583)
+.++||||+++++.+.. ...+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||++
T Consensus 62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~ 138 (336)
T 3g2f_A 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138 (336)
T ss_dssp TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCB
T ss_pred HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 46899999999987653 2368999999999999999864 5569999999999999999999999
Q ss_pred -CCcccCCCCCcEEEcCCCcEEEEecCCccccccCCC-----CccccccccCCCCCCCcccccCC------CCCCccccc
Q 007967 69 -GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD-----RQRSRNTFVGTPCWMAPEVLQPG------SGYNSKADI 136 (583)
Q Consensus 69 -gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~-----~~~~~~~~~GT~~Y~APEil~~~------~~ys~ksDI 136 (583)
||+||||||+|||++.++.+||+|||++..+..... ........+||+.|+|||++.+. ..++.++||
T Consensus 139 ~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 218 (336)
T 3g2f_A 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218 (336)
T ss_dssp CCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH
T ss_pred cceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccch
Confidence 999999999999999999999999999875532211 11222346799999999999742 345678999
Q ss_pred cchhhHHhhhhhCCCCCCCCC-----------------hHHHHHHHHhcCC--CCC--CccccccchHHHHHHHHhhhcC
Q 007967 137 WSFGITALELAHGHAPFSKYP-----------------PMKVLLMTIQNAP--PGL--DYDRDKKFSKSFKEMVAMCLVK 195 (583)
Q Consensus 137 WSLGvILyeLLtG~~PF~~~~-----------------~~~~l~~~i~~~~--~~~--~~~~~~~~S~~lkdLI~~cL~~ 195 (583)
|||||++|+|++|..||.... ........+.... +.+ .+.....+++.+.+||.+||..
T Consensus 219 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (336)
T 3g2f_A 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298 (336)
T ss_dssp HHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC
Confidence 999999999999976653211 1111112222111 111 1112234677899999999999
Q ss_pred CCCCCCCHHHHHh------ccccccC
Q 007967 196 DQTKRPTAEKLLK------HSFFKHA 215 (583)
Q Consensus 196 DP~kRpTa~eIL~------HpfFk~~ 215 (583)
||.+|||+.++++ ++|-++.
T Consensus 299 dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 299 DAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp SGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred ChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 9999999999954 5666544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.64 Aligned_cols=203 Identities=18% Similarity=0.252 Sum_probs=157.1
Q ss_pred CCCCCcccceE-EEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 3 LIDHPNVIRAY-CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L~HPNIVkl~-~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.+.|++++..+ .++..+...|+||||| +|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl 137 (296)
T 3uzp_A 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL 137 (296)
T ss_dssp HHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeE
Confidence 45677655544 4456788999999999 99999998743 467999999999999999999999999999999999999
Q ss_pred E---cCCCcEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 82 L---DTNGVVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 82 l---d~~g~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
+ +.++.+||+|||++.......... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.
T Consensus 138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 3uzp_A 138 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 9 488999999999987654322211 1224568999999999998 5679999999999999999999999998
Q ss_pred CCChH---HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPM---KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~---~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.... ..+..................+++.+.+||.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 217 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 64321 1111111110000001112467899999999999999999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=301.25 Aligned_cols=206 Identities=23% Similarity=0.392 Sum_probs=161.4
Q ss_pred CCCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAY--QDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~--~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++||||++++++|.. ...+|+|||||.+|+|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~d 159 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD 159 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 356899999999999973 347999999999999999987642 35699999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCc------cccccccCCCCCCCcccccCCC--CCCccccccchhhHHhhh
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQ------RSRNTFVGTPCWMAPEVLQPGS--GYNSKADIWSFGITALEL 146 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~------~~~~~~~GT~~Y~APEil~~~~--~ys~ksDIWSLGvILyeL 146 (583)
|||+|||++.++.+||+|||++.......... .......||+.|+|||++.... .++.++|||||||++|+|
T Consensus 160 lkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 239 (317)
T 2buj_A 160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239 (317)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999876432111000 0012346799999999987332 368899999999999999
Q ss_pred hhCCCCCCCCChH-HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 147 AHGHAPFSKYPPM-KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 147 LtG~~PF~~~~~~-~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
++|..||...... ......+.. ....+....++..+.+||.+||..||.+|||+.+++++
T Consensus 240 ~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 240 MFGEGPYDMVFQKGDSVALAVQN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHSSCTTHHHHHTTSCHHHHHHC---C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhCCCChhhhhcccchhhHHhhc---cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 9999999542110 011112222 12233345788999999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=303.70 Aligned_cols=195 Identities=16% Similarity=0.159 Sum_probs=157.7
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY---QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~---~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
..||||+++++++...+..|||||||+||+|.+++.... ...+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 124 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NI 203 (365)
T 3e7e_A 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNF 203 (365)
T ss_dssp GGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred hhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHE
Confidence 459999999999999999999999999999999987642 35699999999999999999999999999999999999
Q ss_pred EEcC-----------CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC
Q 007967 81 LLDT-----------NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG 149 (583)
Q Consensus 81 Lld~-----------~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG 149 (583)
|++. ++.+||+|||+|+.+.... ........+||+.|+|||++. +..|+.++|||||||++|+|++|
T Consensus 204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp EECGGGTCC------CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHS
T ss_pred EecccccCccccccccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhc-CCCCCccccHHHHHHHHHHHHhC
Confidence 9988 8999999999996542211 122234578999999999998 56699999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 150 HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 150 ~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+.||........ .....+ .....++.+.+++..||+.+|.+|++..+.+.+
T Consensus 282 ~~pf~~~~~~~~------~~~~~~---~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 282 TYMKVKNEGGEC------KPEGLF---RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp SCCCEEEETTEE------EECSCC---TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CCccccCCCCce------eechhc---cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 999965322100 000000 112357889999999999999999765544443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=287.85 Aligned_cols=203 Identities=18% Similarity=0.252 Sum_probs=157.6
Q ss_pred CCCCCcccceE-EEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 3 LIDHPNVIRAY-CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L~HPNIVkl~-~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.+.|++++..+ .++...+..|+||||| +|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 137 (296)
T 4hgt_A 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL 137 (296)
T ss_dssp HHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHee
Confidence 45666655554 4557788999999999 99999998753 467999999999999999999999999999999999999
Q ss_pred E---cCCCcEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 82 L---DTNGVVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 82 l---d~~g~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
+ +.++.+||+|||++.......... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.
T Consensus 138 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~ 216 (296)
T 4hgt_A 138 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQ 216 (296)
T ss_dssp ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred eeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhc-CCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence 9 789999999999987653322211 1223568999999999998 5679999999999999999999999997
Q ss_pred CCChH---HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPM---KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~---~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.... .....................+++.+.+||.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 217 GLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 64321 1111111110000001112457899999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=309.79 Aligned_cols=204 Identities=24% Similarity=0.429 Sum_probs=162.9
Q ss_pred CCCCCCcccceEEEEEECC--EEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDS--NLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~--~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
+.++||||+++++++.+.. .+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 62 ~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 141 (396)
T 4eut_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG 141 (396)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHH
Confidence 4679999999999999765 78999999999999999875432 23999999999999999999999999999999999
Q ss_pred cEEE----cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-------CCCCCccccccchhhHHhhhh
Q 007967 79 NILL----DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-------GSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 79 NILl----d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-------~~~ys~ksDIWSLGvILyeLL 147 (583)
|||+ +.++.+||+|||+++..... ......+||+.|+|||++.. ...|+.++|||||||++|+|+
T Consensus 142 NIll~~~~~~~~~~kL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~ 217 (396)
T 4eut_A 142 NIMRVIGEDGQSVYKLTDFGAARELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (396)
T ss_dssp GEEEEECTTSCEEEEECCGGGCEECCCG----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HEEEeecCCCceeEEEecCCCceEccCC----CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHH
Confidence 9999 77788999999998754222 12234689999999999862 145788999999999999999
Q ss_pred hCCCCCCCCC----hHHHHHHHHhcCCCCC--------------------CccccccchHHHHHHHHhhhcCCCCCCCCH
Q 007967 148 HGHAPFSKYP----PMKVLLMTIQNAPPGL--------------------DYDRDKKFSKSFKEMVAMCLVKDQTKRPTA 203 (583)
Q Consensus 148 tG~~PF~~~~----~~~~l~~~i~~~~~~~--------------------~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa 203 (583)
+|..||.... ..+.+...+...+... .......++..+.++|.+||.+||.+|||+
T Consensus 218 tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~ 297 (396)
T 4eut_A 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297 (396)
T ss_dssp HSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred HCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH
Confidence 9999996432 2344444444332211 011124567789999999999999999999
Q ss_pred HHHHhc
Q 007967 204 EKLLKH 209 (583)
Q Consensus 204 ~eIL~H 209 (583)
.+++++
T Consensus 298 ~e~l~~ 303 (396)
T 4eut_A 298 DQFFAE 303 (396)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=321.49 Aligned_cols=207 Identities=26% Similarity=0.444 Sum_probs=171.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++++++.+ ..+|||||||.+|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 456899999999999876 7799999999999999999765556799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
||+.++.+||+|||+++..... .........++..|+|||++. ...|+.++|||||||++|||++ |..||.+....
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCH--HHHTTCSTTSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred EEcCCCcEEEcccccceecCCC--ceecccCCcCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998754221 111122345678899999987 5679999999999999999999 99999987765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc--cccccC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH--SFFKHA 215 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H--pfFk~~ 215 (583)
+.+...... .....+..++..+.+||.+||..||.+|||+.+|++. .+|...
T Consensus 472 ~~~~~i~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 472 EVLDQVERG----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHHcC----CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 555443332 2233346789999999999999999999999999873 555433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=291.44 Aligned_cols=204 Identities=23% Similarity=0.349 Sum_probs=161.9
Q ss_pred CCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCC
Q 007967 3 LIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH--------RQGH 70 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH--------s~gI 70 (583)
.++||||+++++++.... .+|+|||||.+|+|.+++.. ..+++..++.++.||+.||.||| ++||
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 168 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCe
Confidence 379999999999999876 89999999999999999864 57999999999999999999999 8999
Q ss_pred cccCCCCCcEEEcCCCcEEEEecCCccccccCCCCc-cccccccCCCCCCCcccccCCCC-----CCccccccchhhHHh
Q 007967 71 IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCWMAPEVLQPGSG-----YNSKADIWSFGITAL 144 (583)
Q Consensus 71 vHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~-~~~~~~~GT~~Y~APEil~~~~~-----ys~ksDIWSLGvILy 144 (583)
+||||||+|||++.++.+||+|||++.......... .......||+.|+|||++..... ++.++|||||||++|
T Consensus 169 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 248 (342)
T 1b6c_B 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248 (342)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHH
Confidence 999999999999999999999999987553322111 12234689999999999974322 236899999999999
Q ss_pred hhhhC----------CCCCCCCC----hHHHHHHHHhcCCCCCCcc---ccccchHHHHHHHHhhhcCCCCCCCCHHHHH
Q 007967 145 ELAHG----------HAPFSKYP----PMKVLLMTIQNAPPGLDYD---RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL 207 (583)
Q Consensus 145 eLLtG----------~~PF~~~~----~~~~l~~~i~~~~~~~~~~---~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL 207 (583)
+|++| ..||.... ....+...+.........+ .....+..+.+||.+||..||.+|||+.+++
T Consensus 249 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 99999 78987642 2233333333222111111 1134567899999999999999999999999
Q ss_pred hc
Q 007967 208 KH 209 (583)
Q Consensus 208 ~H 209 (583)
+|
T Consensus 329 ~~ 330 (342)
T 1b6c_B 329 KT 330 (342)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=294.71 Aligned_cols=195 Identities=28% Similarity=0.513 Sum_probs=154.4
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCC
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ-DGFEESAIGSILKETLKALDYLHR---QGHIHRDVKA 77 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~-~~~sE~~i~~I~~QIl~gL~yLHs---~gIvHRDLKP 77 (583)
+.++||||+++++++. +..|+|||||+||+|.+++..... ..+++..+..++.||+.||.|||+ +||+||||||
T Consensus 56 ~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp 133 (307)
T 2eva_A 56 SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133 (307)
T ss_dssp HHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSG
T ss_pred hcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCCh
Confidence 4679999999999886 458999999999999999875321 237899999999999999999999 8999999999
Q ss_pred CcEEEcCCCc-EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 78 GNILLDTNGV-VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 78 eNILld~~g~-IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
+|||++.++. +||+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 134 ~NIll~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 134 PNLLLVAGGTVLKICDFGTACDIQTH------MTNNKGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp GGEEEETTTTEEEECCCCC------------------CCTTSSCHHHHT-CCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred hHEEEeCCCCEEEEcccccccccccc------cccCCCCCceEChhhhC-CCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 9999998886 799999998644211 12357899999999998 567999999999999999999999999864
Q ss_pred ChH--HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 157 PPM--KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 157 ~~~--~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
... ........... ......++..+.+||.+||..||.+|||+.+++++
T Consensus 207 ~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 207 GGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CSSHHHHHHHHHTTCC----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccHHHHHHHHhcCCC----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 332 22222222221 22345688999999999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.71 Aligned_cols=198 Identities=21% Similarity=0.383 Sum_probs=140.8
Q ss_pred CCCcccceEEEEE--------ECCEEEEEEecCCCCCHHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--Cccc
Q 007967 5 DHPNVIRAYCSFV--------VDSNLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETLKALDYLHRQG--HIHR 73 (583)
Q Consensus 5 ~HPNIVkl~~~f~--------d~~~l~LVmEy~~GGsL~dll~~~~-~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHR 73 (583)
+||||+++++++. ....+|+|||||. |+|.+++.... .+.+++..++.++.||+.||.|||++| |+||
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~ 162 (337)
T 3ll6_A 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR 162 (337)
T ss_dssp TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCC
T ss_pred cCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEc
Confidence 5999999999995 3445999999995 78988887533 456999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCcEEEEecCCccccccCCCCc---------cccccccCCCCCCCccccc--CCCCCCccccccchhhH
Q 007967 74 DVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ---------RSRNTFVGTPCWMAPEVLQ--PGSGYNSKADIWSFGIT 142 (583)
Q Consensus 74 DLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~---------~~~~~~~GT~~Y~APEil~--~~~~ys~ksDIWSLGvI 142 (583)
||||+|||++.++.+||+|||++.......... .......||+.|+|||++. ....++.++|||||||+
T Consensus 163 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 163 DLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242 (337)
T ss_dssp CCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred cCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence 999999999999999999999987553221110 0112457999999999984 25568899999999999
Q ss_pred HhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 143 ALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 143 LyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
+|+|++|..||......... .. ..........+..+.+||.+||+.||.+|||+.++++|-
T Consensus 243 l~el~~g~~p~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKLRIV----NG---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp HHHHHHSSCCC-------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCCCCcchhHHHhh----cC---cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999999999764432221 11 112233355677899999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.70 Aligned_cols=203 Identities=21% Similarity=0.365 Sum_probs=161.8
Q ss_pred CCCCCCCcccceEEEEEECC--EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS--NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~--~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
|+.++||||+++++++...+ .+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~ 174 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc
Confidence 35689999999999987654 789999999999999998754 356999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 79 NILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 79 NILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|||++.++.+||+|||++.................++..|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 175 NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 175 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp GEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH
T ss_pred eEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH
Confidence 99999999999999999876533222112223356788899999997 55688999999999999999999999864211
Q ss_pred H---------------HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 159 M---------------KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 159 ~---------------~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
. ..+...+... ...+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFHLIELLKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhccccchhhhHHHHHHHhhcC---CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0111222221 122334568899999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=320.38 Aligned_cols=199 Identities=24% Similarity=0.425 Sum_probs=163.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++++++. ++.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 445 l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NI 522 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 522 (656)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhE
Confidence 34679999999999984 56799999999999999998753 34699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++...... ........+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....
T Consensus 523 Ll~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 599 (656)
T 2j0j_A 523 LVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599 (656)
T ss_dssp EEEETTEEEECCCCCCCSCCC------------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EEeCCCCEEEEecCCCeecCCCc--ceeccCCCCCcceeCHHHhc-CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999987553221 11122346788999999997 5679999999999999999997 99999987776
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+.+......... ..+..+++.+.+||.+||..||.+|||+.++++
T Consensus 600 ~~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 600 DVIGRIENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 655444443322 234578899999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.78 Aligned_cols=203 Identities=16% Similarity=0.244 Sum_probs=160.6
Q ss_pred CCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 3 LID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.|. |++|..+..++...+..||||||| +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 58 ~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 135 (483)
T 3sv0_A 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (483)
T ss_dssp HTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEE
Confidence 344 467777878888899999999999 99999998753 467999999999999999999999999999999999999
Q ss_pred E---cCCCcEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 82 L---DTNGVVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 82 l---d~~g~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
| +.++.+||+|||+++.+....... ......+||+.|+|||++. +..++.++|||||||++|+|++|..||.
T Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 9 688999999999997654332211 1223578999999999998 6679999999999999999999999998
Q ss_pred CCCh---HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPP---MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~---~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+... ...+..................++.++.+||..||..+|.+||++.+|++
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 215 GLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 7543 11111111111001111122467899999999999999999999988765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.45 Aligned_cols=177 Identities=23% Similarity=0.260 Sum_probs=140.4
Q ss_pred CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEcCCC-----------
Q 007967 19 DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLH-RQGHIHRDVKAGNILLDTNG----------- 86 (583)
Q Consensus 19 ~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH-s~gIvHRDLKPeNILld~~g----------- 86 (583)
.+.+|||||||.+|++++.+. ...+++..++.|++||+.||.||| ++||+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~ 210 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred cCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCc
Confidence 789999999999997766553 366899999999999999999999 99999999999999999887
Q ss_pred ---------cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhH-HhhhhhCCCCCCCC
Q 007967 87 ---------VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGIT-ALELAHGHAPFSKY 156 (583)
Q Consensus 87 ---------~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvI-LyeLLtG~~PF~~~ 156 (583)
.+||+|||+|+.... ...+||+.|+|||++.+ .. +.++||||+|++ .++++.|..||.+.
T Consensus 211 ~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~aPE~~~g-~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~ 280 (336)
T 2vuw_A 211 SSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMDEDLFTG-DG-DYQFDIYRLMKKENNNRWGEYHPYSNV 280 (336)
T ss_dssp EEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTCSGGGCC-CS-SHHHHHHHHHHHHHTTCTTSCCTHHHH
T ss_pred cccccCCCceEEEeeccccEecCC--------CcEEEeecccChhhhcC-CC-ccceehhhhhCCCCcccccccCCCcch
Confidence 899999999975421 24589999999999983 33 889999998777 78899999998542
Q ss_pred ChHHHHHHHHh-cC--CCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHH-hccccc
Q 007967 157 PPMKVLLMTIQ-NA--PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLL-KHSFFK 213 (583)
Q Consensus 157 ~~~~~l~~~i~-~~--~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL-~HpfFk 213 (583)
.....+...+. .. ........+..+++++++||.+||++| |+.++| +||||+
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 281 LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 11111222222 11 111122234568999999999999987 999999 999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-33 Score=320.31 Aligned_cols=209 Identities=24% Similarity=0.325 Sum_probs=164.2
Q ss_pred CCCCCCcccceEEEEEE------CCEEEEEEecCCCCCHHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 2 SLIDHPNVIRAYCSFVV------DSNLWVVMPFMAEGSCLHLMKIAY-QDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d------~~~l~LVmEy~~GGsL~dll~~~~-~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
+.++||||+++++++.. ++..|+|||||+||+|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 67 ~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrD 146 (676)
T 3qa8_A 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRD 146 (676)
T ss_dssp HHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCC
T ss_pred HhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 46799999999999765 677899999999999999987532 12599999999999999999999999999999
Q ss_pred CCCCcEEEcCCCc---EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 75 VKAGNILLDTNGV---VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 75 LKPeNILld~~g~---IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
|||+|||++.++. +||+|||++...... .......||+.|+|||++. +..++.++|||||||++|+|++|..
T Consensus 147 LKP~NILl~~~g~~~~vKL~DFG~a~~~~~~----~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSLGviLyeLltG~~ 221 (676)
T 3qa8_A 147 LKPENIVLQPGPQRLIHKIIDLGYAKELDQG----ELCTEFVGTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFR 221 (676)
T ss_dssp CCSTTEEEECCSSSCEEEECSCCCCCBTTSC----CCCCCCCSCCTTCSSCSSC-CSCCSTTHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHeEeecCCCceeEEEcccccccccccc----cccccccCCcccCChHHhc-cCCCCchhHHHHHHHHHHHHHHCCC
Confidence 9999999997765 999999998754221 1223468999999999997 6689999999999999999999999
Q ss_pred CCCCCChHHHHHHHH--------h-----cCCCCC------CccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 152 PFSKYPPMKVLLMTI--------Q-----NAPPGL------DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 152 PF~~~~~~~~l~~~i--------~-----~~~~~~------~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
||.+......+...+ . .....+ .......+++.+.+||.+||.+||.+|||+.++++||||
T Consensus 222 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F 301 (676)
T 3qa8_A 222 PFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301 (676)
T ss_dssp SCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred CCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence 997643221110000 0 000000 111224578999999999999999999999999999999
Q ss_pred ccC
Q 007967 213 KHA 215 (583)
Q Consensus 213 k~~ 215 (583)
+..
T Consensus 302 ~~l 304 (676)
T 3qa8_A 302 QAL 304 (676)
T ss_dssp HHH
T ss_pred HHH
Confidence 865
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-33 Score=295.64 Aligned_cols=178 Identities=14% Similarity=0.186 Sum_probs=145.8
Q ss_pred EEEEEEecCCCCCHHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCC
Q 007967 21 NLWVVMPFMAEGSCLHLMKIAY-----QDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGV 95 (583)
Q Consensus 21 ~l~LVmEy~~GGsL~dll~~~~-----~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGl 95 (583)
.++++|+++ +|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~ 257 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence 478888876 789998886331 23477889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccccccCCCCCCCccccc---------CCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHH
Q 007967 96 SACMFDTGDRQRSRNTFVGTPCWMAPEVLQ---------PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI 166 (583)
Q Consensus 96 A~~~~~~~~~~~~~~~~~GT~~Y~APEil~---------~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i 166 (583)
++..... ....+| +.|+|||++. ....|+.++|||||||++|+|++|+.||.+........
T Consensus 258 a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~--- 327 (413)
T 3dzo_A 258 LVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE--- 327 (413)
T ss_dssp CEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG---
T ss_pred eeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH---
Confidence 8653211 234678 9999999993 25568889999999999999999999998754322111
Q ss_pred hcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 167 QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 167 ~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
..+.....+++.+++||.+||.+||.+|||+.++++||||+.+
T Consensus 328 ------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 328 ------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp ------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 1122234678999999999999999999999999999999765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=309.39 Aligned_cols=188 Identities=22% Similarity=0.308 Sum_probs=154.9
Q ss_pred CCCCCCCcccceEEEEEECCE-----EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDSN-----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~-----l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++||||++++++|...+. +|||||||+|++|.+++. ..+++..+..|+.||+.||.|||++||+||||
T Consensus 133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDl 208 (681)
T 2pzi_A 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDL 208 (681)
T ss_dssp GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeccc
Confidence 467899999999999998665 799999999999988654 37999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.+ .+||+|||++...... ...+||+.|+|||++.. .++.++|||||||++|+|++|.+||.+
T Consensus 209 kp~NIll~~~-~~kl~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 209 KPENIMLTEE-QLKLIDLGAVSRINSF-------GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp SGGGEEECSS-CEEECCCTTCEETTCC-------SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ChHHeEEeCC-cEEEEecccchhcccC-------CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcc
Confidence 9999999875 8999999998754221 34679999999999873 458899999999999999999999865
Q ss_pred CChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 156 YPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
.... .. + ........++.+.+||.+||.+||.+||+..+++.|+|+.
T Consensus 279 ~~~~--------~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 279 RYVD--------GL-P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp EECS--------SC-C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccc--------cc-c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 2110 00 0 1111234567899999999999999999999999998875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=270.71 Aligned_cols=171 Identities=21% Similarity=0.175 Sum_probs=139.0
Q ss_pred CCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 2 SLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 2 k~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
+.++||||+++++++.+++.+|+|||||+|++|.++++ .+..+.++..|+.||+.||.|||++||+||||||+|||
T Consensus 86 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIl 161 (286)
T 3uqc_A 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVR 161 (286)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT----TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred hcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh----cCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEE
Confidence 56899999999999999999999999999999999874 34567788999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHH
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV 161 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~ 161 (583)
++.+|.+||+++| |++ .++.++|||||||++|+|++|+.||.+......
T Consensus 162 l~~~g~~kl~~~~-----------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~ 210 (286)
T 3uqc_A 162 VSIDGDVVLAYPA-----------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210 (286)
T ss_dssp EETTSCEEECSCC-----------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC
T ss_pred EcCCCCEEEEecc-----------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh
Confidence 9999999998553 222 378899999999999999999999987554221
Q ss_pred HHHHHh--cCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 162 LLMTIQ--NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 162 l~~~i~--~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+..... .............+++.+++||.+||.+||.+| |+.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 211 LAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp SEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred hHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 100000 000011112235688999999999999999999 9999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=283.48 Aligned_cols=184 Identities=15% Similarity=0.165 Sum_probs=129.2
Q ss_pred CCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.+ .|+||++++++|++++.+|||||||+||+|.++|.. .+.+++. .|++||+.||+|||++|||||||||+||
T Consensus 296 ~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNI 370 (569)
T 4azs_A 296 TQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNV 370 (569)
T ss_dssp HSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGE
T ss_pred HhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhE
Confidence 345 799999999999999999999999999999999875 3567764 5899999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||+.+|++||+|||+|+...... ....+.+||+.|||||++. ..+..++|+|++|+++|+|.++..+|.
T Consensus 371 LL~~dg~vKL~DFGlAr~~~~~~---~~~~t~vGTp~YmAPE~l~--g~~~~~~d~~s~g~~~~~l~~~~~~~~------ 439 (569)
T 4azs_A 371 MVDARQHARLIDFGSIVTTPQDC---SWPTNLVQSFFVFVNELFA--ENKSWNGFWRSAPVHPFNLPQPWSNWL------ 439 (569)
T ss_dssp EECTTSCEEECCCTTEESCC------CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH------
T ss_pred EECCCCCEEEeecccCeeCCCCC---ccccCceechhhccHHHhC--CCCCCcccccccccchhhhccccchhH------
Confidence 99999999999999987653322 2234579999999999997 346778999999999999887654431
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
..+...+. ....+..++..++..+|..|+.......|+|..
T Consensus 440 ---~~l~~~~~---------~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 440 ---YAVWQEPV---------ERWNFVLLLALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp ---HHHHTSCG---------GGCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred ---HHhhcCCC---------CCCcHHHHHHHHhCCCCCCCCChhhhccchhHH
Confidence 11111110 111245677777888888887776666666654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-22 Score=224.58 Aligned_cols=141 Identities=18% Similarity=0.235 Sum_probs=114.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++||||+++..++.+.+..|||||||+||+|.+++.. +..++.||+.||.|||++||+||||||+||
T Consensus 393 l~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NI 462 (540)
T 3en9_A 393 LALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNF 462 (540)
T ss_dssp HHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSE
T ss_pred HHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHE
Confidence 3567999999666666678888999999999999998753 568999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCc----cccccccCCCCCCCcccccC-CCCCCccccccchhhHHhhhhhCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQ----RSRNTFVGTPCWMAPEVLQP-GSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~----~~~~~~~GT~~Y~APEil~~-~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
|++. .+||+|||+|+......... ......+||++|||||++.. ...|+..+|+|+.++-..+.+.++.+|
T Consensus 463 Ll~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 463 IFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9998 99999999997653211100 01235789999999999972 146888899999988888877776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=5.2e-17 Score=165.53 Aligned_cols=89 Identities=16% Similarity=0.170 Sum_probs=73.2
Q ss_pred cceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCCcEE
Q 007967 10 IRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVK 89 (583)
Q Consensus 10 Vkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g~IK 89 (583)
+++++++.. +..|+|||||+||+|.+ +. ...+..++.||+.||.|||++||+||||||+|||++ +|.+|
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence 555555544 45699999999999977 31 133567999999999999999999999999999999 99999
Q ss_pred EEecCCccccccCCCCccccccccCCCCCCCccccc
Q 007967 90 LADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ 125 (583)
Q Consensus 90 L~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~ 125 (583)
|+|||+|+. +..|+|||++.
T Consensus 233 l~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp ECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EEECCCCeE----------------CCCCCHHHHHH
Confidence 999998752 44578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.5e-13 Score=134.98 Aligned_cols=71 Identities=20% Similarity=0.330 Sum_probs=59.4
Q ss_pred EEEEEEecCCC-C----CHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCcEEEcCCCcEEEEecC
Q 007967 21 NLWVVMPFMAE-G----SCLHLMKIAYQDGFEESAIGSILKETLKALDYLH-RQGHIHRDVKAGNILLDTNGVVKLADFG 94 (583)
Q Consensus 21 ~l~LVmEy~~G-G----sL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLH-s~gIvHRDLKPeNILld~~g~IKL~DFG 94 (583)
..|||||||.+ | .|.++.. ..++..+..++.||+.||.||| ++||+||||||+|||++. .++|+|||
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG 214 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGR-----ELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMG 214 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGG-----GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCT
T ss_pred CCEEEEEecCCCCCccccHHHHhh-----ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECc
Confidence 56899999942 3 6666432 1345678899999999999999 999999999999999988 89999999
Q ss_pred Cccc
Q 007967 95 VSAC 98 (583)
Q Consensus 95 lA~~ 98 (583)
+|..
T Consensus 215 ~a~~ 218 (258)
T 1zth_A 215 QAVT 218 (258)
T ss_dssp TCEE
T ss_pred cccc
Confidence 9864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.01 E-value=1.8e-11 Score=130.74 Aligned_cols=67 Identities=18% Similarity=0.213 Sum_probs=56.2
Q ss_pred EEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcCCC----------cEEEEe
Q 007967 23 WVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNG----------VVKLAD 92 (583)
Q Consensus 23 ~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~~g----------~IKL~D 92 (583)
+|||||++|+.|..+. ....+..++.||+.+|.|||++|||||||||.|||++.+| .+.|+|
T Consensus 187 ~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIX 258 (397)
T ss_dssp EEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred eEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence 7999999998875432 2234567899999999999999999999999999998776 388999
Q ss_pred cCCcc
Q 007967 93 FGVSA 97 (583)
Q Consensus 93 FGlA~ 97 (583)
|+-+.
T Consensus 259 ~~Q~V 263 (397)
T 4gyi_A 259 FPQMV 263 (397)
T ss_dssp CTTCE
T ss_pred eCCcc
Confidence 98653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=8.7e-08 Score=94.60 Aligned_cols=85 Identities=18% Similarity=0.139 Sum_probs=69.9
Q ss_pred CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------
Q 007967 6 HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR------------------ 67 (583)
Q Consensus 6 HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs------------------ 67 (583)
|..+.++++++.+.+..|+||||++|.+|.+.+ .+......++.++..+|..||+
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~ 141 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence 677889999999999999999999999987642 1223345788999999999999
Q ss_pred -----------------------------------------CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 68 -----------------------------------------QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 68 -----------------------------------------~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.30 E-value=3.8e-07 Score=88.78 Aligned_cols=79 Identities=14% Similarity=0.150 Sum_probs=60.5
Q ss_pred ccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------
Q 007967 9 VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG------------------- 69 (583)
Q Consensus 9 IVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g------------------- 69 (583)
+.++++++.+++..|+||||++|.+|. . .... ...++.+++..|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~-----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~ 146 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--S-----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERART 146 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--T-----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--c-----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHH
Confidence 567889888888899999999998773 1 1111 2256667777777777643
Q ss_pred ---------------------------------------CcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 70 ---------------------------------------HIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 70 ---------------------------------------IvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 147 RMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.29 E-value=6.4e-07 Score=92.90 Aligned_cols=88 Identities=15% Similarity=0.274 Sum_probs=71.8
Q ss_pred CCcccceEEEEEEC---CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------
Q 007967 6 HPNVIRAYCSFVVD---SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR--------------- 67 (583)
Q Consensus 6 HPNIVkl~~~f~d~---~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs--------------- 67 (583)
+..+.+++.++.+. +..|+||||++|..+.+. ....+++.....++.+++..|..||+
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~ 172 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPG 172 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCS
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCC
Confidence 45688899888776 458999999998876431 12347788889999999999999997
Q ss_pred -------------------------------------------CCCcccCCCCCcEEEcCCCc--EEEEecCCcc
Q 007967 68 -------------------------------------------QGHIHRDVKAGNILLDTNGV--VKLADFGVSA 97 (583)
Q Consensus 68 -------------------------------------------~gIvHRDLKPeNILld~~g~--IKL~DFGlA~ 97 (583)
.+++|+|++++|||++.++. +.|+||+.+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 173 NYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp CHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred CchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 36899999999999987753 6899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.12 E-value=1.6e-07 Score=95.31 Aligned_cols=121 Identities=21% Similarity=0.280 Sum_probs=81.1
Q ss_pred EEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 007967 22 LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR---------------------------------- 67 (583)
Q Consensus 22 l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs---------------------------------- 67 (583)
.|+||+|++|..|..... ..++..+...++.+++..|..||+
T Consensus 91 ~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp SCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred ceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 589999999988765322 347788888889999999999986
Q ss_pred ------------------------CCCcccCCCCCcEEEcC--CCcEEEEecCCccccccCCCCccccccccCCCCC---
Q 007967 68 ------------------------QGHIHRDVKAGNILLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW--- 118 (583)
Q Consensus 68 ------------------------~gIvHRDLKPeNILld~--~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y--- 118 (583)
..++|+|++|.||+++. .+.+.|+||+.+... +.... ......+
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~----~~~~D---l~~~~~~~~~ 239 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS----DPDND---FISLMEDDEE 239 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE----CTTHH---HHTTCCTTTS
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC----ChHHH---HHHHHhhccc
Confidence 13699999999999988 456789999987532 11000 0001111
Q ss_pred CCcccccC-CCCC------------CccccccchhhHHhhhhhCCCCC
Q 007967 119 MAPEVLQP-GSGY------------NSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 119 ~APEil~~-~~~y------------s~ksDIWSLGvILyeLLtG~~PF 153 (583)
..|+.... -..| ....+.|++|.++|.+.+|..+|
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22222110 0011 12358999999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00035 Score=68.74 Aligned_cols=83 Identities=13% Similarity=0.197 Sum_probs=61.3
Q ss_pred ccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------------------
Q 007967 9 VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ-------------------- 68 (583)
Q Consensus 9 IVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~-------------------- 68 (583)
|.++++++.+.+..|+|||+++|.++.+..... ......+..++...|.-||..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~ 155 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQS 155 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHH
Confidence 667889999999999999999998877654321 122334555566666666641
Q ss_pred --------------------------------------CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 --------------------------------------GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 --------------------------------------gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 156 RMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999987777799999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0006 Score=69.40 Aligned_cols=85 Identities=15% Similarity=0.073 Sum_probs=58.0
Q ss_pred ccceEEEEE-ECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-------------------
Q 007967 9 VIRAYCSFV-VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQ------------------- 68 (583)
Q Consensus 9 IVkl~~~f~-d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~------------------- 68 (583)
|.+++.+.. ..+..|+||||++|..+....- ..++......++.++...|..||+.
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~ 149 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKI 149 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHH
Confidence 556666664 3456789999999987765311 2345555555555555555555542
Q ss_pred -----------------------------------------CCcccCCCCCcEEEcC---CCcE-EEEecCCcc
Q 007967 69 -----------------------------------------GHIHRDVKAGNILLDT---NGVV-KLADFGVSA 97 (583)
Q Consensus 69 -----------------------------------------gIvHRDLKPeNILld~---~g~I-KL~DFGlA~ 97 (583)
.++|+|+++.|||++. ++.+ .|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 150 LLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3589999999999987 4554 899999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0022 Score=63.19 Aligned_cols=135 Identities=16% Similarity=0.156 Sum_probs=91.8
Q ss_pred CHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCcccccc
Q 007967 33 SCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111 (583)
Q Consensus 33 sL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~ 111 (583)
+|.++++.. ..+++|+++|.++.|.+.+|.-+-. +.-..+=+-|..|+|..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 688888765 6889999999999999999877622 2222444557999999999987663 2111
Q ss_pred ccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHh
Q 007967 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAM 191 (583)
Q Consensus 112 ~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~ 191 (583)
.....+.|||... ...+.+.=|||||+++|.-+--..| -.....+|+.+..||..
T Consensus 98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~----------------------e~eE~eLS~~LE~LL~~ 152 (229)
T 2yle_A 98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK----------------------ENEERELSPPLEQLIDH 152 (229)
T ss_dssp ----------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC----------------------TTEEECCCHHHHHHHHH
T ss_pred -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC----------------------cccchhhCHHHHHHHHH
Confidence 1123467888764 4556788899999999998852222 22346788899999988
Q ss_pred hhcC-------------------------CCCCCCCHHHHHh
Q 007967 192 CLVK-------------------------DQTKRPTAEKLLK 208 (583)
Q Consensus 192 cL~~-------------------------DP~kRpTa~eIL~ 208 (583)
|..- .+..|.+..+|++
T Consensus 153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp HTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred HHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 8765 2467888888876
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0062 Score=61.34 Aligned_cols=29 Identities=28% Similarity=0.386 Sum_probs=26.6
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVS 96 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA 96 (583)
.+++|+|+++.|||++.++.+.|+||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 57999999999999988889999999865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.00092 Score=68.74 Aligned_cols=30 Identities=23% Similarity=0.319 Sum_probs=25.2
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
..++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 468999999999999964457899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.05 E-value=0.034 Score=56.48 Aligned_cols=30 Identities=30% Similarity=0.372 Sum_probs=26.1
Q ss_pred CCCcccCCCCCcEEEcCC----CcEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTN----GVVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~----g~IKL~DFGlA~ 97 (583)
..++|+|+.+.|||++.+ +.+.|+||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 479999999999999874 689999999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.44 E-value=0.044 Score=54.96 Aligned_cols=28 Identities=29% Similarity=0.318 Sum_probs=23.9
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.++|+|+.+.||+ ..++.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 3899999999999 566788999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.57 E-value=0.065 Score=56.57 Aligned_cols=31 Identities=23% Similarity=0.414 Sum_probs=27.2
Q ss_pred HHCCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 66 Hs~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
+...++|+|++++|||++.++ ++|+||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 456899999999999998876 9999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=91.31 E-value=0.26 Score=50.44 Aligned_cols=25 Identities=8% Similarity=0.109 Sum_probs=22.7
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecC
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFG 94 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFG 94 (583)
.++|+|+.+.|++++.++ +.|+||.
T Consensus 208 ~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 208 SILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp EEECSSCSGGGEEEETTE-EEECSCC
T ss_pred eeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 589999999999999887 8899984
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.76 E-value=0.045 Score=46.55 Aligned_cols=59 Identities=17% Similarity=0.123 Sum_probs=51.4
Q ss_pred HHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceee
Q 007967 245 AQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVK 303 (583)
Q Consensus 245 a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~ 303 (583)
.+.+|+.++.+.++.|+..|+...+...+....+.+....+...|.|.+|.+++.||+.
T Consensus 38 l~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~ 96 (100)
T 2lv7_A 38 IREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVT 96 (100)
T ss_dssp HHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHH
T ss_pred HHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHH
Confidence 45678999999999999999999888777777777778888888999999999999974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=88.47 E-value=0.16 Score=51.00 Aligned_cols=40 Identities=28% Similarity=0.425 Sum_probs=30.4
Q ss_pred HHHHHHHHHH-------CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 58 TLKALDYLHR-------QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 58 Il~gL~yLHs-------~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
+...+.++.. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3444555553 369999999999999887666899998653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=87.98 E-value=0.32 Score=48.80 Aligned_cols=28 Identities=29% Similarity=0.356 Sum_probs=24.2
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999998 4 89999998653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=84.68 E-value=0.66 Score=47.65 Aligned_cols=28 Identities=29% Similarity=0.445 Sum_probs=23.5
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
+++|+|+++.|||++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999997654 8999998653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=84.11 E-value=0.49 Score=48.47 Aligned_cols=30 Identities=23% Similarity=0.410 Sum_probs=26.6
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 369999999999999988889999998654
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.00 E-value=0.49 Score=35.86 Aligned_cols=61 Identities=15% Similarity=0.148 Sum_probs=49.5
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKS 304 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~a 304 (583)
.....+..++....+.++..|+...+...+......+....+...|.+..+.+++.||+..
T Consensus 7 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~ 67 (71)
T 2b1u_A 7 DLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARM 67 (71)
T ss_dssp HHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 3456788899999999999999988877777666666777777778888899999999743
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=81.55 E-value=0.87 Score=47.19 Aligned_cols=29 Identities=24% Similarity=0.373 Sum_probs=24.7
Q ss_pred HCCCcccCCCCCcEEEcCCCcEEEEecCCc
Q 007967 67 RQGHIHRDVKAGNILLDTNGVVKLADFGVS 96 (583)
Q Consensus 67 s~gIvHRDLKPeNILld~~g~IKL~DFGlA 96 (583)
...++|+|+.++|||++.+ .++|+||..+
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a 254 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFA 254 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccc
Confidence 3579999999999999876 4899999765
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=80.12 E-value=0.089 Score=49.40 Aligned_cols=64 Identities=8% Similarity=0.056 Sum_probs=44.8
Q ss_pred HHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeeeecCc
Q 007967 245 AQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKSSVGF 308 (583)
Q Consensus 245 a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~as~~~ 308 (583)
....|..++.+.++.|+..|+...+...+...........+..-|.+..+.+++.||+++....
T Consensus 59 l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~ 122 (197)
T 3pm8_A 59 LRNIFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDK 122 (197)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHHHHHHC----CHHHHHHHHC-------CEEHHHHHHTTCCH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH
Confidence 3567788899999999999999988777777777777888888888899999999999876655
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 583 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-13 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 9e-64
Identities = 86/217 (39%), Positives = 127/217 (58%), Gaps = 10/217 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++ DHPN+++ +F ++NLW+++ F G + + + + ES I + K+TL
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFC-AGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLH IHRD+KAGNIL +G +KLADFGVSA T R R++F+GTP WMA
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMA 178
Query: 121 PEVLQP----GSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
PEV+ Y+ KAD+WS GIT +E+A P + PM+VLL ++ PP L
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ- 237
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
++S +FK+ + CL K+ R T +LL+H F
Sbjct: 238 -PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-62
Identities = 88/237 (37%), Positives = 127/237 (53%), Gaps = 17/237 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +PN++ S++V LWVVM ++A GS L + + +E I ++ +E L+
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS---LTDVVTETCMDEGQIAAVCRECLQ 127
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL++LH IHRD+K+ NILL +G VKL DFG A + + R+T VGTP WMA
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMA 184
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+ Y K DIWS GI A+E+ G P+ P++ L + N P + +K
Sbjct: 185 PEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--ELQNPEK 241
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVK 237
S F++ + CL D KR +A++LL+H F K AKP + L PL K
Sbjct: 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL--------SSLTPLIAAAK 290
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (516), Expect = 3e-61
Identities = 93/263 (35%), Positives = 126/263 (47%), Gaps = 26/263 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + HPN I+ ++ + W+VM + GS L+ ++ +E I ++ L+
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL-EVHKKPLQEVEIAAVTHGALQ 126
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L YLH IHRDVKAGNILL G+VKL DFG ++ M N+FVGTP WMA
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMA 179
Query: 121 PEVLQ--PGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
PEV+ Y+ K D+WS GIT +ELA P M L QN P L
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---S 236
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKA 238
+S+ F+ V CL K RPT+E LLKH F +PP + L R K
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT--------VIMDLIQRTKD 288
Query: 239 L--QLKDAAQLALKKMPSAEQEA 259
+L + +KK+ QEA
Sbjct: 289 AVRELDNLQYRKMKKILF--QEA 309
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-59
Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 5/217 (2%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+++H NV++ Y + ++ + + + G ++ G E + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMA 114
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YLH G HRD+K N+LLD +K++DFG+ A +F +R+R N GT ++A
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL-ATVFRYNNRERLLNKMCGTLPYVA 173
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+L+ + D+WS GI + G P+ + + L+ KK
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKK 231
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
+ ++ LV++ + R T + K ++
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 7e-56
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 6/212 (2%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ H N++ + + L +V + S H + I + FE + I ++T +
Sbjct: 58 LRKTRHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQ 115
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+DYLH + IHRD+K+ NI L + VK+ DFG+ A + G+ WMA
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGL-ATVKSRWSGSHQFEQLSGSILWMA 174
Query: 121 PEVL--QPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR- 177
PEV+ Q + Y+ ++D+++FGI EL G P+S ++ + D +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
K+ K ++A CL K + +RP ++L
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-55
Identities = 51/213 (23%), Positives = 102/213 (47%), Gaps = 13/213 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
S + HPN++R Y F + +++++ + G+ ++ F+E + + E
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELAN 117
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL Y H + IHRD+K N+LL + G +K+ADFG S + R T GT ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTTLCGTLDYLP 172
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+++ G ++ K D+WS G+ E G PF + + +++
Sbjct: 173 PEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-----VEFTFPDF 226
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
++ +++++ L + ++RP ++L+H +
Sbjct: 227 VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 7e-55
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 18/220 (8%)
Query: 1 MSLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56
+ + HPN++R Y S+ + +V M G+ +K + + S +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCR 119
Query: 57 ETLKALDYLHRQGH--IHRDVKAGNILL-DTNGVVKLADFGVSACMFDTGDRQRSRNTFV 113
+ LK L +LH + IHRD+K NI + G VK+ D G++ R +
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVI 174
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL 173
GTP +MAPE+ + Y+ D+++FG+ LE+A P+S+ + + +
Sbjct: 175 GTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232
Query: 174 DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+D+ KE++ C+ +++ +R + + LL H+FF+
Sbjct: 233 SFDKV--AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-54
Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 48/268 (17%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + P ++ Y +F D + + M M GS ++K E +G + +K
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIK 115
Query: 61 ALDYLH-RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
L YL + +HRDVK NIL+++ G +KL DFGVS + D+ N+FVGT +M
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYM 170
Query: 120 APEVLQPGSGYNSKADIWSFGITALELAHGHAPF-------------------------- 153
+PE LQ G+ Y+ ++DIWS G++ +E+A G P
Sbjct: 171 SPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 154 -------------SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKR 200
PPM + + FS F++ V CL+K+ +R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289
Query: 201 PTAEKLLKHSFFKHAKPPELSVKKLFAD 228
++L+ H+F K + E+
Sbjct: 290 ADLKQLMVHAFIKRSDAEEVDFAGWLCS 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 186 bits (472), Expect = 2e-54
Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 9/220 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MS++ HP ++ + +F D+ + ++ FM+ G + + E +++ K
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCK 135
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
L ++H ++H D+K NI+ T + +KL DFG++A + D ++S GT +
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTTGTAEF 191
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APEV + G D+WS G+ + L G +PF + L +++ +D
Sbjct: 192 AAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNMDDSAF 249
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPP 218
S+ K+ + L+ D R T + L+H + P
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 183 bits (466), Expect = 2e-54
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 12/218 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HPN+I+ ++ ++ ++V M +G + + E I++ L+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLE 121
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ LH+ +HRD+K NILLD + +KL DFG S + D GTP ++A
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL----DPGEKLREVCGTPSYLA 177
Query: 121 PEVLQPG-----SGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDY 175
PE+++ GY + D+WS G+ L G PF M +L M I +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-IMSGNYQFGS 236
Query: 176 DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
+S + K++V+ LV KR TAE+ L H FF+
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 3e-53
Identities = 71/235 (30%), Positives = 111/235 (47%), Gaps = 23/235 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
MS +DHP ++ Y +F D L+ + + G L I F+E+ E +
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY--IRKIGSFDETCTRFYTAEIVS 119
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLH +G IHRD+K NILL+ + +++ DFG A + +Q N+FVGT +++
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-AKVLSPESKQARANSFVGTAQYVS 178
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+L +D+W+ G +L G PF + I+ L+YD +K
Sbjct: 179 PELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-----LEYDFPEK 232
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEK------LLKHSFFK--------HAKPPELS 221
F +++V LV D TKR E+ L H FF+ PP+L+
Sbjct: 233 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-53
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 17/220 (7%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN--LWVVMPFMAEGSCLHLMKIAYQDG--FEESAIGSILK 56
+ + HPN++R Y + +N L++VM + G ++ ++ +E + ++
Sbjct: 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116
Query: 57 ETLKALDYLHRQGH-----IHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT 111
+ AL HR+ +HRD+K N+ LD VKL DFG++ +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKA 173
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPP 171
FVGTP +M+PE + YN K+DIWS G EL PF+ + ++ +
Sbjct: 174 FVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232
Query: 172 GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSF 211
+ Y ++S E++ L RP+ E++L++
Sbjct: 233 RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 2e-51
Identities = 46/215 (21%), Positives = 93/215 (43%), Gaps = 9/215 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ + HP +I + +F + +++ F++ G + A E+ + + +++ +
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACE 138
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
L ++H +H D+K NI+ +T VK+ DFG++ + + T +
Sbjct: 139 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----NPDEIVKVTTATAEF 194
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE++ D+W+ G+ L G +PF+ ++ L ++ D D
Sbjct: 195 AAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN-VKRCDWEFDEDAF 252
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
S K+ + L K+ KR T L+H + K
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 57/272 (20%), Positives = 106/272 (38%), Gaps = 16/272 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+++ H N++ + SF L ++ F++ + E I S + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCE 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDT--NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCW 118
AL +LH H D++ NI+ T + +K+ +FG + + + P +
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLFTAPEY 169
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APEV Q ++ D+WS G L G PF + ++ I NA D +
Sbjct: 170 YAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTFDEEAF 227
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVKA 238
K+ S + V LVK++ R TA + L+H + K ++++ + +
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ------KIERVSTKVIRTLKHRRY 281
Query: 239 LQLKDAAQLALKKMPSAEQEAISQSEYQRGVS 270
L + +A Q+GVS
Sbjct: 282 YHTLIKKDLNMVV-SAARISCGGAIRSQKGVS 312
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 2e-49
Identities = 62/255 (24%), Positives = 109/255 (42%), Gaps = 11/255 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ I HPN++ + +L+++M ++ G + + + E ++ + L
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLD 118
Query: 61 ALDYLHRQGHIHRDVKAGNILL---DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
A+ YLH G +HRD+K N+L D + + ++DFG+S D +T GTP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME----DPGSVLSTACGTPG 174
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
++APEVL Y+ D WS G+ A L G+ PF K+ I A D
Sbjct: 175 YVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ-ILKAEYEFDSPY 232
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPLWNRVK 237
S S K+ + + KD KR T E+ L+H + + ++ + ++
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKS 292
Query: 238 ALQLKDAAQLALKKM 252
+ A ++ M
Sbjct: 293 KWKQAFNATAVVRHM 307
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-49
Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN-LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M+ + H N+++ V + L++V +MA+GS + ++ + + +
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWM 119
+A++YL +HRD+ A N+L+ + V K++DFG++ T ++T W
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWT 167
Query: 120 APEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD 178
APE L+ +++K+D+WSFGI E + G P+ + P V+ + G D
Sbjct: 168 APEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAP 222
Query: 179 KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPEL 220
+ E++ C D RP+ +L + +H K EL
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ--LEHIKTHEL 262
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 7e-49
Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 25/282 (8%)
Query: 1 MSLIDHPNVIRAYCSF----VVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56
P+++R + L +VM + G ++ F E I+K
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFV 113
+A+ YLH HRDVK N+L + N ++KL DFG + S T
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS----HNSLTTPC 174
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV---LLMTIQNAP 170
TP ++APEVL Y+ D+WS G+ L G+ PF + + + I+
Sbjct: 175 YTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK-HAKPPELSV------- 222
+ S+ K ++ L + T+R T + + H + K P+ +
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293
Query: 223 --KKLFADLPPLWNRVKALQLKDAAQLALKKMPSAEQEAISQ 262
K+ + D+ A D Q+ +KK+ A + +
Sbjct: 294 EDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLK 335
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-48
Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 11/223 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +D+P ++R L +VM G LH + ++ S + +L +
Sbjct: 63 MHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YL + +HRD+ A N+LL K++DFG+S + +R+ W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 121 PEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PE + ++S++D+WS+G+T E L++G P+ K +V+ Q +
Sbjct: 181 PECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM----ECPP 235
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTA---EKLLKHSFFKHAKPPE 219
+ +++ C + RP E+ ++ ++ A E
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-47
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 11/221 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H +++ Y + +++V +M++GS L +K + + +
Sbjct: 66 MKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ Y+ R ++HRD++A NIL+ N V K+ADFG++ + D + +R W A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTA 182
Query: 121 PEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PE + K+D+WSFGI EL G P+ +VL G
Sbjct: 183 PEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQVERGYRMPCPP 237
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLK--HSFFKHAKPP 218
+ +S +++ C K+ +RPT E L +F +P
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-47
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H +++ Y ++++ +MA G L+ ++ F+ + + K+ +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCE 111
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A++YL + +HRD+ A N L++ GVVK++DFG+S + D D S W
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSP 169
Query: 121 PEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PEVL S ++SK+DIW+FG+ E+ + G P+ ++ + Q GL R
Sbjct: 170 PEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----GLRLYRPH 224
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
S+ ++ C + +RPT + LL +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 44/301 (14%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+HP + +C+F NL+ VM ++ G ++ ++ F+ S E +
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIIL 114
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L +LH +G ++RD+K NILLD +G +K+ADFG+ + NTF GTP ++A
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDYIA 171
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE+L G YN D WSFG+ E+ G +PF ++ + P +
Sbjct: 172 PEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF-----YPRW 225
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEK-LLKHSFFKHAKPPELSVKKLFADLPPLWNRVKAL 239
K K+++ V++ KR + +H F+ EL K++ P
Sbjct: 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRP-------- 277
Query: 240 QLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEEN 299
++K + NFD E L + L D ++ + ++N
Sbjct: 278 KVKSPFDCS------------------------NFDKEFLNEKPRLSFADRALINSMDQN 313
Query: 300 E 300
Sbjct: 314 M 314
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-47
Identities = 44/217 (20%), Positives = 90/217 (41%), Gaps = 12/217 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +D+P ++R + + +VM G + ++ I ++ +
Sbjct: 62 MQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKY--LQQNRHVKDKNIIELVHQVSM 118
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YL +HRD+ A N+LL T K++DFG+S + + +++ W A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 121 PEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PE + ++SK+D+WSFG+ E ++G P+ +V M +
Sbjct: 179 PECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----GCPA 233
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKL---LKHSFFK 213
+ +++ +C D RP + L++ ++
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-46
Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 7/209 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + HP +++ Y + + + +V FM G ++ E+ + + + +
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCE 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YL IHRD+ A N L+ N V+K++DFG+ F D+ S W +
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM--TRFVLDDQYTSSTGTKFPVKWAS 170
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV Y+SK+D+WSFG+ E+ + ++ I G + +
Sbjct: 171 PEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRL 226
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
S +++ C + RP +LL+
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 49/231 (21%), Positives = 86/231 (37%), Gaps = 27/231 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK--------------------- 39
L H N++ + + ++++ + G L+ ++
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 40 IAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACM 99
+ + + K +++L + +HRD+ A N+L+ VVK+ DFG+ A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL-ARD 213
Query: 100 FDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPP 158
+ R WMAPE L Y K+D+WS+GI E + G P+ P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
IQN G D+ ++ ++ C D KRP+ L
Sbjct: 273 DANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-46
Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 28/242 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + HPN+I +F SN+ +V FM + + S I + + TL+
Sbjct: 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 111
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+YLH+ +HRD+K N+LLD NGV+KLADFG++ G R+ V T + A
Sbjct: 112 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF---GSPNRAYTHQVVTRWYRA 168
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL------------------ 162
PE+L Y D+W+ G EL + L
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 163 -----LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217
+T ++ P + +++ + + R TA + LK +F +
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288
Query: 218 PE 219
P
Sbjct: 289 PT 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 6e-46
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 18/220 (8%)
Query: 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDY 64
VIR F + +++ E I + +E S + L+A+ +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERP-EPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 65 LHRQGHIHRDVKAGNILLDTN-GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEV 123
H G +HRD+K NIL+D N G +KL DFG A + DT F GT + PE
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEW 180
Query: 124 LQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSK 183
++ + A +WS GI ++ G PF + ++ S
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-----------GQVFFRQRVSS 229
Query: 184 SFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVK 223
+ ++ CL + RPT E++ H + + P+ + +
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (410), Expect = 7e-46
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S++ HP +IR + +F ++++M ++ EG L + F E
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLR-KSQRFPNPVAKFYAAEVCL 115
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLH + I+RD+K NILLD NG +K+ DFG + + D T GTP ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIA 169
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEV+ YN D WSFGI E+ G+ PF MK + +
Sbjct: 170 PEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-----ELRFPPF 223
Query: 181 FSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKL 225
F++ K++++ + +D ++R E + H +FK +L + +
Sbjct: 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (413), Expect = 1e-45
Identities = 72/303 (23%), Positives = 130/303 (42%), Gaps = 30/303 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+S D P ++ +F L ++ M G + ++ F E+ + E +
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY--HLSQHGVFSEADMRFYAAEIIL 118
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L+++H + ++RD+K NILLD +G V+++D G+ AC F ++ + VGT +MA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL-ACDFS----KKKPHASVGTHGYMA 173
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVLQ G Y+S AD +S G +L GH+PF ++ I + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPDS 231
Query: 181 FSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLPPLWNR 235
FS + ++ L +D +R A+++ + FF+ + ++K L P
Sbjct: 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 291
Query: 236 V----------------KALQLKDAAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDL 279
V K ++L D+ Q + P E Q + N + + L
Sbjct: 292 VNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRL 351
Query: 280 KAQ 282
+A+
Sbjct: 352 EAR 354
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-45
Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 14/236 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ I HPNVI + + +++ +++ + G L + EE A LK+ L
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELV-AGGELFDFLAEKESLTEEEAT-EFLKQILN 124
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGV----VKLADFGVSACMFDTGDRQRSRNTFVGTP 116
+ YLH H D+K NI+L V +K+ DFG++ + D GTP
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIFGTP 180
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
++APE++ +AD+WS G+ L G +PF + L + + +
Sbjct: 181 EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-VSAVNYEFEDE 238
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPELSVKKLFADLPPL 232
S K+ + LVKD KR T + L+H + K + P
Sbjct: 239 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAW--SHPQF 292
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (401), Expect = 9e-45
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 9/212 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M DHPNVI + + ++ FM GS ++ +G +L+
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG-MLRGIAA 139
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT--FVGTPCW 118
+ YL ++HRD+ A NIL+++N V K++DFG+S + D + W
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
APE +Q + S +D+WS+GI E +++G P+ V+ Q+
Sbjct: 200 TAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL----PP 254
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ +++ C KD+ RP +++
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (399), Expect = 9e-45
Identities = 45/217 (20%), Positives = 98/217 (45%), Gaps = 8/217 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56
+ ++HP ++ Y + ++ ++VM ++ + ++ + ++
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIA 118
Query: 57 ETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
+ +AL++ H+ G IHRDVK NI++ VK+ DFG++ + D+G+ +GT
Sbjct: 119 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYD 176
+++PE + G ++++D++S G E+ G PF+ P+ V ++ P
Sbjct: 179 QYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PPSA 236
Query: 177 RDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
R + S +V L K+ R ++ +
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 9e-45
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 7/210 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M +DH N+IR Y + + +V GS L + +Q F + + +
Sbjct: 65 MHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAE 122
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YL + IHRD+ A N+LL T +VK+ DFG+ + D + W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 121 PEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PE L+ ++ +D W FG+T E +G P+ ++L + G R +
Sbjct: 183 PESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE---GERLPRPE 238
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ ++ C RPT L
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 10/220 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M+ +D+P+V R + S + ++ M G L ++D + + + K
Sbjct: 65 MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 122
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
++YL + +HRD+ A N+L+ T VK+ DFG++ + +++ WMA
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-KLLGAEEKEYHAEGGKVPIKWMA 181
Query: 121 PEVLQPGSGYNSKADIWSFGITALEL-AHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
E + Y ++D+WS+G+T EL G P+ P ++ + + +
Sbjct: 182 LESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----PQPP 236
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219
+ ++ C + D RP +L+ F K A+ P+
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQ 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-44
Identities = 59/240 (24%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 1 MSLIDHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
+ +HPNV+R + V ++ L +V + + + + G I ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
+ L+ LD+LH +HRD+K NIL+ ++G +KLADFG++ Q + + V T
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVT 178
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTIQNAPPGL 173
+ APEVL S Y + D+WS G E+ F + L ++ + P
Sbjct: 179 LWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 174 DYDRD--------------------KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
D+ RD + K+++ CL + KR +A L H +F+
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-44
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 11/215 (5%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M + H ++R Y V ++++ +M GS + +K + + + + +
Sbjct: 62 MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ ++ + +IHRD++A NIL+ K+ADFG++ + D + +R W A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTA 178
Query: 121 PEVLQPGSGYNSKADIWSFGITALELA-HGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PE + G + K+D+WSFGI E+ HG P+ +V IQN G R
Sbjct: 179 PEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----IQNLERGYRMVRPD 233
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLK--HSFF 212
+ +++ +C + RPT + L FF
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-43
Identities = 53/274 (19%), Positives = 96/274 (35%), Gaps = 36/274 (13%)
Query: 1 MSLIDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
+ H N+I + ++++V M L+K I L
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLK---TQHLSNDHICYFL 115
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
+ L+ L Y+H +HRD+K N+LL+T +K+ DFG++ D +V T
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL--LMTIQNAPPGL 173
+ APE++ GY DIWS G E+ F + L ++ I +P
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 174 DYDRD------------------------KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
D + +++ L + KR E+ L H
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
Query: 210 SFFK-HAKPPELSVKKLFADLPPLWNRVKALQLK 242
+ + + P + + + + + +LK
Sbjct: 296 PYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLK 329
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-43
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 5/208 (2%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M H N+IR + ++ +M G+ ++ F + +L+
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAA 121
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ YL ++HRD+ A NIL+++N V K++DFG+S + D + + + W A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE + + S +D+WSFGI E+ ++ I + G
Sbjct: 182 PEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLPTPMD 237
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+ +++ C +++ +RP ++
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (389), Expect = 3e-43
Identities = 51/227 (22%), Positives = 102/227 (44%), Gaps = 8/227 (3%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M I HPN+++ + +++ FM G+ L ++ + + + +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
A++YL ++ IHRD+ A N L+ N +VK+ADFG+S M TGD + W A
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTA 184
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE L ++ K+D+W+FG+ E+A + + ++ +R +
Sbjct: 185 PESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDYRMERPEG 240
Query: 181 FSKSFKEMVAMCLVKDQTKRPTAEKLLK--HSFFKHAKPPELSVKKL 225
+ E++ C + + RP+ ++ + + F+ + + K+L
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 8e-43
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 16/236 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ HP + +F L VM + G + + F E E +
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVS 116
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL+YLH + ++RD+K N++LD +G +K+ DFG+ G TF GTP ++A
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PEVL+ + Y D W G+ E+ G PF ++ + + + +
Sbjct: 174 PEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----EIRFPRT 227
Query: 181 FSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
S K ++A L KD +R A+++++H FF ++ KKL P
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 2e-42
Identities = 52/237 (21%), Positives = 95/237 (40%), Gaps = 29/237 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + H N+++ Y L +V + + L + + G E S L + L
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ--DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ Y H + +HRD+K N+L++ G +K+ADFG++ + + T + A
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRA 168
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ------------- 167
P+VL Y++ DIWS G E+ +G F L+ +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 168 -----------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213
P K +S ++++ L D +R TA++ L+H++FK
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-42
Identities = 53/255 (20%), Positives = 88/255 (34%), Gaps = 38/255 (14%)
Query: 1 MSLIDHPNVIRAYCSF--------VVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIG 52
+ L+ H NV+ ++++V F L + F S I
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD--LAGLLSNVLVKFTLSEIK 120
Query: 53 SILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRS-RNT 111
+++ L L Y+HR +HRD+KA N+L+ +GV+KLADFG++ + Q +
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 112 FVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF------------------ 153
V T + PE+L Y D+W G E+
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 154 ---------SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE 204
Y + L + D + +++ LV D +R ++
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 205 KLLKHSFFKHAKPPE 219
L H FF P
Sbjct: 301 DALNHDFFWSDPMPS 315
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-42
Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 28/242 (11%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ ++HPN+++ ++ L++V F+ M + G I S L + L+
Sbjct: 55 LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L + H +HRD+K N+L++T G +KLADFG++ G R+ V T + A
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRA 170
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRD-- 178
PE+L Y++ DIWS G E+ A F + L + +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 179 ----------------------KKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216
+ + +++ L D KR +A+ L H FF+
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 217 PP 218
P
Sbjct: 291 KP 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-42
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 10/210 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
M DHP++++ ++ +W++M G + + + +++ +
Sbjct: 62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLST 119
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL YL + +HRD+ A N+L+ +N VKL DFG+S M D+ + S WMA
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMA 177
Query: 121 PEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
PE + + S +D+W FG+ E L HG PF V+
Sbjct: 178 PESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----PMPP 232
Query: 180 KFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ ++ C D ++RP +L
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 56/266 (21%), Positives = 96/266 (36%), Gaps = 37/266 (13%)
Query: 1 MSLIDHPNVIRAYCSFVV------DSNLWVVMPFMAEGSCLHLMKIAYQDG-FEESAIGS 53
M +DH N++R F + L +V+ ++ E + +
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 54 ILKETLKALDYLHRQGHIHRDVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTF 112
+ + ++L Y+H G HRD+K N+LLD + V+KL DFG + + ++
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSY 182
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTI------ 166
+ + + APE++ + Y S D+WS G EL G F + L+ I
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 167 ------------------QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
Q + + + L T R T +
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 209 HSFFKHAKPPELSVKKLFADLPPLWN 234
HSFF + P + + D P L+N
Sbjct: 303 HSFFDELRDPNVKLPNGR-DTPALFN 327
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-40
Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 30/243 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + H N++R + D L +V F + L + + + S L + LK
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ--DLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
L + H + +HRD+K N+L++ NG +KLA+FG++ R + V T +
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWYRP 169
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA----------- 169
P+VL Y++ D+WS G ELA+ P + L I
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 170 --------------PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215
+ K + + ++++ L + +R +AE+ L+H +F
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
Query: 216 KPP 218
PP
Sbjct: 290 CPP 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 9/212 (4%)
Query: 1 MSLIDHPNVIRAY-CSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETL 59
M HPNV+ + + VV+P+M G + ++ + + I +
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVA 140
Query: 60 KALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNT-FVGTPCW 118
K + +L + +HRD+ A N +LD VK+ADFG++ M+D T W
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 119 MAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDR 177
MA E LQ + +K+D+WSFG+ E + G P+ + + +Q +
Sbjct: 201 MALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----LQ 255
Query: 178 DKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ E++ C RP+ +L+
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 4e-40
Identities = 42/231 (18%), Positives = 88/231 (38%), Gaps = 29/231 (12%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK--------------------- 39
M+ D+PN+++ V + ++ +MA G ++
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 40 -IAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSAC 98
+ I ++ + YL + +HRD+ N L+ N VVK+ADFG+S
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 99 MFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYP 157
++ D ++ WM PE + + Y +++D+W++G+ E ++G P+
Sbjct: 190 IYS-ADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+V+ + ++ +C K RP+ + +
Sbjct: 248 HEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 5e-40
Identities = 36/232 (15%), Positives = 74/232 (31%), Gaps = 15/232 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
++ I + + V++ + S L F + + + +
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF-CSRKFSLKTVLLLADQMIS 114
Query: 61 ALDYLHRQGHIHRDVKAGNIL---LDTNGVVKLADFGVSACMFDTGDRQ----RSRNTFV 113
++Y+H + IHRDVK N L +V + DFG++ D Q R
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGL 173
GT + + G + + D+ S G + G P+ + + +
Sbjct: 175 GTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 174 DYDRD---KKFSKSFKEMVAMCLVKDQTKRPTAE---KLLKHSFFKHAKPPE 219
+ K + F + C +P +L ++ F + +
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-40
Identities = 47/224 (20%), Positives = 89/224 (39%), Gaps = 24/224 (10%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK--------------IAYQDGF 46
L HPN+I + L++ + + G+ L ++ +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 47 EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ 106
+ + + +DYL ++ IHRD+ A NIL+ N V K+ADFG+S +
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ----EVY 180
Query: 107 RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPMKVLLMT 165
+ WMA E L S Y + +D+WS+G+ E+ G P+ ++
Sbjct: 181 VKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---- 235
Query: 166 IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ P G ++ +++ C + +RP+ ++L
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-40
Identities = 65/237 (27%), Positives = 115/237 (48%), Gaps = 11/237 (4%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ P ++ + +F ++ L +++ ++ G + ++ F E + + E +
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVL 140
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
AL++LH+ G I+RD+K NILLD+NG V L DFG+S D F GT +MA
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF--VADETERAYDFCGTIEYMA 198
Query: 121 PEVLQPG-SGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDK 179
P++++ G SG++ D WS G+ EL G +PF+ I + +
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSEPPYPQ 257
Query: 180 KFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPP 231
+ S K+++ L+KD KR A+++ +H FF+ +L+ KK+ A P
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 314
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 44/224 (19%), Positives = 83/224 (37%), Gaps = 20/224 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMK----------------IAYQD 44
L +H N++ + + V+ + G L+ ++ +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 45 GFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD 104
+ + S + K + +L + IHRD+ A NILL + K+ DFG+ A
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL-ARDIKNDS 199
Query: 105 RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164
+ WMAPE + Y ++D+WS+GI EL + P+
Sbjct: 200 NYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+ G + +++ C D KRPT +++++
Sbjct: 259 KMIK--EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-38
Identities = 45/218 (20%), Positives = 87/218 (39%), Gaps = 15/218 (6%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGS------- 53
M + +V+R V+M M G ++ +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 54 -ILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTF 112
+ E + YL+ +HRD+ A N ++ + VK+ DFG++ +++T D R
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-DYYRKGGKG 195
Query: 113 VGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG-HAPFSKYPPMKVLLMTIQNAPP 171
+ WM+PE L+ G + + +D+WSFG+ E+A P+ +VL ++
Sbjct: 196 LLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254
Query: 172 GLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
D+ E++ MC + RP+ +++
Sbjct: 255 ----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-38
Identities = 47/243 (19%), Positives = 91/243 (37%), Gaps = 38/243 (15%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN----LWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILK 56
++ H N++ + D+ LW+V + GS + + + +
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLAL 107
Query: 57 ETLKALDYLH--------RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD-RQR 107
T L +LH + HRD+K+ NIL+ NG +AD G++ D
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167
Query: 108 SRNTFVGTPCWMAPEVLQPGSG-----YNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162
+ N VGT +MAPEVL +ADI++ G+ E+A + + ++
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 163 LMTIQNAPPGL-----------------DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205
+ + P + + + + + +++ C + R TA +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 206 LLK 208
+ K
Sbjct: 288 IKK 290
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (356), Expect = 6e-38
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 19/230 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ ++ P +++ SF +SNL++VM ++A G + F E + +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH--LRRIGRFSEPHARFYAAQIVL 152
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+YLH I+RD+K N+L+D G +++ DFG + + T GTP +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALA 206
Query: 121 PEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKK 180
PE++ GYN D W+ G+ E+A G+ PF P+++ +
Sbjct: 207 PEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-----KVRFPSH 260
Query: 181 FSKSFKEMVAMCLVKDQTKR-----PTAEKLLKHSFFKHAKPPELSVKKL 225
FS K+++ L D TKR + H +F + +K+
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV 310
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-37
Identities = 47/224 (20%), Positives = 96/224 (42%), Gaps = 21/224 (9%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDG--------------F 46
+ H N+I + D L+V++ + ++G+ ++ G
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 47 EESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQ 106
+ S + + ++YL + IHRD+ A N+L+ + V+K+ADFG++ + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 107 RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE-LAHGHAPFSKYPPMKVLLMT 165
++ WMAPE L Y ++D+WSFG+ E G +P+ P ++ +
Sbjct: 193 KT-TNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 166 IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ D+ + M+ C ++RPT ++L++
Sbjct: 251 KEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 20/225 (8%)
Query: 1 MSLIDHPNVIRAYCSFVVDSN--LWVVMPFMAEGSCLHLMK--------------IAYQD 44
+ I H + L V++ F G+ ++ Y+D
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 45 GFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGD 104
+ + K +++L + IHRD+ A NILL VVK+ DFG++ ++ D
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 105 RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLM 164
R WMAPE + Y ++D+WSFG+ E+ A YP +K+
Sbjct: 190 YVRK-GDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEE 245
Query: 165 TIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ G + + + C + ++RPT +L++H
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 63/251 (25%), Positives = 95/251 (37%), Gaps = 42/251 (16%)
Query: 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
+ + H NVI F D + ++VMPFM LMK + E I +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFL 126
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
+ + LK L Y+H G IHRD+K GN+ ++ + +K+ DFG++ +V
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVV 180
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKV--LLMTIQNAPPG 172
T + APEV+ Y DIWS G E+ G F + +M + PP
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 173 LDYDRD------------------------KKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
R S ++ LV D +R TA + L
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
Query: 209 HSFFKHAKPPE 219
H +F+ E
Sbjct: 301 HPYFESLHDTE 311
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 135 bits (340), Expect = 5e-36
Identities = 51/249 (20%), Positives = 83/249 (33%), Gaps = 45/249 (18%)
Query: 1 MSLIDHPNVIRAYCSFV--VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKET 58
+L PN+I V +V + L + + I + E
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEI 138
Query: 59 LKALDYLHRQGHIHRDVKAGNILLDT-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPC 117
LKALDY H G +HRDVK N+++D + ++L D+G+ A + G N V +
Sbjct: 139 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEY---NVRVASRY 194
Query: 118 WMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQNA-------- 169
+ PE+L Y+ D+WS G + PF L+ I
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 170 -------------------------PPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE 204
+ + S + + L D R TA
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 205 KLLKHSFFK 213
+ ++H +F
Sbjct: 315 EAMEHPYFY 323
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (335), Expect = 1e-35
Identities = 31/218 (14%), Positives = 65/218 (29%), Gaps = 15/218 (6%)
Query: 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKAL 62
L + Y + +V+ + L F + K+ L +
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARV 114
Query: 63 DYLHRQGHIHRDVKAGNILLD-----TNGVVKLADFGVSACMFDTGDRQ----RSRNTFV 113
+H + ++RD+K N L+ ++ + DFG+ D +Q R +
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 114 GTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ---NAP 170
GT +M+ G + + D+ + G + G P+ +
Sbjct: 175 GTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 171 PGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208
+ F + F + + P + L
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 50/250 (20%), Positives = 92/250 (36%), Gaps = 40/250 (16%)
Query: 1 MSLIDHPNVIRAYCSFV-----VDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSIL 55
+ + H NVI F + N ++ + +++K + + ++
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLI 127
Query: 56 KETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGT 115
+ L+ L Y+H IHRD+K N+ ++ + +K+ DFG++ +V T
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT------DDEMTGYVAT 181
Query: 116 PCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL------------- 162
+ APE++ YN DIWS G EL G F + L
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 163 -------------LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209
+ ++ P + + +++ LV D KR TA + L H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 210 SFFKHAKPPE 219
++F P+
Sbjct: 302 AYFAQYHDPD 311
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-31
Identities = 51/262 (19%), Positives = 99/262 (37%), Gaps = 53/262 (20%)
Query: 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSI 54
M ++H N+I F ++++VM M + + +++ + + +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQ----MELDHERMSYL 124
Query: 55 LKETLKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVG 114
L + L + +LH G IHRD+K NI++ ++ +K+ DFG++ + +V
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVV 180
Query: 115 TPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVLLMTIQ------- 167
T + APEV+ G GY DIWS G E+ F + I+
Sbjct: 181 TRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 168 ------------------------------NAPPGLDYDRDKKFSKSFKEMVAMCLVKDQ 197
++ D + +K + +++++ LV D
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 198 TKRPTAEKLLKHSFFKHAKPPE 219
KR + + L+H + P
Sbjct: 300 AKRISVDDALQHPYINVWYDPA 321
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (280), Expect = 1e-27
Identities = 55/290 (18%), Positives = 93/290 (32%), Gaps = 54/290 (18%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGS---CLHLMKIAYQDGFEESAIGSILKE 57
+ ++++ F V + + E L L+K G + I K+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 58 TLKALDYLH-RQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTP 116
L LDY+H R G IH D+K N+L++ + A + + + T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 117 CWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK--------------------Y 156
+ +PEVL G+ + ADIWS EL G F
Sbjct: 194 EYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 157 PPMKVLLMTIQNAPPGLD-----------------------YDRDKKFSKSFKEMVAMCL 193
LL + + Y K +K + ++ L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 194 VKDQTKRPTAEKLLKHSFFK------HAKPPELSVKKLFADLPPLWNRVK 237
D KR A L+ H + K + P+ + +D+P + V+
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.8 bits (157), Expect = 9e-13
Identities = 23/154 (14%), Positives = 46/154 (29%), Gaps = 39/154 (25%)
Query: 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLK 60
+ + V + Y V+M + + + +L L+
Sbjct: 68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRVRVENPDE---------VLDMILE 114
Query: 61 ALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMA 120
+ + +G +H D+ N+L+ G + + DF S V
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS----------------VEVGEEGW 157
Query: 121 PEVLQP---------GSGYNSKADIWSFGITALE 145
E+L+ Y ++ DI S L+
Sbjct: 158 REILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 583 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.04 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.95 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 93.52 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 92.46 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.96 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 88.47 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 87.55 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 87.5 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 86.35 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 86.33 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 86.03 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 85.19 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 84.9 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 84.58 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 84.01 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 83.5 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 83.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 80.31 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 80.12 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=398.26 Aligned_cols=207 Identities=40% Similarity=0.726 Sum_probs=183.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++++|||||||+||+|.+++.. +.+++..++.|++||+.||.|||++||+||||||+||
T Consensus 71 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 147 (293)
T d1yhwa1 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (293)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHe
Confidence 4578999999999999999999999999999999998653 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|++||+|||+|+.+.... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+.....
T Consensus 148 Ll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 223 (293)
T d1yhwa1 148 LLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (293)
T ss_dssp EECTTCCEEECCCTTCEECCSTT---CCBCCCCSCGGGCCHHHHS-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EECCCCcEeeccchhheeecccc---ccccccccCCCccChhhhc-CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence 99999999999999997653322 2234578999999999998 5679999999999999999999999999988877
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.+...+....+.+ ..+..+++.+++||.+||.+||.+|||+.|+|+||||+...
T Consensus 224 ~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 224 ALYLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHHHHCSCCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHhCCCCCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 7777766655443 34567899999999999999999999999999999998654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=391.31 Aligned_cols=201 Identities=26% Similarity=0.501 Sum_probs=176.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Ni 137 (263)
T d2j4za1 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 137 (263)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccc
Confidence 46789999999999999999999999999999999998764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||+|...... .....+||+.|||||++. +..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 138 ll~~~~~~kl~DFG~a~~~~~~-----~~~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 211 (263)
T d2j4za1 138 LLGSAGELKIADFGWSVHAPSS-----RRTTLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211 (263)
T ss_dssp EECTTSCEEECCCCSCSCCCCC-----CCEETTEEGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred eecCCCCEeecccceeeecCCC-----cccccCCCCcccCHHHHc-CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998654221 223568999999999998 5679999999999999999999999998876655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.+ ..+..... ..+..+++++++||.+||++||.+|||++|+|+||||..
T Consensus 212 ~~-~~i~~~~~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 212 TY-KRISRVEF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HH-HHHHTTCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HH-HHHHcCCC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 44 44444332 234568999999999999999999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=398.34 Aligned_cols=209 Identities=22% Similarity=0.370 Sum_probs=177.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|||||||+||+|.+++.. .+.+++..++.|++||+.||+|||++||+||||||+||
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NI 134 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134 (271)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHE
Confidence 4678999999999999999999999999999999998754 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||+|+...... ........+||+.|||||++.+...++.++|||||||++|+|++|+.||.......
T Consensus 135 Ll~~~~~~KL~DFG~a~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 135 LLDERDNLKISDFGLATVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp EECTTCCEEECCCTTCEECEETT-EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred EECCCCCEEEccchhheeeccCC-ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999999997653322 22234567999999999999854445788999999999999999999998765544
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.....+..... ....+..+++++++||.+||++||.+|||++|+|+||||+.
T Consensus 214 ~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 214 QEYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHhcCCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 44444443322 22335678999999999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=401.70 Aligned_cols=218 Identities=28% Similarity=0.458 Sum_probs=187.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++.+|+|||||+||+|.+++... +.++|..++.+++||+.||+|||++||+||||||+||
T Consensus 59 l~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI 136 (337)
T d1o6la_ 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHe
Confidence 46789999999999999999999999999999999998764 7899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|++||+|||+|+...... ......+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+
T Consensus 137 Ll~~~g~vkl~DFG~a~~~~~~~---~~~~~~~GT~~Y~aPE~~~-~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 137 MLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp EECTTSCEEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EecCCCCEEEeecccccccccCC---cccccceeCHHHhhhhhcc-CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 99999999999999997653322 2234679999999999998 6789999999999999999999999999877655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADL 229 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~ 229 (583)
.. ..+..... ..+..+|+++++||.+||++||.+|+ ++++|++||||++++|..+..+++.+++
T Consensus 213 ~~-~~i~~~~~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~ 281 (337)
T d1o6la_ 213 LF-ELILMEEI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPF 281 (337)
T ss_dssp HH-HHHHHCCC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred HH-HHHhcCCC----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCC
Confidence 44 44444332 23467899999999999999999999 4999999999999887665555544443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=394.93 Aligned_cols=212 Identities=31% Similarity=0.527 Sum_probs=180.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NI 139 (288)
T d1uu3a_ 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139 (288)
T ss_dssp HHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccc
Confidence 35689999999999999999999999999999999988764 7899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||+|+.+.... ......+.+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+.+..+
T Consensus 140 ll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~~~GT~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 217 (288)
T d1uu3a_ 140 LLNEDMHIQITDFGTAKVLSPES-KQARANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217 (288)
T ss_dssp EECTTSCEEECCCTTCEECC-----------CCCCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccCCCceEEecccccceecccCC-cccccccccCCccccCceeec-cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH
Confidence 99999999999999987653222 222234578999999999998 6689999999999999999999999999877665
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHH------HHhccccccCCCCchh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEK------LLKHSFFKHAKPPELS 221 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~e------IL~HpfFk~~~~~~~~ 221 (583)
....+.. ... ..+..+++++++||.+||++||.+|||++| +++||||+.++|..+.
T Consensus 218 ~~~~i~~-~~~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 218 IFQKIIK-LEY----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp HHHHHHT-TCC----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHHc-CCC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 5544443 322 234578999999999999999999999876 6899999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=392.84 Aligned_cols=209 Identities=42% Similarity=0.721 Sum_probs=181.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|||||||+||+|.+++... .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NI 141 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141 (288)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhe
Confidence 45689999999999999999999999999999999987654 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCccccc----CCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQ----PGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~----~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|++.+|.+||+|||+|+...... ....+.+||+.|+|||++. ....|+.++|||||||++|+|++|+.||.+.
T Consensus 142 ll~~~~~~Kl~DFG~a~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 142 LFTLDGDIKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp EECTTSCEEECCCTTCEECHHHH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eECCCCCEEEEechhhhccCCCc---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999987542211 1223578999999999985 2456899999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
...+.+..+.....+.+ ..+..+++++++||.+||++||.+|||++|+|+||||+..
T Consensus 219 ~~~~~~~~i~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 219 NPMRVLLKIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp CGGGHHHHHHHSCCCCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CHHHHHHHHHcCCCCCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 88777776666654433 3346789999999999999999999999999999999743
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=383.03 Aligned_cols=202 Identities=27% Similarity=0.505 Sum_probs=174.6
Q ss_pred CCCCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccC
Q 007967 1 MSLIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQG--HIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~g--IvHRD 74 (583)
|+.++|||||+++++|++ +..+|||||||+||+|.+++... ..+++..++.|++||+.||+|||++| |+|||
T Consensus 62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrD 139 (270)
T d1t4ha_ 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 139 (270)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSC
T ss_pred HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCC
Confidence 578999999999999986 45699999999999999998764 67999999999999999999999999 99999
Q ss_pred CCCCcEEEc-CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 75 VKAGNILLD-TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 75 LKPeNILld-~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
|||+|||++ .++.+||+|||+|+.... ....+.+||+.|||||++. ..|+.++|||||||++|+|++|+.||
T Consensus 140 iKp~NILl~~~~~~~Kl~DFGla~~~~~-----~~~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 140 LKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp CCGGGEEESSTTSCEEECCTTGGGGCCT-----TSBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cChhhceeeCCCCCEEEeecCcceeccC-----CccCCcccCccccCHHHhC--CCCCCcCchhhHHHHHHHHHHCCCCC
Confidence 999999996 578999999999864311 1223578999999999997 36999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 154 SKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 154 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
.+......+...+..... +...+..+++++++||.+||++||.+|||++|+|+||||+
T Consensus 213 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 213 SECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp TTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCcccHHHHHHHHHcCCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 887766666666655432 2233456889999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-47 Score=392.41 Aligned_cols=208 Identities=28% Similarity=0.439 Sum_probs=170.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|||||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Ni 138 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138 (307)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccce
Confidence 4678999999999999999999999999999999999864 46799999999999999999999999999999999999
Q ss_pred EEc---CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 81 LLD---TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 81 Lld---~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|+. .+|.+||+|||+|+..... ....+.+||+.|||||++. +..|+.++|||||||++|+|++|..||.+..
T Consensus 139 l~~~~~~~~~vkl~DFG~a~~~~~~----~~~~~~~GT~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 139 LYYSLDEDSKIMISDFGLSKMEDPG----SVLSTACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp EESSSSTTCCEEECCC----------------------CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eecccCCCceEEEeccceeEEccCC----CeeeeeeeCccccCcHHHc-CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 994 5789999999998754221 2234578999999999998 5679999999999999999999999999876
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
..+.. ..+......+..+.+..+|+++++||.+||++||.+|||++|+|+||||++..
T Consensus 214 ~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 214 DAKLF-EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHH-HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHH-HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 65544 44444444455555678999999999999999999999999999999998643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.4e-47 Score=398.58 Aligned_cols=221 Identities=25% Similarity=0.371 Sum_probs=185.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|||||||+||+|.+++... ..+++..++.|++||+.||+|||++|||||||||+||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NI 138 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeecccee
Confidence 35678999999999999999999999999999999998764 7799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|.+||+|||+|+.+... .....+||+.|+|||++..+..|+.++|||||||++|+|++|+.||.+.....
T Consensus 139 Ll~~~g~iKl~DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 139 LLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp EECSSSCEEECCCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred EEcCCCcEEEeeeceeeecCCC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998755321 22356899999999999766789999999999999999999999998754322
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCC-----HHHHHhccccccCCCCchhhhhhhcCCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPT-----AEKLLKHSFFKHAKPPELSVKKLFADLP 230 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpT-----a~eIL~HpfFk~~~~~~~~~~~~~~~~~ 230 (583)
.. ..... ........+..+++++++||.+||++||.+||| +++|++||||++++|..+..++..+++.
T Consensus 214 ~~-~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~ 286 (364)
T d1omwa3 214 KH-EIDRM-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 286 (364)
T ss_dssp HH-HHHHH-SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HH-HHHHh-cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcC
Confidence 21 11111 112223345679999999999999999999999 7999999999999887666555544443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-47 Score=390.97 Aligned_cols=215 Identities=29% Similarity=0.514 Sum_probs=186.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|+|||||.||+|..++.. ...+++..++.+++||+.||+|||++||+||||||+||
T Consensus 58 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 135 (316)
T d1fota_ 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135 (316)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchhe
Confidence 4678999999999999999999999999999999998775 46789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||+.+|.+||+|||+|+.... ...+.+||+.|||||++. +..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 136 Ll~~~g~vkL~DFG~a~~~~~------~~~~~~Gt~~Y~APE~l~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 208 (316)
T d1fota_ 136 LLDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208 (316)
T ss_dssp EECTTSCEEECCCSSCEECSS------CBCCCCSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred eEcCCCCEEEecCccceEecc------ccccccCcccccCHHHHc-CCCCCchhhccccchhHHHHHhCCCCCCCcCHHH
Confidence 999999999999999976522 123578999999999998 6679999999999999999999999999877766
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADL 229 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~ 229 (583)
....+... .. ..+..++++++++|.+||.+||.+|+ |+++||+||||++++|..+..++...++
T Consensus 209 ~~~~i~~~-~~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~ 277 (316)
T d1fota_ 209 TYEKILNA-EL----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPY 277 (316)
T ss_dssp HHHHHHHC-CC----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSC
T ss_pred HHHHHHcC-CC----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCC
Confidence 65554443 22 23356899999999999999999996 8999999999999988766555554444
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=395.55 Aligned_cols=210 Identities=34% Similarity=0.610 Sum_probs=172.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeN 79 (583)
|+.++|||||+++++|.+++++|||||||+||+|.+++... +.+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 58 l~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N 135 (322)
T d1s9ja_ 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135 (322)
T ss_dssp GGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence 57889999999999999999999999999999999998764 679999999999999999999997 599999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|||+.+|++||+|||+|+..... ...+++||++|+|||++. +..|+.++||||+||++|||++|+.||.+....
T Consensus 136 ILl~~~~~vkl~DFGla~~~~~~-----~~~~~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 136 ILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp EEECTTCCEEECCCCCCHHHHHH-----TC---CCSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred eeECCCCCEEEeeCCCccccCCC-----ccccccCCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999999865322 224579999999999998 568999999999999999999999999775432
Q ss_pred HHHHHHH-----------------------------------------hcCCCCCCccccccchHHHHHHHHhhhcCCCC
Q 007967 160 KVLLMTI-----------------------------------------QNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQT 198 (583)
Q Consensus 160 ~~l~~~i-----------------------------------------~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~ 198 (583)
....... ....+ +......+|.++++||.+||++||.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~ 287 (322)
T d1s9ja_ 210 ELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPA 287 (322)
T ss_dssp HHHHHC------------------------------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChh
Confidence 2111000 00000 0011124688999999999999999
Q ss_pred CCCCHHHHHhccccccCCCCch
Q 007967 199 KRPTAEKLLKHSFFKHAKPPEL 220 (583)
Q Consensus 199 kRpTa~eIL~HpfFk~~~~~~~ 220 (583)
+|||++|+|+||||+..++...
T Consensus 288 ~R~ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 288 ERADLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp TSCCHHHHHTSHHHHHHHHSCC
T ss_pred HCcCHHHHhhCHhhCcCCcccc
Confidence 9999999999999987654443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=394.37 Aligned_cols=212 Identities=30% Similarity=0.543 Sum_probs=182.8
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.++|||||+++++|++++.+|||||||+||+|.+++... ..+++..++.+++||+.||+|||++||+||||||+|||+
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence 579999999999999999999999999999999998764 679999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
+.+|++||+|||+|+..... .......+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+.....
T Consensus 137 ~~~~~~kl~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 212 (320)
T d1xjda_ 137 DKDGHIKIADFGMCKENMLG---DAKTNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212 (320)
T ss_dssp CTTSCEEECCCTTCBCCCCT---TCCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCCCceeccccchhhhcccc---cccccccCCCCCcCCHHHHc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999998754322 22234578999999999998 678999999999999999999999999987765554
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHH-HHHhccccccCCCCchhhhhh
Q 007967 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE-KLLKHSFFKHAKPPELSVKKL 225 (583)
Q Consensus 163 ~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~-eIL~HpfFk~~~~~~~~~~~~ 225 (583)
.. +....+. .+..+++++++||.+||++||.+|||+. ++++||||+++++..+...+.
T Consensus 213 ~~-i~~~~~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~~~ 271 (320)
T d1xjda_ 213 HS-IRMDNPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEI 271 (320)
T ss_dssp HH-HHHCCCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCS
T ss_pred HH-HHcCCCC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHHhcCC
Confidence 44 4433332 2356899999999999999999999995 899999999887665544444
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=384.36 Aligned_cols=211 Identities=25% Similarity=0.397 Sum_probs=179.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++++|||||||+||+|.+++... +.+++..++.+++||+.||+|||++||+||||||+||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Ni 144 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144 (293)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceE
Confidence 35689999999999999999999999999999999998764 6799999999999999999999999999999999999
Q ss_pred EEcCCC----cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 81 LLDTNG----VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 81 Lld~~g----~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|++.++ .+||+|||+|...... ....+.+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+.
T Consensus 145 ll~~~~~~~~~vkl~DfG~a~~~~~~----~~~~~~~~t~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 145 MLLDRNVPKPRIKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp EESCSSSSSCCEEECCCTTCEECTTS----CBCSCCCCCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEecCCCcccceEecchhhhhhcCCC----ccccccCCCCcccCHHHHc-CCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 998776 5999999998765222 1234568999999999998 567999999999999999999999999987
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
+..+.+. .+...........+..+|..+++||.+||++||.+|||++++|+||||+..++..
T Consensus 220 ~~~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 220 TKQETLA-NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp SHHHHHH-HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred CHHHHHH-HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence 7665554 4444444444444567899999999999999999999999999999999776544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-46 Score=386.74 Aligned_cols=205 Identities=40% Similarity=0.696 Sum_probs=179.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|||||||.||+|..++.. .+.+++..++.|++||+.||.|||++||+||||||+||
T Consensus 69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 146 (309)
T d1u5ra_ 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred HHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence 5789999999999999999999999999999988765543 47799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++.+|.+||+|||+|..... ....+||+.|||||++.+ ...|+.++|||||||++|+|++|..||.+...
T Consensus 147 Ll~~~~~~Kl~DFG~a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 147 LLSEPGLVKLGDFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp EEETTTEEEECCCTTCBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EECCCCCEEEeecccccccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999875421 234689999999999863 34689999999999999999999999998888
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.+.+..+.....+.+ ....+++.+++||.+||++||.+|||++++|+||||.....
T Consensus 220 ~~~~~~i~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 220 MSALYHIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HHHHHHHHHSCCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 777777766654433 23568999999999999999999999999999999986543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-46 Score=394.50 Aligned_cols=212 Identities=24% Similarity=0.397 Sum_probs=182.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++.+|||||||+||+|.+++... .+.+++..++.|++||+.||.|||++|||||||||+||
T Consensus 77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NI 155 (350)
T d1koaa2 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 155 (350)
T ss_dssp HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHe
Confidence 45689999999999999999999999999999999987532 35699999999999999999999999999999999999
Q ss_pred EEc--CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLD--TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld--~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++ .+|.+||+|||+|+.+... ....+.+||+.|||||++. +..|+.++|||||||++|+|++|+.||.+.+.
T Consensus 156 ll~~~~~~~vkL~DFG~a~~~~~~----~~~~~~~gT~~Y~aPEv~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 230 (350)
T d1koaa2 156 MFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230 (350)
T ss_dssp EESSTTSCCEEECCCTTCEECCTT----SCEEEECSCTTTCCHHHHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeccCCCCeEEEeecchheecccc----cccceecCcccccCHHHHc-CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 995 4678999999998765221 2234578999999999998 67799999999999999999999999998776
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCCCc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKPPE 219 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~~~ 219 (583)
.+.+. .+..............+++++++||.+||++||.+|||++|+|+||||+...++.
T Consensus 231 ~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 231 DETLR-NVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HHHHH-HHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred HHHHH-HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 55554 4444444444455577899999999999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=380.05 Aligned_cols=204 Identities=26% Similarity=0.493 Sum_probs=164.5
Q ss_pred CCCCCCCcccceEEEEEE--CCEEEEEEecCCCCCHHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC-----Cc
Q 007967 1 MSLIDHPNVIRAYCSFVV--DSNLWVVMPFMAEGSCLHLMKIA--YQDGFEESAIGSILKETLKALDYLHRQG-----HI 71 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGsL~dll~~~--~~~~~sE~~i~~I~~QIl~gL~yLHs~g-----Iv 71 (583)
|+.++|||||+++++|.+ ++.+|||||||+||+|.+++... ....+++..++.++.||+.||.|||++| |+
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii 136 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence 678999999999999965 46699999999999999998754 2456999999999999999999999976 99
Q ss_pred ccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 72 HRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 72 HRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
||||||+|||++.+|.+||+|||+|+.+.... ......+||+.|||||++. +..|+.++|||||||++|+|++|..
T Consensus 137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyel~tg~~ 212 (269)
T d2java1 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKAFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMP 212 (269)
T ss_dssp ---CCGGGEEECTTSCEEECCHHHHHHC--------------CCCSCCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eCcCchhhcCcCCCCcEEEeeccceeecccCC---CccccCCCCcccCCHHHHc-CCCCChHHHHHhhCHHHHHHhhCCC
Confidence 99999999999999999999999987653221 1224578999999999997 5679999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccc
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFF 212 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfF 212 (583)
||.+.+..+....+...... ..+..+++++++||.+||+.||.+|||+.|||+|||+
T Consensus 213 Pf~~~~~~~~~~~i~~~~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 213 PFTAFSQKELAGKIREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCCCSSHHHHHHHHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCCHHHHHHHHHcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99987766555444443322 2345789999999999999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-46 Score=391.10 Aligned_cols=215 Identities=27% Similarity=0.464 Sum_probs=186.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+...+|+|||||.||+|.+++... +.+++..++.|+.||+.||.|||++|||||||||+||
T Consensus 95 l~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NI 172 (350)
T d1rdqe_ 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHHcCCCcEeecccccccccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHc
Confidence 57889999999999999999999999999999999988764 6799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.+|++||+|||+|+.+.. ...+.+||+.|||||++. +..|+.++|||||||++|+|++|+.||.+.....
T Consensus 173 Ll~~~g~ikL~DFG~a~~~~~------~~~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 245 (350)
T d1rdqe_ 173 LIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp EECTTSCEEECCCTTCEECSS------CBCCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccCCCCCEEeeeceeeeeccc------ccccccCccccCCHHHHc-CCCCCccccccchhHHHHHHHhCCCCCCCcCHHH
Confidence 999999999999999976522 123578999999999998 6789999999999999999999999999877655
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCC
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADL 229 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~ 229 (583)
.+..+... .. ..+..+++++++||.+||.+||.+|+ |+++|++||||+.++|..+..+.+.+++
T Consensus 246 ~~~~i~~~-~~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~ 314 (350)
T d1rdqe_ 246 IYEKIVSG-KV----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314 (350)
T ss_dssp HHHHHHHC-CC----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred HHHHHhcC-CC----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCc
Confidence 55444443 22 22457899999999999999999995 9999999999999987665544444333
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-46 Score=392.85 Aligned_cols=209 Identities=21% Similarity=0.366 Sum_probs=180.8
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++.+|||||||+||+|.+++... ...+++.+++.|++||+.||.|||++||+||||||+||
T Consensus 80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NI 158 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 158 (352)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccc
Confidence 57889999999999999999999999999999999876532 34699999999999999999999999999999999999
Q ss_pred EEc--CCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLD--TNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld--~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||+ .+|.+||+|||+|..+... ....+.+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+...
T Consensus 159 Ll~~~~~~~vkL~DFGla~~~~~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 233 (352)
T d1koba_ 159 MCETKKASSVKIIDFGLATKLNPD----EIVKVTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233 (352)
T ss_dssp EESSTTCCCEEECCCTTCEECCTT----SCEEEECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cccccCCCeEEEeecccceecCCC----CceeeccCcccccCHHHHc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 997 6789999999999765321 2234568999999999998 67899999999999999999999999998777
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.+.+..+ ......++...+..+++++++||.+||++||.+|||+.|+|+||||+...
T Consensus 234 ~~~~~~i-~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 234 LETLQNV-KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHH-HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHH-HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 6655444 44444444455678999999999999999999999999999999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=379.63 Aligned_cols=213 Identities=27% Similarity=0.386 Sum_probs=177.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++++|||||||.|+++..++. ....+++..++.+++||+.||+|||++||+||||||+||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NI 131 (299)
T d1ua2a_ 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131 (299)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceE
Confidence 356899999999999999999999999999887766543 246699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||+|+..... .......+||+.|+|||++.....|+.++|||||||++|+|++|.+||.+....+
T Consensus 132 li~~~~~~KL~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 208 (299)
T d1ua2a_ 132 LLDENGVLKLADFGLAKSFGSP---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208 (299)
T ss_dssp EECTTCCEEECCCGGGSTTTSC---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EecCCCccccccCccccccCCC---cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH
Confidence 9999999999999998754322 2223457899999999999867789999999999999999999999999988777
Q ss_pred HHHHHHhc--CCCCCCc---------------------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 161 VLLMTIQN--APPGLDY---------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 161 ~l~~~i~~--~~~~~~~---------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
.+..+... .+....+ .....+++++++||.+||++||.+|||++|+|+||||++...
T Consensus 209 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 66554432 1100000 011356889999999999999999999999999999997654
Q ss_pred C
Q 007967 218 P 218 (583)
Q Consensus 218 ~ 218 (583)
+
T Consensus 289 p 289 (299)
T d1ua2a_ 289 P 289 (299)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-45 Score=373.62 Aligned_cols=205 Identities=29% Similarity=0.509 Sum_probs=178.5
Q ss_pred CCC-CCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEE
Q 007967 3 LID-HPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNIL 81 (583)
Q Consensus 3 ~L~-HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNIL 81 (583)
.++ |||||+++++|.+++++|||||||+||+|.++++.. +.+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 65 ~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 142 (277)
T d1phka_ 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 142 (277)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Confidence 454 999999999999999999999999999999999764 68999999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC-----CCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 82 LDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP-----GSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 82 ld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~-----~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
++.++.+||+|||+++.+... ......+||+.|+|||++.+ ...|+.++||||+||++|+|++|+.||.+.
T Consensus 143 l~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 143 LDDDMNIKLTDFGFSCQLDPG----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp ECTTCCEEECCCTTCEECCTT----CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EcCCCCeEEccchheeEccCC----CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 999999999999998765321 12234789999999999862 346789999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
+.......++. .......+....+|+++++||.+||++||.+|||++|||+||||+.
T Consensus 219 ~~~~~~~~i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 219 KQMLMLRMIMS-GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp SHHHHHHHHHH-TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CHHHHHHHHHh-CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 77665544444 3344455556789999999999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=386.70 Aligned_cols=208 Identities=25% Similarity=0.389 Sum_probs=171.5
Q ss_pred CCCCCcccceEEEEEE----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 3 LIDHPNVIRAYCSFVV----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
.++|||||+++++|++ +.++|||||||+||+|.++|.......|+|.+++.|++||+.||+|||++||+||||||+
T Consensus 61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~ 140 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 140 (335)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 4689999999999986 467999999999999999987543456999999999999999999999999999999999
Q ss_pred cEEEcC---CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 79 NILLDT---NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 79 NILld~---~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
|||++. .+.+||+|||+|+...... .....+||+.|||||++. +..|+.++|||||||++|+|++|++||.+
T Consensus 141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 141 NLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCC-GGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred ccccccccccccccccccceeeeccCCC----ccccccCCcccCCcHHHc-CCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 999975 5679999999997653321 234578999999999997 66799999999999999999999999977
Q ss_pred CChHHHHHHH---HhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 156 YPPMKVLLMT---IQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 156 ~~~~~~l~~~---i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.......... +......++.+.+..+|+++++||.+||++||.+|||+.|+|+||||++.
T Consensus 216 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 216 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 5543332222 22222223333445789999999999999999999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=368.94 Aligned_cols=214 Identities=26% Similarity=0.421 Sum_probs=178.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++++|||||+++++|++++++|+|||||.+ .+.+++......++++..++.++.||+.||.|||++|||||||||+||
T Consensus 55 l~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNI 133 (298)
T d1gz8a_ 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133 (298)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchhe
Confidence 5789999999999999999999999999965 455566555567799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||+|+...... ......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+
T Consensus 134 l~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~ 210 (298)
T d1gz8a_ 134 LINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 210 (298)
T ss_dssp EECTTSCEEECSTTHHHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred eecccCcceeccCCcceeccCCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH
Confidence 99999999999999987553222 233456899999999998866667899999999999999999999999887776
Q ss_pred HHHHHHhcCC--CCCCc----------------------cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCC
Q 007967 161 VLLMTIQNAP--PGLDY----------------------DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 161 ~l~~~i~~~~--~~~~~----------------------~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
.+........ ....+ .....+++++++||.+||++||.+|||+.|||+||||+++.
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 6655443211 10000 01135688999999999999999999999999999999886
Q ss_pred CC
Q 007967 217 PP 218 (583)
Q Consensus 217 ~~ 218 (583)
.+
T Consensus 291 ~p 292 (298)
T d1gz8a_ 291 KP 292 (298)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=380.04 Aligned_cols=207 Identities=25% Similarity=0.374 Sum_probs=178.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|++++++|||||||+||+|.+++... ...++|.+++.|++||+.||+|||++||+||||||+||
T Consensus 55 l~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NI 133 (321)
T d1tkia_ 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccce
Confidence 45789999999999999999999999999999999988643 34699999999999999999999999999999999999
Q ss_pred EEcCC--CcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTN--GVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~--g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++.+ +.+||+|||+++..... ......+||+.|+|||++. +..|+.++|||||||++|+|++|..||.+...
T Consensus 134 ll~~~~~~~ikl~DFG~~~~~~~~----~~~~~~~~t~~y~ape~~~-~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 134 IYQTRRSSTIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTT----CEEEEEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eecCCCceEEEEcccchhhccccC----Ccccccccccccccchhcc-CCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 99854 48999999998754221 1223568999999999998 66799999999999999999999999998776
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.+.+. .+......++...+..+++++++||.+||.+||.+|||+.|+|+||||++
T Consensus 209 ~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 209 QQIIE-NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHHHH-HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHH-HHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 55544 44444444554555678999999999999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=359.29 Aligned_cols=209 Identities=27% Similarity=0.406 Sum_probs=171.8
Q ss_pred CCCCCcccceEEEEEE-----CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 007967 3 LIDHPNVIRAYCSFVV-----DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKA 77 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d-----~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKP 77 (583)
.++|||||+++++|.. ..++|+|||||.+|.+... .......+++..++.+++||+.||+|||++||+||||||
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp 144 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 144 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCc
Confidence 3589999999999964 3579999999988765543 344456799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 78 GNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 78 eNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
+|||++.++.+||+|||++..... .......+||+.|+|||++. +..|+.++||||+||++|||++|++||.+.+
T Consensus 145 ~NILi~~~~~~kl~dfg~~~~~~~----~~~~~~~~gT~~Y~APE~~~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 145 QNILVTSSGQIKLADFGLARIYSF----QMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCG----GGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cEEEEcCCCCeeecchhhhhhhcc----cccCCCcccChhhcCcchhc-CCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999864422 12334678999999999998 5789999999999999999999999999988
Q ss_pred hHHHHHHHHhcC--CCCC--------------------CccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 158 PMKVLLMTIQNA--PPGL--------------------DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 158 ~~~~l~~~i~~~--~~~~--------------------~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
..+.+..++... +... .......+++.+++||.+||++||.+|||+.|+|+||||+++
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 220 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 776665544311 0000 001124578999999999999999999999999999999987
Q ss_pred CC
Q 007967 216 KP 217 (583)
Q Consensus 216 ~~ 217 (583)
+.
T Consensus 300 ~~ 301 (305)
T d1blxa_ 300 ER 301 (305)
T ss_dssp CC
T ss_pred hh
Confidence 53
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=360.49 Aligned_cols=195 Identities=25% Similarity=0.391 Sum_probs=166.3
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCC-CCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEc
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAE-GSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLD 83 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~G-GsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld 83 (583)
.|||||+++++|++.+.+|+||||+.+ +++.+++... ..+++..++.|++||+.||+|||++||+||||||+|||++
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 144 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe
Confidence 399999999999999999999999986 6788887654 7799999999999999999999999999999999999998
Q ss_pred C-CCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHHHH
Q 007967 84 T-NGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMKVL 162 (583)
Q Consensus 84 ~-~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~~l 162 (583)
. ++.+||+|||+|+.... ....+.+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+..
T Consensus 145 ~~~~~vkl~DFG~a~~~~~-----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----- 214 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214 (273)
T ss_dssp TTTTEEEECCCTTCEECCS-----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred cCCCeEEECccccceeccc-----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----
Confidence 5 47999999999875422 123457899999999999855556788999999999999999999997632
Q ss_pred HHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccCCC
Q 007967 163 LMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHAKP 217 (583)
Q Consensus 163 ~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~~~ 217 (583)
... .... ..+..+|+++++||.+||++||.+|||++|+|+||||+++..
T Consensus 215 -~i~-~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 215 -EII-RGQV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp -HHH-HCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred -HHh-hccc----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 112 2221 234578999999999999999999999999999999997754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=361.48 Aligned_cols=205 Identities=21% Similarity=0.402 Sum_probs=170.0
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+ +..|||||||++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 62 l~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Ni 138 (277)
T d1xbba_ 62 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 138 (277)
T ss_dssp HHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhh
Confidence 467899999999999965 467899999999999998875 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+|+................||+.|+|||++. ...|+.++|||||||++|||++ |..||.+....
T Consensus 139 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 139 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred cccccCcccccchhhhhhccccccccccccccCCCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 999999999999999976544333333334467999999999998 5678999999999999999997 99999987765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHH---Hhccccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL---LKHSFFK 213 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eI---L~HpfFk 213 (583)
+....+..... .+.+..+++++++||.+||+.||.+|||+.+| |+|+|+.
T Consensus 218 ~~~~~i~~~~~----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 218 EVTAMLEKGER----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCC----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 54443333322 23346789999999999999999999999998 4566653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=359.05 Aligned_cols=206 Identities=26% Similarity=0.436 Sum_probs=168.6
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++++++. +..+|||||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||
T Consensus 58 l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~Ni 135 (276)
T d1uwha_ 58 LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNI 135 (276)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHE
Confidence 56889999999999864 56789999999999999988643 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccC--CCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQP--GSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~--~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
|++.++.+||+|||+|+...... .........||+.|||||++.. ...|+.++|||||||++|||++|+.||.+...
T Consensus 136 Ll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 136 FLHEDLTVKIGDFGLATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp EEETTSSEEECCCCCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEcCCCCEEEccccceeeccccC-CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 99999999999999987543221 2222345689999999999863 23589999999999999999999999998877
Q ss_pred HHHHHHHHhcCCCC-CCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 159 MKVLLMTIQNAPPG-LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 159 ~~~l~~~i~~~~~~-~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
...+...+...... .....+..+++++++||.+||..||.+|||+.+|+++
T Consensus 215 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 66665555544322 1223346789999999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=369.16 Aligned_cols=200 Identities=23% Similarity=0.413 Sum_probs=171.7
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHH
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ---------------------DGFEESAIGSILKETLKALD 63 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~---------------------~~~sE~~i~~I~~QIl~gL~ 63 (583)
+|||||+++++|.+.+.+|||||||+||+|.++++.... ..+++..++.|+.||+.||+
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 178 (325)
T d1rjba_ 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178 (325)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999875321 34899999999999999999
Q ss_pred HHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHH
Q 007967 64 YLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITA 143 (583)
Q Consensus 64 yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvIL 143 (583)
|||++|||||||||+|||++.++.+||+|||+|+...... ......+..||+.|||||++. ...|+.++|||||||++
T Consensus 179 yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 179 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILL 256 (325)
T ss_dssp HHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHH
T ss_pred HHHhCCeeeccCchhccccccCCeEEEeeccccccccCCC-ceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHH
Confidence 9999999999999999999999999999999997654322 222233567899999999998 56799999999999999
Q ss_pred hhhhh-CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 144 LELAH-GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 144 yeLLt-G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|||++ |..||.+.+....+...+... ...+.+..+++++++||.+||+.||.+|||++||++|
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~---~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNG---FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcC---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99997 899999877766666666553 2234456789999999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-43 Score=358.89 Aligned_cols=203 Identities=26% Similarity=0.427 Sum_probs=162.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|+|||||+||+|.+++... .+.+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 81 l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NI 159 (299)
T d1jpaa_ 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI 159 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceE
Confidence 57889999999999999999999999999999999987643 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCc--cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCC
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQ--RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYP 157 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~--~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~ 157 (583)
||+.++.+||+|||+|+......... .......||+.|||||++. ...|+.++|||||||++|||++ |..||.+..
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHh-cCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 99999999999999997653322111 1122356899999999998 5689999999999999999997 899999887
Q ss_pred hHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 158 PMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 158 ~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
..+.+....... ..+.+..+++.+.+||.+||+.||.+|||+.+|+++
T Consensus 239 ~~~~~~~i~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 239 NQDVINAIEQDY----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCC----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 766554444332 223446789999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.4e-43 Score=353.11 Aligned_cols=209 Identities=25% Similarity=0.385 Sum_probs=170.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|+||||+.++.+..+... .+.+++..++.|++||+.||+|||++|||||||||+||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NI 131 (286)
T d1ob3a_ 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131 (286)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCcee
Confidence 5788999999999999999999999999987766665432 47799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||+|........ ......|++.|+|||++.....++.++||||+||++|||++|+.||.+....+
T Consensus 132 ll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~ 208 (286)
T d1ob3a_ 132 LINREGELKIADFGLARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (286)
T ss_dssp EECTTSCEEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred eEcCCCCEEecccccceecccCcc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence 999999999999999876533221 22345789999999999866778999999999999999999999999877766
Q ss_pred HHHHHHhcC--CCCCC----------------------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcccccc
Q 007967 161 VLLMTIQNA--PPGLD----------------------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKH 214 (583)
Q Consensus 161 ~l~~~i~~~--~~~~~----------------------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~ 214 (583)
.+....... +.... ......+++.+++||.+||++||++|||+.|+|+||||++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 554433210 00000 0112456889999999999999999999999999999974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=360.08 Aligned_cols=206 Identities=21% Similarity=0.410 Sum_probs=172.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++++++.+ +.+|||||||+||+|.+++... ...+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 63 l~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Ni 140 (285)
T d1u59a_ 63 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140 (285)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhe
Confidence 456899999999999975 5689999999999999987532 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+|+.+..............||+.|+|||++. ...|+.++|||||||++|||++ |..||.+....
T Consensus 141 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp EEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred eeccCCceeeccchhhhcccccccccccccccccCccccChHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999986644333333334567899999999997 5679999999999999999997 99999987765
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHH---Hhccccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKL---LKHSFFK 213 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eI---L~HpfFk 213 (583)
+....+..... .+.+..+++++.+||.+||..||.+|||+.+| |+|+|+.
T Consensus 220 ~~~~~i~~~~~----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 220 EVMAFIEQGKR----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHTTCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 55443333322 23346789999999999999999999999887 5677764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-43 Score=356.54 Aligned_cols=202 Identities=22% Similarity=0.387 Sum_probs=171.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|||||||++|+|.+++.......+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NI 146 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeE
Confidence 45689999999999999999999999999999999998876567799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
||+.++.+||+|||+|+..... .........|++.|+|||++. ...|+.++|||||||++|||++|..||.......
T Consensus 147 Ll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~ 223 (287)
T d1opja_ 147 LVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223 (287)
T ss_dssp EECGGGCEEECCCCCTTTCCSS--SSEEETTEEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EECCCCcEEEccccceeecCCC--CceeeccccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence 9999999999999999754322 122223356899999999998 5679999999999999999999766655545555
Q ss_pred HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 161 VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 161 ~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
.+...+... ...+.+..+++.+++||.+||+.||.+|||+.+|++
T Consensus 224 ~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 224 QVYELLEKD---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcC---CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 555555543 223445678999999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-42 Score=350.81 Aligned_cols=209 Identities=22% Similarity=0.461 Sum_probs=167.5
Q ss_pred CCCCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVK 76 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLK 76 (583)
|+.++|||||++++++.+.+ .+|||||||+||+|.+++... +.+++.+++.|++||+.||+|||++||+|||||
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiK 138 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 138 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcccc
Confidence 45789999999999998754 489999999999999987664 679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCC
Q 007967 77 AGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKY 156 (583)
Q Consensus 77 PeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~ 156 (583)
|+|||++.++.++|+|||.+................+||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.
T Consensus 139 P~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp GGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHc-CCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 9999999999999999998865543333333345678999999999998 567999999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccc
Q 007967 157 PPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFK 213 (583)
Q Consensus 157 ~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk 213 (583)
...+.+...+..... .....+..+|+.+++||.+||++||.+||+..+.+.|+|.+
T Consensus 218 ~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 218 SPVSVAYQHVREDPI-PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SHHHHHHHHHHCCCC-CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCC-CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 887777666665432 33344567899999999999999999999544445566654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=360.50 Aligned_cols=214 Identities=24% Similarity=0.349 Sum_probs=171.2
Q ss_pred CCCCCCCcccceEEEEEEC------CEEEEEEecCCCCCHHHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 007967 1 MSLIDHPNVIRAYCSFVVD------SNLWVVMPFMAEGSCLHLMKI-AYQDGFEESAIGSILKETLKALDYLHRQGHIHR 73 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~------~~l~LVmEy~~GGsL~dll~~-~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHR 73 (583)
|+.++|||||+++++|... .++|||||||++|.+..+... .....+++..++.|++||+.||+|||++||+||
T Consensus 67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHr 146 (350)
T d1q5ka_ 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 146 (350)
T ss_dssp HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 4568999999999999643 458999999977644443332 234569999999999999999999999999999
Q ss_pred CCCCCcEEEcCCC-cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCC
Q 007967 74 DVKAGNILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAP 152 (583)
Q Consensus 74 DLKPeNILld~~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~P 152 (583)
||||+|||++.++ .+||+|||++...... ....+.+||+.|+|||++.+...|+.++||||+||++|||++|+.|
T Consensus 147 DiKp~NILl~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~p 222 (350)
T d1q5ka_ 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222 (350)
T ss_dssp CCCGGGEEECTTTCCEEECCCTTCEECCTT----SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred CCCcceEEEecCCCceeEecccchhhccCC----cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCC
Confidence 9999999999775 8999999998755322 1234568999999999988667899999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcC--------------CCCCC----------ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 153 FSKYPPMKVLLMTIQNA--------------PPGLD----------YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 153 F~~~~~~~~l~~~i~~~--------------~~~~~----------~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|......+.+..++... ..... ......+++++.+||.+||.+||.+|||+.|+|+
T Consensus 223 f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99877766554443210 00000 0112457899999999999999999999999999
Q ss_pred ccccccCCCC
Q 007967 209 HSFFKHAKPP 218 (583)
Q Consensus 209 HpfFk~~~~~ 218 (583)
||||++...+
T Consensus 303 Hp~f~~~~~~ 312 (350)
T d1q5ka_ 303 HSFFDELRDP 312 (350)
T ss_dssp SGGGGGGGCT
T ss_pred CHhhccccCC
Confidence 9999876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=348.56 Aligned_cols=201 Identities=25% Similarity=0.456 Sum_probs=159.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|||||||++|+|.+++... ...+++..+..|+.||+.||+|||+++|+||||||+||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Ni 132 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 132 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGE
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhhe
Confidence 35689999999999999999999999999999999987643 45689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+|+....... .......||+.|+|||++. ...|+.++|||||||++|||++ |.+||......
T Consensus 133 ll~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 133 LVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp EECGGGCEEECSCC--------------------CTTSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred eecCCCCeEecccchheeccCCCc--eeecceecCcccCChHHhc-CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 999999999999999876533221 2223467999999999998 5679999999999999999998 56677665554
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+.+ ..+.... ....+..+++++.+||.+||+.||.+|||+++|++|
T Consensus 210 ~~~-~~i~~~~---~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 210 EVV-EDISTGF---RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHH-HHHHHTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH-HHHHhcC---CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 444 3443321 223345678999999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=352.18 Aligned_cols=206 Identities=21% Similarity=0.445 Sum_probs=169.9
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++++++. ++.+|+|||||++|+|.+++.......+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 62 l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NI 140 (272)
T d1qpca_ 62 MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140 (272)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhe
Confidence 45689999999999875 46689999999999999987665555799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC-CCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG-HAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG-~~PF~~~~~~ 159 (583)
||+.++.+||+|||+|+...... ........||+.|+|||++. ...|+.++|||||||++|||++| .+||......
T Consensus 141 ll~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~ 217 (272)
T d1qpca_ 141 LVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (272)
T ss_dssp EECTTSCEEECCCTTCEECSSSC--EECCTTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred eeecccceeeccccceEEccCCc--cccccccCCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999997653321 12233467899999999998 56799999999999999999995 5555554444
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh--cccccc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK--HSFFKH 214 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~--HpfFk~ 214 (583)
+ +...+... .....+..+++++++||.+||+.||.+|||+.+|++ |+||..
T Consensus 218 ~-~~~~i~~~---~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 218 E-VIQNLERG---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp H-HHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-HHHHHHhc---CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 4 44444432 223344678999999999999999999999999998 788853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=354.73 Aligned_cols=207 Identities=29% Similarity=0.444 Sum_probs=171.2
Q ss_pred CCCCCCCcccceEEEEEECC------EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS------NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~------~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++|||||+++++|...+ ++||||||| |++|..+++. ..+++..++.+++||+.||+|||++||+|||
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrD 146 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 146 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccc
Confidence 45789999999999998765 579999999 6778777653 6799999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.++.+||+|||+|+.... .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.
T Consensus 147 iKp~NIL~~~~~~~kl~Dfg~a~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 147 LKPGNLAVNEDCELKILDFGLARQADS------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCS------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcchhhcccccccccccccceeccCC------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 999999999999999999999875421 22457899999999999866678999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCC----------------------CCCC----ccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 155 KYPPMKVLLMTIQNAP----------------------PGLD----YDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~----------------------~~~~----~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+......+........ +... ......+++.+++||.+||.+||.+|||+.|||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 8776554433222100 0000 1112457899999999999999999999999999
Q ss_pred ccccccCCC
Q 007967 209 HSFFKHAKP 217 (583)
Q Consensus 209 HpfFk~~~~ 217 (583)
||||+....
T Consensus 301 Hp~f~~~~~ 309 (346)
T d1cm8a_ 301 HPYFESLHD 309 (346)
T ss_dssp SGGGTTTC-
T ss_pred ChhhCcCCC
Confidence 999998754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=358.46 Aligned_cols=222 Identities=29% Similarity=0.496 Sum_probs=183.4
Q ss_pred CCCCC-CcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLIDH-PNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~H-PNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.++| |||++++++|.+...+|+|||||.||+|.+++... +.+++..++.+++||+.||+|||++||+||||||+||
T Consensus 83 ~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Ni 160 (322)
T d1vzoa_ 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160 (322)
T ss_dssp HHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccce
Confidence 44555 89999999999999999999999999999998765 6789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCC-CCCccccccchhhHHhhhhhCCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGS-GYNSKADIWSFGITALELAHGHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~-~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~ 159 (583)
|++.+|.+||+|||+|+.+.... .....+..|++.|+|||.+.... .++.++|||||||++|+|++|..||.+....
T Consensus 161 ll~~~~~vkL~DFG~a~~~~~~~--~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 161 LLDSNGHVVLTDFGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp EECTTSCEEESCSSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred eecCCCCEEEeeccchhhhcccc--cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999987553221 22234578999999999997433 5788999999999999999999999775432
Q ss_pred H---HHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCC-----CHHHHHhccccccCCCCchhhhhhhcCCCc
Q 007967 160 K---VLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRP-----TAEKLLKHSFFKHAKPPELSVKKLFADLPP 231 (583)
Q Consensus 160 ~---~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRp-----Ta~eIL~HpfFk~~~~~~~~~~~~~~~~~p 231 (583)
. .+........+ ..+..+++++++||.+||++||.+|| |++|+|+||||+.+++..+..+++..++.|
T Consensus 239 ~~~~~i~~~~~~~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p 314 (322)
T d1vzoa_ 239 NSQAEISRRILKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 314 (322)
T ss_dssp CCHHHHHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHHHhcccCCC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCC
Confidence 2 22222222222 23457899999999999999999999 589999999999998888777777777655
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-42 Score=342.35 Aligned_cols=201 Identities=26% Similarity=0.478 Sum_probs=172.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+++.+|+|||||++|+|..++... ...+++..++.++.||++||+|||++||+||||||+||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Ni 131 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 131 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGE
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeE
Confidence 45789999999999999999999999999999999887654 45689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+|+...... ........||+.|+|||++. ...|+.++|||||||++|||++ |+.||.+....
T Consensus 132 ll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~t~~y~aPE~~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 132 LVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp EECTTCCEEECCCSSCCBCSSSS--CCCCCCSCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred EEcCCCcEEECcchhheeccCCC--ceeecccCCCCCcCCcHHhc-CCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 99999999999999997653322 12233467999999999998 5679999999999999999998 89999998876
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+....+.... ....+..+++++++||.+||+.||.+|||+++|++|
T Consensus 209 ~~~~~i~~~~----~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 209 ETAEHIAQGL----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCC----CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 5544343322 223446788999999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=345.79 Aligned_cols=200 Identities=24% Similarity=0.431 Sum_probs=160.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|. ++.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 62 l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI 139 (273)
T d1mp8a_ 62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139 (273)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhe
Confidence 46789999999999995 57799999999999999987643 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+|+...... ........||+.|+|||++. ...|+.++|||||||++|||++ |.+||.+....
T Consensus 140 ll~~~~~~Kl~DfG~a~~~~~~~--~~~~~~~~gt~~y~apE~l~-~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 140 LVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp EEEETTEEEECC---------------------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred eecCCCcEEEccchhheeccCCc--ceeccceecCcccchhhHhc-cCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999987543221 11223467899999999998 5689999999999999999987 89999988776
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+.......... .+.+..+++.+++||.+||+.||.+|||+.+|++|
T Consensus 217 ~~~~~i~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 217 DVIGRIENGER----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp GHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 66554444322 23456789999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=344.48 Aligned_cols=202 Identities=21% Similarity=0.405 Sum_probs=160.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+...+++|||||.+|++.+++... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 63 l~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NI 141 (283)
T d1mqba_ 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceE
Confidence 45789999999999999999999999999999999887653 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCC-CCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGH-APFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~-~PF~~~~~~ 159 (583)
||+.++.+||+|||+|+................||+.|+|||++. ...|+.++|||||||++|||++|. +||.+...
T Consensus 142 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~- 219 (283)
T d1mqba_ 142 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSN- 219 (283)
T ss_dssp EECTTCCEEECCCCC-----------------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred EECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHc-cCCCCCcccccccHHHHHHHHhCCCCccccCCH-
Confidence 999999999999999976544333223334467899999999998 568999999999999999999854 45555444
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
..+...+... ...+.+..++..+++||.+||..||.+|||+.+|++
T Consensus 220 ~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 220 HEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcc---CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 4444444432 222344668899999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=352.08 Aligned_cols=214 Identities=22% Similarity=0.353 Sum_probs=172.6
Q ss_pred CCCCCCCcccceEEEEEECC-----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVDS-----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~-----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++|||||++++++.... ++||+ +|+.||+|.+++.. +++++..++.+++||+.||+|||++|||||||
T Consensus 60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDI 135 (345)
T d1pmea_ 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDL 135 (345)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 45789999999999997653 34555 55669999999864 57999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.+|.+||+|||+|................+||+.|+|||++.....|+.++||||+||++|+|++|+.||.+
T Consensus 136 Kp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 136 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 99999999999999999999876544433333345678999999999997677889999999999999999999999988
Q ss_pred CChHHHHHHHHhcC-----------------------CCCCCc---cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQNA-----------------------PPGLDY---DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~~-----------------------~~~~~~---~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
....+......... ...... .....++.++++||.+||++||.+|||+.++|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 76554443322210 000000 1124567899999999999999999999999999
Q ss_pred cccccCCCC
Q 007967 210 SFFKHAKPP 218 (583)
Q Consensus 210 pfFk~~~~~ 218 (583)
|||+....+
T Consensus 296 pf~~~~~~~ 304 (345)
T d1pmea_ 296 PYLEQYYDP 304 (345)
T ss_dssp GGGTTTCCG
T ss_pred HhhccCCCC
Confidence 999976543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=346.03 Aligned_cols=209 Identities=25% Similarity=0.458 Sum_probs=168.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|++++|||||+++++|. ++.+|+|||||++|+|.+++.......+++.++..|+.||+.||+|||++||+||||||+||
T Consensus 66 l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI 144 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144 (285)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEE
Confidence 45789999999999985 45689999999999999988776667799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCC-CCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGH-APFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~-~PF~~~~~~ 159 (583)
||+.++.+||+|||+|+...... ........||+.|+|||++. ...++.++|||||||++|||++|. +||.+....
T Consensus 145 ll~~~~~~kl~DfGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~ 221 (285)
T d1fmka3 145 LVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221 (285)
T ss_dssp EECGGGCEEECCCCTTC----------------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EECCCCcEEEcccchhhhccCCC--ceeeccccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999997553222 12223467899999999998 567899999999999999999954 555554544
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh--ccccccCCC
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK--HSFFKHAKP 217 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~--HpfFk~~~~ 217 (583)
+.+ ..+... ...+.+..+++++++||.+||+.||++|||+++|+. ++||....+
T Consensus 222 ~~~-~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 222 EVL-DQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp HHH-HHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHH-HHHHhc---CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 444 434332 223345678999999999999999999999999988 899987653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=349.52 Aligned_cols=207 Identities=22% Similarity=0.309 Sum_probs=166.3
Q ss_pred CCC-CCCcccceEEEEEEC--CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 007967 2 SLI-DHPNVIRAYCSFVVD--SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAG 78 (583)
Q Consensus 2 k~L-~HPNIVkl~~~f~d~--~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPe 78 (583)
+.+ +||||++++++|... ..+|+|||||.+|+|..+. +.+++..++.+++||+.||+|||++||+||||||+
T Consensus 84 ~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~ 158 (328)
T d3bqca1 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 158 (328)
T ss_dssp HHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred HhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhccccccccccc
Confidence 345 599999999999854 5699999999999987652 56999999999999999999999999999999999
Q ss_pred cEEEcCCC-cEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCC
Q 007967 79 NILLDTNG-VVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYP 157 (583)
Q Consensus 79 NILld~~g-~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~ 157 (583)
|||++.++ .+||+|||+|+..... ......+||+.|+|||++.+...|+.++||||+||++|+|++|+.||....
T Consensus 159 NILi~~~~~~vkl~DFG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 159 NVMIDHEHRKLRLIDWGLAEFYHPG----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp GEEEETTTTEEEECCGGGCEECCTT----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ceEEcCCCCeeeecccccceeccCC----CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 99998765 6999999998754322 123456899999999999866778999999999999999999999997654
Q ss_pred hHHH-HHHHH------------hcCCCC--------------------CCccccccchHHHHHHHHhhhcCCCCCCCCHH
Q 007967 158 PMKV-LLMTI------------QNAPPG--------------------LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE 204 (583)
Q Consensus 158 ~~~~-l~~~i------------~~~~~~--------------------~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~ 204 (583)
.... ..... ...... ........+++++++||++||++||.+|||++
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 3221 11110 000000 01112245789999999999999999999999
Q ss_pred HHHhccccccCCC
Q 007967 205 KLLKHSFFKHAKP 217 (583)
Q Consensus 205 eIL~HpfFk~~~~ 217 (583)
|||+||||+.+.+
T Consensus 315 e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 315 EAMEHPYFYTVVK 327 (328)
T ss_dssp HHHTSGGGTTSCC
T ss_pred HHhcCcccCCCCC
Confidence 9999999998865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=345.21 Aligned_cols=214 Identities=23% Similarity=0.335 Sum_probs=167.5
Q ss_pred CCCCCCCcccceEEEEEE--------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVV--------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d--------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|+.++||||++++++|.. ++++|+|||||.++.+..+. .....+++..++.+++||+.||.|||++||+|
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivH 140 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 140 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEe
Confidence 457899999999999865 45699999999877665432 22467999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCC-CccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGD-RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHA 151 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~-~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~ 151 (583)
|||||+|||++.++.+||+|||+++.+..... ........+||++|+|||++.....|+.++||||+||++|+|++|+.
T Consensus 141 rDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 141 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCC
Confidence 99999999999999999999999865432221 11223446899999999999866689999999999999999999999
Q ss_pred CCCCCChHHHHHHHHh--cCCCCCCccc-------------------------cccchHHHHHHHHhhhcCCCCCCCCHH
Q 007967 152 PFSKYPPMKVLLMTIQ--NAPPGLDYDR-------------------------DKKFSKSFKEMVAMCLVKDQTKRPTAE 204 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~--~~~~~~~~~~-------------------------~~~~S~~lkdLI~~cL~~DP~kRpTa~ 204 (583)
||.+......+..... .......... ....++.+++||.+||++||++|||++
T Consensus 221 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~ 300 (318)
T d3blha1 221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300 (318)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 9998776555433322 1111000000 011367789999999999999999999
Q ss_pred HHHhccccccCC
Q 007967 205 KLLKHSFFKHAK 216 (583)
Q Consensus 205 eIL~HpfFk~~~ 216 (583)
|+|+||||+...
T Consensus 301 elL~Hpff~~~p 312 (318)
T d3blha1 301 DALNHDFFWSDP 312 (318)
T ss_dssp HHHHSGGGSSSS
T ss_pred HHHcChhhccCC
Confidence 999999998653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-41 Score=336.48 Aligned_cols=212 Identities=25% Similarity=0.351 Sum_probs=172.4
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+...+++||+|+.|++|..++.. .+.+++..++.+++|++.||+|||++||+||||||+||
T Consensus 55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NI 132 (292)
T d1unla_ 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132 (292)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhcCcCCEEeeccccccccceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccc
Confidence 4688999999999999999999999999999988877654 47799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCChHH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPPMK 160 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~~~ 160 (583)
|++.++.+||+|||.|....... .......++++|+|||++.....++.++||||+||++|+|++|+.||.......
T Consensus 133 li~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 209 (292)
T d1unla_ 133 LINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp EECTTCCEEECCCTTCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred ccccCCceeeeecchhhcccCCC---ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH
Confidence 99999999999999987553222 222345778999999999866668999999999999999999999865444333
Q ss_pred HHHHHHh---cCCCC----------------------CCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhccccccC
Q 007967 161 VLLMTIQ---NAPPG----------------------LDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHSFFKHA 215 (583)
Q Consensus 161 ~l~~~i~---~~~~~----------------------~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~HpfFk~~ 215 (583)
.....+. ..... ........+++.+++||.+||++||.+|||++|+|+||||++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 3222221 11000 0011224578899999999999999999999999999999875
Q ss_pred CC
Q 007967 216 KP 217 (583)
Q Consensus 216 ~~ 217 (583)
.+
T Consensus 290 ~~ 291 (292)
T d1unla_ 290 CP 291 (292)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-41 Score=343.12 Aligned_cols=202 Identities=22% Similarity=0.352 Sum_probs=163.2
Q ss_pred CCCCCcccceEEEEEEC-CEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 007967 3 LIDHPNVIRAYCSFVVD-SNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLHR 67 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~-~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLHs 67 (583)
..+|||||.+++++... ..+|+|||||+||+|.+++.... ...+++..+..++.||+.||.|||+
T Consensus 73 ~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 152 (299)
T d1ywna1 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 152 (299)
T ss_dssp HCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred hcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh
Confidence 34799999999998764 56999999999999999987542 2348999999999999999999999
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhh
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELA 147 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLL 147 (583)
+|||||||||+||||+.++.+||+|||+|+...... ........+||+.|+|||++. +..|+.++|||||||++|||+
T Consensus 153 ~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 153 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp TTCCCSCCCGGGEEECGGGCEEECC------CCSCT-TSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCcCCcCCccceeECCCCcEEEccCcchhhccccc-cccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHH
Confidence 999999999999999999999999999997553332 222334568999999999998 567999999999999999999
Q ss_pred hC-CCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 148 HG-HAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 148 tG-~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
+| .+||.+......+...+.... ....+..+++++++||.+||+.||.+|||+.+|++|
T Consensus 231 t~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 231 SLGASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCC---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 85 678887766555555555432 223346689999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-41 Score=338.85 Aligned_cols=202 Identities=25% Similarity=0.413 Sum_probs=169.2
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||++|++|.+ ..+++|||||++|++.+++... .+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus 65 l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NI 142 (273)
T d1u46a_ 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142 (273)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHh
Confidence 456899999999999965 5789999999999999887654 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+++................|+..|+|||++. +..|+.++|||||||++|||++ |..||.+.+..
T Consensus 143 ll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp EEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 999999999999999987654443333334467888999999998 5679999999999999999997 89999998877
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
+....+.... ...+.+..+++.+++||.+||..||.+|||+.+|++
T Consensus 222 ~~~~~i~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 222 QILHKIDKEG---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTSC---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCC---CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7665544432 223445678999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=341.77 Aligned_cols=202 Identities=22% Similarity=0.392 Sum_probs=165.5
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
|+.++|||||+++++|.+ ...++|||||.+|+|.+++... ...+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 65 l~~l~HpnIv~l~g~~~~-~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI 142 (317)
T d1xkka_ 65 MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142 (317)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEec-CCeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcc
Confidence 456899999999999986 4578889999999999987654 56799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCChH
Q 007967 81 LLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPPM 159 (583)
Q Consensus 81 Lld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~~ 159 (583)
|++.++.+||+|||+|+..... ..........||+.|+|||++. +..|+.++|||||||++|||++ |.+||.+.+..
T Consensus 143 ll~~~~~~kl~DFGla~~~~~~-~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 143 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp EEEETTEEEECCCSHHHHTTTT-CC--------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred eeCCCCCeEeeccccceecccc-cccccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 9999999999999998765332 2222233457899999999998 5679999999999999999998 89999887665
Q ss_pred HHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhcc
Q 007967 160 KVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKHS 210 (583)
Q Consensus 160 ~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~Hp 210 (583)
+... .+.... ..+.+..+++.+++||.+||..||.+|||+.+|++|.
T Consensus 221 ~~~~-~i~~~~---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 221 EISS-ILEKGE---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp GHHH-HHHHTC---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHH-HHHcCC---CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 5443 333321 2233467899999999999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=332.93 Aligned_cols=198 Identities=25% Similarity=0.471 Sum_probs=161.7
Q ss_pred CCCCCCCcccceEEEEEE-CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|++++|||||+++++|.+ .+.+|+|||||++|+|.+++.......+++..++.|+.||+.||.|||+++|+||||||+|
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~N 133 (262)
T d1byga_ 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133 (262)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHh
Confidence 468899999999999864 4668999999999999999976655569999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-CCCCCCCCCh
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH-GHAPFSKYPP 158 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt-G~~PF~~~~~ 158 (583)
||++.+|.+||+|||+++.... ......+|+.|+|||++. +..|+.++|||||||++|||++ |++||...+.
T Consensus 134 il~~~~~~~kl~dfg~s~~~~~------~~~~~~~~~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~ 206 (262)
T d1byga_ 134 VLVSEDNVAKVSDFGLTKEASS------TQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 206 (262)
T ss_dssp EEECTTSCEEECCCCC------------------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred heecCCCCEeecccccceecCC------CCccccccccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH
Confidence 9999999999999999875421 223457899999999998 5679999999999999999998 7888888666
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.+.... +.+. ...+.+..+++++++||.+||..||.+|||+.+++++
T Consensus 207 ~~~~~~-i~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 207 KDVVPR-VEKG---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp GGHHHH-HTTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHH-HHcC---CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 554443 3332 2233456788999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=337.09 Aligned_cols=200 Identities=22% Similarity=0.392 Sum_probs=166.5
Q ss_pred CCCC-CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHH
Q 007967 1 MSLI-DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIA--------------YQDGFEESAIGSILKETLKALDYL 65 (583)
Q Consensus 1 Mk~L-~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~--------------~~~~~sE~~i~~I~~QIl~gL~yL 65 (583)
|+.+ +|||||+++++|.+++.+|+|||||+||+|.+++... ....+++..+..++.||+.||.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 3556 7999999999999999999999999999999998643 135699999999999999999999
Q ss_pred HHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhh
Q 007967 66 HRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALE 145 (583)
Q Consensus 66 Hs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILye 145 (583)
|++||+||||||+|||++.++.+||+|||+|+..... .......||..|+|||.+. ...|+.++|||||||++||
T Consensus 144 H~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~e 218 (309)
T d1fvra_ 144 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWE 218 (309)
T ss_dssp HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHH
T ss_pred hcCCccccccccceEEEcCCCceEEcccccccccccc----ccccceecCCcccchHHhc-cCCCCccceeehhHHHHHH
Confidence 9999999999999999999999999999998644221 1223457899999999998 5679999999999999999
Q ss_pred hhhCC-CCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 146 LAHGH-APFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 146 LLtG~-~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
|++|. +||.+.+..+.... +... ...+.+..+++++++||.+||+.||++|||+.+|++|
T Consensus 219 ll~~~~~p~~~~~~~~~~~~-i~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 219 IVSLGGTPYCGMTCAELYEK-LPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHTTSCCTTTTCCHHHHHHH-GGGT---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCCCHHHHHHH-HHhc---CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99964 67877665554433 3332 2234456789999999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=342.34 Aligned_cols=208 Identities=23% Similarity=0.349 Sum_probs=166.5
Q ss_pred CCCCCCCcccceEEEEEEC-----CEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 007967 1 MSLIDHPNVIRAYCSFVVD-----SNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDV 75 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~-----~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDL 75 (583)
|+.++|||||+++++|... ...++||+||.||+|.+++. .+++++..++.+++||+.||+|||++||+||||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDi 147 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDL 147 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCccccc
Confidence 3568999999999999743 34566677888999999874 367999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 76 KAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 76 KPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
||+|||++.+|.+|++|||+|.... ....+..||+.|+|||++.....++.++|||||||++|+|++|.+||.+
T Consensus 148 Kp~NILi~~~~~~kl~dfg~a~~~~------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 148 KPSNLAVNEDCELKILDFGLARHTD------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp CGGGEEECTTCCEEECCC----CCT------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCccccccccccccccccchhcccC------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 9999999999999999999986432 1224568999999999988666789999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCC----------------------CCc----cccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 156 YPPMKVLLMTIQNAPPG----------------------LDY----DRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 156 ~~~~~~l~~~i~~~~~~----------------------~~~----~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
.+.......+....... ... .....+++++++||.+||.+||.+|||+.|+|+|
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 77655443333221100 000 0123578899999999999999999999999999
Q ss_pred cccccCCC
Q 007967 210 SFFKHAKP 217 (583)
Q Consensus 210 pfFk~~~~ 217 (583)
|||++...
T Consensus 302 p~f~~~~~ 309 (348)
T d2gfsa1 302 AYFAQYHD 309 (348)
T ss_dssp GGGTTTCC
T ss_pred HhhCCCCC
Confidence 99997653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=331.97 Aligned_cols=199 Identities=23% Similarity=0.442 Sum_probs=169.7
Q ss_pred CCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 007967 4 IDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY--------------QDGFEESAIGSILKETLKALDYLHRQG 69 (583)
Q Consensus 4 L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~--------------~~~~sE~~i~~I~~QIl~gL~yLHs~g 69 (583)
.+|||||+++++|.+++.+|+|||||++|+|.++|.... ...+++..+..++.||+.||+|||++|
T Consensus 76 ~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ 155 (299)
T d1fgka_ 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 389999999999999999999999999999999987542 235899999999999999999999999
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh-
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH- 148 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt- 148 (583)
||||||||+|||++.++.+||+|||+++........ .......||+.|+|||.+. ...|+.++|||||||++|||++
T Consensus 156 ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EEeeeecccceeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccC
Confidence 999999999999999999999999998766443322 2234468899999999998 5689999999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 149 GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 149 G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|.+||.+.+.... ...+... ...+.+..+++++++||.+||++||.+|||+.||++
T Consensus 234 g~~p~~~~~~~~~-~~~i~~~---~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 234 GGSPYPGVPVEEL-FKLLKEG---HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp SCCSSTTCCHHHH-HHHHHTT---CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHH-HHHHHcC---CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7999988766544 3444432 222345678999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=340.76 Aligned_cols=206 Identities=25% Similarity=0.416 Sum_probs=158.8
Q ss_pred CCCCCCCcccceEEEEEE------CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 007967 1 MSLIDHPNVIRAYCSFVV------DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRD 74 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d------~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRD 74 (583)
|+.++|||||+++++|.. ..++|+|||||.|+. +..+ ...+++..++.+++||+.||.|||++||+|||
T Consensus 70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l-~~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrD 144 (355)
T d2b1pa1 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL-CQVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144 (355)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEH-HHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHH-HHhh----hcCCCHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 356899999999999964 468999999997664 4433 36799999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCC
Q 007967 75 VKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFS 154 (583)
Q Consensus 75 LKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~ 154 (583)
|||+|||++.++.+|++|||+++..... ......+||+.|+|||++. +..|+.++||||+||++|+|++|++||.
T Consensus 145 lKP~Nil~~~~~~~kl~df~~~~~~~~~----~~~~~~~~t~~y~aPE~l~-~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 145 LKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp CCGGGEEECTTCCEEECCCCC-------------------CCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCccccccccccceeeechhhhhccccc----cccccccccccccChhhhc-CCCCCCCcccccccchHHHHhhCCCCCC
Confidence 9999999999999999999987644221 2234568999999999998 5789999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCC---------------------CC----------------CCccccccchHHHHHHHHhhhcCCC
Q 007967 155 KYPPMKVLLMTIQNAP---------------------PG----------------LDYDRDKKFSKSFKEMVAMCLVKDQ 197 (583)
Q Consensus 155 ~~~~~~~l~~~i~~~~---------------------~~----------------~~~~~~~~~S~~lkdLI~~cL~~DP 197 (583)
+.+........+.... .. ........+++++++||.+||.+||
T Consensus 220 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 299 (355)
T d2b1pa1 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred CCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCCh
Confidence 8765444333221100 00 0001122357889999999999999
Q ss_pred CCCCCHHHHHhccccccCC
Q 007967 198 TKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 198 ~kRpTa~eIL~HpfFk~~~ 216 (583)
.+|||++|||+||||+...
T Consensus 300 ~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 300 AKRISVDDALQHPYINVWY 318 (355)
T ss_dssp TTSCCHHHHHTSTTTGGGC
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999998643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-39 Score=332.00 Aligned_cols=202 Identities=20% Similarity=0.379 Sum_probs=168.7
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh----------------------cCCCCHHHHHHHHHHH
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY----------------------QDGFEESAIGSILKET 58 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~----------------------~~~~sE~~i~~I~~QI 58 (583)
|+.++||||++++++|.+.+.+++|||||.+|+|.+++.... ...+++..+..|+.||
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 467899999999999999999999999999999999986431 1248899999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccc
Q 007967 59 LKALDYLHRQGHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWS 138 (583)
Q Consensus 59 l~gL~yLHs~gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWS 138 (583)
+.||+|||++|||||||||+|||++.++.+||+|||+|+...... ......+..||+.|+|||++. ...|+.++||||
T Consensus 150 ~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS 227 (301)
T d1lufa_ 150 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWA 227 (301)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHH-HCCCCHHHHHHH
T ss_pred HHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHc-cCCCChhhhhcc
Confidence 999999999999999999999999999999999999987553322 222334568899999999998 678999999999
Q ss_pred hhhHHhhhhhCC-CCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 139 FGITALELAHGH-APFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 139 LGvILyeLLtG~-~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|||++|||++|. +||.+.+..+.......... .+.+..+++++.+||.+||+.||.+|||+.+|++
T Consensus 228 ~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~----~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI----LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC----CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999874 68888777665544433322 2334678999999999999999999999999965
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=332.46 Aligned_cols=199 Identities=22% Similarity=0.395 Sum_probs=169.3
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAY----------------QDGFEESAIGSILKETLKALDYLHRQ 68 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~----------------~~~~sE~~i~~I~~QIl~gL~yLHs~ 68 (583)
+|||||+++++|.+.+.+|+|||||++|+|.++++... ...+++..+..|+.||+.||+|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 79999999999999999999999999999999987642 23589999999999999999999999
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhh
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAH 148 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLt 148 (583)
|+|||||||+|||++.++.+||+|||+++...... ........+||+.|+|||++. ...++.++|||||||++|||++
T Consensus 165 ~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHT
T ss_pred CeeecccccccccccccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHh
Confidence 99999999999999999999999999987653322 222334568999999999998 5679999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 149 -GHAPFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 149 -G~~PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
|.+||.+.+..+.+...+.... ....+..+++.+++||.+||+.||.+|||+++|++
T Consensus 243 ~g~p~~~~~~~~~~~~~~i~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 243 LGSSPYPGMPVDSKFYKMIKEGF---RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTCCSSTTCCSSHHHHHHHHHTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCC---CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7777777666666655555432 22334568899999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-39 Score=328.17 Aligned_cols=202 Identities=22% Similarity=0.385 Sum_probs=171.1
Q ss_pred CCCCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 007967 1 MSLIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQ--------DGFEESAIGSILKETLKALDYLHRQGHIH 72 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~--------~~~sE~~i~~I~~QIl~gL~yLHs~gIvH 72 (583)
|++++|||||+++++|..+..+++|||||.+|+|.+++..... ..+++..+..++.||+.||.|||+++|+|
T Consensus 77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 5688999999999999999999999999999999998875421 24789999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhC-CC
Q 007967 73 RDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHG-HA 151 (583)
Q Consensus 73 RDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG-~~ 151 (583)
|||||+|||++.++++||+|||+|+....... .......+||+.|+|||.+. +..|+.++|||||||++|||++| .+
T Consensus 157 rDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~ 234 (308)
T d1p4oa_ 157 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQ 234 (308)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred ceEcCCceeecCCceEEEeecccceeccCCcc-eeeccceecccccCCHHHHc-cCCCCcccccccHHHHHHHHHhCCCC
Confidence 99999999999999999999999976543322 22233457899999999998 56789999999999999999997 58
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 152 PFSKYPPMKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 152 PF~~~~~~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
||.+.+..+.+........ .+.+..+++.+++||.+||+.||.+|||+.+|++
T Consensus 235 p~~~~~~~~~~~~i~~~~~----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 235 PYQGLSNEQVLRFVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TTTTSCHHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHhCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888776665544444322 2334678899999999999999999999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-39 Score=328.84 Aligned_cols=204 Identities=24% Similarity=0.358 Sum_probs=164.3
Q ss_pred CCCCCCCcccceEEEEEE-CCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 007967 1 MSLIDHPNVIRAYCSFVV-DSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGN 79 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d-~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeN 79 (583)
|++++|||||++++++.+ ++.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 82 l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~N 160 (311)
T d1r0pa_ 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 160 (311)
T ss_dssp HHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHh
Confidence 467899999999999876 56899999999999999987643 4568889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCc-cccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCCCCh
Q 007967 80 ILLDTNGVVKLADFGVSACMFDTGDRQ-RSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSKYPP 158 (583)
Q Consensus 80 ILld~~g~IKL~DFGlA~~~~~~~~~~-~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~~~~ 158 (583)
||++.++.+||+|||+++......... .......||+.|+|||.+. ...++.++|||||||++|||++|..||.....
T Consensus 161 ILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~ 239 (311)
T d1r0pa_ 161 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239 (311)
T ss_dssp EEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred EeECCCCCEEEecccchhhccccccccceecccccccccccChHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence 999999999999999997654332221 1223357899999999988 56799999999999999999997777765443
Q ss_pred HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHhc
Q 007967 159 MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLKH 209 (583)
Q Consensus 159 ~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~H 209 (583)
...+...+.... ....+..+++.+.+||.+||..||.+|||+.||++|
T Consensus 240 ~~~~~~~i~~g~---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 240 TFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---CHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCC---CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 333333333322 122345688999999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-38 Score=320.58 Aligned_cols=206 Identities=23% Similarity=0.323 Sum_probs=159.4
Q ss_pred CCCCCCCcccceEEEEEECC----EEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------C
Q 007967 1 MSLIDHPNVIRAYCSFVVDS----NLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR--------Q 68 (583)
Q Consensus 1 Mk~L~HPNIVkl~~~f~d~~----~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs--------~ 68 (583)
|++++|||||++++++.+.+ .+|+|||||++|+|.++++. ..+++..+..++.|++.||.|||+ +
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~ 127 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence 46789999999999998754 68999999999999999875 579999999999999999999996 5
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCccccccCCCCcc-ccccccCCCCCCCcccccCCC-----CCCccccccchhhH
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSACMFDTGDRQR-SRNTFVGTPCWMAPEVLQPGS-----GYNSKADIWSFGIT 142 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~~~~~~~~~~~-~~~~~~GT~~Y~APEil~~~~-----~ys~ksDIWSLGvI 142 (583)
||+||||||+||||+.++.+||+|||+++.......... .....+||+.|+|||++.... .++.++|||||||+
T Consensus 128 ~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvv 207 (303)
T d1vjya_ 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred CeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHH
Confidence 999999999999999999999999999986644332221 223578999999999987322 25678999999999
Q ss_pred HhhhhhCCCCCCCCC--------------hHHHHHHHHhcCC--CCCCcc-ccccchHHHHHHHHhhhcCCCCCCCCHHH
Q 007967 143 ALELAHGHAPFSKYP--------------PMKVLLMTIQNAP--PGLDYD-RDKKFSKSFKEMVAMCLVKDQTKRPTAEK 205 (583)
Q Consensus 143 LyeLLtG~~PF~~~~--------------~~~~l~~~i~~~~--~~~~~~-~~~~~S~~lkdLI~~cL~~DP~kRpTa~e 205 (583)
+|||++|..||.... ....+........ +.+... ........+.+|+.+||+.||.+|||+.|
T Consensus 208 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred HHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 999999988874311 1222222222211 111111 11234567999999999999999999999
Q ss_pred HHhc
Q 007967 206 LLKH 209 (583)
Q Consensus 206 IL~H 209 (583)
|+++
T Consensus 288 i~~~ 291 (303)
T d1vjya_ 288 IKKT 291 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-36 Score=306.91 Aligned_cols=210 Identities=17% Similarity=0.257 Sum_probs=157.9
Q ss_pred CCCCCCc-ccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcE
Q 007967 2 SLIDHPN-VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNI 80 (583)
Q Consensus 2 k~L~HPN-IVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNI 80 (583)
+.++|+| |+.++.++.+++..++||||| +|++.+.+.. ..+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus 57 ~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NI 134 (299)
T d1ckia_ 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 134 (299)
T ss_dssp HHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhc
Confidence 4565555 666677778899999999999 5667666544 356799999999999999999999999999999999999
Q ss_pred EEc---CCCcEEEEecCCccccccCCCC----ccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 81 LLD---TNGVVKLADFGVSACMFDTGDR----QRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 81 Lld---~~g~IKL~DFGlA~~~~~~~~~----~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
|++ .+..+||+|||+|+.+...... .......+||+.|||||++. +..|+.++|||||||++|||++|..||
T Consensus 135 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~el~tg~~P~ 213 (299)
T d1ckia_ 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPW 213 (299)
T ss_dssp EECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT-TBCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHh-CCCCCChhhEEecCHHHHHHHhCCCcc
Confidence 985 3557999999999866433221 12234568999999999998 667999999999999999999999999
Q ss_pred CCCChHHHHHHHHh--cCCCCC-CccccccchHHHHHHHHhhhcCCCCCCCCHH---HHHhcccccc
Q 007967 154 SKYPPMKVLLMTIQ--NAPPGL-DYDRDKKFSKSFKEMVAMCLVKDQTKRPTAE---KLLKHSFFKH 214 (583)
Q Consensus 154 ~~~~~~~~l~~~i~--~~~~~~-~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~---eIL~HpfFk~ 214 (583)
.............. ...... .......+++++.+||..||..+|.+||++. ++|+|+|.+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 214 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp CCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 87654332211111 000000 1112346889999999999999999999986 4567776543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-35 Score=301.34 Aligned_cols=201 Identities=15% Similarity=0.200 Sum_probs=159.7
Q ss_pred CCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEEcC
Q 007967 5 DHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILLDT 84 (583)
Q Consensus 5 ~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILld~ 84 (583)
+|+||+.+++++.++...|+||||| ||+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~ 136 (293)
T d1csna_ 59 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 136 (293)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECC
T ss_pred CCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecC
Confidence 4599999999999999999999999 78999987653 457999999999999999999999999999999999999964
Q ss_pred -----CCcEEEEecCCccccccCCC----CccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCCCC
Q 007967 85 -----NGVVKLADFGVSACMFDTGD----RQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPFSK 155 (583)
Q Consensus 85 -----~g~IKL~DFGlA~~~~~~~~----~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF~~ 155 (583)
++.+||+|||+|+....... ........+||+.|||||++. +..|+.++|||||||++|+|++|..||.+
T Consensus 137 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 137 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhc-CCCCChHHHHHHhhHHHHHHHhCCCcCCC
Confidence 57899999999976543221 112234578999999999998 67899999999999999999999999976
Q ss_pred CCh---HHHHHHHHhcCCCCCCccccccchHHHHHHHHhhhcCCCCCCCCHHHHHh
Q 007967 156 YPP---MKVLLMTIQNAPPGLDYDRDKKFSKSFKEMVAMCLVKDQTKRPTAEKLLK 208 (583)
Q Consensus 156 ~~~---~~~l~~~i~~~~~~~~~~~~~~~S~~lkdLI~~cL~~DP~kRpTa~eIL~ 208 (583)
... ......................+++++.+++..|+..+|.+||+++.+.+
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 216 LKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 432 12111111110001111223567899999999999999999999876643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-33 Score=291.91 Aligned_cols=206 Identities=28% Similarity=0.400 Sum_probs=155.4
Q ss_pred CCCCcccceEEEEEE--CCEEEEEEecCCCCC-HHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q 007967 4 IDHPNVIRAYCSFVV--DSNLWVVMPFMAEGS-CLHLMKIAYQDGFEESAIGSILKETLKALDYLHR-QGHIHRDVKAGN 79 (583)
Q Consensus 4 L~HPNIVkl~~~f~d--~~~l~LVmEy~~GGs-L~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs-~gIvHRDLKPeN 79 (583)
+.|||||++++++.. ....++||+++..+. ............+++..++.+++||+.||.|||+ +||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 358999999999864 467777777765554 4444444455679999999999999999999998 899999999999
Q ss_pred EEEcCCCc------EEEEecCCccccccCCCCccccccccCCCCCCCcccccCCCCCCccccccchhhHHhhhhhCCCCC
Q 007967 80 ILLDTNGV------VKLADFGVSACMFDTGDRQRSRNTFVGTPCWMAPEVLQPGSGYNSKADIWSFGITALELAHGHAPF 153 (583)
Q Consensus 80 ILld~~g~------IKL~DFGlA~~~~~~~~~~~~~~~~~GT~~Y~APEil~~~~~ys~ksDIWSLGvILyeLLtG~~PF 153 (583)
||++.++. ++++|||.|..... .....+||+.|+|||++. ...|+.++||||+||++++|++|+.||
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDE------HYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB------CCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred eeeeccCcccccceeeEeeccccccccc------ccccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCC
Confidence 99987653 99999999864422 123468999999999998 567999999999999999999999999
Q ss_pred CCCChH------HHHHHHHh--cC------------------------CCCC-----------CccccccchHHHHHHHH
Q 007967 154 SKYPPM------KVLLMTIQ--NA------------------------PPGL-----------DYDRDKKFSKSFKEMVA 190 (583)
Q Consensus 154 ~~~~~~------~~l~~~i~--~~------------------------~~~~-----------~~~~~~~~S~~lkdLI~ 190 (583)
...... ..+...+. .. .... ........++.+++||.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence 754321 11111110 00 0000 01112346788999999
Q ss_pred hhhcCCCCCCCCHHHHHhccccccCC
Q 007967 191 MCLVKDQTKRPTAEKLLKHSFFKHAK 216 (583)
Q Consensus 191 ~cL~~DP~kRpTa~eIL~HpfFk~~~ 216 (583)
+||.+||.+|||++|+|+||||++..
T Consensus 310 ~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHCCCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999664
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.56 E-value=9.4e-17 Score=151.43 Aligned_cols=118 Identities=17% Similarity=0.151 Sum_probs=82.8
Q ss_pred CCCCCcccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCcEEE
Q 007967 3 LIDHPNVIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHRQGHIHRDVKAGNILL 82 (583)
Q Consensus 3 ~L~HPNIVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs~gIvHRDLKPeNILl 82 (583)
.+.|++++..+++. . .++||||+.++.+. .+++..+..++.||+.+|.|||++||+||||||+|||+
T Consensus 70 ~l~~~~v~~~~~~~--~--~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv 136 (191)
T d1zara2 70 KLQGLAVPKVYAWE--G--NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 136 (191)
T ss_dssp HTTTSSSCCEEEEE--T--TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred HccCCCcceEEEec--C--CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee
Confidence 46889999887653 2 37999999876532 25566778899999999999999999999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCccccccccC-CCCCCCcccccCCCCCCccccccchhhH
Q 007967 83 DTNGVVKLADFGVSACMFDTGDRQRSRNTFVG-TPCWMAPEVLQPGSGYNSKADIWSFGIT 142 (583)
Q Consensus 83 d~~g~IKL~DFGlA~~~~~~~~~~~~~~~~~G-T~~Y~APEil~~~~~ys~ksDIWSLGvI 142 (583)
+.+ .++|+|||+|.....+... .+.. ... .-.+.+ .+.|+.++|+||+.--
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~-----~~l~rd~~-~~~~~f--~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWR-----EILERDVR-NIITYF--SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHH-----HHHHHHHH-HHHHHH--HHHHCCCCCHHHHHHH
T ss_pred eCC-CEEEEECCCcccCCCCCcH-----HHHHHHHH-HHHHHH--cCCCCCcccHHHHHHH
Confidence 865 4899999998644211100 0000 000 001222 2568889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.04 E-value=0.00039 Score=65.68 Aligned_cols=82 Identities=18% Similarity=0.189 Sum_probs=54.8
Q ss_pred ccceEEEEEECCEEEEEEecCCCCCHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------
Q 007967 9 VIRAYCSFVVDSNLWVVMPFMAEGSCLHLMKIAYQDGFEESAIGSILKETLKALDYLHR--------------------- 67 (583)
Q Consensus 9 IVkl~~~f~d~~~l~LVmEy~~GGsL~dll~~~~~~~~sE~~i~~I~~QIl~gL~yLHs--------------------- 67 (583)
+.+++.++.+++..|+||++++|..+..... +......++.++...|..||+
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~-------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTT-------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEeccccccccccc-------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 5677888889999999999999987754321 001112223333333333332
Q ss_pred --------------------------------C------CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 68 --------------------------------Q------GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 68 --------------------------------~------gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
. .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 26899999999999877666799998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.97 E-value=0.0036 Score=58.42 Aligned_cols=28 Identities=21% Similarity=0.272 Sum_probs=24.4
Q ss_pred CcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 70 HIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 70 IvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999887667899998653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.95 E-value=0.021 Score=57.72 Aligned_cols=28 Identities=25% Similarity=0.358 Sum_probs=24.2
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.++|+|+.+.|||++.++ ++|+||..|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 589999999999998765 8999998653
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=93.52 E-value=0.0035 Score=50.36 Aligned_cols=61 Identities=15% Similarity=0.153 Sum_probs=55.3
Q ss_pred HHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeeeecC
Q 007967 247 LALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKSSVG 307 (583)
Q Consensus 247 ~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~as~~ 307 (583)
.+|..++....+.|+..|+.+.+...+.++.+.+....+...|.|..+.+++.||+++.+|
T Consensus 27 ~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am~h 87 (87)
T d1s6ja_ 27 ELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVH 87 (87)
T ss_dssp THHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTTCCCC
T ss_pred HHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHcC
Confidence 4577789999999999999999998888888888889999999999999999999998876
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=92.46 E-value=0.011 Score=43.98 Aligned_cols=58 Identities=9% Similarity=0.035 Sum_probs=53.3
Q ss_pred HHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCcccccccccee
Q 007967 245 AQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESV 302 (583)
Q Consensus 245 a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv 302 (583)
...+|+.++....+.|+..++.+.+...+.++.+.+....+...|.+..+.+++.|||
T Consensus 3 l~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl 60 (61)
T d2fcea1 3 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFI 60 (61)
T ss_dssp HHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHH
T ss_pred HHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhc
Confidence 3457888999999999999999999999999999999999999999999999999996
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.96 E-value=0.048 Score=52.45 Aligned_cols=30 Identities=27% Similarity=0.406 Sum_probs=26.5
Q ss_pred CCCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 68 QGHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 68 ~gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999764
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.47 E-value=0.036 Score=43.24 Aligned_cols=61 Identities=8% Similarity=0.002 Sum_probs=55.1
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKS 304 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~a 304 (583)
....+++.++....|.++..|+.+.+...++.+.+.+....+..-|.+..+.++|.||+.+
T Consensus 21 ~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~ 81 (83)
T d1wlza1 21 AITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSR 81 (83)
T ss_dssp HHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHH
T ss_pred HHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHH
Confidence 4557788999999999999999999999999999999999999999999999999999753
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=87.55 E-value=0.04 Score=41.16 Aligned_cols=59 Identities=15% Similarity=0.094 Sum_probs=52.4
Q ss_pred HHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceee
Q 007967 245 AQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVK 303 (583)
Q Consensus 245 a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~ 303 (583)
...+|+.++...++.|+..+++..+...+....+.+....+...|.+..+.+++.||++
T Consensus 5 l~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~ 63 (65)
T d1fw4a_ 5 IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQ 63 (65)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHH
T ss_pred HHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHH
Confidence 45677888999999999999999888888888888888899999999999999999964
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=87.50 E-value=0.031 Score=42.04 Aligned_cols=60 Identities=13% Similarity=0.064 Sum_probs=52.7
Q ss_pred HHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeee
Q 007967 245 AQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKS 304 (583)
Q Consensus 245 a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~a 304 (583)
++.+|+.++...++.|+..|+...+...+....+.+....+...|.+.++.+++.||+..
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~ 62 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSC 62 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHH
T ss_pred HHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHH
Confidence 456788899999999999999999888888888888888899999999999999999743
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=86.35 E-value=0.066 Score=41.12 Aligned_cols=60 Identities=15% Similarity=0.064 Sum_probs=53.7
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVK 303 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~ 303 (583)
..+.+|..++....|.|+..++...+...+....+.+....+...|.+..+.+++.||+.
T Consensus 11 el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~ 70 (77)
T d1f54a_ 11 EFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLA 70 (77)
T ss_dssp HHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHH
T ss_pred HHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHH
Confidence 345678999999999999999999998888888888888899999999999999999975
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=86.33 E-value=0.063 Score=40.92 Aligned_cols=60 Identities=13% Similarity=0.039 Sum_probs=53.9
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVK 303 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~ 303 (583)
..+.+|..++....+.|+..++...+...++...+......+...|.+..+.+++.||+.
T Consensus 9 el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~ 68 (73)
T d2pq3a1 9 EFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLT 68 (73)
T ss_dssp HHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred HHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHH
Confidence 456788999999999999999999998888888888888899999999999999999974
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=86.03 E-value=0.048 Score=42.00 Aligned_cols=60 Identities=12% Similarity=0.170 Sum_probs=53.0
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVK 303 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~ 303 (583)
..+.+|+.++....+.|+..|+...+...+......+....+...|.|..+.+++.||+.
T Consensus 10 ~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~ 69 (77)
T d1oqpa_ 10 EILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIR 69 (77)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHH
T ss_pred HHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence 456778889999999999999999998888888888888888889999999999999974
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=85.19 E-value=0.11 Score=40.61 Aligned_cols=60 Identities=15% Similarity=0.055 Sum_probs=52.4
Q ss_pred HHHHHHhcCCchh-hhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceee
Q 007967 244 AAQLALKKMPSAE-QEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVK 303 (583)
Q Consensus 244 ~a~~~~~~~~~~~-~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~ 303 (583)
..+..|..++... +|.|+..++.+.+...+....+.+.+..+...|.|..+.+++.||+.
T Consensus 16 ~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~ 76 (82)
T d1wrka1 16 EFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLV 76 (82)
T ss_dssp HHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHH
T ss_pred HHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHH
Confidence 4456788889885 69999999999999888888888888999999999999999999963
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=84.90 E-value=0.069 Score=41.08 Aligned_cols=61 Identities=10% Similarity=0.003 Sum_probs=53.6
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKS 304 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~a 304 (583)
....+|+.++...++.|+..++...+...+..+.+.+....+...|.+..+.+++.||+.-
T Consensus 10 el~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~ 70 (75)
T d1jc2a_ 10 ELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKM 70 (75)
T ss_dssp HHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHH
T ss_pred HHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHH
Confidence 3456788899999999999999999888888888888888999999999999999999753
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=84.58 E-value=0.12 Score=38.91 Aligned_cols=59 Identities=14% Similarity=0.124 Sum_probs=49.5
Q ss_pred HHHHHhcCCchhhhhcchhhhhcCccccCCC-hhhHHhhcccccCCCCccccccccceee
Q 007967 245 AQLALKKMPSAEQEAISQSEYQRGVSAWNFD-IEDLKAQASLVRDDDDMLETKEENESVK 303 (583)
Q Consensus 245 a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd-~~d~~~~~~l~~~ddd~~~~~d~~Efv~ 303 (583)
...+|+.++....+.|+..++...+...+.. ..+.+.+..+...|.|.++.+++.||+.
T Consensus 4 l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~ 63 (68)
T d1c7va_ 4 ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMD 63 (68)
T ss_dssp HHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHH
T ss_pred HHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence 4467788899999999999999888776664 5667778888899999999999999973
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=84.01 E-value=0.082 Score=41.19 Aligned_cols=61 Identities=13% Similarity=0.080 Sum_probs=50.4
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeeee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKSS 305 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~as 305 (583)
..+.+|+.++.+.++.|+..|+...+...+ .....+....+...|.|..+.+++.||+...
T Consensus 7 e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~ 67 (81)
T d2opoa1 7 DRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFA 67 (81)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 346788899999999999999998876665 4455566788889999999999999998653
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=83.50 E-value=0.089 Score=40.98 Aligned_cols=60 Identities=10% Similarity=-0.000 Sum_probs=52.2
Q ss_pred HHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeee
Q 007967 245 AQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKS 304 (583)
Q Consensus 245 a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~a 304 (583)
...+|+.++...++.|+..|+.+.+...+..+...+....+...|.+.++.+++.||+..
T Consensus 17 l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~ 76 (81)
T d1fi5a_ 17 LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEF 76 (81)
T ss_dssp HHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHH
T ss_pred HHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHH
Confidence 345788899999999999999999888888888888888888889999999999999753
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=83.31 E-value=0.09 Score=40.95 Aligned_cols=60 Identities=15% Similarity=0.043 Sum_probs=52.4
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVK 303 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~ 303 (583)
..+.+|..++...++.|+..|+...+...+.++.+.+....+...|.+..+.+++.||+.
T Consensus 15 el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~ 74 (81)
T d1avsa_ 15 EFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLV 74 (81)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHH
T ss_pred HHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHH
Confidence 355678899999999999999999888778888888888888889999999999999974
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=80.31 E-value=0.43 Score=46.06 Aligned_cols=27 Identities=33% Similarity=0.482 Sum_probs=22.1
Q ss_pred CCcccCCCCCcEEEcCCCcEEEEecCCcc
Q 007967 69 GHIHRDVKAGNILLDTNGVVKLADFGVSA 97 (583)
Q Consensus 69 gIvHRDLKPeNILld~~g~IKL~DFGlA~ 97 (583)
++||+|+.++|||++. + ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 6899999999999974 3 4589998653
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.12 E-value=0.17 Score=40.47 Aligned_cols=60 Identities=8% Similarity=-0.136 Sum_probs=47.8
Q ss_pred HHHHHHhcCCchhhhhcchhhhhcCccccCCChhhHHhhcccccCCCCccccccccceeeee
Q 007967 244 AAQLALKKMPSAEQEAISQSEYQRGVSAWNFDIEDLKAQASLVRDDDDMLETKEENESVKSS 305 (583)
Q Consensus 244 ~a~~~~~~~~~~~~~~is~~e~~~g~~~~nfd~~d~~~~~~l~~~ddd~~~~~d~~Efv~as 305 (583)
.....|+.++.+.++.++.+|+...+...+.+.+.+ ...+...|.|.+|.+++.||+.|.
T Consensus 11 ~~~~~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l--~~i~~~~D~d~dG~l~~~EF~~am 70 (95)
T d1c07a_ 11 KYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLL--AHIWSLCDTKDCGKLSKDQFALAF 70 (95)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHH--HHHHHHHCTTCSSSEETTTHHHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHH--HHHHHHhCCCCCCeEcHHHHHHHH
Confidence 345678889999999999999998887776655444 466667888899999999998664
|